covid<NUMBER> global pandemic caused infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> presented major public health challenge reasons completely understood percapita mortality covid<NUMBER> varies several orders magnitude countries <NUMBER> numerous sources heterogeneity hypothesized higher mortality observed older populations men <NUMBER> <NUMBER> patientlevel behaviors smoking might also impact <NUMBER> potentially relevant factors include economic activity environmental variation temperature <NUMBER> urban settings increased population density would expected enhance viral transmission <NUMBER> addition public health responses covid<NUMBER> pandemic may influence percapita mortality various strategies implemented ranging robust testing programs lockdown stayathome orders mandates regarding social distancing face mask usage practices theoretical benefit social distancing stayathome orders implementation mandates regarding use masks public spaces must assessed quickly implementation potential reduce morbidity mortality mask usage public postulated decrease infection blocking spread respiratory droplets <NUMBER> successfully implemented coronavirus outbreaks ie sars mers <NUMBER> context ongoing pandemic assessed impact masks percapita covid<NUMBER>related mortality controlling aforementioned factors hypothesized countries mask use either accepted cultural norm favored government policies national level percapita mortality might reduced compared remaining countries methods data <NUMBER> countries coronavirus mortality testing data available retrieved publicly available source may <NUMBER> <NUMBER> <NUMBER> archived testing data april also downloaded <NUMBER> date countrys first reported infection first death obtained european centre disease prevention control <NUMBER> mean temperature country pandemic estimated using average monthly temperature countrys largest city public sources <NUMBER> <NUMBER> online news reports searched identify countries public wore masks early outbreak based tradition well countries ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint national government mandated recommended maskwearing public april <NUMBER> <NUMBER> population <NUMBER> fraction population age <NUMBER> years age <NUMBER> male female ratio per country <NUMBER> surface area <NUMBER> gross domestic product per capita <NUMBER> percent urbanization <NUMBER> adult smoking prevalence <NUMBER> <NUMBER> <NUMBER> <NUMBER> obtained publiclyavailable databases whether nation isolated political entity island also recorded prevalence infectious process subject exponential growth decay appears linear time graphed logarithmic scale <NUMBER> therefore postulated logarithm countrywide infection prevalence would linearly related duration infection country addition analysis postulated deaths coronavirus would follow infections delay average time infection coronavirus onset symptoms <NUMBER> days <NUMBER> time symptom onset death average <NUMBER> days <NUMBER> therefore time infection death expected <NUMBER> days <NUMBER> <NUMBER> incubation mortality times prespecified <NUMBER> <NUMBER> therefore date countrys initial infection estimated earlier <NUMBER> days first reported infection <NUMBER> days first death <NUMBER> <NUMBER> <NUMBER> deaths may <NUMBER> <NUMBER> would typically reflect infections beginning <NUMBER> days previously april <NUMBER> therefore recorded time first infection country april <NUMBER> also recorded period outbreak <NUMBER> mandating activity restrictions april <NUMBER> <NUMBER> public maskwearing recommended april <NUMBER> univariate analysis characteristics countries abovemedian percapita mortality compared remaining lower mortality countries twogroup ttest odds ratio highmortality group calculated logistic regression significant predictors percapita coronavirus mortality univariate analysis analyzed stepwise backwards multivariable linear regression analysis dependent variable logarithm base <NUMBER> percapita coronavirusrelated mortality importance relative public health weeks country spent lockdown using masks percapita testing levels retained model statistical analysis performed xlstat <NUMBER> addinsoft new york alpha p value <NUMBER> deemed statistically significant study approved virginia commonwealth university office research subjects protection ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint total <NUMBER> countries reported coronavirus mortality testing data may <NUMBER> <NUMBER> <NUMBER> lowermortality countries <NUMBER> deaths per million population contrast average <NUMBER> deaths per million population <NUMBER> highermortality countries p<NUMBER> table <NUMBER> median value <NUMBER> deaths per million population assumed island nations might find less challenging isolate protect populations however <NUMBER> <NUMBER> lowmortality countries isolated islands compared <NUMBER> <NUMBER> highmortality countries country surface area population associated coronavirus mortality table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint countries older populations suffered higher coronavirus mortality countries low mortality average <NUMBER> population age <NUMBER> compared <NUMBER> highmortality countries table <NUMBER> sex ratio associated countrywide mortality p<NUMBER> table <NUMBER> smoking prevalence average <NUMBER> low mortality countries <NUMBER> highmortality countries p<NUMBER> table <NUMBER> colder countries associated higher coronavirus mortality univariate analysis mean temperature <NUMBER> c sd <NUMBER> c lowmortality countries <NUMBER> c sd <NUMBER> c highmortality countries p<NUMBER> table <NUMBER> urbanization associated coronavirus mortality lowmortality countries average <NUMBER> population urban compared <NUMBER> population highmortality countries p<NUMBER> table <NUMBER> richer countries suffered higher coronavirus related mortality mean gdp per capita <NUMBER> lowmortality countries <NUMBER> highmortality countries table <NUMBER> p<NUMBER> asian countries masks used extensively public essentially beginning outbreak <NUMBER> including thailand <NUMBER> japan <NUMBER> <NUMBER> south korea <NUMBER> <NUMBER> taiwan <NUMBER> hong kong <NUMBER> <NUMBER> <NUMBER> vietnam <NUMBER> malaysia <NUMBER> cambodia <NUMBER> <NUMBER> philippines <NUMBER> table <NUMBER> fact mongolia <NUMBER> laos <NUMBER> public began wearing masks cases confirmed countries despite fact outbreak tended appear <NUMBER> countries quite early countries experienced low percapita coronavirus mortality may <NUMBER> mean <NUMBER> per million sd <NUMBER> table <NUMBER> world health organization initially advised widespread mask wearing public united states cdc <NUMBER> <NUMBER> nonetheless western governments mandated recommended wearing masks general public march <NUMBER> masks required public venezuela beginning march <NUMBER> <NUMBER> <NUMBER> slovakia masks mandated shops transit march <NUMBER> <NUMBER> broadly public march <NUMBER> <NUMBER> masks required public czechia march <NUMBER> <NUMBER> uzbekistan march <NUMBER> <NUMBER> masks mandated indoor public spaces slovenia march <NUMBER> <NUMBER> austria mandate wear masks shops announced march <NUMBER> expectation masks would available april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> <NUMBER> manifest jan <NUMBER> <NUMBER> government initially recommended confined badly ventilated spaces <NUMBER> south korea jan <NUMBER> <NUMBER> use masks traditional <NUMBER> south korea initially trouble obtaining enough masks end february government began control distribution masks public <NUMBER> jan <NUMBER> <NUMBER> use masks traditional january <NUMBER> government limit mask exports limit sales pharmacies needed personal use <NUMBER> jan <NUMBER> <NUMBER> <NUMBER> surgical masks traditionally used also recommended public transport crowded places january <NUMBER> <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> multivariable linear regression significant predictors logarithm countrys percapita coronavirus mortality included duration infection country duration wearing masks percentage population age <NUMBER> urbanization p<NUMBER> table <NUMBER> duration infection country controlled trend time lockdown negatively associated mortality percapita testing positively associated mortality though neither association significant table <NUMBER> population wearing masks percapita mortality tended increase week factor <NUMBER> <NUMBER> <NUMBER> <NUMBER> hand population wearing masks percapita mortality tended increase week factor <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared baseline condition without masks lockdown percapita mortality increased week <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint country <NUMBER> population living urban environment another country tend suffer mortality <NUMBER> higher <NUMBER> <NUMBER> <NUMBER> country percentage population age <NUMBER> <NUMBER> higher another country tend suffer mortality <NUMBER> higher <NUMBER> <NUMBER> <NUMBER> table <NUMBER> trend towards positive association testing may <NUMBER> probably reflects greater recognition coronavirusrelated mortality testing well increased incentive countries test suffer intense outbreak noted testing positively associated mortality may <NUMBER> <NUMBER> lowmortality countries performed <NUMBER> test every <NUMBER> members population highmortality countries performed <NUMBER> test every <NUMBER> members population p<NUMBER> table <NUMBER> presumably testing performed early would better help contain outbreak april <NUMBER> earliest testing data archived lowmortality countries tested <NUMBER> <NUMBER> population compared <NUMBER> <NUMBER> highmortality countries p<NUMBER> table <NUMBER> april <NUMBER> <NUMBER> lowmortality countries tested <NUMBER> <NUMBER> population compared <NUMBER> <NUMBER> highmortality countries p<NUMBER> table <NUMBER> early testing lowers mortality one might expect negative regression coefficients testing associated less mortality however log percapita testing april <NUMBER> <NUMBER> included model table <NUMBER> also includes later testing early testing inversely related mortality coefficient <NUMBER> p<NUMBER> likewise log percapita testing april <NUMBER> <NUMBER> included model table <NUMBER> early testing still tended inversely related coronavirus mortality coefficient <NUMBER> p<NUMBER> <NUMBER> countries performed <NUMBER> test every <NUMBER> people country may <NUMBER> <NUMBER> order testing least faeroe islands iceland falkland islands uae bahrain faeroe falkland islands reported coronavirusrelated deaths remaining <NUMBER> countries percapita mortality median value highest percapita mortality among group <NUMBER> per million population <NUMBER> <NUMBER> people seen iceland ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> results confirm <NUMBER> months since appearance covid<NUMBER> late <NUMBER> remains great deal variation countries related mortality countries lower half mortality experienced average covid<NUMBER>related percapita mortality <NUMBER> deaths per million population contrast average <NUMBER> deaths per million remaining countries independent predictors mortality included urbanization fraction population age <NUMBER> years duration outbreak country period outbreak subject cultural norms government policies favoring maskwearing public results support universal wearing masks public suppress spread coronavirus <NUMBER> given low levels coronavirus mortality seen asian countries adopted widespread public mask usage early outbreak seems highly unlikely masks harmful one major limitation evidence concerning actual levels maskwearing public available countries particularly western countries recommended rather mandated maskwearing public united states practice steadily increasing change occurred overnight analysis based norms policies compared intentiontotreat analysis clinical trial much randomized controlled data effect maskwearing spread respiratory viruses relates influenza one recent metaanalysis <NUMBER> trials families students religious pilgrims found relative risk influenza use face masks <NUMBER> <NUMBER> reduction though findings statistically significant <NUMBER> combining trials <NUMBER> cases groups assigned wear masks compared <NUMBER> cases control groups <NUMBER> direct applicability results maskwearing population level uncertain instance heterogeneity methods component trials one trial assigning mask wearing person respiratory illness another close contacts remainder ill contacts <NUMBER> maskwearing inconsistent groups living together could wear mask bathing sleeping eating brushing teeth <NUMBER> <NUMBER> <NUMBER> one studies reviewed parents wore mask day night sleeping next sick child <NUMBER> different trial students asked wear mask residence hall least <NUMBER> hours daily rather time <NUMBER> bottom line nearly impossible people constantly maintain mask wear around people live contrast wearing mask public transit shopping quite feasible addition infection propagates multiple generations population benefits multiply exponentially even one accepts masks would reduce transmissions <NUMBER> <NUMBER> cycles infection maskwearing would reduce level infection population <NUMBER> compared nonmask wearing population <NUMBER> <NUMBER> <NUMBER> highly unlikely anyone ever randomize entire ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> countries populations either wear wear masks public policies formulated based best evidence available recent study demonstrated <NUMBER> patients infected sarscov<NUMBER> asked cough without cloth mask viral load nearby petri dish reduced cloth mask patients half detectable cloth mask <NUMBER> nationwide policies ban large gatherings close schools businesses tended associated lower mortality though statistically significant fashion however full accounting would consider local policies often varied within country moreover businesses schools individuals made decisions limit contact independent government policies adoption numerous public health policies time make difficult tease relative importance colder average monthly temperature associated higher levels covid<NUMBER> mortality univariate analysis accounting independent variables nonetheless environmental factors could influence either human behavior stability spread virus particles worthy study percapita testing early april <NUMBER> <NUMBER> later may <NUMBER> positively associated reported coronavirusrelated mortality seems likely countries test low level missing many cases previously identified <NUMBER> countries iceland faeroe islands uae performed <NUMBER> tests per million population april <NUMBER> <NUMBER> mortality <NUMBER> <NUMBER> point <NUMBER> may <NUMBER> could add hightesting group falkland islands bahrain <NUMBER> countries tested one tenth population <NUMBER> countries mortality <NUMBER> per million <NUMBER> <NUMBER> people less degree results would apply larger less isolated less wealthy countries unknown statistical support benefit high levels testing might demonstrated additional diverse countries able test level one limitation study ultimate source mortality data often governments may resources provide full accounting public health crises interest summary older age population urbanization longer duration outbreak country independently associated higher countrywide percapita coronavirus mortality lockdowns amount viral testing statistically significant predictors countrywide coronavirus mortality controlling variables use masks public important readily modifiable public health measure societal norms government policies supporting maskwearing public independently associated lower percapita mortality covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint currently worlds attention focused news coronavirus pandemic right difficult assess true extent pandemic since number infected people depends number tests performed number deaths coronavirus depends specifics causeofdeath registration particular country even region reason many researchers analyzing influenza epidemics analyze mortality specific cause rather mortality causes since almost impossible make mistake fact death coronavirus pandemic first pandemic human history even first pandemic last <NUMBER> years famous deadly <NUMBER> spanish flu pandemic viboud lessler <NUMBER> postwar years <NUMBER> influenza pandemic also causing significant losses among elderly usually observed regular influenza epidemics also middle ages rizzo et al <NUMBER> paper consider patterns mortality spanish flu pandemic <NUMBER> using data italy usa countries currently leading number persons infected covid<NUMBER> analysis mortality <NUMBER> adjacent years may help us better understand course scale current pandemic statistical yearbooks published shortly <NUMBER> respective countries used data source italy primarily ministro di agricultura industrie e commercio maic direzione generale della statistica dirstat maic <NUMBER> maic <NUMBER>a maic <NUMBER>b us data used vital statistics rates united states <NUMBER> edition bureau census <NUMBER> agespecific mortality rates italian population taken human mortality database human mortality database first consider trends mortality rate <NUMBER> italy usa figure <NUMBER> shows values crude death rates per <NUMBER> population calendar year italy see mortality rose sharply <NUMBER> subsequent years fell quite rapidly crude death rate prewar <NUMBER> given comparison significant war losses italy <NUMBER> <NUMBER> mortality already returned prewar values similar pattern observed mortality trends <NUMBER> united states see figure <NUMBER> case italy united states surge mortality <NUMBER> fairly rapid drop mortality <NUMBER> however well known spanish flu epidemic passed waves first cases flu recorded united states march <NUMBER> second deadly peak spanish flu observed fall <NUMBER> better understand development spanish flu epidemic <NUMBER> <NUMBER> makes sense consider changes mortality causes month monthly mortality changes <NUMBER> <NUMBER> italy shown figure <NUMBER> follows figure acute phase spanish flu epidemic observed fall <NUMBER> surge mortality october april <NUMBER> elevated mortality wave totally disappeared time spring peak spanish flu epidemic <NUMBER> practically effect total mortality figure <NUMBER> shows monthly mortality changes italy <NUMBER> follows figure spanish flu spring wave little effect total mortality almost first half <NUMBER> previous two years however increased number deaths influenza spanish flu reported italy <NUMBER> even <NUMBER> see figure <NUMBER> figure <NUMBER> shows monthly mortality changes united states figure one see slight increase mortality spring <NUMBER> looks insignificant compared peak mortality observed october case italy decrease mortality normal levels occurred april <NUMBER> figures <NUMBER> <NUMBER> show acute phase pandemic high mortality lasted one two months complete mortality decline normal levels took eight months consider agespecific mortality changes <NUMBER> case current coronavirus pandemic observed older people likely die coronavirus younger ones observation surprising analysis mortality italy <NUMBER> demonstrated older people die often regular flu epidemics rizzo et al <NUMBER> however <NUMBER> pandemic excess mortality observed older also middle ages rizzo et al <NUMBER> spanish flu pandemic <NUMBER> differs flu epidemics significant relative increase mortality middle ages figure <NUMBER> shows agespecific mortality rates italian women <NUMBER> figure italian men given due significant war losses <NUMBER> distorting agespecific mortality pattern figure <NUMBER> shows significant increase mortality ages <NUMBER> <NUMBER> years spanish flu pandemic <NUMBER> <NUMBER> increased mortality rate among middleaged women also observed age <NUMBER> mortality change time cannot say mortality older ages unaffected epidemic figure <NUMBER> shows agespecific mortality women age <NUMBER> italy <NUMBER> seen spanish flu epidemic added additional mortality increment <NUMBER> already high mortality rate old age effect spanish flu epidemic mortality also analyzed using time series mortality data method latent variables gavrilovet al <NUMBER> gavrilova gavrilov <NUMBER> aim conducted factor analysis mortality period <NUMBER> used socalled ptechnique factor analysis analysis occurs across different time points observations values hazard rates different years ages <NUMBER> <NUMBER> applied factor analysis procedure promax rotation method using stata release <NUMBER> statistical package identified two factors capable explaining almost <NUMBER> variance temporal changes hazard rates thus mortality evolution italy described following model μ x α <NUMBER> x α <NUMBER> x f <NUMBER> α <NUMBER> x f <NUMBER> x age time αx α <NUMBER> x α <NUMBER> x three sets parameters depending age f <NUMBER> f <NUMBER> two sets parameters depending time sets coefficients determined factor analysis models studying variation factors time noted first factorcomparable senescent mortality gavrilov gavrilova <NUMBER> willmoth <NUMBER> chiefly concerning «old ages» population remained remarkably stable period <NUMBER> see figure <NUMBER> second factor comparable background mortality gavrilov gavrilova <NUMBER> observed «young» population declined beginning century figure <NUMBER> shows trends background agerelated senescent mortality factors italy figure peaks background mortality noticeable <NUMBER> epidemic spanish flu <NUMBER>s world war ii figure shows italy effect spanish flu epidemic mortality even stronger effect hostilities world war ii also seen subsequent influenza epidemics noticeable impact background mortality data presented clearly demonstrate spanish flu pandemic cannot compared later flu epidemics pandemics influenza effect mortality distinctive feature <NUMBER> pandemic high percentage deaths among young middleaged people relatively low increase mortality among elderly studies shown phenomenon observed among population europe united states remote regions latin america pacific islands mortality elderly spanish flu even higher younger ages believed exposure influenza viruses childhood could protective effect elderly europe usa <NUMBER> pandemic simonsen et al <NUMBER> returning epidemic coronavirus noted certain similarity damage respiratory system produced coronavirus spanish flu virus including acute respiratory distress syndrome cilek et al <NUMBER> right preliminary estimates regarding impact coronavirus epidemic total mortality italian institute statistics instituto nazionale di statistica regularly publishes number deaths causes municipalities website wwwistatit according data period march <NUMBER> march <NUMBER> <NUMBER> <NUMBER> people died studied municipalities italy period <NUMBER> <NUMBER> people died municipalities thus number deaths studied municipalities italy march <NUMBER> doubled comparison death toll italy october <NUMBER> peak epidemic five times higher october <NUMBER> united states mortality october <NUMBER> <NUMBER> times higher october <NUMBER> data suggest coronavirus epidemic must taken seriously yet coronavirus epidemic significant differences spanish flu epidemic main difference group highest risk death coronavirus mainly elderly people burden chronic diseases although deaths healthy middleaged adults also occur mortality older ages highly seasonal mainly due seasonal influenza epidemics rosano et al <NUMBER> therefore effect coronavirus pandemic mortality better assessed studying entire set data seasonal mortality including data <NUMBER> currently insufficient one assume coronavirus epidemic likely lead parallel upward shift mortality ages <NUMBER> years semilog coordinates similar happened spanish flu epidemic ages <NUMBER> years fig <NUMBER> optimism inspired fact acute period spanish flu epidemic unusually high mortality last long one two months remembered waves epidemic continued <NUMBER> <NUMBER> impact total mortality negligible therefore hope case coronavirus pandemic acute phase heralded mortality surge last long crude death rate per <NUMBER> population calendar year italy source maic <NUMBER> <NUMBER>a <NUMBER>b popul econ author manuscript available pmc <NUMBER> july <NUMBER> crude death rate per <NUMBER> population calendar year united states source bureau census <NUMBER> gavrilova gavrilov page <NUMBER> popul econ author manuscript available pmc <NUMBER> july <NUMBER> crude death rates month per <NUMBER> population italy starting january <NUMBER> rates computed annual basis source authors estimations based maic <NUMBER> maic <NUMBER>a maic <NUMBER>b certain confined occupational regional populations substantial exposure sarscov<NUMBER> virus causes novel coronavirus disease populations provide opportunity estimate mortality might occur many members population exposed covid<NUMBER> outbreak occurring diamond princess cruise ship february <NUMBER> resulted deaths <NUMBER> passengers provided window effect virus elderly <NUMBER> united states large populations new york state city epicenter national outbreak provide opportunity estimate mortality children young adults finally may <NUMBER> <NUMBER> <NUMBER> new york metropolitan transit authority mta workers died coronavirus <NUMBER> <NUMBER> <NUMBER> population provides opportunity estimate mortality older working adults previously studied knowledge estimated publicly available sources coronavirusrelated mortality age group diamond princess cruise ship united states nationally new york city state among new york metropolitan transit authority workers <NUMBER> <NUMBER> <NUMBER> age breakdown new york citys population determined dividing covid<NUMBER> deaths mortality rates reported new york city department health <NUMBER> new york state population age breakdown obtained census <NUMBER> united states population total decade tabulated <NUMBER> <NUMBER> results among children new york city ages <NUMBER> <NUMBER> years coronavirus mortality estimated <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> tables <NUMBER> <NUMBER> nationally infants age <NUMBER> tended higher mortality <NUMBER> <NUMBER> compared children age <NUMBER> <NUMBER> <NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> larger datasets permit lower bound mortality among exposed populations determined greater certainty therefore lower bound <NUMBER> confidence interval ci ages <NUMBER> lower bound ci ny state residents age <NUMBER> listed lower bound <NUMBER> ci exposed age <NUMBER> ny state residents age <NUMBER> listed lower bound <NUMBER> ci exposed age <NUMBER> lower end ci nyc residents age <NUMBER> listed rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint new york mta <NUMBER> employees represented transport workers union <NUMBER> total <NUMBER> <NUMBER> mta workers died coronavirus may <NUMBER> <NUMBER> subways buses division <NUMBER> employees <NUMBER> <NUMBER> new york city mta workers died coronavirus whose ages could determined public sources one <NUMBER>s <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>s <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>s <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>s <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER>s <NUMBER> <NUMBER> ci <NUMBER> none younger <NUMBER> older <NUMBER> agedistribution known deaths applied <NUMBER> total deaths bus subways division estimate numbers deaths decade table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> age distribution mta employees <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> <NUMBER> distribution number <NUMBER> bus subway workers calculated age decade table <NUMBER> among new york mta workers pandemic mortality estimated <NUMBER> <NUMBER> ages <NUMBER> <NUMBER> <NUMBER> ages <NUMBER> <NUMBER> <NUMBER> ages <NUMBER> <NUMBER> <NUMBER> ages <NUMBER> tables <NUMBER> <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint age ranges passengers diamond princess cruise ship time coronavirus outbreak published table <NUMBER> <NUMBER> total <NUMBER> <NUMBER> passengers died coronavirus may <NUMBER> <NUMBER> including one woman <NUMBER>s table <NUMBER> <NUMBER> seven diamond princess passengers <NUMBER>s died covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ages <NUMBER> <NUMBER> years mortality <NUMBER> <NUMBER> <NUMBER> confidence limits <NUMBER> <NUMBER> <NUMBER> <NUMBER> tables <NUMBER> <NUMBER> lower bound mortality exposed populations <NUMBER> <NUMBER> years age comes data new york state mortality <NUMBER> <NUMBER> <NUMBER> confidence limits <NUMBER> <NUMBER> <NUMBER> <NUMBER> tables <NUMBER> <NUMBER> four diamond princess passengers <NUMBER>s died covid<NUMBER> <NUMBER> <NUMBER> mortality age group <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> tables <NUMBER> <NUMBER> lower bound mortality exposed elderly obtained data new york city observed mortality ages <NUMBER> <NUMBER> <NUMBER> <NUMBER> confidence limits <NUMBER> <NUMBER> <NUMBER> <NUMBER> tables <NUMBER> mortality age decades diamond princess might actually higher ages <NUMBER> <NUMBER> passengers died disclosed table <NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint study found mortality coronavirus among highly exposed populations heavily dependent age ranging <NUMBER> <NUMBER> age <NUMBER> <NUMBER> <NUMBER> <NUMBER>s important people especially older adults take precautions avoid infection strength study method require estimation prevalence infection case fatality ratios since consensus values yet emphasized tabulated mortality rates infection fatality rates fractions infected people die rather listed mortality rates fraction entire population died children seem low risk mortality coronavirus around <NUMBER> <NUMBER> new york city date however national data suggest infants may higher risk coronavirusrelated mortality children schools closed pandemic exposure children virus even new york likelihood less groups studied mta workers diamond princess passengers presumably schools reopen mortality among children increase still likely mortality among children remain several orders magnitude older adults mortality among young adults age <NUMBER> fairly low still important consideration individual institutional decisionmaking one new york mta worker late <NUMBER>s died coronavirus second new york transit worker mid<NUMBER>s died coronavirus though technically mta employee therefore factor analysis <NUMBER> new york state data confirms deaths workers <NUMBER>s unprecedented would useful localities national authorities could release coronavirus demographic data broken granularity instance colleges would interested data age <NUMBER> years first study mortality among new york transit workers knowledge analysis group helps characterize mortality among older working age adults first confirmed case coronavirus infection new york city reported march <NUMBER> <NUMBER> <NUMBER> mta workers forbidden wear masks gloves march <NUMBER> <NUMBER> <NUMBER> march <NUMBER> two mta workers died coronavirusthe first mta workers suffer fate <NUMBER> announcement mta would provide workers masks came march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> mta able obtain <NUMBER> n<NUMBER> masks workers <NUMBER> april <NUMBER> governor new york announced order require <NUMBER>day notification period public would required wear masks unable socially distance public transit <NUMBER> therefore delay <NUMBER> weeks presence infection city mta obtaining masks <NUMBER> weeks public required wear masks transit rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint based new york transit worker data mortality risk among exposed populations continues increase progressively <NUMBER>s <NUMBER>s sole fatality uss theodore roosevelt coronavirus outbreak occurred <NUMBER>yearold sailor <NUMBER> highlyexposed populations fraction population infected less <NUMBER> ships outbreaks board tested uss theodore roosevelt <NUMBER> <NUMBER> sailors <NUMBER> tested positive virus <NUMBER> diamond princess <NUMBER> <NUMBER> passengers <NUMBER> tested positive coronavirus half symptomatic <NUMBER> among new york mta workers group universally tested <NUMBER> workers <NUMBER> either tested positive <NUMBER> entered quarantine <NUMBER> workers <NUMBER> populations known tested negative false negatives tested wrong time less exposure fellow passengers workers less susceptible infection study number limitations diamond princess passengers mta workers exposed virus observed mortality underestimates potential mortality also might differences diamond princess population mta workers population large mta workers mostly minorities one could argue suffered excess mortality preexisting medical conditions hand many disabled excluded working travelling sea study estimate mortality among nursing home patients substantially higher general population rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint scientific information isi web science trends prevalence mortality due infection outbreaks results show rising trends transmission prevalence mortality rate due coronavirus covid<NUMBER> period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> infected <NUMBER> people worldwide resulting <NUMBER> deaths mortality rate <NUMBER> infections frequent among male gender <NUMBER> years age mean growth rate index total number cases january <NUMBER> march <NUMBER> <NUMBER> <NUMBER> growth rate index mortality rate <NUMBER> positive association prevalence mortality rate r <NUMBER> <NUMBER> novel coronavirus covid<NUMBER> highly contagious affected large number people worldwide still spreading mutable prevalence mortality outbreak trends global health officials taken priority measures prevent outbreaks emerging pathogen across globe however rising number cases mortality risk estimates demonstrating enhanced public health mediations good hygienic conditions social distancing movement limitations may control covid<NUMBER> epidemics key words biological trends coronavirus covid<NUMBER> <NUMBER>ncov prevalence outbreak viral infections frequent infectious diseases common triggers constituting major health socioeconomic harms meo et al <NUMBER> late december <NUMBER> earlier named novel coronavirus <NUMBER>ncov currently named coronavirus covid<NUMBER> emerged wuhan china resulted challenging outbreaks many regions china expanding globally human infections coronavirus covid<NUMBER> raised great public health apprehension globally third millennium three major threatening infectious diseases outbreaks happened following outbreak sarscov <NUMBER> zhong et al <NUMBER> merscov <NUMBER> novel coronavirus covid<NUMBER> emerged globally threatened entire world coronaviruses zoonotic infections transmitted animal animal animal human human human li et al <NUMBER> world health organization <NUMBER> covid<NUMBER> first appeared last week december <NUMBER> infection cases originated bats snakes seafood among people living visiting wuhan china humantohuman transmission also confirmed world health organization <NUMBER> wang et al <NUMBER> callaway cyranoski <NUMBER> biological epidemiological trends prevalence mortality rate changing daily initially china bears large burden diseases whereas incidence gradually increasing countries mainly europe united states america despite recent efforts understand novel coronavirus covid<NUMBER> science community researchers general population would like information current biological epidemiological situations study aimed investigating mutable biological epidemiological trends prevalence mortality outbreaks coronavirus covid<NUMBER> infections study conducted department physiology college medicine king saud university riyadh saudi arabia obtained data biological epidemiological trends global number confirmed cases number deaths due coronavirus covid<NUMBER> infections around world data obtained world health organization centers disease control prevention cdc reports various countries allied ministries also obtained data search engines including worldometercoronavirus moreover also reviewed literature published institute scientific information isi web knowledge thomson reuters pubmed medline appropriate findings recorded assessed growth factor factor quantity multiplies time daily cases divided cases previous day growth factor <NUMBER> indicates increasing pattern whereas values <NUMBER> show decline pattern worldometercoronavirus study information biological epidemiological trends global prevalence mortality due novel coronavirus covid<NUMBER> infections obtained world health organization worldometercoronavirus centers disease control prevention reports various countries allied ministries hence ethical approval required data recorded analyzed results expressed numbers percentages regression analysis performed pvalue <NUMBER> considered significant results established available information time publication originating mentioned sources data interpreted carefulness however outbreak evolving rapidly swift change numbers global number cases number deaths due novel coronavirus covid<NUMBER> infection presented table table <NUMBER> contents covid<NUMBER> highly effected various countries including united states america italy france spain germany switzerland iran figure <NUMBER> however highest mortality rate found italy spain united kingdom france iran figure <NUMBER> outbreak novel coronavirus covid<NUMBER> started december <NUMBER> <NUMBER> results shows rising trends transmission prevalence mortality rate due coronavirus covid<NUMBER> study also analyzed daily cases death growth factors coronavirus covid<NUMBER> identified january <NUMBER> march <NUMBER> <NUMBER> growth factor number cases worldwide <NUMBER> <NUMBER> mean <NUMBER> growth factor death rates <NUMBER> <NUMBER> mean <NUMBER> positive association prevalence mortality rate r <NUMBER> <NUMBER> showed mutable change daily case growth factor mortality rate figure <NUMBER> coronavirus infection emerging global health concern infected significant portion worlds population study investigated biological epidemiological trends prevalence mortality due outbreaks novel coronavirus covid<NUMBER> infection covid<NUMBER> infection expanding <NUMBER> countries territories infected <NUMBER> people caused <NUMBER> <NUMBER> deaths period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> table coronavirus covid<NUMBER> infection rapidly transmitted disease still spreading phase predictions infection expand one people globally derived estimates ongoing covid<NUMBER> epidemic found still mean growth factor number cases mortality rate <NUMBER> highly contagious biological characteristics meo et al <NUMBER> zoonotic disease persontoperson transmission droplet contact transmission wu et al <NUMBER> infected people transmit disease present clinical symptoms rothe et al <NUMBER> main reason disease could swiftly spread wuhan china various corners globe recently epicenter diseases appears shifted wuhan china european world mainly italy united states america world health organization <NUMBER> many countries including china italy saudi arabia new zealand poland ireland denmark spain france cancelled international flights implemented worlds largest restrictive quarantines policies minimize transmission disease burden prevention spread disease countries permitting people enter leave country without strict screening passenger covid<NUMBER> infection airports quilty et al <NUMBER> evaluated usefulness thermal passenger screening covid<NUMBER> infection airports exit entry points authors found effectiveness entry screening dependent effectiveness exit screening destination authors identified <NUMBER> infected travelers detected incubation period asymptomatic subclinical cases chan et al <NUMBER> quilty et al <NUMBER> also reported airport screening unlikely detect sufficient proportion covid<NUMBER> infected travelers screening intended barrier preventing infected people entering country however evidence effectiveness remains limited reasons health officials still unable control spread contagious disease transmission disease closely linked asymptomatic infected people visiting countries covid<NUMBER> pandemic figure <NUMBER> disease still spreading mutable prevalence mortality outbreak trends epidemiological trends show novel coronavirus covid<NUMBER> highly contagious affected <NUMBER> people mortality rate <NUMBER> number cases proportional number deaths great fluctuation biological epidemiological trends growth factor number cases mortality rates global health officials taken high priority measures prevent outbreaks emerging pathogen across globe still coronavirus covid<NUMBER> swiftly spreading mutable biological trends rising number cases mortality risk estimates demonstrating dire need enhanced public health mediations good hygienic conditions social distancing movement limitations control covid<NUMBER> epidemics researchers supporting project number rsp<NUMBER> king saud university riyadh saudi arabia authors declare conflict interests callaway e cyranoski <NUMBER> microbial agents commonly lead childhood infections viruses developed countries infants preschool children viral infection <NUMBER> times year schoolage children adolescents <NUMBER> times year <NUMBER> study published american centers disease control prevention <NUMBER> pathogens detected <NUMBER> <NUMBER> pneumonia cases patients aged day <NUMBER> years <NUMBER> pathogens viruses <NUMBER> <NUMBER> viruses may cause several clinical conditions require hospitalization picu bronchiolitis pneumonia chronic lung diseases severe manifestations myocarditis encephalitis sepsis besides known agents recently new generation viruses including human metapneumovirus hmpv coronavirus bocavirus also lead cause manifestations <NUMBER> <NUMBER> study aimed bring clinical characteristics patients viral infections requiring picu admission winter season turkey initially descriptive properties variables mean median number percentage found numerical variables checked normal distribution student test used normally distributed numerical variables mannwhitney u test used variables normal distribution two groups compared comparison numerical values multiple groups anova used variables normal distribution kruskal vallis test used variables normal distribution comparison categorical variables carried chisquare test fisher exact test effective presenting finding mortality revealed regression analysis multivariate regression analysis performed determining mortality risk factor critical ph pco <NUMBER> value found roc curve roc analysis performed evaluate relationship blood ph mortality pvalue <NUMBER> considered significant results evaluated using statistical package social sciences spss <NUMBER> chicago usa program data <NUMBER> patients severe viral infections followed picu <NUMBER> centers turkey <NUMBER> patients <NUMBER> <NUMBER> girls <NUMBER> <NUMBER> boys mortality rate <NUMBER> <NUMBER> mean prism score <NUMBER>±<NUMBER> patients died <NUMBER>±<NUMBER> patients discharged p <NUMBER> median age patients <NUMBER> months fortyseven percent patients one year age <NUMBER> patients one year age mortality rate <NUMBER> <NUMBER> age groups respectively p <NUMBER> seen <NUMBER> patients admitted emergency department <NUMBER> admitted inpatient service hospital <NUMBER> patients accepted inpatient emergency services hospitals mean duration symptoms admission hospital <NUMBER>±<NUMBER> days duration stay picu one day <NUMBER> days hospital duration two days <NUMBER> days symptoms cough <NUMBER> fever <NUMBER> nasal discharge <NUMBER> gastrointestinal symptoms <NUMBER> neurological symptoms seizures changes consciousness <NUMBER> rash <NUMBER> patients hypoxia found <NUMBER> tachypnea <NUMBER> fever <NUMBER> tachycardia <NUMBER> hypotension <NUMBER> patients physical examinations revealed respiratory findings <NUMBER> prolonged capillary filling <NUMBER> neurological findings <NUMBER> gastrointestinal system findings <NUMBER> patients indication picu admission respiratory dysfunction <NUMBER> circulatory dysfunction <NUMBER> neurologic dysfunction <NUMBER> mods <NUMBER> patients time admission followup respiratory failure observed <NUMBER> cardiovascular failure <NUMBER> hematological failure <NUMBER> renal failure <NUMBER> hepatic failure <NUMBER> patients regression analysis mods found predictor mortality odds ratio <NUMBER> confidence interval ci <NUMBER> p <NUMBER> anemia found <NUMBER> leukocytosis <NUMBER> leukopenia <NUMBER> thrombocytosis <NUMBER> thrombocytopenia <NUMBER> prolonged inr <NUMBER> electrolyte imbalance <NUMBER> patients acidosis found <NUMBER> alkalosis <NUMBER> high pco <NUMBER> <NUMBER> elevated lactate <NUMBER> patients mean lactate value <NUMBER>±<NUMBER> patients died <NUMBER>±<NUMBER> patients discharged p <NUMBER> regression analysis acidosis found predictor mortality odds ratio <NUMBER> ci <NUMBER> p <NUMBER> found ph ≤<NUMBER> negatively affected survival specificity <NUMBER> sensitivity <NUMBER> pco <NUMBER> ≥<NUMBER> mm hg also shown negative effect survival specificity <NUMBER> sensitivity <NUMBER> clinical laboratory findings time admission patients associated mortality shown table <NUMBER> agerelated discriminating factors shown table <NUMBER> anteriorposterior chest radiograph revealed positive findings <NUMBER> patients infiltration <NUMBER> atelectasis <NUMBER> pleural effusion <NUMBER> pneumothorax <NUMBER> statistically significant difference found patients died discharged terms chest radiograph findings <NUMBER> patients underlying disease neurologic <NUMBER> respiratory <NUMBER> cardiovascular <NUMBER> immunological <NUMBER> hematologicaloncological <NUMBER> renal <NUMBER> others metabolic disease chromosomal anomalies <NUMBER> sixty percent patients died underlying disease rate <NUMBER> discharged patients p <NUMBER> total number viruses detected nasal swabs patients hospitalized picu number viruses multiple reproductions included excluded patients died mortality rates viruses evaluated shown table <NUMBER> multiple viruses detected <NUMBER> patients multiple viruses isolated <NUMBER> patients died <NUMBER> discharged patients p <NUMBER> patients detected singlevirus infection statistically difference species virus patients survived patients died p <NUMBER> viruses evaluated among patients multiple viruses excluded <NUMBER> patients coronavirus found died table <NUMBER> median age patients influenza <NUMBER> <NUMBER> months median age patients viruses influenza <NUMBER> <NUMBER> months p <NUMBER> median prism score <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> median pelod score <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients influenza median prism score <NUMBER> <NUMBER> median pelod score <NUMBER> <NUMBER> patients viruses influenza p <NUMBER> relationships indication picu admission organ failures time admission revealed followup species viruses isolated shown table <NUMBER> among <NUMBER> patients received antiviral therapy <NUMBER> antibiotic therapy <NUMBER> antifungal therapy <NUMBER> patients died <NUMBER> patients discharged received antiviral therapy p <NUMBER> median duration stay mv <NUMBER> <NUMBER> days median duration stay picu <NUMBER> <NUMBER> median duration hospital <NUMBER> <NUMBER> days patients received antiviral therapy median duration stay mv <NUMBER> <NUMBER> days median duration stay picu <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> median duration hospital <NUMBER> days patients receive antiviral therapy p <NUMBER> found virus species affect mortality patients received receive antiviral therapy table <NUMBER> <NUMBER> patients required respiratory support treatments renal replacement therapy performed <NUMBER> plasma exchange <NUMBER> ecmo <NUMBER> patients viral respiratory tract infections common infections worldwide important cause mortality age groups particularly children <NUMBER> retrospective observational study conducted order analyze course seasonal viral infections respiratory tract patients hospitalized picus <NUMBER> centers representing whole country bunch studies literature investigating relationship viruses morbidity comparison singlemultiple viruses relationship diseases viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current study multidirectional comprehensively analyzed issues large population requiring picu viral respiratory tract infections constitute significant proportion patients admitted picus winter patients require advanced intensive care support high mortality morbidity rates line study group shows high mortality rate <NUMBER> supports justification multicenter survey although respiratory tract viruses commonly cause lower respiratory tract infections presentation extrapulmonary clinical manifestations also likely children one year age <NUMBER> <NUMBER> similarly common cause hospitalization respiratory symptoms study fever neurological symptoms circulatory disorders shock common indications hospitalization patients one year compared older children table <NUMBER> patients one year age presenting respiratory symptoms hypoxia well need mv common attributed situation rsv frequently observed age group literature rsv prevalent infancy picu admission though influenza bocavirus common patients less one year age <NUMBER> <NUMBER> <NUMBER> statistically evaluated initial symptoms clinical laboratory radiological virus species four parameters duration stay mechanical ventilation mv duration stay picu duration hospitalization mortality accordingly assessed relationship among presenting symptoms virus species severity disease observed presenting symptoms effect mortality neurologic symptoms hypotension tachycardia hypoxia also found liver renal function test abnormalities higher lactate values related death eightyseven percent mortalities presented acidosis table <NUMBER> critical ph value related mortality critical pco <NUMBER> ≤<NUMBER> ≥<NUMBER> mm hg respectively regression analysis acidosis alone found increase mortality <NUMBER> folds light findings predicted patients neurological symptoms tachycardia hypotension low levels pulse <NUMBER> acidosis impaired liver renal function time admission higher morbidity mortality kumar et al showed organ failure patients hospitalized icu h<NUMBER>n<NUMBER> infection increased mortality <NUMBER> also kendirli et al demonstrated correlation organ failures mortality patients presented h<NUMBER>n<NUMBER> infection <NUMBER> similarly study mortality rates higher regression analysis demonstrated initial presentation mods increased mortality <NUMBER>folds study shown rsv common agent patients needed intensive care <NUMBER> definitely compatible findings spaeder fackler reported virus species affect durations stay picu hospital well development mods mortality <NUMBER> study also investigated virus species organ failure relationship emerging indications picu admission demonstrated correlation virus species diagnosis admission picu type organ failure developed table <NUMBER> however <NUMBER> patients died <NUMBER> winter season rsv parainfluenza influenza secondary bacterial agent observed half patients died easy blame viral agents leading causes mortality frequent accompaniment secondary bacterial agents similar literature found secondary bacterial infections negatively affected mortality <NUMBER> <NUMBER> <NUMBER> present study multiple viruses detected <NUMBER> patients although also contrary opinions <NUMBER> <NUMBER> <NUMBER> detection multiple viruses affect mortality duration stay picu <NUMBER> <NUMBER> <NUMBER> similarly showed multiple viruses affect mortality multiple virus isolated patients excluded coronavirus revealed lethal virus three eight patients coronavirus died table <NUMBER> coronavirus known primary agent upper respiratory tract infection common cold <NUMBER> coronavirus defined causal agent sars severe acute respiratory syndrome severely progresses adults disease lasts shorter shows milder progression children <NUMBER> unlike literature coronavirus presented severe symptoms organ failures group patients table <NUMBER> lower respiratory tract infections caused coronavirus types sars rare studies found incidence pneumonia bronchitis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore study incidence coronavirus low consistent literature unlike coronavirus caused lower respiratory tract infections emerged lethal viral agent table <NUMBER> however <NUMBER> patients coronavirus secondary bacterial infections coronavirus solely responsible mortality although secondary infections found <NUMBER> patients found <NUMBER> patients presented viral infections received antibiotics sixtytwo percent patients received antiviral treatment oseltamivir antiviral therapy started nasal swab results patients severe infection findings found antiviral therapy affect mortality table <NUMBER> including influenza subgroup though studies literature showing oseltamivir initiated early period effective <NUMBER> <NUMBER> <NUMBER> however weakness study data gathered capable differentiating initiation timing antiviral therapy studies needed issue influenza already known agent benefits oseltamivir separately evaluated influenza subgroup found median patient age <NUMBER> months higher prism pelod scores compared rest viral agents influenza common older children progressed severely therefore oseltamivir preferred children especially one year age presented severe symptoms likely influenza consistent literature comorbidities common present study <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although <NUMBER> patients died underlying disease statistical correlation lacking described literature <NUMBER> <NUMBER> study found mechanical respiratory support administered majority patients renal replacement therapy applied group organ failure progression expected found prism pelod scores higher patients died found tachycardia hypotension hypoxia acidosis impaired liver renal tests mods time admission factors associated mortality predictors severely progressing disease found acidosis increased mortality <NUMBER>folds mods <NUMBER>folds respiratory symptoms common besides respiratory symptoms incidence circulatory disorders shock findings also high patients less one year age fever tachycardia neurologic symptoms incidence anemia leukocytosis thrombocytopenia impaired renal tests electrolyte imbalance high patients less one year age consequently acidosis mods time admission patient less one year age symptoms mentioned alert clinicians possible poor prognosis although could show relationship virus type severity mortality rsv parainfluenza influenza commonly isolated viruses patients died coronavirus found lethal virus although coronavirus known primary agent upper respiratory tract infection common cold result study attributed incidence secondary bacterial infections high patients coronavirus detected context studies needed investigate relationship coronavirus mortality study could demonstrate effects oseltamivir mortality duration hospitalization stay picu including influenza subgroup studies reporting oseltamivir initiated within first <NUMBER> hours beneficial therefore oseltamivir preferred children present severe symptoms likely influenza methods performed systematic review metaanalysis using five <NUMBER> databases compare predictors death covid<NUMBER> sars mers <NUMBER> randomeffects model metaanalysis calculated odds ratios <NUMBER> <NUMBER> confidence intervals <NUMBER> ci results <NUMBER> articles <NUMBER> retrieved <NUMBER> studies <NUMBER> included metaanalysis results showed males higher <NUMBER> likelihood death females <NUMBER> <NUMBER> ci <NUMBER> age <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> diabetes comorbidity <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> chronic lung disease <NUMBER> <NUMBER> ci <NUMBER> hypertension authors declare conflict interest related work new coronavirus sarscov<NUMBER> pandemic early <NUMBER> poses enormous challenge global public health coronavirus disease <NUMBER> covid<NUMBER> caused virus spread rapidly throughout world taking thousands lives <NUMBER> months critical refine incidence mortality risks covid<NUMBER> effective management general public patients outbreak report investigate incidence mortality risks infection analyzing age composition <NUMBER> infected patients <NUMBER> fatal cases <NUMBER> individuals general public china results show relatively low incidence risk young people high mortality risk seniors notably mortality risk could high <NUMBER> people older <NUMBER> years furthermore study suggests good medical service effectively reduce mortality rate viral infection <NUMBER> less agedependent risks incidence mortality covid<NUMBER> hubei province parts china january <NUMBER> <NUMBER> new pathogenic virus causing pneumonia identified sample bronchoalveolar lavage fluid patient wuhan hubei province china pathogen typical features coronavirus family therefore classified subgenus sarbecovirus orthocoronavirinae subfamily <NUMBER> <NUMBER> virus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease causes named coronavirus disease <NUMBER> third epidemic coronavirus emerged human population twentyfirst century following severe acute respiratory syndrome coronavirus sars outbreak <NUMBER> middle east respiratory syndrome coronavirus mers outbreak <NUMBER> <NUMBER> <NUMBER> coronavirus one main causes human respiratory disease owing frequent crossspecies infections emerging virus rapidly became challenge global public health due spreading humantohuman transmission majority earliest covid<NUMBER> patients linked huanan seafood wholesale market however humantohuman transmission frequently occurred epidemic gradually growing <NUMBER> march <NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed cases reported china internationally <NUMBER> cases reported <NUMBER> countries <NUMBER> <NUMBER> number infected individuals far surpassing sars mers sarscov<NUMBER> cause severe even fatal respiratory diseases acute respiratory distress syndrome reported sarscov<NUMBER> likely affect older males comorbidities suggesting age comorbidity may risk factors poor outcomes <NUMBER> <NUMBER> china reported death rate approached <NUMBER> total number covid<NUMBER> patients february <NUMBER> present information regarding prevalence casefatality clinical features epidemiology covid<NUMBER> remains scarce however relatively accurate evaluation incidence mortality required help refine risk assessment ensure public patients managed effective way therefore necessary quantitatively evaluate risks individual groups different ages genders paper report initial analysis public data local authorities study shows incidence risk covid<NUMBER> might low <NUMBER> children could <NUMBER> <NUMBER>yearold adults results also suggest mortality risk might <NUMBER> patients older <NUMBER> years notably mortality risk significantly different patients hubei province parts china basic information covid<NUMBER> cases released official websites national health commission china local branches collected data total <NUMBER> identified cases published february <NUMBER> based completeness data involved <NUMBER> cases study <NUMBER> covid<NUMBER> cases residents outside hubei province total <NUMBER> fatal cases included analysis among <NUMBER> fatal cases <NUMBER> cases reported residents hubei province <NUMBER> cases reported residents parts china epidemiological characteristics age gender location carefully checked remove missing values duplicated records composition age general public obtained data <NUMBER> individuals general census china <NUMBER> <NUMBER> census data collected whole country including <NUMBER> provinces autonomous regions municipalities directly central government ethical approval study written informed consent participants study required accordance local legislation national guidelines estimated incidence risk covid<NUMBER> different age groups general public maximum likelihood approach approach given age composition general public incidence risk different age groups age composition covid<NUMBER> cases obtained p incidece age incidence risk age group p age proportion age group general public assumed incidence risk different age groups could obtained logistic function age likelihood observation age composition <NUMBER> covid<NUMBER> cases maximized searching optimized µ γ consequently incidence risk achieved maximum likelihood approach risk given logistic function age estimated parameters µ γ assess mortality risk covid<NUMBER> general public used maximum likelihood approach similar mentioned obtained age composition fatal cases covid<NUMBER> p age infection mortality p mortality infection age p age infection p mortality age infection p mortality infection age risk mortality condition individuals age infection state p age infection mortality age composition fatal cases covid<NUMBER> study assumed infection happens age groups general public therefore p age infection p age applied maximum likelihood approach obtain mortality risk covid<NUMBER> different age groups general public p mortality infection age maximum likelihood approach mortality risk given aforementioned logistic function age mortalityspecific µ γ eliminate concern high mortality risk older people may inflate mortality rate infected population imputed mortality rate infected people p mortality infection p mortality age infection public data total <NUMBER> identified covid<NUMBER> cases included analysis <NUMBER> <NUMBER> males <NUMBER> <NUMBER> females covid<NUMBER> cases male female ratio turned roughly equal across age groups age covid<NUMBER> patients ranged <NUMBER> <NUMBER> years mean <NUMBER> years age gender composition covid<NUMBER> patients public reference presented table <NUMBER> compared general public covid<NUMBER> cases higher average age higher proportion people aged <NUMBER> years collected detailed information <NUMBER> fatal cases plotted age composition cases general public figure <NUMBER> evident death occurs frequently older based age composition <NUMBER> covid<NUMBER> cases <NUMBER> individuals general public estimated incidence risk maximum likelihood approach results show disease occur age groups significant difference males females figure <NUMBER> difference incidence risk different genders observed groups <NUMBER> <NUMBER> years old age <NUMBER> years males slightly higher incidence risk women increase negligible people <NUMBER> years old result support previous report sarscov<NUMBER> generally affects males females epidemic <NUMBER> incidence risk low children teenagers rapidly increases adults adults <NUMBER> years age risk higher <NUMBER> full exposure virus assessment mortality risk significantly higher mortality risk older adults figure <NUMBER>a estimated fatal probability <NUMBER> individuals <NUMBER> years <NUMBER> people older <NUMBER> years calculated risk much higher previous reports stated result consistent earlier studies supporting hypothesis older age associated increased risk mortality covid<NUMBER> patients analysis total <NUMBER> fatal cases suggests mortality rate <NUMBER> general infection however noticed mortality rate covid<NUMBER> reports significantly different identified cases hubei province parts china <NUMBER> compare mortality risk hubei provinces china divided <NUMBER> fatal cases two subsets <NUMBER> cases hubei province <NUMBER> cases parts china aforementioned statistical analysis mortality risk applied two subsets nine different age groups account variability obtained standard deviation estimates applying method <NUMBER> simulated data sets generated initial estimation results show mortality risk <NUMBER> ± <NUMBER> people <NUMBER> years outside hubei province risk high <NUMBER> ± <NUMBER> corresponding age group hubei province figure <NUMBER>b mortality risk falls <NUMBER> people younger <NUMBER> years parts china people <NUMBER> years risk <NUMBER> hubei province also calculated expectation mortality rates general infection inside outside hubei province <NUMBER> <NUMBER> respectively results suggest significantly higher mortality risk covid<NUMBER> seniors given previous report <NUMBER> probably due published report accounting increasing death rate identified covid<NUMBER> cases previous study crude mortality rate <NUMBER> rate <NUMBER> march <NUMBER> <NUMBER> <NUMBER> deaths among <NUMBER> identified covid<NUMBER> cases march <NUMBER> <NUMBER> still <NUMBER> covid<NUMBER> patients critical condition china reported survival probability critically ill patients continuously decreased increase time since admission intensive care unit <NUMBER> analysis based composition age different populations therefore less affected disease progression patients especially increasing death rate critically ill patients age reported independent predictor adverse outcome sars mers comorbidities low immune function older people might major cause higher mortality coronaviruses <NUMBER> <NUMBER> <NUMBER> prompt administration antibiotics prevent infection strengthening immune support treatment might reduce mortality seniors <NUMBER> data showed mortality rate covid<NUMBER> five times higher hubei province parts china result supported early publication stated estimated case fatality rate mainland china excluding hubei <NUMBER> far less hubei province excluding city wuhan <NUMBER> wuhan city <NUMBER> <NUMBER> one hand difference may partially explained insufficient medical resources due large number patients hubei province outbreak according <NUMBER> annual brief report health service development wuhan city <NUMBER> hospital beds per <NUMBER> people however hospital bed utilization ratio <NUMBER> <NUMBER> reached <NUMBER> <NUMBER> respectively <NUMBER> shown even normal circumstances spare beds hand detailed information majority fatal cases <NUMBER> <NUMBER> total hubei province published january <NUMBER> <NUMBER> mortality rate early reported cases may overstated case detection highly biased toward severe cases however strongly suggest international authorities try best immediately prevent covid<NUMBER> patients overloading health care system hypothesis smoothrunning health care system effectively reduce mortality rate covid<NUMBER> strongly supported low mortality rate parts china conclusion investigated incidence mortality risks infection analyzing age composition covid<NUMBER> patients general public china data show relatively low incidence risk young people high mortality risk older adults therefore prudent strengthen tertiary preventive clinical care oldaged patients reduce mortality furthermore results also support conclusion good medical service effectively reduce mortality rate viral infection <NUMBER> less study could value medical authorities implement effective medical service lack complete data covid<NUMBER> cases potentially increases occurrence selection measurement biases study therefore largescale epidemiological studies necessary elucidate risk factors covid<NUMBER> general public datasets generated study available upon request ethical review approval required study human participants accordance local legislation institutional requirements written informed consent participants legal guardiannext kin required participate study accordance national legislation institutional requirements coronaviridae represent important family animal human viruses <NUMBER> <NUMBER> permanent circulation four common human coronaviruses hku<NUMBER> nl<NUMBER> oc<NUMBER> e<NUMBER> cause <NUMBER> respiratory infections worldwide present continents <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> mortality poorly assessed clear chronic carriers well asymptomatic carriers studies shown many asymptomatic carriers symptomatic patients <NUMBER> <NUMBER> three epidemic episodes emerging coronaviruses reported first severe acute respiratory syndrome sars coronavirus little impact global morbidity mortality <NUMBER> <NUMBER> <NUMBER> recognized cases <NUMBER> deaths <NUMBER> <NUMBER> second middle east respiratory syndrome merscoronavirus remained localized saudi arabia small epidemic mainly nosocomial infections south korea <NUMBER> merscoronavirus like sarscoronavirus highlighted major danger nosocomial transmission healthcare personnel health essential epidemics <NUMBER> finally sarscov<NUMBER> novel coronavirus appeared december <NUMBER> expanded affected <NUMBER> <NUMBER> <NUMBER> <NUMBER> people worldwide <NUMBER> <NUMBER> <NUMBER> time writing significant number cases occurred far east incontestably contagious quasiexperimental study diamond princess cruise ship showed confinement infected patients uninfected patients resulted rapid infection uninfected patients leading <NUMBER> additional cases board <NUMBER> however coronaviruses common circulation remain predominant global distribution nonnegligible mortality <NUMBER> <NUMBER> aim study share experience reference laboratory representing approximately <NUMBER> serious diagnosed respiratory infections particularly seasonal france allow evaluation relative mortality different human coronaviruses presented hospitals marseille compared sarscov<NUMBER> assistance publiquehôpitaux de marseille aphm covers public hospitals marseille including four university hospitals la timone hospital conception hospital north hospital south hospital corresponds <NUMBER> beds <NUMBER> <NUMBER> admissions year <NUMBER> ihu méditerranée infection diagnostic laboratory tests samples aphm respiratory viruses suspected molecular biology used diagnosis results monitored weekly automated surveillance system diagnostic laboratory coupled laboratory informa <NUMBER> guangzou china <NUMBER> <NUMBER> <NUMBER> <NUMBER> zeng <NUMBER> guangzou china <NUMBER> <NUMBER> <NUMBER> <NUMBER> killerby <NUMBER> usa <NUMBER> <NUMBER> <NUMBER> kiyuka <NUMBER> kenya <NUMBER> <NUMBER> owusu <NUMBER> ghana <NUMBER> cases <NUMBER> dube <NUMBER> south africa <NUMBER> controls <NUMBER> tuberculosis <NUMBER> <NUMBER> <NUMBER> sipulwa <NUMBER> kenya <NUMBER> <NUMBER> subramoney <NUMBER> south africa <NUMBER> <NUMBER> nunes <NUMBER> south africa <NUMBER> <NUMBER> leviet <NUMBER> vietnam <NUMBER> <NUMBER> <NUMBER> tion system nexlabs <NUMBER> sarscov<NUMBER> epidemiological data obtained online platform gathering data public agencies <NUMBER> statistical analyses performed using biostatgv software <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> deaths france <NUMBER> deaths occurred care establishment <NUMBER> year aphm reported <NUMBER> deaths estimated approximately <NUMBER> deaths care establishments france occurred aphm hospitals estimate provides approximation number people affected pathogen france according number people died year aphm hospitals <NUMBER> january <NUMBER> <NUMBER> december <NUMBER> <NUMBER> <NUMBER> samples tested ihu méditerranée infection diagnostic laboratory among <NUMBER> samples positive coronavirus eight deaths mortality rate <NUMBER> among identified coronaviruses <NUMBER> identified hku<NUMBER> one death mortality rate <NUMBER> <NUMBER> identified nl<NUMBER> two deaths mortality rate <NUMBER> <NUMBER> identified e<NUMBER> one death mortality rate <NUMBER> <NUMBER> identified oc<NUMBER> four deaths mortality rate <NUMBER> three hundred eightyone coronaviruses diagnosed <NUMBER> assigned four strains table <NUMBER> systematic testing molecular biology sarscov<NUMBER> performed <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> total <NUMBER> samples patients presenting infectious symptoms tested ihu méditerranée infection diagnostic laboratory among <NUMBER> samples positive coronaviruses two deaths mortality rate <NUMBER> <NUMBER> samples hku<NUMBER> <NUMBER> samples nl<NUMBER> <NUMBER> samples oc<NUMBER> <NUMBER> samples <NUMBER>e cases sarscov<NUMBER> identified among sam ples two deaths one patient oc<NUMBER> mortality rate <NUMBER> one patient hku<NUMBER> mortality rate <NUMBER> deaths nl<NUMBER> e<NUMBER> period period ihu méditerranée infection regional centre detection novel coronavirus sarscov<NUMBER> time writing <NUMBER> analyses performed suspected cases since emergence novel pathogen four cases sarscov<NUMBER> identified addition <NUMBER> french nationals returning hubei province tested twice negative sarscov<NUMBER> <NUMBER> march <NUMBER> total <NUMBER> <NUMBER> patients tested positive sarscov<NUMBER> worldwide <NUMBER> deaths mortality rate <NUMBER> among organisation economic cooperation development oecd countries <NUMBER> patients tested positive sarscov<NUMBER> <NUMBER> deaths mortality rate <NUMBER> table <NUMBER> france <NUMBER> people tested positive sarscov<NUMBER> three deaths mortality rate <NUMBER> study compared mortality rate sarscov<NUMBER> oecd countries <NUMBER> mortality rate common coronaviruses identified aphm patients <NUMBER> <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> chisquared test performed p value <NUMBER> significant study found mortality rate common coronavirus infections <NUMBER> france comparison mortality rate sarscov<NUMBER> european american developed countries comparable economic level <NUMBER> table <NUMBER> extrapolation deaths aphm hospitals correct metropolitan france would represent <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases patients hospitalized respiratory infection common coronaviruses <NUMBER> months almost many cases sarscov<NUMBER> worldwide fact mortality respiratory infections extremely dependent quality care access care <NUMBER> little chance emergence sarscov<NUMBER> could change statistic significantly fear could larger impact virus case suicide motivated fear sarscov<NUMBER> reported india <NUMBER> addition coronaviruses rarely tested systematically around world may persist pharynx asymptomatic people representing potential source population immunity <NUMBER> furthermore noted systematic studies coronaviruses yet sarscov<NUMBER> found percentage asymptomatic carriers equal even higher percentage symptomatic patients data sarscov<NUMBER> may soon available reduce relative risk associated specific pathology funding work supported french government investments future programme managed national agency research méditerranéeinfection <NUMBER>iahu<NUMBER> ethical approval applicable testing repatriates approved ethical board committee protection persons cpp ile de france vi <NUMBER> february <NUMBER> outbreak coronavirus disease <NUMBER> covid<NUMBER> aroused peoples concern coronavirus seven human coronaviruses hcovs discovered far including hcov<NUMBER>e hcovnl<NUMBER> hcovoc<NUMBER> hcovhku<NUMBER> severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus <NUMBER> existing studies show cardiovascular disease increased incidence severity coronavirus infection time myocardial injury caused coronavirus infection one main factors contributing poor prognosis review recent clinical findings relationship coronaviruses cardiovascular diseases underlying pathophysiological mechanisms discussed review aimed provide assistance prevention treatment covid<NUMBER> advances relationship coronavirus infection cardiovascular diseases hcov<NUMBER>e hcovoc<NUMBER> <NUMBER> discovered <NUMBER>s hcovnl<NUMBER> <NUMBER> hcovhku<NUMBER> <NUMBER> later discovered upper respiratory tract infections asthma bronchiolitis pneumonia evidence showing infant elderly immunocompromised patients likely infected high mortality rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> infected patients likely develop severe disease states <NUMBER> <NUMBER> <NUMBER> <NUMBER> varghese et al <NUMBER> retrospectively analyzed clinical data <NUMBER> children hcov infection including <NUMBER>e hku<NUMBER> nl<NUMBER> oc<NUMBER> found approximately <NUMBER> children cardiovascular disease hcovinfected children cardiovascular disease likely receive respiratory support enter pediatric intensive care unit picu suggesting underlying cardiovascular disease increased severity hcov infection children cabeça et al found children heart disease likely infected hcovs <NUMBER> presence congenital heart disease significant risk factor severe coronavirus infection children less five years old <NUMBER> table <NUMBER> hypotension found small number patients four hcov infections <NUMBER> table <NUMBER> relevant evidence showing hcov infection cause heart injury however kim et al reported hcovs detected children kawasaki disease characterized acute systemic vasculitis childhood may induce severe cardiovascular complications <NUMBER> serological tests suggest hcov<NUMBER>e may involved occurrence kawasaki disease <NUMBER> therefore still need pay attention cardiovascular complications facing four kinds hcov infection severe acute respiratory syndrome <NUMBER> broke globally <NUMBER> different human coronavirus described previously severe acute respiratory infection clinical manifestations fever dry cough lungs main locations lesions patients quickly develop acute respiratory distress syndrome ards multiple organ failure high mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> much relevant evidence showing preexisting comorbid conditions one major determinants fatality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported presence cardiovascular diseases hypertension heart disease associated adverse outcomes mortality sars patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> wong et al reviewed medical records fatal cases found <NUMBER> patients died comorbid conditions hypertension coronary artery disease <NUMBER> chen et al found patients combined hypertension cerebrovascular diseases likely develop ards <NUMBER> another study hu et al showed incidence rates critical conditions multiple organ dysfunction syndrome mods among sars patients cardiovascular cerebrovascular diseases <NUMBER>fold <NUMBER>fold higher patients without underlying disease suggesting cardiovascular cerebrovascular diseases major risk factors sars patients devolve critical conditions mods eventually lead death <NUMBER> table <NUMBER> regarding cardiovascular complications sars patients found sars patients subclinical diastolic impairment without contraction involvement damage may reversible upon clinical recovery <NUMBER> another study yu et al found cardiovascular complications including hypotension tachycardia common sars patients usually selflimiting bradycardia cardiac hypertrophy less common arrhythmias rare <NUMBER> acute myocardial infarction also seen sars patients <NUMBER> sarscov reported found <NUMBER> <NUMBER> patients heart samples patients died sars toronto outbreak <NUMBER> might explain myocardial damage discovered sars patients <NUMBER> reports indicating sarscov also attacks small blood j u r n l p r e p r f cardiovascular disease increased mortality mers <NUMBER> banik suggested sufficient attention paid mers patients combined underlying diseases reduce occurrence serious complications mortality <NUMBER> table <NUMBER> heart damage also reported mers patients <NUMBER> merscov found kidneys deceased patients detected heart tissue heart showed significant histological changes <NUMBER> <NUMBER> however animal model study clearly stated merscov rna could seen cardiac tissue implying direct cardiac pathology <NUMBER> mechanism heart injury mers infection remains unclear requires research covid<NUMBER> broke end <NUMBER> disease caused infection sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> similar sarscov merscov sarscov<NUMBER> βcov <NUMBER> covid<NUMBER> similar sars mers manifests extensively pathological viral lung inflammation <NUMBER> although similar sarscov merscov sarscov<NUMBER> characteristics <NUMBER> <NUMBER> early cases suggest covid<NUMBER> may severe sars mers however rapidly increasing number cases increasing evidence humantohuman transmission suggest sarscov<NUMBER> contagious sarscov merscov lower fatality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> april <NUMBER> <NUMBER> overall mortality covid<NUMBER> <NUMBER> globally <NUMBER> fatality rate different different regions times ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptoms covid<NUMBER> infection appear incubation period approximately <NUMBER> days <NUMBER> fever fatigue dry cough main manifestations covid<NUMBER> patients symptoms nasal congestion runny nose sore throat diarrhea <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients severe cases often experience dyspnea andor hypoxemia one week onset <NUMBER> severe cases covid<NUMBER> progress rapidly acute respiratory distress syndrome septic shock metabolic acidosis difficult correct coagulopathy <NUMBER> current case reports show sarscov<NUMBER> infection may cardiovascular symptoms addition typical respiratory symptoms small number patients atypical clinical manifestations may start cardiovascular symptoms chest tightness palpitations chest pain study liu et al found <NUMBER> <NUMBER> patients palpitations first symptom <NUMBER> also reported <NUMBER> patients experienced chest pain hospitalization <NUMBER> addition wang et al found <NUMBER> patients covid<NUMBER> arrhythmias <NUMBER> according relevant studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> proportion covid<NUMBER> patients comorbid cvds hypertension coronary artery disease cerebrovascular disease larger patients comorbidities without comorbidities suggesting patients cvd may susceptible sarscov<NUMBER> infection moreover incidence cvd patients severe fatal cases covid<NUMBER> higher patients nonsevere cases survived <NUMBER> <NUMBER> <NUMBER> according reports chinese center disease control prevention <NUMBER> deaths hypertension <NUMBER> cardiovascular diseases suggesting underlying cardiovascular diseases may one important risk factors poor prognosis patients covid<NUMBER> <NUMBER> seen number covid<NUMBER> patients cardiovascular disease large also patients poor tolerance severe pneumonia likely develop severe cases table <NUMBER> cardiac complications electrocardiography abnormities diastolic dysfunction acute myocardial injury reported patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases severe myocarditis reduced systolic function reported covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> infectionrelated myocarditis likely associated myocardial injury <NUMBER> <NUMBER> according study li et al common organ damage outside lungs heart injury<NUMBER> serum myocardial necrosis markers hypersensitive troponin hstni creatine kinase ck increased varying degrees patients mild severe cases covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however risk heart injury higher patients severe cases approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients mild cases approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> percentage heart injury covid<NUMBER> patients died approximately <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> higher survived nterminal probrain natriuretic peptide ntprobnp levels also reported increased<NUMBER> <NUMBER> <NUMBER> increased hstni probnp expression levels may risk factors severe illness high mortality covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore found high hstni levels associated increased levels inflammation neutrophils il<NUMBER> crp pct decreased levels immunity lymphocytes monocytes cd<NUMBER> cd<NUMBER> cells suggesting cardiac injury may something cytokine storm resulting overaggressive host immune response <NUMBER> <NUMBER> table <NUMBER> two recent studies published jama cardiology reported cardiovascular complications covid<NUMBER> detail <NUMBER> <NUMBER> shi et al found cardiac injury common condition among hospitalized patients covid<NUMBER> wuhan china associated higher risk inhospital mortality <NUMBER> guo et al reported myocardial injury significantly associated fatal outcome covid<NUMBER> myocardial injury associated cardiac dysfunction arrhythmias inflammation may potential mechanism myocardial injury <NUMBER> table <NUMBER> j u r n l p r e p r f covid<NUMBER> may induce new cardiovascular diseases aggravate potential cardiovascular diseases shortterm longterm cardiovascular effects covid<NUMBER> effects specific treatments unclear need investigation epidemic spread sarscov<NUMBER> evolved multiple subtypes recent study researchers proposed subdivision global sarscov<NUMBER> population sixteen welldefined subtypes focusing widely shared polymorphisms nonstructural nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> cistrons structural spike nucleocapsid accessory orf<NUMBER> genes <NUMBER> six virus subtypes predominant population accounting <NUMBER> samples isolated around world subtypes showed geographical structure two clusters smaller one comprised isolates mostly sampled western hemisphere subtypes ii vi ix x xi larger one whose isolates sampled western eastern hemispheres subtypes iii iv v vii viii xii xiii xiv xv xvi <NUMBER> researchers believed genetic structure determined sarscov<NUMBER> population provides substantial guidelines maximizing effectiveness trials testing candidate vaccines drugs <NUMBER> another earlier study population genetic analyses <NUMBER> sarscov<NUMBER> genomes indicated viruses evolved two major types designated l well defined two different single nucleotide polymorphisms snps <NUMBER> l type <NUMBER> prevalent type <NUMBER> type found ancestral version l type aggressive spread quickly prevalent early stages outbreak wuhan frequency l type decreased early january <NUMBER> severe j u r n l p r e p r f selective pressure placed human intervention l type <NUMBER> contrary l type stype evolutionarily older less aggressive might increased relative frequency due weaker selective pressure <NUMBER> also reported among <NUMBER> viruses isolated wuhan <NUMBER> <NUMBER> l type <NUMBER> <NUMBER> type <NUMBER> however among <NUMBER> viruses isolated outside wuhan <NUMBER> <NUMBER> l type <NUMBER> <NUMBER> type <NUMBER> comparison suggests l type significantly prevalent wuhan places recent studies clinical characteristics outcomes patients covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> <NUMBER> outside wuhan <NUMBER> <NUMBER> <NUMBER> showed mortality covid<NUMBER> patients proportion patients cardiac injury outside wuhan lower wuhan table <NUMBER> although many reasons different incidence cardiac injury outcome covid<NUMBER> outside wuhan shortage medical resources wuhan role different sarscov<NUMBER> subtypes cannot ignored relationship sarscov<NUMBER> subtypes mortality covid<NUMBER> cvd complications need immediate comprehensive studies combine genomic data epidemiological data records clinical symptoms patients coronavirus disease <NUMBER> according references see patients underlying cvd may likely become infected coronavirus cvd may one risk factors poor prognosis high mortality cov infection studies however explored mechanisms underlying associations believe possible mechanisms may related inflammation cardiovascular diseases hypertension coronary heart disease cerebrovascular disease metabolicrelated diseases reported metabolic syndrome downregulate key mediator hosts innate immune response pathogenesis affecting function innate humoral immune systems <NUMBER> chronic lowgrade inflammatory disease widely recognized feature coronary heart disease occurrence closely related inflammation <NUMBER> occurrence hypertension associated oxidative stress inflammation activation immune system <NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor α tnfα levels higher patients hypertension patients normal blood pressure <NUMBER> may explain patients underlying cardiovascular disease found clinic susceptible infection kulcsar et al showed merscov infection lead prolonged respiratory tract inflammation immune cell dysfunction changes expression profile inflammatory mediators <NUMBER> lymphopenia increased inflammatory mediators found sarscov<NUMBER> infection <NUMBER> immune disorders caused sarscov infection also reported <NUMBER> may lead exacerbation original cardiovascular disease related death patients found clinic due heart failure <NUMBER> <NUMBER> <NUMBER> according information released shanghai municipal health family planning commission first covid<NUMBER> death shanghai individual <NUMBER> years old severe history hypertension cardiac insufficiency analysis cause death suggested patient died heart failure systemic multiple organ dysfunction therefore sarscov<NUMBER> infection inducement exacerbations <NUMBER> overall heart lungs inseparable normal physiological functions human body one hand comorbidities complications heart increase risk pneumonia infection exacerbation hand pneumonia infection may aggravate existing cardiovascular diseases increased blood pressure increased heart failure recurrence myocardial infarction fever common symptom patients coronavirus infection <NUMBER> <NUMBER> <NUMBER> fever promotes immune functions humans animals decreases pathogenicity microbes antibody production tcell activation neutrophil function macrophage oxidative metabolism reported increase presence fever <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however avoid excessively elevated body temperature affecting normal physiological functions body activate sympathetic nerves regulate circulatory function increase heart rate cardiac output <NUMBER> increase heart rate long period time lead increased myocardial oxygen consumption decreased cardiac output may cause ischemia heart failure <NUMBER> many diseases fever symptoms may complicated myocarditis spotted fever rickettsioses infection <NUMBER> severe fever thrombocytopenia syndrome <NUMBER> drug reaction eosinophilia systemic symptoms <NUMBER> dengue <NUMBER> <NUMBER> <NUMBER> complicated scrub typhus <NUMBER> herpes simplex virus infection <NUMBER> enteric fever <NUMBER> decrease cardiac function may occur febrile illnesses whether myocardial damage due fever underlying infection known <NUMBER> weissinger et al found pigs bacterial infection elevated body temperature serum ck lactate dehydrogenase ld j u r n l p r e p r f gammaglobulin gg levels increased administration antibiotics pigs lowering body temperature reduced ck ld levels gg levels remained elevated suggesting infection decrease study indicated levels ck ld elevated due fever caused infection <NUMBER> k l et al discovered longer duration fever related occurrence pericarditis myocardial infarction <NUMBER> therefore heart injury coronavirus infection may related fever severe pneumonia cause significant gas exchange disturbances lead hypoxemia hypoxia reduces energy production required cell metabolism increases bodys anaerobic digestion acidosis oxygen free radicals accumulated cell destroy phospholipid layer cell membrane hypoxia continues intracellular calcium ion concentration increases significantly leading series cell damage processes including apoptosis <NUMBER> time hypoxia also induce inflammatory reactions infiltration inflammatory cells release cytokines leading tissue ischemia may even cause myocardial infarction<NUMBER> <NUMBER> <NUMBER> previous lessons coronavirus influenza shown viral infections cause acute coronary syndrome <NUMBER> <NUMBER> arrhythmia <NUMBER> exacerbation heart failure <NUMBER> mainly due combination significant systemic inflammation response localized vascular inflammation arterial plaque along effects <NUMBER> <NUMBER> <NUMBER> evidence shown sarscov induces expression proinflammatory cytokines monocyte chemotactic protein <NUMBER> mcp<NUMBER> transforming growth factorbeta <NUMBER> tgfbeta<NUMBER> tnf il<NUMBER> ilj u r n l p r e p r f <NUMBER> interferonβ ifnβ sars patients experimental animal models infected sarscov <NUMBER> <NUMBER> tnf il<NUMBER> family il<NUMBER> family cytokines considered proinflammatory mediators heart failure obvious negative inotropic effects may explain heart failure complications sars infection <NUMBER> acute heart injury might due cytokine storm resulting overaggressive host immune response sars infection <NUMBER> evidence indicating myocardial inflammation induced sarscov mainly mediated macrophages resultant production chemokines <NUMBER> <NUMBER> nuclear factorκb nfκb signaling pathway associated induction proinflammatory cytokines activated sarscovinfected mice treatment drugs inhibited nfκb activation led reduction inflammation sarscovinfected cultured cells mice significantly increased mouse survival sarscov infection indicating activation nfκb signaling pathway represents major contribution inflammation induced sarscov infection nfκb inhibitors promising antivirals infections caused sarscov potentially pathogenic human coronaviruses <NUMBER> sarscov<NUMBER> appears affect themyocardium cause myocarditis <NUMBER> myocardial injury likely associated infectionrelated myocarditis andor ischemia <NUMBER> increases inflammatory factors crp il<NUMBER> il<NUMBER> also discovered sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> wu et al believed sarscov<NUMBER> may cause heart damage cytokine storm <NUMBER> evidence shown sarscov<NUMBER> may mainly affect lymphocytes especially cd<NUMBER> cells resulting significant decrease lymphocyte numbers <NUMBER> extent lymphopenia increase inflammatory cytokines related severity disease <NUMBER> critically ill covid<NUMBER> patients higher levels il<NUMBER> il<NUMBER> tnfα lactate dehydrogenase ldh creactive protein patients mild covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting inflammatory indicators important factor early diagnosis severe covid<NUMBER> patients coronavirus infection inflammatory state places patients hypercoagulable state example covid<NUMBER> leads increase ddimer levels <NUMBER> patients decrease activated partial thromboplastin time aptt <NUMBER> patients decrease pt <NUMBER> patients increasing risk embolism <NUMBER> hypercoagulability induced inflammation might contribute plaque rupture subsequent thrombosis myocardial injury <NUMBER> therefore clinicians pay attention covid<NUMBER> patients coronary heart disease prevent myocardial injury myocardial infarction septic shock seen serious complication sars mers covid<NUMBER> <NUMBER> <NUMBER> approximately <NUMBER> sarscov<NUMBER> infections complicated shock <NUMBER> reported left ventricular dysfunction occurs approximately <NUMBER> patients within <NUMBER> hours onset septic shock incidence increase <NUMBER> <NUMBER> <NUMBER> days onset septic shock <NUMBER> myocardial dysfunction cardiovascular inflammation might lead elevated creatine kinase troponin <NUMBER> might explain high hstni deceased patients addition abovementioned accompanying symptoms anxiety stress also lead adverse reactions accelerated heart rhythms elevated blood pressure especially critically ill patients <NUMBER> <NUMBER> health anxiety could found coronavirusinfected patients <NUMBER> generally everyone experiences health anxiety degree associated vigilance potential healthrelated threat protective however excessive health anxiety detrimental <NUMBER> literature indicates stress activate hypothalamicpituitaryadrenal axis j u r n l p r e p r f sympathetic nervous system leading increase peripheral glucocorticoid catecholamine levels <NUMBER> high plasma catecholamine levels associated increased risk heart failure altered autonomic activity depression lead arrhythmias activated sns alters cardiac wall contractility increases apoptotic pathways cardiomyocytes contributing cvd development although relevant study covid<NUMBER> patients suffering anxiety medical workers reported anxious direct contact patients <NUMBER> <NUMBER> study sun et al showed chinese showed acute posttraumatic stress symptoms covid<NUMBER> outbreak <NUMBER> therefore psychological counseling conducted patients timely manner anxiolytic drugs could used necessary mentioned sarscov reported lead myocardial infection marked decrease ace<NUMBER> expression may responsible myocardial dysfunction adverse cardiac outcomes patients sars <NUMBER> direct sarscov infection cardiomyocytes may also lead myocarditis impaired myocardial function coronavirusinduced myocarditis subsequent progression dilated cardiomyopathy described rabbit models <NUMBER> sarscov found heart samples patients died sars <NUMBER> pathological findings showed marked increase macrophage infiltration patients sarscov heart evidence myocardial damage merscov detected heart tissue heart showed significant histological changes mers patients <NUMBER> <NUMBER> however animal model study clearly stated merscov rna could seen cardiac tissue implying direct cardiac pathology <NUMBER> although myocarditis reported sporadic autopsy cases <NUMBER> still clear pathological evidence supporting sarscov<NUMBER> directly cause heart damage frequently used drugs hospitalization glucocorticoids antiviral drugs well antibiotics secondary qt interval prolongation caused use drugs hospitalization cannot ignored antiviral drugs lopinavir ritonavir antibiotics azithromycin moxifloxacin levofloxacin antifungal drugs glucocorticoids antiarrhythmic drugs potential risk prolonging qtc interval <NUMBER> <NUMBER> drugassociated qt prolongation associated increased arrhythmic nonarrhythmic mortality therefore continues important metric drug safety <NUMBER> small study france enrolling <NUMBER> treated patients <NUMBER> nonrandomized controls showed hydroxychloroquine alone combination azithromycin shortened time resolution viral shedding covid<NUMBER> <NUMBER> based study clinicians many countries begun using medications clinical practice multiple randomized trials initiated occasional case reports hydroxychloroquine prolonging qt interval provoking torsade de pointes used treat systemic lupus erythematosus <NUMBER> <NUMBER> <NUMBER> <NUMBER> widely used antibiotic azithromycin gradually recognized rare cause prolonged qt severe arrhythmia increased risk sudden death <NUMBER> <NUMBER> <NUMBER> <NUMBER> although reports arrhythmia death caused use hydroxychloroquine use hydroxychloroquine azithromycin also noted <NUMBER> j u r n l p r e p r f active support expected management based early prognostic indicators may improve recovery appropriate treatment heart failure arrhythmia acute coronary syndrome thrombosis still important continued global cooperation multiple methods specific evidencebased treatment strategies covid<NUMBER> emerge order protect wider population antibody testing effective vaccines needed make history covid<NUMBER> treatment related issues need attention firstly use acei arb drugs controversial earlier phase covid<NUMBER> epidemic recently published studies suggested need patients hypertension stop using acei arb switch antihypertensive medicine <NUMBER> <NUMBER> <NUMBER> conjectures <NUMBER> based disease mechanism early stage outbreak acei arb may increase infection new coronavirus aggravation covid<NUMBER> increasing expression ace<NUMBER> denied clinical evidence see continuous treatment covid<NUMBER> patients hypertension acei arb cause deterioration condition also continue exert cardiovascular protection even improve prognosis <NUMBER> <NUMBER> <NUMBER> secondly pay attention application hydroxychloroquine <NUMBER> <NUMBER> <NUMBER> <NUMBER> azithromycin <NUMBER> <NUMBER> <NUMBER> <NUMBER> side effects prolonging qt interval drugs used treat covid<NUMBER> patients antiviral drugs lopinavir ritonavir antibiotics moxifloxacin levofloxacin antifungal drugs glucocorticoids antiarrhythmic drugs cause qt interval prolongation attract attention reference sapp et al would help minimize risk druginduced ventricular arrhythmia treatment covid<NUMBER> <NUMBER> thirdly recent study jama reported mortality rate patients mechanical ventilation treatment <NUMBER> <NUMBER> multiple studies around world shown mortality rate covid<NUMBER> patients using ventilator still high <NUMBER> <NUMBER> <NUMBER> believed ventilator used cautiously patients covid<NUMBER> reduce mortality patients using ventilator <NUMBER> <NUMBER> new guidelines established use ventilator patients covid<NUMBER> advocate application staged breathing support methods delay use ventilator simple oxygen treatment like nasal oxygen supply may safer effective fourth methylprednisolone classical immunosuppressive drugs important stop delay progress pneumonia proved effective treatment acute respiratory distress syndrome ards recent study <NUMBER> wu al found administration methylprednisolone appeared reduce risk death covid<NUMBER> patients ards however received methylprednisolone treatment <NUMBER> <NUMBER> patients died rather high mortality <NUMBER> indication timing dosage duration application methylprednisolone needs investigation fifth early report showed remdesivir highly effective control sarscov<NUMBER> infection vitro <NUMBER> recent study published lancet showed remdesivir reduce mortality covid<NUMBER> patients <NUMBER> however another clinical trial showed remdesivir accelerates recovery advanced covid<NUMBER> <NUMBER> another clinical trial showed significant difference clinical outcome <NUMBER>day <NUMBER>day course remdesivir <NUMBER> data suggested remdesivir reduce mortality covid<NUMBER> patients j u r n l p r e p r f effect shortening course disease mild patients early medication may better application remdesivir needs researches clinical data indicate comorbid cardiovascular disease aggravate severity coronavirus infection leading poor prognosis coronavirus may cause myocardial injury prognosis patients complicated myocardial injury poor mechanism coronavirus causing myocardial injury drug treatment options remain studied authors declared conflicts interest work j u r n l p r e p r f abbreviation ck creatine kinase ldh lactate dehydrogenase hstni hypersensitive troponin ckmb creatine kinasemyocardial band isoenzyme probnp pro brain natriuretic peptide crp creactive protein il interleukin tnt troponin <NUMBER> <NUMBER> <NUMBER> <NUMBER> death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> assessed weekly mortality causes year <NUMBER> epidemiological week <NUMBER> compared previous year data obtained national civil registry information center cnirc acronym portuguese estimate expected mortality <NUMBER> confidence interval projecting observed mortality <NUMBER> population <NUMBER> five capitals highest incidences possible identify excess deaths pandemic period age group affected <NUMBER> years old <NUMBER> excess deaths occurred population <NUMBER> <NUMBER> years old strong correlation r <NUMBER> excess deaths city number deaths confirmed epidemiological surveillance excess deaths capital lowest incidence among population <NUMBER> years old estimate epidemiological surveillance managed capture <NUMBER> mortality associated covid<NUMBER> pandemic cities studied considering simplicity method low cost reliability assessing real burden disease believe assessment excess mortality associated covid<NUMBER> pandemic widely used complementary tool regular epidemiological surveillance use encouraged december <NUMBER> increase hospitalizations pneumonia unknown etiology observed wuhan hubei china initially disease associated exposure seafood wild animal market transmission person person confirmed january <NUMBER> <NUMBER> new coronavirus isolated identified cause pneumonia outbreak january <NUMBER> confirmed first case thailand january <NUMBER> <NUMBER> first case confirmed korea two cases beijing one case guangdong china <NUMBER> february <NUMBER> world health organization announced name coronavirus disease<NUMBER> covid<NUMBER> main symptoms acute phase disease fever cough myalgia dyspnea day international committee taxonomy viruses ictv named new coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> technical visit carried <NUMBER> <NUMBER> february estimated r<NUMBER> basic number reproduction cases new coronavirus initially <NUMBER> <NUMBER> even recognized occurrence coronavirus pandemic march <NUMBER> virus already spread many countries end april <NUMBER> million cases <NUMBER> thousand deaths registered five continents <NUMBER> brazil first case covid<NUMBER> confirmed february <NUMBER> <NUMBER> <NUMBER> days sustained transmission declared march <NUMBER> first death confirmed end april <NUMBER> <NUMBER> thousand cases <NUMBER> deaths confirmed mortality coefficient <NUMBER> deaths per <NUMBER> million inhabitants brazil among <NUMBER> countries highest number deaths <NUMBER> despite high number confirmed cases deaths brazil date efforts diagnose suspected cases believed testing far necessary covid<NUMBER> testing laboratory network established gradually first centralized three units national influenza center nic later included private laboratories state public health laboratory network <NUMBER> recommendation march <NUMBER> mass testing covid<NUMBER> resulted shortage tests worldwide scale added increase cases country compromised testing capacity brazil public network also private health network <NUMBER> may contributing underestimation real magnitude disease country may happening worldwide broad clinical spectrum disease hinder clinical diagnosis added scarcity laboratory resources overload health care network allow epidemiological surveillance systems detect cases deaths reliable assessment burden covid<NUMBER> essential health managers country governments better decide magnitude duration nonpharmacological interventions control disease objective study analyze excess deaths mortality coefficient due current sarscov<NUMBER> pandemic capitals highest number cases recorded routine surveillance systems brazil study based official public data analyzed time series cases deaths due infection covid<NUMBER> excess deaths first months pandemic six brazilian capitals present study five brazilian capitals highest absolute numbers confirmed cases covid<NUMBER> fortaleza são paulo rio de janeiro manaus recife selected figure <NUMBER> validate method capital porto alegre also studied one lowest incidence rates covid<NUMBER> recently conducted serological survey proving low seroprevalence rate <NUMBER> mortality data collected website national civil registry information center cnirc acronym portuguese <NUMBER> made available information deaths registered notary offices across country years <NUMBER> <NUMBER> brazil notary offices legal period <NUMBER> days enter data contained death certificates signed attending physician cnirc deaths due covid<NUMBER> pneumonia severe acute respiratory syndrome septicemia undetermined causes deaths included analysis criteria used presented annex deaths external causes excluded brazilian law definition cause death death certificate preferably made attending physician obligation diagnostic hypothesis laboratory confirmation therefore group deaths respiratory causes covid<NUMBER> pneumonia severe acute respiratory syndrome causes including previous septicemia deaths undetermined causes data confirmed cases deaths covid<NUMBER> collected repository brazil project performs extraction official sources following preestablished pattern <NUMBER> deaths classified according date confirmation case notification system notifiable diseases sinan acronym portuguese available wide consultation <NUMBER> obtain covid<NUMBER> mortality data confirmed sinan search death dates directly databases reports state municipal health secretariats <NUMBER> <NUMBER> <NUMBER> possible obtain data symptom onset date municipalities rio de janeiro manaus order make possible compare temporal quality information data obtained day may <NUMBER> <NUMBER> demographic data collected brazilian institute geography statistics ibge acronym portuguese website estimates population brazilian capitals age group quarterly basis continuous national household sample survey pnadc acronym portuguese <NUMBER> first quarter <NUMBER> estimated population last quarter <NUMBER> used <NUMBER> estimated population last quarter <NUMBER> used ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> assessed weekly mortality causes year <NUMBER> epidemiological week <NUMBER> compared previous year calculated expected mortality <NUMBER> <NUMBER> confidence interval projecting <NUMBER> mortality rate <NUMBER> population period excess mortality defined starting first sequence two consecutive weeks death toll upper limit <NUMBER> confidence interval ending first two consecutive weeks death toll limit <NUMBER> mortality data entered <NUMBER> days death evaluated correlation cases officially confirmed health departments excess deaths epidemiological week <NUMBER> constructed linear regression mortality rate age group calculated period excess mortality expected number deaths age group calculated projecting <NUMBER> death rate age group <NUMBER> population excess mortality age group calculated number deaths observed minus expected number deaths ratio mortality rates calculated dividing mortality rate age group <NUMBER> period excess mortality mortality rate observed <NUMBER> statistical analyzes performed using stata <NUMBER> program results presented graphs tables built microsoft® excel® program table <NUMBER> shows population epidemiological situation cities studied also present excess deaths causes period classified excess mortality observe different incidence rates per <NUMBER> inhabitants lowest <NUMBER> porto alegre highest <NUMBER> recife case fatality rate varied <NUMBER> porto alegre highest rate manaus <NUMBER> figure <NUMBER> shows exception porto alegre <NUMBER> cities highest incidence covid<NUMBER> excess mortality identified cities são paulo rio de janeiro increase <NUMBER> confidence interval general mortality epidemiological week <NUMBER> compared previous year cities first cases confirmed laboratory diagnosis occurred respectively epidemiological weeks <NUMBER> <NUMBER> findings suggest may underreporting cases deaths covid<NUMBER> epidemiological surveillance identified syndromic surveillance excess deaths cities recife fortaleza manaus excess deaths identified week <NUMBER> manaus risk dying se <NUMBER> respiratory disease <NUMBER> times greater period previous year considering causes deaths increase <NUMBER> times assuming week <NUMBER> probably still include deaths numbers expected even higher figure <NUMBER> see strong pearson correlation r <NUMBER> number confirmed deaths sinan excess deaths epidemiological week <NUMBER> six cities studied slope regression suggests excess deaths <NUMBER> times greater official number deaths reported week <NUMBER> r²<NUMBER> p<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure <NUMBER> b made data municipalities possible collect mortality data covid<NUMBER> based date death são paulo fortaleza recife verify mortality confirmed covid<NUMBER> corresponds <NUMBER> excess deaths table <NUMBER> shows mortality rate age group causes possible verify age group affected <NUMBER> years old <NUMBER> excess deaths causes also excess deaths population aged <NUMBER> <NUMBER> years representing <NUMBER> total excess mortality causes <NUMBER> deaths observed excess <NUMBER> deaths causes first weeks epidemic <NUMBER> brazilian cities affected covid<NUMBER> increase greater cities higher incidences <NUMBER> excess deaths occurred population <NUMBER> <NUMBER> years old findings compatible observed clinical studies bulletins brazilian epidemiological surveillance excess deaths among children <NUMBER> years age increase overall mortality city porto alegre incidence covid<NUMBER> moment analysis lower aspects reinforce consistency findings number deaths occurred epidemiological week <NUMBER> confirmed official epidemiological surveillance system corresponded <NUMBER> excess deaths occurred period considering data collected <NUMBER> days end week <NUMBER> believe almost investigations deaths closed therefore estimate epidemiological surveillance system <NUMBER> total mortality burden disease unexpected finding since viruses influenza chikungunya also characterized mortality burden often greater measured etiological investigation patient mortality associated viruses better assessed calculating excess mortality occurs periods epidemic <NUMBER> <NUMBER> using similar methodology possible estimate new york city excess deaths first four weeks <NUMBER> however conventional epidemiological surveillance able identify <NUMBER> deaths covid<NUMBER> <NUMBER> excess deaths period <NUMBER> portugal excess mortality occurred march <NUMBER> april <NUMBER> <NUMBER> <NUMBER> times higher explained deaths reported covid<NUMBER> officially reported <NUMBER> underestimation mortality surveillance systems occur result several factors part explained failure report another part difficulty identifying cases present atypical ways late complications disease underestimation mortality surveillance systems occur result several associated factors part explained failure notification laboratory investigation patients would case definition criterion another part consequence difficulty identifying cases present atypical clinical forms deaths late complications disease fact still unknown proportion patients covid<NUMBER> serious potentially fatal cardiovascular complications acute coronary syndrome myocarditis arrhythmias cardiogenic shock cases may identified attending physicians routine situations <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> allcause mortality exceeded upper limit confidence interval <NUMBER> week first laboratoryconfirmed death cities são paulo rio de janeiro suggests already many deaths would captured conventional epidemiological surveillance system based individual notification cases covid<NUMBER> characterized majority mild cases confused clinically influenza even respiratory syncytial virus occurs time year two brazilian cities <NUMBER> therefore plausible believe sarscov<NUMBER> circulated widely circulation identified beginning brazilian epidemic patients covid<NUMBER> worsen around <NUMBER>th day symptom death often occurs <NUMBER> weeks onset symptoms may important transmission even first case identified county santa clara medical examinercoroner identified sarscov<NUMBER> autopsy patient died home unknown cause february <NUMBER> history travel abroad first case community transmission usa identified regular epidemiological surveillance february <NUMBER> <NUMBER> <NUMBER> influenza pandemic state são paulo possible identify mortality respiratory diseases population already upper limit <NUMBER> expected two weeks confirmation community viral circulation state <NUMBER> findings reinforce sensitivity usefulness surveillance excess deaths complementary strategies traditional epidemiological surveillance based notification investigation suspected clinical cases another relevant aspect fact excess mortality week <NUMBER> strong pearson correlation official mortality r <NUMBER> reinforces consistency findings slope regression line indicates excess deaths <NUMBER> cities <NUMBER> times number deaths official surveillance system time demonstrates potential type surveillance opportunity detect changes pattern mortality effectively importantly complementing traditional epidemiological surveillance present study limitations many consequence fact assessment made moment epidemic still beginning data may still incomplete addition death records obtained registry information system instead sim mortality information system check consistency diagnosis follow recommendations world health organization classification basic cause death choice due fact sim takes least <NUMBER> months consolidate information free access consultations emphasize limitation restricted analysis excess deaths respiratory causes since cause death interfere assessment mortality causes another limitation related use data registry offices system data available years <NUMBER> <NUMBER> therefore possible use average mortality rate several years would appropriate <NUMBER> <NUMBER> even limitations results quite consistent showing affected ages strong correlation mortality found official surveillance system excess mortality addition period increase mortality coincident pandemic addition excess deaths identified city low incidence covid<NUMBER> excess mortality tool already used assess mortality associated climatic events earthquakes epidemics good temporal definition caused influenza virus respiratory syncytial virus chikungunya <NUMBER> <NUMBER> <NUMBER> like ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> cdc usa euromomo project tracks mortality data european countries weekly assess excess mortality monitor impact influenza epidemics systems managing capture excess mortality associated covid<NUMBER> pandemic ongoing <NUMBER> <NUMBER> obtaining excess deaths regardless cause recorded death certificates seems best estimate mortality pandemic <NUMBER> believe surveillance aimed excess mortality simple lowcost easytoimplement tool collaborate lot traditional epidemiological surveillance therefore use expanded countries encouraged world health organization countries already mortality systems could easily adapted purpose important characteristic approach depend flow investigation cases health professionals involved preparedness response activities major epidemics necessarily depend laboratory research surveillance excess mortality useful especially lowincome countries addition depend initial clinical suspicion able sensibly identify deaths associated occurrence different atypical phenomena diverse epidemics extreme weather events earthquakes ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure <NUMBER> weekly mortality observed <NUMBER> black line expected dotted <NUMBER> confidence interval gray area respiratory causes left causes right city dotted arrow indicates date confirmation first case black arrow indicates date first confirmed death city yellow area represents period mortality data still incomplete ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint coronaviruses single stranded positive sense rna viruses among sarscov merscov caused outbreaks affecting multiple countries severe disease global threatening widespread infectivity rapid progress high variance mortality rate nonspecial treatment somewhat sarscov<NUMBER> wuhan china <NUMBER> treatments currently defined primary remedy vaccination prophylaxis nowadays treatments cases range supportive treatment including fluid balance nutrition support invasive ventilation renal replacement therapy vasopressors corticosteroids immunoglobulins etc antiviral treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> specific antiviral treatments interferons ifn ribavirin lopinavir related antiviral agents clinically use specific antivirals especially utility ifns still great debate efficacy safety treatmentrelated adverse effects initial vitro investigations demonstrated type interferons ifnα ifnβ inhibit replication sars coronavirus sarscov <NUMBER> based previous studies morgenstern et al investigated combination effect ifnβ ribavirin prevent sarscov yield potential benefits ribavirin plus ifnβ treatment sars <NUMBER> illuminated possible antiviral treatment sars several vitro studies determined possible efficacious effect ifnα<NUMBER>b ribavirin treatment merscov infection <NUMBER> <NUMBER> subsequently investigators examined efficacy drugs animal study macaques <NUMBER> hours inoculated merscov favorable outcomes <NUMBER> could make contributions increase survival rate improve oxygen saturation associated rapid resolution pyrexia radiographic lung opacities respiratory improvements <NUMBER> even prophylaxis efficacy <NUMBER> <NUMBER> review anecdotal experiences greatly needed rational use type ifns coronavirus therefore conducted updated systematic review metaanalysis recapitulate relevant studies evaluate safety efficacy tolerability treatmentrelated outcomes type ifns coronavirus infection clinical practice expectation provide robust evidence whether ifns served firstline agents coronavirus infection including sarscov<NUMBER> study performed accordance prisma preferred reporting items systematic reviews metaanalyses <NUMBER> systematic literature search databases conducted two independent reviewers february <NUMBER> articles contained relevant information ifn coronavirus initially searched pubmed cochrane library web science database science direct wanfang data china national knowledge infrastructure cnki without time period language region restriction mesh terms search keywords search combined references included studies reviews also manually searched used following search terms using boolean operators <NUMBER> interferon ifn antivir drug effect drug ther combination drug ther <NUMBER> coronavirus middle east respiratory syndrome merscov mers virus sars severe acute respiratory syndrome sarscov <NUMBER> clinical trials regarding type ifn ifnα ifnβ solely combinationally treatment coronavirus infections prophylaxis <NUMBER> human studies regardless randomized controlled trial rct casecontrol studies observational study cohort studies case series <NUMBER> compared treatment outcomes ifn remedies supportive treatment corticosteroids ifns <NUMBER> vitro studies animal models <NUMBER> cellular molecular histological pathological mechanism studies hypothesis <NUMBER> pharmaceutical mechanism toxicology hypothesis addressing ifn related agents coronavirus <NUMBER> antiviral therapies include type ifn <NUMBER> repeated studies staged trials studies without comparison information <NUMBER> reviews comments letters two investigators independently reviewed electronically manually retrieved articles screening titles abstracts potentially relevant studies selected fulltext review performed disagreements solved discussion still unsolved third supervisor included article thoroughly reviewed following baseline information extracted table <NUMBER> first author publication year region study type participants diagnostic method coronavirus data collection method time admission treatment start time diagnosis treatment start primary endpoints treatmentrelated adverse effects addition study design treatment plan including ifn dosage frequency duration main findings conclusions extracted detail table <NUMBER> data total mortality rate <NUMBER>day survival <NUMBER>day survival <NUMBER>month survival transferring rate intensive care unit icu required intubation mechanical ventilation resolution pyrexia respiratory improvement days recorded possible metaanalysis better understanding severity case mortality rate coronavirus divided patients critically ill patients mild ill patient critically ill defined coronavirusinfected patients severe comorbidities respiratory distress failure directly indirectly transferred icu needing intubation mechanical ventilation extracorporeal membrane oxygenation ecmo admitted primary treatment mild ill patients defined realtime polymerase chain reaction rtpcr laboratory confirmed coronavirus infected asymptomatic otherwise laboratory well patients dichotomous variables analyzed using review manager version <NUMBER> cochrane collaboration oxford united kingdom mantelhaenszel method crude ors <NUMBER> confidence intervals cis calculated continuous variables mean difference md <NUMBER> ci applied singlerate metaanalysis performed using stata <NUMBER> software stata corporation college station texas usa assigned weight study based withinstudy variance betweenstudy heterogeneity heterogeneity manuscripts tested using chisquare test low pvalue indicating high heterogeneity pvalue ≥<NUMBER> indicating low heterogeneity <NUMBER> index statistics <NUMBER> indicating interstudy heterogeneity <NUMBER> <NUMBER> <NUMBER> fixed effects model applied otherwise random effects model applied <NUMBER> analysis pvalue less <NUMBER> considered significant initial database search yielded <NUMBER>articles figure <NUMBER> addition six articles added manual searching retrieved study lists relevant reviews two papers added expert suggestion eliminating <NUMBER> duplicate articles <NUMBER> titles abstracts screened comprehensively screening <NUMBER> full texts <NUMBER> studies complied eligibility criteria included last among three rcts <NUMBER> <NUMBER> one published yet <NUMBER> four retrospective cohort studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> four case series <NUMBER> <NUMBER> <NUMBER> <NUMBER> one prospective cohort study <NUMBER> one openlabel preliminary study <NUMBER> one openlabel prospective randomized study <NUMBER> one retrospective observational study <NUMBER> turner et al firstly explored whether prophylactic recombinant ifns could decrease cov<NUMBER>e catch rate reduce severity coronavirus cold symptoms <NUMBER> welldesign randomized placebocontrol study <NUMBER> recruited absolutely healthy volunteers participants study found coldcatch rate mean nasal symptom score mean total symptom score mean number days total symptom score ＞<NUMBER> much lower ifns prophylaxis group placebo group reached significant difference table <NUMBER> account insufficient data inconsistent initial study design complexity human bodies case variance statistical synthesizing impossible regarding abovementioned parameters table <NUMBER> total mortality rate investigated variance critically mild ill patients basis analysis mortality rate <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> <NUMBER> critically mild ill coronavirusinfected patients presented high heterogeneity random effect model used figure <NUMBER> study systematically investigated application type interferons hcovs infection clinical practice according review ifns mainly acted vital role rapid resolution lung abnormalities respiratory improvements better oxygen saturation reduced needs supplemental oxygen support less increase creatine kinase level indispensable advanced life support increase survival meantime several adverse effects detected including drop platelet drop hemoglobin rise lipase bilirubin emergency pancreatitis one critically ill case terminal phage disease treatmentrelated outcomes couldnt rule effects agents like ribavirin still need investigation <NUMBER> side effects life threating much easier solve compared respiratory distress intractable hyoxemia rapid progress renal hepatic failure tolerability type ifns acceptable premature discontinuation ifn secondary adverse effects found case apart remedy effect ifn coronavirus infection described also found prophylaxis efficacy ifn coronavirus infection <NUMBER> <NUMBER> increased enhanced utility ifn clinical practice altawfiq et al reported experience five critically ill patients died multiorgan failure treatment ifn plus ribavirin concluded combination antivirals may contribute merscovinfected patients <NUMBER> preclinical data suggested addition vast majority adverse effects reported think conclusion may objective included critically ill patients multiple comorbidities mechanical ventilation importantly diagnosed late admission mortality rate significantly related comorbidities like chronic renal failure diabetes mellitus coronary artery disease hypotension elevated creatinine anemia etc age <NUMBER>year <NUMBER> <NUMBER> whats severity illness greatest predictor reduced survival multivariate analysis <NUMBER> adverse effects couldnt absolutely ascribe ifn alone critically ill patients may suffer respiratory abnormality internal environment disturbance diseaserelated complications beyond side effects least drop hemoglobin level found related ribavirin temporal toxicity <NUMBER> <NUMBER> cheng et al concluded research even steroid therapy alone mortality rate appeared low compared conservative treatment pneumonia caused sarscov combination effective antiviral steroid associated better outcome <NUMBER> results omrani et al retrospective cohort study ifn plus ribavirin decreased mortality rate supportive treatment didnt significantly increase adverse effects apart antiviral therapy management primarily focus strict lungprotective ventilation <NUMBER> analysis indicated overall mortality rate coronavirusinfected critically ill patients <NUMBER> <NUMBER> mild ill patients accordance imran khalids conclusion delay remedy would increase mortality <NUMBER> caculated mortality rate may higher actual level publication bias consequence early dignosis intervention would greatly improve outcomes <NUMBER> also suggested us paying attention early screen close contacts suspected patients disease equally crucial clinically combination ifn ribavirin reletively widely adopted coronavirus onfection though lack robust evidence <NUMBER> one welldesigned randomized placebocontrol trial regarding effects recombinant ifnβ<NUMBER>b plus opinavirritonavir registed <NUMBER> still pending completion <NUMBER> rct primary secondary outcomes mortality icu mortality hospital <NUMBER>day mortality <NUMBER>day mortality sequential organ failure assessment scores baseline study days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> seems best conceived trial determine efficacy antivirals coronavirus infection looking forward successful administration clinical trial calling largescale prospective randomized studies assess role antivirals treatments coronavirus better guide clinical practice conclusion type interferons seem improve respiratory distress relieve lung abnormalities present better saturation reduce needs supplemental oxygen support type interferons seem well tolerated dont increase life threating adverse effects still recommend type interferons serving firstline antivirals coronavirus infections within local protocols timely administration monitoring adverse events interferons may used treat sarscov<NUMBER> infected patients welldesigned largescale prospective randomized control trials greatly needed provide robust evidence topic financial nonfinancial benefits received received table <NUMBER> study designs treatment strategies outcomes included studies evaluation safety efficacy tolerability treatmentrelated outcomes interferon coronavirus infection clinical practice coronaviruses covs enveloped viruses positive singlestranded rna virus widely distributed humans animals cause respiratory infections humans <NUMBER> nowadays ongoing pandemic covid<NUMBER> caused novel coronavirus syndromecoronavirus<NUMBER> sarscov<NUMBER> emerging rapidly evolving situation <NUMBER> april <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> deaths total confirmed around world suggesting overall death rate covid<NUMBER> <NUMBER> although sarscov<NUMBER> sarscov share similarities phylogeny clinical trials new type coronavirus seems higher spread lower mortality <NUMBER> study reported sarscov<NUMBER> invades cells predicated receptor angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> blocking reninangiotensin system prevent newonset diabetes reduce risk diabetes complications <NUMBER> du et al <NUMBER> found elderly <NUMBER> years old showed higher risk suffering disease especially severe complications patients experience entering managed antonio secchi intensive care unit icu finding indicated complications may risk factor adverse consequences recent metaanalysis reported hypertension diabetes copd cardiovascular disease cerebrovascular disease major risk factors patients covid<NUMBER> impact risk factors covid<NUMBER> mortality explored <NUMBER> therefore metaanalysis first aims explore possible clinical mortality diabetes covid<NUMBER> analyze diabetes patients infected sarscov<NUMBER> exposed worst clinical prognostic risk evaluate reliability evidence result may help government formulate prevention policies respond outbreak covid<NUMBER> ultimately contributing better clinical management patients covid<NUMBER> diabetes preferred reporting items metaanalyses prisma guidelines used determined include studies involving covid<NUMBER> sarscov<NUMBER> diabetes find relevant primitive articles performed comprehensive retrieval databases involving medline via pubmed embase web science following words also reviewed reference lists based recognized literature find additional eligible studies first screened titles abstracts articles publications may involve data concerning covid<NUMBER> sarscov<NUMBER> diabetes primitive studies carefully examined nation restrictions study inclusion criteria follows <NUMBER> studies reporting data covid<NUMBER> nonsurvivors survivors laboratoryconfirmed covid<NUMBER> patients <NUMBER> studies limited mankind contained original data published english appeared form either abstract fulltext exclusion criteria follows <NUMBER> duplicate studies letters case reports abstracts reviews <NUMBER> research focusing morbidity rather mortality collected following information study publication year first authors name sample size age dead group alive group assessed quality involved research newcastleottawa scale <NUMBER> metaanalysis conducted via review manager <NUMBER> calculating <NUMBER> index evaluate heterogeneity <NUMBER> values <NUMBER> <NUMBER> <NUMBER> <NUMBER> considered homogeneous low moderate high heterogeneous levels respectively <NUMBER> value <NUMBER> random effects model rem would applied <NUMBER> value <NUMBER> fixed effects model fem would applied pooled odds ratios ors different studies corresponding <NUMBER> confidence intervals cis used estimate relationship diabetes mortality patients covid<NUMBER> sensitivity analysis repeated impact study evaluated deleting different individual studies time total <NUMBER> potentially relevant articles identified using search strategy databases <NUMBER> reference lists four hundred sixty studies remained ruling duplicates screening titles abstracts <NUMBER> research articles satisfy inclusion criteria ruled scanning main body reserving <NUMBER> records another seven articles excluded finally nine qualified articles met eligibility criteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> steps document retrieval shown fig <NUMBER> meanwhile common characteristic included studies listed table <NUMBER> metaanalysis involved <NUMBER> cases <NUMBER> dead <NUMBER> alive overall published <NUMBER> one study <NUMBER> reported settings icu isolation wards articles high quality nos score less <NUMBER> outcome forest plot connection diabetes mortality patients covid<NUMBER> shown fig <NUMBER> results showed close relationship diabetes mortality covid<NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> pooled data calculated fem heterogeneity appeared studies chose age subgroup significant difference age ≥ <NUMBER> subgroup age <NUMBER> subgroup <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> respectively fig <NUMBER> result insufficient data impact age stratification mortality covid<NUMBER> carried meanwhile study demonstrated heterogeneity <NUMBER> <NUMBER> upon eliminating impact yuans study wangs study results significantly affected pooled outcomes <NUMBER> dropped <NUMBER> <NUMBER> therefore assumed studies yuan et al wang et al may sources heterogeneity metaanalysis sensitivity analysis results showed ors ranged <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> risk publication bias analyzed beggs test p <NUMBER> eggers regression test p <NUMBER> indicating significant publication bias metaanalysis metaanalysis suggested mortality patients covid<NUMBER> significantly related diabetes <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> meanwhile value <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> indicated heterogeneity exists studies addition sensitivity analysis revealed excluding single study rem converted fem total outcomes still held confident validity data obtained study showing powerful correlation diabetes mortality patients covid<NUMBER> despite unclear pathophysiology observed severe fatal cases covid<NUMBER> occur elderly patients potential complications especially diabetes <NUMBER> according reports diabetes high blood glucose levels important predictors severity death patients infected different viruses involving sarscov merscov <NUMBER> <NUMBER> study found elderly patients chronic diseases including diabetes higher risk severe covid<NUMBER> infection death <NUMBER> insulin resistance promotes synthesis endglycosylation products stimulates production proinflammatory cytokines oxidative stress adhesion molecules resulting higher likelihood infection worse prognosis <NUMBER> infection leads destruction pancreatic beta cells decreased pancreatic insulin content changes hosts ability respond normally glucose tolerance tests <NUMBER> previous study suggested sars coronavirus uses ace<NUMBER> receptor enter damage islet cells cause acute diabetes <NUMBER> relevant study exploring role ace<NUMBER> covid<NUMBER> diabetic patients recent metaanalysis retrieved data <NUMBER> chinese patients diagnosed sarscov<NUMBER> infection found prevalence diabetes <NUMBER> <NUMBER> metaanalysis explored possible mortality diabetes covid<NUMBER> therefore metaanalysis results found significant relationship diabetes mortality covid<NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> may contribute better clinical management patients covid<NUMBER> diabetes compared younger patients patients aged <NUMBER> showed higher risk initial complications severe symptoms prone multiple organ involvement death <NUMBER> similarly feng et al <NUMBER> recruited <NUMBER> covid<NUMBER> patients three different cities china survival rate patients <NUMBER> years old significantly lower young patients factors leading poor health include physiological changes aging multiple agerelated complications study held opinion older peoples suspicion detection threshold sars<NUMBER> lower temperature decline pulmonary function shortness breath <NUMBER> management began diagnosis classification elderly order achieve appropriate level care simultaneously age subgroup analysis results indicated significant difference age ≥ <NUMBER> subgroup age <NUMBER> subgroup however chose threshold age stratification <NUMBER> years old age ≥ <NUMBER> subgroup would <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> research impact age stratification mortality covid<NUMBER> diabetic patients carried first attempt use metaanalysis prove whether mortality patients covid<NUMBER> related diabetes time study limitations first due inadequate data access information diabetes duration time diagnoses diabetes type diabetes medications complications thus cannot conduct risk stratification subgroup analysis within diabetic population second obtained information regarding age gender covid<NUMBER> patients factors might influence accuracy results bmi <NUMBER> measurements instruments detection sarscov<NUMBER> meanwhile populations included study mainly asian populations conclusions even important cannot extended automatically caucasian populations finally patients diagnosed covid<NUMBER> may multiple chronic diseases simultaneously hypertension cardiovascular disease cerebrovascular disease copd may affect accuracy results meanwhile samples quite enough largescale studies needed metaanalysis showed diabetes increases mortality patients covid<NUMBER> results indicated disturbance blood glucose covid<NUMBER> patients importantly metaanalysis grades reliability evidence basic clinical research diabetes dysfunction covid<NUMBER> patients december <NUMBER> pneumonia caused new coronavirus spread wuhan china unbiased sequencing samples patients pneumonia reveals previously unknown type betacoronavirus similar severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> causative agent named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronavirus study group disease caused named coronavirus disease <NUMBER> covid<NUMBER> world health organization <NUMBER> <NUMBER> sarscov<NUMBER> new type highly diverse enveloped positive single stranded rna virus cause range symptoms including selfreported fever fatigue dry cough myalgia diffi corresponding author email address liujinggiwhueducn j liu <NUMBER> authors contributed equally work culty breathing <NUMBER> evidence transmission pattern sarscov<NUMBER> humantohuman spread respiratory droplets caused coughing sneezing <NUMBER> <NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> cases <NUMBER> <NUMBER> <NUMBER> deaths world <NUMBER> nevertheless vaccine antiviral treatment human coronavirus therefore crucial determine drug treatment plan soon possible deal outbreak covid<NUMBER> <NUMBER> corticosteroids good inhibitory effect inflammatory factors often used auxiliary treatment viral pneumonia main antiinflammatory effect glucocorticoids inhibit large number proinflammatory genes encode cytokines chemokines cell adhesion molecules inflammatory enzymes receptors address inflammatory process restore homeostasis <NUMBER> however results clinical studies role corticosteroids remain controversial retrospective study showed vast majority sars patients received satisfactory results use corticosteroids <NUMBER> retrospective observational study mers patients result showed patients given corticosteroids likely require inclusion criteria metaanalysis follows <NUMBER> subjects study patients coronavirus infection <NUMBER> patients divided experimental group using corticosteroids control group using corticosteroids <NUMBER> outcomes included use corticosteroids critical noncritical patients mortality length stay los adverse reactions corticosteroids exclusion criteria <NUMBER> patients enrolled different articles <NUMBER> commentaries editorials case reports letters familybased studies <NUMBER> patients studies <NUMBER> years old two researchers zhenwei yang jialong liu performed inclusion exclusion literature also independently extracted data included studies differences resolved third investigator xixian zhao consensus extracted following variables authors publication year study design viral type population treatment details including corticosteroid use types doses corticosteroids treatments outcome measures use corticosteroids critical noncritical patients mortality los adverse reactions corticosteroids including bacterial infection hyperglycemia hypocalcemia hypokalemia used newcastleottawa scale nos <NUMBER> includes patient selection study comparability outcome assessment three components evaluate quality original study work done two authors zhenwei yang jialong liu agreed upon discussion statistical analyses study performed stata<NUMBER> stata college station tx usa dichotomized data calculated risk ratio rr <NUMBER> confidence interval ci continuous data calculated weighted mean difference wmd <NUMBER> ci heterogeneity among studies assessed chi squared <NUMBER> tests randomeffects model used either p <NUMBER> <NUMBER> <NUMBER> defined significant heterogeneity across articles otherwise fixedeffects model used carried sensitivity analysis stability combined results addition also performed subgroup analysis virus type explore source heterogeneity publication bias assessed funnel plots shown fig <NUMBER> total number records initially determined based search strategy <NUMBER> removing <NUMBER> duplicates deleted another <NUMBER> articles reading title abstract article eliminated <NUMBER> articles reading fulltext articles remaining <NUMBER> studies four enrolled patients two nonadult patients <NUMBER> control group using corticosteroids finally <NUMBER> articles included metaanalysis <NUMBER> <NUMBER> <NUMBER> <NUMBER> study characteristics <NUMBER> patients <NUMBER> articles included systematic review metaanalysis due one article give number people treated corticosteroids <NUMBER> patients sarscov infection two included patients merscov infection remaining two included patients sarscov<NUMBER> infection <NUMBER> articles describing use corticosteroids critical noncritical patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> articles recorded mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> three studies reported los <NUMBER> <NUMBER> <NUMBER> <NUMBER> articles described adverse reactions corticosteroids <NUMBER> <NUMBER> addition studies nos scores ≥<NUMBER> details included study presented table <NUMBER> results showed patients severe conditions likely require corticosteroids therapy rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> fig <NUMBER> significant heterogeneity among studies <NUMBER> <NUMBER> p <NUMBER> random effects model adopted similar results also observed subgroup analysis patients sarscov<NUMBER> infection rr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> patients sarscov infection rr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> sensitivity analysis showed result stable pooled rr nine studies revealed mortality higher patients received corticosteroids therapy rr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> fig <NUMBER> performed subgroup analysis found mortality neither sarscov rr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> merscov rr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> correlated corticosteroids therapy sensitivity analysis showed result stable excluded study <NUMBER> result different previous conclusion los longer corticosteroid group wmd <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> fig <NUMBER> result found subgroup analysis patients sarscov infection wmd <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> shown table <NUMBER> examined publication bias included literature use corticosteroids critical noncritical patients mortality funnel plots showed publication bias use corticosteroids critical noncritical patients fig <NUMBER> might publication bias mortality fig <NUMBER> b sarscov<NUMBER> emerging virus effective antiviral treatment present covid<NUMBER> patients mainly treated symptomatic therapy clinic corticosteroids widely used symptomatic treatment severe pneumonia however considerable controversy whether covid<NUMBER> patients treated corticosteroids russell colleagues recommend corticosteroids used sarscov<NUMBER>induced lung injury shock outside clinical trial <NUMBER> team frontline physicians china different perspective recommended short courses corticosteroids lowtomoderate dose used prudently critical patients covid<NUMBER> pneumonia <NUMBER> important provide evidence corticosteroid treatment patients coronavirus systematic review metaanalysis result indicated patients severe conditions likely require corticosteroids therapy similar results also observed subgroup patients sarscov<NUMBER> infection patients sarscov infection study showed concentrations cytokines interleukin <NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> serum covid<NUMBER> patients higher healthy adults addition cytokines il<NUMBER> il<NUMBER> il<NUMBER> concentrations intensive care unit icu patients higher nonicu patients revealed patients covid<NUMBER> usually accompanied increased immune factors inflammatory responses concentrations immune factors associated severity disease <NUMBER> autopsy revealed bilateral diffuse alveolar injury fibrous mucinous exudate interstitial mononuclear inflammatory infiltration dominated lymphocytes similar sarscov merscov infections <NUMBER> known corticosteroids directly inhibit virus replication main role antiinflammatory suppress immune response <NUMBER> early stage inflammation glucocorticoids reduce capillary dilation inflammatory cell exudation leukocyte infiltration phagocytosis late stage glucocorticoids inhibit excessive proliferation capillaries fibroblasts furthermore binding receptors glucocorticoids inhibit nuclear transcription factorκb nfκb signaling inhibit transcription translation inflammatory factors <NUMBER> explained corticosteroids therapy needed severely ill patients coronavirus infection analysis demonstrated patients treated corticosteroids higher mortality rate longer los might multiple mechanisms contributed outcomes study shows glucocorticoids inhibit production il<NUMBER> interferonγ ifnγ lymphocytes shift cell responses th<NUMBER> th<NUMBER> type induce programmed cell death variety different immunologically relevant cells including immature b cell precursors mature cells <NUMBER> another study find preexisting cd<NUMBER> cells associated lower viral shedding less severe disease <NUMBER> evidence use corticosteroids may lead prolonged removal viral rna airways <NUMBER> blood <NUMBER> feces patients <NUMBER> resulting longer hospital stays ultimately increasing risk mortality addition analysis found patients receiving corticosteroid therapy likely develop bacterial infection due immunosuppression could make disease worse lead death also performed subgroup analysis result indicated mortality neither sarscov merscov associated corticosteroids therapy sensitivity analysis showed use corticosteroids associated mortality excluded study <NUMBER> therefore need treat result caution analysis found patients receiving corticosteroids therapy might cause serious adverse reactions bacterial infection hypokalemia however two studies analysis reported data adverse reactions corticosteroids bias might occurred due limited number patients several metaanalyses explored role corticosteroids viral pneumonia shown adverse consequences metaanalysis corticosteroid use patients sars total <NUMBER> studies corticosteroids included <NUMBER> inconclusive <NUMBER> provided conclusive data harms corticosteroids <NUMBER> metaanalysis corticosteroid use patients influenza pneumonia results showed compared placebo corticosteroids associated higher mortality longer icu los higher rate secondary infection mechanical ventilation days <NUMBER> addition metaanalysis included ten studies <NUMBER> recovered sars patients showed patients received higher cumulative doses longer treatment durations steroids likely develop osteonecrosis <NUMBER> metaanalyses indicated patients coronavirus pneumonia could benefit corticosteroid treatment however limitations metaanalysis first included studies retrospective cohort studies historical control studies etc low level evidence lack randomized controlled trials optimized design second uniform standard time dosage hormones used various studies third effects corticosteroids may influenced therapeutic options antiviral drugs finally due rapid evolution sarscov<NUMBER> situation studies published developments intended reported reasons confidentiality lead publication bias patients severe conditions likely require corticosteroids corticosteroids could lead higher mortality longer los higher rate bacterial infection hypokalemia therefore corticosteroid used caution treatment covid<NUMBER> patients corticosteroids recommended patients mild conditions moderate corticosteroids used patients severe conditions suppress immune response reduce symptoms nevertheless multicenter clinical trials needed verify conclusion authors designed study zhenwei yang jialong liu yunjiao zhou designed literature search searched articles zhenwei yang jialong liu xixian zhao contributed data extraction process authors analysed data zhenwei yang wrote first draft article authors revised article approved final version authors competing interests research work supported research grant national natural science foundation china jing liu grant <NUMBER> wuhan university jing liu grant <NUMBER>kf<NUMBER> world health organization reported severe acute respiratory syndrome coronavirus<NUMBER> known covid<NUMBER> late december <NUMBER> china april <NUMBER> <NUMBER> based report ie httpswwwwho intemergenciesdiseasesnovelcoronavirus<NUMBER>situationreports numbers laboratoryconfirmed cases mortalities <NUMBER> <NUMBER> respectively moreover sequence similarity scores covid<NUMBER> bat sarslike sarscov merscov <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> epidemiologically covid<NUMBER> outbreak spread <NUMBER> countries resulting risk assessment status high purpose several authors recently carried researches covid<NUMBER> mostly based clinical epidemiological views included potential symptoms ways covid<NUMBER> transmission epidemic issues <NUMBER> among hellewell et al proposed stochastic transmission model resulted case contact isolations control covid<NUMBER> outbreak <NUMBER> moreover peeri et al compared epidemics three types coronaviruses namely sars mers covid<NUMBER> concluded frequent outbreaks found two previous ones challenges covid<NUMBER> covered applications internet things iot beneficial control incidence among people <NUMBER> two systematic reviews metaanalysis studies available literature proposed five useful factors ie clinical laboratory imaging features procalcitonin measurements outcomes confirmed cases predicting severity covid<NUMBER> disease <NUMBER>e<NUMBER> current study comparisons incidence mortality well recovery death rates among countries covid<NUMBER> sarscov higher incidence rates performed using metaanalysis approach developed metamums tool statistical analyses used subgroup forest plots using event rate risk ratio statistics data metaanalysis could extracted open datasets <NUMBER> original wellknown data resources covid<NUMBER> world health organization ie https wwwwhointemergenciesdiseasesnovelcoronavirus<NUMBER> situationreports worldometers ie httpswww worldometersinfocoronavirus retrieved parameters countries metaanalyzed total sample size cumulative confirmed cases cumulative mortalities total recovered cases data highrisk countries terms incidence related covid<NUMBER> extracted april <NUMBER> <NUMBER> moreover summary table sarscov available httpswwwwhointcsrsars countrycountry<NUMBER>pdfuaequals<NUMBER> period november <NUMBER> <NUMBER>eaugust <NUMBER> <NUMBER> analysis environment metamums tool comprehensive metaanalysis tool without limitations number size data entry <NUMBER> <NUMBER> analysis dichotomous data done <NUMBER> confidence interval set lower upper limits based risk ratio rr well event rate er interventions involved <NUMBER> calculations analyses pvalues less <NUMBER> statistically significant evaluation heterogeneity analyzed countries calculating <NUMBER> test cochranes q test whenever significant heterogeneity present randomeffects model used otherwise utilize fixedeffects model additionally subgroup analysis carried among target countries compare effect sizes incidence vs mortality recovery vs mortality using risk ratio subgroup analysis performed comparing effect sizes incidence mortality recovery rates using event rate current metaanalysis n <NUMBER> <NUMBER> patients covid<NUMBER> infection n <NUMBER> <NUMBER> sarscov available retrieved initial research worldometer freely accessible databases incidence vs mortality recovery vs mortality ratios also determined indeed subgroup analyses also performed evaluation learning significant differences er rr event rates incidence recovery mortality covid<NUMBER> sarscov infections following incidence event rates covid<NUMBER> sarscov infections forest plots illustrated figure <NUMBER>a showing relationships two infectious diseases logit er <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> logit er <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> incidence rate covid<NUMBER> sarscov p <NUMBER> outcomes apply cumulative incidence rates p <NUMBER> mortality event rates covid<NUMBER> sarscov infections follows forest plots figure <NUMBER>b shows relationships two viral diseases logit er <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> logit er <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> mortality rate sarscov infection covid<NUMBER> infection p <NUMBER> also considering cumulative mortality rate p <NUMBER> recovery event rate covid<NUMBER> sarscov infections forest plots illustrated figure <NUMBER>a showing relations diseases logit er <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> recovery rate sarscov infection covid<NUMBER> infection p <NUMBER> results using cumulative recovery rate p <NUMBER> incidence vs mortality results covid<NUMBER> sarscov infections forest plots illustrated figure <NUMBER>b show relations two diseases log rr <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> log rr <NUMBER> à <NUMBER> <NUMBER> à <NUMBER> ul <NUMBER> à <NUMBER> p <NUMBER> mortality rate higher incidence rate infection groups subgroup analysis showed sars infection mortality rate incidence rate comparison covid<NUMBER> disease p <NUMBER> cumulative incidence vs mortality rateof covid<NUMBER> sarscov infections reflected results p <NUMBER> recovery vs mortality results covid<NUMBER> sarscov infections forest plots illustrated figure <NUMBER> showing relations two diseases log rr <NUMBER> <NUMBER> <NUMBER> <NUMBER> ul <NUMBER> <NUMBER> p <NUMBER> log rr <NUMBER> <NUMBER> <NUMBER> <NUMBER> ul <NUMBER> <NUMBER> p <NUMBER> resulted recovery rate mortality rate infectious groups subgroup analysis shown sars infection recovery rate vs mortality rate higher covid<NUMBER> p <NUMBER> cumulative recovery rate vs mortality rate covid<NUMBER> sarscov infections reflected results p <NUMBER> recent news reported covid<NUMBER> mortality rate combination sars mers <NUMBER> however one note comes statistical analysis whole population world countries essential factors rapid virus spread known also super spreading people played vital role previous sarscov case fatality rate <NUMBER> mers case fatality rate <NUMBER> outbreaks also needs special attention covid<NUMBER> well <NUMBER> summary demonstrated statistical analyses incidence mortality recovery rates covid<NUMBER> sarscov along subgroups analysis hopefully would shed evidence controlling new infectious disease limitations current metaanalysis use open datasets data observational numbers reported incidence mortality recovery values countries higher incidence values highrisk countries based criteria assessment involved current metaanalysis might influenced selection bias future due nature metaanalysis evaluation publication bias possible current metaanalysis provided information incidence mortality recovery rates covid<NUMBER> sarscov infectious diseases based event rate evaluation incidence rate covid<NUMBER> higher sarscovs mortality recovery rates sarscov higher comparison covid<NUMBER> hand risk ratio subgroup analysis incidence vs mortality recovery vs mortality covid<NUMBER> sarscov revealed new findings higher mortality recovery rates sarscov covid<NUMBER> comparison incidence mortality rates respectively declared covid<NUMBER> outbreak caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> pandemic march <NUMBER> <NUMBER> <NUMBER> initially superspreading events cruise ship japan mass gathering religious group south korea skiing resorts italy austria popular pilgrimage city iran contributed rapid dissemination globally since rate global spread accelerated widespread epidemics occurred numerous countries sarscov<NUMBER> virus genetically closely related severe acute respiratory syndrome coronavirus sarscov first pandemic threat novel deadly coronavirus emerged late <NUMBER> caused outbreak severe acute respiratory syndrome sars sarscov highly lethal faded intense public health mitigation measures <NUMBER> contrast novel sarscov<NUMBER> emerged december <NUMBER> rapidly caused global pandemic sars <NUMBER> outbreak ceased june <NUMBER> global total <NUMBER> reported cases <NUMBER> deaths case fatality rate <NUMBER>·<NUMBER> cases acquired nosocomially <NUMBER> comparison middle east respiratory syndrome coronavirus merscovanother deadly coronavirus currently presenting pandemic threatemerged <NUMBER> caused <NUMBER> reported cases <NUMBER> deaths <NUMBER> countries high case fatality rate <NUMBER> <NUMBER> merscov wide spread dromedary camels zoonotic cases continue occur unlike sarscov emerged wildlife eliminated intermediate host reservoir new coronavirus sarscov<NUMBER> less deadly far transmissible merscov sarscov virus emerged december <NUMBER> june <NUMBER> <NUMBER> <NUMBER> months first pandemic wave global count rapidly approaching <NUMBER> million known cases passed <NUMBER> <NUMBER> deaths <NUMBER> broad clinical spectrum high transmissibility eradicating sarscov<NUMBER> done sarscov <NUMBER> seem realistic goal short term personal view summarise key epidemiological characteristics sarscov<NUMBER> comparison epidemic coronaviruses pandemic influenza explore makes sarscov<NUMBER> different pandemic influenza virus epidemic severe coronaviruses sarscov merscov study various characteristics virus including transmission severity characteristics case fatality rates mortality individuals disease • basic reproductive rate r <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> similar higher r <NUMBER> sarscov pandemic influenza • mortality due sarscov<NUMBER> sarscov strongly skewed towards people older <NUMBER> years dissimilar <NUMBER> <NUMBER> influenza pandemics • proportion symptomatic people requiring hospital admission higher sarscov<NUMBER> infections <NUMBER> influenza pandemic • population risk admission intensive care unit five six times higher patients infected sarscov<NUMBER> fairly mild <NUMBER> influenza pandemic • case fatality rate probably around <NUMBER> adjusting asymptomatic mild illness serological studies aid refining estimate estimating ability new pathogen spread key measure emerging disease outbreak metric used describe spread basic reproductive rate r <NUMBER> r <NUMBER> defined average number secondary transmissions one infected person r <NUMBER> greater <NUMBER> epidemic growing r <NUMBER> estimates sarscov sarscov<NUMBER> merscov influenza pandemics summarised appendix p <NUMBER> r <NUMBER> sars outbreak <NUMBER> estimated <NUMBER>•<NUMBER> <NUMBER>•<NUMBER> early months end april public health control measures introduced <NUMBER> various control measures soon reduced transmissibility <NUMBER>·<NUMBER> wide iqr <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> <NUMBER> merscov r <NUMBER> unmitigated estimated <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> consistent merscov never caused sustained epidemics <NUMBER> <NUMBER> sarscov<NUMBER> recent china joint mission concluded trans mission sarscov<NUMBER> mostly driven clusters close contacts particularly family clusters less community transmission <NUMBER> since statement released conclusion challenged although superspreading events continue occur pandemic studies estimated r <NUMBER> <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> <NUMBER>·<NUMBER> <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> therefore average r <NUMBER> <NUMBER>·<NUMBER> seems reasonable estimate appendix p <NUMBER> comparison initial r <NUMBER> estimate <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic <NUMBER>·<NUMBER> <NUMBER> later estimated <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> mitigation initiated <NUMBER> r <NUMBER> <NUMBER> influenza pandemic estimated around <NUMBER>·<NUMBER> first wave july <NUMBER> <NUMBER> r <NUMBER> values important implications disease control r <NUMBER> magnitude indicates level mitigation efforts needed bring epidemic control <NUMBER> mitigation reduces effective transmission coefficient called r e r e needs reduced less <NUMBER> ensure cessation epidemic done rapid case identification quarantine measures physical distancing prevent secondary transmissions childhood diseases measles cessation epidemic spread achieved effective vaccine however vaccine never major tool control pandemics either occurred era modern vaccines <NUMBER> vaccine became available first waves already occurred sarscov<NUMBER> r <NUMBER> value approximately <NUMBER>·<NUMBER> transmission would need reduced <NUMBER> reach r e less <NUMBER> <NUMBER>r <NUMBER> transmissibility coefficient declines time control measures start effect seen successful eradication sarscov <NUMBER> <NUMBER> contrast sarscov sarscov<NUMBER> merscov limited transmissibility even absence mitigation although virus caused several nosocomial outbreaks since <NUMBER> mainly hospitals saudi arabia jordan south korea <NUMBER> three coronaviruses longer incubation period time infection symptom onset influenza viruses one study estimated mean incubation period sarscov<NUMBER> <NUMBER>·<NUMBER> days ranging <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> days <NUMBER> another study estimated median incubation period <NUMBER>·<NUMBER> days found <NUMBER>·<NUMBER> people showed symptoms within <NUMBER>·<NUMBER> days infection <NUMBER> study china estimated incubation period <NUMBER>·<NUMBER> days <NUMBER> notable difference sarscov sarscov<NUMBER> merscov kinetics virus shedding whereas sarscov merscov tropism lower airways less virus present upper respiratory tract tropism different sarscov<NUMBER> sarscov<NUMBER> average viral load family cluster <NUMBER>·<NUMBER> × <NUMBER>⁵ copies per upper respiratory tract swab first <NUMBER> days live virus isolates obtained swabs first week illness <NUMBER> study hong kong <NUMBER> high viral loads found first samples obtained admission hospital finding con firmed study china <NUMBER> found high viral load onset symptoms declined following <NUMBER> days quick decline viral load makes isolation quarantine patients sarscov<NUMBER> contacts much chal lenging less effective done soon possible illness onset order reduce trans mission contrast sarscov viral loads peaked <NUMBER> days symptom onset <NUMBER> <NUMBER> allowing full extra week identify isolate cases transmission occurred difference would part explain sars could eradicated <NUMBER> compared trajectory seen sarscov<NUMBER> pandemic increasing evidence transmission asymptomatic people although proportion individuals presymptomatic remains unknown clear covid<NUMBER> broad clinical picture includes asymptomatic mild illness <NUMBER> <NUMBER> study iceland <NUMBER> found <NUMBER> pcrpositive cases symptoms although individuals showed symptoms later number days remains unknown unofficial data china suggest <NUMBER> cases asymptomatic <NUMBER> viral shedding might occurring prolonged periods study viral load <NUMBER> respiratory tract samples faeces blood <NUMBER> patients covid<NUMBER> found viral load <NUMBER>⁵<NUMBER>⁶ copies per ml <NUMBER> weeks symptom onset viral shedding tended longer stool samples however june <NUMBER> <NUMBER> docu mented evidence faecaloral transmission viral load higher persists longer lower respiratory tract patients severely ill covid<NUMBER> <NUMBER> sars lower respiratory tract infection occurred without upper respi ratory tract infection consequence transmission sarscov infrequent first <NUMBER> days illness <NUMBER> unlike transmission influenza transmission household settings rare <NUMBER> key difference sarscov<NUMBER> pandemic influenza age distribution patients severely ill mortality rate people infected sarscov<NUMBER> increases steeply age fatal outcomes almost exclusively seen people older <NUMBER> years table <NUMBER> agerelated increase severe morbidity mortality also observed sarscov although far greater case fatality hong kong case fatality due sarscov <NUMBER> age group <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> people <NUMBER> years older <NUMBER> <NUMBER> sars covid<NUMBER> children rarely severe illness table <NUMBER> recently rare hyperinflammatory syndrome reported children covid<NUMBER> <NUMBER> one study looking close household contacts people covid<NUMBER> <NUMBER> children adults secondary attack rate <NUMBER> whether children transmit virus effectively adults still unknown clinical case fatality case definition fever respiratory symptoms including pneumonia around <NUMBER> hubei province around <NUMBER> rest china south korea <NUMBER> usa case fatality rates among patients covid<NUMBER> less <NUMBER> people aged <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> people aged <NUMBER> years older early outbreak deaths children young adults younger <NUMBER> years <NUMBER> although patients <NUMBER> covid<NUMBER> mild clinical illness considerable demand intensive care subset patients develop acute respiratory distress syndrome requirement respiratory support higher sarscov<NUMBER> cases influenza pandemic <NUMBER> table <NUMBER> study <NUMBER> patients admitted hospital new york ny usa <NUMBER> required intensive care median age <NUMBER> years danish study <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic <NUMBER> found proportion patients pandemic influenza never exceeded <NUMBER>·<NUMBER> total national intensive care unit icu bed capacity icu admission rate estimated approximately one patient per <NUMBER> patients infected influenza h<NUMBER>n<NUMBER> <NUMBER> figures lacking covid<NUMBER> pandemic evident icu capacity pandemic crucial element lombardy italy estimated <NUMBER>·<NUMBER> covid<NUMBER> cases needed icu bed <NUMBER> comparing rates difficult people <NUMBER> pandemic younger <NUMBER> years whereas sarscov<NUMBER> affects mainly older individuals compared key variables features <NUMBER> <NUMBER> influenza pandemics sarscov<NUMBER> sarscov merscov table <NUMBER> fatality rates <NUMBER> italy <NUMBER> average age death italy <NUMBER> years mortality italy people older <NUMBER> years <NUMBER> <NUMBER> mortality impact seasonal pandemic influenza long estimated excess mortality baseline excess mortality ideally estimated mortality time series updated per week end pandemic <NUMBER> <NUMBER> study excess mortality <NUMBER> influenza pandemic used data <NUMBER> countries <NUMBER> found global burden approximately <NUMBER> <NUMBER> deaths mean excess mortality seasonal influenza <NUMBER>·<NUMBER>·<NUMBER> per <NUMBER> <NUMBER> people younger <NUMBER> years <NUMBER>·<NUMBER>·<NUMBER> per <NUMBER> <NUMBER> people aged <NUMBER> years <NUMBER>·<NUMBER>·<NUMBER> per <NUMBER> <NUMBER> people aged <NUMBER> years older <NUMBER> early study excess mortality covid<NUMBER> south korea italy studies china would helpful june <NUMBER> <NUMBER> lombardy italy mortality rate covid<NUMBER> reached <NUMBER> per <NUMBER> <NUMBER> population <NUMBER> notably data end outbreak numbers expected increase patients spent <NUMBER> weeks intensive care thus yet resolved infection timely european morbidity mortality euromomo surveillance system updated per week great resource accessing excess mortality studies relating covid<NUMBER> pandemic european countries <NUMBER> website shows z score elevations time series deaths due cause allowing comparison elevations caused seasonal influenza euromomo data show high covid<NUMBER> associated excess mortality number countries including italy spain uk sweden whereas countries germany norway greece found low excess mortality appendix p <NUMBER> case fatality rates shown table <NUMBER> <NUMBER> usa centers disease control prevention also reports substantial elevation national respiratory deaths <NUMBER> com parison influenza pandemic excess mortality ranged extreme <NUMBER> mild <NUMBER> past <NUMBER> years table <NUMBER> study modelling global excess mortality moderate <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic <NUMBER> found respiratory excess mortality rate <NUMBER>·<NUMBER> deadly <NUMBER> influenza pandemic estimates show <NUMBER> global population died <NUMBER> however excess mortality <NUMBER> pandemic much greater severe seasonal influenza <NUMBER>·<NUMBER> deaths global population <NUMBER> <NUMBER> mean age death varied greatly past pandemics one excess mortality study also looked excess years life lost <NUMBER> using years life lost metric study found three influenza pandemics <NUMBER> <NUMBER> <NUMBER> similar size effect although early draw conclusions effect covid<NUMBER> might higher terms excess mortality possibly numbers somewhere <NUMBER> <NUMBER> influenza pandemics however terms excess years life lost mean age <NUMBER> years covid<NUMBER> fatalities covid<NUMBER> pandemic would score lower perhaps similarly <NUMBER> <NUMBER> influenza pandemics time data needed covid<NUMBER> pandemic accurately compared past pandemics broad clinical spectrum become evident find true attack rate sarscov<NUMBER> serological studies needed meanwhile look reported cases deaths number tests per <NUMBER> <NUMBER> population understanding testing broader clinical case definition mean higher rate cases currently country different phase pandemic lead bias early country comparisons official figures available usa south korea uk spain germany south africa table <NUMBER> appendix pp <NUMBER> feb <NUMBER> <NUMBER> hubei earliest affected province china <NUMBER> <NUMBER> confirmed cases covid<NUMBER> <NUMBER> deaths reported <NUMBER> figures correspond <NUMBER>·<NUMBER> population affected mortality rate <NUMBER>·<NUMBER> per <NUMBER> <NUMBER> population low compared certain countries europe <NUMBER> possibly people mild symptoms tested <NUMBER> <NUMBER> <NUMBER> serological surveys shed light discrepancies comparison seasonal influenza attack rates range <NUMBER> every winter <NUMBER>  recent study <NUMBER> modelled possible scenarios covid<NUMBER> <NUMBER> basis epidemiology seasonal coronaviruses oc<NUMBER> hku<NUMBER> study assumed wintertime r <NUMBER> <NUMBER>·<NUMBER> summertime r <NUMBER> <NUMBER>·<NUMBER> predicted winter cycles covid<NUMBER> pandemic phase comparison h<NUMBER>n<NUMBER> influenza pandemic started mexico february <NUMBER> june total <NUMBER> countries reported <NUMBER> <NUMBER> laboratoryconfirmed cases <NUMBER> july <NUMBER> peak h<NUMBER>n<NUMBER> influenza infections seen copenhagen second wave hit november <NUMBER> <NUMBER> previous pandemics shown influenza transmission occur summer seasonality difficult predict temperature humidity makes difference viral survival environment study using enveloped virus phi<NUMBER> surrogate virus <NUMBER> found infectivity sensitive temperature decreased two orders magnitude <NUMBER>°c <NUMBER>°c data effect temperature available sarscov study sarscov found twolog reduction virus titre <NUMBER> h <NUMBER>°c <NUMBER> humidity <NUMBER> <NUMBER>°c sarscov persisted <NUMBER> days lowest level inactivation occurred <NUMBER> relative humidity inacti vation faster <NUMBER>°c <NUMBER>°c humidity levels experimental data suggest sarscov<NUMBER> might less able survive summer mortality study <NUMBER> <NUMBER> cities usa <NUMBER> influenza pandemic found cities implemented mitigation strategies early delayed flatter epidemic curve <NUMBER> lower peak mortality <NUMBER> lower overall mortality thus mitigating policies paramount importance ensure burden healthcare system remains manageable examples china south korea early signs bending curve seen europe show influencing spread sarscov<NUMBER> possible however socio economical costs enormous long lasting radical containment measures used curb pandemic affected countries approach taken south korea especially effective done rapidly applying extensive testing quarantine contact tracing individuals large church group early stages outbreak also schools closed international arrivals quarantined <NUMBER> weeks <NUMBER> china south korea singapore show mitigation using combination contact tracing rigorous social distancing measures possible <NUMBER> however new outbreaks started occur countries renewed control measures implemented countries denmark italy spain germany relied mostly social distancing hygiene measures population lockdowns various magnitudes intensity draconic measures used epidemics progressing fast capacity effective case identification contact tracing containment became impossible consensus rigorous mitigation measures needed early slow sarscov<NUMBER> transmission <NUMBER> drastic measures quarantine mobility restrictions put place china europe usa different used plague <NUMBER>th century covid<NUMBER> pandemic far shown measures could possibly halt pandemic individuals follow specific country guidelines first disease x scenario become reality <NUMBER> sarscov<NUMBER> pandemic already caused severe morbidity mortality older adults much higher pandemic influenza although children clearly less affected role transmission virus still needs studied early stage pandemic effective treatments antivirals passive immunisation schemes development safe effective vaccine take time thus supportive treatment hos pitals currently available efforts slow limit spread virus continue goal reduce impact virus prevent overwhelming healthcare system protect people highest risk severe outcomes waiting effective vaccine treatments historical evidence influenza pandemics occurred past century shows us pandemics personal view tend come waves first <NUMBER> years population immunity buildsup naturally vaccination number infected cases tends decrease observation likely trajectory sarscov<NUMBER> virus however near future require transition new normal combination physical distancing enhanced testing quarantine contact tracing needed long time clinical research testing antivirals vaccine candidates ongoing scientists learn regions countries first affected also epidemiological phylogenetic studies yield much information risk factors age disease transmission role children transmission better estimate case fatality highly likely sarscov<NUMBER> another pandemic might another coronavirus influenza virus paramyxovirus completely new disease believe learning experience crucial meet future pandemic threat far better preparation terms testing adequate stocks personal protective equipment critical care capability international pandemic planning needed ensure collaboration countries including better surveillance emerging infections especially zoonoses controlling outbreak everything mitigating casualties economic losses joblessness loneliness even loss human dignity end life ep sak drafted personal view mk contributed description influenza virus merscov sarscov sarscov<NUMBER> ug dhh np fc ms helped data ug provided expertise south korea dhh provided expertise usa np fc provided expertise italy ms contributed data denmark ls contributed historical analysis previous influenza pandemics mk received funding versatile emerging infectious disease observatory horizon <NUMBER> project grant <NUMBER> dhh supported cooperative agreement u<NUMBER> c<NUMBER> us centers disease control prevention international society travel medicine ls supported carlsberg foundation grant c<NUMBER> authors declare competing interests editorial note lancet group takes neutral position respect territorial claims published maps institutional affiliations respiratory viruses wellknown causes acute exacerbation chronic obstructive pulmonary disease aecopd also important pathogens concomitant pneumonia copd cpcopd however differences viral infection pattern clinical impacts respiratory viruses two groups well investigated clinical microbiological data copd patients admitted aecopd n ¼ <NUMBER> cpcopd n ¼ <NUMBER> january <NUMBER> december <NUMBER> reviewed excluding <NUMBER> patients <NUMBER> aecopd <NUMBER> cpcopd undergo multiplex rtpcr test respiratory viruses demographic characteristics identified viruses clinical outcomes aecopd cpcopd groups compared respiratory viruses identified <NUMBER> aecopd group <NUMBER> cpcopd groups common virus influenza virus aecopd group <NUMBER> versus human coronavirus <NUMBER> cpcopd group influenza virus significantly common aeacopd group cpcopd group p <NUMBER> inhospital mortality aecopd cpcopd <NUMBER> <NUMBER> respectively p <NUMBER> among cpcopd patients inhospital mortality patients viral infection group bacterial infection group viralbacterial coinfection <NUMBER> <NUMBER> <NUMBER> respectively p ¼ <NUMBER> respiratory viruses commonly identified aecopd cpcopd influenza virus human coronavirus common viruses identified aecopd cpcopd patients respectively mortality rates viral infection group significantly lower bacterial infection viralbacterial coinfection group cpcopd patients j med virol <NUMBER> <NUMBER> <NUMBER> chronic obstructive pulmonary disease copd one leading global causes mortality morbidity pingleton et al <NUMBER> pena et al <NUMBER> according recent study overall prevalence copd estimated high <NUMBER> worlds population soriano et al <NUMBER> acute exacerbation copd aecopd concomitant pneumonia copd cpcopd two serious conditions often complicate copd wedzicha seemungal <NUMBER> mullerova et al <NUMBER> respiratory viruses wellknown cause aecopd responsible <NUMBER> aecopd seemungal et al <NUMBER> rohde et al <NUMBER> recently newly discovered respiratory viruses human metapneumovirus human coronavirus nl<NUMBER> hku<NUMBER> bocavirus added important causes aecopd ringshausen et al <NUMBER> kherad et al <NUMBER> also development application technology detect viral nucleic acid detection respiratory viruses aecopd markedly improved mohan et al <NUMBER> hand role respiratory viruses cpcopd well investigated recently reports role respiratory viruses cpcopd patients mallia johnston <NUMBER> ko et al <NUMBER> molinos et al <NUMBER> vanspauwen et al <NUMBER> moreover previous studies several limitations focused specific virus influenza virus mallia johnston <NUMBER> rtpcr test performed small portion studies patients ko et al <NUMBER> molinos et al <NUMBER> furthermore best knowledge none prior studies compared viral etiologies clinical outcomes aecopd cpcopd aimed investigate distributions clinical impact respiratory viruses aecopd cpcopd patients retrospective cohort study performed asan medical center <NUMBER>bed tertiary referral hospital seoul republic korea current study focused copd patients admitted january <NUMBER> december <NUMBER> patients admitted hospital due copd study period screened diagnosed aecopd cpcopd included study see definitions data regarding clinical outcomes microbiologic results collected according standardized protocol patient admitted hospital study period first admission included aecopd cpcopd groups also clinical samples obtained patients within first <NUMBER> hr admission included study study protocol approved institutional review board asan medical center informed consent waived due retrospective nature study diagnosis severity copd defined global initiative chronic obstructive lung disease gold guidelines vestbo et al <NUMBER> aecopd defined clinically presentation least two following symptoms increased shortness breath increased sputum volume purulence definite pneumonic infiltration chest xray anthonisen et al <NUMBER> cpcopd defined pneumonia copd patients pneumonia defined presence new radiographic pulmonary infiltration plus two following fever <NUMBER>˚c higher hypothermia <NUMBER>˚c ii leukocytosis leukopenia white blood cells <NUMBER>mm <NUMBER> <NUMBER>mm <NUMBER> iii purulent tracheal aspirate sputum pingleton et al <NUMBER> mandell et al <NUMBER> microbiological examination included gram stain culture sputum endotracheal aspirates bronchoalveolar lavage bal fluid blood cultures binax urinary antigen test streptococcus pneumoniae legionella pneumophilia serogroup <NUMBER> binax inc portland pcr assay using bd probetec et atypical pneumonia assay becton dickinson diagnostic systems sparks md used detect atypical pathogens including mycoplasma pneumoniae chlamydophilia pneumoniae l pneumophila viral detection multiplex rtpcr kit seeplex <NUMBER>rv ace detection kit seegene inc seoul korea influenza virus b respiratory syncytial virus b adenovirus human metapneumovirus parainfluenza virus types <NUMBER> <NUMBER> enterovirus rhinovirus human coronavirus <NUMBER>e nl<NUMBER> oc<NUMBER> hku<NUMBER> used rtpcr kit used study validated published studies bibby et al <NUMBER> gharabaghi et al <NUMBER> data aecopd cpcopd groups compared using students ttest mannwhitney u test continuous variables x <NUMBER> test fishers exact test categorical data also multivariate logistic regression analysis performed identify independent risk factors mortality particularly cpcopd patients variables showing reasonable relationship mortality pvalues less <NUMBER> univariate analysis included multivariate analysis results expressed adjusted odds ratios aors <NUMBER> confidence intervals cis furthermore performed separate x <NUMBER> test inhospital mortality cpcopd patients different etiologies pvalues twotailed statistical significance set p <NUMBER> statistical analyses performed using spss version <NUMBER> windows ibm spss inc chicago il <NUMBER>yearstudy period total <NUMBER> copd patients admitted asan medical center patients <NUMBER> patients classified aecopd group <NUMBER> patients classified cpcopd group excluding <NUMBER> patients <NUMBER> aecopd <NUMBER> cpcopd undergo multiplex rtpcr test respiratory viruses <NUMBER> aecopd patients <NUMBER> cpcopd patients finally included analysis table shows baseline characteristics patients laboratory data mean age aesd <NUMBER> ae<NUMBER> <NUMBER> patients <NUMBER> male diabetes mellitus common comorbidity followed congestive heart failure malignancy congestive heart failure tended common aecopd group <NUMBER> vs <NUMBER> p ¼ <NUMBER> recent fev <NUMBER> significantly lower aecopd cpcopd group <NUMBER> predicted value vs <NUMBER> p ¼ <NUMBER> aecopd patients also likely receive systemic steroid treatment <NUMBER> vs <NUMBER> p <NUMBER> home oxygen therapy time admission <NUMBER> vs <NUMBER> p ¼ <NUMBER> median values white blood cells counts creactive protein crp level procalcitonin level significantly higher cpcopd patients baseline characteristics shown table si analyzed respiratory samples respiratory samples comprised nasal swabs sputum samples n ¼ <NUMBER> bal n ¼ <NUMBER> n ¼ <NUMBER> table ii includes distributions pathogens identified one respiratory pathogens identified <NUMBER> aecopd patients <NUMBER> <NUMBER> cpcopd patients <NUMBER> p <NUMBER> among aecopd patients <NUMBER> patients viral infections <NUMBER> <NUMBER> <NUMBER> bacterial infections <NUMBER> <NUMBER> <NUMBER> immunosuppresed hosts follows daily administration corticosteroids least <NUMBER> mg per day prednisolone equivalent drug ii solid organ hematopoietic stem cell transplant recipients iii patients received chemotherapy underlying malignancy last <NUMBER> months iv patients underlying acquired immune deficiency disorder table ii indicates distributions viral pathogens identified groups viral infections tended common aecopd group p ¼ <NUMBER> influenza virus n ¼ <NUMBER> commonly identified virus aecopd group followed rhinovirus n ¼ <NUMBER> parainfluenza virus n ¼ <NUMBER> human coronavirus n ¼ <NUMBER> contrast human coronavirus common virus cpcopd group n ¼ <NUMBER> followed rhinovirus n ¼ <NUMBER> parainfluenza virus n ¼ <NUMBER> influenza virus n ¼ <NUMBER> influenza virus significantly common aecopd group cpcopd group <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> p <NUMBER> almost influenza virus types identified two groups type <NUMBER> aecopd <NUMBER> cpcopd table ii also lists distributions bacterial pathogens groups bacterial infections significantly common cpcopd group p <NUMBER> pneumoniae n ¼ <NUMBER> commonly identified aecopd group followed pseudomonas aeruginosa n ¼ <NUMBER> klebsiella pneumoniae n ¼ <NUMBER> staphylococcus aureus n ¼ <NUMBER> contrast aureus common bacteria cpcopd group n ¼ <NUMBER> followed acinetobacter baumannii n ¼ <NUMBER> p aeruginosa n ¼ <NUMBER> k pneumonia n ¼ <NUMBER> aureus baumannii significantly common cpcopd group aecopd group p <NUMBER> figure <NUMBER> shows seasonal distribution admitted patients study period number admitted patients largest winter season december february groups figure s<NUMBER> shows seasonal distribution viral pathogen aecopd cpcopd influenza virus predominated december february parainfluenza virus human coronavirus mainly present may november january june respectively human metapneumovirus peaked spring season april may rhinovirus respiratory syncytial virus present throughout year little winter season dominancy table iii compares clinical outcomes aecopd cpcopd groups despite initial icu admission rate significantly different groups <NUMBER> vs <NUMBER> p ¼ <NUMBER> cpcopd patients initially admitted general ward likely need icu care aecopd patients hospital stay <NUMBER> vs <NUMBER> p <NUMBER> among patients needed icu care median length icu stay <NUMBER> vs <NUMBER> days p <NUMBER> total mechanical ventilation time <NUMBER> hr vs <NUMBER> hr p <NUMBER> significantly longer cpcopd group median hospital stay significantly longer cpcopd group <NUMBER> vs <NUMBER> days p <NUMBER> inhospital mortality significantly higher cpcopd group <NUMBER> vs <NUMBER> p <NUMBER> among cpcopd patients inhospital mortalities patients viral infection group bacterial infection group viralbacterial coinfection <NUMBER> <NUMBER> <NUMBER> respectively p ¼ <NUMBER> table sii however difference inhospital mortality groups among aecopd patients p ¼ <NUMBER> table siii results separate x <NUMBER> test conducted using data inhospital mortality among cpcopd patients revealed viral infection group significantly better outcome bacterial infection p <NUMBER> viral bacterial coinfection p <NUMBER> groups however inhospital mortality rates patients bacterial infection alone viralbacterial coinfections significantly different p ¼ <NUMBER> univariate logistic regression analysis identified single viral infection significant independent predictor <NUMBER> day mortality cpcopd patients hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p ¼ <NUMBER> single viral infection remained significant predicting factor multivariate logistic regression analysis hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p ¼ <NUMBER> table siv respiratory viruses frequently identified aecopd <NUMBER> cpcopd <NUMBER> distribution identified viruses two groups showed different patterns influenza virus common pathogen aecopd versus human coronavirus cpcopd rhinovirus reported common cause aecopd majority prior investigations seemungal et al <NUMBER> rohde et al <NUMBER> hutchinson et al <NUMBER> mcmanus et al <NUMBER> hershenson <NUMBER> although human metapneumovirus martinello et al <NUMBER> respiratory syncytial virus dimopoulos et al <NUMBER> occasionally reported common cause found influenza virus <NUMBER> commonly identified virus aecopd group followed rhinovirus <NUMBER> hong kong group also showed influenza virus commonly identified aecopd patients ko et al <NUMBER> however findings interpreted caution studies included aecopd patients admitted general hospitals therefore bias might introduced less severely affected patients come tertiary care hospital unexpectedly human coronavirus commonly identified virus cpcopd group reported excluding outbreaks severe acute respiratory syndrome sarscoronavirus peiris et al <NUMBER> human coronavirus never regarded common cause pneumonia presence viruses pneumonia patients necessarily mean viruses true pathogen pneumonia current study <NUMBER> cpcopd patients human coronavirus infection <NUMBER> <NUMBER> bacterial coinfection including six aureus two pneumoniae prior report showed increase aureus acquisition sars period yap et al <NUMBER> recently polish group reported human coronavirus nl<NUMBER> increases streptococcal adherence respiratory epithelial cells golda et al <NUMBER> human coronavirus nl<NUMBER> infection associated increase plateletactivating factor receptor pafr expression promotes adherence pneumoniae study supports work golda et al saw events vitro assay finding suggests human coronavirus infection might associated risk pneumonia development bacterial coinfection copd patients studies needed confirm result regarding bacterial pathogens identified present investigation aureus baumannii significantly commonly identified cpcopd group aecopd group bacteria well known cause healthcare associated pneumonia hcap hospital acquired pneumonia hap yoo et al <NUMBER> however baumannii listed cause aecopd aureus uncommon cause aecopd approximately <NUMBER> domenech et al <NUMBER> reissig et al <NUMBER> exposure recent antibiotics hospital stay might influenced type pathogen <NUMBER> cpcopd events hospitalacquired infections health care associated pneumonia patients cpcopd aureus group received antibiotics frequently pathogen group <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> p <NUMBER> addition previous studies performed korea showed aureus baumannii important pathogens particularly hcap hap patients ranges <NUMBER> <NUMBER> respectively choi et al <NUMBER> hong et al <NUMBER> although aecopd patients greater severity disease cpcopd patients baseline pulmonary function test cpcopd patients associated poorer clinical outcomes aecopd patients terms length hospital stay hospital mortality found investigators date compared outcomes aecopd cpcopd recently spanish group compared clinical outcomes <NUMBER> aecopd patients <NUMBER> cpcopd patients huerta et al <NUMBER> similar results study aecopd patients greater severity disease cpcopd patients however results inhospital mortalities aecopd group cpcopd group <NUMBER> <NUMBER> respectively quite different patients especially cpcopd group <NUMBER> aecopd group <NUMBER> cpcopd group thought differences might reflect different severities illness two patient populations icu admission rate patients two groups different spanish study <NUMBER> aecopd group <NUMBER> cpcopd group versus <NUMBER> <NUMBER> studied patients difference might explain outcome difference two groups among patients viral infection regard bacterial coinfection <NUMBER> aecopd patients <NUMBER> cpcopd patients bacterial coinfection respectively notably among cpcopd patients viral infection group significantly better outcomes bacterial infection group viral bacterial coinfection group finding suggests bacterial coinfection complicates viral infection lead poorer outcomes however according separate x <NUMBER> test mortality rates patients bacterial infection alone virusbacteria coinfection significantly different thus seems impact viral infection mortality cpcopd patients bacterial infection may nearly patients tertiary referrals hospitals study population might representative general population third viruses identified sensitive rtpcr could bystanders rather causative pathogens admitted patients neither aecopd cpcopd included controls might indirectly able estimate proportion nonsignificant colonizers however possible due retrospective design study also difficult establish causeeffect relationship clear whether people developed aecopd cpcopd following infection fourth study include control patients viral infection alone without aecopd cpcopd thus difficult determine precise role virus mortality due aecopd cpcopd also due retrospective nature study data missing example difficult obtain accurate time transfer hospitals data prior antibiotics use since often know long patient resident transferring hospital could take account finally since number virus relatively small characteristics viral infection could compared groups conclusion respiratory viral infection common aecopd cpcopd however distribution respiratory viruses involved different two groups patients clinical outcomes cpcopd patients viral infection better bacterial infection viralbacterial coinfection factors associated clinical outcomes cpcopd patients included age presence bacterial infection findings warrant future studies larger scale appropriate control patients yk contributed study conception design hck shc jwh hss sbh cml contributed acquisition data hck shc yk contributed analysis interpretation data hck shc contributed statistical analysis hck shc yk contributed writing manuscript hck shc jwh sbh cml yk contributed review accepting manuscript yk identified guarantor paper taking responsibility integrity work whole inception published article coronavirus disease <NUMBER> covid<NUMBER> new disease within four months origin wuhan china spread two hundred countries around world affecting <NUMBER> people caused <NUMBER> deaths april <NUMBER> <NUMBER> <NUMBER> march <NUMBER> <NUMBER> world health organization declared covid<NUMBER> pandemic alarming levels spread severity inaction <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> sufficiently genetically divergent closely related severe acute respiratory syndrome coronavirus sarscov considered new humaninfecting betacoronavirus <NUMBER> mainly affects respiratory tract illness ranges severity asymptomatic mild severe critical disease although current estimate case fatality rate covid<NUMBER> <NUMBER> <NUMBER> patients may become severe critically ill requiring icu care mechanical ventilation <NUMBER> since covid<NUMBER> new disease knowledge disease still incomplete evolving many casecontrol studies shown patients covid<NUMBER> underlying diabetes mellitus develop severe clinical course also increased mortality however studies small sample size data heterogenous conflicting addition data prevalence diabetes patients covid<NUMBER> also clear hence metaanalysis conducted primary objective exploring relationship underlying diabetes severity mortality covid<NUMBER> disease secondary objective determining prevalence diabetes patients covid<NUMBER> since metaanalysis therefore institutional board ethics committee approval required prisma preferred reporting items systematic reviews metaanalyses moose metaanalysis observational studies epidemiology guidelines consulted stages design analysis reporting metaanalysis <NUMBER> <NUMBER> <NUMBER> protocol metaanalysis registered international prospective register systematic reviews prospero vide registration number crd<NUMBER> available full nihr national institute health research website httpswwwcrdyorkacukprosperodisplayrecordphprecordid<NUMBER> three authors ak saa sk independently searched screened selected studies according search inclusion exclusion criteria pubmed database searched papers english language using following keywords <NUMBER>ncov ncov<NUMBER> novel coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> coronavirus coronavirus covid<NUMBER> corona virus since first report covid<NUMBER> disease published december <NUMBER> <NUMBER> <NUMBER> limited search articles published since january <NUMBER> <NUMBER> last search performed april <NUMBER> <NUMBER> since high likelihood duplicate publications covid<NUMBER> <NUMBER> especially set patients reported english well chinese languages hence restricted search papers published english language reason restricted search pubmed database search databases addition included study carefully evaluated study setting author list exclude duplicate publication inclusion exclusion criteria studies follows <NUMBER> studies english language pubmed database <NUMBER> study design casecontrol categorized patients two groups depending severity clinical course mortality patients covid<NUMBER> ie composite endpoint studies without categorization included study data diabetes mellitus group <NUMBER> study observational retrospective prospective interventional studies controlled uncontrolled drug trials excluded <NUMBER> study included least <NUMBER> patients covid<NUMBER> <NUMBER> participants adult patients covid<NUMBER> studies describing exclusively pediatric population excluded however studies adult pediatric patients included studies describing exclusively pregnant women also excluded following data extracted study date online publication pmid number study setting total number patients demographic data number patients composite endpoint number patients diabetes mellitus among patients without composite endpoint studies missing data corresponding authors studies contacted request provide missing data primary outcome interest occurrence composite endpoint purpose study labelled severe clinical course defined occurrence one two endpoints depending studys <NUMBER> <NUMBER> iii american thoracic society guidelines <NUMBER> patients features severe clinical course categorized good clinical course secondary outcome interest study prevalence diabetes mellitus patients covid<NUMBER> assessment quality studies including risk bias national institute health nih tool casecontrol studies used tool developed jointly national heart lung blood institute nhlbi research triangle institute international <NUMBER> uses composite score twelve domains domain scored <NUMBER> <NUMBER> depending response yes respectively studies categorized good quality scored ≥<NUMBER> points fair quality scored <NUMBER> points poor quality scored <NUMBER> points categorical data displayed n continuous data mean sd study reported data median iqr range method described wan et al used calculate mean sd <NUMBER> study prevalence diabetes mellitus patients covid<NUMBER> pooled proportion <NUMBER> confidence interval ci taken effect size first raw proportion study extracted transformed freemantukey double arcine method stabilize variance <NUMBER> pooled proportion obtained using dersimonianlaird random effects model <NUMBER> study association diabetes mellitus composite endpoint severe clinical course pooled odds ratio <NUMBER> ci taken effect size performed metaanalysis using generic inverse variance approach dersimonianlaird random effects model <NUMBER> p value <NUMBER> used show statistically significant association metaanalysis subgrouped according composite endpoint severe disease mortality assess heterogeneity among studies <NUMBER> statistic calculated <NUMBER> value <NUMBER> indicated substantial heterogeneity take care heterogeneity among studies calculate conservative result odds ratios pooled using random effects model explore source heterogeneity metaregression analysis done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates addition heterogeneity among studies ≥<NUMBER> sensitivity analysis also performed identifying removing outlier studies evaluated publication bias visual inspection funnel plot begg <NUMBER> egger <NUMBER> tests funnel plot symmetrical p value begg egger tests <NUMBER> significant publication bias considered exist metaanalysis however publication bias found trim fill analysis duval tweedie <NUMBER> used evaluate number missing studies recalculation pooled odds ratio done addition missing hypothetical studies using keywords <NUMBER>ncov ncov<NUMBER> novel coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> coronavirus coronavirus covid<NUMBER> corona virus limiting entrez date <NUMBER>jan<NUMBER> <NUMBER>apr<NUMBER> initially <NUMBER> publications english language retrieved pubmed database screened relevance figure <NUMBER> carefully going abstracts full texts needed publications <NUMBER> potentially relevant studies selected evaluated detail potential inclusion <NUMBER> studies excluded following reasons <NUMBER> <NUMBER> studies comparative data covid<NUMBER> patients without composite endpoint <NUMBER> <NUMBER> studies small less <NUMBER> participants <NUMBER> <NUMBER> studies diabetes one comparative factors <NUMBER> <NUMBER> study duplicate publication hence remaining <NUMBER> studies included qualitative well quantitative synthesis metaanalysis figure <NUMBER> study characteristics <NUMBER> included studies given table <NUMBER> online publication date studies pubmed database february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> twenty <NUMBER> <NUMBER> studies single centres remaining <NUMBER> <NUMBER> multicentre studies studies <NUMBER> <NUMBER> mainland china remaining <NUMBER> studies two <NUMBER> usa one <NUMBER> france total included patients <NUMBER> <NUMBER> <NUMBER> reported mainland china <NUMBER> <NUMBER> usa <NUMBER> <NUMBER> france median number patients included studies <NUMBER> iqr <NUMBER> quality study assessed using nih tool casecontrol studies <NUMBER> results shown table <NUMBER> scores follows <NUMBER> score <NUMBER> studies <NUMBER> <NUMBER> score <NUMBER> studies <NUMBER> <NUMBER> score <NUMBER> study <NUMBER> twelve domains assessed tool three domains studies given <NUMBER> score sample size justification blinding assessors adjusting confounding variables thus <NUMBER> studies <NUMBER> judged good quality scores ≥<NUMBER> remaining <NUMBER> study <NUMBER> judged fair quality scores <NUMBER> none included study judged poor single study fair quality paper published cdc usa covid<NUMBER> cases reported us <NUMBER> thus registry data rather hospitalbased study table <NUMBER> shows characteristics included patients total number patients <NUMBER> proportion males <NUMBER> <NUMBER> thus male female ratio approximately <NUMBER> <NUMBER> pooled mean age <NUMBER>±<NUMBER> years <NUMBER> patients <NUMBER> <NUMBER> patients composite endpoint labelled severe clinical course reasons composite endpoint mortality <NUMBER> studies <NUMBER> <NUMBER> patients severity <NUMBER> studies <NUMBER> <NUMBER> patients <NUMBER> studies severity composite endpoint reasons follows predefined criteria <NUMBER> studies icu requirement versus requirement <NUMBER> studies invasive ventilation requirement versus requirement <NUMBER> studies progressive disease versus stable disease <NUMBER> studies refractory disease versus responsive disease <NUMBER> study ards versus ards <NUMBER> study diabetes present <NUMBER> patients total <NUMBER> patients covid<NUMBER> pooled prevalence diabetes calculated <NUMBER> <NUMBER> ci <NUMBER> using freemantukey double arcine transformation dersimonianlaird random effects model figure <NUMBER> however heterogeneity among studies substantial <NUMBER> value <NUMBER> explore source heterogeneity metaregression analyses done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates supplementary table <NUMBER> supplementary figure <NUMBER> results metaregression showed proportion diabetes patients covid<NUMBER> influenced age studies higher patient age higher proportion diabetes p<NUMBER> type composite endpoint studies reporting mortality endpoint higher proportion diabetes p<NUMBER> country study studies outside china higher proportion diabetes p<NUMBER> influence number patients studies quality score studies subgroup analysis revealed proportion diabetes mellitus china <NUMBER> <NUMBER> ci <NUMBER> countries china mainly usa <NUMBER> <NUMBER> ci <NUMBER> high heterogeneity data shown sensitivity analysis also done excluding <NUMBER> outlier studies revealed pooled prevalence diabetes <NUMBER> <NUMBER> ci <NUMBER> patients covid<NUMBER> acceptable <NUMBER> value <NUMBER> supplementary figure <NUMBER> <NUMBER> included studies metaanalysis <NUMBER> used severity composite endpoint <NUMBER> used mortality composite endpoint presence diabetes found significantly associated severe covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> well mortality due covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> combine pooled odds ratio composite endpoints labelled severe clinical course <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER> mortality endpoint heterogeneity among studies low <NUMBER> <NUMBER> severity endpoint heterogeneity among studies substantial <NUMBER> <NUMBER> thus combined heterogeneity also substantial <NUMBER> <NUMBER> explore source heterogeneity metaregression analyses done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates supplementary table <NUMBER> supplementary figure <NUMBER> results metaregression showed odds ratio influenced age studies higher patients age lower odds ratio p<NUMBER> addition found cdc study usa <NUMBER> good quality registry data significantly influenced outcome metaanalysis mainly responsible significant heterogeneity hence sensitivity analysis performed excluding study revealed significant combined pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> <NUMBER> value <NUMBER> acceptable heterogeneity supplementary figure <NUMBER> main outcome metaanalysis ie association diabetes mellitus severe clinical course covid<NUMBER> publication bias evaluated visual inspection funnel plot begg egger tests <NUMBER> <NUMBER> funnel plot figure <NUMBER> found mildly asymmetric beggs rank correlation test funnel plot asymmetry kendalls τ <NUMBER> well eggers regression test funnel plot asymmetry z <NUMBER> statistically significant p<NUMBER> hence trim fill analysis duval tweedie <NUMBER> used evaluate number missing studies recalculated pooled odds ratio addition missing hypothetical studies recalculated pooled odds ratio association diabetes mellitus severe clinical course covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> supplementary figure <NUMBER> redrawn funnel plot addition four missing hypothetical studies symmetrical supplementary figure <NUMBER> adjusting heterogeneity well publication bias corrected pooled odds ratio diabetes mellitus associated severe clinical course covid<NUMBER> ieboth mortality severity still significant <NUMBER> figure <NUMBER> summarise results metaanalysis <NUMBER> studies <NUMBER> patients found diabetes mellitus significantly associated mortality risk covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> low heterogeneity <NUMBER> <NUMBER> addition diabetes mellitus associated severe covid<NUMBER> including risk ards icu requirement invasive ventilatory requirement pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> combined pooled odds ratio diabetics developing severe covid<NUMBER> dying due ie composite endpoint <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> adjusting heterogeneity among studies well publication bias corrected pooled odds ratio diabetes associated severe clinical course covid<NUMBER> still significantly high <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> secondary outcome also calculated pooled prevalence diabetes mellitus patients covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> uncorrected <NUMBER> <NUMBER> ci <NUMBER> adjusting heterogeneity many strengths metaanalysis first best knowledge first large metaanalysis specific influence diabetes severity covid<NUMBER> well mortality addition also studied prevalence diabetes among covid<NUMBER> patients second included large number studies patient population sixteen thousand spanning three continents third included large studies <NUMBER> patients thus study contributed robust data diabetescovid<NUMBER> association without increasing heterogeneity fourth avoided including duplicate studies limiting search single database limiting search english articles carefully going included articles study setting author list fifth synthesizing results taken care heterogeneity well publication bias appropriate statistical tools first discussing secondary outcome metaanalysis determined corrected pooled prevalence diabetes mellitus covid<NUMBER> patients close <NUMBER> higher prevalence usa china results prevalence similar large chinese nationwide study <NUMBER> patients shown prevalence diabetes covid<NUMBER> patients <NUMBER> <NUMBER> another small metaanalysis <NUMBER> chinese studies <NUMBER> patients fadini et al <NUMBER> also reported prevalence diabetes covid<NUMBER> patients <NUMBER> study well previous studies indicate prevalence diabetes patients covid<NUMBER> range <NUMBER> similar population prevalence diabetes general population china usa <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> thus metaanalysis supports previously held notion susceptibility diabetic population covid<NUMBER> infection might increased similar nondiabetic population <NUMBER> primary important outcome metaanalysis study association diabetes mortality severity covid<NUMBER> disease found diabetic patients covid<NUMBER> twice likely develop severe covid<NUMBER> disease twice likely die due odds ratio close <NUMBER> severity well mortality thus patients covid<NUMBER> diabetes likely develop ards need icu care need invasive ventilation vulnerable succumb results similar two small metaanalyses fadini et al <NUMBER> studies <NUMBER> patients wang et al <NUMBER> studies <NUMBER> patients gave odds ratio <NUMBER> <NUMBER> respectively diabetic patients developing adverse disease due sarscov<NUMBER> infection <NUMBER> <NUMBER> another systematic review <NUMBER> studies singh et al also suggested diabetes determinant severity mortality covid<NUMBER> patients <NUMBER> however metaanalysis largest <NUMBER> studies conclusively shown association diabetes covid<NUMBER> mortality well severity whether diabetes independent determinant severity studied guo et al casecontrol study china <NUMBER> compared diabetic nondiabetic covid<NUMBER> patients found even absence comorbidities diabetics higher risk severe pneumonia uncontrolled inflammatory response higher levels tissue injuryrelated enzymes higher hypercoagulable state found serum levels inflammatory biomarkers creactive protein ddimer il<NUMBER> serum ferritin coagulation index significantly higher diabetic patients compared without suggesting patients diabetes susceptible inflammatory storm leads worsening covid<NUMBER> <NUMBER> pathogenesis increased mortality severity covid<NUMBER> patients diabetes still unclear severe acute respiratory syndrome sars outbreak <NUMBER> middle east respiratory syndrome mers outbreaks <NUMBER> <NUMBER> also resulted increased severity fatality patients diabetes mellitus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous outbreaks also caused coronaviruses namely sarscov merscov respectively elucidate mechanism enhanced disease severity diabetics following merscov infection kulcsar et al <NUMBER> used animal model mice made susceptible merscov infection expressing human dipeptidyl peptidase <NUMBER> dpp<NUMBER> type <NUMBER> diabetes induced administering highfat diet upon infection merscov diabetic mice prolonged phase severe disease delayed recovery independent viral titres histological examination revealed diabetic mice delayed prolonged systemic inflammation fewer inflammatory monocytemacrophages cd<NUMBER> cells lower levels chemokine ligand <NUMBER> cxc motif chemokine <NUMBER> expression lower levels tumor necrosis factor alpha tnfα interleukin il <NUMBER> il <NUMBER>b arginase <NUMBER> expression higher levels il <NUMBER>a expression data suggested increased disease severity observed diabetes likely due dysregulated immune response resulted severe prolonged lung pathology <NUMBER> since patients diabetes multiple immune dysregulations phagocytic cell dysfunction inhibition neutrophil chemotaxis impaired tcell mediated immune response altered cytokine production ineffective microbial clearance <NUMBER> dysregulated immune responses may result cytokine profile resembling secondary haemophagocytic lymphohistiocytosis patients severe sarscov<NUMBER> infection characterised increased il <NUMBER> il <NUMBER> granulocytecolony stimulating factor interferonγ inducible protein <NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α tnfα <NUMBER> <NUMBER> addition type <NUMBER> diabetes mellitus coronavirus infection also shared pathogenic pathways therapeutic implications <NUMBER> two coronavirus receptors angiotensin converting enzyme <NUMBER> ace<NUMBER> dpp<NUMBER> also transducers metabolic pathways regulating glucose homeostasis renal cardiovascular physiology inflammation dpp<NUMBER> inhibitors widely used subjects type <NUMBER> diabetes effect lowering blood glucose levels however effects dpp<NUMBER> inhibition immune response patients diabetes still controversial completely understood <NUMBER> two recent metaanalyses shown dpp<NUMBER> inhibitors increased risk various infections <NUMBER> <NUMBER> third metaanalysis showed increased risk infections dpp<NUMBER> inhibitors <NUMBER> whether dpp<NUMBER> inhibitors increase susceptibility severity sarscov<NUMBER> infection needs studied future trials results metaanalysis three major implications current covid<NUMBER> pandemic first since diabetes lead severe covid<NUMBER> prevention diabetics imperative responsibility treating physicians advice diabetic patients take extraprecautions social distancing hand hygiene protect coronavirus infection <NUMBER> second increased vigilance outpatient clinics diabetes covid<NUMBER> threshold testing infection diabetic patients lowered <NUMBER> third patient covid<NUMBER> comorbid diabetes taken potentially serious even though may show mild symptoms presentation patients need extra monitoring threshold hospital icu admission also needs lowered results metaanalysis also implications india often called diabetes capital world according <NUMBER> estimate age standardised diabetes prevalence southeast asia including india among ages <NUMBER> years estimated <NUMBER> <NUMBER> ci <NUMBER> actual number people diabetes india <NUMBER> million <NUMBER> <NUMBER> drivers type <NUMBER> diabetes south asia include genetic epigenetic factors intrauterine early life factors high carbohydrate dietary patterns increase physical inactivity <NUMBER> factors increase prevalence diabetes also major factors causation obesity hypertension metabolic syndrome fatty liver cardiovascular cerebrovascular diseases resultant increase morbidity mortality fact diabetes along cardiovascular disease chronic kidney disease accounted <NUMBER> <NUMBER> <NUMBER> deaths respectively south asia <NUMBER> current covid<NUMBER> pandemic metaanalysis well multiple studies shown covid<NUMBER> particularly severe patients comorbidities increased hospitalization icu ventilatory requirements <NUMBER> <NUMBER> huge population burden diabetes india urgent strong measures taken flatten curve covid<NUMBER> pandemic india lead disastrous consequences overburdening already stretched healthcare system india especially elderly population india comorbidities diabetes hypertension cardiac diseases need special protection enumerated preceding paragraph blood sugars need better controlled health condition need better monitored even face lockdown measures teleconsultation telemedicine <NUMBER> metaanalysis two limitations shown diabetes associated covid<NUMBER> severity mortality however cannot said whether diabetes acting independent factor responsible severity mortality confounding factor many conditions elderly age hypertension cardiovascular disease obesity often coexist diabetes comorbidities shown associated severe covid<NUMBER> mortality spite limitation implication metaanalysis remain unchanged diabetic need protected covid<NUMBER> need extra care infected second limitation metaanalysis able document role glycemic control severity mortality covid<NUMBER> shown previously poor glycemic control terms high hba<NUMBER>c significantly associated increased risk various infections <NUMBER> <NUMBER> however none included studies covid<NUMBER> metaanalysis evaluated glycemic control one factors associated severity andor mortality needs explored trials conclusion shown metaanalysis presence underlying diabetes patients covid<NUMBER> associated twofold increased risk mortality well twofold increased risk severity covid<NUMBER> necessitates enhanced prevention covid<NUMBER> diabetics increased vigilance patients diabetes covid<NUMBER> lower threshold monitoring hospitalization icu care diabetics develop infection results metaanalysis emphasizes need investigation pathogenic mechanism relationship diabetes covid<NUMBER> explore therapeutic implications none authors declare conflicts interest author contributions ak designed study ak saa sk searched screened selected articles ak ps nb extracted data articles ak ps performed data analysis interpretation ak drafted manuscript authors contributed writing editing manuscript aa supervised study coronavirus disease <NUMBER> covid<NUMBER> novel viral respiratory disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> first report took place china <NUMBER> subsequently spread across globe rapidly <NUMBER> april <NUMBER> total <NUMBER> confirmed infections reported <NUMBER> deaths <NUMBER> upon emerging covid<NUMBER> known approved specific effective antiviral treatment treat fatal disease <NUMBER> therefore utmost urgency identify potential therapies sarscov<NUMBER> infected patients <NUMBER> covid<NUMBER> resemble severe acute respiratory syndrome sars middle eastern respiratory syndrome mers phylogenetically symptomatically variety agents tried according clinical experience sars mers <NUMBER> <NUMBER> broadspectrum antiviral agent ribavirin <NUMBER> protease inhibitor lopinavir ritonavir <NUMBER> <NUMBER> immune upregulator interferon <NUMBER> <NUMBER> commonly used addition vitro vivo studies suggested chloroquine hydroxychloroquine <NUMBER> <NUMBER> remdesivir <NUMBER> arbidol <NUMBER> effective inhibiting viral replication sarsassociated coronavirus cov merscov sarscov<NUMBER> infections <NUMBER> however efficacy safety treatments covid<NUMBER> remains unclear <NUMBER> systematic reviews previously summarized clinical trials potential therapeutic agents sars mers covid<NUMBER> resulting inconclusive outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> herein conduct review identify efficacy safety current option therapies sars mers besides covid<NUMBER> attempt identify promising therapy sarscov<NUMBER> infected patients present study conducted according preferred reporting items systematic reviews metaanalyses prisma guidelines previously published protocol prospero crd<NUMBER> comprehensive searching pubmed embase cochrane library china national knowledge infrastructure cnki china science technology journal database vip wanfang data performed inception april <NUMBER>th <NUMBER> without language restriction unpublished trials also identified clinical trial registry platforms httpclinicaltrialsgov httpwwwchictrorgcn preprint articles also retrieved websites medrxiv httpswwwmedrxivorg biorxiv httpswwwbiorxivorg manual search conducted screening reference lists inclusive studies search strategy consisting patient relevant terms covid<NUMBER> middle east respiratory syndrome severe acute respiratory syndrome etc intervention relevant terms lopinavir ritonavir chloroquine hydroxychloroquine interferon ribavirin remdesivir arbidol etc applied medical subject headings mesh free text comprehensive search syntax available supplemental table <NUMBER> two authors z z hz independently screened titles abstracts fulltext retrieved articles identify eligibility figure <NUMBER> studies considered inclusion randomized controlled trials rcts prospective cohort retrospective cohort studies performed among adult patients covid<NUMBER> mers sars evaluated efficacy safety anticoronavirus agents furthermore studies considered excluded lacked control group target quantitative outcomes vitro vivo studies disagreements resolved discussions corresponding author z g primary outcomes study included mortality virological eradication clinical improvement secondary outcomes included improvement symptoms time j u r n l p r e p r f become afebrile improvement chest radiography results utilization mechanical ventilation intensive care unit admission adverse events aes data extraction independently conducted two authors h z z z using standardized data collection form included study characteristics author year publication region study design sample size population characteristics age gender indication intervention characteristics anticoronavirus agents dosage duration concomitant therapy outcomes mortality viral eradication clinical outcomes aes risk bias inclusive rcts assessed accordance cochrane collaboration risk bias tool <NUMBER> methodological quality assessment prospective cohort retrospective cohort studies performed using newcastle ottawa scale nos <NUMBER> risk bias individual study rated low moderate high quality evidence assessed gradepro software graded high moderate low low <NUMBER> dichotomous data shown relative risks rr <NUMBER> confidence intervals cis continuous variables calculated weight mean difference wmd associated <NUMBER> cis using randomeffects model <NUMBER> <NUMBER> representing notable heterogeneity <NUMBER> subgroup analysis treatments including hydroxychloroquine lopinavirritonavir alone combination ribavirin alone combination arbidol interferon performed detect robustness results sensitivity analysis conducted sequential elimination study pool potential publication bias assessed using visual inspection funnel plots number included studies ten statistics performed using stata software version<NUMBER> statacorp college station texas usa p<NUMBER> indicating statistically significant difference present searches totally identified <NUMBER> citations excluded <NUMBER> publications cautious screening titles abstracts <NUMBER> potential studies fulltext assessed eligibility <NUMBER> excluded reviews contain eligible comparators report outcomes interest case series others figure <NUMBER> finally <NUMBER> articles <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients met inclusion criteria retrieved quantitative synthesis table <NUMBER> <NUMBER> rcts <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prospective studies <NUMBER> <NUMBER> whilst remaining <NUMBER> trials retrospective studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thirteen studies conducted china <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> canada <NUMBER> <NUMBER> <NUMBER> <NUMBER> saudi arabia <NUMBER> <NUMBER> <NUMBER> france <NUMBER> <NUMBER> studies involving patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies involving patients sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies involving patients mers <NUMBER> <NUMBER> interventions included arbidol <NUMBER> study <NUMBER> arbidol lopinavirritonavir <NUMBER> study <NUMBER> hydroxychloroquine <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> interferon corticosteroid <NUMBER> studies <NUMBER> <NUMBER> lopinavirritonavir <NUMBER> studies <NUMBER> <NUMBER> lopinavirritonavir plus ribavirin corticosteroids <NUMBER> studies <NUMBER> <NUMBER> ribavirin <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> ribavirin interferon <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> ribavirin corticosteroids <NUMBER> study <NUMBER> table <NUMBER> primary outcomes mortality reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> virological clearance reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical improvement reported <NUMBER> study <NUMBER> patients <NUMBER> secondary outcomes radiographical improvement reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> acute respiratory disease syndrome ards reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> intubation reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> adverse events aes reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> leukopenia reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> anemia reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> thrombocytopenia reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> transaminitis reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> j u r n l p r e p r f elevated total bilirubin reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> elevated creatinine reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> bradycardia reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> diarrhea reported <NUMBER> studies <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> considering rcts information randomization unclear <NUMBER> studies <NUMBER> <NUMBER> concealing allocation absent unclear <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> moreover blinding participants outcome assessors absent unclear <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> supplementary table s<NUMBER> therefore decided identify <NUMBER> studies risk bias terms observational studies nos scores <NUMBER> indicating studies low risk bias supplementary table s<NUMBER> performed metaanalysis <NUMBER> studies <NUMBER> patients demonstrating data mortality indication considered <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared comparators interventions could notably reduce mortality seven studies <NUMBER> patients documented data virological eradication indication taken consideration <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pooled result j u r n l p r e p r f showed virological eradication ability interventions equal comparator group rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> subgroup analysis combination lopinavirritonavir arbidol combination lopinavirritonavir ribavirin corticosteroids appeared show superior ability virological eradication generating rr <NUMBER> <NUMBER> ci <NUMBER> rr <NUMBER> <NUMBER> ci <NUMBER> respectively additionally value p interaction less <NUMBER> indicating significant difference across treatments <NUMBER> studies <NUMBER> patients demonstrated time become afebrile present data diversity showing mean±sd medium range thus could generate metaanalysis outcome addition results controversial one hand one study reported hydroxychloroquine treatment significantly shortened fever recovery time control group <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> <NUMBER> hand chen et al showed hydroxychloroquine treatment observed difference time course become afebrile <NUMBER> vs <NUMBER> <NUMBER> another <NUMBER> studies also documented lopinavirritonavir arbidol combination interferon corticosteroids therapies effects time course defervescence compared control therapy <NUMBER> <NUMBER> radiographical improvement metaanalysis <NUMBER> studies generated rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> indicating superior ability interventions radiographical improvement subgroup analysis combination lopinavirritonavir arbidol hydroxychloroquine showed notable inadequate inclusive studies perform sensitivity analysis assess influence included study generate funnel plot evaluate publication bias either reason quality evidence outlined table <NUMBER> quality findings relevant mortality virological clearance radiographical improvement prevalence ards intubation mechanical ventilation low addition total aes leukopenia anemia thrombocytopenia diarrhea transaminitis increased total bilirubin low quality evidence well however outcome quality clinical improvement increased creatinine low bradycardia moderate quality evidence upon emergency sarscov<NUMBER> conducted systematic review metaanalysis identify potential therapeutic options covid<NUMBER> based previous studies therapies sars mers present review included <NUMBER> articles involving <NUMBER> patients compared control treatment anticoronavirus interventions significantly reduced mortality notably augmented clinical improvement radiographical improvement without significant effect symptoms alleviation time become afebrile virologic eradication incidence ards intubation aes hydroxychloroquine earned reputation potential promising role covid<NUMBER> <NUMBER> increasing number studies conducted published <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently chloroquine hydroxychloroquine demonstrated inhibit sarscov<NUMBER> vitro ec<NUMBER>µm ec<NUMBER>µm respectively <NUMBER> <NUMBER> underlying mechanisms inferred follows <NUMBER> weakly alkaline chloroquine could increase endosomal ph therefore block virus infection <NUMBER> <NUMBER> <NUMBER> spike protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> blocker chloroquine hydroxychloroquine interfered glycosylation cellular sarscov receptor thus inhibit virus attacking <NUMBER> <NUMBER> immunomodulant chloroquine hydroxychloroquine could counteract proinflammatory cytokine storm critically ill patients covid<NUMBER> <NUMBER> <NUMBER> unfortunately outcomes hydroxychloroquine <NUMBER> <NUMBER> additionally hydroxychloroquine therapy improved radiographical benefit <NUMBER> despite accompanied aes especially diarrhea <NUMBER> date could recommend hydroxychloroquine superior standard care sarscov<NUMBER> infection need wait larger randomized trials target population sensitive endpoints valid value hydroxychloroquine covid<NUMBER> inhibitor human immunodeficiency virus hiv protease lopinavirritonavir major focus recommended patients mers <NUMBER> covid<NUMBER> <NUMBER> reported lopinavir could inhibit sarscov merscov replication vitro ec<NUMBER> <NUMBER> μm <NUMBER> μm respectively <NUMBER> lopinavir also found demonstrated antiviral effect sarscov<NUMBER> vero e<NUMBER> cells ec<NUMBER> <NUMBER> μm <NUMBER> ritonavir effect coronavirus prolonged bioavailability j u r n l p r e p r f lopinavir inhibiting hosts cytochrome p<NUMBER> <NUMBER>a<NUMBER> enzyme <NUMBER> five studies reported effectiveness safety lopinavirritonavir alone combination therapy lopinavirritonavir alone combination ribavirin corticosteroids show mortality benefit however lopinavirritonavirbased treatments observed inconsistent results virological clearance rr <NUMBER> lopinavirritonavir alone revealed ineffective lowering virus load sarscov<NUMBER> <NUMBER> <NUMBER> lopinavirritonavir accompanying arbidol ribavirin augmented eradication sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speculated lopinavirritonavir <NUMBER> mg<NUMBER> mg twice daily may reach minimal lopinavir serum concentration <NUMBER> μm <NUMBER> μm inadequate inhibition sarscov<NUMBER> <NUMBER> nevertheless lopinavirritonavir accompanied agents showing effects sarscov<NUMBER> might decrease inhibitory concentration lopinavir produce synergy <NUMBER> furthermore lopinavirritonavirbased therapies documented notably better clinical radiographical improvement reduced incidence ards intubation take adverse reactions consideration aes rate comparable groups conversely lopinavirritonavir alone showed tendency diarrhea events combination lopinavirritonavir ribavirin corticosteroids reduced incidence diarrhea significantly suspected lopinavirritonavir alone show demonstrably beneficial effects covid<NUMBER> lopinavirritonavir combinations might play roles eradication sarscov<NUMBER> <NUMBER> extensively used therapies ribavirin ribavirinbased combinations ribavirin reported tightly bind sarscov<NUMBER> rna dependent rna polymerase rdrp binding energy <NUMBER> kcalmol thus may used covid<NUMBER> <NUMBER> <NUMBER> studies reporting sars mers patients treated ribavirin combinations ribavirin metaanalysis yielded inconsistent results mortality rr <NUMBER> <NUMBER> combination ribavirin corticosteroids showed remarkable lower mortality j u r n l p r e p r f compared control group addition patients treated ribavirinbased therapies showed comparable rates intubation mechanical ventilation control group note major problem ribavirin significantly higher incidence adverse events especially bradycardia anemia transaminitis compared control group intriguingly combination ribavirin interferon observe problems summarily inconsistent benefit considerable safety concerns low quality evidence hard make clear recommendation use ribavirin ribavirinbased combinations covid<NUMBER> revealed arbidol vitro antiviral activity early replication stage sarscov <NUMBER> however arbidol alone generated equivalent outcome patients covid<NUMBER> compared control group addition lopinavirritonavir showed better efficacy <NUMBER> furthermore interferon widely used sars mers epidemic <NUMBER> <NUMBER> studies reported combinations interferon unfortunately difference noted treatment control group terms mortality intubation rate adverse reactions recommendation treatments uncertain small sample size study risk low quality <NUMBER> <NUMBER> <NUMBER> firstly best knowledge first systematic review metaanalysis capability anticoronavirus agents conversely ribavirin might cause safety concern especially bradycardia currently growing trials related anticoronavirus agents ongoing including lopinavirritonavir initial therapy associated lower mortality compared matched cohorts lopinavirritonavir rescue therapy observed difference mortality compared matched cohorts lopinavirritonavir initial therapy associated lower rate incubation use corticosteroids reduced dose compared matched cohorts lopinavirritonavir rescue therapy observed difference rates intubation oxygen desaturation compared matched cohorts c oronavirus disease <NUMBER> caused novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> confirmed cases covid<NUMBER> growing rapidly spread <NUMBER> countries regions <NUMBER> number reported mortalities worldwide <NUMBER> predicting casefatality rate approximately <NUMBER> <NUMBER> based data centers covid<NUMBER> often results acute respiratory distress syndrome ards leading cause death covid<NUMBER> positive patients respiratory failure without multiple organ dysfunction ie cardiac andor renal <NUMBER> <NUMBER> <NUMBER> <NUMBER> currently specific therapies covid<NUMBER> patients provided supportive care recent reports commentaries suggested severity covid<NUMBER> may due cytokine storm <NUMBER> excessive uncontrolled release cytokines response pathologic event viral infection <NUMBER> suggestions due increased inflammatory cytokine levels interleukin<NUMBER> il<NUMBER> well fever cytopenia hyperferritinemia <NUMBER> <NUMBER> moreover commentaries accompanied calls use broad immunosuppression steroids iv immunoglobulin andor selective cytokine blockade therapeutic approach covid<NUMBER> <NUMBER> <NUMBER> patient mortality could improved immunosuppressive therapies evidence changes specific cytokines incomplete often observed single timepoint limited comparison control groups <NUMBER> <NUMBER> additionally described recent commentaries reviews use immunosuppressive therapies treat critically ill patients including ards often challenging due potential cause harm highlighting need rigorous data support proposed trials <NUMBER> <NUMBER> overall aim study characterize inflammatory profile critically ill covid<NUMBER> patients first <NUMBER> days icu stay potentially identify therapeutic targets specific objectives <NUMBER> determine inflammatory analytes changing covid<NUMBER> icu patients healthy controls <NUMBER> determine inflammatory analyte differences covid<NUMBER> covid<NUMBER> negative − icu patients <NUMBER> determine changes relevant inflammatory analytes time covid<NUMBER> icu patients study approved western university human research ethics board enrolled consecutive patients admitted level<NUMBER> academic icu london health sciences centrevictoria campus london ontario suspected covid<NUMBER> based standard hospital screening procedures <NUMBER> collected daily blood samples starting admission <NUMBER> days covid<NUMBER>− patients <NUMBER> days covid<NUMBER> patients covid<NUMBER> status confirmed part standard hospital testing detection two sarscov<NUMBER> viral genes using polymerase chain reaction <NUMBER> patient baseline characteristics recorded admission included age sex comorbidities laboratory values arterial partial pressure inspired oxygen pf ratio chest radiograph findings although icu severity illness scores validated covid<NUMBER> patients calculated multiple organ dysfunction score mods sequential organ failure assessment sofa score covid<NUMBER> covid<NUMBER>− patient groups enable objective comparison illness severity also categorized patient groups confirmed suspected sepsis diagnosis using sepsis <NUMBER> criteria clinical interventions received observation period included consisted antibiotics antiviral agents systemic corticosteroids vasoactive medications renal replacement therapy highflow oxygen therapy mechanical ventilation invasive noninvasive final participant groups constructed ageand sexmatching covid<NUMBER> icu patients covid<NUMBER>− icu patients well healthy controls blood samples previously banked translational research centre london canada directed dr fraser httpstranslationalresearchcentrecom <NUMBER> <NUMBER> standard operating procedures used ensure samples treated rapidly equally blood obtained via indwelling catheters daily morning placed immediately ice transferred negative pressure hood blood centrifuged plasma isolated aliquoted <NUMBER> µl frozen −<NUMBER>°c samples remained frozen use freezethaw cycles avoided levels <NUMBER> inflammatory analytes determined using multiplexed biomarker immunoassay kits according manufacturers instructions milliporesigma <NUMBER> summit drive burlington enzymelinked immunosorbent assay elisa former plasma inflammatory analytes measured using bioplextm <NUMBER> suspension array system biorad laboratories hercules ca used luminex xmaptm fluorescent beadbased technology luminex corp austin tx bioanalyte concentrations calculated standard curves using fiveparameter logistic regression bioplex manager <NUMBER> software latter plasma levels timp<NUMBER> rd systems duo set dy<NUMBER> diluted <NUMBER> <NUMBER> timp<NUMBER> rd systems duo set dy<NUMBER> diluted <NUMBER> timp<NUMBER> rd systems duo set dy<NUMBER> diluted <NUMBER> <NUMBER> measured elisa medians interquartile ranges iqrs frequency used report icu patient baseline characteristics continuous categorical variables respectively continuous variables compared using mannwhitney u tests kruskalwallis tests appropriate categorical variables compared using fisher exact chisquare p <NUMBER> considered statistically significant daily analyte concentrations also reported medians iqrs comparisons groups examined using mannwhitney u tests given number analytes analyzed risk false positives p value <NUMBER> used standard statistical significance receiver operating characteristic roc curves conducted determine sensitivity specificity continuous variables predicting mortality areaunderthecurve auc calculated variable coordinates curves analyzed identify cutoff values based highest sensitivity specificity predicting mortality analyses conducted using spss version <NUMBER> ibm corp armonk ny covid<NUMBER> analyte data visualized nonlinear dimensionality reduction full data matrix using tdistributed stochastic nearest neighbor embedding tsne algorithm <NUMBER> tsne assumes optimal representation data lies manifold complex geometry low dimension embedded full dimensional space raw data feature selection pooled analyte data across <NUMBER> icu days covid<NUMBER> covid<NUMBER>− cohorts normalized observations within analyte random forest classifier trained variables predict covid<NUMBER> status random forest set decision trees consequently able interrogate collection trees identify features highest predictive value viz features frequently appear near top decision tree limited decision trees maximum depth five levels constrained forest <NUMBER> trees avoid overfitting small dataset explored ability perform automated classification covid<NUMBER> versus covid<NUMBER>− patients analyte spectra conservatively employing single decision tree limiting maximum tree depth three levels trained tested classifier using fivefold crossvalidation approach investigated <NUMBER> covid<NUMBER> icu patients median years age <NUMBER> iqr <NUMBER> <NUMBER> ageand sexmatched covid<NUMBER>− icu patients median years age <NUMBER> iqr <NUMBER> <NUMBER> ageand sexmatched healthy controls median years age <NUMBER> iqr <NUMBER> p <NUMBER> baseline demographic characteristics comorbidities laboratory values chest radiograph findings reported table <NUMBER> covid<NUMBER>icu patients significantly higher unilateral pneumonia whereas covid<NUMBER> icu patients likely bilateral pneumonia sepsis confirmed infectious pathogen identification <NUMBER> covid<NUMBER>icu patients sepsis suspected remaining <NUMBER> reported baseline measures nonsignificant patients although mortality rate <NUMBER> determined covid<NUMBER> icu patients measured <NUMBER> inflammatory analytes plasma using either fluorescent beadbased multiplex technology elisa table <NUMBER> shows <NUMBER> inflammatory analytes significantly different covid<NUMBER> icu patients healthy controls remaining <NUMBER> nonsignificant analytes shown supplemental table <NUMBER> supplemental digital content <NUMBER> httplinkslwwcom ccxa<NUMBER> significantly different analytes elevated covid<NUMBER> icu patients relative healthy controls except mmp<NUMBER> decreased covid<NUMBER> covid<NUMBER>− cohorts plotted two dimensions following dimensionality reduction stochastic neighbor embedding fig <NUMBER>a dimensionality reduction shows daily analyte measurements icu days <NUMBER> two cohorts distinct easily separable determine analytes informative covid<NUMBER> status classification performed feature selection random forest classifier top six features identified binary outcome covid<NUMBER> versus covid<NUMBER>− following order tumor necrosis factor tnf granzyme b heat shock protein <NUMBER> hsp<NUMBER> interleukin<NUMBER> il<NUMBER> interferongammainducible protein <NUMBER> ip<NUMBER> elastase <NUMBER> fig <NUMBER>b trained tested simple decisiontree classifier yielded classifier accuracy ability analytes predict covid<NUMBER> status <NUMBER> p <NUMBER> fivefold crossvalidation supplemental table <NUMBER> supplemental digital content <NUMBER> http linkslwwcomccxa<NUMBER> lists <NUMBER> inflammatory analytes significantly different covid<NUMBER> covid<NUMBER>patients icu days <NUMBER> remaining <NUMBER> nonsignificant analytes icu days <NUMBER> shown supplemental table <NUMBER> supplemental digital content <NUMBER> httplinkslwwcomccx a<NUMBER> significant analytes elevated covid<NUMBER> icu patients relative covid<NUMBER>icu patients many analytes significantly different covid<NUMBER> covid<NUMBER>− patients time top six analytes determined feature classification icu days <NUMBER> listed first tnf granzyme b hsp<NUMBER> il<NUMBER> ip<NUMBER> elastase <NUMBER> also significantly different covid<NUMBER> covid<NUMBER>− patients starting icu day <NUMBER> time course six markers shown figure <NUMBER> feature matrix day <NUMBER> covid<NUMBER> icu patients classified mortality using random forest classifier <NUMBER> trees threefold crossvalidation hsp<NUMBER> leading analyte associated covid<NUMBER> death roc curve conducted determine sensitivity specificity hsp<NUMBER> predicting mortality auc hsp<NUMBER> <NUMBER> indicating perfect sensitivity specificity <NUMBER> covid<NUMBER> icu patients using youdens index hsp<NUMBER> cutoff value predicting mortality <NUMBER> pgml note addition <NUMBER> covid<NUMBER>− cases analysis auc cutoff hsp<NUMBER> remained study measured <NUMBER> inflammatory analytes plasma obtained icu patients covid<NUMBER> covid<NUMBER>− well ageand sexmatched healthy controls given number analytes measured used two complimentary methods analyze data conventional population statistics machine learning data indicate presence unique inflammatory profile characterized early sustained elevations circulating tnf granzyme b hsp<NUMBER> il<NUMBER> circulating levels ip<NUMBER> increased transiently icu days <NUMBER> elastase <NUMBER> consistently elevated icu days <NUMBER> finally plasma levels hsp<NUMBER> covid<NUMBER> icu patients associated mortality despite exploratory nature study data generated suggest six inflammatory analytes could considered investigation potential biomarkers andor therapeutic targets changes potentially useful inflammatory analytes identified study larger cohorts necessary elucidate role host response ie il<NUMBER> required <NUMBER> patients per cohort reach statistical significance based <NUMBER> power alpha <NUMBER> covid<NUMBER> icu patients similar reported earlier cohorts china <NUMBER> <NUMBER> seattle <NUMBER> italy <NUMBER> respect age comorbidities clinical presentation contrast covid<NUMBER>− icu patients keeping findings seattle cohort covid<NUMBER> icu patients higher prevalence bilateral pneumonia covid<NUMBER>− icu patients higher illness severity scores covid<NUMBER> icu patients although differences statistically significant due small sample size given ventilated covid<NUMBER> icu patients reported higher mortality <NUMBER> comparable ards cohorts <NUMBER> mods sofa scores validated covid<NUMBER> icu patients lower median mods sofa scores patients may accurately represent illness severity relative covid<NUMBER>− icu patients indeed mortality <NUMBER> covid<NUMBER> icu patients whereas covid<NUMBER>− icu patients survived discharge compared healthy controls covid<NUMBER> icu patients exhibit clinical laboratory evidence systemic inflammation increased circulating cytokine levels eg tnf il<NUMBER> il<NUMBER> il<NUMBER> together lymphopenia cd<NUMBER> cd<NUMBER> cells characterize purported cytokine storm associated severe covid<NUMBER> mediator release pattern compared seen secondary hemophagocytic lymphohistiocytosis hyperinflammatory syndrome commonly triggered viral infections small percentage severe sepsis patients characterized fulminant fatal hypercytokinaemia multiple organ failure however compared covid<NUMBER>− icu patients covid<NUMBER> icu patients exhibited pattern cytokine elevation unique previous reports elevations sustained dominated tnf serine proteases granzyme b elastase <NUMBER> latter findings may particular clinical relevance preclinical models suggest sarscov<NUMBER> entry cells may blocked protease inhibitors <NUMBER> contrast studies sepsis ards found persistently elevated levels circulating tnf covid<NUMBER> icu patients potent acute master regulator proinflammatory response tnf typically upregulated quickly early following exposure invading pathogen tissue damage secondary mediators propagate inflammation circulating levels tnf quickly normalize <NUMBER> <NUMBER> persistently elevated levels tnf covid<NUMBER> icu patients could potential target antitnf therapy either neutralizing antibodies small molecule inhibitors <NUMBER> granzyme b expressed specifically cytolytic granules natural killer cells cytotoxic lymphocytes functions targeted cell death mediator traditionally considered cause apoptosis tumor virally infected cells <NUMBER> extracellular soluble granzyme b levels elevated autoimmune diseases infections including human endotoxemia model severe sepsis <NUMBER> furthermore granzyme b retains much proteolytic activity exposed plasma granzyme b degrade several extracellular membrane components involved production release andor processing proinflammatory cytokines <NUMBER> <NUMBER> granzyme b activates il<NUMBER> cleavage proil<NUMBER> <NUMBER> <NUMBER> turn promotes cellular apoptosis via induction granzyme b activation il<NUMBER> also induces synthesis release antiviral response mediators interferongamma ifnγ moreover il<NUMBER> known increase adhesion molecule expression endothelial cells icam<NUMBER> vcam<NUMBER> thereby increasing microvascular leukocyte adhesion <NUMBER> hsp<NUMBER> elevated covid<NUMBER> icu patients associated mortality chaperone protein induced response environmental physical chemical stresses hsp<NUMBER> usually cytoprotective limiting consequences damage facilitating cellular recovery via caspase inhibition conversely hsp<NUMBER> also exacerbate stress response signaling tissue destruction aid immunosurveillance transporting intracellular peptides distant immune cells <NUMBER> extracellular hsp<NUMBER> also promotes inflammation activating tolllike receptors promoting entry granzyme b cells initiating cellular apoptosis <NUMBER> <NUMBER> interestingly hsp<NUMBER> part receptor complex interacts binding domain spike protein infectious bronchitis virus member family coronaviridae enabling viral entry lung kidney cells <NUMBER> ip<NUMBER> inflammatory chemokine released monocytes endothelial cells aids recruitment activated cells sites tissue inflammation either protecting promoting infection actions ip<NUMBER> depend host immune status genetic background <NUMBER> previous studies suggest ip<NUMBER> protective coronavirusinduced severe acute respiratory syndrome sars <NUMBER> <NUMBER> whereas others shown improved infectious disease outcomes blocking ip<NUMBER> neutralizing antibodies <NUMBER> elastase <NUMBER> also serine protease slowly increases covid<NUMBER> icu patients <NUMBER> icu days neutrophil azurophilic granules well monocytesmacrophages mast cells contain elastase <NUMBER> <NUMBER> upon degranulation elastase <NUMBER> either released circulation mobilized leukocyte plasma membranes subsequently deposited vascular endothelium subendothelial spaces <NUMBER> <NUMBER> covid<NUMBER> icu patients elevated elastase <NUMBER> levels may contribute increased pulmonary vascular permeability injury elevated elastase <NUMBER> demonstrated various severe inflammatory conditions contribute development ards <NUMBER> exploratory study identified unique pattern inflammation covid<NUMBER> icu patients could considered study biomarkers andor therapeutic targeting hypothesisgenerating data however study also several limitations first studied critically ill patients cannot determine inflammatory changes contributing icu admissions second given limited number patients available study used two complimentary methods independently analyze data methods arrived similar conclusions third covid<NUMBER> study population relatively small however still generated strongly significant data eg true positives fulfilled urgent need exploratory data focus future hypothesisdriven studies larger cohorts finally report mortality clinical outcome future studies larger sample sizes explore whether reported changes inflammatory analytes correlate additional clinical outcomes functional status survivors summary report sustained elevations unique combination inflammatory analytes covid<NUMBER> icu patients exploratory data consistent slow absent improvement covid<NUMBER> patients despite stateoftheart icu care could aid future hypothesisdriven research using larger icu cohorts wwwccejournalorg <NUMBER> • volume <NUMBER> • e<NUMBER> supplemental digital content available article direct url citations appear html pdf versions article journals website httpjournalslwwcomccejournal coronavirus disease <NUMBER> covid<NUMBER> caused significant morbidity mortality date number new cases deaths continue rise alarming rate <NUMBER> although cases covid<NUMBER> asymptomatic mild severity minority patients experience severe symptoms covid<NUMBER> along complications acute respiratory distress syndrome ards coagulopathy multiple organ failure mof death number comorbidities associated increased risk severity mortality covid<NUMBER> patients including hypertension diabetes cerebrovascular disease chronic kidney disease chronic obstructive pulmonary disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals preexisting cardiovascular diseases shown poor outcomes covid <NUMBER> <NUMBER> <NUMBER> study chinese center disease control <NUMBER> cases reported case fatality rate <NUMBER> patients preexisting cardiovascular disease specific data mortality heart failure <NUMBER> due looming possibility poor drug compliance complications related disruption medical services number patients new decompensated heart failure may increase <NUMBER> currently plausible mechanisms sarscov<NUMBER> severe acute respiratory syndrome <NUMBER> infect human cells include binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor inducing hyperinflammation cytokine storm high expression ace<NUMBER> receptor commonly found patients heart failure <NUMBER> <NUMBER> systematic review metaanalysis wanted investigate association heart failure poor outcome patients covid<NUMBER> performed systematic search literature pubmed europepmc scopus cochrane central database medrxiv preprint studies search terms heart failure covid<NUMBER> removal duplicates abstracts screened two independent authors ey rp irrelevant articles excluded inclusion criteria study studies studied patients preexisting hf comorbidity covid<NUMBER> infection outcome interest mortality poor prognosis defined incidence severe covid<NUMBER> infection admission icu use ventilator patients preexisting heart failure coronavirus diseasethis systematic search conforms preferred reporting items systematic reviews metaanalyses prisma data extraction carried ey rp mal ih using standardized form containing following details author name year publication study design sample size metaanalysis conducted using review manager revman v<NUMBER> cochrane collaboration software hazard ratio hr odds ratio <NUMBER> confidence interval ci used pooled measures dichotomous data heterogeneity assessed using inconsistency index i<NUMBER> ranging <NUMBER> statistically significant heterogeneity defined <NUMBER> value <NUMBER> p <NUMBER> mantel haenszel method used determine generic inverse variance method used determine hr random effects models implemented analyses significant heterogeneity sensitivity analyses done test statistical robustness pooled results see whether significant change pooled results exclusion studies j u r n l p r e p r f single studies high heterogeneity metaanalysis prevalence done pooling events hf per total patients using metaanalysis proportion smallstudy effects risk publication bias assessed qualitatively using funnel plot analysis quantitatively using regressionbased eggers test extracted <NUMBER> potential articles search <NUMBER> duplicates removed titles abstracts remaining <NUMBER> articles screened obtained <NUMBER> potentially relevant articles excluded <NUMBER> studies due following reasons four studies systematic reviews two studies metaanalyses three articles literature reviews <NUMBER> articles report outcome interest finally included remaining <NUMBER> studies qualitative synthesis metaanalysis <NUMBER> patients <NUMBER> studies majority study subjects males ranging <NUMBER> <NUMBER> two studies reported male subjects minorities <NUMBER> three studies reported statistically significant difference risk hospitalization covid<NUMBER> patients preexisting heart failure seven studies reported statistically significant difference mortality patients covid<NUMBER> without preexisting hf three studies reported statistically significant difference incidence newonset hf hospitalized patients covid <NUMBER> figure <NUMBER> sixteen studies available metaanalysis determine pooled prevalence heart failure among patients covid<NUMBER> metaanalysis revealed pooled prevalence heart failure <NUMBER> <NUMBER> figure <NUMBER> regressionbased eggers test showed indication smallstudy effects heart failure poor outcome p<NUMBER> pooled hr mortality patients coronavirus disease <NUMBER> preexisting heart failure p<NUMBER> comparison mortality patients coronavirus disease <NUMBER> accompanied preexisting heart failure without heart failure p<NUMBER> indication smallstudy effects risk hospitalization patients preexisting heart failure p<NUMBER> incidence newonset heart failure p<NUMBER> number included studies <NUMBER> risk hospitalization patients preexisting heart failure pooled hr mortality patients coronavirus disease <NUMBER> preexisting heart failure incidence new onset heart failure thus results less reliable analysis using funnel plot generated asymmetrical result heart failure poor outcome figure <NUMBER>a comparison mortality patients coronavirus disease <NUMBER> accompanied preexisting heart failure without heart failure figure <NUMBER>b figure <NUMBER>a showing somewhat less asymmetry compared figure <NUMBER>b based cochrane collaboration recommendation performed funnel plot analysis metaanalysis involving <NUMBER> studies metaanalysis observed association hf poor outcome patients covid<NUMBER> higher risk death hospitalization preexisting hf higher mortality preexisting hf compared patients without hf types pneumonia preexisting cardiovascular diseases including hf risk factors poor prognosis course pneumonia <NUMBER> effect infective organism myocardium cause nonischemic cardiac injury systemic inflammatory response particularly excessively elevated covid<NUMBER> also result kidney injury impair sodium water metabolism may precipitate worsening hf <NUMBER> recent studies role ace<NUMBER> covid<NUMBER> infection reported ace<NUMBER> levels <NUMBER> higher male patients hf <NUMBER> <NUMBER> <NUMBER> finding explains higher risk poor prognosis hospitalization death population event occurrence covid<NUMBER> metaanalysis majority studies higher number male patients female patients patients coexisting hf diabetes proinflammatory state membranebound ace<NUMBER> protein cleaved adam<NUMBER> resulting release ace<NUMBER> interstitium blood circulation <NUMBER> inflammatory response occurs covid<NUMBER> elevated immune response <NUMBER> <NUMBER> might also explain increase mortality patients covid<NUMBER> accompanied hf excessive inflammatory response oxidative stress patients predispose severe clinical course covid<NUMBER> <NUMBER> phenomenon particularly significant patients preexisting hf since patients suffer decreased circulatory physiological reserves older patients hf commonly suffer multiple comorbidities deterioration function multiple organ systems functional decline <NUMBER> ace<NUMBER> enzyme involved raas pathway however differs ace capable converting angiotensin angiotensin ii furthermore opposed vasoconstrictor property angiotensin type <NUMBER> receptors ace<NUMBER> via ace<NUMBER> receptors cleaves angiotensin ii angiotensin <NUMBER> vasodilatory properties <NUMBER> based explanations easy us conclude regarding dangers upregulation ace<NUMBER> patients treated reninangiotensin system blockers rasb one study even proposed ceasing administration rasb patients covid<NUMBER> drugs <NUMBER> however seem case several authors questioned hypothesis <NUMBER> <NUMBER> <NUMBER> <NUMBER> rationale rebuttal based upon several vitro studies revealed upon entry alveolar cells using membranebound ace<NUMBER> receptors sarscov<NUMBER> downregulates expression causes internalization ace<NUMBER> receptors result process decrease angiotensinii angiotensin <NUMBER> conversion increase availability angiotensin ii bind at<NUMBER> receptor induces cellular inflammation oxidative stress vasoconstriction fibrosis aldosterone activation may eventually lead lung injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> use rasb may serve protective measure lung injury inhibition angiotensin ii synthesis using aceis blockade at<NUMBER>r arbs would result skew raas towards angiotensin <NUMBER> subsequent interaction masreceptors may minimize risk lung injury <NUMBER> <NUMBER> result metaanalysis similar previous studies patients preexisting heart hf demonstrated elevated risk poor outcome hospitalization death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared diseases based pooled results patients hf suffering sarscov<NUMBER> infection threefold increased risk inhospital mortality compared patients hf develop influenza <NUMBER> <NUMBER> <NUMBER> studies shown poorer prognosis patients hf develop influenza <NUMBER> <NUMBER> result decreased physiological reserve influenza virus infection patients hf associated severe course significant hemodynamic compromise often requires cardiac support <NUMBER> influenza vaccination patients associated reduced risk allcause cardiovascular death furthermore receiving <NUMBER> influenza vaccine associated <NUMBER> reduction allcause cardiovascular death allcause death <NUMBER> <NUMBER> ci<NUMBER> p<NUMBER> cardiovascular death <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> event influenza infection patients heart failure may fail cope increased metabolic demand caused infection result decompensation exacerbation heart failure symptoms may occur <NUMBER> j u r n l p r e p r f patients hf currently classified highpriority group vaccinated influenza vaccine <NUMBER> based findings effective vaccine sarscov<NUMBER> infection becomes available patients hf prioritized vaccinated even case covid<NUMBER> observed limitations metaanalysis use preprint studies included metaanalysis additionally several studies conducted citiesregions posing risk subject overlap data regarding difference newonset worsening hf patients studies rarely available data regarding staging hf also rarely found additionally patients hf suffering severe course covid<NUMBER> infection data regarding use vasopressors inotropic agents well incidence cardiogenic shock lacking conclusion patients hf increased risk poor outcomes hospitalization death covid<NUMBER> significant difference mortality patients without hf observed hf showing higher mortality rates findings probably stem reduced physiological reserves patients hf mortality patients hf accompanied sarscov<NUMBER> infection higher patients influenza lower patients merscov thus sarscov<NUMBER> vaccine becomes available patients hf prioritized vaccinated j u r n l p r e p r f journal preproof j u r n l p r e p r f late <NUMBER> novel form coronavirus named sarscov<NUMBER> stands severe acute respiratory syndrome coronavirus <NUMBER> started spreading province hubei china claimed numerous human lives <NUMBER> <NUMBER> january <NUMBER> world health organization declared novel coronavirus outbreak public health emergency international concern pheic <NUMBER> <NUMBER> february <NUMBER> selected official name covid<NUMBER> stands coronavirus disease <NUMBER> infectious disease caused novel coronavirus later march <NUMBER> declared covid<NUMBER> pandemic <NUMBER> <NUMBER> coronavirus family viruses usually causes respiratory tract disease infections fatal cases sars mers covid<NUMBER> kinds coronavirus affect animals sometimes rare occasions coronavirus jumps animal species human population novel coronavirus might jumped animal species human population begun spreading <NUMBER> recent study shown coronavirus outbreak starts take less four weeks overwhelm healthcare system hospital capacity gets overwhelmed death rate jumps <NUMBER> artificial intelligence ai shown effective tool predicting medical conditions adverse events help caregivers medical decisionmaking <NUMBER> <NUMBER> study proposed datadriven predictive analytics algorithm based artificial intelligence ai machine learning determine health risk predict mortality risk patients covid<NUMBER> developed system help hospitals medical facilities decide needs get attention first higher priority hospitalized triage patients system overwhelmed overcrowding eliminate delays providing necessary care algorithm predicts mortality risks based patients physiological conditions symptoms demographic information proposed system includes set algorithms preprocessing data extract new features handling missing values eliminating redundant useless data elements selecting informative features preprocessing data use machine learning algorithms develop predictive model classify data predict medical condition calculate probability risk mortality rest paper organized follows section ii introduce different methods model architecture discuss method providing detailed information model data preprocessing challenges encountered steps mitigate challenges feature selection feature extraction section iii describe results conclusion paper used dataset <NUMBER> laboratoryconfirmed covid<NUMBER> patients <NUMBER> countries around world including male female patients average age <NUMBER> <NUMBER> disease confirmed detection virus nucleic acid <NUMBER> original dataset contained <NUMBER> data elements patient including demographic physiological data data cleaning stage removed useless redundant data elements data source admin id admin name data imputation techniques used handle missing values analyzing data found <NUMBER> patients recovered covid<NUMBER> accurate unbiased model made sure dataset balanced balanced dataset equal observations recovered deceased patients created train test model data observations patients training dataset selected randomly completely separate testing data figure <NUMBER> shows highlevel architecture system outcome label contained multiple values patients health status considered patient discharged hospital patients stable situation symptoms recovered patients total <NUMBER> features extracted symptoms doctors medical notes patients health status also extracted additional <NUMBER> features patients demographic physiological data made total <NUMBER> features consulted medical team make sure best features extracted selected next step feature selection primary purpose feature selection find informative features eliminate redundant data reduce dimensionality complexity model <NUMBER> used univariate multivariate filter method wrapper method rank features select best feature subset <NUMBER> figure <NUMBER> demonstrates steps filter wrapper method used feature selection filter methods popular especially large datasets since usually fast much less computationally intensive wrapper methods filter methods use specific metric score individual feature subset features together popular metrics used filter methods include correlation coefficient fisher score mutual information entropy consistency chisquare parameters <NUMBER> applying different filter wrapper methods chose <NUMBER> features <NUMBER> features final feature set includes demographic features age sex province country age travel history general medical information comorbidities diabetes cardiovascular disease … also patient symptoms chest pain chills colds conjunctivitis cough diarrhea discomfort dizziness dry cough dyspnea emesis expectoration eye irritation fatigue gasp headache lesions chest radiographs little sputum malaise muscle pain myalgia obnubilation pneumonia myelofibrosis respiratory symptoms rhinorrhea somnolence sputum transient fatigue weakness etc figure <NUMBER> shows correlation heatmap dataset features figure <NUMBER>a shows correlation features outcome ie mortality risk figure <NUMBER>b shows correlation features figure <NUMBER>a selecting best feature subset used various machine learning algorithms build predictive model research used different algorithms including support vector machine svm neural networks random forest decision tree logistic regression knearest neighbor knn <NUMBER> <NUMBER> <NUMBER> neural network algorithm achieved best performance accuracy used grid search find best hyperparameters neural network best neural network results achieved two hidden layers <NUMBER> neurons first layer <NUMBER> neurons second layer used sigmoid function hidden layer activation function used stochastic gradient optimizer constant learning rate regularization rate alpha <NUMBER> svm model configured linear kernel regularization parameter c<NUMBER> random forest algorithm ensemble learning method combined multiple decision tree predictors trained based random data samples feature subsets <NUMBER> configured random forest algorithm <NUMBER> trees forest used <NUMBER>fold random crossvalidation overlap replacement evaluate developed model calculated overall accuracy machine learning algorithms compare also generated receiver operating characteristic roc curves every algorithm calculated area curve auc confusion matrix made sure overlap common patient training testing datasets level next section provide results performance developed system purpose study create predictive algorithm help hospitals medical facilities maximize number survivors providing accurate reliable tool help medical decision making triage covid<NUMBER> patients effectively accurately pandemic explained section ii several metrics accuracy roc auc confusion matrix used evaluate developed model table <NUMBER> demonstrates prediction accuracy predicting mortality patients covid<NUMBER> using <NUMBER>fold crossvalidation various machine learning algorithms table<NUMBER> accuracy mortality prediction patients covid<NUMBER> using <NUMBER>fold crossvalidation figure <NUMBER> demonstrates compares roc curves auc every machine learning algorithm used research results demonstrate developed algorithm able accurately predict mortality risk patients covid<NUMBER> based patients physiological conditions symptoms demographic information figure <NUMBER> shows mortality risk predicted algorithm sample patients ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint strated better discriminative ability area curve <NUMBER> <NUMBER> ci <NUMBER> sequential organ failure assessment score area curve <NUMBER> <NUMBER> ci <NUMBER> curb<NUMBER> score area curve <NUMBER> <NUMBER> ci <NUMBER> based cutoff value <NUMBER> acute physiology chronic health evaluation ii score could predict death patients coronavirus disease <NUMBER> sensitivity <NUMBER> specificity <NUMBER> kaplanmeier analysis showed survivor probability patients coronavirus disease <NUMBER> acute physiology chronic health evaluation ii score less <NUMBER> notably higher patients acute physiology chronic health evaluation ii score greater equal <NUMBER> p <NUMBER> conclusions acute physiology chronic health evaluation ii score effective clinical tool predict hospital mortality patients coronavirus disease <NUMBER> compared sequential organ failure assessment score curb<NUMBER> score acute physiology chronic health evaluation ii score greater equal <NUMBER> serves early warning indicator death may provide guidance make clinical decisions crit care med <NUMBER> xx<NUMBER> key words acute physiology chronic health evaluation ii score coronavirus disease <NUMBER> mortality risk factor severe acute respiratory syndrome coronavirus <NUMBER> n december <NUMBER> cluster acute pneumonia infected severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> known coronavirus disease <NUMBER> occurred wuhan china <NUMBER> <NUMBER> <NUMBER> disease rapidly spread throughout china many countries total <NUMBER> cases <NUMBER> deaths reported china whereas <NUMBER> cases <NUMBER> deaths reported <NUMBER> countries regions outside china february <NUMBER> <NUMBER> mortality hospitalized patients <NUMBER> <NUMBER> <NUMBER> <NUMBER>day mortality critical patients reported <NUMBER> considerable <NUMBER> covid<NUMBER> emerged major global health threat however clinical scoring system reported identify patients potentially unfavorable prognosis quickly clinical practice patients treatment observed patients rapidly deteriorated developing respiratory failure acute respiratory distress syndrome ards even multiple organ failure leading death evaluation various organ functions may predict mortality patients covid<NUMBER> acute physiology chronic health evaluation apache ii score sequential organ failure assessment sofa score commonly used assess disease severity estimate hospital mortality general critical illnesses <NUMBER> <NUMBER> confusion urea respiratory rate blood pressure age <NUMBER> curb<NUMBER> score commonly used assess severity mortality pneumonia <NUMBER> scoring system may also used assess mortality covid<NUMBER> study aimed describe difference epidemiologic clinical characteristics survivors deaths attempt provide effective clinical tool predict probability death among patients covid<NUMBER> singlecenter retrospective study done tongji hospital tongji hospital located wuhan hubei province endemic areas covid<NUMBER> one major tertiary teaching hospitals responsible treatments patients severe covid<NUMBER> assigned government recruited inpatients cared icu january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> diagnosed covid<NUMBER> according world health organization interim guidance <NUMBER> laboratory confirmation covid<NUMBER> performed local health authority previously described <NUMBER> data patients achieved reviewing admission logs histories available electronic medical records patient care resources patients followed february <NUMBER> <NUMBER> study approved ethics commission tongji hospital tjirb<NUMBER> data extraction performed physicians using standardized form collect data demographic characteristics exposure history huanan seafood market delay time illness onset hospitalization underlying chronic medical conditions symptoms onset admission vital signs laboratory finding complications outcomes date disease onset defined day symptom noticed patients glasgow coma score gcs sofa score curb<NUMBER> score apache ii score assessed within <NUMBER> hours admission length hospitalization outcome state patient recorded ards defined according berlin definition <NUMBER> acute kidney injury identified according kidney disease improving global outcomes definition cardiac injury defined serum levels cardiac biomarkers eg troponin <NUMBER>th percentile upper reference limit new abnormalities shown electrocardiography echocardiography <NUMBER> based clinical implications laboratory indices identified cutoff value indicators upper lower limits normal range values presented mean ± sd number percentage continuous variables categorical variables respectively difference categorical variables survivors deaths groups compared chisquare test fisher exact test appropriate whereas continuous variables compared using student test spearman correlation analysis performed among significant variables univariate analysis univariate multivariate cox regression analysis used explore effect apache ii score sofa score curb<NUMBER> score occurrence death taking account potential bias variables absolute value correlation coefficient less <NUMBER> included initial model multivariate cox regression analysis receiver operating characteristics roc analyses conducted evaluate compare predictive value three scoring systems scoring system largest area curve auc roc curve selected analysis cutoff value selected scoring system determined based maximum youden index patients covid<NUMBER> classified two groups low risk less cutoff point value high risk greater equal cutoff point value kaplanmeier method used compare survival two groups logrank test p value less <NUMBER> considered statistically significant analyses performed sas <NUMBER> sas institute cary nc r project version <NUMBER> r project statistical computing vienna austria httpcranrprojectorg january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> <NUMBER> inpatients symptoms covid<NUMBER> admitted icu tongji hospital patients <NUMBER> patients <NUMBER> diagnosed suspected cases one patient <NUMBER> suffered cardiac arrest immediately admission therefore <NUMBER> patients including <NUMBER> survivors <NUMBER> deaths enrolled study patients <NUMBER> admitted icu directly <NUMBER> patients transferred wards days stay ward icu admission <NUMBER> ± <NUMBER> except pneumothorax occurrence rate complications much higher deaths p <NUMBER> duration hospitalization deaths survivors similar <NUMBER> ± <NUMBER> days <NUMBER> ± <NUMBER> days respectively p <NUMBER> table <NUMBER> laboratory abnormalities admission frequently observed deaths survivors elevated level wbc monocyte ddimer aspartate aminotransferase total bilirubin lactate dehydrogenase creatine kinase blood urea nitrogen creatinine hypersensitive troponin procalcitonin observed deaths compared survivors p <NUMBER> total bilirubin greater <NUMBER> μmoll documented seven deaths <NUMBER> three survivors <NUMBER> neutrophiltolymphocyte ratio <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> platelettolymphocyte ratio <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> higher deaths survivors prothrombin time activated partial thromboplastin time longer whereas levels platelet albumin lower deaths p <NUMBER> table <NUMBER> total <NUMBER> patients <NUMBER> presented bilateral pneumonia six patients <NUMBER> showed unilateral pneumonia table <NUMBER> appendix figure <NUMBER> multivariable cox regression analyses high apache ii score adjusted hazard ratio hr <NUMBER> <NUMBER> ci <NUMBER> sofa score adjusted hr <NUMBER> <NUMBER> ci <NUMBER> increased hospital mortality risk patients covid<NUMBER> table <NUMBER> roc analyses used determine cutoff value three scoring systems evaluating hospital mortality risk auc <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> apache ii sofa curb<NUMBER> scores cutoff point value <NUMBER> <NUMBER> <NUMBER> respectively comparing two scoring systems apache ii score better predictor hospital mortality covid<NUMBER> sensitivity specificity <NUMBER> <NUMBER> respectively p <NUMBER> fig <NUMBER> patients divided two groups based cutoff point value apache ii score low risk less <NUMBER> high risk greater equal <NUMBER> median followup time since admission <NUMBER> days range <NUMBER> kaplanmeier analysis showed survivor probability patients covid<NUMBER> low risk significantly higher patients high risk p <NUMBER> median survival time patients highrisk group <NUMBER> days <NUMBER> ci <NUMBER> fig <NUMBER> retrospective study epidemiology clinical characteristics patients covid<NUMBER> half patients organ dysfunctions apache ii score demonstrated independently associated hospital mortality patients covid<NUMBER> furthermore apache ii score performed better predict hospital mortality patients covid<NUMBER> compared sofa curb<NUMBER> scores apache ii score greater equal <NUMBER> serves early warning indicator death may help provide guidance make clinical decisions sarscov<NUMBER> coronavirus transmitted humans like sarscov middle eastern respiratory syndrome merscov viruses related high mortality patients critical illness cohort <NUMBER> critical patients sars canada <NUMBER> patients died <NUMBER> days <NUMBER> fiftyeight percentage patients died <NUMBER> days saudi arabia cohort <NUMBER> patients mers <NUMBER> yang et al <NUMBER> reported <NUMBER> critically ill patients covid<NUMBER> died <NUMBER> days cohort two thirds critically ill patients died mortality patients covid<NUMBER> higher previously seen critically ill patients sars mers several reasons follows first large number covid<NUMBER> cases occurred short period time led difficulty hospitalization treatment cohort duration onset hospitalization longer deaths medicine remains inadequate considerable mortality patients covid<NUMBER> clinically predictive system early warning mortality risk urgently needed cutoff value apache ii score covid<NUMBER> much lower predict mortality several reasons may explain first gcs important component apache ii score direct damage nervous system sarscov<NUMBER> rarely reported patients disturbance consciousness study suffered hypoxemiainduced ischemic hypoxic encephalopathy one attributed underlying cerebral hemorrhage second apache ii score assessed according characteristics patients first day icu admission abnormal levels serum sodium potassium observed patients patients got scores corresponding part apache ii score finally according observation several patients deteriorated stay hospital days quickly died although timely given powerful empirical treatments including glucocorticoid immunoglobulin mechanical ventilation etc patients still hard recover covid<NUMBER> recent study showed median apache ii score survivors deaths critically ill patients covid<NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> indicated covid<NUMBER> might variable mortal compared pneumonia caused pathogens studies needed confirm findings apache ii score sofa score curb<NUMBER> score commonly used describe multiple organ function assessing disease severity estimate hospital mortality <NUMBER> <NUMBER> <NUMBER> according recent reports underlying disorder significantly common severe cases compared nonsevere cases medical history coronary heart disease independent determinant critical illness patients covid<NUMBER> <NUMBER> also associated higher risk mortality patients covid<NUMBER> <NUMBER> cohort half patients one underlying comorbidities coronary heart disease common deaths survivors suggested comorbidities played important role death patients covid<NUMBER> age also identified associated severity death patients covid<NUMBER> based present previous studies <NUMBER> <NUMBER> <NUMBER> three score systems apache ii score includes comorbidities age whereas curb<NUMBER> score takes account age sofa score takes account neither may explain apache ii score performed better two predicting mortality patients covid<NUMBER> notably sarscov<NUMBER> mainly caused lung lesions organs injury cannot neglected present study found platelettolymphocyte ratio higher deaths survivors qu et al <NUMBER> also demonstrated high platelettolymphocyte ratio associated severe illness patients covid<NUMBER> platelettolymphocyte ratio mainly reflects level systemic inflammation high value may lead adverse outcome recent studies shown proportion developing liver injury patients severe covid<NUMBER> significantly higher mild patients <NUMBER> <NUMBER> <NUMBER> study also found proportion liver dysfunction higher deaths group survivors group consistent study <NUMBER> currently studies mechanisms sarscov<NUMBER>related liver injury limited shown sarscov<NUMBER> also uses angiotensin converting enzyme <NUMBER> entry receptor sarscov <NUMBER> whether results liver damage patients remains investigated troponin significantly increased patients severe covid<NUMBER> compared milder illness <NUMBER> mechanisms may similar myocardial injury severe respiratory illnesses myocardial oxygen demand heightened inflammation rampant <NUMBER> studies need confirm mechanisms underlying findings still limitations study first present study retrospective singlecenter study relatively small sample size second patients enrolled icu tongji hospital patients transferred hospitals isolation units patients likely progress adverse outcomes therefore mortality patients covid<NUMBER> study may much higher general population <NUMBER> may generalized third treatments may influence outcomes patients covid<NUMBER> study aimed apply characteristics patients first day admitted icu predict outcome patients covid<NUMBER> additional research needed understand role apache ii score risk stratification patients covid<NUMBER> apache ii score identified effectively clinical tool predict mortality patients covid<NUMBER> compared sofa score curb<NUMBER> score future researches needed explore whether application apache ii score patients covid<NUMBER> could reduce mortality improve patient outcomes december <NUMBER> novel coronavirus disease covid<NUMBER> broke wuhan china caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> covid<NUMBER> affirmed humantohuman transmissibility <NUMBER> spread worldwide raised high attention within china internationally world health organization reported <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths globally march <NUMBER> <NUMBER> <NUMBER> evaluated global pandemic day <NUMBER> retrospect studies outbreak severe acute respiratory syndrome sars guangdong <NUMBER> gradually faded warming weather coming basically ended july <NUMBER> documented temperature variations might affected sars outbreak <NUMBER> study korea found risk influenza incidence significantly increased low daily temperature lowhigh relative humidity positive significant association observed diurnal temperature range dtr <NUMBER> moreover temperature <NUMBER> dtr <NUMBER> linked death respiratory diseases study demonstrated absolute humidity significant correlations influenza viral survival transmission rates <NUMBER> couple studies reported covid<NUMBER> related meteorological factors decreased temperature increasing <NUMBER> <NUMBER> effects mortality reported therefore assume weather conditions might also contributed mortality covid<NUMBER> capital hubei province one largest city central china wuhan located middle yangtze river delta typical subtropical humid monsoon climate cold winters warm summers <NUMBER> average annual temperature rainfall <NUMBER> °c<NUMBER> °c <NUMBER> mm<NUMBER> mm respectively <NUMBER> besides wuhan owns area <NUMBER> km <NUMBER> population <NUMBER> million <NUMBER> <NUMBER> far covid<NUMBER> caused <NUMBER> deaths globally ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint caused <NUMBER> deaths wuhan although deaths may affected many factors present explore effect meteorological angel generalized additive model gam data <NUMBER> january <NUMBER> absolute humidity calculated according previous study measured vapor pressure vp <NUMBER> density water vapor absolute humidity ρ v gm <NUMBER> mass moisture per total volume air associated vp via ideal gas law moist portion air e vapor pressure vp r v gas constant water vapor <NUMBER> jkg k daily ambient temperature k vp commonly used indicator absolute humidity calculated ambient temperature relative humidity using clausiusclapeyron relation <NUMBER> briefly first calculated saturation vapor pressure e mb daily ambient temperature using following equation e <NUMBER> denotes saturation vapor pressure reference temperature <NUMBER> <NUMBER> k equals <NUMBER> mb l denotes latent heat evaporation water <NUMBER> kjkg r v gas constant water vapor <NUMBER> jkg k denotes daily ambient temperature k vp pa calculated combining e calculated using eq <NUMBER> relative humidity rh descriptive analysis performed used generalized additive model gam analyze associations meteorological factors temperature dtr relative humidity absolute humidity daily mortality covid<NUMBER> core analysis gam quasipoisson link function based previous studies <NUMBER> <NUMBER> first built basic models mortality ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint outcomes without including air pollution weather variables incorporated smoothed spline functions time accommodate nonlinear nonmonotonic patterns mortality time thus offering flexible modeling tool introduced weather variables analyzed effects mortality akaikes information criterion used measure well model fitted data consistent several recent timeseries studies <NUMBER> <NUMBER> penalized smoothing spline function applied control effects confounding factors time trends dayofweek air pollution core gam equation day observation ey expected number daily mortality covid<NUMBER> day α intercept β regression coefficient x daily level weather variables day denotes smoother based penalized smoothing spline based quasi akaike information criterion qaic <NUMBER> degrees freedom df used time trends <NUMBER> df air pollutants temperature relative humidity dow categorical variable indicating date week establishing core model also considered lag effects weather conditions death covid<NUMBER> examined potentially lagged effects ie single day lag lag <NUMBER> lag <NUMBER> multipleday average lag lag <NUMBER> lag <NUMBER> <NUMBER> exposure response correlation curves weather variables covid<NUMBER> mortality plotted using spline function gam also performed sensitivity analysis changing df penalized smoothing spline function <NUMBER> <NUMBER> calendar time <NUMBER> <NUMBER> temperature humidity statistical analyses twosided <NUMBER> level significance analyses conducted using r software version <NUMBER> gam fitted mgcv package version <NUMBER> effect estimates expressed percentage changes <NUMBER> confidence intervals cis daily mortality covid<NUMBER> associated per <NUMBER> unit increase weather variables correlation results mortality counts covid<NUMBER> meteorological measures air pollutant concentrations presented table <NUMBER> mortality counts covid<NUMBER> negatively associated relative humidity r −<NUMBER> pm <NUMBER> r −<NUMBER> pm <NUMBER> r −<NUMBER> positive ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint association covid<NUMBER> mortality observed dtr r <NUMBER> <NUMBER> r <NUMBER> covid<NUMBER> mortality current day generally curves tended associated covid<NUMBER> mortality dtr strongly positive temperature addition curves associated relative humidity absolute humidity presented similar linear trends indicated higher level humidity might cause decrease covid<NUMBER> mortality study conducted wuhan <NUMBER> january <NUMBER> <NUMBER> february <NUMBER> order investigate association weather variables daily death number covid<NUMBER> significant positive effect dtr daily mortality counts covid<NUMBER> first identified study also found significant negative association covid<NUMBER> mortality observed temperature absolute humidity results indicate effects dtr also paid attention mortality covid<NUMBER> study demonstrated negative association covid<NUMBER> case fatality temperature positive association dtr results consistent following investigations respiratory diseases mortality increased decreasing temperature <NUMBER> strongly associated low temperature <NUMBER> another study found cold heat effects may adverse impact respiratory mortality <NUMBER> otherwise study conducted <NUMBER> east asian cities showed increased dtr associated increased risk mortality respiratory cardiovascular diseases <NUMBER> cold season cumulative relative risk nonaccidental respiratory cardiovascular death increased high dtr values tabriz <NUMBER> timeseries study done shanghai effect dtr daily chronic obstructive pulmonary disease copd mortality showing <NUMBER>°c elevation <NUMBER>day moving average dtr accounted <NUMBER> increased risk copd mortality <NUMBER> review cold exposure immune function reported lower temperature may repress immune function <NUMBER> particularly previous finding suggested phagocytic function pulmonary alveolar macrophages declined cold stress vitro experiment <NUMBER> breathing cold air lead bronchial constriction may promote susceptibility pulmonary infection <NUMBER> additionally since sarscov<NUMBER> sensitive heat high temperature makes difficult survive mention beneficial factors virus transmission like indoor crowding poor ventilation cold days <NUMBER> also cold temperature discovered associated reduction lung function increases exacerbations people copd <NUMBER> addition dtr represents stable measure temperature indicator temperature variability evaluate effects human health including mortality ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint morbidity <NUMBER> besides abrupt temperature changes may add burden cardiac respiratory system causing cardiopulmonary events high dtr levels may source environmental stress <NUMBER> findings highlight need strengthen awareness effects temperature dtr covid<NUMBER> mortality researchers confirmed respiratory infection enhanced unusually cold low humidity conditions <NUMBER> indicating low humidity may also important risk factor respiratory diseases worse study data <NUMBER> years found humidity important determinant mortality lowhumidity levels may cause large increase mortality rates potentially influenzarelated mechanisms <NUMBER> similar study carried united states <NUMBER> consistent finding results also indicated risk dying covid<NUMBER> decreased absolute humidity increasing breathing dry air could cause epithelial damage andor reduction mucociliary clearance lead render host susceptible respiratory virus infection formation droplet nuclei essential transmission exhaled respiratory droplets settle rapidly high humidity hard contribute influenza virus spread <NUMBER> moreover transmission pandemic influenza virus efficient cold dry conditions <NUMBER> influenza virus survival rate increased markedly accordance decreasing absolute humidity <NUMBER> may similar coronavirus therefore increase covid<NUMBER> mortality may also related lower humidity winter however many limitations ignored firstly factors may affect covid<NUMBER> mortality population migration government intervention secondly ecologic timeseries study design adopted study might exist ecologic fallacy furthermore difficult obtain meteorological air pollution data individual level nevertheless study showed dtr might associated death risk covid<NUMBER> wuhan deserves investigation first study investigate effects temperature dtr humidity daily mortality covid<NUMBER> chinese population utilizing publicly accessible data covid<NUMBER> statistics weather variables finding shows daily mortality covid<NUMBER> positively association dtr negatively relative humidity summary study suggests temperature variation humidity may important factors affecting covid<NUMBER> mortality gam generalized additive model ci confidence interval rr relative risk applicable applicable ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint datasets used andor analyzed current study available websites authors declare conflict interest work supported novel coronavirus disease science technology major project gansu province ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint fig <NUMBER> exposureresponse curves meteorological factors covid<NUMBER> daily mortality counts wuhan china <NUMBER> january <NUMBER> february <NUMBER> xaxis concurrent day meteorological data yaxis predicted log relative risk rr shown solid line dotted lines represent <NUMBER> confidence interval ci covid<NUMBER> coronavirus disease dtr diurnal temperature range ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint first case new coronavirus disease <NUMBER> mexico confirmed february <NUMBER> th <NUMBER> <NUMBER> since government mexico launched series preventive measures adhere world health organization sarscov<NUMBER> strategic preparedness response plan aimed limiting spread virus <NUMBER> national campaign healthy distance implemented march <NUMBER> rd may <NUMBER> th <NUMBER> included social distance hand washing general confinement selfisolation covid<NUMBER> associated symptoms <NUMBER> days limited economic mobility <NUMBER> globally individual factors associated covid<NUMBER> mortality found male sex age <NUMBER> years ethnicity hypertension diabetes cardiovascular disease respiratory disease among others <NUMBER> <NUMBER> according <NUMBER> national health nutrition survey ensanut<NUMBER> mexico <NUMBER> adults age <NUMBER> obese <NUMBER> overweight <NUMBER> diabetic <NUMBER> hypertensive <NUMBER> considering states mexico hold heterogeneous distribution prevalence comorbidities regions increased burden diseases sociodemographic related factors higher risk encountering severe manifestations covid<NUMBER> might require hospitalization critical care well higher covid<NUMBER> mortality rates deemed order curb pandemic national decisions ought coordination local level united states sociodemographic health factors related covid<NUMBER> vary importantly across counties <NUMBER> <NUMBER> <NUMBER> mexico <NUMBER> municipalities distributed <NUMBER> states basis territorial organization political administrative division <NUMBER> june <NUMBER> st <NUMBER> federal government gave states country responsibility deciding reopening social educational economic activities based traffic light system established moh <NUMBER> covid<NUMBER> however expected linger within communities several months even years come targeted public policy interventions regions highly vulnerable covid<NUMBER> crucial safeguard protect strengthen communities facing pandemic therefore objective study analyze municipalitylevel factors associated higher mortality rate mr covid<NUMBER> mexico pinpoint locations expected suffer high covid<NUMBER> mortality coronavirus pandemic surveillance mexico carried using sentinel model proposed pan american health organization paho <NUMBER> model works <NUMBER> nationally representative health facilities monitor coronavirus cases test sarscov<NUMBER> conducted ten percent suspected cases <NUMBER> suspected severe acute respiratory syndrome signs breathing difficulty deaths hospitalized suspected covid<NUMBER> cases operational definition suspected case mexico individual last <NUMBER> days presented least <NUMBER> following signs symptoms cough fever headache accompanied least one following signs symptoms dyspnea arthralgia myalgia odynophagiapharyngeal burning rhinorrhea conjunctivitis andor chest pain <NUMBER> confirmed case covid<NUMBER> defined person diagnosis given national network public health laboratories recognized institute epidemiological diagnosis reference indre met criteria suspected case <NUMBER> used daily updated open data source general directorate epidemiology mexican moh includes demographic health information confirmed negative suspect cases covid<NUMBER> <NUMBER> extracted data june <NUMBER> th <NUMBER> number confirmed symptomatic cases deaths municipalitylevel level obtained data variables hypothesized could linked differential testing practices exposure sarscov<NUMBER> recent complete information census records identify municipalitylevel factors associated mortality rate covid<NUMBER> adjusted negative binomial regression model dependent variable sum confirmed covid<NUMBER> deaths symptomatic cases n<NUMBER> <NUMBER> municipality residence independent variables quintiles distribution sociodemographic health outcomes within municipality expected mortality rates emr municipality incidence rate ratios irr <NUMBER> confidence intervals estimated better understand association mr covid<NUMBER> municipalitylevel factors addition main objective study also fitted ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> <NUMBER> <NUMBER> observations <NUMBER> positive symptomatic cases covid<NUMBER> <NUMBER> negative <NUMBER> suspect cases proportion deaths <NUMBER> positive cases <NUMBER> negative cases <NUMBER> suspect cases moment analysis two thirds municipalitylevel symptomatic cases almost half reported deaths due covid<NUMBER> data shown table <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> table <NUMBER> municipalitylevel factors associated high cumulative incidence rate covid<NUMBER> similar associated high mortality except authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> states oaxaca chihuahua guerrero casefatality rates covid<NUMBER> higher <NUMBER> individual level also explored characteristics confirmed symptomatic cases associated higher lethality covid<NUMBER> order observed risk factors observed countries remain mexican context supplementary table <NUMBER> concordance municipalitylevel results diabetes belonging indigenous ethnic group obesity associated higher risk mortality due coronavirus individual risk factors lethalitycase age <NUMBER> male sex hypertension ckd copd immunosuppression addition received medical care private health institutions associated lower lethality covid<NUMBER> compared cared public health services individuals sought medical attention <NUMBER> <NUMBER> days onset symptoms higher risk dying compared received medical care <NUMBER> <NUMBER> days onset symptoms supplementary table <NUMBER> illustrate municipalitylevel factors associated cumulative incidence lethality rates june <NUMBER> th <NUMBER> disaggregated month found municipalitylevel factors association cumulative incidence mortality rate covid<NUMBER> varied within course pandemic mexico ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> municipalitylevel factors found associated higher risk mortality covid<NUMBER> population density prevalence diabetes obesity mortality rate diabetes proportion indigenous population economically active population rate economic units operate essential activities covid<NUMBER> outbreak first high proportion population economically active may reflect lower confinement increased mobility higher population density may related less social distancing high connectivity secondly high mortality rate diabetes means inadequate control glucose levels negative impact immune cardiovascular systems crucial bodys response covid<NUMBER> <NUMBER> also lower access quality medical care weaker local health care systems <NUMBER> despite individual level hypertension associated higher lethality covid<NUMBER> municipality level mortality rate hypertension associated high mortality covid<NUMBER> within states highest prevalence hypertension lower mortality risk covid<NUMBER> result could explained fact prevalence used model came adults already diagnosed hypertension according previous surveys represented approximately <NUMBER> total cases hypertensive population access health care services antihypertensive medication <NUMBER> nevertheless unknown unobserved variables prior demand healthcare services might reflecting inverse association hypertension covid<NUMBER> mortality ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint important note cumulative incidence cases indigenous populations low however risk mortality coronavirus higher municipalities lower proportion indigenous population findings could indicate lower access healthcare services testing combined dynamic epidemic migrates marginalized areas higher proportion indigenous population countries found many mechanisms underlying higher lethality covid<NUMBER> ethnic minorities related marginalization conditions locality residence work conditions health inequalities <NUMBER> <NUMBER> marginalized conditions nonsewage service dirt floors inversely associated mortality covid<NUMBER> communities household characteristics mostly remote low connectivity could protective sarscov<NUMBER> exposure notwithstanding marginalized remote communities could also lower access testing sarscov<NUMBER> health care could lead underreporting cases deaths special screening strategies tracing isolation contacts within vulnerable communities essential favor prevention deaths covid<NUMBER> <NUMBER> may <NUMBER> mexican moh published list <NUMBER> municipios de la esperanza hope municipalities last <NUMBER> days prior may <NUMBER> confirmed cases covid<NUMBER> adjacent municipalities confirmed cases list guide state governors restart nonessential activities may <NUMBER> <NUMBER> <NUMBER> however according results <NUMBER> municipalitylevel high risk worse outcomes event outbreak june <NUMBER> <NUMBER> <NUMBER> symptomatic cases <NUMBER> deaths due covid<NUMBER> confirmed municipalities identification municipalities high burden risk factors severe illness death covid<NUMBER> critical establish convenient health policies ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint municipality level many municipalities locations susceptible outbreak onset pandemic evolves mexico municipalities confirmed cases yet populations risk becoming seriously ill covid<NUMBER> could greater burden disease upcoming months contingency measures mobility restrictions eased soon targeted approach crucial prevent control onset new outbreaks within municipalities include testing isolation contact tracing well general measures according threestage traffic light system established mexico reactivate economy reduce contingency measures <NUMBER> additional municipalitylevel factors associated cumulative incidence mortality covid<NUMBER> identified municipalities condition extreme poverty higher casefatality rate covid<NUMBER> example oaxaca chihuahua guerrero states municipalities casefatality rates higher <NUMBER> finding suggests low availability tests communities per limitations within study que precision estimations depends quality databases example aging data variables <NUMBER> years may reflect heterogeneous changes within municipalities <NUMBER> nevertheless data previous years still holds relation following years useful find expected associations obesity diabetes hypertension prevalence information ensanut<NUMBER> representatively state level reducing variability within municipalities however rest variables mortality rates diabetes hypertension information disaggregated municipality finally ecological design study prevented us establishing causal associations ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint knowledge first study estimated mortality rate covid<NUMBER> using burden related comorbidities sociodemographic characteristics order identify municipalities risk high mortality rates coronavirus mexico findings could contribute national strategic preparedness response plans towards new normality <NUMBER> informing municipalitylevel level factors ought consider decisionmaking process public health interventions minimize negative impact covid<NUMBER> health livelihoods atrisk communities based results considered good moment modify current epidemiological surveillance strategy confirming covid<NUMBER> positive cases deaths populations might underreported sentinel surveillance approach instance indigenous communities communities extreme poverty could affected risks covid<NUMBER> afflicting health population also increasing food insecurity domestic violence disrupting routine care chronic diseases economic repercussions might bring critical count data impact covid<NUMBER> amongst populations identify prioritize address needs vulnerable populations using small area demographic characteristics burden comorbidities covid<NUMBER> useful identify locations risk covid<NUMBER> mortality mexico municipalitylevel risk factors associated high mortality rates covid<NUMBER> high proportion population economically active high population density high proportion indigenous population high diabetes mortality based characteristics many municipalities experienced high mortality yet prone epidemic curve progresses therefore warn overconfidence premature easing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mobility restrictions contingency measures local governments ought reinforce local strategies prevent outbreaks vulnerable communities covid<NUMBER> since first atypical pneumonia case caused novel coronavirus reported wuhan china december <NUMBER> <NUMBER> <NUMBER> novel cases also reported thailand japan republic korea hong kong taiwan us countries europe <NUMBER> outbreak still ongoing coronavirus soon identified cause outbreak tentatively named <NUMBER>ncov world health organization <NUMBER> <NUMBER> feb <NUMBER> world health organization officially named sarscov<NUMBER> severe acute respiratory syndrome coronavirus<NUMBER>and sarscov<NUMBER> infection named coronavirus disease <NUMBER> <NUMBER> coronaviruses enveloped nonsegmented positivesense rna viruses belonging family j u r n l p r e p r f <NUMBER> coronaviridae human coronavirus infections mild except two betacoronaviruses severe acute respiratory syndrome coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> caused <NUMBER> cumulative cases past mortality rates <NUMBER> sarscov <NUMBER> merscov <NUMBER> <NUMBER> sarscov<NUMBER> infectious pneumonia similar clinical features including fever cough shortness breath <NUMBER> <NUMBER> sarscov infectious pneumonia however current trends suggest sarscov<NUMBER> transmissible spreads faster sarscov merscov study analyzed compared epidemic features covid<NUMBER> hubei province regions china explored differences regions better understand epidemic covid<NUMBER> provide different control strategies toward hubei province regions china comprehensive search chinese center disease control prevention official websites announcements <NUMBER> performed <NUMBER> jan <NUMBER> <NUMBER> feb <NUMBER> relevant data distribution infection reported day obtained <NUMBER> fig<NUMBER> differences suggested sarscov<NUMBER> infectious transmittable compared sarscov since chinese national health commission announcements confirmed suspected cases <NUMBER> jan <NUMBER> number confirmed cases continued increase especially hubei province <NUMBER> feb <NUMBER> total number confirmed cases china reached <NUMBER> including <NUMBER> hubei province wuhan <NUMBER> confirmed cases fig<NUMBER> <NUMBER> however growth rate began decrease <NUMBER> jan <NUMBER> continued decline past days rebounding <NUMBER> feb <NUMBER> fell earlier regions hubei province present growth rate confirmed cases <NUMBER> nationwide growth rate significantly higher hubei province regions<NUMBER> versus <NUMBER> fig<NUMBER> <NUMBER> number suspected patients also declining <NUMBER> feb <NUMBER> total number suspected cases <NUMBER> china including <NUMBER> hubei province fig<NUMBER> number suspected patients growth rate increased suspected patients significantly higher hubei province regions fig<NUMBER>and <NUMBER> number suspected patients began decline hubei province <NUMBER> feb <NUMBER> regions <NUMBER> feb <NUMBER> slowly increasing fig<NUMBER> <NUMBER> confirmed cases <NUMBER> deaths reported nationwide j u r n l p r e p r f <NUMBER> <NUMBER> feb <NUMBER> mortality <NUMBER> mortality <NUMBER> <NUMBER> hubei province regions nationwide respectively fig<NUMBER> mortality covid<NUMBER> significantly increased hubei province compared regions nationwide patients admitted hospitals treatment discharged died since <NUMBER> feb <NUMBER> trend significantly increased fig<NUMBER> <NUMBER> feb <NUMBER> number discharged patients <NUMBER> exceeded number hospitalized patients change suggested initial control outbreak enhanced confidence fighting disease since first official announcement <NUMBER> dec <NUMBER> wuhan municipal health commission <NUMBER> infection quickly spread china internationally defined public health emergency international concern pheicon <NUMBER> january <NUMBER>the pathogen soon isolated apatients alveolar lavage identified novel coronavirus <NUMBER> human severe acute respiratory syndrome sars virus middle eastern respiratory syndrome mers virus sarscov<NUMBER> belong betacovs bat coronavirus bcov sarscov<NUMBER> share <NUMBER> sequence identity confirming sarscov<NUMBER> zoonotic origin <NUMBER> <NUMBER> r <NUMBER> indication transmissibility virus representing average number new infections generated infectious person totally naïve population r <NUMBER> estimates sars reported range <NUMBER> different mathematical methods used estimate r <NUMBER> sarscov<NUMBER> produced range <NUMBER> <NUMBER> based different epidemic stages <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prominent area hubei province wuhan <NUMBER> cases suggested mass outbreak covid<NUMBER> community spread wuhan previous report indicated among nonresidents wuhan <NUMBER> contact residents wuhan including <NUMBER> visited city <NUMBER> suggested mostly associated feb <NUMBER> test reagents rtpcr assay began widely used hubei province along lung ct diagnostic criteria represent large number patients mass outbreak <NUMBER> feb <NUMBER> decrease rate confirmed patients <NUMBER> feb <NUMBER> illusion due lack enough test reagents also suspected cases began significantly decrease <NUMBER> feb <NUMBER> suspected cases confirmed ruled test reagents widely used new diagnostic criteria lung ct according recent report chinese center disease control prevention overall mortality <NUMBER> noncomorbidity mortality <NUMBER> patients covid<NUMBER> <NUMBER> lower sars mers mortality covid<NUMBER> significantly higher hubei province regions nationwide<NUMBER> versus <NUMBER> may following factors <NUMBER> virulence pathogenicity virus decreased <NUMBER>nd <NUMBER>rd generation transmission <NUMBER> <NUMBER>a significant number mild asymptomatic patients seek medical attention <NUMBER>early patients cannot confirmed due lacking nucleic acid test <NUMBER>some severe patients comorbidity lost opportunity timely treatment due insufficient medical resources early days epidemic high mortality hubei province may overestimated mortality regions better reflect pathogenicity covid<NUMBER> good news since <NUMBER>feb <NUMBER> number recovered cases exceeded number deaths number discharged patients exceeded number hospitalized patients trend increased past days suggests initial control outbreak enhanced confidence fighting disease initially lack disease awareness inappropriate prevention control led rapid epidemic infections hubei province emergence <NUMBER>nd <NUMBER>rdgeneration infections community spread thanks dr edward c mignot shandong university linguistic advice dwj hsl full access data study takes responsibility integrity data accuracy data analysis lq idea designed study zzf contributed reviewed approved final version authors conflicts interest disclose approval required number discharged cases exceeds number dead poor dietary habits considered secondleading risk factors mortality disabilityadjusted lifeyears dalys world poor dietary habits responsible <NUMBER> million deaths <NUMBER> million dalys <NUMBER> <NUMBER> example following dietary habits among leading risk factors early death disability european countries habits low intakes whole grains fruit vegetables nuts seeds high intakes alcohol sodium western dietary habits consuming diet processed high red processed meat diets high sugarsweetened beverages low milk kinds dietary habits regarded rising health concern dietary patterns different based cultural environmental technological economic factors however dietary patterns becoming similar due increasing living standards growing globalization food sector <NUMBER> <NUMBER> mertens et al <NUMBER> explored dietary intakes four different european counters using individuallevel dietary intake adults nationallyrepresentative surveys denmark france czech republic italy reported higher intake fruits vegetables lower intakes sweetened beverages alcohol italy individuals denmark czech republic higher intake vegetables comparison population subgroups within countries shows difference dietary preferences beliefs practices particular consumer groups example highlyeducated persons women higher intake fish nuts seeds along lower intake red processed meats <NUMBER> individuallevel reported dietary data countries could used useful tool make connection health environment foods common denominator <NUMBER> recent review study reported detailed assessment patients dietary nutritional risks along medical lifestyle environmental factors suitable risk management strategies make sensible way deal covid<NUMBER> <NUMBER> diet nutrition variance impact immune system competence addition determine risk severity infections relation diet nutrition infection immunity bidirectional <NUMBER> macro micronutrients phytonutrients diet fruits colorful vegetables improve healthy immune responses microand phytonutrients provide antioxidants antiinflammatory nutrients like betacarotene vitamin c vitamin e polyphenolic compounds resulting modulating immune functions <NUMBER> <NUMBER> nutritional deficiencies energy protein specific micronutrients shown contribute depressed immune function increased susceptibility infections sufficient intake iron zinc vitamins e b<NUMBER> b<NUMBER> vital overall maintenance immune function <NUMBER> new epidemics coronavirus disease <NUMBER> covid<NUMBER> become pandemic world currently make hypothesis geographical variation dietary factors could role infection mortality rates covid<NUMBER> world therefore aimed explore relation dietary factors global infection mortality rates covis<NUMBER> study current ecological study countries national dietary data global dietary databases united nations <NUMBER> coronavirus disease statistics world health organization included <NUMBER> countries coronavirus disease statistics consecutively checked recent data dietary factors countriesstates met eligibility criteria investigation statistics coronavirus disease covid<NUMBER> situation dashboard website world health organization <NUMBER> april <NUMBER> <NUMBER> following countries excluded analysis due statistics covid<NUMBER> comoros north korea kiribati lesotho malawi marshall islands micronesia nauru palau samoa sao tome principe solomon islands south sudan tajikistan tonga turkmenistan tuvalu vanuatu yemen following countries excluded study due data national dietary factors website global dietary database <NUMBER> populations countries extracted united nations statistics division <NUMBER> estimated populations year <NUMBER> considered countries countries population year <NUMBER> therefore authors checked years <NUMBER> <NUMBER> <NUMBER> accordingly population <NUMBER> used following country algeria population <NUMBER> considered following countries lybia sierra leone population <NUMBER> extracted following countries mali mauritania papua new guinea sudan <NUMBER> following countries bhutan bosni burkina faso fiji guyana niger nigeria pakistan uae populations following countries available <NUMBER> period therefore population following countries included study based eligibility criteria countries central african republic djibouti djibouti dominica gabon kosovo lebanon liberia moldova russia saint kitts nevis syria somalia democratic republic cong finally <NUMBER> countriesstates included study general characteristics countries presented median interquartile range iqr mean std deviation number percentage confirmed dead cases presented median interquartile range due nonnormal distribution data normality outcomes examined drawing histogram box plot number confirmed cases divided total population country multiplied <NUMBER> obtain infection rate covid<NUMBER> per one million persons number dead cases divided total number confirmed cases divided total population multiplied <NUMBER> obtain mortality rate<NUMBER> persons infection mortality rates determined median interquartile range following dealing potential outliers upper limit values considered extremely higher limit values infection mortality rates crude infection rate categorized following groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> per one million person infection mortality rates transformed ln technique obtain normally distributed histogram ethical aspect applicable study median crude infection rate covid<NUMBER> <NUMBER> iqr <NUMBER> ranged <NUMBER> <NUMBER> per <NUMBER> persons median mortality rate covid<NUMBER> <NUMBER> iqr <NUMBER> ranged <NUMBER> <NUMBER> per <NUMBER> persons two highest percentage crude infection rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> per one million persons table <NUMBER> study showed crude infection rate raised increasing consuming fruits r<NUMBER> p<NUMBER> unprocessed red meats r<NUMBER> p<NUMBER> fruit juices r<NUMBER> p<NUMBER> total protein r<NUMBER> p<NUMBER> calcium r<NUMBER> p<NUMBER> potassium r<NUMBER> p<NUMBER> total milk r<NUMBER> p<NUMBER> regarding crude mortality rate per <NUMBER> persons study showed crude mortality rate raised increasing consuming unprocessed red meats r<NUMBER> p<NUMBER> sugar sweetened beverages r<NUMBER> p<NUMBER> fruit juices r<NUMBER> p<NUMBER> calcium r<NUMBER> p<NUMBER> total milk r<NUMBER> p<NUMBER> however mortality rate decreased following increasing consuming nonstarchy vegetables r<NUMBER> p<NUMBER> see table <NUMBER> regression analysis showed crude infection rate increased raising consuming fruits beta <NUMBER> p<NUMBER> calcium beta <NUMBER> p<NUMBER> however infection rate decreased rising consuming beans legumes beta <NUMBER> p<NUMBER> table <NUMBER> effect dietary factors crude mortality rate covid<NUMBER> examined regression analysis analysis showed crude mortality rate increased raising consuming sugarsweetened beverages beta <NUMBER> p<NUMBER> whereas crude mortality rate covid<NUMBER> decreased increasing fruits consuming beta <NUMBER> p<NUMBER> beans legumes beta <NUMBER> p<NUMBER> presented table <NUMBER> comparison dietary factors countries different infection rates examined table <NUMBER> fig <NUMBER> study showed countries higher infection rates <NUMBER> higher intake fruits p<NUMBER> fruit juices p<NUMBER> calcium p<NUMBER> potassium p<NUMBER> total milk p<NUMBER> however countries lower intake unprocessed red meats p<NUMBER> total protein p<NUMBER> aim foodbased dietary guidelines maintain general health population prevent noncommunicable diseases <NUMBER> foodbased dietary guidelines recommend intake whole grains fruit vegetables lowfat dairy fish low intake red processed meat sugarsweetened food products alcohol salt <NUMBER> present study showed crude infection rate covid<NUMBER> increased raising consuming fruits calcium decreased increasing consuming beans legumes regarding mortality rate analysis showed crude mortality rate increased raising consuming sugarsweetened beverages decreased increasing fruits consuming beans legumes antiinflammatory strategies inside foods nutrients <NUMBER> <NUMBER> since coronavirus serious inflammatory consequences acute pneumonia persons <NUMBER> human coronavirus infections cause mild severe diseases systemic inflammation high fever cough acute respiratory tract infection dysfunction internal organs leading death virus classified ribonucleic acid rna virus virus genome often escapes innate immune system particularly malfunctioning <NUMBER> entering coronavirus organism activates innate immunity intervenes first instance engulf invader severity diseases locates within ability innate immune cells stem viral infection <NUMBER> virus less ability replicate induce pathological state case stronger innate immune system immune system suppressed virus body activates adaptive immunity coronavirus enables produce viral enzymes proteases enzymes proteases damage immunity inhibit signaling pathways type interferon ifn along nuclear factorκb facilitating innate immune evasion <NUMBER> apart agerelated micronutrient inadequacy nutritional status person role developing risk sarscovii infection clinical course disease outcomes hence maintenance host macroand micronutrient status considered crucial preventive measure covid<NUMBER> <NUMBER> coronavirus infection primarily attacked immune cells however virus developed viral proteins overtime counteracts innate immune system <NUMBER> viral proteins antagonize interferon inf stimulate inflammatory proteins il<NUMBER> family member cytokines <NUMBER> inflammatory state pathogenesis disease escalated abnormal production cytokines shown sars <NUMBER> hypothesis higher intake fruits makes persons risk infection covid<NUMBER> despite fruits vegetables antiinflammatory antioxidant factors important role enhancing immune system responses <NUMBER> higher intake micronutrients makes barrier improving human immune system response pathogens due role fruits high glycemic index study showed beans legumes positive role reducing infection rate covid<NUMBER> human body requires substates plant proteins improve respond vial pathogens human body unable produce substrates <NUMBER> therefore body needs substates protect organs coronavirus assume immune body system unable recognize virus early times comparison dietary factors countries different infection rates therefore available proteins essential body make response pathogen beans legumes effective reduce rate mortality covid<NUMBER> well role age suppression immune system must overlooked population countries higher infection rate older compared counters low infection rate <NUMBER> example france italy compared iraq saudi arabia available evidence indicates adults aged <NUMBER> years older patients preexisting medical conditions likely severeven deadlycoronavirus infection population groups <NUMBER> therefore make hypothesis aged population countries high infection rates main factor low immune system impacts aging immune system reflect multiple levels levels decreased production b cells bone marrow thymus diminished functions mature lymphocytes secondary lymphoid tissues elderly persons respond immune challenges robustly young individual <NUMBER> higher intake fruits vegetables may beneficial enhance immune system aged populations diet alone may insufficient tailored micronutrient supplementation based specific agerelated needs necessary <NUMBER> many micronutrients required immunecompetence especially vitamin c e bs iron selenium zinc moreover dietary pattern essential maintain nutritional status individual however diet alone could adequate certain metabolic lifestyle conditions elderlies coexisting medical conditions cigarette smoking occupational exposure environmental toxins <NUMBER> fruits several vitamins minerals fruits ground level may quite suitable make final judgment older persons age <NUMBER> experience immune dysregulation less ability respond immune challenges response pathogens antigens mitogens decreases <NUMBER> decrease number circulating lymphocytes loss immune cells characteristics immune system older people <NUMBER> moreover older peoples reduced production cells involved thymus consequently diminished function mature lymphocytes secondary lymphoid tissues <NUMBER> lifetime exposure antigens several sources oxidative stress cause dysregulation immune system makes risk infections age groups <NUMBER> role fruits enhancing immunity micronutrients exhibiting pleiotropic roles supporting immune function vitamins minerals support develop maintain physical barriers produce activate antimicrobial proteins <NUMBER> mechanisms micronutrients supporting growth differentiation motilitychemotaxis innate cells phagocytic killing activities neutrophils macrophages promotion recovery inflammation eg cytokine production antioxidant activity <NUMBER> potential mechanisms fruits may back antiviral immune induction modulation immunoregulatory defense induction autophagy apoptosis genetic epigenetic regulation <NUMBER> stimulation defensins cathelicidins may reduce replication virus raise levels antiinflammatory cytokines reducing levels proinflammatory cytokines <NUMBER> hypothesis higher intake fruits suppresses role stimulation defensins cathelicidins common denominator reflects role nutrition dietary recommendations viral infections including covid<NUMBER> relation diet immunity <NUMBER> made hypothesis based immunological effects higher intake fruits patients covid<NUMBER> taking account patients ages evidence highlights diet important effect immune system disease vulnerability peoples role nutrients nutrient combinations back effects immune system cell activation modification production signaling molecules gene expression <NUMBER> relation fruits beans legumes crude mortality rate weak p<NUMBER> p<NUMBER> respectively contrast strong relation sugarsweetened beverages ssbs p<NUMBER> possible role sugarsweetened beverages infection rate may back role weight gain risk obesity review study observational clinical trials showed higher intake ssbs raised risk weight gain obesity <NUMBER> evidence confirmed elsewhere <NUMBER> <NUMBER> accordingly maccioni et al <NUMBER> recruited <NUMBER> individuals aged <NUMBER> crosssectional study airway infection germany study reported obese persons consistently higher frequency upper lower respiratory tract infections rtis evidence reported elsewhere <NUMBER> <NUMBER> obesity responsible dysregulation immune system mediation different immune metabolic thrombogenic responses <NUMBER> higher intake ssbs reported highincome countries <NUMBER> effect higher calcium intake raising infection rates could due effect calcium risk chronic diseases rather direct effect metaanalysis showed increased incidence myocardial infarction persons consume higher levels calcium pooled relative risk <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> p<NUMBER> <NUMBER> addition calcium reported trigger ischemic cell death <NUMBER> daily recommended allowanceintake dietary factors different across countries required mention food intake varies markedly based sociodemographic factors like age gender educational level make stratification results study based sociodemographic aspects since published covid<NUMBER> confirmed cases according age gender educational level besides crosscountry caparison individuallevel dietary data challenged dietary surveys performed various survey characteristics data collection methods possible influence comparison results however used fao dietary data represent nationally representative sample agesex educational level categories present study showed higher intake fruits sugarsweetened beverages positive effect infection mortally rates covid<NUMBER> respectively contrast higher intake beans legumes negative effect increasing infection mortality rates possible reason role fruits sugarsweetened beverages infection mortally rates back indirect effect weight gain obesity role age authors declare conflicts ineptest article protected copyright rights reserved coronavirus disease <NUMBER> covid<NUMBER> viral respiratory illness caused novel coronavirus ncov covid<NUMBER> highly contagious <NUMBER> million cases nearly <NUMBER> thousand deaths worldwide april <NUMBER> <NUMBER> <NUMBER> <NUMBER> targeting organs coronavirus believed lungs airways however patients often evidence damage organs significantly increases mortality <NUMBER> <NUMBER> pathophysiological foundation multiorgan damage may associated organspecific immune response disseminated coronavirus secondary hypoxemia systemic cytokine storm medication <NUMBER> attempt determine distributional temporal patterns liver injury patients covid<NUMBER> focus clinical significance determinants change conducted multicenter retrospective cohort study included <NUMBER> patients hubei province multicenter retrospective cohort study patients covid<NUMBER> admitted following study exclusion criteria applied <NUMBER> patients follows age younger <NUMBER> older <NUMBER> years pregnancy severe medical conditions including liver cirrhosis <NUMBER> cases chronic renal dysfunction chronic kidney disease stage <NUMBER> ckd <NUMBER> leukemia cancer acquired immune deficiency syndrome acute myocardial infarction hospitalization acute pulmonary embolism due longterm pulmonary embolism disease history longterm bed rest coagulopathy stoke acute pancreatitis transfer hospitals fig <NUMBER> chest computed tomography ct throatswab specimens obtained patients upon admission covid<NUMBER> diagnosed clinical manifestations chest ct realtime polymerase chain reaction rtpcr according world health organization interim guidance new coronavirus pneumonia prevention control program <NUMBER>th edition published national article protected copyright rights reserved health commission china time admission patients fever suspected respiratory infection plus one following clinical manifestations including respiratory rate greater <NUMBER> breathsminute severe respiratory distress oxygen saturation spo <NUMBER> less <NUMBER> room air classified severe cases <NUMBER> staging covid<NUMBER> evaluation organ damages conducted team physicians study approved central institutional ethics committee ratified hospital waiver requirement documentation informed consent granted analyzing existing data without interfering patient treatment demographic clinical characteristics medical history laboratory tests radiological reports therapeutic intervention outcome data obtained patients electronic medical records clinical symptoms including fever cough fatigue dyspnea comorbidities extracted laboratory examination included complete blood count creactive protein crp procalcitonin ddimer serum biochemical tests liver kidney heart coagulation dysfunction medical history comprised coexistence chronic obstructive pulmonary disease copd type <NUMBER> diabetes mellitus t<NUMBER>dm hypertension coronary heart disease cerebrovascular disease chronic liver disease ckd cancer autoimmune diseases unilateral bilateral lesions chest ct scan images recorded analyzed personal identification information eg name id study subjects anonymized replaced coding system data extraction data reviewed confirmed experienced physicians doublechecked ensure accuracy acute lung injury ali acute respiratory distress syndrome ards septic shock defined according interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected <NUMBER> acute kidney injury defined elevation serum creatinine level ≥<NUMBER> μmoll within <NUMBER> hours <NUMBER> acute liver injury defined levels serum alanine aminotransferase alt <NUMBER>fold upper limit normal uln increase liver enzyme levels defined levels serum liver enzyme uln cardiac injury defined serum level cardiac troponin hypersensitive troponin uln <NUMBER> clinical disseminated intravascular coagulation dic defined according international society thrombosis haemostasis isth criteria diagnosing article protected copyright rights reserved dic <NUMBER> primary endpoint recorded evaluated longitudinal cohort <NUMBER>day allcause death data reviewed confirmed two certified physicians ensure accuracy categorical variables presented frequency continuous variables described median interquartile range iqr means continuous variables compared using independent group tests data normally distributed otherwise mannwhitney test used proportions categorical variables compared using chisquare test proportions categorical variables compared using chisquare test fisher exact test distribution highest liver enzyme levels eg alt ast alp tbil severity covid<NUMBER> presented using kernel density estimation dynamic changes liver enzyme levels severity covid<NUMBER> presented using locally weighted scatterplot smoothing loess site modeled random effect mixedeffect cox model mixedeffect cox proportional hazards regression models used investigate relationship liver enzyme levels allcause mortality among patients mixedeffect cox models adjusted age gender coexisting chronic diseases including hypertension coronary artery disease cerebrovascular disease t<NUMBER>dm ckd ordinal logistic regression analysis applied evaluate association baseline characteristics medications happened peaking liver enzymes peak levels inhospital liver enzymes longitudinal cohort liver function markers trichotomized parallel lines assumption model also tested met p values <NUMBER>sided alpha level <NUMBER> used define statistical significance analyses conducted using r version <NUMBER> r foundation statistical computing vienna austria spss version <NUMBER> ibm armonk ny usa selected baseline liver characteristics enrolled patients shown table <NUMBER> total <NUMBER> adult patients covid<NUMBER> included analysis median age <NUMBER> iqr <NUMBER>accepted article <NUMBER> nonsevere cases <NUMBER> <NUMBER> classified severe cases total <NUMBER> <NUMBER> patients reported chronic liver disease among patients <NUMBER> recorded fatty liver diseases <NUMBER> viral hepatitis supporting table s<NUMBER> median day acute liver injury alt <NUMBER> uln occurs day <NUMBER> iqr <NUMBER> symptom onset fig <NUMBER> determine distribution trajectory parameters indicating liver functions patients enrolled study multiple results liver function tests recorded hospitalization less disperse nonsevere cases levels increased grew disperse disease became severe nonsevere severe case distribution widest separation ast level fig <NUMBER>b loess models illustrated trajectory alt ast alp tbil nonsevere severe patients hospitalization fig <NUMBER>c models suggested significant elevation ast level upon admission maintained higher levels severe group nonsevere group although significant difference alt nonsevere group severe group magnitude increase alt dramatic ast upon admission however rapidly increased surpassed uln value reached peak within <NUMBER> <NUMBER> days admission severe group alp level higher severe group nonsevere group groups rose gradually hospitalization largely stayed normal range fluctuation tbil levels mild nonsevere severe group dynamic changes indicators suggested potential mechanisms covid<NUMBER>associated liver injury impaired liver function closely related mortality covid<NUMBER> patients associations increased alt ast alp tbil levels allcause mortality assessed using mixedeffect cox model hospital sites treated random effect age gender comorbidities adjusted confounders hazard ratios associations alt ast alp tbil article protected copyright rights reserved allcause mortality depicted table <NUMBER> kaplanmeier survival curves elevation alt ast alp tbil levels allcause mortality illustrated fig <NUMBER> among liver enzymes elevated ast associated highest mortality risk compared patients ast normal range allcause mortality risk significantly increased <NUMBER>fold <NUMBER> confidence interval ci <NUMBER> p <NUMBER> patients ast <NUMBER> <NUMBER> ul increased <NUMBER>fold <NUMBER> ci <NUMBER> p <NUMBER> patients ast <NUMBER> ul adjusting age gender comorbidities moreover elevation enzymes tbil also significantly associated adverse outcomes covid<NUMBER> table <NUMBER> supporting table s<NUMBER> s<NUMBER> given discharge might competing risk death analyzed association liver function <NUMBER>day mortality covid<NUMBER> using cumulative risk analysis avoid potential overestimation risk hazard estimates model ast ranging <NUMBER> <NUMBER> ul <NUMBER> ul associated significantly increased risk allcause mortality adjusted hr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> ul adjusted hr <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> ast <NUMBER> ul supporting table s<NUMBER> ordinal regression analysis revealed effects age sex coexisting diseaseadjusted baseline characteristics hospital medication peak alt ast alp tbil levels covid<NUMBER> patients longitudinal cohort tables <NUMBER> male gender systemic corticosteroids application lymphocyte count decrease neutrophil count increase fever factors positively associated elevated alt levels table <NUMBER> use antifungal drugs lymphocyte count decrease chronic liver disease systemic corticosteroids use male gender leading factors positively associated elevated ast levels alp levels tightly associated antifungal drug use neutrophil counts increase chronic liver disease male gender antifungal antiviral systemic corticosteroids use platelet count reduction main factors positively correlated increased tbil levels neutrophil count increase lymphocyte count decrease male gender common factors positively associated elevated alt ast alp tbil levels hospitalization table <NUMBER> article protected copyright rights reserved multiorgan injury significantly increases mortality often evident patients covid<NUMBER> <NUMBER> study presents trajectories liver enzyme levels hospitalization depicts clinical significance multicenter retrospective cohortderived data set <NUMBER> individuals liver injury mild transient nonsevere patients major finding elevation ast level frequent significant increase alt severe patients hospital admission ast levels highest correlation mortality compared indicators reflecting liver injury contradictory hepatitisinduced liver injury increase alp significant toward latter phase disease mainly stayed within normal range elevated alt ast alp tbil levels associated increased risks mortality among liver enzymes elevated ast associated highest mortality risk common factors associated elevated liver injury indicators lymphocyte count decrease neutrophil count increase dyspnea male gender liver biopsy specimens patients covid<NUMBER> showed moderate microvascular steatosis mild lobular portal lesion <NUMBER> <NUMBER> liver damage may associated organspecific immune response coronavirus secondary hypoxemia systemic inflammation response medication previous study showed angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor expression low hepatocytes expressed cholangiocytes liver <NUMBER> suggesting cholangiocytes might direct target severe acute respiratory syndrome sarscoronavirus <NUMBER> cov<NUMBER> invading liver however study alp index cholangiocytes injury mainly stayed within normal range hospitalization elevation alt ast indicators hepatocyte injury common severe patients covid<NUMBER> pathological analysis liver tissue patient died covid<NUMBER> failed demonstrate cholangiocyte damage viral infiltration liver elevations lactate dehydrogenase ldh gammaglutamyl transpeptidase ggt also reflect bile duct injury significant <NUMBER> thus hypothesis cholangiocytes mediating viralassociated injury needs investigation study observed ast elevation upon admissions followed increase alt previous studies also reported ast increase frequent alt severe patients upon admission <NUMBER> <NUMBER> article protected copyright rights reserved alt elevation primary manifestation liver injury <NUMBER> <NUMBER> <NUMBER> ordinal regression analysis also showed ast elevation positively correlated increase neutrophil counts decrease lymphocyte counts baselinepathological alterations proven indicators disease severity <NUMBER> <NUMBER> early elevation ast association indicators disease severity suggest immunemediated inflammation may play critical role liver impairment severe patients covid<NUMBER> mechanisms mediate early ast elevation severe patients warrant study combination antibiotics antivirals systemic corticosteroids widely utilized covid<NUMBER> treatment <NUMBER> <NUMBER> antifungal medication likely applied weaker patients study use antifungal drugs antibiotics antivirals systemic corticosteroids exhibited positive correlation elevated liver enzymes although data could prove causal effect drugs liver damage drug hepatotoxicity treatment coronavirus infection needs considered due emergent situation insufficient report diagnosis chronic liver disease <NUMBER> patients recorded history chronic liver disease <NUMBER> nonalcoholic fatty liver disease nafld <NUMBER> viral hepatitis much lower prevalence china <NUMBER> <NUMBER> unable assess whether coexistence chronic liver comorbidities increases susceptibility liver injury sarscov<NUMBER> infection previous studies shown sarscov<NUMBER> may aggravate liver injury patients viral hepatitis <NUMBER> <NUMBER> therefore liver injury patients chronic liver disease needs investigated monitored limitations exist research study retrospective cases sufficient history illness multiple tests liver function carried different time intervals patient bias may occur due increased number tests patients liver dysfunction observational studies demonstrate association causation whether abnormal liver function caused sarscov<NUMBER> inflammation needs investigated direct clinical evidence conclusion dynamic patterns liver injury indicators potential risk factors may provide important explanation covid<NUMBER>associated liver injury increase liver injury indicators strongly associated risk mortality parameters especially ast may need monitored hospitalization article protected copyright rights reserved december <NUMBER> series pneumonia cases linked seafood wet animal wholesale market emerged wuhan hubei china <NUMBER> deep sequencing analysis lower respiratory tract samples indicated novel coronavirus named <NUMBER> novel coronavirus <NUMBER>ncov <NUMBER> <NUMBER> feb <NUMBER> total <NUMBER> cases confirmed infection nationwide <NUMBER> severe cases <NUMBER> death cases another <NUMBER> suspected cases <NUMBER> reports also released exported cases many countries determined situation deemed public health emergency international concern <NUMBER> jan <NUMBER> <NUMBER> symptoms <NUMBER>ncov infected pneumonia ncip include fever andor respiratory illness lymphopenia radiologic abnormality <NUMBER> <NUMBER> <NUMBER> among clinical features radiologic characteristics ncip especially important diagnosing predicting prognosis herein summarize clinical radiologic characteristics <NUMBER> confirmed cases analyze association radiologic findings mortality cases retrospective study approved institutional review boards hubei public health clinical center central hospital wuhan written informed consent calculated upper zone <NUMBER> consolidation × <NUMBER> <NUMBER> distribution × <NUMBER> right left lungs <NUMBER> ground glass opacity ×<NUMBER> <NUMBER> distribution × <NUMBER> right left lungs middle zone b <NUMBER> consolidation × <NUMBER> <NUMBER> distribution × <NUMBER> right left lungs <NUMBER> ground glass opacity × <NUMBER> <NUMBER> distribution × <NUMBER> right left lungs lower zone c <NUMBER> consolidation × <NUMBER> <NUMBER> distribution right lung <NUMBER> <NUMBER> distribution left lung <NUMBER> ground glass opacity × <NUMBER> <NUMBER> distribution right lung <NUMBER> <NUMBER> distribution left lung patients treated intravenous ribavirin <NUMBER>g twice daily andor oral oseltamivir <NUMBER> mg twice daily antibiotics including levofloxacin moxifloxacin sulbactam cefoperazone piperacillin meropenem used patients also received glucocorticoid intravenous immunoglobulin administration technical parameters included <NUMBER>section scanner <NUMBER> mm collimation <NUMBER> mm intervals ct examinations performed patient supine position breathholding following inspiration without administration contrast material images obtained mediastinal width <NUMBER> hu level <NUMBER> hu parenchymal width <NUMBER> hu level <NUMBER> hu window settings two experienced pulmonologists yml yw reviewed images independently final finding reached consensus discrepancy ct findings included ground glass opacity consolidation air bronchogram nodular opacities ground glass opacity ggo defined hazy areas increased opacity attenuation without concealing underlying vessels consolidation defined homogeneous opacification parenchyma obscuring underlying vessels air bronchogram defined pattern airfilled lowattenuation bronchi background opaque highattenuation airless lung nodular opacities defined focal round opacities either solid nodules ggos diameter � <NUMBER> cm presence lymphadenopathy defined lymph node � <NUMBER> cm shortaxis diameter ct scans scored axial images referring method described previously <NUMBER> extent involvement abnormality assessed independently <NUMBER> zones upper carina middle carina inferior pulmonary vein lower inferior pulmonary vein location lesion defined peripheral outer onethird lung central otherwise ct findings graded <NUMBER>point scale <NUMBER> normal attenuation <NUMBER> groundglass attenuation <NUMBER> consolidation lung zone total six lung zones patient assigned following scale according distribution affected lung parenchyma <NUMBER> normal <NUMBER> <NUMBER> abnormality <NUMBER> <NUMBER> abnormality <NUMBER> <NUMBER> abnormality <NUMBER> <NUMBER> abnormality fourpoint scale lung parenchyma distribution multiplied radiologic scale described points zones added final total cumulative score value ranging <NUMBER> to<NUMBER> fig <NUMBER> continuous variables expressed median interquartile range iqr compared mannwhitney u test wilcoxon test categorical variables expressed number compared χ <NUMBER> test fishers exact test appropriate twosided α less <NUMBER> considered statistically significant statistical analyses done using spss version <NUMBER> table <NUMBER> <NUMBER> patients diagnosed <NUMBER> novel coronavirus <NUMBER>ncov infected pneumonia ncip included <NUMBER> men <NUMBER> women median age <NUMBER> years iqr <NUMBER> <NUMBER> patients discharged recovered condition twice negative test <NUMBER>ncov viral rna throatswab specimens <NUMBER> patients died hospital median age mortality group higher compared survival group <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> comorbidity rate mortality group significantly higher survival group <NUMBER> vs <NUMBER> p <NUMBER> especially comorbid hypertension diabetes cardiac disease <NUMBER> patients developed acute respiratory distress syndrome required noninvasive ventilator mechanical ventilation <NUMBER> died one <NUMBER> years old man oxygenation index <NUMBER> mmhg recovered treatment significant differences survival group mortality group respect patient sex symptoms ct features including location extent distribution involvement abnormality shown table <NUMBER> median days ct scans <NUMBER> iqr <NUMBER> symptom onset patients predominant ct characteristics consisted ground glass opacity <NUMBER> bilateral sides involved <NUMBER> peripheral central distribution <NUMBER> lower zone involved <NUMBER> lymphadenopathy pleural effusion relatively seldom seen <NUMBER> <NUMBER> median ct score mortality group higher compared survival group <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> frequency consolidation <NUMBER> vs <NUMBER> p <NUMBER> air bronchogram <NUMBER> vs <NUMBER> p <NUMBER> fig <NUMBER> receiver operating characteristic curve analysis fig <NUMBER> optimal cutoff value ct score <NUMBER> sensitivity <NUMBER> specificity <NUMBER> prediction mortality area receiver operating characteristic curve <NUMBER> <NUMBER> confidence interval <NUMBER> <NUMBER> initial reexamined ct features day <NUMBER> iqr <NUMBER> symptom onset survival group compared <NUMBER> patients shown fig <NUMBER> cases exhibited certain degree progression however morphology lesions location extent distribution involvement abnormality significantly changed compared admission table <NUMBER> mortality group ct scores progressed rapidly short time <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> lung zones involved table <NUMBER> novel coronavirus ncov new strain previously identified humans <NUMBER> <NUMBER>ncov causes symptoms similar sars based recent clinical data <NUMBER> <NUMBER> capable spreading human human cities contagious characteristic <NUMBER> basic reproductive number estimated <NUMBER> <NUMBER> mortality <NUMBER> included patients infected <NUMBER>ncov <NUMBER> much higher reported <NUMBER> <NUMBER> feb <NUMBER> <NUMBER> giving priority <NUMBER>ncov detection severe cases shortness test kits hospital initially potential false negative results <NUMBER>ncov viral rna detection mild cases might account discrepancy consistent recent reports results suggest <NUMBER>ncov likely infect elderly people chronic comorbidities result weaker immune functions patients <NUMBER> <NUMBER> <NUMBER>ncovassociated death also related elder age underlying illnesses especially hypertension diabetes cardiac disease consistently several recent reports regarding ct findings <NUMBER>ncov infected pneumonia ncip <NUMBER> <NUMBER> <NUMBER> results showed ct manifestations ncip featured predominant ground glass opacities ggo <NUMBER> mixed consolidations <NUMBER> mainly peripheral <NUMBER> combined peripheral central distributions <NUMBER> bilateral <NUMBER> lower lung zones <NUMBER> mostly involved merely consolidation central distribution pleural effusions lymphadenopathy relatively rarely seen initially ct images might ggo nodules patchy ggo mostly peripherally distributed consolidations extensive distributions seen pneumonia progressed consolidation air bronchogram extensive distribution well multiple involved lung zones common mortality group suggesting severe clinical course abnormalities pathologically correlated diffuse alveolar damage similar conclusions drawn h<NUMBER>n<NUMBER> pneumonia h<NUMBER>n<NUMBER> pneumonia h<NUMBER>n<NUMBER> pneumonia sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> members virus family ncip shared much common ground mers sars ct features subpleural basilar airspace lesions ggos consolidations conspicuous ct characteristics three kinds virus pneumonia pleural effusions common patients died mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> comprehensively evaluated ct features ncip calculated ct score patient ct scores much higher mortality group compared survival group <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> <NUMBER> p <NUMBER> admission mortality group scores markedly increased short time <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> suggesting progressive course ncip although ct scores diminished maintained relatively stable level period time survival group <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> suggesting might take long time recover chest imaging ncip controlled found optimal cutoff value ct score <NUMBER> sensitivity <NUMBER> specificity <NUMBER> predict mortality hope simple scoring method according ct scans may help triage patients screening patients need aggressive treatment closely monitoring however efficacy approach decrease mortality remains validated future studies although definite diagnosis ncip cannot achieved using imaging features alone viral pneumonia imaging patterns share similarity ct features summarized might helpful differentiation various pathogens pneumonia triage patients limitations study first retrospective study including <NUMBER> inpatients outpatients suspected undiagnosed cases deficiency detection kits <NUMBER>ncov potential false negative results ruled second information collected significant part patients rechecked ct scans pulmonologists although experienced evaluated ct images finally lack information regarding interobserver agreement study emphasis final consensus interpretation rather independent reading pandemics environments behaviors inequalities epidemic erodes social cohesiveness source danger fellow human beings source danger wife children parents epidemic goes long enough bodies start pile nobody dig graves fast enough put people morality start break <NUMBER> dr alfred crosby americas forgotten pandemic influenza <NUMBER> across millennia disease outbreaks impacted societies reinforced human perception frailty mortality <NUMBER> dramatic demographic shifts past century escalated difficulty containing pandemic rise globalization urbanization facilitated rapid spread pathogens one continent another flight hours yet comparison drawn <NUMBER> coronavirus pandemic <NUMBER> influenza pandemic widely available tools respond disease outbreaks remained nearly public health interventions still first line defense pandemic absence vaccine <NUMBER> understanding environment plays significant role disease dynamics determining health individuals always essential aspect controlling managing infectious diseases example history urban planning past century highlighted built environments effect preventing chronic infectious diseases <NUMBER> however function human behaviors social ideologies stemmed darker side humanity must also acknowledged important component determining lives survives deadliest periods disease pandemics midst world war influenza pandemic spread worldwide <NUMBER> outstanding lethality <NUMBER> universal consensus pandemics origin understood caused h<NUMBER>n<NUMBER> subtype influenza virus avian swine genetic origins <NUMBER> <NUMBER> <NUMBER> course pandemic estimated one third worlds population approximately <NUMBER> million persons became infected total deaths estimated <NUMBER> million arguably high <NUMBER> million <NUMBER> historically curve influenza deaths humans ushaped peaks among infants elderly nevertheless <NUMBER> influenza pandemic exhibited wshape agerelated fatality addition third peak among young adults <NUMBER> <NUMBER> death rates individuals <NUMBER> <NUMBER> years age <NUMBER> times higher previous years <NUMBER> <NUMBER> influenza pandemic occurred three distinctive waves <NUMBER>month period europe asia north america first wave pandemic began spring <NUMBER> lasted approximately six months particularly virulent mimicked typical seasonal flu symptomology mortality <NUMBER> <NUMBER> <NUMBER> however due possible viral mutation course summer wartime troop movements first wave followed rapid succession fatal second third waves autumn <NUMBER> septembernovember winter spring <NUMBER> januarymay respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> united states first outbreak flulike illnesses detected march <NUMBER> <NUMBER> cases camp funston fort riley kansas <NUMBER> <NUMBER> within week number influenza cases quintupled throughout army installation <NUMBER> end month approximately <NUMBER> soldiers hospitalized <NUMBER> died developing pneumonia <NUMBER> nevertheless thousands soldiers continually deployed world war traveled across atlantic ocean europe disease first appeared april <NUMBER> among american soldiers military camp near bordeaux france <NUMBER> <NUMBER> influenza presentation form benign fever accompanied coldlike symptoms attending american doctors believed underlying cause haemophilus influenzae pathogenic bacterium formally called pfeiffers bacillus <NUMBER> spring <NUMBER> wave influenza affected nearly <NUMBER> soldiers april july five american soldiers died <NUMBER> although mortality first pandemic wave minor comparison waves come spain first european country disease spread wide sectors population thus causing significant level mortality may june <NUMBER> <NUMBER> influenza deaths madrid represented mortality rate <NUMBER> deaths per <NUMBER> people <NUMBER> period another <NUMBER> unconfirmed influenza deaths attributed different respiratory system pathologies unconfirmed deaths combined confirmed influenza deaths mortality rate would <NUMBER> per <NUMBER> people highest mortality figure traceable pandemic <NUMBER> point little written documented strain outbreak epidemiologic indications due wartime censorship however mortality rate one single etiological agent could overlooked may <NUMBER> spanish newspaper el sol first published report sickness ha yet diagnosed doctors headlines around world labeled one worst pandemics human history <NUMBER> <NUMBER> thus derivation spanish influenza conceived <NUMBER> september <NUMBER> second deadly wave pandemic emerged within united states <NUMBER> soldiers camp devens army training camp outside boston massachusetts sailors aboard receiving ship commonwealth pier boston began reporting flulike symptoms <NUMBER> <NUMBER> months end <NUMBER> cases reported camp devens approximately onequarter total camp <NUMBER> soldiers succumbed influenza <NUMBER> massachusetts department health informed local newspapers epidemic stated unless precautions taken disease probability spread civilian population city <NUMBER> nearby navy radio school within harvard university cambridge massachusetts cases influenza reported among group <NUMBER> young men studying radio communications <NUMBER> concluded cambridge experienced <NUMBER> cases influenza among meager population <NUMBER> residents ultimately leading mortality rate <NUMBER> per <NUMBER> <NUMBER> time new york state board health new york city added influenza list reportable diseases required cases isolated home city hospital <NUMBER> moreover document entitled fighting influenza transit systems board health adopted plan set operation schedules many business would elongate time window transit service reduce congestion <NUMBER> <NUMBER> lieu subway suspension royal copeland city health commissioner staggered workdays industry instead everyone arriving work <NUMBER> come later earlier <NUMBER> cities seattle washington followed suit controlling transmission influenza within public transit environments requiring passengers wear face masks boarding streetcars figure <NUMBER> <NUMBER> interestingly commissioner copeland issue order close schools prohibition public gatherings theaters new york city stated rational issue general closing orders making public flurry situation keep danger panic wanted people go business without constant fear hysterical sense calamity <NUMBER> unlike new york city public gatherings prohibited social distancing encouraged closure theaters movie houses night schools cities namely chicago illinois reno nevada madison wisconsin <NUMBER> <NUMBER> also call volunteers help nurse infirmed chicago cities throughout united states due severe deficit professional nurses shortage resulting deployment nurses military camps failure use trained african american nurses <NUMBER> despite social distancing efforts employed new york city chicago philadelphia pennsylvania choose ignore initiatives september <NUMBER> <NUMBER> city held fourth liberty loan drive parade gathered <NUMBER> philadelphians within days parade <NUMBER> people dead another <NUMBER> cases influenza reported every bed citys <NUMBER> hospitals filled city forced close churches schools theaters places public amusement <NUMBER> <NUMBER> <NUMBER> week parade <NUMBER> philadelphians died <NUMBER> pile corpses philadelphia coldstorage plants used temporary morgues trolley car manufacturer donated <NUMBER> packing crates used coffins <NUMBER> early october single day influenza deaths reached record numbers philadelphia <NUMBER> deathsoctober <NUMBER> <NUMBER> new york city <NUMBER> deathsoctober <NUMBER> <NUMBER> <NUMBER> virus continued journey westward louisiana texas new mexico utah california washington wearing sixply gauze masks became mandatory washington parts california <NUMBER> <NUMBER> example san francisco california individuals fined <NUMBER> us dollars usd equivalent approximately <NUMBER> usd today seized public without face masks <NUMBER> salt lake city utah officials placed quarantine signs doors <NUMBER> homes occupants infected influenza <NUMBER> end second wave left mark deadliest three waves coincided end world war november <NUMBER> <NUMBER> <NUMBER> people celebrated armistice day parades large gatherings public health calamity lurking influenza resurgence cities <NUMBER> <NUMBER> december <NUMBER> second wave pandemic passed health threat far australia third wave erupted january <NUMBER> eventually drifted back europe united states <NUMBER> <NUMBER> cases <NUMBER> deaths reported first five days january san francisco side country new york city <NUMBER> cases <NUMBER> deaths reported <NUMBER> even though eradication influenza appeared louisiana washington many residents san antonia texas began complaining new surge influenza cases reported <NUMBER> <NUMBER> precautionary measure states like massachusetts illinois began request special appropriations study influenza treatment train women practical nurses response nursing shortage <NUMBER> nursing shortage dire areas country american red cross asked local businesses grant workers day volunteered hospitals night <NUMBER> mortality rate third wave high second wave end war eliminated conditions enabled rapid widespread transmission virus deaths third wave paled comparison annihilation second wave <NUMBER> onequarter american population infected influenza pandemic affecting everyone believed president woodrow wilson contracted virus april <NUMBER> negotiating treaty versailles end world war <NUMBER> pandemic finally came end summer <NUMBER> although minor fourth wave appeared spring <NUMBER> throughout isolated areas new york city pandemic ended simply individuals infected either died developed immunity estimated death toll <NUMBER> people united states pandemic lowered average life expectancy <NUMBER> years <NUMBER> world war worst cases influenza pandemic came overcrowded military barracks ships poor ventilation <NUMBER> quickly found one way heal infected wounds expose patients sunlight openair june <NUMBER> sir arthur everett shipley eminent scientist time determined openair treatment infirmed wounded soldiers first eastern general hospital success particularly influenza related pneumonia <NUMBER> <NUMBER> pandemic clinched united states health officials converted schools halls large private houses emergency openair hospitals <NUMBER> openair hospitals became common practice time <NUMBER> pandemic <NUMBER> <NUMBER> combination outdoor air sunlight reduced number infections deaths reported openair hospitals specifically medics found regular meals warmth plenty fresh air sunlight helped severely ill patients recover better indoor nursed patients <NUMBER> researchers also revealed healthcare facilities designed high ceilings large windows effect openair hospitals <NUMBER> accordingly natural ventilation fresh air best way prevent transmission influenza well infectious diseases <NUMBER> openair therapy one popular techniques dealing common often deadly respiratory infections time antibiotics replaced <NUMBER>s <NUMBER> absence vaccine novel pathogens antibiotics protect influenza secondary bacterial infections many authorities suggested nonpharmaceutical interventions control pandemic <NUMBER> <NUMBER> social distancing become wellestablished nonpharmaceutical public health measure slow spread communicable diseases social distancing measures implemented closing schools restaurants theaters well banning restriction public gatherings transportation among cities united states <NUMBER> pandemic <NUMBER> point initiation duration decision relax social distancing measures profoundly impacted mortality rates period <NUMBER> example cities philadelphia <NUMBER> deaths per <NUMBER> <NUMBER> weeks initiated social distancing measures later shorter periods tended spikes deaths overall higher death rates figure <NUMBER> <NUMBER> <NUMBER> philadelphia first cases influenza appeared september <NUMBER> <NUMBER> <NUMBER> however philadelphia public health director dr wilmer krusen understated risk disease transmission dr krusen assured people sick soldiers suffering casual seasonal influenza could avoided staying warm allowed large public gatherings notably fourth liberty loan drive parade september <NUMBER> <NUMBER> mentioned previously result philadelphia experienced mortality acceleration <NUMBER> higher average american city <NUMBER> comparison cities minneapolis minnesota <NUMBER> deaths per <NUMBER> <NUMBER> weeks ordered social distancing measures sooner longer periods slowed transmission rate lowered overall death rates <NUMBER> <NUMBER> furthermore cities relaxed social distancing measures prematurely experienced multiple spikes deaths observed st louis missouri due low death rate city lifted restrictions public gatherings less two months influenza outbreak began however sharp higher spike new cases soon followed <NUMBER> <NUMBER> research comparing <NUMBER> american cities suggested implementation early interventions control spread influenza may significantly decreased rate transmission mortality observed <NUMBER> cities across united states including milwaukee wisconsin indianapolis indiana effective interventions reduced transmission rates <NUMBER> <NUMBER> lower level mortality due quick public health response first days epidemic introduction broad measures designed promote social distancing <NUMBER> <NUMBER> initially american medical community minimized scale scope influenza pandemic create false sense security countrys largest cities including philadelphia <NUMBER> yet issue beyond medical community public health crisis brought light urban environment deficiencies namely proliferation municipal waste unsanitary living conditions <NUMBER> always well understood presence threat infectious diseases shaped urban planning united states early <NUMBER>th century pandemic urban environments new york city chicago american cities densely populated characterized crowded tenement housing proximity factories animal yards slaughterhouses little airflow light <NUMBER> <NUMBER> even <NUMBER> influenza outbreak cities plagued cholera tuberculosis typhoid epidemics <NUMBER> medical models specifically miasma theory idea diseases caused noxious form bad air prevailed also sense congestion pollution lack sunshine poor airflow contributed illness <NUMBER> <NUMBER> response urban planning efforts introduced zoning spatially segregate residential commercial industrial uses housing regulations require light airflow order improve overcrowding unsanitary urban living conditions <NUMBER> <NUMBER> <NUMBER> pandemic urban reformers engineers tried prevent infection improving waste removal housing quality creating technological enhancements control environmental nuisances hazards trivial cooperation municipal government leadership interference private interest sector often blocked immediate effective action <NUMBER> result schism public health community ultimately impacted lives millions <NUMBER> epidemic diseases random events afflicted societies capriciously without warning typically unfold across wide spectrum communities diverse race age gender socioeconomic status <NUMBER> <NUMBER> <NUMBER> pandemic affected youngest wealthiest people without boundaries racially composition country time predominately black white point medical public health reports documented african americans suffered higher morbidity mortality rates several diseases comparison white americans <NUMBER> specifically web du bois prominent sociologist civil rights activist found analysis <NUMBER> us census african american mortality rates two three times higher several diseases including tuberculosis pneumonia diarrheal disease comparison white american mortality rates <NUMBER> dubois argued disparities reflected social conditions racial susceptibilities <NUMBER> poor workingclass urban neighborhoods social conditions like overcrowded housing poor sanitation service unsafe drinking increased vulnerability influenza <NUMBER> <NUMBER> us census set <NUMBER> minimum population threshold urban category <NUMBER> us census <NUMBER> american population defined urban <NUMBER> onset pandemic urban environments within american cities composed predominantly <NUMBER> white population <NUMBER> period <NUMBER> african american population lived southern parts united states millions began migrating north search better job opportunities living conditions <NUMBER> first great migration rural south northern cities starting <NUMBER> larger share african americans lived urban areas <NUMBER> pandemic <NUMBER> still average comparison white americans fewer african americans less <NUMBER> lived high population density urban areas epicenters outbreak <NUMBER> hence norms disease morbidity mortality african americans changed pandemic second wave fall <NUMBER> african americans lower influenza morbidity mortality rates higher case fatality rate comparison white population <NUMBER> unexpected phenomenon african americans expected higher influenza morbidity mortality explanations <NUMBER> pandemic norm crossover included <NUMBER> unequal exposure based african americans lived eg urban vs rural environments <NUMBER> higher exposure less virulent spring wave provided african americans immunity <NUMBER> military segregation allowed less crowding among african american soldiers <NUMBER> underreporting influenza cases deaths african americans <NUMBER> evidence first spring wave especially rampant south induce higher influenza exposure among majority african americans living rural southern areas clear understanding first great migration left large portion african americans cramped dilapidated impoverished segregated conditions less access sanitation urban social programs northern cities segregated african american neighborhoods may functioned makeshift quarantine yet cities baltimore maryland detroit michigan segregation created crowded urban ghettoes tuberculosis became one top three causes death among urban african americans <NUMBER> individuals tuberculosis lung damage susceptible influenza would explain higher proportion african american influenza cases developed pneumonia also higher case fatality rates second wave <NUMBER> entrenched racial economic discrimination within united states seemed protected endangered african americans <NUMBER> pandemic throughout world war many doctors called military service shortage doctors nurses medical staff caused hospitals reject patients particularly african americans <NUMBER> american red cross served recruiter nurses army racial discriminatory practices american red cross african american women tried gain entry nurses rebuffed devastation pandemic forced army drop ban african american nurses racial discrimination still surpassed need healthcare areas november <NUMBER> <NUMBER> edition chicago defender reported dean ohios hiram college refused allow african american nurse named olive walker care influenza patients college <NUMBER> <NUMBER> african american doctors also found color line rigid trying care white americans time <NUMBER> racism legalized segregation restricted african americans nonwhite americans access healthcare professionals facilities cities across nation african americans received substandard care segregated hospitals confined hospitals served african americans many infected people died without seeing doctor due sheer number bodies overwhelmed capacity hospitals heavy burden medical staff <NUMBER> african american influenza patients exceeded limit frederick douglass memorial hospital one philadelphias two african american hospitals pushed medical director establish emergency annex african american parochial school <NUMBER> richmond virginia african american patients received care hospital basement city opened separate hospital staffed african americans elementary school <NUMBER> <NUMBER> baltimore afroamerican newspaper criticized provident hospital african american facility city turning patients away <NUMBER> <NUMBER> prohibition public gatherings included funerals wakes prevented families properly grieving many victims buried without coffins thrown unmarked burial grounds native americans practiced different burial practices became exposed virus alarming rates september <NUMBER> <NUMBER> navajos died influenza apache county new mexico <NUMBER> across country mass graves dug accommodate pile corpses <NUMBER> african american bodies particular neglected general public infrastructure baltimore sanitation department employees refused dig graves african american influenza victims citys african american cemetery could accommodate graves <NUMBER> <NUMBER> pandemic took heavy human toll entire families communities devastation bereavement violence erupted areas people shot wearing masks rates homicides suicides skyrocketed <NUMBER> white supremacist ideologies racist scientific theories advanced bigoted false notions biological physiological moral inferiority african americans blamed pandemic <NUMBER> throughout first great migration period african americans highly visible thought diseases <NUMBER> pandemic heightened existing prejudices reinforced contemporary newspaper headlines rush negroes city starts health inquiry negros arrive thousandsperil health negro influx brings disease <NUMBER> memory <NUMBER> pandemic left lasting blemish public health planning practice reflected moral relationships deterioration humanity period magnitude events death influenza pandemic served reference point hopefully severe worstcase scenario december <NUMBER> novel coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> detected wuhan hubei province peoples republic china <NUMBER> following weeks infections spread across china countries around world <NUMBER> <NUMBER> covid<NUMBER> first confirmed spread united states january <NUMBER> <NUMBER>yearold man returned washington state january <NUMBER> <NUMBER> traveling visit family wuhan china diagnosed <NUMBER> january <NUMBER> <NUMBER> first case persontoperson covid<NUMBER> transmission confirmed united states married couple <NUMBER>yearold wife returned china <NUMBER> subsequently became symptomatic transmitted infection husband march <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> deaths worldwide <NUMBER> world health organization classified covid<NUMBER> outbreak pandemic june <NUMBER> <NUMBER> two million confirmed cases <NUMBER> deaths united states <NUMBER> numbers however include thousands americans estimated <NUMBER> people new york city died without tested covid<NUMBER> coronavirus pandemic united states highest number known cases world exploded course march april <NUMBER> start march cases tied overseas travel extremely limited testing available many parts country new york maryland indiana north carolina louisiana period number cases doubling every <NUMBER> <NUMBER> days <NUMBER> one precipitating source community transmission unique covid<NUMBER> cruise ships cruise ships previously settings infectious diseases outbreaks compact closed environments contact travelers many countries crew transfers ships <NUMBER> confirmed covid<NUMBER> cases occurred diamond princess grand princess cruise ship voyages latter sailed roundtrip departing san francisco february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> four stops made mexico voyage <NUMBER> crew <NUMBER> passengers voyage remained board second voyage departed san francisco <NUMBER> february <NUMBER> voyage b planned return <NUMBER> march <NUMBER> <NUMBER> healthcare provider california reported two patients traveled voyage covid<NUMBER> symptoms one confirmed positive covid<NUMBER> test subsequently <NUMBER> additional covid<NUMBER> cases among voyage passengers confirmed california <NUMBER> march <NUMBER> centers disease control prevention cdc response team transported helicopter grand princess cruise ship collect specimens <NUMBER> passengers crew covid<NUMBER> respiratory symptoms among <NUMBER> individuals <NUMBER> <NUMBER> positive covid<NUMBER> test results included two passengers <NUMBER> crew members high attack rate among passengers crew partially attributed high proportion asymptomatic infections disembarkation passengers symptomatic crew members asked selfquarantine cabins room service replaced public dining grand princess cruise ship docked oakland california <NUMBER> march <NUMBER> everyone transferred landbased sites <NUMBER>day quarantine period <NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> persons available test positive covid<NUMBER> test results additional covid<NUMBER> cases linked several additional cruises also reported across united states <NUMBER> march <NUMBER> <NUMBER> cruise lines international association announced <NUMBER>day voluntary suspension cruise operations united states cdc issued level <NUMBER> travel warning cruise travel deferred worldwide first preliminary description outcomes among covid<NUMBER> patients united states reported march <NUMBER> cdc report indicated fatality highest persons aged ≥<NUMBER> ranging <NUMBER> <NUMBER> followed persons aged <NUMBER> years <NUMBER> <NUMBER> aged <NUMBER> years <NUMBER> <NUMBER> aged <NUMBER> years <NUMBER> aged ≤<NUMBER> years <NUMBER> <NUMBER> pediatric <NUMBER> years covid<NUMBER> cases less <NUMBER> total cases united states demonstrated much milder symptoms may even cough fever <NUMBER> although severe covid<NUMBER> illness leading hospitalization including intensive care unit icu admission death occur adults age <NUMBER> cases <NUMBER> hospitalizations <NUMBER> icu admissions <NUMBER> deaths occurred among adults aged ≥<NUMBER> years <NUMBER> likewise longterm residential care facilities particularly risk covid<NUMBER> washington female resident longterm care skilled nursing facility contracted covid<NUMBER> epidemiologic investigation determined <NUMBER> cases covid<NUMBER> associated facility including <NUMBER> residents <NUMBER> staff members <NUMBER> visitors majority covid<NUMBER> cases women <NUMBER> median age <NUMBER> years range <NUMBER> years among facility residents <NUMBER> years range <NUMBER> years among staff members <NUMBER> years range <NUMBER> years among visitors total <NUMBER> covid<NUMBER> cases associated nursing facility <NUMBER> residents <NUMBER> visitors <NUMBER> staff members hospitalized ultimately <NUMBER> persons <NUMBER> residents <NUMBER> visitor died result covid<NUMBER> <NUMBER> believed limitations effective infection control prevention staff members working multiple facilities contributed spread within facilities existence underlying medical conditions found important risk factor among facility residents common chronic underlying conditions hypertension <NUMBER> cardiac disease <NUMBER> renal disease <NUMBER> diabetes mellitus <NUMBER> obesity <NUMBER> pulmonary disease <NUMBER> <NUMBER> midmarch <NUMBER> entire united states including four territories reported cases covid<NUMBER> <NUMBER> april <NUMBER> nationwide case doubling time approximately <NUMBER> days yet areas louisiana doubling time <NUMBER> days <NUMBER> moreover time louisiana ranked <NUMBER>th nation approximately <NUMBER> confirmed cases nearly <NUMBER> deaths <NUMBER> african american <NUMBER> <NUMBER> explosion cases new orleans anecdotally linked influx travelers mardi gras yet theory explain situation shreveport another louisiana hotspot covid<NUMBER> cases <NUMBER> initially race ethnicity data reported covid<NUMBER> cases covid<NUMBER>associated hospitalization surveillance network covidnet created using existing infrastructure influenza hospitalization surveillance network flusurvnet respiratory syncytial virus hospitalization surveillance network rsvnet order conduct populationbased surveillance <NUMBER> first month <NUMBER> march <NUMBER> surveillance united states <NUMBER> patients hospitalized covid<NUMBER> surveilled among covid<NUMBER> patients underlying conditions data <NUMBER> one underlying medical conditions common conditions hypertension <NUMBER> obesity <NUMBER> chronic lung disease <NUMBER> diabetes mellitus <NUMBER> cardiovascular disease <NUMBER> <NUMBER> hence majority persons hospitalized covid<NUMBER> underlying medical conditions among patients race ethnicity data <NUMBER> white <NUMBER> african american <NUMBER> hispanic <NUMBER> asian <NUMBER> unknown race <NUMBER> considering african americans comprise <NUMBER> united states population overrepresentation african american covid<NUMBER> cases sheds light issues often overlooked dr frank snowden professor emeritus history yale university stated interview new yorker epidemics reflect relationships environmentthe built environment create natural environment responds <NUMBER> communicable diseases existed humankind since days hunting gathering shift agrarian life occurred thousands years ago formation communities way built environments created ideal conditions epidemics built environments manmade settings constructed operated purpose human activity include physical sites humans live work range scale homes neighborhoods buildings cities evidence shown high occupant density built environments encourage transmission airborne pathogens cause common cold influenza chicken pox whooping cough tuberculosis even covid<NUMBER> increased social interactions direct contact individuals <NUMBER> open interior spaces high degree spatial connectivity opportunity social encounters facilitate spread pathogens well others <NUMBER> therefore coronavirus pandemic put spotlight relationship built environments pathogenic infections public health march <NUMBER> <NUMBER> cdc recommended social distancing also called physical distancing modern society <NUMBER> <NUMBER> <NUMBER> states followed suit issued stayathome orders detailed directives every person ordered stay place residence except necessary perform essential activities essential activities included grocery shopping obtaining medical prescriptions service providing care others outdoor physical activity <NUMBER> many states including maryland massachusetts prohibited gatherings <NUMBER> people mandated individuals stay least six feet apart <NUMBER> states throughout country ordered businesses close banned nonessential gatherings size implemented telework policies possible instance new york pharmacies retailers hospitals manufacturing plants financial institutions allowed open <NUMBER> closure schools businesses restaurants without carryout delivery options leisure activities including theaters fitness facilities essence created abandonment many built environment structures many restaurants even carryout delivery options still needed cut hours switch mobile payment systems create new protocols operation face challenges coronavirus pandemic <NUMBER> retailers namely grocery stores implemented daily senior shopping hour atrisk population added six feet apart points checkout lines help customers maintain physical distance <NUMBER> <NUMBER> amid coronavirus pandemic companies enabled workfromhome structures keep businesses running assist employees social distancing compliance nonetheless working remotely growing trend pandemic essentially created millions teleworkers overnight <NUMBER> public transportation infrastructure another essential feature built environments also impacted severity coronavirus pandemic compliance social distancing directives many cities significantly reduced public transit service eg subways buses thereby negatively affecting many individuals needing transit access new yorks metropolitan transit authority closed nonessential lines concentrating resources transit routes supported essential personnel urgent personal business <NUMBER> new orleans regional transit authority defined set essential destinations eliminated routes serve locations <NUMBER> list essential destinations included healthcare facilities pharmacies grocery stores many agencies like chicago transit authority also imposed adhoc sanitation regimes minimize spread virus well requirement face masks riders <NUMBER> necessity preventative measures underscored detroit city bus driver vented social media anger coughing bus rider subsequently died <NUMBER> days later covid<NUMBER> <NUMBER> addition reduction public transit various municipalities throughout united states service commuter trains amtrak also disrupted throughout coronavirus pandemic due social distancing shelterinplace orders <NUMBER> march <NUMBER> amtrak announced <NUMBER> reduction suspension complete cancellation various train lines throughout northeast corridor country including amtrak hartford winter park express lines <NUMBER> amtrak also required passengers wear face masks <NUMBER> furthermore department homeland security dhs issued notice arrival restrictions early march <NUMBER> whereby airline passengers arriving china iran certain european countries required travel one <NUMBER> airports dhs established enhanced entry screening capabilities <NUMBER> march <NUMBER> <NUMBER> department state disseminated global level <NUMBER> health advisorydo travel advised american citizens avoid international travel due covid<NUMBER> <NUMBER> airborne pathogens easily transmitted indoor air unfortunately indoor environments designed prevent rapid dissemination new diseases <NUMBER> ventilation pattern airflow controls direction droplet distribution generated respiratory activities building occupants thus essential environments high occupant density mobility hospitals schools offices designed minimize spread airborne infections <NUMBER> administrators building operators searching ways promote good design amenity built environments even coronavirus pandemic new design planning policies trying provide achievable guidance environmental decisionmakers building operators indoor occupants attempt minimize infectious disease transmission particularly dense urban environments <NUMBER> consequently new sarscov<NUMBER> virus made profound impact planning environmental laws urban infrastructures according university oregons biology built environment center stringent social distancing measures building cleaning efforts needed put place reduce exposure sarscov<NUMBER> <NUMBER> moreover involved series strategies including changes ventilation systems eg increased outside air fractions improve indoor air window operations eg open windows dilute indoor contaminants also emerged research center <NUMBER> modifications well architectural techniques combined public health interventions used efficiently disable diseases virulence protect occupants buildings airborne pathogens <NUMBER> <NUMBER> classifications guidelines shown filtration part ventilation system proven way block penetration outside pathogens buildings <NUMBER> <NUMBER> filtration improve indoor air quality effectively reduce pathogen loads released air <NUMBER> <NUMBER> natural light ultraviolet lights following proper protocols may also ability inactivate sarscov<NUMBER> <NUMBER> studies shown viruses susceptible ultraviolet germicidal irradiation uvgi factors including humidity airflow patterns uvgi energy intensity duration able impact uvgi effectiveness inactivating pathogens <NUMBER> <NUMBER> <NUMBER> <NUMBER> indoor humidity levels also discovered vital survivability covid<NUMBER> research team found indoor humidity levels <NUMBER> may help minimize spread survival sarscov<NUMBER> little risk indoor mold growth <NUMBER> designs airconditioning systems supported central humidification targeted inroom humidification may necessary episodes pathogen transmission risk <NUMBER> coronavirus pandemic exposed weaknesses american healthcare system specifically consortium hospitals <NUMBER> hospitals approximately <NUMBER> beds united states even pandemic fewer doctors fewer beds per capita developed countries <NUMBER> <NUMBER> according data organization economic cooperation development united states approximately <NUMBER> beds per <NUMBER> people <NUMBER> higher rates hospitalizations chronic conditions require hospitalization including diabetes mellitus asthma compounded shortage hospital beds pandemic furthermore hospital emergency departments many areas including rural communities well equipped modern ailments pressures coronavirus pandemic <NUMBER> designing guidance aid healthcare facilities clinics cope increasing volume covid<NUMBER> cases create small scale segregation rooms <NUMBER> guidance controlling covid<NUMBER> healthcare settings indicated patients isolated placed private rooms private bathroom moreover airborne infection isolation rooms used patients undergoing aerosol generating procedures intubation chest compressions <NUMBER> combat ongoing covid<NUMBER> pandemic dutch architecture firm suggested studio prototype vital house constructed quickly sustainable prefabricated wooden materials vital house temporary healthcare center could provide icus communication large green patio enable faster patient recovery <NUMBER> building popup triage tents immediately outside hospitals solution employed medical centers throughout unites states <NUMBER>tent <NUMBER>bed hospital new york citys central park <NUMBER>feet <NUMBER>feet tent <NUMBER> patients durham north carolina constructed exclusively covid<NUMBER> patients number cases needing care exceeded hospital capacity <NUMBER> <NUMBER> standing tents empty spaces hospital overpasses proximity emergency rooms enabled healthcare workers rapidly sequester crisis pandemic patients <NUMBER> another environmental issue may amplified covid<NUMBER> transmission infection healthcare workers may inadvertently spread disease patients example covid<NUMBER> found spread across four buildings life care center consortium skilled nursing facilities washington <NUMBER> <NUMBER> course events points inadequate infection prevention control measures hospitals healthcare facilities stated world health organization sarscov<NUMBER> survive surfaces hours several days example sarscov<NUMBER> rna identified variety surfaces cabins symptomatic asymptomatic infected passengers <NUMBER> days cabins vacated diamond princess cruise ship disinfection procedures conducted <NUMBER> reducing number flat surfaces germs sit deemed another way keep pathogens viruses transferring patients healthcare workers around building <NUMBER> control germs bacteria surfaces designers often avoided difficulttoreach areas tight corners buildings overlycomplicated designs hightouch surfaces <NUMBER> according markovitz hospital designers attempted find smart materials infrastructure easily disinfected washed <NUMBER> also certain materials already standardized healthcare may find application public spaces including antibacterial fabrics finishes nonporous materials already exist eg copper well inevitably developed facilitate cleaning sanitizing <NUMBER> moving forward also important architectures immediately remove hightouch design features buildings <NUMBER> large public spaces airports hotels hospitals gyms offices begun moving toward automation mitigate contagion coronavirus pandemic revealed using technology remotely control mosttouched surfaces developing touchless technology eg automatic doors voiceactivated elevators cellphonecontrolled hotel room entry handsfree light switches temperature controls significantly mitigate spread viruses <NUMBER> much united states exception essential workers undergone nearly three months social distancing addition shelterinplace orders coronavirus pandemic compared others currently employed working home essential workers must work outside home workers including healthcare workers grocery store staff transit operators likely african american approximately <NUMBER> college degree <NUMBER> furthermore one four essential workers said someone family healthcare worker employment classification considered essential throughout united states <NUMBER> essential workers putting risk order keep others alive maintain functioning society countrys shelterinplace orders addition risk many essential workers also designated economically vulnerable one three essential workers reported living household made less <NUMBER> usd year one seven lacked health insurance <NUMBER> moreover millions essential workers rely government assistance programs <NUMBER> <NUMBER> <NUMBER> lack options many workers cannot afford quit jobs spite heightened risk sarscov<NUMBER> exposure employment polarization emerged among essential workers result inherent inequalities persist within united states example clear economic social distinction salaried pulmonologist treats respiratory system covid<NUMBER> patients hourly waged grocery store cashier processes bags customer purchases yet considered essential aside difference wages highly educated pulmonologist socially revered showered personal protective equipment campaigns grocery store cashier largely ignored undervalued unsupplied simple face masks clear essential positions require relatively educational credentials certifications skills necessary tend easy learn nontechnical therefore pool particular workers large easy employers hire fire workers atwill simple economic concepts supply demand partly account polarization essential workers coronavirus pandemic norms inequality within united states contributes bulk circumstance jobs essential workers likely held women people color immigrants end april <NUMBER> cdc reported <NUMBER> essential workers diagnosed covid<NUMBER> <NUMBER> meat poultry processing facilities throughout <NUMBER> states <NUMBER> people died <NUMBER> also disclosed processing employees communicated language cultural barriers lived crowded multigenerational housing commuted work together likewise workers incentivized work illness thereby indicating lack appropriate healthcare options <NUMBER> many essential workers poorly compensated members marginalized underrepresented groups generally less political economic capital compared white american male addition poor compensation <NUMBER> essential workers lack health insurance <NUMBER> workers would borrow money pay unexpected <NUMBER> usd medical bill <NUMBER> within communities color many essential workers stated previously covid<NUMBER> testing inequities observed several areas throughout country lack access covid<NUMBER> walkup testing well widespread testing <NUMBER> observations reported physicians may less likely refer african americans covid<NUMBER> testing arrive signs infection <NUMBER> <NUMBER> <NUMBER> reasons included dismissiveness african american health complaints inequitable racebased incomebased hierarchy patients <NUMBER> pilot data shown comparison white patients african american patients covid<NUMBER> symptoms six times less likely receive testing treatment <NUMBER> institutional structural inequalities fueled racism sexism forms discrimination impeded ability people color secure employment livable wages healthcare access insurance opportunity upward mobility plus given societal expectation groups women particular provide service care type work often undervalued <NUMBER> women color stand intersection multiple oppressive identities experience amalgamated effects racial ethnic gender biases deeprooted cultural attitudes stereotypes women color often devalued work deprioritized needs <NUMBER> historically contemporaneously shown wage disparities example every dollar earned fulltime yearround working white men hispanic women earn <NUMBER> cents african american women earn <NUMBER> cents white women earn <NUMBER> cents <NUMBER> <NUMBER> social distancing industry disruptions greatly exacerbated preexisting economic fragility women essential workers many women color employment healthcare service industry places frontlines coronavirus pandemic table <NUMBER> <NUMBER> <NUMBER> although overwhelming percentage women work housekeeping cleaners <NUMBER> nursing assistants <NUMBER> personal care aids <NUMBER> women color also disproportionately work several industries also hit hardest pandemic related job losses <NUMBER> <NUMBER> women color women comprise <NUMBER> <NUMBER> <NUMBER> <NUMBER> accommodationsfood services healthcaresocial assistance industries respectively two hardest hit industries unemployment reported us department labor <NUMBER> <NUMBER> impact social distancing limited economic social inequalities geographic disparities covid<NUMBER> cases mortality alarming compared states first case covid<NUMBER> reported louisiana march <NUMBER> <NUMBER> yet june <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths louisiana ranked <NUMBER>th mortality rate <NUMBER> deaths per <NUMBER> people <NUMBER> <NUMBER> <NUMBER> geographic variations necessary function exclusively regional spatial imbalances variations manifestation residential segregation practices still currently held united states <NUMBER> overwhelmingly one point <NUMBER> louisianas covid<NUMBER> deaths african american despite racial group comprising <NUMBER> states population <NUMBER> <NUMBER> <NUMBER> <NUMBER> although african americans <NUMBER> still maintain highest percentage covid<NUMBER> deaths louisiana current racial breakdown deaths <NUMBER> white <NUMBER> louisiana population <NUMBER> latinx <NUMBER> louisiana population <NUMBER> asian <NUMBER> louisiana population <NUMBER> since majority deaths louisiana african americans intersection race racism covid<NUMBER> epidemiological trend seems strongly suggestive hypothesis inequality especially since similar trends identified throughout united states including illinois michigan north carolina wisconsin even nations capital washington dc <NUMBER> <NUMBER> <NUMBER> <NUMBER> exact cause racial disproportionality covid<NUMBER> cases mortality yet uncovered effect underlying racial health disparities namely kidney disease asthma diabetes mellitus obesity also risk factors covid<NUMBER> needs closely examined <NUMBER> <NUMBER> <NUMBER> <NUMBER> notion economic social disparities create perpetuate health disparities cannot ignored discussed previously institutional structural inequalities played significant role social determinants health conditions birth growth living learning working playing aging african americans example several african americans well communities color tend live food transit recreational deserts polluted densely impoverished areas raising children singleparent households <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> social determinants health contributed poorer covid<NUMBER> outcomes additionally many african americans reside areas people unable effectively social distance prisons homeless shelters <NUMBER> finally systemic racism barrier healthcare treatment african americans present well coronavirus pandemic research shown african americans rate healthrelated information receive family members churches highly due overarching sense medical establishment distrust stemming historical injustices eg tuskegee syphilis experiment among population <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unfortunately impeded access medical care magnified existing health disparities coronavirus pandemic also endangered communities color recognizable routes discrimination early april <NUMBER> cdc took <NUMBER> degree turn instructed use cloth face coverings bandanas without considering implications gang affiliation violence racial profiling <NUMBER> <NUMBER> created sense anxiety among communities color unfounded specifically african american men racially profiled wearing surgical masks effort reduce covid<NUMBER> risk expressed level psychological distress due fear racially profiled <NUMBER> <NUMBER> released video showed two african american men facemask followed walmart store police officer wood river illinois although incident occurred march <NUMBER> prior cdc face covering recommendation individuals throughout country well within rights use selfprotecting efforts reduce covid<NUMBER> risk african americans targeted community color increase antiasian discrimination origination covid<NUMBER> wuhan china <NUMBER> federal bureau investigation reported asian americans experiencing increased hate crimes due coronavirus global outbreak <NUMBER> midland texas three asian american family members including <NUMBER>yearold baby <NUMBER>yearold child stabbed sams club store suspect indicated attacked family thought family chinese infecting people coronavirus <NUMBER> also new york city teenagers attacked <NUMBER>yearold woman city bus spewed antiasian statements accused causing coronavirus another <NUMBER>yearold allegedly kicked <NUMBER>yearold man racist motives separate incident <NUMBER> even midst remarkable times hatred bigotry continued reign united states reflecting reimagining new post pandemic normal epidemics category disease seem hold mirror human beings really say obviously everything relationship mortality death lives show moral relationships toward people seeing today <NUMBER> distinct similarities differences comparing <NUMBER> <NUMBER> pandemics historical accounts influenza pandemic current coronavirus pandemic demonstrate poverty inequality social determinants health create support conditions disease transmission exacerbation existing health conditions disparities table <NUMBER> <NUMBER> interestingly public health response pandemics albeit tempered varying levels political resistance impacted human behavior mandated social distancing use face masks however unlike influenza pandemic widespread daily protests demonstrations within least <NUMBER> american cities throughout world completely eclipsed overshadowed public health orders social distancing public gathering prohibition coronavirus pandemic <NUMBER> <NUMBER> protests rallied systemic police brutality african americans specifically killing george floyd minneapolis police support black lives matter movement <NUMBER> <NUMBER> unique moment history illustrated convergence two public health crises <NUMBER> coronavirus pandemic <NUMBER> african american genocide impacted annihilation institutional structural systematic systemic racism within united states new normal post covid<NUMBER> reimagined fundamental dynamics entrenched ideologies acceptable living equality need addressed strongly reexamined order country move forward social distancing shelterinplace orders place throughout country since approximately middle march <NUMBER> bought country time curb spread virus limit number covid<NUMBER> cases deaths reduce healthcare system strain allow reflection preparation next phase <NUMBER> following pandemic containment mitigation phases third suppression phase allows slow emergence quarantine status requires essential elements order prevent ascent covid<NUMBER> infections <NUMBER> elements include measurable benchmarks surveilling epidemiological trends eg decline covid<NUMBER> deaths <NUMBER> days fortifying healthcare system eg sufficient personal protective equipment healthcare workers transforming public health infrastructure eg demonstrated ability convey social distancing recommendations change behavior residents <NUMBER> <NUMBER> elements implemented aspects social distancing relaxed yet old normal living still cannot return likely return initial reopening establishments gatherings still capped <NUMBER> people restaurants need adopt social distancing seating welcome patrons however recommended governmental public health officials individuals <NUMBER> years age medically vulnerable continue shelterinplace final phase reopening <NUMBER> staggered partial reopening approach new environmental safeguards temperature ventilation checks mandatory handwashingsanitizing every entry periodically throughout day may used schools businesses <NUMBER> also may need quarantine travelers high prevalence covid<NUMBER> areas governmental regulations may institute proof immunity documentation spending fourteen days isolation entering new country travelers beyond successful initial reopening least four weeks significant increase new covid<NUMBER> cases six feet social distancing measure may paused still ban gatherings exceed <NUMBER> people four months initial reopening <NUMBER> throughout phase transitions critical public health leaders political administrators overall general public work together order control mitigate eradicate covid<NUMBER> stated secretarygeneral antónio guterres united nations coronavirus pandemic public health emergency became economic social human rights crisis specifically working together respecting human rights time crisis effective inclusive solutions emergency today recovery tomorrow achieved <NUMBER> even new kind normalcy everyone may still practice consistent better hygiene handwashing coughing sneezing greet interact differently <NUMBER> people may need create new ways meeting friends colleagues impressively within past couple decades sharing economy expanded created environments new components multiple people share spaces shared spaces including cowork environments eg wework rooms homes eg airbnb cars eg uber bikes eg capital bikeshare elements built environment increase potential opportunities environmentally mediated pathways pathogen exposure need reexamined <NUMBER> coronavirus pandemic also may accelerate development riskmitigating efforts designed reduce humantohuman interactions upgrade building ventilation physical barriers adopt automation technologies robotics artificial intelligence vision systems <NUMBER> given severity pandemic compliance social distancing directives many american cities significantly reduced public transit service mentioned previously agencies like chicago transit authority implemented sanitation regimes minimize spread covid<NUMBER> many transit agencies may move new standard face masks always required anyone boards train bus <NUMBER> social distancing measures prompted organizations embrace videoconferencing virtual classrooms telemedicine types interactions may become norm moving forward fear contagion companies shifted protocols operation prior coronavirus pandemic many businesses already abandoning cash payments wake outbreak many may permanently switch digital payments structural building modifications eg voiceactivated elevators environmental adjustments eg telework capabilities may much easier acclimatization many americans wake post covid<NUMBER> existence yet changing perceptions attitudes behaviors deeply entrenched american way living much challenging hill climb issues surrounding injustices related many social determinants health new pandemic illuminated issues overwhelmingly disproportion covid<NUMBER> mortality rates african americans highlights need address longstanding inequalities racism united states created inequality access healthcare housing wealth education employment social determinants health either promote undermine ones health longevity order move forward racism needs addressed needs new tailored approaches reach disadvantaged well circumstances generated racist ideologies practices politices instance louisiana initially launched drivethrough testing african american <NUMBER>yearold woman walked mile heat get tested <NUMBER> demonstrated covid<NUMBER> testing site accessible many individuals cars live transit deserts cannot afford private transit upon learning public health officials targeted zip codes highest rates covid<NUMBER> reported deaths deployed testing areas populationbased testing contact tracing pandemic vital order predict allocate resources control spread virus implement evidencebased interventions highrisk areas however evidencebased interventions achievable accurate data evidence early april <NUMBER> cdc began including race ethnicity data morbidity mortality weekly report <NUMBER> many states yet release demographic data deaths sarscov<NUMBER> may exploiting inequalities united states virus similar past well future pathogens discriminate race social construct man created covid<NUMBER> contained vulnerable populations continue spread communities alter future human existence pesky flus town white black rich poor included tour <NUMBER> author unknown prose poem <NUMBER> influenza pandemic thousands years disease outbreaks devastated societies <NUMBER> coronavirus pandemic different densely populated urban environmental conditions shaped <NUMBER> influenza pandemic experience current day coronavirus pandemic quite similar influenza coronavirus pandemics occurred nearly century apart one similarity events undeniable public health response disease outbreaks remained virtually unchanged social distancing face covering efforts unfortunately role human behaviors social ideologies stemmed darker side humanity effect response coronavirus pandemic also progressed considerably review revealed american burden inequalities injustices related environments human behavior significantly impacts morbidity mortality rates among vulnerable communities observed <NUMBER> influenza pandemic presentday coronavirus pandemic revealed exposed many inequalities inhabit united states however opportunity presented allow improvements advancements overall social uplift society epidemic extreme respiratory deterrence pneumonia shortness breath sarscov<NUMBER> viral infection began wuhan hubei province china december <NUMBER> rapidly spread across china beyond human human transmission february <NUMBER> <NUMBER> world health organization officially named new coronavirus disease coronavirus disease <NUMBER> covid<NUMBER> covid<NUMBER> patients diagnosed pneumonia many treated using chinese medicines secondary therapies april <NUMBER> <NUMBER> total figure infected patients crossed <NUMBER> <NUMBER> million people worldwide <NUMBER> deaths <NUMBER> patients recovered preliminary reports suggest certain drugs chloroquine antiviral nucleotide analogues remdesivir inhibit viral replication target new coronavirus although usefulness clinic still debate expert us committee developed us nih guidelines covid<NUMBER> treatment released regularly updated manuscript reviews epidemiology etiology mortality covid<NUMBER> clinical symptoms potential therapeutic drugs highlighting seriousness damageinduced sarscov<NUMBER> covid<NUMBER> review epidemiology potential treatments <NUMBER> novel coronavirus december <NUMBER> wuhan hubei province china announced active epidemic pneumonia associated novel coronavirus identified severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> next weeks infections spread throughout china elsewhere world <NUMBER> <NUMBER> chinese media clinical science institutions reacted swiftly latest virus identified viral genome sequence shared quickly worldwide <NUMBER> january <NUMBER> <NUMBER> world health organization announced outbreak public health emergency international concern pheic <NUMBER> february <NUMBER> <NUMBER> named disease coronavirus disease <NUMBER> covid<NUMBER> caused novel coronavirus <NUMBER> consortium foreign experts collaborating chinese colleagues various specializations sought hold outbreak <NUMBER> first infected cases associated food market wuhan <NUMBER> coronaviruses enveloped positive sense singlestranded rna genome infecting humans wide range animals first time characterized cultured tyrell bynoe <NUMBER> patients flu common cold <NUMBER> known coronaviruses based morphology spherical virions central shell surface projections identical solar corona latin corona means crown <NUMBER> four separate subfamilies alpha beta gamma delta coronaviruses alpha beta coronaviruses appear come mammals especially bats whereas gamma delta coronaviruses derive pigs birds <NUMBER> genome length ranges <NUMBER>kb <NUMBER>kb among seven subtypes coronavirus may ability infect humans betacoronavirus considered dangerous one causes significant morbidity mortality humans sarscov<NUMBER> virus belongs genus betacoronavirus <NUMBER> <NUMBER> four main operational genes encodes spike protein nucleocapsid protein n membrane glycoprotein small membrane protein sm additional membrane glycoprotein occurring hcovoc<NUMBER> hku<NUMBER> betacoronaviruses <NUMBER> figure <NUMBER> presents figure <NUMBER> sarscov structure b microscopic images <NUMBER> micron indicate nc nucleocapsid spikes e envelope c two dimensional class averages data b e spike attachment outer capsid f sarscov spikes red nucleocapsid yellow spikes <NUMBER> figure reproduced beniac et al <NUMBER> permission article made available via pmc open access subset unrestricted research reuse secondary analysis form means acknowledgement original source sarscov<NUMBER> structure virus sequence <NUMBER> similar batrelated coronavirus throughout entire genome <NUMBER> according specific medicine antiviral found treat prevent novel coronavirus <NUMBER> noted chinese medication cm including oral administration protective herbal formulae usage cm sachets herbal medicine fumigations etc typically used deter manage novice coronavirus china epidemic begins <NUMBER> <NUMBER> chinese herbal traditional medicines also used <NUMBER> combat sars severe infectious disease epidemic china covid<NUMBER> <NUMBER> <NUMBER> preliminary studies show virus shares high genome resemblance <NUMBER> batderived sars coronaviruses <NUMBER> therefore virus initially named <NUMBER> novel coronavirus <NUMBER>ncov coronavirus rna based enveloped entity named <NUMBER> nm long surface spikes solar corona presence <NUMBER> coronaviral genome enclosed envelope bears four main structural proteins including spike protein binds angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor mediates fusion envelope cell membranes host cell first reported patients happened december <NUMBER> <NUMBER> beginning morbidity low however january <NUMBER> hit turning point significant rise infected patients occurred cities outside hubei province second half month due movement people chinese lunar new year <NUMBER> exponential rise january <NUMBER> <NUMBER> infection traveled countries draws significant global interest occurrence humantohuman infection reported clusters affected family members medical staff <NUMBER> contact droplets fomite <NUMBER> <NUMBER> far proof intrauterine infection documented <NUMBER> reported <NUMBER> cases covid<NUMBER> infections across china late january <NUMBER> <NUMBER> virus believed incubation periods ranging approximately <NUMBER> days time infection symptoms basis following sources <NUMBER> incubation time covid<NUMBER> <NUMBER> <NUMBER> days recorded <NUMBER> <NUMBER> chinese national health commission initially expected <NUMBER> <NUMBER> days incubation period <NUMBER> cdc united states america assumes incubation period <NUMBER> <NUMBER> days covid<NUMBER> <NUMBER> <NUMBER> doctors healthcare practitioners leading chinese group dxycn predicts incubation period <NUMBER> <NUMBER> days <NUMBER> days report released february <NUMBER> <NUMBER> incubation time observed long <NUMBER> days range <NUMBER> days average <NUMBER> days <NUMBER> stated february <NUMBER> <NUMBER> press conference long duration incubation represent double exposure <NUMBER> days specified point regarded sense studys key results <NUMBER> nevertheless recently jama report released february <NUMBER> <NUMBER> <NUMBER>day incubation period infected patient identified <NUMBER> hubei province registered another case infected patients january <NUMBER> <NUMBER> <NUMBER> calculated mean incubation period <NUMBER> days incubation duration varied <NUMBER> <NUMBER> days <NUMBER>day maximum limit may known conservative <NUMBER> comparison viruses found table <NUMBER> director general dr tedros adhanom ghebreyesus said inaugural remarks covid<NUMBER> press briefing march <NUMBER> <NUMBER> <NUMBER> mortality rate globally comparison seasonal influenza normally kills fewer <NUMBER> affected individuals <NUMBER> initially press conference wednesday january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> listed <NUMBER> mortality rate estimation however january <NUMBER> <NUMBER> specified early provisional estimate might changed <NUMBER> elderly patients specific illnesses considered higher risk regardless whether coronavirus <NUMBER> patients heart disease high blood pressure diabetes treated ace<NUMBER>increasing drugs may high risk serious covid<NUMBER> infection <NUMBER> mortality rate comparison viruses shown table <NUMBER> covid<NUMBER> fatality rate age sex comorbidity shown table <NUMBER> table <NUMBER> table <NUMBER> respectively typically covid<NUMBER> triggers flulike symptoms fever cough symptoms develop pneumonia chest strain chest pain difficulty breath elderly people patients chronic health conditions looks like begins fever leads dry coughing one week infection conditions become harsh lead breath shortening approximately <NUMBER> patients requiring hospital treatment medication <NUMBER> covid<NUMBER> illness appears seldom induce runny nose sneezing sore throat around <NUMBER> patients symptoms painful throat sneezing stuffy nose typically symptoms seasonal flu cold <NUMBER> <NUMBER> patients may develop pain hemoptysis many may also completely asymptomatic <NUMBER> <NUMBER> older people comorbidity serious alveolar injury prone experience respiratory failure <NUMBER> onset disease demonstrate rapid progression organ dysfunction eg acute kidney injury shock acute cardiac injury acute respiratory distress syndrome ards death severe cases <NUMBER> sometime patients might develop lower normal white blood cell count thrombocytopenia lymphopenia increased creactive protein level extended activated thromboplastin time <NUMBER> <NUMBER> <NUMBER> <NUMBER> infected cases found mild normal fever flu patients recover home short patient upper respiratory tract symptoms fever leukopenia lymphopenia suspected tables <NUMBER> <NUMBER> <NUMBER> date proven effective antiviral therapies infection caused sarscov<NUMBER> treatment several hospitals includes use prophylactic antibiotics prevent secondary infection initial reports shown antivirals antibiotics combination given orally benefits <NUMBER> january <NUMBER> <NUMBER> joint research team shanghai institute materia medica shanghai tech university conducted silicon drug screening enzyme activity testing reported <NUMBER> agents significant antiviral activity sarscov<NUMBER> <NUMBER> following drugs used covid<NUMBER> invitro use clinic still debate time chloroquine commonly used antimalarial autoimmune medication recently identified possible broad spectrum antiviral drug <NUMBER> <NUMBER> vitro chloroquine reported variable bioactive agent antiviral activity rna viruses rabies virus <NUMBER> poliovirus <NUMBER> hiv <NUMBER> <NUMBER> hepatitis c virus <NUMBER> chloroquine known prevent infection cells virus increasing endosomal ph needed virus cell fusion interfering glycosylation sarscov cell receptors <NUMBER> china national center biotechnology development recently reported chloroquine one three drugs promising profile current sarscov<NUMBER> chloroquine remodeling explored hospitals beijing central chinas hunan province south chinas guangdong province <NUMBER> drug could potentially prevent sarscov<NUMBER> infection low molecular concentrations chloroquine halfmaximal effective concentration ec<NUMBER> <NUMBER> μm halfcytotoxic concentration cc<NUMBER> greater <NUMBER> μm <NUMBER> however treating malaria minor risks adverse events macular retinopathy cardiomyopathy whichare side effects caused long term use chloroquine <NUMBER> <NUMBER> <NUMBER> evidently chloroquine could used treatment covid<NUMBER> effectiveness safety long term use <NUMBER> narrative letter chinese authors reported chloroquine phosphate used many clinical trials marked efficacy covid<NUMBER> oral administration chloroquine distributed widely across body including lung ec<NUMBER> value vero e<NUMBER> cells <NUMBER> μm clinically attainable patients rheumatoid arthritis received <NUMBER> mg administration demonstrated plasma <NUMBER> hydroxychloroquine derivative chloroquine may lower adverse effects chloroquine <NUMBER> administration chloroquine covid<NUMBER> experimental therefore ethical trial approval necessary ethically justifiable best treatment available ie offlabel additional information chloroquines effects usefulness treatment covid<NUMBER> patients soon published due experimental use emerging outbreak due high number patients infected lack approved drugs timely release information may critical confirms currently evidence randomized control trials warn specific covid<NUMBER> drug treatments unlicensed therapies performed sense ethicallyapproved clinical trials strict supervision controlled emergency use unregistered procedures system meuri meanwhile recommendations clinical management severe acute respiratory infection novel coronavirus sarscov<NUMBER> infection suspected <NUMBER> authors tend agree viewpoint view chloroquine experimental outbreak perfect environment even use chloroquine offlabel followed many concerns first health patients followed close supervision ethical approach offlabel drug use also varies country country raising concerns regarding equity offlabel drug use could cause severe medication shortages needed malaria since chloroquine remains crucial medication treatment malaria many parts world <NUMBER> use chloroquine phosphate expert consensus published february <NUMBER> <NUMBER> multicenter collaboration group department science technology guangdong province health commission guangdong province preliminary measures recommended panel include blood tests rule risk anemia thrombocytopenia leukopenia well serum electrolyte abnormalities andor hepatic renal function dysfunctions recommended rule development qt interval prolongation bradycardia perform patient interviews find visual andor mental disturbance electrocardiography routinely recommended quinolones macrolides ondansetron well various antiarrhythmic antidepressant antipsychotic drugs prolong qt interval avoided recommended panel <NUMBER> remedsivir analogue adenosine incorporates nascent viral rna chains resulting premature termination recently recognized potential antiviral medication broad variety rna viruses including sars merscov cultivated cells mice nonhuman primates nhp models <NUMBER> <NUMBER> <NUMBER> ec<NUMBER> value remdesivir vero e<NUMBER> cells sarscov<NUMBER> <NUMBER> μm indicating working concentration likely attained nhp models remdesivir also effectively inhibited virus infection human cell line huh<NUMBER> cells human liver cancer susceptible sarscov<NUMBER> <NUMBER> animal experiments showed remdesivir significantly reduce viral load merscov lung tissue infected mice enhance lung function minimize pathological damage lung tissue <NUMBER> february <NUMBER> <NUMBER> china favipiravir approved treatment <NUMBER> novel influenza currently drug undergoes clinical trials treat covid<NUMBER> favipiravir inhibitor new type rnadependent polymerase rna rdrp <NUMBER> value favipiravir ec<NUMBER> vero e<NUMBER> cells cells used novel coronavirus study high <NUMBER> μm although vivo research required test antiviral nucleoside also shown <NUMBER> effective protecting mice ebola virus <NUMBER> preliminary results total <NUMBER> patients including experimental group control group shown favipiravir potent antiviral effect lopinavir ritonavir <NUMBER> convalescent plasma monoclonal antibodies suggested therapies treatment covid<NUMBER> patients convalescent plasma immunoglobulins used last resort improve survival rate patients sars whose condition continued deteriorate pulsed methylprednisolone therapy <NUMBER> addition studies found shorter hospital stay lower mortality patients treated convalescent plasma <NUMBER> probability includes leronlimab humanized monoclonal antibody ccr<NUMBER> antagonist nucleoside rna polymerase inhibitor galidesivir shown survival benefits many deadly virus infections considered potential useful candidates treatment <NUMBER> <NUMBER> lopinavir ritonavir hiv protease inhibitors suppress cleavage polyprotein multiple functional proteins rajavithi hospital thailand infectious disease team used combination oseltamivir antiinfluenza agent lopinavirritonavir successfully improve status patients severe conditions <NUMBER> baricitinib used treatment rheumatoid arthritis inhibitor aak<NUMBER> janus kinase recommended control viral replication <NUMBER> machine learning models predicted ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> drugs disrupt proteins inhibit viral entry target cells <NUMBER> use baricitinib susceptible covid<NUMBER>associated patients ongoing pneumonia taken strict caution <NUMBER> clinical trials presently focus efficacy different drugs immunoglobulins arbidol hydrochloride combined interferon atomization ritonavir plus oseltamivir asc<NUMBER>f plus oseltamivir mesenchymal stem cell treatment lopinavir plus ritonavir hydroxychloroquine darunavir plus cobicistat methylprednisolone washed microbiota transplantation <NUMBER> <NUMBER> repurposing available drugs immediate use treatment sarscov<NUMBER> infections could improve available clinical management <NUMBER> study xiaoling xu et al suggests tocilizumab important therapy serious covid<NUMBER> patients offered new therapeutic approach deadly infectious disease <NUMBER> virus sarscov<NUMBER> fatal disease high mortality rate total <NUMBER> certified cases <NUMBER> deaths recorded world date efficacious proven medicinal therapy committee us experts developed treatment guidelines covid<NUMBER> patients regularly updated <NUMBER> model drug chloroquine proposed could potentially work novel coronavirus remdesvir nucleoside analogue also holds promise use treating covid<NUMBER> patients additional proposed drugs covid<NUMBER> drugs approved fda treatment pathologies including ribavirin penciclovir nitazoxanide nafamostat chloroquine two wellknown drugs broad spectrum activity ie remdesivir gs<NUMBER> favipiravir t<NUMBER> leronlimab humanised monoclonal antibody ccr<NUMBER> antagonist arbidol hydrochloride combined interferon atomisation lopinavir plus ritonavir ritonavir plus oseltamivir asc<NUMBER>f plus oseltamivir mesenchymal stem cell treatment could also choice treatment covid<NUMBER> patients lopinavir ritonavir hiv protease inhibitors suppress cleavage polyprotein multiple functional proteins based historical records human reports sars prevention h<NUMBER>n<NUMBER> influenza chinese herbal formula may effective solution covid<NUMBER> prevention highrisk populations although usefulness clinic purpose still demonstrated short sarscov<NUMBER> highly transmissible virus clinical trials required finding confirming promising drug candidates effective vaccines covid<NUMBER> infectious disease caused recently discovered novel coronavirus new virus caused disease unknown outbreak began wuhan china december <NUMBER> covid<NUMBER> pandemic announced march <NUMBER> affecting many countries globally <NUMBER> covid<NUMBER> appear many symptoms fever fatigue dry cough anorexia myalgia muscle ache dyspneashortness breath expectoration coughing spitting material lungs bronchi trachea sputum pharyngalgia diarrhea loose watery stoolsnausea dizziness headache vomiting abdominal pain respiratory system symptoms common onset disease pneumonia appears frequent serious manifestation infection characterized primarily fever cough dyspnea bilateral infiltrates chest imaging <NUMBER> <NUMBER> diagnosis researchers define gold standard lateral methods overwhelm pandemic via early diagnosis disadvantages high duration rtpcr reverse transcription polymerase chain reaction low sensitivity antigenantibody tests high radiation exposure computer tomography ct since methods many disadvantages rapid diagnosis prescreening test crucial keep population wellbeing physicians labor important factor fight novel coronavirus addition decision support systems dss improved artificial intelligence ai machine learning methods timesaving activities physicians rapid analysis chest xray cxr scans ct infection rate mortality rate machine learning methods helpful tools researchers trying build tools prescreening covid<NUMBER> study defines deployed environment <NUMBER> rapid evaluation mortality rate cxr scans via machine learning tools analysis explained study submitted work euvsvirus hackathon <NUMBER> article goes follows sec <NUMBER> discusses diagnosis methods disadvantages sec <NUMBER> reveals algorithms detail sec <NUMBER> evaluation algorithm deployed platform sec <NUMBER> concludes work rtpcr gold standard diagnose covid<NUMBER> <NUMBER> necessary keep mind enough studies evaluate accuracy predictive values tests sensitivity testing depends precise rtpcr assay type specimen duration illness testing study china <NUMBER> samples collected <NUMBER> patients bronchoalveolar lavage fluid positive results <NUMBER> <NUMBER> patients <NUMBER> percent specimens upper respiratory tract fewer positive results <NUMBER> pharyngeal swabs <NUMBER> positive results <NUMBER> percent <NUMBER> nasal swabs <NUMBER> positive results <NUMBER> percent researchers study suggest testing specimens multiple sides may improve sensitivity <NUMBER> according statement study necessary studies evaluating rtpcr tests second diagnostic tool defined literature ct according study wuhan china <NUMBER> patients chest ct <NUMBER> percent sensitivity based positive rtpcr results researchers suggest chest ct could primary tool diagnose covid<NUMBER> unfortunately specificity <NUMBER> percent words <NUMBER> <NUMBER> patients false positive <NUMBER> ct scan pediatric patients also avoided due radiation <NUMBER> besides problem resources diagnose sufficient literature machine learning methods also applied diagnosis ct images <NUMBER> <NUMBER> used supporting clinicians decisions however applied large number samples exploit speed ai interpretation therefore lateral rapid diagnostic tools required preelimination steps according statement pneumonia common clinical manifestation fatal outcomes inspiration solution order diagnose pneumonia cxr appears useful tool diagnose community acquired pneumonia fact gold standard clinical evaluation microbiologic test results <NUMBER> unfortunately covid<NUMBER> cxr limitations study <NUMBER> patients patients abnormality cxr even positive initial rtpcr cxr may normal early mild disease <NUMBER> test used frequently due low radiation exposure health systems governments also enough xray scan devices satisfy population spite cxr lowcost diagnostic tool healthcare chest xrays used frequently keep mind study limitations researchers stated inspires second part solution researchers also publish ai architectures according detection covid<NUMBER> patients <NUMBER> <NUMBER> evaluating fact cxr enough speak certain diagnosis supporting parameter provided physician conditions ai catch condition study parameter defined mortality rate shows risk mortality person infected covid<NUMBER> disease people higher risk severe illness highrisk covid<NUMBER> people <NUMBER> years older people live nursing home longterm care facility also people ages underlying medical conditions particularly well controlled including people chronic lung disease moderate severe asthma serious heart conditions immunocompromised many conditions cause person immunocompromised including cancer treatment smoking bone marrow organ transplantation immune deficiencies poorly controlled hiv aids prolonged use corticosteroids immune weakening medications people severe obesity body mass index bmi <NUMBER> higher diabetes chronic kidney disease undergoing dialysis liver disease <NUMBER> risk evaluation parameter direct patients diagnostic services identify patients risk <NUMBER> proposed solution prescreening covid<NUMBER> <NUMBER> mantiscovid hybrid platform proposed via study evaluation platform two outputs screening group patients prediction risk covid<NUMBER> via cxr mortality rate two parameters used decision support system direct patient highly sensitive tests case <NUMBER> mantiscovid httpsscanmantiscopecomlangen <NUMBER> httpseuvsvirusorg <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mantiscovid cannot catch covid<NUMBER> patient via ai elimination cxr physician change approaching style patient via evaluating mortality rate patient symptoms negative test results higher mortality rate population advised follow patient closely advise evaluated clinicians although forecasting mortality rate easy due dependence many conditions tried estimate mathematical model linear regression terms <NUMBER> parameters via using open datasets patients <NUMBER> system works cloud web page physician access system available computations system designed scattered millions people provide scalability via cloud flow diagram platform seen fig <NUMBER> system two types forecasting mortality rate cxr posteroanterior pa chest view via ai elimination methods used implement processing flow forecasting mortality rate given following details development open source datasets used python code data synthesis grouping sets given <NUMBER> dataset used compute mortality rate open source covid<NUMBER> survival calculator mortality rate dataset modeled linear regression method connecting <NUMBER> parameters <NUMBER> chosen mortality rate factors age sex height weight health conditions asthma carcinoma chronic kidney disease compromised immune system coronary heart disease chronic obstructive lung disease diabetes hiv positive hypertension high blood pressure chronic illness blood type smoking type discarded mortality rate adjustment parameters obtain minimum dataset methods used obtain linear regression model mortality rate open source libraries associated python scikitlearn <NUMBER> presentation cxr pa patient elimination ai platform three types ai algorithms available check whether person risky flow diagram seen fig <NUMBER> sequence direct role detect risk xray scans aim hybrid module used certain diagnosis due low sensitivity occurring via pa chest view used decision support system clinician first model generated classify whether input image xray image model trained via dataset containing cxr pa scans <NUMBER> images images <NUMBER> images <NUMBER> <NUMBER> dataset divided training <NUMBER> percent test <NUMBER> percent sets image detected besides xray image algorithms processed warns user check uploaded image keras library used generate convolutional neural network cnn architecture starting point classifier <NUMBER> input layer <NUMBER> convolutional filters size <NUMBER>x<NUMBER> inserted rectified linear unit relu activation function inputs accepted <NUMBER>x<NUMBER> redgreenblue rgb colors makes input shape <NUMBER>x<NUMBER>x<NUMBER> max pooling layers <NUMBER> hidden layers inserted <NUMBER>x<NUMBER> filter convolution hidden layer contains <NUMBER> convolutional filters size <NUMBER>x<NUMBER> relu activation functions addition maxpooling layer <NUMBER>x<NUMBER> filters flatten operation applied fully connected layer added <NUMBER> units relu activation function later dropout technique applied rate <NUMBER> avoid overfitting finally fully connected layer used unit sigmoid function <NUMBER> image xray image <NUMBER> otherwise classifier ai middle revealing whether patient risky covid<NUMBER> pneumonia trained model modified version alexnet <NUMBER> according open datasets strengthened currently obtained covid<NUMBER> patients day day <NUMBER> dataset split train <NUMBER> test <NUMBER> validation <NUMBER> enable platform evaluation totally contains <NUMBER> normal <NUMBER> covid<NUMBER> <NUMBER> pneumonia patient data <NUMBER> ai architecture object classifier training batch sizes given fig <NUMBER> last part defined object detection case detection lung opacity parts associated bacteria type pneumonia ai neural network trained tiny version look yolo <NUMBER> mark single objects cxr pa images anomaly named lung opacity dataset used part annotated cxr pa obtained open source datasets <NUMBER> system presented paper contains <NUMBER> different machine learning techniques provide rapid analysis cxr pa view mortality rate evaluation algorithms evaluated one one allocated data evaluation results seen within following details <NUMBER> linear regression model forecast mortality rate evaluation contains allocated <NUMBER> patient data gathered open source dataset mean squared error standard deviation actual predicted values computed <NUMBER> <NUMBER> respectively fig <NUMBER> shows details actual predicted values via testing <NUMBER> conditions <NUMBER> binary classifier check whether uploaded image xray scan evaluation contains additional <NUMBER> xray <NUMBER> random images used evaluation binary classifier algorithm correctly predicted values xray scans random samples given <NUMBER> <NUMBER> separately observed averaged accuracy <NUMBER> percent <NUMBER> classifier separate covid<NUMBER>pneumonianormal patients part contains randomly selected <NUMBER> patient data separated via ai algorithm sensitivity risky patient detection covid<NUMBER>pneumonia <NUMBER> percent sensitivity detection normal patients <NUMBER> percent confusion matrix seen following fig <NUMBER> main objective detection risky patients high accuracy system conditions improved via gathering patient data known covid<NUMBER> certainly lesion detection bacteria type xray scans part contains randomly selected <NUMBER> patient data analyzed via ai algorithm evaluation criterion comparing number lesions real annotated predicted xray scans allocated dataset divided three groups <NUMBER> lesions <NUMBER> image <NUMBER> lesion <NUMBER> image lesion <NUMBER> image detected actual number lesions groups given <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> mantiscovid cloudbased prescreening platform would useful elimination nonrisky patients coronavirus pandemic since algorithms developed evaluated using open source data platforms system needs evaluated via clinical perspective legal authorities platform internetbased prediagnosis tool verified via universities covid<NUMBER> diagnosis however physician would also use tool assistant scan diagnose patients due rapid diagnosis requirement prevent spreading coronavirus fact gold standards used diagnose covid<NUMBER> patients also high false alarm rates epidemiology disease fully known future work clinical validation internetbased platform start known legal authorities state art ai architectures used increase sensitivity specificity platform integration platform continue chest anteroposterior ap views chest ct ultrasound images providing novel ai architectures infection rate novel coronavirus would also evaluated usage tracking patients locations coronavirus pandemic platform would also used scanning society terms mortality rate xray scans illnesses symptoms studies identify case fatality rate infection rate case proper data collected train ai ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ruan q <NUMBER> china <NUMBER> overlapping publication du r <NUMBER> china <NUMBER> overlapping publication chen <NUMBER> china <NUMBER> overlapping publication impact cardiovascular disease cardiac injury inhospital mortality patients covid<NUMBER> systematic review metaanalysis past two decades pandemic severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> taken severe death tolls worldwide <NUMBER> <NUMBER> deaths respectively <NUMBER> late <NUMBER> another virus lethal respiratory infection potential identified severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged heralded another global pandemic <NUMBER> since outbreak wuhan <NUMBER> countries regions reported confirmed cases coined covid<NUMBER> describe coronavirus disease <NUMBER> declared outbreak public health emergency international concern <NUMBER> <NUMBER> april <NUMBER> nearly <NUMBER> <NUMBER> <NUMBER> infections <NUMBER> <NUMBER> deaths worldwide within less <NUMBER> months covid<NUMBER> registered mortality record higher sars mers combined <NUMBER> <NUMBER> overwhelming fatality cases caused covid<NUMBER> much concern raised determine risk factors poor prognosis advanced age male sex <NUMBER> <NUMBER> previous research reported patients underlying cardiovascular disease cvd prone viral infection also greater risk developing severe cases admitted intensive care unit <NUMBER> <NUMBER> sarscov<NUMBER> attack respiratory system targeting ace<NUMBER> however high tissuespecificity ace<NUMBER> expression cardiovascular system cardiomyocytes may particularly prone damage <NUMBER> several studies reported high incidence elevated cardiac troponin hospitalised patients especially critical conditions <NUMBER> <NUMBER> thus patients cvd complications may poor prognosis infected sarscov<NUMBER> therefore conducted systematic review metaanalysis available evidence evaluate association underlying cvd incident cardiac injury inhospital mortality risk patients covid<NUMBER> metaanalysis conducted accordance preferred reporting items systematic reviews metaanalyses statement <NUMBER> meta analysis observational studies epidemiology statement <NUMBER> comprehensive search performed pubmed embase web science databases <NUMBER> january <NUMBER> <NUMBER> april <NUMBER> following search terms included coronavirus covid<NUMBER> <NUMBER>ncov sarscov<NUMBER> cardiovascular disease coronary heart disease hypertension cardiac injury myocardia injury mortality death fatality addition reference lists relevant articles reviewed potential studies studies included metaanalysis met following criteria <NUMBER> exposure factor cvd coronary heart disease cardiac disease healthcare delivery economics global health figure <NUMBER> preferred reporting items systematic reviews metaanalyses flow diagram study selection chronic cardiac disease hypertension acute cardiac injury <NUMBER> outcome interest inhospital mortality <NUMBER> study population adult patients confirmed sarscov<NUMBER> infection avoid duplication contacted authors whose studies conducted hospital batch patients enrolled specific information identifying patients could provided study largest sample size included two researchers xl bg independently screened search results titles abstracts potentially relevant studies retrieved full texts evaluation two authors xl bg independently identified eligible studies based inclusion criteria disagreements resolved discussion another researcher ts two researchers xl bg independently extracted data enrolled studies via preset standardised form following information extracted first author publication year study design location patients enrolled period age sex prevalence comorbidities exposure factors level adjustment newcastleottawa scale terms <NUMBER> total score nine stars applied evaluate quality case series studies cohort studies separately studies <NUMBER> points considered high quality analyses performed using stata v<NUMBER> software unadjusted ors <NUMBER> cis calculated common risk estimates pooled due limited data multivariable adjusted outcomes heterogeneity among studies evaluated cochrans qstatistic <NUMBER> test <NUMBER> ≤<NUMBER> fixed effects model adopted otherwise random effects model applied metaanalysis metaregression analysis performed test potential sources heterogeneity among studies sensitivity analyses also performed omitting one study time evaluate influence individual study pooled results publication bias evaluated visual inspection asymmetry funnel plots patients public involved design conduct reporting dissemination plans research initial database search yielded <NUMBER> studies figure <NUMBER> removing duplicate publications <NUMBER> studies left screened title abstract identified <NUMBER> articles fulltext review <NUMBER> studies excluded due relevant outcome exposure interest duplicated publication primary study medical intervention study online supplementary file <NUMBER> additional studies met inclusion criteria screening reference lists several studies published institution authors contacted ensure overlapping cohorts analysed separate studies altogether <NUMBER> studies comprising <NUMBER> patients included metaanalysis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> main characteristics included studies summarised table <NUMBER> <NUMBER> studies two case series design <NUMBER> <NUMBER> remaining eight cohort studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies conducted wuhan china except one study enrolled patients nationwide <NUMBER> patients accrued end december <NUMBER> february <NUMBER> mean age ranged <NUMBER> years old <NUMBER> <NUMBER> <NUMBER> years old proportion male patients ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence cvd hypertension ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients experienced cardiac injury hospitalisation table <NUMBER> eight studies <NUMBER> <NUMBER> <NUMBER> reported relationship underlying cvd inhospital mortality risk <NUMBER> patients <NUMBER> deaths unadjusted model five studies <NUMBER> <NUMBER> <NUMBER> consistently revealed significantly higher death risk cvd group remaining three studies <NUMBER> <NUMBER> <NUMBER> reported significant relationship cvd inhospital mortality figure <NUMBER> overall summary estimate demonstrated patients cvd approximately fivefold higher risk mortality compared noncvd patients unadjusted <NUMBER> p<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> heterogeneity across studies nonsignificant <NUMBER> <NUMBER> p<NUMBER> seven studies <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> deaths included preexisting hypertension inhospital mortality analysis unadjusted ors six studies <NUMBER> <NUMBER> reported significantly higher mortality risk patients previous hypertension remaining study <NUMBER> showed significant association figure <NUMBER> pooled unadjusted effect hypertension mortality risk <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> moderate heterogeneity <NUMBER> <NUMBER> p<NUMBER> cardiac injury eight studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> deaths except one <NUMBER> reported acute cardiac injury significantly associated high mortality risk unadjusted model figure <NUMBER> pooled effect studies unadjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> heterogeneity <NUMBER> <NUMBER> p<NUMBER> showed patients elevated troponin levels significant higher mortality risk normal troponin levels visual inspection funnel plots show significant asymmetry online supplementary file <NUMBER> sensitivity analyses conducted systematically excluding one study time results remained consistent primary analyses online supplementary file <NUMBER> explore potential sources heterogeneity metaregression applied test influence study design sample size mean age male proportion none factors contributed significantly observed heterogeneity online supplementary file <NUMBER> study evaluated impact underlying cvd hypertension acute cardiac injury inhospital mortality patients covid<NUMBER> results showed positive association previous cvd hypertension fatal outcomes unadjusted ors <NUMBER> cis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significant relationship acute cardiac injury inhospital mortality unadjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov singlestrand rna virus shares several similarities sarscov merscov genetic sequencing clinical presentation equipped robust capacity humantohuman transmission <NUMBER> <NUMBER> outset capacity <NUMBER>ncov spread infect people wuhan china alarming infection rippled throughout rest world causing severe morbidity mortality <NUMBER> therefore pressing need identify risk factors poor prognosis among patients covid<NUMBER> patients cardiovascular comorbidities found vulnerable coronavirus infection may poor prognoses <NUMBER> previous metaanalyses systematically tested relationship cvd severity disease nonuniform definitions clinical outcome <NUMBER> <NUMBER> metaanalysis zuin et al <NUMBER> included three studies reported positive association hypertension mortality risk patients covid<NUMBER> study reinforced conclusion found patients cvd history also almost fivefold higher risk mortality comparing noncvd patients however since results obtained using unadjusted ors exact role cvd risk stratification patients already known subject ► previous studies showed covid<NUMBER> patients preexisting cardiovascular disease cvd likely admitted intensive care unit inhospital cardiac injury commonly seen critically ill patients however relationship cvd cardiac injury fatal outcomes fully elucidated might study add ► systematic review metaanalysis found inhospital morality risk significantly higher covid<NUMBER> patients underlying cvd hypertension patients acute cardiac injury worse prognosis might impact clinical practice ► among patients covid<NUMBER> established cardiovascular comorbidities acute myocardial injury recognised earlier aggressive treatment may warranted elevated troponin may considered important predictor mortality risk covid<NUMBER> still undetermined may several mechanisms account high mortality risk covid<NUMBER> patients cvd history first patients underlying cvd likely decline unstable haemodynamic status infected <NUMBER>ncov <NUMBER> severe pneumonia places considerable workload cardiac ventricles may exacerbate preexisting left ventricular dysfunction even causing cardiogenic shock <NUMBER> second inflammatory reactions caused <NUMBER>ncov infection might convert chronic coronary artery disease acute coronary syndrome <NUMBER> <NUMBER> profound systemic inflammation wave along local inflammatory infiltration may lead hypercoagulative state atherosclerotic plaque rupture may culminate thrombotic events <NUMBER> third priority treatments favour limiting nosocomial viral transmission neglecting medical issues might predispose cvd patients unfavourable clinical outcomes current interim guidelines suggest patients stsegment elevation myocardial infarction consider thrombolysis first covid<NUMBER> era <NUMBER> severe adverse effects cerebral haemorrhage insufficient undesignated coronary revascularisation caused thrombolysis increase risk death acute cardiac injury commonly recorded patients covid<NUMBER> <NUMBER> incidence cardiac injury among enrolled studies ranged <NUMBER> <NUMBER> higher prevalence cvd <NUMBER> suggested <NUMBER>ncov might attack cardiomyocytes different pathways exacerbating already compromised cardiovascular system <NUMBER>ncov infection may lead cardiac injury secondary conditions causing oxygen supplement insufficiency severe pneumonia anaemia hypotension bradycardia furthermore attacking myocardium via highly expressed ace<NUMBER> directly <NUMBER>ncov precipitated release cytokine chemokine waves caused myocardial inflammation even leading fulminant myocarditis severe cases <NUMBER> <NUMBER> meanwhile results complied guo et al <NUMBER> reported death risk cardiac injury much higher preexisting cvd study revealed patients copresence cvd cardiac injury registered highest mortality rate <NUMBER> underlying cvd relatively favourable prognosis mortality rate <NUMBER> furthermore elevated troponin reported associated high risk acute respiratory distress syndrome hepatic dysfunction acute renal injury patients covid<NUMBER> <NUMBER> <NUMBER> study shi et al <NUMBER> demonstrated elevated troponin independent risk factor death adjusting confounders <NUMBER> thus index may considered biomarker predict mortality risk patients covid<NUMBER> studies warranted confirm finding provide probable suggestions risk stratification patients covid<NUMBER> best knowledge study first systematic review metaanalysis investigate association underlying cvd acute cardiac injury mortality risk patients covid<NUMBER> metaanalysis may provide insights prognosis stratification patients covid<NUMBER> however important limitations mentioned first metaanalysis conducted unadjusted ors due limited data multivariableadjusted outcomes observed association cvd cardiac injury mortality might confounded risk factors advanced age cofounder adjustment may distort metaanalysis results towards less significant risk thus large cohort studies multivariate analysis needed provide evidence issue second study could determine causal effects cardiovascular comorbidities mortality due inherent limitations observational studies future studies aiming investigate causal association warranted third heterogeneity among studies cardiac injury significantly high may caused study design patient inclusion criteria however metaregression exploring potential sources find significant results results remained consistent sensitivity analyses finally studies enrolled conducted wuhan china therefore results treated caution extrapolated populations since wuhan initial epicentre outbreak early evidence may provide clinical implications insights researchers clinicians parts world covid<NUMBER> patients underlying cardiovascular comorbidities including cvd hypertension may face greater risk fatal outcomes acute cardiac injury may act marker inhospital mortality risk given unadjusted results metaanalysis future welldesigned studies multivariate analysis warranted confirm findings coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged december <NUMBER> rapidly spread worldwide <NUMBER> globally onslaught covid<NUMBER> outbreak public health system continues despite unprecedented mobilization mortality critical ill patients covid<NUMBER> reported variously low <NUMBER> high <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> bhatraju et al <NUMBER> reported ratio patients covid<NUMBER> <NUMBER> years age died greater patients less <NUMBER> years age <NUMBER> patients study saurabh aggarwal et al reported three patients aged <NUMBER> years older died <NUMBER> critically ill covid<NUMBER> patients early medical intervention reduce mortality depended early effective assessment <NUMBER>the application scoring systems facilitate effective evaluation emergency critical care physicians screen severe patients present however specific scoring systems evaluation covid<NUMBER> patients another option adopt existing scoring systems used predicting mortality severe patients scoring systems sequential organ failure assessment sofa recent quick sequential organ failure assessment qsofa help emergency critical care physicians prognosis predicting mortality sofa scoring system developed <NUMBER> international group experts <NUMBER> sofa describes condition multiple organ dysfunction several parameters including oxygenation index arterial oxygen tension pao <NUMBER> fraction inspiration oxygen fio <NUMBER> mean arterial pressure glasgow coma scalegcs creatinine urine j u r n l p r e p r f several studies revealed sofa score could predict morbidity mortality specific application validated severely ill patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore interest determine whether sofa score could predict mortality covid<NUMBER> population qsofa score introduced third international consensus definitions sepsis septic shock sepsis<NUMBER> composed three clinical parameters systolic blood pressure≤<NUMBER> mmhg respiratory rate≥<NUMBER> breathsminute altered mental status qsofa score created initially evaluation septic patients several recent studies described effectiveness predicting mortality patients different diseases <NUMBER> <NUMBER> sofa qsofa widespread application screen patients lifethreatening conditions emergency critical care department <NUMBER> several studies <NUMBER> <NUMBER> <NUMBER> suggested sofa qsofa highperformance assessments evaluate risk mortality critically ill patients scoring systems assist emergency critical care physicians predict mortality patients especially resourceconstrained scenarios covid<NUMBER> epidemic scenario shortage medical resources however knowledge study validated performance sofa qsofa severelycritically ill covid<NUMBER> patientsthis study conducted aim evaluate prognostic value sofa qsofa models regard inhospital mortality covid<NUMBER> patients j u r n l p r e p r f managed emergency medical team deployed wuhan team independently managed covid<NUMBER> ward local hospital temporarily constructed covid<NUMBER> patients comprised <NUMBER> beds diagnosis treatment plan novel coronavirus <NUMBER> issued national health commission china adopted criterion diagnosis classification treatment covid patients covid<NUMBER> ward searched adult patients age <NUMBER> years diagnosed severecritical covid<NUMBER> admitted ward january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> computerized registration system ward criterion severecritical covid<NUMBER> followed diagnosis treatment plan novel coronavirus download httpwwwnhcgovcn table <NUMBER> <NUMBER> identified <NUMBER> records eligible study inclusion cases divided subgroup young age <NUMBER> years senior age ≥<NUMBER>years analysis study conducted approval local institutional review board undertaken accordance principles declaration helsinki research human participants insert table <NUMBER> receiver operating characteristic roc curve analysis applied discriminatory evaluation performance sofa qsofa scores classification performance scoring systems discriminate survivors nonsurvivor evaluated calculating area curve auc roc <NUMBER> confidence intervals <NUMBER>ci conducted delong test <NUMBER> comparison aucs sofa qsofa rapid scoring system score largest youden index defined optimal cutoff value predicting covid<NUMBER> mortality based optimal cutoff value calculated sensitivity specificity positive predictive value ppv negative predictive value npv scoring systems pvalue<NUMBER> accepted statistically significant data entered ibm statistical product service solutions spss version <NUMBER> j u r n l p r e p r f windows analyzed medcalc ® <NUMBER> initially included <NUMBER> severely critically ill patients admitted covid<NUMBER> ward however final analysis dataset included <NUMBER> patients excluding <NUMBER> patients missing data figure <NUMBER> total mean age patients study population <NUMBER> sd ±<NUMBER> years <NUMBER> patients <NUMBER>were male baseline characteristics comorbidities including diabetes hypertension cardiovascular disease chronic pulmonary disease cerebral vascular disease malignant tumor survivors nonsurvivors study sample listed table <NUMBER> insert table <NUMBER> insert figure<NUMBER> among <NUMBER> cases initially identified excluded <NUMBER> cases missing data final analysis dataset included <NUMBER> cases variables showed significant differences survivors nonsurvivors included age respiratory rate systolic blood pressure mean arterial pressure peripheral oxygen saturation roc curves sofa qsofa scoring systems predicting inhospital mortality depicted part figure <NUMBER> aucs were<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively significant difference two scoring systemsp<NUMBER> based largest youden index optimum cutoff value <NUMBER> used predict inhospital mortality using sofa score sensitivity specificity ppv npv <NUMBER> <NUMBER> j u r n l p r e p r f <NUMBER> <NUMBER> respectively similarly optimum cutoff value <NUMBER> used predict inhospital mortality using qsofa score sensitivity specificity ppv npv <NUMBER> <NUMBER> <NUMBER> <NUMBER>respectively table <NUMBER> sensitivity specificity sofa considerably higher qsofa therefore sofa score better predict mortality critically ill covid<NUMBER>patients qsofa score insert table <NUMBER> table <NUMBER> sensitivities specificities accuracy rates sofa qsofa predicting verify importance sofa predictor covid<NUMBER> conduct univariable multivariable logistic regression analysis univariable logistic analysis age sofa qsofa predictors covid<NUMBER>p<NUMBER> multivariable logistic regression analysis age sofa predictors covid<NUMBER> table <NUMBER> insert table <NUMBER> table <NUMBER> univariate multivariate logistic analysis inpatient death covid<NUMBER> roc sofa qsofa scores subgroups predicting inhospital mortality depicted however sofa complex timeconsuming needs six parameters four laboratory results superiorities qsofa simple rapid practical studies suggests qsofa low sensitive inhospital mortality hospitalized patients suspected infection <NUMBER> absence specific riskscoring system covid<NUMBER> studied performance sofa qsofain evaluation severely critically ill patients order identify effective riskscoring system covid<NUMBER> patients knowledge first research evaluate performance sofa qsofa predicting mortality risk severely ill covid<NUMBER> patients retrospective study investigated performance sofa qsofa scores predictors prognosis severely critically ill covid<NUMBER> patients initially determined sofa score ≥<NUMBER> qsofa score ≥<NUMBER> associated mortality severely ill covid<NUMBER> patients furthermore study showed sofa score highly sensitive marker inhospital mortality covid<NUMBER> patients prognostically superior qsofa setting analysis sofa illustrated acceptable predictive performance inhospital mortality roc curve analysis overall subgroup analysis time admission sofa score ≤<NUMBER> highly predictive spontaneous survival covid<NUMBER> patients high npv overall analysis of<NUMBER> sofa functions gate keeper accurately identifying lowrisk patients greater predictive advantage sofa attributable higher number clinical parameters inclusion six important variables scoring system facilitated accurate patient stratification univariate analysis found five mean arterial pressure <NUMBER> severely ill patients lower platelet count metaanalysis conducted lippi colleagues <NUMBER> low platelet counts associated increased risk mortality patients covid<NUMBER> zhang et al <NUMBER> reported higher bilirubin level lower oxygenation index observed severely critically ill covid<NUMBER> patients furthermore higher serum creatinine levels admission predictive factor disease severity patients pathogenic mechanisms underlying changes abovementioned clinical indicators covid<NUMBER> patients need studied although indicators perceived least predictive factors mortality risk critically ill patients <NUMBER> aucs qsofa overall subgroup analysis lower sofa therefore considered accuracy sofa higher prerequisite parameters sofa determined medical assessment laboratory examination nevertheless need recognize qsofa simple fast acceptable accuracy used emergency room admission parameters sofa cannot acquired time novel study explored effectiveness sofa qsofa scoring systems predicting mortality risk severely critically ill covid<NUMBER> patients ascertained practical value identifying severely critically ill covid<NUMBER> patients higher mortality risk however limitations study need considered study limited small sample size studies larger number severely critically ill covid<NUMBER> patients fulfill inclusion criteria would enable amore effective evaluation sofa qsofa scoring systems singlecenter study may affected selection bias regard study population multicenter studies required prospectively validate clinical utility sofa qsofa scores severely critically ill covid<NUMBER> patients moreover prognostic value scoring j u r n l p r e p r f systems among patient subgroups stratified gender groups underlying diseases analyzed owing limited sample size furthermore limited availability information details outofhospital therapy nursing care captured finally several riskscoring tools acute physiology chronic health evaluation scoring systems find widespread application critical care unit emergency departments however retrospective study based medical records information could collected could permit calculation sofa qsofa scores future studies needed comparatively explore performance scoring systems covid<NUMBER> patient population sofa scoring systems admission high classification performance predicting mortality risk severely critically ill covid<NUMBER> patients acceptable npv screening patients performance predicting patients qsofa accepted inferior sofa journal preproof transmission sarscov<NUMBER> occurs primarily via respiratory route whereby droplets containing virus travel infected individual coughs sneezes unclear whether virus also transmitted via aerosol route via smaller particles requiring droplet transmission <NUMBER> <NUMBER> early research found infected individuals suffer minor symptoms <NUMBER> <NUMBER> <NUMBER> conversely older individuals particularly coexisting morbidities eg hypertension diabetes asthma andor obesity likely experience severe symptoms die <NUMBER> <NUMBER> <NUMBER> data albeit largely anecdotal indicate death toll infection disproportionately greater among minorities among residents live inner cities andor rural communities <NUMBER> greater vulnerability groups believed due combination poverty higher prevalence comorbid diseases poor accessibility health care <NUMBER> terms differences urban rural areas exposure covid<NUMBER> although high population density large cities metropolitan areas major risk factor contracting virus rural areas may uniquely vulnerable due older age structure many rural communities higher prevalence chronic illnesses eg diabetes hypertension relative lack health care facilities services <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> since outbreak sarscov<NUMBER> united states geographic information systems gis used quickly map distribution diffusion pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> however knowledge little published analysis geographic disparities infections deaths among urban suburban rural communities <NUMBER> <NUMBER> additionally empirical data explore risk factors associated sarscov<NUMBER> infections fatalities needed order inform policies including preparation response mitigation recovery strategies <NUMBER> <NUMBER> <NUMBER> ecological analysis investigates spatial patterns covid<NUMBER> relative socioeconomic contexts different types communities across united states using data us counties metropolitan areas data confirmed cases deaths covid<NUMBER> compiled released center systems science engineering csse johns hopkins university compiled data collated us centers disease control prevention cdc individual states local health agencies used countylevel data <NUMBER> us counties least one case infection may <NUMBER> <NUMBER> data new york city includes <NUMBER> boroughs counties manhattan bronx kings queens richmond provided single unit original data set numbers cases deaths kansas city missouri jackson county home kansas city reported separately original data consolidated one county excluded cases assigned state level affiliated specific county calculated incidence rates death rates per <NUMBER> county metropolitan area using <NUMBER> population data us census bureau order examine spatial disparities metropolitan nonmetropolitan counties used urbanrural continuum locale codes us department agriculture usda <NUMBER> <NUMBER> <NUMBER> briefly usda codes based size countys urban population location relative metropolitan areas different sizes counties located inside metropolitan statistical areas msas divided <NUMBER> subcategories counties largest msas <NUMBER> million population assigned locality <NUMBER> counties populations <NUMBER> <NUMBER> million locality <NUMBER> populations smaller <NUMBER> locality <NUMBER> counties located outside metropolitan area assigned subcategory ranging <NUMBER> <NUMBER> depending size urban population whether adjacent metro area among <NUMBER> counties nearly <NUMBER> counties united states reported data covid<NUMBER> infections deaths <NUMBER> large msas <NUMBER> mediumsized msas <NUMBER> small msas <NUMBER> nonmetropolitan rural counties additionally census bureau classifies metropolitan counties <NUMBER> subcategories central urban counties outlying suburban counties subcategories help differentiate urban suburban communities within metropolitan areas investigate spatial variations covid<NUMBER> cases deaths performed multiple regression analyses using subset original data<NUMBER> counties <NUMBER> casesas recommended cdc order mitigate analytical problems caused counties small number cases preserve anonymity cases <NUMBER> confirmed cases deaths county used dependent variables respectively used data countylevel social vulnerability indices <NUMBER> created cdc independent variables indices included percent population aged <NUMBER> percent population poverty percent minority percent uninsured population density considered primary predictor since densely populated communities make easier infections spread indeed rationale public health intervention social distancing <NUMBER> older individuals higher prevalence preexisting chronic illnesses vulnerable symptomatic infections included percent population aged <NUMBER> <NUMBER> light welldocumented health disparities rich poor whites minorities eg blacks hispanics native americans hypothesized poverty level percentage minority population would positively correlated disease burden <NUMBER> <NUMBER> <NUMBER> <NUMBER> however assessment number infections deaths covid<NUMBER> largely dependent availability testing <NUMBER> therefore included percent population tested state level testing data available county level additionally conducted sensitivity analyses using smaller sample comprised <NUMBER> rural counties including population density independent variable regression analysis explore whether population density helpful predictor rural areas sparsely populated united states expected population density would less effective predicting variations coronavirus infections deaths across rural communities excluded <NUMBER> cases less <NUMBER> total affiliated specific county covid<NUMBER> pandemic affected <NUMBER> <NUMBER> us counties <NUMBER> states washington dc among large cities associated metropolitan areas affected new york city nations largest city <NUMBER> population <NUMBER> million <NUMBER> boroughs recorded <NUMBER> confirmed cases representing <NUMBER> nations total infections new york metropolitan area comprises <NUMBER> counties span new york new jersey pennsylvania <NUMBER> population <NUMBER> million accounts nearly <NUMBER> <NUMBER> confirmed cases nations infections table <NUMBER> new york metro metropolitan areas including chicago boston philadelphia detroit los angeles washington dc miami new orleans atlanta among top <NUMBER> terms number confirmed incident cases top <NUMBER> metropolitan areas represent nearly <NUMBER> confirmed cases covid<NUMBER> united states large metropolitan areas also highest number coronavirus fatalities table <NUMBER> <NUMBER> deaths new york msa accounts nearly <NUMBER> total deaths nationwide followed msas including detroit boston chicago philadelphia los angeles washington dc new orleans noteworthy detroit new orleans become second eighth largest hotspots despite population rankings considerably lower <NUMBER>th <NUMBER>th largest msas los angeles chicago second third largest metropolitan areas contrary ranked lower terms infections deaths corresponding populations would suggest <NUMBER> confirmed cases <NUMBER> <NUMBER> may <NUMBER> <NUMBER> deaths <NUMBER> <NUMBER> recorded <NUMBER> metropolitan counties usda locale codes <NUMBER> table <NUMBER> words <NUMBER> <NUMBER> infections <NUMBER> <NUMBER> deaths recorded <NUMBER> nonmetropolitan rural counties usda locale codes <NUMBER> metropolitan counties especially located large msas populations <NUMBER> million highest rates infection death rates rural nonmetropolitan counties general lowest rates infection mortality especially nonmetro counties populations less <NUMBER> adjacent msa ie locales <NUMBER> <NUMBER> figure <NUMBER> however noteworthy counties completely rural andor adjacent msas urban populations less <NUMBER> ie locale <NUMBER> average infection rate nearly high small msa counties ie locale <NUMBER> likewise nonmetro counties urban population <NUMBER> <NUMBER> total <NUMBER> less <NUMBER> confirmed cases <NUMBER> less <NUMBER> deaths original data excluded assigned state level affiliated specific county <NUMBER> adjacent msas ie locale <NUMBER> average mortality rate large medium msa counties within metropolitan areas central urban counties much higher incidence mortality rates outlying suburban counties figure <NUMBER> summary urban counties highest levels rural counties lowest levels suburban counties intermediate levels incident fatal covid<NUMBER> cases mapping incidence mortality rates granular scale example individual counties building blocks metropolitan areas allows us visualize detailed patterns covid<NUMBER> figures <NUMBER> <NUMBER> noted surprising highest infection rates large cities associated metropolitan areas especially northeast corridor stretches boston washington dc midwest ie detroit chicago new orleans addition large metropolitan areas small metropolitan areas rural counties far away major cities including southwest georgia northeast arizona northwest new mexico spans large portion navajo nation westcentral colorado southcentral idaho show surprisingly high rates confirmed cases inspection top <NUMBER> counties highest infection rates shows <NUMBER> counties small msas <NUMBER> counties rural nonmetro see table <NUMBER> lincoln county arkansas outlying county population <NUMBER> <NUMBER> small pine bluff msa highest infection rate ie <NUMBER> per <NUMBER> population nearly <NUMBER> times larger new york city ranked <NUMBER> incidence rate <NUMBER> per <NUMBER> population thus several small metro areas rural areas notable exceptions generalization covid<NUMBER> cases limited large metropolitan areas examination covid<NUMBER> mortality rates underscores observation small metropolitan areas nonmetropolitan counties disproportionately affected table <NUMBER> county highest mortality rate <NUMBER> deaths per <NUMBER> randolph ga population <NUMBER> rural county near alabama border table <NUMBER> results regression models covid<NUMBER> incident cases presented table <NUMBER> expected variables population density percent population aged <NUMBER> percent population tested covid<NUMBER> showed statistically significant positive correlations confirmed cases covid<NUMBER> population density strongest predictor variations infections among counties explains <NUMBER> variations infections impact testing rates understandable substantiates epidemiologists call expanding testing control spread coronavirus poverty percent minority population significant showed negative correlations incidence rates one possible explanation reflects likelihood poverty minority populations factors lead individuals untested percent uninsured population showed positive sign statistically significant could also affected shortages testing overall regression model explained nearly half variation incidence rates <NUMBER> covid<NUMBER> across <NUMBER> counties multicollinearity significant factor among independent variables included model variance inflation factor vif values independent variable low <NUMBER> data shown results sensitivity analysis found rural counties used population density became insignificant b <NUMBER> std error <NUMBER> infections model explained less <NUMBER> variations infections adjusted r square <NUMBER> finding indicates population density less likely risk factor rural counties rural areas general much lower population densities comparison metropolitan counterparts results regression model using covid<NUMBER> deaths dependent variable similar observed model confirmed cases population density remained strongest predictor covid<NUMBER> mortality rates variables percent older population poverty showed expected significant positive associations covid<NUMBER> deaths consistent hypothesis elderly poor greater risks covid<NUMBER> deaths percent minority population significant negative one possible explanation data coronavirus deaths disaggregated race ethnicity whites majority death tolls counties percent uninsured population positive significant could result underestimates undercounting covid<NUMBER> induced fatalities especially disadvantaged communities ie inner cities remote rural communities regression model explains <NUMBER> variations covid<NUMBER> across <NUMBER> counties results sensitivity analysis using rural counties regressing mortality population density alone similar findings infections article analyzes countrywide data ongoing covid<NUMBER> pandemic focus spatial disparities among metropolitan nonmetropolitan communities covid<NUMBER> epidemic areas us continues mount findings must considered interim appraisal definitive conclusions reached epidemic abated relevant data presently available included however several notable trends apparent large densely populated cities surrounding metropolitan areas hotspots covid<NUMBER> pandemic terms incidence mortality general larger metropolitan areas including urban suburban areas higher incidence mortality rates smaller nonmetropolitan areas however may <NUMBER> nonmetropolitan areas span <NUMBER> counties united states amassed nearly <NUMBER> <NUMBER> confirmed cases <NUMBER> <NUMBER> deaths covid<NUMBER> striking infection rates small metropolitan areas eg albany ga pine bluff ar grand island ne numerous rural counties eg bledsoe tn nobles mn marion oh ranked high nationally likewise mortality rates small metropolitan areas eg albany ga grant island ne houmathibodaux la farmington nm nonmetropolitan counties eg randolph early mitchell counties southwest georgia toole county montana actually exceed larger cities complete explanation paradox apparent likely involves chance local factors become important smaller communities example high rates albany georgia traced presence infected individual <NUMBER> funerals highly attended <NUMBER> introduction infected individual thus disproportionate effect disease rates population relatively small densely aggregated additionally likely limited health care facilities small cities rural communities critical bottleneck access services many rural areas tend higher poverty rates much older populations higher prevalence comorbidities populations may vulnerable symptomatic serious courses disease populations <NUMBER> regression analyses support hypotheses correlations covid<NUMBER> infections deaths selected socioeconomic contextual factors including population density proportions elderly residents poverty testing state level reasonable suggest densely populated areas communities aging povertystricken lack testing risk covid<NUMBER> moreover results sensitivity analyses corroborate population density effective predictor covid<NUMBER> infections mortality metropolitan areas rural areas unexpected results socioeconomic risk factors including proportion minority uninsured population largely due use disaggregated data undertesting underreporting despite weakness findings corroborate anecdotal observations empirical research highlight vulnerability disadvantaged communities <NUMBER> <NUMBER> findings geographic heterogeneity sociodemographic correlates covid<NUMBER> outbreak inform policy government efforts address uneven distribution covid<NUMBER> cases across demographic groups geographic areas <NUMBER> given fact implementations nationwide lockdown social distancing practices pandemic may showing signs receding large metropolitan areas predicted continue diffuse cities small places rural communities findings support provision additional testing facilities services including mobile health clinics telehealth services help rural communities underserved undertested pandemic <NUMBER> <NUMBER> <NUMBER> important note data subject several methodological limitations including ecologic nature analysis biases related underand sometimes ascertainment cases first primary data spatial study counties individuals thus cannot validly conclude example counties high prevalence population aged <NUMBER> higher mortality rates individuals <NUMBER> older furthermore due unavailability disaggregated data findings based analysis total counts infections deaths county prohibiting us identifying disparities demographic groups eg gender age raceethnicity within population <NUMBER> would obviously valuable conduct indepth analysis using individuallevel data examine racialethnic disparities infection mortality rates data racialethnic breakdowns released health agencies later stages focus early analysis identify regions geographic disparities order probe underlying causes behind thus ecologic approach valid appropriate first step process ascertainment bias another important potential limitation incidence rate obviously depends frequency testing shortages testing equipment remain critical problem disease control epidemiological analysis therefore low prevalence rates many areas especially sparsely populated rural counties likely artifacts lower rates testing validated positive association infections testing rate state level regression analysis <NUMBER> thus underascertainment disproportionately reflect poorer rural counties whose true prevalence rates likely higher recorded conversely data also susceptible inflation mortality rates occur individuals ill etiologically unrelated diseases succumb diseases infected large metropolitan areas new york city thousands individuals may die day due noncoronavirus causes lung cancer cardiovascular disease etc many individuals coronavirus infection doubtlessly exacerbated preexisting illness way causally contributed deaths however deaths underlying causes presence positive covid<NUMBER> serological test likely recorded coronavirus death even contribution virus death modest deaths nonpandemic circumstances would attributable noncoronavirus causes likely counted deaths due coronavirus actual autopsy rate present health crisis expected exceptionally low type ascertainment bias likely would complex different effects rural metropolitan areas example rural areas lower rate testing would fail identify decedents coronavirus cases likely would lead underestimate effect virus mortality summary analysis found covid<NUMBER> infections deaths surprisingly highly concentrated large cities surrounding metropolitan areas however equivalently high rates found small cities nonmetropolitan rural communities communities high proportions elder populations high poverty rates high population density found high risk covid<NUMBER> moreover magnitude infections deaths positively associated testing rates state level supports expanding testing capacities undertested areas especially rural communities stem spread virus findings subject ascertainment biases considered provisional guides geography underlying risk factors pandemic united states december <NUMBER> new coronavirus known sarscov<NUMBER> emerged wuhan china highly infectious virus leads coronavirus disease <NUMBER> covid<NUMBER> given rise global pandemic april <NUMBER> <NUMBER> <NUMBER>m confirmed cases <NUMBER> deaths due disease <NUMBER> covid<NUMBER> pandemic unlike anything experienced lives patterns catastrophic disease familiar engaged aging research epidemiological analysis cases fatalities identified numerous risk factors mortality complications arising covid<NUMBER> specifically risk serious complications mortality increases dramatically later ages <NUMBER> <NUMBER> <NUMBER> higher males females ages <NUMBER> <NUMBER> recent editorial journal noted covid<NUMBER> could considered disease older people <NUMBER> effect age risk death due covid<NUMBER> increases exponentially age case fatality rates risk dying among diagnosed covid<NUMBER> order <NUMBER> <NUMBER> <NUMBER> children high <NUMBER> older individuals china <NUMBER> even higher older italians <NUMBER> americans <NUMBER> striking increaseover <NUMBER>foldin risk lifespan fact men likely women die covid<NUMBER> caught attention public fully understand implications patterns increased risk age men versus women need place context age sex affect risk chronic diseases long known risk dying increases exponentially course adult life also exponential increase holds individual causes death c c e p e n u c r p <NUMBER> also observe male bias total mortality rates <NUMBER> death due specific diseases <NUMBER> note consider age sex epidemiological risk factors covid<NUMBER> context agespecific diseases suggest insights might gain comparison data covid<NUMBER> cases deaths obtained outbreaks china <NUMBER> italy <NUMBER> new york city <NUMBER> data italy provided estimates case fatality rates cfr chinese data included corrections several biases provide accurate estimate infection fatality ratio ifr new york city <NUMBER> provides measures terms deaths per <NUMBER> population measures risk dying covid<NUMBER> anyone particular age class regardless infection status age classes italy china calculated <NUMBER>year intervals plots sources age shown youngest age interval new york city fewer larger age classes data death rates plotted function mean age within age class eg age <NUMBER> years age shown <NUMBER> yrs n u c r p information ageand sexspecific death rates per <NUMBER> population specified group united states obtained cdcs <NUMBER> national vital statistics report <NUMBER> death rates typically averaged across <NUMBER>year intervals plots age shown youngest age interval data analysis carried using r statistical package mortality rate doubling time mrdt calculated time years δx would take mortality rate age x µx double µxδx <NUMBER>µx adult mortality rates increase exponentially age following gompertz trajectory µx αe βx semilog plot log<NUMBER>mortality versus age intercept given logα slope equal β calculate mrdt δx log<NUMBER>β <NUMBER> confidence intervals mrdt provided direct derivations confidence intervals β determined using confint function r calculate β used lm function r fit leastsquares regression lines plots log<NUMBER>mortality versus age range midadult life ages <NUMBER> years time see consistently linear patterns logtransformed mortality versus age fitted lines shown drawn range ages used regression model covid<NUMBER> fatality rates whether calculated percase basis cfr italy ifr china terms deaths per <NUMBER> population new york city exhibit clear c c e p e n u c r p pattern exponential increase age figure <NUMBER> males females also observe malebiased mortality ages pattern clearly seen cfr plotted semilog scale figure <NUMBER>b pattern agerelated severity outcomes covid<NUMBER> mirrored overall mortality rate function age previous studies shown cdc vital rate data <NUMBER> show exponential increase age allcause causespecific mortality figure <NUMBER> range ages calculate slopes log<NUMBER>cfr versus age see consistently strong linear relationship r <NUMBER> ≥ <NUMBER> figure <NUMBER>b<NUMBER>d allcause mortality mortality rates us appear double approximately every <NUMBER> years figure <NUMBER> subset agerelated causes mortality shown figure <NUMBER> see mrdts years range <NUMBER> copd <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> diabetes <NUMBER> ci <NUMBER> <NUMBER> covid<NUMBER> cfr mrdts found <NUMBER> italian females <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> italian males <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> china <NUMBER> ci <NUMBER> <NUMBER> new york data calculated death rate per <NUMBER> exhibits shallower slope leading doubling time <NUMBER> years major causes mortality males tend higher risk dying ages figure <NUMBER> pattern seen risk death covid<NUMBER> scale difference sexes consistent seen common causes mortality axis figures <NUMBER>a <NUMBER>b shows logtransformed mortality tick marks separating <NUMBER>fold differences thus although figure <NUMBER>a shows deaths per <NUMBER> individuals figure <NUMBER>b shows cfr equal c c e p e n u c r p distance males females given age would suggest equally increased risk males data italy show clear male bias cfr ages <NUMBER> cfr <NUMBER> <NUMBER> times greater males females although bias seen ages appears reduction relative risk males later ages degree male bias appears comparable see heart disease greater seen death due diabetes combined influenza pneumonia figure <NUMBER>a scientists <NUMBER> <NUMBER> <NUMBER> popular press made much fact age greatest risk factor covid<NUMBER> dynamics agespecific mortality including exponential increase age similar doubling times well sexbias mortality seen covid<NUMBER> mirror major causes mortality possible explanation agerelated increase risk mortality could agerelated decline immune inflammatory responses lead turn cytokine storm <NUMBER> likely contributing factor given general age leads decline adaptive immune function increase proinflammatory activity <NUMBER> however unlikely complete story least two reasons first virtually physiological systems cellular processes decline age limited immune inflammatory pathways <NUMBER> second diversity preexisting conditions appear increase risk covid<NUMBER> including hypertension coronary heart disease diabetes <NUMBER> high body mass index <NUMBER> people age average number comorbid conditions steadily increases greater number comorbid conditions lower life expectancy <NUMBER> c c e p e n u c r p geroscience concept holds treatments target underlying molecular pathways aging biology shape physiological decline could turn decrease risk many different agerelated diseases improve outcomes succumb disease <NUMBER> <NUMBER> light coronavirus pandemic researchers also suggested putative geroprotective treatments rapamycin senolytics might used treat prevent covid<NUMBER> <NUMBER> <NUMBER> example would great interest understand role widelyknown agingrelated molecular pathwaysmtor signaling iis signaling cell senescencein response coronavirus infection recovery covid<NUMBER> geroscience seen major strategic advances discovery treatments increase healthspan laboratory organisms <NUMBER> evidence efficacy longevityderived interventions treating acute symptoms agerelated disease least lab <NUMBER> <NUMBER> doubt interaction aging biology covid<NUMBER> mortality seems likely better understanding relationship would inform biology viral susceptibility progression lifethreatening outcomes also aging creates pernicious environment augments negative consequence viral load specific causes mortality mrdt <NUMBER> confidence intervals causes <NUMBER> <NUMBER> heart disease <NUMBER> malignant neoplasms <NUMBER> <NUMBER> copd <NUMBER> <NUMBER> diabetes <NUMBER> <NUMBER> kidney disease <NUMBER> <NUMBER> one also tge<NUMBER> denominations referred clinical similarity tge common cause viral diarrhea pigs europe time important difference tge however neonatal pigs affected since denominations considered unsatisfactory scientific point view name new syndrome quickly changed epidemic diarrheaed first ed outbreak occurred farm spring <NUMBER> second <NUMBER> months later distance <NUMBER> miles httpdxdoiorg<NUMBER>jvirusres<NUMBER> <NUMBER>© <NUMBER> elsevier bv rights reserved former suckling piglets affected pigs <NUMBER> weeks older also adults showed acute diarrhea lasting one week outbreak lasted <NUMBER> weeks farm autumn <NUMBER> also following winter several new outbreaks reported clinical diagnosis possibility differentiation tge thus based high morbidity fatteners adult animals absence disease neonatal freshly weaned pigs diarrheal cases tgev excluded laboratory examination fact ed observed farms recent history tge outbreak thus tgev immune animals increased conviction tgev involved <NUMBER> ed spread rapidly pig farms particulary fattening herds mortality rare effect outbreak estimated <NUMBER> weeks feed cost similar disease pattern observed early seventies belgium rapid spread occurred neighbouring countries western europe also suckling pigs affected remained free diarrhea even mothers suffered watery diarrhea several days neonatal pig mortality could occur starvation sick mothers often suffered agalactia additional sign observed belgium later also reported gemany mentioned england fatteners found dead particularly towards end fattening period occurred repeatedly farms others mortality rate high <NUMBER> could encountered due dehydration accompanying diarrhea animals suddenly died acute back muscle necrosis clinical link ed infection clear pathogenetic background never revealed belgian pigs highly stress positive time severe belly ache often observed adult animals outbreak ed may trigger general baby pig mortality occurred due ed agent much attention given new diarrheal syndrome etiology intensively investigated however assumed viral agent involved since bacteriological examination faecal material reveal specific bacterial cause none known porcine viruses could associated new virus therefore suspected much changed <NUMBER> wood <NUMBER> veterinary investigation centre norwich england described new diarrheic syndrome differed ed affected pigs ages including neonatal suckling pigs mortality variable restricted young piglets averaged around <NUMBER> new disease resembled tge closely ed tgev excluded using direct immunofluorescence intestines applying established serological techniques available detection antitgev antibodies differentiation tge clinical basis became difficult often impossible new syndrome called ed<NUMBER> differentiate <NUMBER> ed<NUMBER> baby pigs involved ed<NUMBER> economically much important ed<NUMBER> ed<NUMBER> also quickly spread european continent recognised belgium <NUMBER> reports countries including netherlands germany france bulgaria hungary switzerland followed soon belgium mortality rates neonates breeding farms varied considerably could high <NUMBER> large variation <NUMBER> <NUMBER> average <NUMBER> variation mortality neonatal pigs litter bound explained time also farm bound appeared associated farm size still many small family farms time farm structure one several farrowing units number neonatal pig litters present start outbreak number pregnant sows due farrow within one week appearance disease signs possibly factors differences virulence virus isolates given attention new evolution ed<NUMBER> involvement baby pigs larger economic impact yielded better opportunities collecting material etiological studies experimental reproduction disease development virological serological techniques <NUMBER> chasey cartwright <NUMBER> reported detection virus like particles pensaert debouck <NUMBER> described isolation new coronaviruslike agent cvla diarrheic pigs research groups succeeding reproducing diarrhea experimental pigs soon isolation new coronavirus extensive pathogenesis studies performed colostrum deprived pigs one belgian isolates designated coronavirus cv<NUMBER> isolated month <NUMBER> <NUMBER> became prototype strain pedv europe debouck pensaert <NUMBER> debouck et al <NUMBER> ed<NUMBER> soon named porcine epidemic diarrhea ped caused ped virus pedv denomination still stands present early studies pedv neonates debouck pensaert <NUMBER> debouck et al <NUMBER> soon clear pathogenesis resembled much tgev experience gathered research tgev helped much approach study new enteric disease lack success cultivate virus cell cultures forced produce clean virus stocks oral inoculation colostrum deprived pigs performing surgery <NUMBER> h later rinsing vivo produced virus lumen infected small intestines <NUMBER> h keeping pig incubator debouck pensaert <NUMBER> clean pig adapted virus stocks served experimental pig inoculation experiments produce hyperimmune serum preparation conjugate immunofluorescence conjugate detect virus tissues serological tests developed detect antibodies elisa study possible relationship coronaviruses immunoelectron microscopy genome analysis ped isolates available time immunoelectron microscopy pedv related known porcine coronaviruses tgev haemagglutinating encephalomyelitis virus discrete relationship members genus alphacoronavirus later demonstrated using sensitive tests origin pedv thus unknown potential parent coronavirus could indicated elisa test soon used routine serology crucial question whether ed<NUMBER> agent ed<NUMBER>pedv related whether ed<NUMBER>pedv totally new infectious material containing ed<NUMBER> agent earlier outbreaks available retrospective serological survey carried sow sera collected slaughterhouses belgium starting <NUMBER> thus prior emergence ed<NUMBER> <NUMBER> european continent antibodies pedv found sera collected <NUMBER> present <NUMBER> sows collected <NUMBER> <NUMBER> sows <NUMBER> <NUMBER> sows <NUMBER> results indicated coronavirus ped responsible first ed<NUMBER> outbreaks ed<NUMBER> outbreaks thus accepted pedv emerged <NUMBER> later widened host tropism growing adult swine towards neonatal pigs finding interesting evolutionary point view thus pedv presumably started cause diarrhea <NUMBER> feeders fatteners adult swine suddenly acquired tropism neonatal pigs became rather devastating disease even emergence ed<NUMBER>pedv outbreaks breedingfinishing farms still involve neonatal pigs assumed ed<NUMBER> pedv cocirculating swine population also possible farms experienced earlier ed<NUMBER> infection immune sows protected offspring pedv lactogenic immunity groups fattening pigs become susceptible must however mentioned crossprotection ed<NUMBER> pedv never studied also first epidemic phase new pedv virus often persisted breedingfinishing farms weaned feeder pigs endemic ped sow population immune protecting offspring feeder pigs became susceptible loosing maternal protection highly variable mixed clinical picture time ascribed possible cocirculation original ed<NUMBER> agent presumed variant pedv population genome analysis available ed<NUMBER> infectious material also longer available retrospectively examine issue ed<NUMBER>pedv likely variant ed<NUMBER> variants pedv relatively easy emerge unusual animal coronaviruses known easily undergo genetic alterations recombination insertions deletions repeatedly demonstrated pedv genome analyses isolates recent outbreaks asia usa fan et al <NUMBER> li et al <NUMBER> jarvis et al <NUMBER> vlasova et al <NUMBER> oka et al <NUMBER> even <NUMBER> recent cases ped europe varying types clinical manifestations either without affection neonatal pigs observed see later question origin pedv thus presumed ancestor ed<NUMBER> agent <NUMBER> unanswered indications possible evolution another known called parental coronavirus even comparative studies known coronaviruses using detailed genome analyses different genes including gene far discrete antigenic relationship involving n protein without cross protection detected animal members genus alphacoronavirus feline infectious peritonitis virus fipv tgev porcine respiratory coronavirus prcv canine coronavirus ccov mink coronavirus mcv use monoclonal antibodies n proteins human alphacoronaviruses nl<NUMBER> <NUMBER>e cross reactivity detected pedv sastre et al <NUMBER> alphacoronavirus also proteins cross reacts pedv mcv et al <NUMBER> nucleotide sequence pedv nucleocapsid gene typical coronavirus motifs show pedv within region genome sequenced shows indeed greatest homology human <NUMBER>e tgev prcv fipv ccov feline enteric coronavirus fecv bridgen et al <NUMBER> interesting mention similar pedv several alphacoronaviruses including human <NUMBER>e tgev prcv ccov fecv fipv use cellular receptor aminopeptidase n apn virus entry cells host weiss navasmartin <NUMBER> seems common evolutionary characteristic still genetic antigenic diversity pedv alphacoronaviruses largealso crossreactivity reported pedv coronaviruses belonging beta gamma delta generathe genomic data presented use cellular receptor suggest common origin alphacoronaviruses carrierwild animal species source virus often described coronaviruses cannot excluded soon detection experimental studies neonatal pigs revealed target cells pedv limited epithelium covering intestinal villi pathogenesis thus highly similar tgev debouck pensaert <NUMBER> debouck et al <NUMBER> cv<NUMBER> virus infection villous enterocytes neonatal pigs caused rapid cell desquamation throughout small intestine within <NUMBER> h inoculation somewhat slower observed tgev still villous atrophy induced pedv abrupt extensive rapid severe dehydration occurred leading death neonatal pigs due similarity pathogenesis tgev much scientific knowledge acquired tge diagnosis −immunity −prevention could almost invariably applied ped apparent difference tgev probably minor importance clinical point view epithelial cells colonic villi also infected desquamation observed still question colonic site replication contributes disease severity ped diarrhea fatteners sows often accompanied apparent belly ache clinical sign seen tge question arises colon infection may contribute clinical manifestation results pathogenesis studies obtained caesarean derived colostrum deprived neonatal pigs upon inoculation european prototype strain cv<NUMBER> seventies practically identical observed recently asia usa epidemics socalled original us pedv strains stevenson et al <NUMBER> kim chae <NUMBER> point debate pedv evolution particularly since occurrence asia emergence usa arising pedv genetic variants influencing virulence history europe presented allows assume ed<NUMBER>pedv variant ed<NUMBER> acquired tropism intestinal enterocytes neonatal pigs new tropism expanded increased virus virulence since vulnerable age became affected piglets mortality became important economic aspect disease currently two major pedv variants described usa upon routine genome analyses usa isolates first also called original us pedv appears highly virulent second called sindel strains standing insertions deletions gene virus associated milder clinical outbreaks similar genotypic variants detected asia sindels already <NUMBER> highly virulent since <NUMBER> adopting genomic identification appears cv<NUMBER> classified sindel isolate apparently belonging different cluster compared us indels carvajal et al <NUMBER> considering pathogenesis virulence european prototype strain cv<NUMBER> seventies evaluated sites degree replication degree villous atrophy real difference exists recent highly virulent original us pedv isolates usa example pig adapted c<NUMBER> experimentally inoculated neonatal piglets caused villous atrophy villous length reduction normal value <NUMBER> low <NUMBER> throughout small intestine within <NUMBER> h start diarrhea coussement et al <NUMBER> much depends virulence pedv determined virulence pedv isolate considered merely point view virusneonatal pig interaction parameters duration incubation period rapidity severity enterocyte desquamation degree extent atrophy villi production virulent virus quantities severity diarrhea cv<NUMBER> classified highly virulent despite identification sindel isolates sindels isolates systematically mean low virulence recently shown us study chunming et al <NUMBER> <NUMBER> litters <NUMBER> days old suckling pigs inoculated sindel iowa <NUMBER> strain presence ped negative mothers severity clinical signs mortality pigs varied <NUMBER> liters <NUMBER> <NUMBER> severe clinical signs observed <NUMBER> <NUMBER> litters two <NUMBER> sows developed diarrhea observed despite similar background sows environment experiment severity disease rather variable appeared pigs body weight birth sows health conditions lactation influential factors experiment mentioned chunming et al <NUMBER> one litter also inoculated original us pedv strain high virulence concluded virulence sindel isolate generally lower based longer incubation period shorter duration diarrhea limited regions virus infection overall lower pig mortality <NUMBER> vs <NUMBER> original additional parameters sites extent deletions insertions seqence differences gene may play important role recent publication chen et al <NUMBER> pathogenicity differences <NUMBER> uspedv prototype strains sindelvariant stain compared conventional neonatal pigs experimental infections enteric disease evidenced clinical signsfecal virus shedding gross histopathological intestinal lesions significantly lower sindel strainhoweverthe molecular basis virulence differences elucidated since early beginning europe clear ped disease show much variability even different litters pigs particularly suckling mother differences high variation pig mortality different litters <NUMBER> <NUMBER> observation also made seventies europe first epidemic occurred reason never unravelled even variability experienced virulence severity ped disease related interaction virusfarm population thus field outbreaks result ped outbreak much difficult predict evaluate define since next possible virulence differences isolates next variation among litters suckling pigs many additional factors play role determining clinical outcome infection include immune status sows dose virus exposure farm herd size pig farming management others may interacting different way moreover procedures applied intentional infection feed back sow population speed induction immunity passively transfered litter could considered potential cause worsening clinical status suckling pigs fact practice also source pathogens giltssows andor newborn piglets thus possible particularly fully susceptible pig population even pedv strains similar virulence mortality rates losses much higher continents regions farms extensive highly industrialised pig farming overall health status population apparently also plays important role genomic changes surely occur ped virus isolates advised careful associating virulence changes different clinical picture observed farms often hastily concluded variants varying virulence arisen based genome analysis without testing virulence factors experimental pigs genome analysis certainly useful may directional repeated comparative animal inoculation experiments called new isolates clinically denominated candidate virulencevariants need carried standardized way solid conclusions virulence made indicated large variations often observed one isolate neonatal non suckling pig preferably colostrum deprived reliable even essential purpose parameters duration incubation period timewise follow site degree villous affection small intestine needed must repeated calling pedv isolate variant impact virulence stressed pig adapted virus strains used known major genomic modifications arise pedv cell culture passaged well porcine nonporcine cells vero cells epidemiology ped europe still quite puzzling pedv outbreaks late seventies early eighties occurred breeding fattening swine farms acute outbreaks neonatal pig mortality encountered breedingfattening farms became infected first time pedv often became endemic farrowingfinishing farms successive groups pigs became infected upon weaning losing lactogenic protection immune mothers virus could persist whether virus persisted original outbreak somewhat unpredictable could also disappear farm farm size number sows structure number units played role also ped persistence regularly occurred fattening farms using system continuous introduction feeder pigs originating numerous different breeders typical case persistent diarrhea caused pedv lasting <NUMBER> months breedingfinishing farm described netherlands pijpers et al<NUMBER> feature regularly observed europe eighties recent experience usa <NUMBER> <NUMBER> <NUMBER> shown management practices adopted epidemic phase infection turn ped endemicenzootic long lasting form jung saif <NUMBER> pedv infections regular cause associated viral diarrheal picture weaned feeder pigs serological study belgium <NUMBER> pedv associated diarrhea <NUMBER> <NUMBER> groups feeder pigs arrival fattening farms callebaut et al <NUMBER> virus remained prevalent swine populations western europe eighties serosurvey belgian sows using sera collected slaughterhouses thus mostly originating different farms showed pedv antibodies <NUMBER> <NUMBER> <NUMBER> <NUMBER> similar percentages sows positive germany <NUMBER> regional locations france spain netherlands bulgaria antibodies found scandinavia northern ireland usa australia <NUMBER> antibodies detected sera received taiwan first evidence presence pedv asia eighties advanced fewer outbreaks breeding farms seen even though virus still detected general economic impact ped become lower belgium <NUMBER> <NUMBER> groups feeder pigs <NUMBER> commercial finishing herds using inall production system examined serocoversion pedv tgev none groups seroconverted tgev <NUMBER> seroconverted pedv diarrhea observed <NUMBER> van reeth pensaert <NUMBER> hungarian study published <NUMBER> <NUMBER> <NUMBER> faecal samples weaned pigs diarrhea tested positively pedv nagy et al <NUMBER> nineties acute ped outbreak described spain involving fattening unit <NUMBER> pigs diarrhea starting <NUMBER> weeks old pigs one barn affecting pigs <NUMBER> <NUMBER> kg subsequently spreading barns carvajal et al <NUMBER> isolated outbreak described <NUMBER> england large finishing herd weaners brought <NUMBER> month period positive sows found breeding herds supplying weaners pritchard et al <NUMBER> epidemic ped occurred despite low pedv seroprevalence <NUMBER> fatteners <NUMBER> different finishing units positive antibodies pedvmay <NUMBER> january <NUMBER> interest disease economic point view became low europe research performed ped practically serosurveys carried serological survey sows farrow finish herds carried belgium <NUMBER> revealed gilts positive pedv antibodies <NUMBER> <NUMBER> considered farms <NUMBER> <NUMBER> fattening farms examined pev antibodies none positive pensaert unpublished appeared pedv except focal case disappearing european swine population towards turn century reason attention follow given anymore viral infection field interest fully moved asia however somewhat atypical ped outbreak occurred unexpectedly po valley northern italy <NUMBER> martelli et al <NUMBER> occurred may <NUMBER> june <NUMBER> area densely populated pigs outbreak started four cases occurring fattening farms may july clinical cases detected august september october two new cases appeared first fattening unit second nursery threesite production unit disease spread winter <NUMBER> affecting <NUMBER> farms including fattening units well farrowtofinish farrowtoweaner farms pedv positive farms still detected mid<NUMBER> end <NUMBER> disease progressively disappeared sozzi et al <NUMBER> <NUMBER> sporadic outbreaks observed grower finisher herds efsa <NUMBER> epidemic italy <NUMBER> inclined us forecast new episode ped epidemics europe occur recently due increased attention following <NUMBER> epidemic usa single limited ped outbreaks sporadically diagnosed europe one case ukraine dastjerdi et al <NUMBER> occurred <NUMBER>sow farm <NUMBER> farrowings week mortality pigs less <NUMBER> days old approached <NUMBER> virus closely related original us strains reported form north america sequence identity <NUMBER> isolates cases reported belgium theuns et al <NUMBER> holland van der wolf et al <NUMBER> france grasland et al <NUMBER> germany hanke et al <NUMBER> portugal mesquita et al <NUMBER> italy basis genetic sequence closely related sequenced classified sindel strains german isolate showed <NUMBER> identity oh<NUMBER> strain isolated usa january <NUMBER> size clinical disease outbreaks variable outbreak involved belgium <NUMBER> fattening farm mortality france <NUMBER> farrow finish farm mortality <NUMBER> pigs one week <NUMBER> weaning germany <NUMBER> farms <NUMBER> fattening <NUMBER> <NUMBER> mortality <NUMBER> breeding <NUMBER> mortality respectively portugal started one farm pig mortality defined virus spread <NUMBER> pig farms period <NUMBER> months data seen much unexplained variation ped clinical disease outcome except possibility outbreak ukraine doubtful european isolates anything involved us epidemic similar focal cases must occurred europe us outbreak likely neither recognized diagnosed reported ped sindel strains present europe cv<NUMBER> appears earliest known representative carvajal et al <NUMBER> remarkable many european countries large epidemic occurred despite several indications breeding population densely populated swine raising regions negative antibodies pedv thus presumably fully susceptible difficult understand virus pedv gradually regressed swine population europe absence special control measures vaccination applied control programmes installed puzzling aspect last decennia pedv still focally present europe cause epidemic despite high numbers susceptibleseronegative farms despite dense swine populations regions one would expect virus pedv replicates high titers swine easily rapidly spread one swine farm another would able maintain swine population previously explained outbreak occurred breeding farm pedv virus could persist easily successive litters pigs losing lactogenic protection weaning become susceptible target infection fact persistence virus pedv would almost natural feature similar endemic character observed porcine enzootic enteric viruses swine rotaviruses swine enteroviruses others tgev cannot serve example europe largely eliminated swine population due emergence early eighties closely related porcine respiratory coronavirus prcv prcv tgev deletion mutant acquired respiratory tropism shows epidemiological advantage rapid aerogenic spreading causing protective immunity tgev endemic prcv thus replaced tgev europe would interesting study mechanisms behind regressionwaning pedv europe could virus non swine ancestor temporarily become adapted swine really swineborne evolution would unique animal coronaviruses could virus maintain population present sufficient high dose allowing continue infection chain reaching low level quantityeg farm basis longer able waning pedv apparently occurred parts asia within <NUMBER> decennia presence continent degree europe intriguing closely follow epidemiological course evolution pedv usa epidemic phase passed coronavirus disease<NUMBER> disease caused <NUMBER>ncovsarscov<NUMBER> novel β coronavirus group <NUMBER>b <NUMBER> illness ranges asymptomatic mild infection severe respiratory tract infections humans seen severe acute respiratory syndrome sars middle east respiratory syndrome mers presentations include fever coughing dyspnea watery diarrhea myalgia severe lymphopenia prolonged coagulation profiles cardiac disease sudden death <NUMBER> <NUMBER> since emergence wuhan hubei province china december <NUMBER> covid<NUMBER> increased rapidly china progressed worldwide january <NUMBER> <NUMBER> declared outbreak public health emergency international concern pheic may <NUMBER> <NUMBER> cases confirmed globally including americas europe eastern mediterranean southeast asia africa <NUMBER> deaths reported <NUMBER> coagulopathy reported ddimer elevations seen <NUMBER> covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> previous studies communityacquired pneumonia cap chronic obstructive pulmonary disease copd patients shown ddimer level higher severe cases may used prognostic biomarker <NUMBER> <NUMBER> <NUMBER> ddimer <NUMBER> μgml one risk factors mortality adult inpatients covid<NUMBER> <NUMBER> however role ddimer covid<NUMBER> patients fully investigated study showed ddimer levels patient groups stratified clinical severities imaging staging inhospital death assessed role ddimer biomarker disease severity clinical outcome enrolled patients confirmed covid<NUMBER> referred renmin hospital wuhan university wuhan china designated center prioritized treating critical illness january <NUMBER> march <NUMBER> <NUMBER> confirmed cases defined epidemiological history consistent two clinical manifestations microbiological evidence respiratory blood specimens positive sarscov<NUMBER> realtime reverse transcription polymerase chain reaction rtpcr assay virus gene sequencing according novel coronavirus pneumonia diagnosis treatment guideline <NUMBER>th ed chinese published national health commission china <NUMBER> symptom onset determined earliest clinical manifestations consistent covid<NUMBER> fever cough dyspnea muscle pain diarrhea fatigue recorded medical history taken upon admission exclusion criteria included pregnancy cancer hematologic malignancy chronic liver disease acute coronary syndrome surgery trauma within <NUMBER> days patients without ddimer testing upon admission retrospectively collected demographic clinical data laboratory parameters chest ct imaging prognosis electronic nursing medical records using standardized data collection form study approved institutional ethics board renmin hospital wuhan university wdry<NUMBER>k<NUMBER> complete blood count coagulation profile renal liver function creatine kinase electrolytes myocardial enzymes cd<NUMBER> cd<NUMBER> cell counts creactive protein procalcitonin collected routinely admission ddimer level tested using immunoturbidimetric assay reference range <NUMBER> mgl sysmex cs<NUMBER> doppler ultrasound ct pulmonary angiography done patients high clinical suspicion pulmonary embolismdeep vein thrombosis pe dvt chest ct scan done inpatients clinically severity covid<NUMBER> patients classified mild moderate severe critically ill according novel coronavirus pneumonia diagnosis treatment guideline <NUMBER>th ed national health commission china supplement table <NUMBER> <NUMBER> radiologically area affected lungs consistent viral pneumonia patients first chest ct admission measured classified ≤ <NUMBER> <NUMBER> ≥ <NUMBER> total lung area according oxygenation index oi admission patients grouped <NUMBER> groups group <NUMBER> oi ≥ <NUMBER> mmhg group <NUMBER> oi <NUMBER> mmhg group <NUMBER> oi <NUMBER> mmhg group <NUMBER> oi <NUMBER> mmhg scores sofa qsofa itsh disseminated intravascular coagulation dic curb<NUMBER> communityacquired pneumonia wells rule <NUMBER> revised geneva score <NUMBER> assessing pulmonary embolism pe risk patient documented continuous data accorded normal distribution homogeneity variance expressed mean ± sd compared independent samples test expressed median <NUMBER>th percentile compared wilcoxon rank sum test categorical variables expressed number percentage compared chisquare tests fishers exact test explore risk factors associated mortality univariable multivariable logistic regression models used considering total number deaths n <NUMBER> study avoid overfitting model excluded variables univariable analysis betweengroup differences significant number events small calculate odds ratios therefore chose age sofa qsofa isthdic score curb<NUMBER> lymphocyte count ddimer seven variables multivariable logistic regression model correlations ddimer clinical staging chest ct staging oxygenation index inhospital mortality evaluated kendalls taub coefficient analysis assess predictive value ddimer mortality receiver operating characteristic roc analysis conducted calculations area roc curve auc sensitivity specificity statistical analyses performed spss v<NUMBER> spss inc chicago il usa p value less <NUMBER> considered statistically significant designated referral center novel coronavirus infection patients hospitalized confirmed rtpcr excluding subjects using exclusion criteria included <NUMBER> consecutive inpatients january <NUMBER> march <NUMBER> <NUMBER> final analysis mean age <NUMBER> patients <NUMBER> ± <NUMBER> years ranging <NUMBER> <NUMBER> years average time symptom onset admission <NUMBER> ± <NUMBER> days nearly one third patients comorbidities hypertension common <NUMBER> followed diabetes mellitus <NUMBER> mild moderate cases severe cases critically ill cases accounted <NUMBER> <NUMBER> <NUMBER> patients respectively average length hospital stay <NUMBER> ± <NUMBER> days using revised geneva score none belonged high probability group risk pe four patients belonged high probability group using wells rule fortunately ruled pevte doppler ultrasonography ct pulmonary angiography seventeen patients died hospitalization ddimer elevation ≥ <NUMBER> mgl seen <NUMBER> <NUMBER> patients since patients normal ddimer <NUMBER> mgl admission survived patients grouped ddimer levels <NUMBER> <NUMBER> <NUMBER> mgl univariable multivariable logistic regression models table <NUMBER> univariable analysis age sofa score qsofa score isthdic score curb<NUMBER> lymphocytopenia elevated ddimer associated death variables included multivariable logistic regression model ddimer greater <NUMBER> mgl admission variable associated increased odds mortality <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> comparison demographic clinical characteristics normal ddimer group elevated ddimer group shown table <NUMBER> major laboratory markers chest imaging features upon admission recorded table <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients affected lungs ≤ <NUMBER> <NUMBER> ≥ <NUMBER> total area predominant changes seen ground glass opacity <NUMBER> followed patchy consolidation <NUMBER> fibrous stripes <NUMBER> irregular consolidated nodules <NUMBER> <NUMBER> patients received oxygen therapy including nasal cannulaface mask <NUMBER> noninvasive mechanical ventilation <NUMBER> invasive mechanical ventilation <NUMBER> extracorporeal membrane oxygenation one patient anticoagulation therapy prescribed <NUMBER> cases distributions ddimer levels among patients different clinical staging chest ct staging survived deceased hospitalization presented figs roc analysis identified ddimer <NUMBER> mgl upon admission optimal cutoff level discriminate survivors nonsurvivors area roc <NUMBER> standard error <NUMBER> <NUMBER> confidence interval ci <NUMBER> p <NUMBER> fig <NUMBER> <NUMBER> included patients ddimer <NUMBER> mgl predicting inhospital mortality ddimer level <NUMBER> mgl sensitivity <NUMBER> specificity <NUMBER> table <NUMBER> demonstrated patients diagnosed covid<NUMBER> ddimer elevation upon admission common associated increased disease severity inhospital mortality ddimers one fragments produced plasmin cleaves fibrin break clots assays routinely used part diagnostic algorithm exclude diagnosis thrombosis however pathologic nonpathologic process increases fibrin production breakdown also increases plasma ddimer levels <NUMBER> examples include deep vein thrombosispulmonary embolism arterial thrombosis disseminated intravascular coagulation conditions pregnancy inflammation cancer chronic liver diseases post trauma surgery status vasculitis among adults admitted emergency room infections instead vtepe common reason ddimer elevation <NUMBER> present study patient confirmed pedvt supports application ddimer covid<NUMBER> diagnostic tool thromboembolism addition three patients elevated ddimer several studies shown ddimer levels associated severity communityacquired pneumonia clinical outcome <NUMBER> <NUMBER> however ddimer used biomarker viral pneumonia <NUMBER> <NUMBER> though ddimer elevation observed articles describing clinical features covid<NUMBER> whether level ddimer marker severity examined present study significant correlation ddimer levels disease severity stratified area affected lungs chest ct oxygenation index well clinical staging according interim guideline addition higher percentage ddimer elevation seen present study previously reported <NUMBER> <NUMBER> may due higher percentage severecritically ill cases referred hospital another demonstration correlation ddimer level disease severity suggests assay may used early marker severity chest ct scans complement ct clinical staging inhospital mortality also associated increased ddimer levels suggesting assay may used single useful biomarker clinical outcome patients covid<NUMBER> zhou et al reported ddimer <NUMBER> μgml risk mortality <NUMBER> study objective design population statistical analysis zhous study different zhous study retrospective cohort study describe risk factors mortality clinical course included patients discharged died january <NUMBER> <NUMBER> mortality rate higher compared study <NUMBER> vs <NUMBER> explore risk factor mortality zhou et al chose age coronary heart disease sofa score lymphocyte ddimer variables multivariable logistic regression model ddimer defined categorical variable analysis levels ≤ <NUMBER> μgl <NUMBER> ≤ <NUMBER> μgl <NUMBER> μgl chosen laboratory method ddimer assay described present case control study focused predictive value ddimer inhospital deaths using receiver operating characteristic analysis analysis ddimer defined continuous variable testing used immunoturbidimetric assay reference range <NUMBER> mgl sysmex cs<NUMBER> despite differences study design analysis findings conclusions two studies inconsistent zhou et al concluded potential risk factors older age high sofa score ddimer greater <NUMBER> μgl instead levels ≤ <NUMBER> μgl <NUMBER> ≤ <NUMBER> μgl could help clinicians identify patients poor prognosis found using cutoff value <NUMBER> ddimer levels upon admission inhospital mortality auc <NUMBER> sensitivity specificity <NUMBER> <NUMBER> respectively findings present study suggest elevated ddimer level admission <NUMBER> mgl may identify patients higher risk inhospital mortality therefore inform physicians suitable candidates intensive care early intervention worth noting findings suggest associations ddimer levels disease severity mortality evidence still lacking causal mechanisms whether associations specific effects sarscov<NUMBER> infection consequences systemic inflammatory response sarscov<NUMBER> infection dysregulation coagulationanticoagulation cascades results worsening lung pathology <NUMBER> influenza pathogenesis augmenting viral replication immune pathogenesis attributed aberrant coagulation system including cellular protein components <NUMBER> pathological features covid<NUMBER> include diffuse alveolar damage cellular fibromyxoid exudates desquamation pneumocytes hyaline membrane formation pulmonary edema hyaline membrane formation interstitial mononuclear inflammatory infiltrates dominated lymphocytes greatly resemble seen sars mers coronavirus infection <NUMBER> <NUMBER> presumably observed ddimer elevation signify hyperfibrinolysis state increased inflammatory burden induced sarscov<NUMBER> infection logistic regression model estimate risk factors associated mortality systematic anticoagulation therapy significantly associated reduced risk mortality however recent observational study including <NUMBER> hospitalized covid<NUMBER> patients paranjpe et al found treatment dose anticoagulant associated reduced risk mortality especially among patients required mechanical ventilation <NUMBER> longer duration treatment associated reduced risk mortality adjusted hr <NUMBER> per day <NUMBER> ci <NUMBER> p <NUMBER> whether anticoagulation fig <NUMBER> <NUMBER>yearold male diagnosed covid<NUMBER> presented fever coughing hemoptysis chest ct upon admission showing ground glass opacities patchy consolidation elevated ddimer level <NUMBER> mgl wells score geneva score curb<NUMBER> score <NUMBER> <NUMBER> <NUMBER> respectively wells score suggested high probability pulmonary embolism ct pulmonary angiography b c doppler ultrasonography carried ruled pulmonary embolism deep vein thrombosis lower extremities therapy confers survival benefit patients hospitalized covid<NUMBER> needs research prospective randomized trials currently potential benefits need weighed risk bleeding study limitations first current study done single center overall mortality <NUMBER> lower compared reported studies done wuhan <NUMBER> <NUMBER> considerably higher reported provinces <NUMBER> <NUMBER> researches may needed extrapolated wider patient population second study retrospective nature patients included systematically assessed presence pedvt clinically suspected third look value serial ddimer monitoring assessing covid<NUMBER> patients conclusion ddimer levels commonly elevated patients infected sarscov<NUMBER> significantly higher levels found critical illness may used prognostic marker inhospital mortality supplementary information accompanies paper httpsdoiorg<NUMBER> <NUMBER>s<NUMBER>z likelihood ratio <NUMBER> related accuracy integrity part work even ones author personally involved appropriately investigated resolved resolution documented literature availability data materials dataset supporting conclusions article included within article additional files ethics approval consent participate study investigates clinical characteristics risk factors covid<NUMBER> mortality establishes novel scoring system predict mortality risk covid<NUMBER> patients methods cohort <NUMBER> hospitalized covid<NUMBER> patients wuhan china <NUMBER> died <NUMBER> recovered included present study demographic clinical laboratory data admission collected electronic medical records january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> clinical outcomes collected march <NUMBER> <NUMBER> multivariable logistic regression used explore association potential risk factors covid<NUMBER> mortality receiver operating characteristic curve used predict covid<NUMBER> mortality risk analyses conducted april <NUMBER> independent risk factors covid<NUMBER> mortality included older age male sex history diabetes lymphopenia increased procalcitonin could help clinicians identify covid<NUMBER> patients poor prognosis earlier stage covid<NUMBER> mortality risk score model may assist clinicians reducing covid<NUMBER>related mortality implementing better strategies effective use limited medical resources december <NUMBER> several pneumonia cases unknown origin identified wuhan hubei china <NUMBER> <NUMBER> pathogen identified novel coronavirus belonging βcoronavirus genus renamed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> previously named <NUMBER>ncov <NUMBER> novel virus shared <NUMBER> sequence identity bat sarslike coronavirus <NUMBER> sequence severe acute respiratory syndrome coronavirus sarscov <NUMBER> sarscov<NUMBER> strong affinity angiotensinconverting enzyme <NUMBER> receptors early indicator potential becoming pandemic threat <NUMBER> clinical characteristics covid<NUMBER> well described <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> published analyses focused specifically covid<NUMBER> mortality <NUMBER> addition limited studies exploring potential risk factors covid<NUMBER> mortality therefore present study examines potential risk factors covid<NUMBER> mortality aims establish covid<NUMBER> mortality risk prediction model singlecenter hospital authors obtained medical records <NUMBER> hospitalized patients laboratoryconfirmed diagnosed covid<NUMBER> tongji hospital january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> march <NUMBER> clinical outcomes total hospitalized patient population collected exclusion patients still hospitalized n<NUMBER> transferred hospitals n<NUMBER> total <NUMBER> eligible patients included final analysis patients missing procalcitonin pct n<NUMBER> lymphocyte count ly n<NUMBER> data excluded leaving <NUMBER> <NUMBER> patients included analyses pct ly covid<NUMBER> mortality respectively study population selection shown appendix figure <NUMBER> laboratoryconfirmed case covid<NUMBER> defined positive realtime reverse transcriptase polymerase chain reaction rtpcr test result assay obtained oral pharyngeal swab specimens investigators collected demographic information exposure history medical history comorbidities signs symptoms chest computed tomography laboratory findings admission clinical outcomes electronic medical records laboratory results blood count chemical analysis coagulation testing included laboratory testing date disease onset sarscov<NUMBER> laboratory confirmation hospital admission discharge death also recorded study approved tongji hospital ethics committee oral pharyngeal swab samples stored <NUMBER>ml virus preservation solution collected sarscov<NUMBER> viral nucleic acid detection virus rna extracted within <NUMBER> hours tianlong pana<NUMBER> automatic nucleic acid extraction system tianlong china referring previous studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> age <NUMBER> years ≥<NUMBER> years sex female male history hypertension yesno diabetes yesno lymphopenia <NUMBER>×<NUMBER> <NUMBER> l ≥<NUMBER>×<NUMBER> <NUMBER> l increased alanine aminotransferase <NUMBER> ul ≥<NUMBER> ul increased lactate dehydrogenase <NUMBER> ul ≥<NUMBER> ul increased ddimer <NUMBER> mgl ≥<NUMBER> mgl increased pct <NUMBER> ngml ≥<NUMBER> ngml included multivariable logistic regression model analysis pct ly covid<NUMBER> mortality pct ly categorized three groups according tertile distribution pvalue trend calculated group medians association pct concentration risk covid<NUMBER> mortality also evaluated using restricted cubic splines <NUMBER> konts defined <NUMBER>th <NUMBER>th <NUMBER>th percentiles pct concentrations reference value or<NUMBER> <NUMBER> ngml pct concentrations data <NUMBER>th <NUMBER>th percentiles deleted variables statistically significant level p<NUMBER> multivariable logistic regression included prediction model receiver operating characteristic curve used prediction covid<NUMBER> mortality youden index used identify optimal cut point <NUMBER> novel scoring model established mortality risk scores determined multivariate logistic regression reflect weights impact covid<NUMBER> mortality mortality risk score calculated according ors rounded nearest integer <NUMBER> total risk score sum scores variable age sex history diabetes lymphopenia increased pct spss version <NUMBER> sas version <NUMBER> used conduct statistical analyses analyses conducted april <NUMBER> twosided statistical tests considered significant p<NUMBER> baseline characteristics recovered patients n<NUMBER> patients died covid<NUMBER> n<NUMBER> shown table <NUMBER> compared recovered patients died covid<NUMBER> likely male older tended shorter time onset symptoms death shorter time hospital stay p<NUMBER> addition patients died covid<NUMBER> higher proportion comorbidities including hypertension diabetes coronary heart disease p<NUMBER> presence clinical symptoms fever cough fatigue p<NUMBER> <NUMBER> patients decreased ly <NUMBER> increased levels lactate dehydrogenase <NUMBER> increased creactive protein <NUMBER> increased ddimer <NUMBER> increased pct <NUMBER> mononucleosis <NUMBER> increased alanine aminotransferase <NUMBER> increased aspartate aminotransferase <NUMBER> observed additionally lymphopenia neutrophilia thrombocytopenia leukocytosis increased aspartate aminotransferase increased creatinine increased lactate dehydrogenase increased ddimer prolonged thrombin time increased pct significantly different recovered patients died covid<NUMBER> p<NUMBER> table <NUMBER> table <NUMBER> adjustment lymphopenia increased alanine aminotransferase increased lactate dehydrogenase increased ddimer substantially change association <NUMBER>sd sd<NUMBER> ngml increase pct concentration associated <NUMBER>fold increased risk covid<NUMBER> mortality adjustment potential confounders or<NUMBER> <NUMBER> ci<NUMBER> <NUMBER> spline regression analysis indicated association pct concentrations covid<NUMBER> mortality nonlinear p<NUMBER> nonlinearity appendix figure <NUMBER> association ly levels risk covid<NUMBER> mortality presented appendix table <NUMBER> table <NUMBER> adjustment increased aspartate aminotransferase increased creatinine increased ddimer increased pct ly t<NUMBER> marginally higher risk covid<NUMBER> mortality compared t<NUMBER> or<NUMBER> <NUMBER> ci<NUMBER> <NUMBER> p<NUMBER> trend appendix table <NUMBER> <NUMBER>sd sd<NUMBER> ×<NUMBER> <NUMBER> l decrease ly concentration associated <NUMBER> increased risk covid<NUMBER> mortality adjustment potential confounders or<NUMBER> <NUMBER> ci<NUMBER> <NUMBER> appendix table <NUMBER> categorical variable model covid<NUMBER> mortality prediction shown table <NUMBER> age <NUMBER> years ≥<NUMBER> years sex female male history diabetes yesno increased pct <NUMBER> ngml ≥<NUMBER> ngml significantly associated covid<NUMBER> mortality lymphopenia <NUMBER>×<NUMBER> <NUMBER> l ≥<NUMBER>×<NUMBER> <NUMBER> l marginal association covid<NUMBER> mortality order fully inform clinical utilization authors developed novel scoring system covid<NUMBER> mortality risk table <NUMBER> optimal cut point covid<NUMBER> mortality risk <NUMBER> area receiver operating curve covid<NUMBER> mortality risk score <NUMBER> <NUMBER> ci<NUMBER> <NUMBER> appendix figure <NUMBER> study hospitalized covid<NUMBER> patients wuhan china conducted midjanuary late march <NUMBER> authors found patients male elderly <NUMBER> years history diabetes lymphopenia increased pct tended higher odds mortality adjustment potential confounders significant independent associations observed older age male sex history diabetes lymphopenia increased pct higher risk covid<NUMBER> mortality age median<NUMBER> years iqr<NUMBER> years overall population present study higher individuals studies might related fact serious patients admitted tongji hospital consistent previous study <NUMBER> current study found increased age positively correlated risk covid<NUMBER> mortality prior studies report older age independent predictor mortality sars mers <NUMBER> <NUMBER> macaque model found older macaques tended stronger host innate responses sarscov infection compared younger macaque <NUMBER> additionally increased age tcell bcell function become potentially defective overproduction type <NUMBER> cytokines might implicated poor clinical prognosis covid<NUMBER> infection <NUMBER> <NUMBER> findings might help explain relationship older age covid<NUMBER> mortality observed studies compared female patients male patients higher odds covid<NUMBER> mortality adjustment potential risk factors inconsistent findings another study based <NUMBER> patients two different hospitals <NUMBER> might due part difference size study sample different sociodemographic composition study populations however studies also found male patients tended higher risk covid<NUMBER> mortality <NUMBER> consistent present study moreover previous studies reported men women affected sars mers infection <NUMBER> <NUMBER> compared men women may tend healthier lifestyles behaviors combined gender differences immune response might explain potential mechanism behind observed sex difference <NUMBER> findings present study indicated patients history diabetes higher odds covid<NUMBER> mortality adjustment potential risk factors previous studies found presence diabetes increased morbidity mortality patients covid<NUMBER> consistent present findings <NUMBER> <NUMBER> addition prior study found plasma glucose levels diabetes independent predictors mortality morbidity patients sars <NUMBER> patients diabetes tended higher affinity cellular binding efficient virus entry decreased viral clearance diminished cell function increased susceptibility hyperinflammation cytokine storm syndrome could contributing factors greater susceptibility covid<NUMBER> among diabetics generally poorer prognosis <NUMBER> studies yet investigated whether pct independent risk factor covid<NUMBER> mortality study showed pct concentrations positively correlated covid<NUMBER> mortality adjustment potential risk factors although inflammatory mediator pct established marker bacterial infection antibiotic stewardship <NUMBER> <NUMBER> pct reported associated clinical prognosis myocardial infarction cancer sepsis patients ventilatorassociated pneumonia <NUMBER> <NUMBER> <NUMBER> addition previous studies found high pct concentration independent prognostic biomarker mortality risk healthy populations critically ill patients <NUMBER> <NUMBER> <NUMBER> sepsis pct promotes inflammation immunosuppression play dual role biomarker diagnosis prognosis well disease mediator <NUMBER> vitro liappis et al <NUMBER> therefore pctincreased covid<NUMBER> mortality might implicated induction proinflammatory cytokines although exact mechanism behind requires investigation previous studies shown deceased patients covid<NUMBER> tended lower lymphocyte count consistent findings present study <NUMBER> <NUMBER> however zhou colleagues <NUMBER> find significant association lymphopenia covid<NUMBER> mortality adjustment potential risk factors different sample size study population sociodemographic composition might explain observed differences present study revealed patients lymphopenia higher risk covid<NUMBER> mortality whereas prior study found percentage lymphocytes blood negatively correlated severity prognosis covid<NUMBER> <NUMBER> sarscov<NUMBER> might contribute destruction lymphatic organs cause lymphocytic dysfunction induce apoptosis necrosis lymphocytes suppress lymphocytes via disordered metabolic molecules might work collectively result lymphopenia <NUMBER> studies needed clarify underlying mechanism strengths present study include relatively large sample size ability investigate associations potential risk factors covid<NUMBER> mortality moderate statistical power study first authors aware report male sex increased pct levels lymphopenia independent risk factors covid<NUMBER> mortality additionally novel scoring system established predict mortality risk covid<NUMBER> patients present study nonetheless limitations taken consideration first present study performed single medical center thus findings may representative general population second authors yet collected information treatments present study mechanism risk factors covid<NUMBER> mortality still requires study study hospitalized covid<NUMBER> patients wuhan china found many patients least one comorbidity hypertension diabetes coronary heart disease common preexisting conditions older age male sex history diabetes lymphopenia increased pct admission significant associations covid<NUMBER> mortality independent risk factors assist clinicians identifying patients likely poorer prognosis early stage clinical course disease addition covid<NUMBER> mortality risk score model developed study intended help clinicians reduce covid<NUMBER> related mortality implementing better strategies effective use limited medical resources work supported grants hust covid<NUMBER> rapid response call <NUMBER>kfyxgyj<NUMBER> authors would like thank study subjects participating present study cy ql contributed equally work cy xf wl cocorresponding authors cy ql xf wl designed study interpreted data wrote first draft paper cy ql wl xw take responsibility accuracy data analysis cy ql wl wl performed data collection designed studys analytic strategy authors read approved final manuscript financial disclosures reported authors paper coronavirus disease <NUMBER> covid<NUMBER> current pandemic disease caused positivesense rna virus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> along highly infectious capacity virus mortality rates reported range <NUMBER> <NUMBER> <NUMBER> reported patients covid<NUMBER> hypertension may increased risk adverse outcomes unadjusted epidemiological studies summarizing characteristics covid<NUMBER> epidemic china despite limited sample sizes previous studies reported hypertension hazard ratio hr <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> mortality respectively <NUMBER> <NUMBER> however neither previous studies adjusted confounding factors example age emerging strongest predictor covid<NUMBER>related death <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> required viral entry sarscov<NUMBER> <NUMBER> ace<NUMBER> widely expressed human body expression found gastrointestinal tract heart kidney alveolar cells lungs <NUMBER> <NUMBER> angiotensinconverting enzyme inhibitors aceis angiotensin receptor blockers arbs two types reninangiotensinaldosterone system raas inhibitors widely used treating hypertension heart renal failure reports animal models <NUMBER> humans <NUMBER> suggesting expression ace<NUMBER> may increased treatment acei arb reports incriminated arbs <NUMBER> might augment patients susceptibility viral host cell entry propagation <NUMBER> although effects aceis arbs ace<NUMBER> humans still inconclusive previous findings led growing concern aceis arbs may increase decrease mortality patients covid <NUMBER> <NUMBER> therefore evidence impact medications patients covid<NUMBER> urgently needed investigated <NUMBER> consecutive patients admitted huo shen hospital hospital dedicated solely treatment covid<NUMBER> wuhan china tested hypothesis treatment hypertension especially raas inhibitors might impact mortality patients covid <NUMBER> retrospective observational study comparing association hypertensive status antihypertensive treatment class mortality among hospitalized patients covid <NUMBER> <NUMBER> <NUMBER> brief clinical manifestations covid<NUMBER> defined development fever andor respiratory symptoms computed tomography ct imaging showing characteristics consistent covid<NUMBER> normal decreased white blood cell wbc count normal decreased lymphocyte count early stage disease patients suspicious epidemiological history ie contact novel coronavirusinfected people patients wuhan fever respiratory symptoms plus two clinical manifestations clear epidemiological history three clinical manifestations considered possible covid<NUMBER> case patients considered possible covid<NUMBER> cases without laboratory confirmation sarscov<NUMBER> infection admitted huo shen hospital confirmation sarscov<NUMBER> infection defined suspect cases one following serological findings realtime fluorescent reverse transcriptionpcr rtpcr positive new coronavirus nucleic acid ii viral gene sequence highly homologous known new coronaviruses iii sarscov<NUMBER>specific igm igg detected serum sarscov<NUMBER>specific igg detectable reaches titration least fourfold increase convalescence compared acute phase study approved national health commission china institutional review board huo shen hospital wuhan china written informed consent waived ethics committee designated hospital patients emerging infectious diseases patients demographic characteristics clinical data symptoms comorbidities laboratory findings outcomes hospitalization collected electronic medical records two investigators rz yc data independently reviewed entered computer database two analysts cg yc primary endpoint allcause mortality hospitalization endpoints included time elapsed onset symptoms discharge rates use invasive mechanical ventilation severity covid <NUMBER> severity covid<NUMBER> categorized mild severe critical mild included nonpneumonia mild pneumonia cases severe characterized dyspnoea respiratory frequency <NUMBER>min blood oxygen saturation <NUMBER> pao <NUMBER> fio <NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> within <NUMBER> h critical cases defined respiratory failure requiring mechanic ventilation septic shock andor multiple organ dysfunctionfailure <NUMBER> <NUMBER> final date followup <NUMBER> april <NUMBER> median duration followup hospitalization <NUMBER> <NUMBER> days diagnosis hypertension given patients physician prior infection sarscov<NUMBER> data collected patients documented medical files eg diagnosed patients antihypertensive drugs blood pressure <NUMBER> mmhg upon admission still identified history hypertension impact antihypertensive treatments covid formal committee adjudicate status hypertension however diagnoses rechecked two individual investigators rz yc data collection using office systolic blood pressure <NUMBER> mmhg andor diastolic blood pressure values <NUMBER> mmhg <NUMBER> criteria figure <NUMBER> shows flow chart study antihypertensive regimens principle unchanged hospitalization whenever patients previous prescriptions admission discontinuation alteration antihypertensive treatment hospitalization physicians discretion required antihypertensive medication hospitalization prior prescription discontinued medications prior admission treated calcium channel blockers ccbs diuretics cohorts without antihypertensive antihypertensive treatments well cohorts raas inhibitors aceiarbs nonraas inhibitors betablockers ccbs diuretics stratified time admission according preadmission medications <NUMBER> patients death events taking spirolactone categorized nonraas inhibitors group analysis patients included raas inhibitor cohort whenever least one raas inhibitor acei arb prescribed disregarding whether treated betablocker ccb diuretics nevertheless sensitivity analysis performed including patients treated solely one medication supplementary material online table s<NUMBER> continuous variables normal distribution expressed mean ± standard deviation sd skewed distribution expressed median ± interquartile range iqr categorical variables presented counts percentages means two continuous variables compared independent students ttest mannwhitney utest appropriate frequencies categorical variables compared using fishers exact test survival estimated kaplanmeier method figure <NUMBER> variances outcomes exposure cohorts assessed multivariable cox proportional hazards model covariates multivariable model included age continuous variable sex medical history diabetes insulintreated diabetes myocardial infarction treatment percutaneous coronary intervention pci coronary artery bypass grafting cabg renal failure chronic heart failure asthma chronic obstructive coronary disease copd stroke binary variables cox proportionality assumptions checked using schoenfeld residuals transformed time assumptions met models formal correction multiple testing taking account observational nature analysis <NUMBER> details statistical approaches metaanalysis provided supplementary material online methods analyses performed using rproject r foundation vienna austria twosided pvalue <NUMBER> considered statistically significant total <NUMBER> consecutive hospitalized patients confirmed covid<NUMBER> enrolled study median time symptom onset discharge last followup <NUMBER> <NUMBER> days baseline characteristics presented table <NUMBER> results laboratory tests presented supplementary material online tables s<NUMBER>s<NUMBER> among patients <NUMBER> <NUMBER> <NUMBER> medical history hypertension compared patients without hypertension hypertension older often prior history diabetes angina stroke renal failure previous revascularization pci cabg receiving medication diabetes hypertension spectrum symptoms covid<NUMBER> admission two cohorts differ significantly <NUMBER> <NUMBER> patients hypertension taking antihypertensive medications medical history symptoms onset blood pressure admission differ significantly patients antihypertensive medications medications except patients antihypertensive medications treated often oral medication diabetes <NUMBER> <NUMBER> patients treated raas inhibitors <NUMBER> <NUMBER> treated betablockers ccbs diuretics nonraas inhibitors supplementary material online table s<NUMBER> medical history blood pressure admission differ significantly raas inhibitortreated raasi þ nonraas inhibitortreated patients raasi <NUMBER> patients reported shivering admission raasi cohort compared none raasi þ cohort table <NUMBER> total <NUMBER> <NUMBER> patients died hypertension cohort <NUMBER> <NUMBER> died hypertension cohort crude hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER>a adjustment confounders hypertension still associated twofold increase risk mortality compared hypertension adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table <NUMBER> time symptom onset discharge comparable two cohorts however patients hypertension propensity develop severecritical covid<NUMBER> disease p trend <NUMBER> likely receive invasive mechanical ventilation p <NUMBER> table <NUMBER> patients hypertension without antihypertensive treatment <NUMBER> significantly higher rate mortality compared antihypertensive <NUMBER> treatments <NUMBER> vs <NUMBER> <NUMBER> hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER>b table <NUMBER> adjustment risk mortality still higher patients without antihypertensive treatment hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> patients treated raas inhibitors <NUMBER> <NUMBER> betablockers ccbs diuretics nonraas inhibitors numerical difference rates mortality raas inhibitor nonraas inhibitor cohorts nonsignificant adjustment <NUMBER> vs <NUMBER> <NUMBER> adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> time symptom onset discharge severity covid<NUMBER> percentage ventilation similar two cohorts understand whether aceis arbs distinct effects outcomes also compared influence aceis arbs nonraas inhibitors compared nonraas inhibitors risks mortality patients arbs aceis numerically lower since sample size small groups results could largely due play chance however results show obvious propensity arbs aceis adverse hr <NUMBER> far mortality concerned supplementary material online table s<NUMBER> explore potential risk factors mortality performed multivariable cox regression analysis backwardsstepwise selection identify predictors mortality total seven variables identified namely fatigue age hypertension myocardial infarction renal failure respiratory rate chronic heart failure results shown supplementary material online tables s<NUMBER> s<NUMBER> figure s<NUMBER> recently three groups china reported data regarding influence raas inhibitors covid<NUMBER> patients summarized available data metaanalysis <NUMBER> <NUMBER> <NUMBER> together current data found compared nonraas inhibitors raas inhibitors associated lower risk mortality relative risk <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> regardless model used main findings analysis summarized follows adjustment confounders compared nonhypertensive patients hypertensive patients continued demonstrate twofold relative increase risk covid<NUMBER> mortality ii patients history hypertension without antihypertensive treatment associated significantly higher risk mortality compared antihypertensive treatments iii relative rates mortality severity covid<NUMBER> percentages ventilation statistically different patients treated raas inhibitors nonraas inhibitors however metaanalysis raas inhibitors tend associated lower risk mortality patients covid<NUMBER> hypertension reported increased risk adverse outcomes chen et al suggested chronic hypertension frequent among patients died compared recovered patients <NUMBER> line finding wu et al found hypertension hr <NUMBER> death <NUMBER> patients covid<NUMBER> <NUMBER> zhou et al found hypertension hr <NUMBER> inhospital mortality <NUMBER> patients covid <NUMBER> <NUMBER> meanwhile also study enrolled <NUMBER> patients suggested adjustment confounders hypertension longer independent risk factor covid <NUMBER> <NUMBER> current study found adjustment confounders patients hypertension still significantly twofold higher risk mortality compared patients hypertension far limited clinical evidence demonstrating antihypertensive treatments could influence prognosis covid <NUMBER> despite lack evidence council hypertension european society cardiology esc recommends physicians patients continue treatment usual antihypertensive therapy <NUMBER> analysis showed patients antihypertensive treatments preadmission lower rate mortality compared without treatment hypertension data support escs recommendation stating patients discontinue change antihypertensive treatment unless instructed physician recently ace<NUMBER> identified necessary viral entry sarscov<NUMBER> ace generates angiotensin ii angiotensin ace<NUMBER> degrades angiotensin ii angiotensin <NUMBER> binding mas receptor shifts balance vasoconstriction angiotensin ii vasodilation normal circumstances circulating levels soluble ace<NUMBER> low functional role ace<NUMBER> lungs appears relatively limited <NUMBER> may upregulated certain medications clinical states led twofold concern whereby aceis arbs might affect severity mortality covid <NUMBER> <NUMBER> one aceis could directly inhibit ace<NUMBER> however despite substantial structural homology ace ace<NUMBER> enzyme active sites distinct result aceis clinical use directly affect ace<NUMBER> functions <NUMBER> addition concern use aceis arbs increase expression ace<NUMBER> <NUMBER> therefore increase patient susceptibility viral host cell entry propagation conflicting limited evidence stemming laboratory clinical studies shown changes serum pulmonary ace<NUMBER> levels response aceis arbs <NUMBER> however even acei arb could actually modify ace<NUMBER> levels activity target tissue beds evidence still lacking indicate whether would facilitate greater involvement spike protein cell entry sarscov<NUMBER> given uncertainty due lack clinical data advocates objectors toward use raas inhibitors covid<NUMBER> pandemic study found risks mortality adjustment significantly different raas inhibitors nonraas inhibitors furthermore pooling previously published data <NUMBER> <NUMBER> <NUMBER> studylevel metaanalysis found patients raas inhibitor use possibly associated lower risk mortality take home figure underlying mechanism patients could eventually benefit raas inhibitors covid<NUMBER> putative however results laboratory studies reported initial engagement sarscov<NUMBER> spike protein ace<NUMBER> abundance downregulated cell surfaces <NUMBER> downregulation ace<NUMBER> dysregulation activity lungs may facilitate initial neutrophil infiltration response bacterial endotoxin may result unopposed angiotensin ii accumulation local raas activation <NUMBER> animal study also shown mouse models exposure sarscov<NUMBER> spike protein induced acute lung injury limited raas blockade <NUMBER> therefore researchers hypothesized high ace<NUMBER> expression could deleterious contamination phase whereas high ace<NUMBER> expression could contrast beneficial inflammation phase <NUMBER> may possibly prevent organ injury covid <NUMBER> <NUMBER> verify results well hypothesis also designed randomized controlled trial ongoing investigating issue nct<NUMBER> described data showed untreated hypertensive patients highest risk remaining questions kind medication given patients ccbs raas inhibitors ii could medications mitigate risk patients iii use raas inhibitors affect risk infection equally exposed virus limitations multivariableadjusted cox proportional hazard models performed attempt estimate true treatment effects antihypertensive medications however usual deficiency observational studies exists inability include relevant confounders especially unmeasured causing bias cannot adjusted ii although current study enrolled <NUMBER> patients knowledge far one largest cohorts reported <NUMBER> patients raas inhibitors <NUMBER> patients nonraas inhibitors compared statistically underpowered findings interpreted cautiously iii retrospective study data electrocardiogram echocardiography recorded detail study owing limitations imposed isolation ward urgency containing covid<NUMBER> epidemic iv data study permit shortterm assessment clinical outcomes impact antihypertensive treatments longterm prospective studies investigating effects treatments still needed hypertension independently associated mortality covid<NUMBER> discontinuation antihypertensive treatment suspected associated increased risk mortality patients raas inhibitors exposed higher risk mortality study pooling previously published data studylevel metaanalysis use raas inhibitors shown possibly associated lower risk mortality nevertheless due observational nature study results interpreted cautiously considered obvious additional risk continue raas inhibitors patients covid<NUMBER> infection since december <NUMBER> cluster pneumonia attacked human beings <NUMBER> pathogen designated sarscov<NUMBER> international committee taxonomy viruses pneumonia named coronavirus disease<NUMBER> world health organization <NUMBER> nowadays one million confirmed cases <NUMBER> deaths occurred <NUMBER> countriesterritories according report april <NUMBER> th <NUMBER> rapidly increasing patients especially critical mortal patients brought big challenge public health lai <NUMBER> et al found mortality correlated country health care resources however many countries invasive ventilator intensive care unit icu far adequate treatment critical patients clinical workers pay attention risk factors covid<NUMBER> critical disease death identify critical patients early allocate medical resources rationally timely adjust treatment plan enhance efficacy reduce risk death article analyzed clinical characteristics covid<NUMBER> patients criticalmortal illness noncritical illness <NUMBER> literatures <NUMBER> patients identify risk factors covid<NUMBER> patients develop critical disease death order effectively predict progression disease make early treatment response allocate medical resources better way systematic review metaanalysis reported accordance preferred reporting items systematic reviews metaanalyses prismastatement selected relevant studies published jan <NUMBER> <NUMBER> mar <NUMBER> <NUMBER> data extraction evaluation literature quality conducted independently <NUMBER> investigators zzhtwl microsoft excel database used record available information including baseline details comorbidities clinical manifestations disagreement resolved another investigator pf minors <NUMBER> used assess bias risk analyses performed using microsoft excel state software version <NUMBER> revman software version <NUMBER> results included studies performed fixedeffect models mantelhaenszel method randomeffect models cases significant heterogeneity studies used <NUMBER> statistics assess magnitude heterogeneity <NUMBER> <NUMBER> <NUMBER> represented low moderate high degrees heterogeneity respectively chosen proper effect model based analysis results fixed effect model used <NUMBER> ≤ <NUMBER> random effect model used <NUMBER> ＞<NUMBER> statistical heterogeneity among results sensitivity analysis conducted determine source heterogeneity significant clinical heterogeneity excluded randomized effects model used metaanalysis p <NUMBER> considered statistical significance based previous search strategy <NUMBER> studies searched online database deleting duplicate records total <NUMBER> records retained <NUMBER> articles excluded titles abstracts <NUMBER> remaining <NUMBER> articles deleted various reasons last <NUMBER> articles included metaanalysis finally total <NUMBER> studies <NUMBER> patients included <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> selected studies published <NUMBER> different sample patient sizes ranged <NUMBER> <NUMBER> patients clinical outcome defined icu admission <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> refractory <NUMBER> study <NUMBER> severity <NUMBER> studies <NUMBER> sp<NUMBER> <NUMBER> ＜ <NUMBER>in <NUMBER> study <NUMBER> onset ards <NUMBER> study <NUMBER> death remaining investigation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> risk bias applicability concerns included studies showed table <NUMBER> none studies considered seriously flawed according minors assessment <NUMBER> included studies scored <NUMBER> <NUMBER> studies considered low risk bias selection demographical characteristics included studies shown table <NUMBER> results <NUMBER> included studies total amount <NUMBER> patients showed proportion male significant higher criticaldeath group compared noncritical group male <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> median ages ranged <NUMBER> <NUMBER> years old criticalmortal group across enrolled studies median ages ranged <NUMBER> <NUMBER> years old noncritical grouptable<NUMBER> median ages generally higher criticaldeath group compared noncritical group furthermore age <NUMBER> years analyzed subgroup guan <NUMBER> tian <NUMBER> total amount <NUMBER> patients metaanalysis showed proportion patients older <NUMBER> years higher criticaldeath group compared noncritical group age <NUMBER> years old <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> five studies showed proportion current smoker statistically significant higher criticalmortal group compared noncritical group current smoking <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> heterogeneity estimates male age <NUMBER> years old current smoking among identified studies <NUMBER> <NUMBER> comorbidities patients included studies shown table <NUMBER> compared difference prevalence comorbidities criticalmortal patients noncritical patients diabetes cardiovascular disease respiratory disease heterogeneity test results calculated <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus fixedeffect model used analyses proportion diabetes cardiovascular disease respiratory disease statistically significant higher criticalmortal group compared noncritical group diabetes<NUMBER>r <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER>cardiovascular disease <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> respiratory disease <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> hypertension heterogeneity test showed <NUMBER> <NUMBER> given severity illness severity epidemic might contribute heterogeneity classified studies two subgroups according whether study site located wuhan however heterogeneity still exists random effect model used result indicated higher proportion hypertension criticalmortal groupor <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER> malignancy fixedeffect modeli <NUMBER> <NUMBER> metaanalysis showed proportion malignancy higher criticaldeath group yet without statistical significanceor <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> study clinical manifestation included <NUMBER> studies total <NUMBER> cases clinical features showed table <NUMBER> results metaanalysis showed table <NUMBER> fever temperature ≥ <NUMBER>°c proportion fever statistically laboratory examination included studies<NUMBER> studies total <NUMBER> cases shown table <NUMBER> wbc <NUMBER>x<NUMBER> <NUMBER> per l analysis results fixed effectmodeli <NUMBER> <NUMBER>showed proportion wbc <NUMBER>x<NUMBER> <NUMBER> per l statistically lower criticalmortal group<NUMBER>r <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER>figure<NUMBER> ast <NUMBER>ul cr ≥ <NUMBER>μmoll hsctni <NUMBER> pgml heterogeneity test results calculated <NUMBER> <NUMBER> <NUMBER> <NUMBER> used fixedeffect model analyses proportion ast <NUMBER>ul cr ≥ <NUMBER>μmoll hsctni <NUMBER> pgml statistically significant higher criticaldeath group compared noncritical group ast <NUMBER>ul<NUMBER>r <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER>cr ≥ <NUMBER>μmoll<NUMBER>r <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> hsctni <NUMBER> pgml<NUMBER>r <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> <NUMBER> value pct <NUMBER> ngml ldh <NUMBER>ul ddimer <NUMBER>mgl respectively <NUMBER> <NUMBER> <NUMBER> random effect model results metaanalysis showed male aged <NUMBER> smoking patients might face greater risk developing critical mortal condition comorbidities hypertension diabetes cardiovascular disease respiratory diseases could also greatly affect prognosis covid<NUMBER> found patients shortness breathdyspnea likely develop critical illness even die patients fever progressed better without fever laboratory examinations wbc ast cr hsctni pct ldh ddimer could imply progression covid<NUMBER> coronavirus enveloped nonsegmented singlestranded rna virus <NUMBER> present six human coronaviruses identified sarscov<NUMBER> isolated lower respiratory tract pneumonia patients unknown causes wuhan identified seventh human coronaviruses <NUMBER> sarscov<NUMBER> attacks alveolar epithelial cells via angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> ace isozyme mainly distributed cardiovascular kidneys testes lung colon organizations <NUMBER> main role ace<NUMBER> incise ang ii generate ang <NUMBER> mediates protective effects vasodilation antiinflammatory antiproliferation antagonize ang iiinduced vascular smooth muscle contraction cell proliferation fibrosis promotion vascular inflammation <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> binds ace<NUMBER> receptor surface alveolar epithelial cells expression ace<NUMBER> alveolar epithelial cells downregulated mechanisms internalization shedding viral replication <NUMBER> increased concentration ang ii leads inflammatory response exudation neutrophils macrophages fibrinous resulting loss pulmonary ventilation function difficulty maintaining oxygenation <NUMBER> time viral infection cause imbalance helper<NUMBER> helper<NUMBER> responses induce inflammatory storm increasing levels inflammatory factors interleukin<NUMBER> interleukin<NUMBER> interleukin<NUMBER> <NUMBER> inflammatory storm critical patients releases cytokines causing systemic immune injury may important cause multiple organ failure even death <NUMBER> studies found women less susceptible viral infection men possibly protection x chromosome sex hormones play important role innate adaptive immunity <NUMBER> time men tend associated bad lifestyle habits smoking underlying diseases result majority critical mortal patients male bodys immunity declines age elderly patients likely develop critical illness even die therefore patient male <NUMBER> years old smoking patient higher risk developing critical illness death patients combined basic diseases diabetes hypertension body state stress long time immunity tends low moreover longterm history diabetes hypertension damage vascular structure likely develop critical disease infection patients chronic heart disease likely infected due weakened heart function low immunity infected sarscov<NUMBER> likely acute cardiovascular events develop severe diseases patient previous respiratory diseases chronic obstructive pulmonary disease patients lung function damaged lower resistance virus prone developing ards thus underlying diseases diabetes hypertension cardiovascular disease respiratory disease risk factors disease progression consistent analytical results paper common clinical manifestations covid<NUMBER> patients fever cough sputum <NUMBER> patients immune response low may manifest normal body temperature shortness breath dyspnea suggests poor lung function lacking oxygen therefore patient found difficulty breathing fever necessary alert deterioration patients condition viral infection cause inflammation human body various inflammatory factors produced inflammatory storm cause systemic immune damage even cause multiorgan failure patients laboratory indicator shows pct <NUMBER> ngml higher risk progression critical illness study showed total number wbc early stage disease normal reduced <NUMBER> however wbc <NUMBER>x<NUMBER> <NUMBER> l means better clinical outcome paper therefore total number wbc found higher previous one patient may associated infections aggravated disease moment clinicians might pay attentions patients improve treatment ast <NUMBER>ul ldh <NUMBER>ul cr ≥ <NUMBER> moll indicates liver kidney dysfunctions involved corresponding treatments taken time prevent deterioration disease current studies shown <NUMBER> covid<NUMBER> patients abnormal coagulation function <NUMBER> monocytes tissue cells activated injury causing release cytokines expression tissue factors finally causing hypercoagulability blood increase risk thrombosis likely cause ischemia hypoxia due embolization viscera leads progression disease critical disease death ddimer <NUMBER>mgl indicates hypercoagulability blood suggests deterioration patients time sarscov<NUMBER> cause myocardial injury direct andor indirect action direct injury infect cardiomyocytes identifying ace<NUMBER> receptor indirect injury may caused inflammatory storm inducing immune response andor oxygen supply imbalance inducing acute respiratory distress syndrome hsctni <NUMBER>pgml strongly suggests possibility deterioration patients condition quality literature included study high analysis rigorous conclusions drawn study highly credible however metaanalysis also limitations studies included metaanalysis crosssectional studies insufficient demonstration ability b patients metaanalysis chinese aim use findings study predict overall profile patients including countries races c detailed patient information iconograph oxygen ion index available studies time analysis conclusions metaanalysis still need verified relevant studies careful design rigorous execution larger sample size study analyzed risk factors progression critical illness death covid<NUMBER> patients help assessing patient status identify critical patients early pay close attention risk factors relevant laboratory risk value appears timely personalized treatment regimens needed enhance efficacy reduce risk death fig <NUMBER> flow diagram study selection process table <NUMBER> minors rating scale①a clearly stated aim②inclusion consecutive patients ③prospective collection data④ endpoints appropriate aim study⑤unbiased assessment study endpoint⑥followup period appropriate aim study⑦loss follow less <NUMBER>⑧ prospective calculation study size⑨appropriate selection control group⑩synchronization control group ⑪baseline comparable groups ⑫appropriately statistical analysis global ideal score <NUMBER> comparative studies huang c heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences male age＞<NUMBER> years old current smoking criticalmortal noncritical patients figure <NUMBER> metaanalysis laboratory examination covid<NUMBER> cases fixeffect model wbc <NUMBER>x<NUMBER> <NUMBER> per l ast <NUMBER>ul cr ≥ <NUMBER>μmoll hsctni <NUMBER> pgml randomeffect model pct <NUMBER> ngml ldh <NUMBER>ul ddimer <NUMBER>mgl heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences laboratory examination criticalmortal noncritical patients severe critical disease defined according <NUMBER>th version guidelines diagnosis treatment covid<NUMBER> issued national health commission china follows severe disease met anyone following criteria shortness breath respiratory rate rr ≥<NUMBER> timesmin finger pulse oxygen saturation ≤<NUMBER> resting state arterial partial oxygen pressure pao <NUMBER> oxygen absorption concentration fio <NUMBER> ≤<NUMBER> mm hg <NUMBER> mm hg <NUMBER> kpa pulmonary imaging showed lesions progressed <NUMBER> within <NUMBER> hours b critical disease met anyone following conditions respiratory failure need mechanical ventilation shock organ failure requiring icu monitoring treatment clinical data severe critical covid<NUMBER> patients nucleic acid test respiratory samples sputum nasopharynx swab negative twice row sampling time interval least <NUMBER> hours continuous variable normal distribution represented mean ± standard deviation sd continuous variable nonnormal distribution represented median interquartile range iqr categorical variable displayed count percentage chisquare test used compare mortality rate among groups spss <NUMBER> statistical software ibm used statistical analysis p <NUMBER> considers significant table <NUMBER> table <NUMBER> table <NUMBER> total <NUMBER> <NUMBER> patients died <NUMBER> <NUMBER> patients healed discharged last <NUMBER> <NUMBER> patients remained hospital table <NUMBER> mortality rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients aged ≤<NUMBER> years patients aged <NUMBER> years patients aged <NUMBER> years patients aged ≥<NUMBER> years respectively comparison analysis revealed difference found among four group patients p <NUMBER> figure <NUMBER> notably ards p <NUMBER> mods p <NUMBER> correlated increased mortality rate electrolyte disorders p <NUMBER> hypoproteinemia p <NUMBER> associated mortality risk figure <NUMBER> meanwhile earlier study focusing chinese covid<NUMBER> patients observes median age around <NUMBER> years <NUMBER> study disclosed mean age severe critical covid<NUMBER> patients <NUMBER> years indicating severe critical disease popular aged population might result elders poor immunity increased basic diseases terms gender found proportion men twice women severe critical covid<NUMBER> patients might due men commonly outside public place instead women severe critical covid<NUMBER> patients complications lung diseases also common men medical history observed hypertension diabetes common severe critical covid<NUMBER> patients line conditions mers <NUMBER> regard clinical symptoms severe critical covid<NUMBER> patients admission observed fever dry f g u r e <NUMBER> mortality rate among different agesubgroups f g u r e <NUMBER> correlation common complications postadmission mortality rate ards acute respiratory distress syndrome mods multiple organ dysfunction cough common symptoms accordance findings previous studies covid<NUMBER> <NUMBER> similar patients merscov sars coronavirus infection <NUMBER> <NUMBER> terms laboratory indexes discovered blood routine indexes hepatic renal function indexes inflammation indexes commonly abnormal severe critical covid<NUMBER> patients might account covid<NUMBER> mainly acted lymphocytes especially lymphocytes similar sarscov <NUMBER> merscov <NUMBER> patients therefore essential timely monitor prevent ards mods potency however electrolyte disorders hypoproteinemia associated prognosis latter previously reported independent risk factor severe merscov infection <NUMBER> serum albumin could reflect nutritional status therefore related severe critical covid<NUMBER> aspect treatment regimen treatment procedures set according guidelines accumulating clinical experience based antiviral drugs supported treatments among antiviral drugs commonly used lopinavir ritonavir tablets clinical outcome covid<NUMBER> patients essential issue explored according previous metaanalysis mortality rate covid<NUMBER> patients ranges <NUMBER> <NUMBER> <NUMBER> meanwhile severe covid<NUMBER> patients present higher mortality rate <NUMBER> time study disclosed <NUMBER> patients still hospitalization therefore mortality rate might greatly underestimated <NUMBER> outcome criticalill covid<NUMBER> patients seldom report disclosed study found mortality rate high <NUMBER> severe critical covid<NUMBER> patients higher previous studies might longer followup duration study b criticalill patients also included study furthermore previous study reveals mortality rate severe mers around <NUMBER> <NUMBER> higher compared severe critical covid<NUMBER> patients study healed discharged rate <NUMBER> severe critical covid<NUMBER> patients realized acceptable notably observed small proportion patients discharged accordance current discharge standard tested positive new type coronavirus nucleic acid within <NUMBER> days isolation returned hospital treatment therefore suggested least three consecutive negative tests necessity discharge limitations existed study firstly since retrospective study potential bias residual confounding might exist secondly patients retrieved icu database therefore patients might represent general severe critical covid<NUMBER> patients thirdly still proportion patients hospitalization therefore mortality rate discharged rate might influenced summary severe critical covid<NUMBER> presents high mortality rate occurrence ards mods greatly increases mortality risk therefore essential early intervention prevent mildmoderate covid<NUMBER> progressing severe critical covid<NUMBER> early prevention ards mods also important improve prognosis covid<NUMBER> yiping yin httpsorcidorg<NUMBER> ince beginning year <NUMBER> several studies regarding epidemiological physiopathological clinical aspects novel coronavirus disease <NUMBER> covid <NUMBER> published rapid manner greatly contributed fast understanding novel disease rapidly helped physicians relatedhealth care workers policy makers better comprehension covid<NUMBER> novel disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> date may <NUMBER> <NUMBER> disease resulted considerable morbidity mortality worldwide <NUMBER> laboratoryconfirmed cases <NUMBER> deaths increasing evidence higher mortality risk associated presence cardiovascular involvement patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel coronavirus sarscov<NUMBER> appears easily transmittable contagious greater infectivity somehow similar higher morbidity mortality depending area considered compared severe acute respiratory syndrome coronavirus sars middle east respiratory syndrome coronavirus mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapidly increasing incidence patients sarscov<NUMBER> developed severe pneumonia pulmonary edema acute respiratory distress syndrome cardiovascular compromise multiple organ failure death cardiovascular diseases cvd still number one killer world represent leading noncommunicable epidemic since numerous patients cvd using angiotensinconverting enzyme inhibitors acei angiotensin receptor blockade arb drug agents clinical studies may necessary explore potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> despite theoretical concerns physiological uncertainties concerning effect ace inhibitors arb angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace inhibitors arb continued patients covid<NUMBER> otherwise stable condition position supported multiple medical scientific societies needs explored randomized clinical trials search potential associations pharmacological drugs susceptibility prognosis covid <NUMBER> exact mechanism cardiac injury among patients covid<NUMBER> still remains uncertain however different possible mechanisms manifested recent studies elaborated <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonischemic events ischemic myocardial involvement <NUMBER> main pathophysiological mechanisms acute cardiac injury covid<NUMBER> patients <NUMBER> believed nonischemic myocardial injury predominant secondary multiple mechanisms analyzed article huang et al <NUMBER> reported recently <NUMBER> patients covid<NUMBER>associated acute cardiac injury manifesting myocardial inflammation troponin tni elevation decreased left ventricular systolic function wang et al <NUMBER> recently reported findings <NUMBER> patients hospitalized covid<NUMBER> found <NUMBER> patients developed acute cardiac injury patients intensive care unit likely cardiac alterations <NUMBER> nonicu patients cardiac arrhythmias seen <NUMBER> patient known coronary artery disease heart failure patients higher risk others higher mortality covid<NUMBER> associated acute myocarditis acute myocardial infarction rapidonset heart failure <NUMBER> observation clearly suggests cardiovascular involvement especially cardiac injury possibly associated morbid clinical outcomes covid<NUMBER> therefore assess potential mechanisms cardiac injury association inflammation covid<NUMBER> patients aim analyze effect different serum biomarkers inflammation cardiac involvement incidence clinical outcomes mortality delineate importance guiding therapeutic management better cardiovascular outcome especially hospitalized patients covid<NUMBER> conducted electronic search pubmed medline web science scopus identify journal articles published english december <NUMBER> april <NUMBER> using medical subject heading text words coronavirus disease <NUMBER> covid<NUMBER> sarscov<NUMBER> cardiac injury biomarkers inflammation cardiac involvement fig <NUMBER> search articles reported observational studies clinical trials promoting relation cardiac involvement inflammation covid<NUMBER> considered articles eligible initial inclusion focused subject citations relevant articles reviewed capture additional studies also manually searched reference previous reviews records received fulltext review additional articles search years included referenced existing articles included pertinent important data present article randomized trials neither interventional studies available time investigation hence observational studies longterm prospective cohort studies casecontrol crosssectional studies also included article eligible inclusion studies written english published peerreviewed journal provides outcome data cardiac injury inflammation covid<NUMBER> study accordance ethical standards institutional research committee <NUMBER> helsinki declaration later amendments comparable ethical standards included studies first categorized whether study compared clinical outcomes cardiac involvement inflammation covid<NUMBER> patients initial search authors separately screened abstracts based eligibility criteria abstracts articles disagreement uncertainty reviewed discussed consensus reached due lack prospective randomized controlled clinical studies inflammation cardiac involvement exact mechanism cardiac injury among patients covid<NUMBER> still remains uncertain however different possible mechanisms manifested recent clinical observational studies elaborated discussed table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirusassociated acute myocarditis alhogbani <NUMBER> described evidence coronavirusassociated acute myocarditis manifested myocardial edema acute myocardial injury apical lateral walls left ventricle regional myocardial injury may result direct viral myocardial infection inflammation however according recent pathological study performed xu et al <NUMBER> scarce interstitial mononuclear inflammatory infiltrates myocardial tissue without substantial cardiac muscle tissue damage patient covid<NUMBER> suggesting coronavirus might directly impair hand study performed guo et al <NUMBER> plasma troponin levels positively linear correlated significant manner plasma highsensitivity creactive protein crp levels indicating myocardial injury may closely associated inflammatory pathogenesis progress disease considering patients elderly people probable association coronary heart disease whether myocardial injury directly associated sarscov<NUMBER> infection still unclear direct evidence demonstrating sarscov<NUMBER> infects myocardial tissue pericardial effusion liquid patients covid<NUMBER> currently lacking interest hundred thousands bodies available autopsy studies prospective investigation reported far elucidation disease pathogenesis prospective histopathological studies crucial future proper treatment case renewed outbreaks another plausible mechanism involves ace<NUMBER> latter human cell receptor strong binding affinity virus spike protein sarscov<NUMBER> since ace<NUMBER> also highly expressed heart reasonable hypothesize covid<NUMBER>induced cardiac injury might mediated ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> key counter regulatory enzyme degrades angiotensin ii angiotensin<NUMBER> thereby attenuating effects vasoconstriction sodium retention fibrosis although angiotensin ii primary substrate ace<NUMBER> enzyme also cleaves angiotensin angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also participates hydrolysis peptides ace<NUMBER> expressed broadly including heart kidneys lung alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> complexity underlying reninangiotensinaldosterone system raas clearly shows different responses different modulators presence sarscov <NUMBER> infection fig <NUMBER> enzyme active sites ace ace<NUMBER> distinct therefore ace inhibitors clinical use directly affect ace<NUMBER> activity <NUMBER> experimental animal studies shown mixed findings respect effects ace inhibitors arb ace<NUMBER> levels activity tissue <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies shown arb may increase messenger rna expression protein levels ace<NUMBER> tissue <NUMBER> <NUMBER> others showed effect <NUMBER> ostensibly inconsistent results demonstrate complex raas responses emphasize notion findings experimental animal studies may extrapolate similar physiological responses humans fact shows importance relevance human studies performed matter shed light comprehension least theoretically druginduced increased ace<NUMBER> expression produced acei arb might aggravate lung injury patients covid<NUMBER> however henry et al <NUMBER> previous clinical study showed beneficial effect acei patients admitted viral pneumonia retrospectively investigated impact ace inhibitors statins rates intubation death <NUMBER> adult patients positive respiratory viral polymerase chain reaction test found lower rates death intubation patients continued use ace inhibitors odds ratio ¼<NUMBER> <NUMBER> confidence interval ci <NUMBER> hospital stay moreover patients ace inhibitors hospital admission subsequently discontinued medication higher mortality patients ace inhibitor admission observed significantly reduction pulmonary inflammatory response cytokine release caused virus infection <NUMBER> addition mortensen et al <NUMBER> found significant decrease mortality length stay mechanical ventilation patients taking ace inhibitors arb hospitalized pneumonia compared matched cohort study done kuba et al <NUMBER> provided first genetic proof molecular evidence severe lung failure mortality associated sarscov demonstrated infections sarscov resulted ace<NUMBER> downregulation binding sarscov spike protein ace<NUMBER> contributed severity lung pathologies showed severity could attenuated blocking reninangiotensin pathway <NUMBER> authors mentioned fact providing molecular link sarscov pathogenesis role raas lung failure envisioned novel target therapeutic management recombinant ace<NUMBER> protein could treatment block virus spreading modulation reninangiotensin system could also utilized protect patients covid<NUMBER> beneficial effect aceiarb may related compensatory increase ace<NUMBER> <NUMBER> however evidence regarding use aceiarb patients covid<NUMBER> infection still emerging larger prospective randomized clinical studies required present patients covid<NUMBER> previously used acei arb use drug agents may need discontinued based current data another possible mechanism involved cardiac injury may increased cytokine secretion covid<NUMBER> previous research <NUMBER> patients established clinical diagnosis sarscov prospectively studied li et al <NUMBER> found significantly higher left ventricular index myocardial performance <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> longer isovolumic relaxation time <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> milliseconds p <NUMBER> lower flow propagation velocity <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> cms p <NUMBER> dopplerderived cardiac output <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> lmin p <NUMBER> observed acute infection compared <NUMBER> days decrease left ventricular ejection fraction correlated moderately elevated lactate dehydrogenase level r −<NUMBER> p <NUMBER> whereas higher index myocardial performance correlated weakly increase creatine kinase level r <NUMBER> p <NUMBER> <NUMBER>day echocardiographic followup study found reversible subclinical diastolic left ventricular impairment appears common finding acute sarscov infection even among patients without underlying cardiac disease suggested left ventricular dysfunction acute phase disease might attributable cytokine storm syndrome resulting overaggressive host immune response sarscov infection <NUMBER> huang et al <NUMBER> found severely ill patients covid<NUMBER> admitted intensive care unit higher plasma levels cytokines including interleukin il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor igginduced protein <NUMBER> also higher plasma levels monocyte chemoattractant protein<NUMBER> macrophage inflammatory protein <NUMBER>alpha tumor necrosis factor α indeed serious lifethreatening disease clinical features systemic inflammation methemoglobinemia hemodynamic instability multiple organ failure trademark clinical endorsement cytokine storm syndrome severe uncontrolled dysfunctional immune response involving continuous activation proliferation lymphocytes macrophages markers inflammatory response crp procalcitonin leukocytes also found significantly increased among patients suffered cardiac injury <NUMBER> infectionrelated increased cytokine release identified elevated plasma level several inflammatory biomarkers various inflammatory serum markers shown elevated patients covid<NUMBER>related cardiac injury crp procalcitonin ferritin ddimer il<NUMBER> il<NUMBER> granulocyte colonystimulating factor igginduced protein <NUMBER> chemokine ligand <NUMBER> tumor necrosis alpha therefore storming activation secretion inflammatory cytokines lead apoptosis necrosis myocardial cells covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> regard huang et al <NUMBER> demonstrated imbalance helper <NUMBER> helper <NUMBER> responses resulting cytokine storm may contributed myocardial injury patients covid<NUMBER> release inflammatory cytokines infection may cause reduction coronary blood flow decreased oxygen supply another interesting factor consider presence preexisting cvds might also render patients susceptible covid<NUMBER>induced heart injury shi et al <NUMBER> demonstrated patients cardiac injury history coronary heart disease <NUMBER> hypertension <NUMBER> significantly prevalent patients without cardiac injury wang et al <NUMBER> found similar percentages patients critically ill covid<NUMBER> <NUMBER> underlying heart diseases <NUMBER> hypertension reasonable assume patients predisposing cvds coronary artery disease heart failure susceptible cardiac injury patients infected covid<NUMBER> myocardial ischemia infarction left ventricular systolic dysfunction likely occur ultimately leading sudden deterioration intrinsic inflammatory process within atherosclerotic plaques coronary walls exacerbated systemic inflammatory response covid<NUMBER> making susceptible fissure initiating acute coronary syndrome <NUMBER> altered myocardial demandsupply ratio association increased cardiometabolic demand myocardial tissue result myocyte hypoxia alteration context systemic infection associated acute respiratory illnessrelated hypoxia impair myocardial oxygen demandsupply relationship lead acute myocardial injury <NUMBER> addition systemic inflammation also causes endothelial dysfunction increases procoagulant activity blood contribute formation occlusive thrombi ruptured coronary plaque context inflammation hypoxemic state covid<NUMBER> atrial fibrillation may supervene worsening prognosis developing heart failure <NUMBER> several observational studies reported evidence higher morbidity mortality risk associated findings inflammation cardiovascular involvement especially cardiac injury patients covid<NUMBER> therefore concluded cardiac injury common condition among hospitalized patients covid<NUMBER> associated higher risk inhospital mortality <NUMBER> first study showing cardiac injury independently associated increased risk mortality patients covid<NUMBER> unfortunately study lacks imaging evidence nuclear magnetic resonance ct scans echocardiography determine features myocardial injury inflammation hence due current limited evidence based clinical investigation observational studies question whether novel coronavirus directly injure cardiac tissue requires investigation demonstration context <NUMBER> recent case reports documenting myocardial inflammation damage mri histological studies patients covid<NUMBER> <NUMBER> <NUMBER> recent case reports highlight importance clinical surveillance laboratory testing directly targeting serum troponin levels guarantee appropriate rapid identification atypical cases acute illness covid<NUMBER> proceed prompt isolation patients eventually reduce transmission viral diseases harm myocardial cells direct myocyte damage virus systemic inflammatory responses han et al <NUMBER> studied analyzed detail main laboratory markers associated cardiac injury covid<NUMBER> patients investigated correlation heart injury severity disease specifically analyzed serum levels creatine kinase isoenzymemb myohemoglobin myo cardiac tni ultratni nterminal probrain natriuretic peptide ntprobnp <NUMBER> covid<NUMBER> patients patients divided <NUMBER> groups according strict diagnostic criteria clinical condition mild <NUMBER> cases severe <NUMBER> cases critical <NUMBER> cases positive rate myo ultratni ntprobnp higher severe cases critical cases compared mild cases differences among groups statistically significant p <NUMBER>these findings showed higher concentrations venous blood creatine kinase isoenzymemb myo ultratni ntprobnp associated severity mortality covid<NUMBER> note authors analyzed <NUMBER> cardiac injury parameters death n <NUMBER> alive patients n <NUMBER> <NUMBER> parameters significantly higher death alive group p <NUMBER> therefore authors concluded careful monitoring myocardial enzyme profiles great importance reducing complications mortality covid<NUMBER> patients <NUMBER> context interesting metaanalysis performed lippi et al <NUMBER> total number <NUMBER> patients found tni plasma values significantly increased patients severe covid<NUMBER> compared patients milder forms disease therefore seems rational assume initial measurements serum biomarkers cardiac injury performed immediately hospitalization covid<NUMBER> patients inhospital monitoring may help identifying subset severe cases possible cardiac involvement consequently predict progression towards worse clinical scenario guo et al <NUMBER> performed retrospective singlecenter case series study analyzed <NUMBER> patients confirmed covid<NUMBER> mean age <NUMBER> ± <NUMBER> years evaluated association underlying cvd myocardial injury fatal outcomes patients covid<NUMBER> <NUMBER> patients <NUMBER> patients <NUMBER> discharged hospital <NUMBER> patients <NUMBER> died overall <NUMBER> <NUMBER> patients underlying cvd including hypertension coronary heart disease cardiomyopathy <NUMBER> <NUMBER> exhibited myocardial injury indicated elevated troponin tnt levels mortality hospitalization <NUMBER> patients without underlying cvd normal tnt levels <NUMBER> underlying cvd normal tnt levels <NUMBER> without underlying cvd elevated tnt levels <NUMBER> underlying cvd elevated tnts fig <NUMBER> patients underlying cvd likely exhibit elevation tnt levels compared patients without cvd <NUMBER> vs <NUMBER> plasma tnt levels demonstrated high significantly positive linear correlation plasma highsensitivity crp levels β <NUMBER> p <NUMBER> ntprobnp levels β <NUMBER> p <NUMBER> hospitalization patients elevated tnt levels frequent malignant arrhythmias use glucocorticoid therapy <NUMBER> vs <NUMBER> mechanical ventilation <NUMBER> vs <NUMBER> higher compared patients normal tnt levels mortality rates patients without use aceiangiotensin receptor blockers <NUMBER> <NUMBER> therefore authors concluded myocardial injury significantly associated fatal outcome covid<NUMBER> prognosis patients underlying cvd without myocardial injury relatively favorable myocardial injury associated cardiac dysfunction arrhythmias inflammation may potential mechanism myocardial injury aggressive treatment may considered patients high risk myocardial injury interestingly authors demonstrated high significantly positive linear correlation troponin plasma highsensitivity crp levels biomarkers cardiac injury systemic inflammation respectively fig <NUMBER> guo et al <NUMBER> observed <NUMBER> <NUMBER> patients exhibited myocardial injury demonstrated elevation troponin levels mortality markedly higher patients elevated tnt levels normal tnt levels <NUMBER> vs <NUMBER> nearly <NUMBER> mortality covid<NUMBER> patients underlying cvd elevated troponin levels addition data ntprobnp showed serum elevation presence malignant arrhythmias significantly common patients elevated tnt levels moreover serum levels ntprobnp significantly correlated tnt levels respect gao et al <NUMBER> studying <NUMBER> patients covid<NUMBER> reported best cutoff value ntprobnp <NUMBER> pgml predicting inhospital death found excellent sensitivity good specificity fig <NUMBER> patients high ntprobnp values significantly increased risk death comparing low values adjustment potential risk factors ntprobnp independently correlated inhospital death <NUMBER> results <NUMBER> latter studies argue favor concept greater cardiac injury greater ventricular dysfunction covid<NUMBER> patients also patients underlying cvd prone experience myocardial injury course covid<NUMBER> known direct association sarscov<NUMBER> qt interval prolongation electrocardiogram covid<NUMBER> patients however known association prolonged qt interval cardiac arrhythmias among certain drug agents may utilized therapeutic management covid<NUMBER> hydroxychloroquine azithromycin utilized potential pharmacological agents prophylaxis therapeutic management covid<NUMBER> drug agents known provoke malignant ventricular arrhythmias certain patients <NUMBER> <NUMBER> <NUMBER> hydroxychloroquine acts entry postentry stages sarscov<NUMBER> via effects endosomal ph resulting underglycosylation ace <NUMBER> receptors required viral entry since may prolong qt interval develop ventricular arrhythmias given extreme cautious association qt interval prolonging drugs fig <NUMBER> case reports patients systemic lupus erythematosus showing hydroxychloroquineinduced qt interval prolongation developing torsade de pointes <NUMBER> <NUMBER> azithromycin increasingly recognized antibiotic may cause qt prolongation malignant ventricular arrhythmias nonpausedependent polymorphic ventricular tachycardia torsade des points increased risk sudden cardiac death <NUMBER> limited data evaluating safety clinical outcome combination therapy <NUMBER> pharmacological agents effect combination qt interval arrhythmia risk studied therefore multiple randomized clinical trials currently ongoing studies table <NUMBER> shows certain care safety considerations consider novel coronavirus sarscov<NUMBER> appears transmittable greater infectivity somehow similar higher morbidity mortality depending area considered compared sars mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> far greater incidence patients sarscov<NUMBER> developed severe pneumonia pulmonary edema acute respiratory distress syndrome cardiovascular compromise multiple organ failure death oudit et al <NUMBER> previously demonstrated sarscov genome positively detected myocardial tissue <NUMBER> patients sarscov infection raises possibility direct damage cardiomyocytes virus sarscov<NUMBER> may share mechanism sarscov <NUMBER> viruses highly homologous genome <NUMBER> <NUMBER> animal experimental studies shown strains coronavirus infection may seriously affect heart example coronavirus infection may induce cardiomyopathy results cardiac chamber dilatation impairment systolic function simulating dilated cardiomyopathy rabbits <NUMBER> context cardiomyopathy interesting note dong et al <NUMBER> reported <NUMBER> endstage heart failure patients infected covid<NUMBER> <NUMBER> severe illness presentation <NUMBER> patients male typical lymphopenia significantly increased crp level three patients elevated tni later evolution period tni increased significantly days death moreover levels crp brain natriuretic peptide significantly higher interesting finding tni level <NUMBER> critically ill patients increased significantly <NUMBER>fold indicating important myocardial injury patients endstage heart failure seemed older comorbidity poor general condition greater myocardial injury higher mortality rate covid<NUMBER> according novel knowledge acquired recent studies covid<NUMBER> patients manifested cardiac injury presented severe acute illness requiring noninvasive invasive ventilation compared patients without cardiac injury also manifested clearly abnormal laboratory radiographic findings mortality half hospitalized patients worth comparing cardiovascular findings covid<NUMBER> sars <NUMBER> years ago <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> yu et al <NUMBER> studied cardiovascular complications sars <NUMBER> hospitalized patients observed hypertension occurred <NUMBER> patients <NUMBER> developed persistent tachycardia including <NUMBER> continued tachycardia outpatient followup therefore tachycardia could explained fever already subsided neither explained coexisting hypotension present comparatively small number patients although tachycardiarelated cardiovascular complications common patients sars generally selflimiting associated mortality types cardiac arrhythmias uncommon patients sars transient atrial fibrillation occurred <NUMBER> patient history cardiac disease therefore cardiac arrhythmiaassociated effect coronavirus causes sars low total <NUMBER> <NUMBER> patients developed arterial desaturation needed oxygen therapy however <NUMBER> <NUMBER> patients admitted intensive care unit <NUMBER> <NUMBER> patients died due pneumonia <NUMBER> contrast sars findings half patients cardiac injury experienced inhospital death covid<NUMBER> indicating novel coronavirusinduced cardiac injury associated major adverse clinical outcomes worse prognosis <NUMBER> indeed cardiac injury found independently associated increased risk mortality patients covid<NUMBER> myocardial injury common pathways inflammation significantly associated higher risk inhospital mortality figure <NUMBER> hydroxychloroquine therapy according cardiovascular risk hcq hydroxychloroquine qtc corrected qt interval reprinted permission ind pac electrophysiol j <NUMBER> overall fatal outcome covid<NUMBER> identified several potential mechanisms myocardial tissue damage namely coronavirusassociated acute myocarditis ace<NUMBER> receptor binding affinity virus spike protein increased cytokine secretion hypoxiainduced cardiac myocyte apoptosis myocardial injury found related cardiac dysfunction ventricular arrhythmias independently associated increased risk mortality patients covid<NUMBER> inflammation may potential mechanism myocardial injury high significantly positive linear correlation troponin plasma highsensitivity crp levels biomarkers cardiac injury systemic inflammation respectively although several possible mechanisms myocardial tissue damage exact mechanism cardiac injury needs explored welldesigned clinical studies strong efforts continued research cardiovascular complications identification risk factors poor prognosis covid<NUMBER> steadily needed given high infectivity lethality covid<NUMBER> enormous economic social impact worldwide outbreak elucidation disease pathogenesis prospective histopathological studies crucial future treatment case renewed outbreaks cvds still number one killer world represent leading noncommunicable epidemic since numerous patients cvd using aceiarb drug agents clinical studies may necessary explore potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> despite theoretical concerns physiological uncertainties concerning effect raas inhibitors ace<NUMBER> ace inhibitors arb drug agents continued patients covid<NUMBER> otherwise stable condition <NUMBER> <NUMBER> <NUMBER> position supported multiple medical scientific societies needs explored randomized clinical trials search potential associations pharmacological drugs susceptibility prognosis covid<NUMBER> high morbidity mortality covid<NUMBER> monumental economic burden social impact despair new pandemic outbreak thread potential utilization novel sarscov<NUMBER> biologic weapons make preponderant necessity better comprehend therapeutic management lethal disease emerging acute infectious disease covid<NUMBER> may become chronic epidemic genetic recombination therefore ready reemergence covid<NUMBER> coronaviruses near future nothing declare considerations <NUMBER> <NUMBER> <NUMBER> series pneumonia cases unknown origin emerged wuhan hubei province china december <NUMBER> clinical presentations similar viral pneumonia <NUMBER> pneumonia newly recognized illness spread rapidly across country around world days initial outbreak chinese scientists managed identify novel coronavirus <NUMBER> later named severe acute respiratory syndromecoronavirus <NUMBER> sarscov<NUMBER> virus classified ß cov group <NUMBER>b least similarity genetic sequence severe acute respiratory syndromecoronavirus sarscov<NUMBER> sars zoonosis caused sarscov<NUMBER> first appeared china <NUMBER> spread <NUMBER> countries <NUMBER> causing global outbreak <NUMBER> cases <NUMBER> coronaviruses viruses singlestranded rna enveloped fatcoated substance virus belongs coronaviridae family encountered humans mammals although coronavirus infection generally mild previous two betacoronavirus epidemics namely sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov caused cumulative case <NUMBER> patients <NUMBER> case fatality rate sarscov<NUMBER> <NUMBER> merscov <NUMBER> <NUMBER> clinical spectrum sarscov<NUMBER> pneumonia ranges mild critically ill cases previous studies reported epidemiological findings clinical presentation clinical outcomes however specific information identifying critically ill patients remains unknown recently cardiac injury reported associated mortality <NUMBER> mortality critically ill patients sarscov<NUMBER> pneumonia substantial <NUMBER> older patients comorbidities adult respiratory distress syndrome ards increased risk death <NUMBER> therefore studying association acute cardiac injury mortality covid<NUMBER> essential justified prevention preparation hospitals facing global pandemics systematic review metaanalysis aimed explore association acute cardiac injury mortality need intensive care unit icu care acute respiratory distress syndrome ards severe covid<NUMBER> patients covid<NUMBER> metaanalysis accomplished agreement preferred reporting items systematic reviews metaanalysis prisma statement <NUMBER> included research articles adult patients diagnosed covid<NUMBER> information hsctnl cardiac injury clinical grouping outcome clinically validated definition mortality need icu care acute respiratory distress syndrome ards severe covid<NUMBER> following types article excluded articles original research eg case report series review articles letters editor editorials commentaries duplicate publication nonenglish articles systematically searched pubmed scopus europepmc proquest cochrane central databases search terms covid<NUMBER> sarscov<NUMBER> cardiac disease cardiovascular disease acute cardiac injury ards critically ill covid<NUMBER> search results limited year <NUMBER> duplicate results removed remaining articles independently screened relevance abstracts two authors remaining investigators read full selected articles met requirements provided final suggestions articles thoroughly read fulfilled criteria included study final inclusion studies merely based agreements investigators disagreement resolved consensus full text residual articles assessed according inclusion exclusion criteria search finalized march <NUMBER>th <NUMBER> data extraction performed independently two authors used standardized forms include authors year study study design age gender hsctnl including cutoff point history hypertension history coronary arterycardiovascular diseases cardiac injury mortality ards need icu care severe covid<NUMBER> definition cardiac injury follows included studies includes highly sensitive cardiac troponin hsctnl n<NUMBER>th percentile regardless electrocardiography echocardiography result studies reported elevation hsctnl <NUMBER>th percentile considered cardiac injury primary outcome mortality secondary outcomes ards need icu care severe covid<NUMBER> acute respiratory distress syndrome defined per world health organization interim guidance severe acute respiratory infection sari covid<NUMBER> including acute onset chest imaging origin pulmonary infiltrates oxygenation impairment <NUMBER> severe covid<NUMBER> defined patients following features time admission <NUMBER> respiratory distress ≥<NUMBER> breaths per min <NUMBER> oxygen saturation rest ≤<NUMBER> <NUMBER> ratio partial pressure arterial oxygen pao<NUMBER> fractional concentration oxygen inspired air fio<NUMBER> ≤<NUMBER> mmhg <NUMBER> critical complication respiratory failure septic shock andor multiple organ dysfunctionfailure <NUMBER> perform metaanalysis review manager <NUMBER> copenhagen cochrane collaboration <NUMBER> stata version <NUMBER> statacorp lp texas <NUMBER> usa used continuous variables reported means standard deviations sds calculated using inversevariance method dichotomous variables calculated using mantelhaenszel formula random effects models used regardless heterogeneity mean differences mds risk ratios rrs reported <NUMBER> confidence intervals cis continuous dichotomous variables respectively pvalue twotailed statistical significance set ≤<NUMBER> sensitivity analysis leaveoneout performed single heterogeneity heterogeneity assessed qstatistic test <NUMBER> test <NUMBER> statistic measured percentage total variation across studies due clinical methodological heterogeneity instead chance significant q statistics p b <NUMBER> indicated heterogeneity across studies random effect model utilized metaanalysis otherwise fixedeffect model utilized substantial heterogeneity represented <NUMBER> n<NUMBER> <NUMBER> assess smallstudy effect publication bias performed regressionbased eggers test continuous variable harbords test binary outcome also performed qualitative assessment publication bias using inverted plot analysis asymmetrical shape indicates publication bias found total <NUMBER> records <NUMBER> remained removal duplicates one hundred twentyone records excluded screening titleabstracts assessing <NUMBER> fulltext eligibility excluded <NUMBER> fulltext articles <NUMBER> dichotomous outcome interest elevated troponincardiac injury andor hsctni n <NUMBER> <NUMBER> specific population myocarditis cardiovascular manifestation n <NUMBER> included <NUMBER> studies qualitative synthesis <NUMBER> metaanalysis fig <NUMBER> total <NUMBER> patients <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> baseline characteristics included studies presented table <NUMBER> studies retrospective observational included studies defined cardiac injury hsctni elevation <NUMBER>th percentile studies specify definition cardiac injury however studies presumably used similar definition existing studies fig <NUMBER> metaanalysis showed cardiac injury associated higher mortality rr <NUMBER> <NUMBER> <NUMBER> p b <NUMBER> <NUMBER> <NUMBER> p <NUMBER> sensitivity analysis showed heterogeneity mortality outcomes level hsctni higher patients primary secondary outcome mean difference <NUMBER> pgml <NUMBER> <NUMBER> p <NUMBER> <NUMBER> <NUMBER> p <NUMBER> fig <NUMBER> funnelplot analysis showed asymmetrical shape outcomes fig <NUMBER>a b c indicating possible publication bias regressionbased harbords test showed indication smallstudy effects mortality p <NUMBER> eggers test showed indication smallstudy effects sensitive troponin primary secondary outcome p <NUMBER> metaanalysis demonstrated acute cardiac injury represented elevated troponin concentration associated increased mortality need icu care severe covid<NUMBER> although association cardiac injury ards show statistical significance essential clinical standpoint findings beneficial considered clinical management prevention preparation patient safety issues hospital setting covid<NUMBER> global pandemic previously reported mortality critically ill patients covid<NUMBER> fig <NUMBER> cardiac injury secondary outcome cardiac injury associated increased need icu care severe covid<NUMBER> association significant ards ards acute respiratory distress syndrome icu intensive care unit pneumonia high survival period nonsurvivors likely within <NUMBER> <NUMBER> weeks icu admission elderly patients comorbidities ards increased risk mortality consequently severity covid<NUMBER> pneumonia poses high burden hospital care resources shortage medical personnel <NUMBER> previously letter editor reporting metaanalysis <NUMBER> studies showed troponin levels associated severity disease presented standardized mean difference result subgroup analysis cardiac injury severe covid<NUMBER> supported notion best authors knowledge study first metaanalysis evaluates relationship cardiac injury mortality covid<NUMBER> presents effect estimate dichotomous form rr also applicable secondary outcome present metaanalysis showed cardiac injury associated rr <NUMBER> mortality result gave clinicians information impact clinical importance cardiac injury mortality covid<NUMBER> shown study likely due cytokine storm syndrome fulminant myocarditis fulminant myocarditis primarily caused viral infection arises quickly progresses rapidly results severe heart failure circulatory failure clinical presentation hypotension cardiogenic shock mortality rate high <NUMBER> <NUMBER> <NUMBER> portion patients covid<NUMBER> interstitial mononuclear cells shown infiltrate myocardium autopsies <NUMBER> case reports covid<NUMBER>induced myocarditis also available <NUMBER> <NUMBER> exact mechanism still unknown myocardial damage might due direct injury virus exacerbated hosts secondary immune response phenomenon observed viral myocarditis causes possibly also applies covid<NUMBER> <NUMBER> <NUMBER> following spike protein activation transmembrane protease serine <NUMBER> tmprss<NUMBER> viral surface spike protein binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> receptorbinding domain rbd sarscov<NUMBER> protein higher binding affinity human ace<NUMBER> significantly higher compared sarscov<NUMBER> <NUMBER> <NUMBER> although ace<NUMBER> slightly expressed cardiomyocyte highly expressed pericytes covid<NUMBER> may attack pericytes essential endothelial stability causing capillary endothelial dysfunction leads microcirculatory disorders <NUMBER> explains although ace<NUMBER> slightly expressed cardiomyocytes covid<NUMBER> may cause cardiac injury patients cardiovascular comorbidity heart failure thought susceptible cardiac injury due significantly increased ace<NUMBER> expression <NUMBER> reflected metaanalysis six studies showing patients cardiovascular metabolic disease risk increased severity <NUMBER> however rise troponin cardiac injury also paralleled increase inflammatory biomarkers may indicate role cytokine storm addition direct cardiac injury <NUMBER> manifestation may explain cardiac injury potentially linked ards might surrogate marker cytokine storm vice versa <NUMBER> metaanalysis suggests elevated troponin cardiac injury associated poor outcomes nevertheless troponin cardiac injury marker poor prognosis patients covid<NUMBER> simply encourage inclusion troponin constructing prognostication model patient covid<NUMBER> <NUMBER> highlysensitive troponin primary secondary outcome elevated hsctni associated poor outcome hsctni highlysensitive troponin pandemic risk stratification triage necessary troponin potential indicator highrisk patients limitation study first presence publication bias possibly due shortage studies pertinent issues articles included study preprints nevertheless authors made exhaustive efforts ensure sound studies included studies china patients might overlap across reports second included studies also mostly retrospective design cardiac injury associated mortality need icu care severity disease patients covid<NUMBER> high mortality covid<NUMBER> likely due cytokine storm fulminant myocarditis december <NUMBER> series pneumonia cases unknown etiology emerged wuhan central china population <NUMBER> million people thought related exposure huanan seafood wholesale market <NUMBER> <NUMBER> condition later confirmed coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> different normal pathogens virus powerful extended rapidly chinese cities countries thus leading widespread pneumonia <NUMBER> <NUMBER> <NUMBER> number covid<NUMBER> cases sharply increased china <NUMBER> times outside china number affected countries tripled consideration alarming levels spread severity world health organization characterized covid<NUMBER> pandemic march <NUMBER> <NUMBER> covid<NUMBER> poses great public health clinical burden worldwide epidemiological clinical characteristics patients covid<NUMBER> reported sarscov<NUMBER> infection wide clinical spectrum including asymptomatic infection mild respiratory disease severe pneumonia acute respiratory failure even death hematological changes including lymphopenia thrombocytopenia reported patients covid<NUMBER> similar sars <NUMBER> <NUMBER> <NUMBER> abnormal coagulation common complication covid<NUMBER> manifested pulmonary vascular leakage intravascular thrombosis disseminated intravascular coagulation thrombocytopenia also common clinical manifestation associated poor outcome patients communityacquired pneumonia <NUMBER> platelets contribute hemostasis also participate inflammation host defense response latter especially important lungs infected although many cases thrombocytopenia reported patients severe viral pneumonia thus suggestive clinical characteristic covid<NUMBER> association baseline platelets changes adverse covid<NUMBER> outcome remains unclear hospitalbased cohort study conducted patients laboratoryconfirmed covid<NUMBER> evaluate association platelets admission mortality particularly dynamic changes circulating platelets role disease progression retrospective cohort study conducted <NUMBER> patients covid<NUMBER> central hospital wuhan january <NUMBER> <NUMBER> followed march <NUMBER> <NUMBER> covid<NUMBER> diagnosed according world health organization interim guidance <NUMBER> patients laboratoryconfirmed human infection throat swab specimens enrolled malignant tumors post craniocerebral operation died admission treatment antiplatelet drugs transferred medical institutions excluded enrolled patients followed discharge death requirement informed consent waived due urgency collect data emerging sarscov<NUMBER> study approved ethics committees central hospital wuhan case report forms nursing records laboratory findings radiological characteristics reviewed team physicians treat patients covid<NUMBER> demographic characteristics gender age comorbidities chronic obstructive pulmonary disease hypertension diabetes cardiovascular disease cerebrovascular disease chronic kidney disease clinical manifestations laboratory findings treatment outcomes discharge death extracted electronic medical records laboratory data including white blood cell count neutrophil count lymphocyte count hemoglobin platelet count creactive protein procalcitonin blood urea nitrogen creatinine total bilirubin alanine aminotransferase aspartate aminotransferase fibrinogen ddimer lactate dehydrogenase creatine kinase arterial blood gases lactate pao <NUMBER> fio <NUMBER> ratio collected admission additional platelet parameters including plateletcrit pct mean platelet volume mpv fl platelet distribution width platelet larger cell ratio plcr also gathered according test projectmanual reagent instructions central hospital wuhan normal reference interval platelet count <NUMBER> × <NUMBER> <NUMBER> l therefore thrombocytopenia defined blood platelet <NUMBER> × <NUMBER> <NUMBER> l nonthrombocytopenia defined blood platelet <NUMBER> × <NUMBER> <NUMBER> l acute physiology chronic health evaluation ii scores apache ii sequential organ failure assessment curb<NUMBER> criteria determined within <NUMBER> h admission data treatment measures including antibiotic antivirus glucocorticoid intravenous immunoglobulin therapy respiratory support acquired hospitalization throat swab samples collected suspected patients admission laboratory confirmation sarscov<NUMBER> performed using realtime reverse transcriptionpolymerase chain reaction according manufacturers protocol beijing genomics institution geneodx biotechnology co ltd repeated tests sarscov<NUMBER> performed confirmed patients verify viral clearance hospital discharge baseline characteristics continuous categorical variables presented median interquartile range n respectively examined mannwhitney u test χ <NUMBER> test fishers exact test appropriate association baseline platelet parameters mortality risk estimated cox proportional hazards regression models terms following confounders age sex baseline comorbidities including chronic obstructive pulmonary disease hypertension diabetes chronic kidney disease cardiovascular disease cerebrovascular disease glucocorticoid immunoglobulin might affect hematopoietic system treatments common clinical practice addition decreased lymphocyte count represents progression disease creactive protein represents overall inflammation augment blood lactate represents acute lung injury tissue hypoxia andor oxygen debt associated mortality critical patients <NUMBER> therefore also considered regression models smoothing spline presenting association baseline platelet levels platelets change subsequent mortality generated utilizing generalized additive model survival curve plotted using kaplanmeier method examined using logrank test statistical analyses performed using r software r foundation httpwwwrprojectorg version <NUMBER> empowerstats http wwwempowerstatscom xy solutions inc boston unless otherwise indicated twosided significance level p <NUMBER> used evaluate statistical significance among <NUMBER> covid<NUMBER> patients median <NUMBER> days range <NUMBER> <NUMBER> days followup period <NUMBER> <NUMBER> discharged survived <NUMBER> <NUMBER> died clinical characteristics patients stratified admission platelets presented table median age <NUMBER> years <NUMBER> <NUMBER> patients male significant differences comorbidities observed patients thrombocytopenia nonthrombocytopenia patients thrombocytopenia admission likely older higher apache ii score nonthrombocytopenia patients administered antibiotics treated ribavirin <NUMBER> oseltamivir <NUMBER> arbidol <NUMBER> empiric systemic glucocorticoid therapy <NUMBER> intravenous immunoglobulin <NUMBER> used antiinflammatory treatment noninvasive ventilation used <NUMBER> patients <NUMBER> thrombocytopenia group higher proportion noninvasive ventilation therapy <NUMBER> vs <NUMBER> mortality rate <NUMBER> vs <NUMBER> without thrombocytopenia dynamic changes platelet count day <NUMBER> day <NUMBER> onset disease tracked determine major clinical features observed covid<NUMBER> progression compared nonsurvivors level platelets showed increasing trend survivors admission p <NUMBER> figure <NUMBER> additionally platelets negatively associated apache ii score higher indicates higher disease severity admission figure <NUMBER> admission patients thrombocytopenia lower white blood cell neutrophil lymphocyte count higher levels procalcitonin creactive protein compared without thrombocytopenia table remarkable differences found levels total bilirubin aspartate aminotransferase blood urea nitrogen creatinine ddimer indicators significantly higher patients thrombocytopenia without thrombocytopenia decreased levels pao <NUMBER> fio <NUMBER> observed thrombocytopenia group compared nonthrombocytopenia group analysis platelet parameters revealed patients thrombocytopenia lower levels platelets pct higher levels mpv plcr without thrombocytopenia cox proportional hazard regression models adjusted several deathrelated risk factors admission including age sex baseline comorbidities lymphocyte count blood lactate creactive protein glucocorticoid therapy intravenous immunoglobulin results revealed adjustment potential confounders platelets pct independent risks mortality table ii doseresponse analyses per <NUMBER> × <NUMBER> <NUMBER> l increment platelet count significantly associated abbreviations apache ii acute physiology chronic health evaluation ii copd chronic obstructive pulmonary disease fio <NUMBER> fraction inspired oxygen iqr interquartile range pao <NUMBER> partial pressure oxygen p values indicate differences thrombocytopenia nonthrombocytopenia patients table iii analysis <NUMBER> patients platelet count <NUMBER> × <NUMBER> <NUMBER> l association still robust smoothing spline plotted visually present nonlinear relationship platelets admission mortality observed mortality decreased elevating platelet count curve gradually tends gentle platelet count <NUMBER> × <NUMBER> <NUMBER> l figure <NUMBER>a continuous tracking changes platelets within first <NUMBER> days admission revealed platelets increased risk death decreased treatment viceversa figure <NUMBER>b analysis showed worst outcome noted subgroup patients platelet level <NUMBER> × <NUMBER> <NUMBER> l admission decrease <NUMBER> days followed patients platelet level <NUMBER> × <NUMBER> <NUMBER> l admission increase <NUMBER> days patients platelet level <NUMBER> × <NUMBER> <NUMBER> l admission decrease <NUMBER> days patients platelet level <NUMBER> × <NUMBER> <NUMBER> l admission increase <NUMBER> days figure <NUMBER> patients covid<NUMBER> usually rapid progression pneumonitis even develop ards death among <NUMBER> covid<NUMBER> patients enrolled admitted platelets normal range thrombocytopenia although majority current studies revealed decreased number platelets groups severe covid<NUMBER> <NUMBER> <NUMBER> research investigated dynamic changes platelets estimated association baseline platelets platelets change subsequent mortality patients infected sarscov<NUMBER> present study clinical characteristics compared patients without thrombocytopenia cox proportional hazard regression analysis used adjust several deathrelated risk factors admission study highlights following thrombocytopenia admission associated mortality almost three times higher patients without thrombocytopenia b platelet count independent risk factor covid<NUMBER> mortality c dynamic changes platelets closely related death treatment study highlights platelet monitoring might important covid<NUMBER> prognosis data presented hazard ratios hr <NUMBER> confidence intervals p trend estimated using median value quartile model <NUMBER> adjusted age sex baseline comorbidities including chronic obstructive pulmonary disease hypertension diabetes chronic kidney disease cardiovascular disease cerebrovascular disease model <NUMBER> adjusted model <NUMBER> plus glucocorticoid therapy intravenous immunoglobulin blood lactate creactive protein lymphocyte count enhanced platelet activation leading platelet deposition damaged pulmonary blood vessels supported various clinical studies thrombocytopenia important feature sars <NUMBER> <NUMBER> thrombocytopenia exceeded <NUMBER> incidence rate patients sars important indicator poor prognosis <NUMBER> <NUMBER> <NUMBER> metaanalysis <NUMBER> covid<NUMBER> patients reported thrombocytopenia associated threefoldenhanced risk severe covid<NUMBER> lower platelet count observed mortality <NUMBER> similar study current work confirmed thrombocytopenia admission associated death patients covid<NUMBER> platelets patients sars negatively correlated svcam<NUMBER> levels svcam<NUMBER> involved adhesion chemotaxis contributes early vascular injury suppression cell function vascular injury immunosuppression may explain poor outcome <NUMBER> using cox regression model multivariate analysis found platelets pct independent risk factors predict death although platelets routinely measured daily role platelets pct predicting outcome patients covid<NUMBER> previously reported correlation platelet dynamics disease prognosis studied different platelet thresholds used epidemiological studies incidence risk factors consequences thrombocytopenia among critically ill patients <NUMBER> <NUMBER> cohort nonlinear relationship platelets admission mortality observed trend tends gentle platelet count <NUMBER> × <NUMBER> <NUMBER> l figure <NUMBER>a analysis showed patients platelet level <NUMBER> × <NUMBER> <NUMBER> l admission decrease <NUMBER> days highest mortality rate whereas platelet level <NUMBER> × <NUMBER> <NUMBER> l admission increase <NUMBER> days lowest mortality rate moreover thrombocytopenia close relationship prognosis even within normal reference range dynamic changes platelets within first <NUMBER> days admission negatively correlated prognosis cox proportional hazards regression models displayed <NUMBER> decrease mortality risk every <NUMBER> × <NUMBER> <NUMBER> l increase platelets summary platelet count important prognostic marker patients covid<NUMBER> dynamic levels platelets treatment closely associated death pct calculated platelet count levels admission still retained detrimental effect clinical outcome <NUMBER> mechanism sarscov<NUMBER> thrombocytopenia poorly understood several potential explanations considered <NUMBER> histological examinations lung necropsy patients covid<NUMBER> revealed bilateral diffuse alveolar damage cellular fibromyxoid exudates interstitial mononuclear inflammatory infiltrates dominated lymphocytes finding raised possibility immunopathological damage lung tissues <NUMBER> damaged lung tissues would cause platelet activation aggregation lungs thrombi formation site injury may lead consumption platelets megakaryocytes addition sarscov<NUMBER> induces lowgrade disseminated intravascular coagulopathy state characterized elevation ddimers fibrinogen table iii association increase platelet per <NUMBER> × <NUMBER> <NUMBER> l mortality risk increase per <NUMBER> × <NUMBER> <NUMBER> l whole range platelet count p value increase per <NUMBER> × <NUMBER> <NUMBER> l platelets <NUMBER> × <NUMBER> <NUMBER> l p value data presented hazard ratios hr <NUMBER> confidence intervals model <NUMBER> adjusted age sex baseline comorbidities including chronic obstructive pulmonary disease hypertension diabetes chronic kidney disease cardiovascular disease cerebrovascular disease model <NUMBER> adjusted model <NUMBER> plus glucocorticoid therapy intravenous immunoglobulin blood lactate creactive protein lymphocyte count figure <NUMBER> nonlinear relationship platelets admission b platelet changes mortalitythe smoothing splines generated utilizing generalized additive model adjusted age sex baseline comorbidities including chronic obstructive pulmonary disease hypertension diabetes chronic kidney disease cardiovascular disease cerebrovascular disease glucocorticoid therapy intravenous immunoglobulin blood lactate creactive protein lymphocyte count red line indicates risk mortality blue dot line indicates <NUMBER> confidence intervals increases consumption platelets damaged lungs lungs may sites platelet release mature megakaryocytes <NUMBER> inflammation longterm oxygen treatment also result extensive alveolar damage pulmonary pathological changes pulmonary capillary bed morphologically altered thus affecting lung megakaryocyte fragmentation megakaryocytopoiesis increased consumption decreased production platelet may affect thrombocytopenia similar sars coronavirus sarscov<NUMBER> thrombocytopenia may involve mechanisms new condition may directly infect hematopoietic precursor cells inhibit growth cd <NUMBER> cd<NUMBER>a expressed human bone marrow cd<NUMBER> cells sarscov<NUMBER> may induce growth inhibition binding cd<NUMBER> cd<NUMBER>a hematopoietic cells bone marrow stromal cells resulting abnormal hematopoiesis immunodeficiency <NUMBER> body undergoes immunemediated hematopoietic stem cell damage thereby leading thrombocytopenia study subjected several limitations first observational study cannot conclude reported associations platelet parameters mortality causal second cannot exclude possibility remaining residual confounding unmeasured potential confounders third pathological mechanism platelet parameters progression covid<NUMBER> remains poorly defined clinical basic research necessary clarify issue although study first identify association platelet parameters mortality risk patients covid<NUMBER> largescale multicenter study warranted confirm findings hospitalbased cohort study among <NUMBER> confirmed patients covid<NUMBER> revealed association baseline platelets platelets change subsequent mortality hence monitoring platelets hospitalization may important prognosis patients sarscov<NUMBER> novel coronavirus covid<NUMBER> infection outbreak posed major threat international health system economy study aimed investigating biological epidemiological trends prevalence mortality due outbreaks novel coronavirus covid<NUMBER> infections data global outbreak covid<NUMBER> obtained world health organization worldometer centers disease control prevention cdc research institutes information also recorded research documents published global scientific journals indexed pub med institute scientific information isi web science trends prevalence mortality due covid<NUMBER> infection outbreaks results show rising trends transmission prevalence mortality rate due coronavirus covid<NUMBER> period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> infected <NUMBER> people worldwide resulting <NUMBER> deaths mortality rate <NUMBER> infections frequent among male gender <NUMBER> years age mean growth rate index total number cases january <NUMBER> march <NUMBER> <NUMBER> <NUMBER> growth rate index mortality rate <NUMBER> positive association prevalence mortality rate r<NUMBER> novel coronavirus covid<NUMBER> highly contagious affected large number people worldwide still spreading mutable prevalence mortality outbreak trends global health officials taken priority measures prevent outbreaks emerging pathogen across globe however rising number cases mortality risk estimates demonstrating enhanced public health mediations good hygienic conditions social distancing movement limitations may control covid<NUMBER> epidemics biological epidemiological trends prevalence mortality due outbreaks novel coronavirus covid<NUMBER> diabetes mellitus dm complex chronic disease characterized high blood glucose absolute relative insulin deficiency includes type<NUMBER> diabetes type <NUMBER> diabetes special type diabetes among morbidity type <NUMBER> diabetes highest global prevalence t<NUMBER> dm <NUMBER> estimated <NUMBER> billion <NUMBER> <NUMBER> total number deaths caused high fasting plasma ages <NUMBER> million type <NUMBER> diabetes accounted <NUMBER> million deaths <NUMBER> novel coronavirus pneumonia covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> seriously endangering human life health property safety march <NUMBER> <NUMBER> world health organization announced global pandemic <NUMBER> many early studies found patients chronic diseases diabetes severe worse prognosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> number retrospective analysis patients covid<NUMBER> showed prevalence diabetes patients increased varying degrees condition usually serious general patients <NUMBER> <NUMBER> <NUMBER> analysis china chinese center disease control prevention cdc shows mortality combined diabetic patients <NUMBER> overall mortality <NUMBER> <NUMBER> national institutes health italy reported prevalence diabetes patients died sarscov<NUMBER>infection <NUMBER> <NUMBER> according preliminary data american centers disease control prevention march <NUMBER> <NUMBER> diabetes common basic health condition among people infected sarscov<NUMBER> <NUMBER> furthermore estimated yy wz contributed equally work cofirst authors project funded treatment novel coronavirus pneumonia covid <NUMBER> integrated traditional chinese medicine western medicine <NUMBER>yfs<NUMBER> sponsors involved design execution writing study authors report conflicts interest data sharing applicable article datasets generated analyzed current study <NUMBER> patients need admitted icu <NUMBER> diabetic patients likely suffer serious infection due hyperglycemia chronic inflammatory state microcirculation damage factors <NUMBER> found type <NUMBER> diabetes may increase expression angiotensin converting enzyme <NUMBER> ace<NUMBER> lung <NUMBER> novel coronavirus pneumonia promoted ace<NUMBER> binding site sarscov<NUMBER> decrease ace<NUMBER> expression may result severe lung injury infection <NUMBER> serious infections serious diseases glucocorticoids damage insulin sensitivity infectious diseases lead high mortality diabetic patients <NUMBER> however covid<NUMBER> mortality combined diabetes still clear duration age gender race blood glucose control diabetes may effect mortality covid<NUMBER> study solve metaanalysis necessary report system review plan accordance preferred report item system review metaanalysis plan prismap guidelines <NUMBER> <NUMBER> study conducted accordance prisma extension statement nma <NUMBER> population adult dead covid<NUMBER> included study restrictions region gender age patients intervention study investigate comparisons diabetes nondiabetes covid<NUMBER> patients according whether diabetes mellitus combined divided diabetes group trail diabetes group comparison patients die excluded outcomes primary outcome mortality ofcovid<NUMBER> patients secondary outcomes include blood glucose control level inflammatory markers study design studies mortality covid<NUMBER> included study mortality covid<NUMBER> fbg fasting blood glucose pbg postprandial blood glucose hba<NUMBER>c glycated hemoglobin crp creactive protein computer retrieval three english database including pubmed embase cochrane library <NUMBER> chinese databases including china national knowledge infrastructure cnki database wanfang data knowledge service platform vip information resource integration service platform cqvip china biology medicine disc sino med searched inception april <NUMBER> <NUMBER> language limitation english chinese addition google scholar baidu scholar used find potential missing papers time limitation literatures novel coronavirus pneumonia covid<NUMBER> mortality prognosis blood glucose control diabetes type <NUMBER> diabetes type <NUMBER> diabetes new coronavirus pneumonia crp key words search identify eligible studies reference lists relevant publications reviewed manual search example search process presented table <NUMBER> based predetermined inclusion criteria two independent reviewers evaluate titles abstracts exclude papers considered relevant remaining provisions included assessment reviewers carefully examine full text potentially relevant article process study identification exclusion described prisma flow chart differences research options resolved consultation record excel file fig <NUMBER> two researchers independently screened literature extracted data cross checked case difference shall settled discussion consultation third party process literature selection first step read title excluding obviously irrelevant literature second step read abstract full text determine whether include necessary contact author original study email phone obtain uncertain important information study content data extraction includes <NUMBER> basic information first author publication time research location sample size sex ratio age research type <NUMBER> outcome indicators concern <NUMBER> relevant elements bias risk assessment bias risk assessment included study <NUMBER> researchers independently assessed bias risk included study nos scale cross checked results data analysis conducted review manager version <NUMBER> stata <NUMBER> software mac risk ratio rr used analysis statistic <NUMBER> ci provided heterogeneity results analyzed x <NUMBER> test test level <NUMBER> degree heterogeneity determined byi <NUMBER> statistical heterogeneity results study fixed effect model used metaanalysis statistical heterogeneity results study source heterogeneity analyzed excluding influence obvious clinical heterogeneity random effect model used metaanalysis level metaanalysis set <NUMBER> significant clinical heterogeneity treated subgroup analysis sensitivity analysis descriptive analysis substantial heterogeneity studies conduct subgroup analysis explore heterogeneity avoid post hoc analysis subgroup analysis conducted according <NUMBER> hypotheses race course diabetes glucose level improve reliability subgroup analysis evaluate credibility subgroup analysis according guidance credible subgroup analysis enough studies included metaregression conducted explore heterogeneity subgroup effects occur simultaneously subgroup analysis regression analysis considered credible draw funnel chart allcause mortality outcome indicators diabetes diabetes covid<NUMBER> patients ensure stability results conduct sensitivity analysis results excluding studies included analysis one one reanalyzing results comparing differences reobtained results original results way able assess impact individual studies overall outcomes robustness integrity studies important factor affecting accuracy results conclusions metaanalysis integrity included studies mainly measured reporting bias publication bias common therefore study identify report bias publication bias assessment funnel plot drawn investigate publication bias funnel plot asymmetric publication bias exists research small sample statistically significant results published obvious asymmetry funnel plot likely publication bias <NUMBER> egger test conducted statistical assessment publication bias publication bias considered exist p <NUMBER> <NUMBER> <NUMBER> patient public involvement patients public participate study since confidential patient data involved study formal ethics approval required framework prisma statements nma applied guide review authors perform study results disseminated peerreviewed publication covid<NUMBER> widespread world causing great casualties property losses battle related mankind study comprehensive systematic review aim compare mortality covid<NUMBER> diabetes nondiabetes analyze sex age course disease race blood glucose control level covid<NUMBER> dead patients prognosis patients new diabetes mellitus predicted blood glucose control strengthened clinical treatment epidemiology covid<NUMBER> incidence severity illness mortality seem shifted towards older people particularly diabetes hypertension cardiovascular disease <NUMBER> considering research costs data arrange study analyze diabetes related complications next study consider providing systematic review role diabetes complications development covid<NUMBER> meanwhile great practical significance clarify harm diabetes public health also provide reference clinicians modification required update protocol include changes entire research process conceptualization yan yang wen zhong chunguang xie data curation xiaoxu fu formal analysis yan yang wen zhong funding acquisition chunguang xie according world health organization records <NUMBER> december <NUMBER> pneumonia unknown cause detected wuhan china first reported country office china <NUMBER> th january <NUMBER> media around world report news humantohuman transmission new coronavirus <NUMBER> th january declares outbreak public health emergency international italy iran south korea already experienced significant outbreak new coronavirus <NUMBER> march <NUMBER> covid<NUMBER> declared pandemic confirmed cases covid<NUMBER> every continent except antarctica particularly worrying new coronavirus high degree transmissibility infectivity along great potential develop severe illness death wang et al <NUMBER> indeed minimise impact covid<NUMBER> pandemic public health <NUMBER> countries worldwide impose strict restrictions movement people social gatherings hale et al <NUMBER> following drastic measures taken china attempt flattening curve italy first country outside china experience largescale health impact covid<NUMBER> imposed partial nationwide lockdown since <NUMBER> march <NUMBER> whilst italian government praised implementation measure never employed modern democratic nations since wwii given evidence virus spread underdetected northern part country already since late january <NUMBER> strict measures might imposed late consequence outbreak put unprecedented strain italian healthcare system resulting exceptionally high number coronavirus deaths currently second highest world us covid<NUMBER> outbreak spread aggressively countries like spain france uk us country disparities covid<NUMBER> deaths became distinct particular italy shown highest case fatality rate germany austria norway among countries lowest rate global health <NUMBER> <NUMBER> accordingly media constantly trying dig underlying reasons behind country differentials covid<NUMBER> deaths comparing covid<NUMBER> deaths across countries however challenging several reasons ranging disparities testing coverage criterial defining covid<NUMBER> death practice postmortem examination garcíabasteiro et al <NUMBER> one way overcome inconsistency differences measurement incidence fatality consider excess mortality data weekly daily excess deaths instance would allow scientists compare observed deaths <NUMBER> mortality patterns typically observed previous years leon et al <NUMBER> exploiting daily death registrations data published italian statistical office istat paper provides first evidencebased assessment impact covid<NUMBER> mortality life expectancy first hardest hit epicentres outside china three main features characterise present analysis first covid<NUMBER> deaths estimated using excess mortality measures rather relying official report number deaths attributed covid<NUMBER> way mortality estimation suffer biases related sampling testing reporting policies second analysis focusses specifically bergamo brescia two hardest hit provinces lombardy northern italy two provinces sometimes compared wuhan given position epicentres outbreak experienced rapid escalation number infections resulting insufficiency healthcare resources intensive care units porcheddu et al <NUMBER> highly clustered nature local transmission results high concentration severe illnesses deaths one area jia et al nd therefore direct impact covid<NUMBER> mortality average life expectancy likely felt subnational level rather whole country finally moment writing epidemics bergamo brescia appear contained given epidemic curve presented downward trend first wave infections results presented thus based mainly hard number observed regions rather forms simulations underlying assumptions focusing areas outbreak appears slowed allows us capture fuller picture impact virus mortality life expectancy hence using complete reliable data number deaths first largestscale outbreak outside china paper provides first unbiased account mortality impact covid<NUMBER> consequence life expectancy analysis compare mortality rates <NUMBER> <NUMBER> across age gender categories provide estimations life expectancy changes following covid<NUMBER> pandemic motivation driving analysis discussed next session main methodological choices regarding measures geographical areas discussed depth background section provide short description policy measures implemented tackling epidemic next set results divided two parts first rough excess mortality rates presented values used construct potential life expectancy based different assumptions rest year <NUMBER> final discussion part underline important lessons drawn evidence conclude paper aims provide first evidencebased assessment human life consequences covid<NUMBER> pandemic based unbiased weekly death registrations data particular choice using overall daily mortality rather official covid<NUMBER> figures motivated two major concerns first last couple months become clear exists uniform way classifying covid<NUMBER> death variation across countries counting mortality mortality covid<NUMBER> italy instance include persons tested positive virus died official covid<NUMBER> death toll statistics regardless preexisting diseases may caused death onder et al <NUMBER> likewise whilst countries like belgium france <NUMBER> nd april <NUMBER> include coronavirus deaths outside hospitals official daily report countries like uk italy spain countries belgium uk us record covid<NUMBER> deaths also suspected cases require positive laboratory diagnosis like germany netherlands roser et al <NUMBER> addition epidemic worsens counting fatalities becomes difficult people dying home longterm care facilities might indeed tested simply resource allocation prioritises emergency operations even within country difficult compare number cases deaths different regions given disparities regional policies testing strategies capacities therefore weekly death registrations data causes comparable across countries regions leon et al <NUMBER> important given need share generalisable information order track progress epidemics guide implementation prevention control measures well plan relax social distancing measures second advantage using overall mortality measure allows us capture negative spillovers associated drop supply hospitalbased services due covid<NUMBER> reduced access hospitals emergency rooms often closed outbreak acute hospital beds clinical activities could contribute peaks mortality medical conditions directly related epidemic obviously deaths considered death indirect consequence covid<NUMBER> words study consider excess allcause rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> mortality period epidemic like provides complete assessment impact covid<NUMBER> population health human life existing literature relied mortality measures especially casefatality rates cfr cdc covid<NUMBER> response team <NUMBER> giangreco <NUMBER> khafaie rahim <NUMBER> onder et al <NUMBER> informative international historical comparisons since casefatality rates calculated number deaths divided number confirmed cases absence accurate estimation infection rates reference population makes denominator cfr relies heavily testing strategies capacities although much attention media devoted increasing number coronavirus testing many people possible <NUMBER> little said sampling strategy possible way obtain reliable information infection rates selecting testing representative sample population galeotti surico <NUMBER> approach countries actually implemented recently april <NUMBER> iceland austria first countries carry randompopulation screening test understandable since testing used measure containment isolating infected patients together tracing however testing suspected cases implies selection bias sampling approach fails provide unbiased estimates infection rates population matter many tests country runs figures infection rates based unrepresentative sample testing thus likely misestimation true prevalence another important feature present study specific geographical focus bergamo brescia two hardest hit relatively small provinces lombardy northern italy due clustering nature virus outbreak analysis national level would underestimate scale impact covid<NUMBER> mortality life expectancy total population approximately <NUMBER> million two provinces largescale excess mortality indeed affect life expectancy population small areas addition containment measures lockdown introduced late given virus already circulated undetected region early january <NUMBER> leco di bergamo <NUMBER> reuters <NUMBER> allows epidemic develop purest form showing potential impact virus absence intervention measures reduce spread hence indicators like life expectancy calculated reference population naturally one experiencing consequences epidemic contrary national data considered outbreaks contained negative impact epidemic potential years life loss might end heavily underestimated finally study extends beyond current studies health impact covid<NUMBER> typically focus mortality focusing life expectancy related measures whilst studying covid<NUMBER> mortality rates certainly important need collapsed index universal enough provide reliable measure human life lost regard life expectancy consistent objective measure human development since represents overall wellbeing populations simple nonbias form ghislandi et al <NUMBER> sen <NUMBER> furthermore reliable measures life expectancy available countries since nineteenth century makes possible use life expectancy historical comparisons human costs associated major events early morning <NUMBER> th february <NUMBER> first severe local case covid<NUMBER> diagnosed europe small hospital codogno municipality south east milan rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> authorities reacted tracing connections patient one soon became clear identification patient zero would difficult impossible indeed later studies shown covid<NUMBER> present lombardy region since first half january <NUMBER> cereda et al <NUMBER> leco di bergamo <NUMBER> reuters <NUMBER> area around codogno immediately declared red zone complete lockdown enforced <NUMBER> municipalities universities schools lombardy immediately closed region enter probably serious public health economic crisis afterwwii period however ten days following presence patient one nature epidemic downplayed media authorities including health experts testing strategies changed due course patients showing combination symptoms tested lockdowns gradually slowly introduced became clear important outbreaks way <NUMBER> march <NUMBER> whole lombardy declared orange zones one day rest italy nonessential activities however stopped <NUMBER> rd march <NUMBER> nature adequacy response covid<NUMBER> epidemic discussed elsewhere still ongoing winfield <NUMBER> context brief excursus useful order understand timing geographic distribution events specifically timing crucial bergamo first hardest hit province lombardy <NUMBER> march <NUMBER> beds intensive care units icus main hospital city already filled become clear later wave hospitalizations deaths started around first days march indeed already noticed bergamo case flattening epidemic curve policies introduced late hence effective similar situation days delay said brescia rely compendium administrative data provided italian national institute statistics istat use daily death counts causes municipality level disaggregated sex age class <NUMBER> <NUMBER> <NUMBER> <NUMBER> … <NUMBER> <NUMBER> cover period <NUMBER> st january <NUMBER> th april years <NUMBER> <NUMBER> observation period extends <NUMBER> th april importantly istat collect release data daily death counts municipalities <NUMBER> today data available municipalities meet following three criteria included recently established national register resident population anpr ii recorded least <NUMBER> deaths <NUMBER> st january <NUMBER> th april iii recorded increase least <NUMBER> number deaths registered <NUMBER> st march <NUMBER> th april <NUMBER> compared <NUMBER> average period areas interest ie provinces bergamo brescia <NUMBER> municipalities included anpr totaling <NUMBER> <NUMBER> respectively istat released daily death data relative <NUMBER> <NUMBER> municipalities province bergamo <NUMBER> municipalities province brescia addition dataset rely four sources information first make use annual death counts municipality level disaggregated sex age class <NUMBER> <NUMBER> <NUMBER> <NUMBER> … <NUMBER> <NUMBER> data extend <NUMBER> second obtain data resident population municipality level disaggregated sex singleyear age classes <NUMBER>…<NUMBER> january <NUMBER> years <NUMBER> reclassify age classes match <NUMBER> data collected released istat ad hoc better document evolution local mortality upon covid<NUMBER> epidemics outbreak istat focusing far subgroup municipalities excess mortality <NUMBER> likely attributable epidemics rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> ones used istat daily annual death counts <NUMBER> <NUMBER> <NUMBER> <NUMBER> … <NUMBER> <NUMBER> aggregate data accordingly third use data monthly live births disaggregated sex municipality level data available december <NUMBER> finally collect data monthly death counts disaggregated sex municipality level data available december <NUMBER> estimate resident population age sex provinces bergamo brescia <NUMBER> st january <NUMBER> following steps first aggregate resident population data year age class sex province level estimate female male resident population age class provincial level <NUMBER> st january <NUMBER> means linear extrapolation based years <NUMBER> <NUMBER> likewise use available data monthly live births january <NUMBER> december <NUMBER> estimate monthly births <NUMBER> provinces bergamo brescia measure excess mortality time <NUMBER> difference observed expected number deaths <NUMBER> defined expected number deaths average number deaths observed period <NUMBER> calculate seasonal life expectancy <NUMBER> st january <NUMBER> th april years <NUMBER> separated men women purpose calculate seasonal agespecific mortality rates year numerators ie death counts recorded daily thus aggregation period <NUMBER> st january <NUMBER> th april provincial level straightforward corresponding exposures ie denominators estimated follows starting estimated resident population <NUMBER> st january <NUMBER> counted agespecific persondays <NUMBER> th april theoretically counts function four demographic events namely births ageing migration dying daily inflow births estimated using monthly birth data assuming births uniformly distributed month effect ageing ie individuals might transition inand given age interval modeled giving individual probability <NUMBER> turning one year older observation period outflows due deaths straightforward agespecific death counts known daily basis neglect migration population study quarantined sum exposed population day age group x given population alive day t<NUMBER> age group x plus age age group x day minus either die age group x age age group x day express obtained daily exposure values terms personyears multiplying <NUMBER> <NUMBER> leap years derive agespecific mortality rates period <NUMBER> st january <NUMBER> th april finally life tables built following standard procedures outlined human mortality database protocol estimate confidence intervals life expectancies bootstrapping using monte carlo simulation methods assuming death counts follow binomial distribution andreev shkolnikov <NUMBER> chiang <NUMBER> method proposed arriaga <NUMBER> allows decomposing changes life expectancy agespecific contributions applied approach order assess agegroups primary contributed change seasonal life expectancy <NUMBER> <NUMBER> estimating life expectancy end year harvesting ie reduction mortality rates following peak mortality associated shock events taken consideration hence estimate life expectancy entire <NUMBER> considering two alternative scenarios define conservative business usual conservative scenario full harvesting assume mortality rate end year <NUMBER> approach main effect covid<NUMBER> would anticipate mortality first quarter rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> year <NUMBER> scenario probably likely one represents clearly defined upper bound life expectancy <NUMBER> scenario harvesting set zero assume end epidemic mortality rates go back average levels recorded previous years good reasons assume mortality reduce substantially end first wave covid<NUMBER> infections example resources health services directed covid<NUMBER> patients people medical conditions cancer undertreated likewise although vulnerable people selfisolation locking inside highly possible would get virus later restriction measures lifted matter fact mortality epidemic wave might actually increase especially among working age population consequence lockdowns likely economic recessions observed example greece laliotis et al <NUMBER> however paper making assumptions indirect impact covid<NUMBER> pandemic mortality epidemic ends therefore anything years life lost due covid<NUMBER> year <NUMBER> may fact underestimated based evolution daily mortality observed <NUMBER> th april posit epidemics area interest ie provinces bergamo brescia <NUMBER> th april estimate life expectancy entire <NUMBER> need project evolution deaths <NUMBER> th april use cubic spline extrapolation project number daily deaths age class <NUMBER> th april <NUMBER> th april <NUMBER> th april project mortality end year based two scenarios conservative scenario assume end covid<NUMBER> epidemics deaths age class occur total number deaths <NUMBER> equals total number deaths registered <NUMBER> <NUMBER> cumulative number deaths end epidemics age class exceeds total number deaths registered <NUMBER> assume zero deaths occur end epidemics age class business usual scenario assume mortality return average levels recorded <NUMBER> recent years data annual death counts available thus possible derive number deaths occurring <NUMBER> th april difference annual death counts deaths registered <NUMBER> th april years <NUMBER> know daily distribution deaths <NUMBER> th make two assumptions age groups <NUMBER> assume deaths occur uniformly period <NUMBER> st may <NUMBER> st december <NUMBER> age groups ≥<NUMBER> assume deaths may december <NUMBER> occur following <NUMBER> average distribution monthly deaths assume deaths distribute uniformly within month may december <NUMBER> proceed estimation population exposure day <NUMBER> st january <NUMBER> st december <NUMBER> scenarios following procedure detailed finally aggregate death counts population exposure values entire year derive agespecific mortality rates life expectancies scenarios bergamo brescia represent highest number municipalities outlier number deaths distribution across provinces displayed figure <NUMBER> clearly bergamo province shows higher number red areas addition figure a<NUMBER> appendix shows municipalities within lombardy comparing graph veneto region together lombardy epicenter first clusters covid<NUMBER> last week <NUMBER> <NUMBER> last year data yearly death counts disaggregated age sex municipality level available rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint february evident covid<NUMBER> outbreak hit lombardy much harder veneto losses observable areas bergamo brescia indeed whole country provinces display monumental upward trend mortality maps plot change total number deaths recorded jan <NUMBER>apr <NUMBER> <NUMBER> respect <NUMBER> average table <NUMBER> shows age sex distribution total excess mortality province compared average number people died period five years <NUMBER> excess number deaths <NUMBER> january <NUMBER> <NUMBER> april <NUMBER> bergamo brescia sums <NUMBER> <NUMBER> mortality excess mortality witnessed bergamo covid<NUMBER> affected slightly men women <NUMBER> excess deaths whilst national level <NUMBER> covid<NUMBER> deaths involve male mortality global health <NUMBER> <NUMBER> however almost gender balance number deaths reflect equality relative mortality risk sexes general men <NUMBER> times likely die covid<NUMBER> women fact risk dying men higher women across ages except <NUMBER> bergamo risk ratio slightly one age clearly represents important predictor absolute excess mortality related covid<NUMBER> example table <NUMBER> one deduce sample man <NUMBER> years <NUMBER> times <NUMBER> times likely die person <NUMBER> <NUMBER> years age respectively number people dying covid<NUMBER> peaks <NUMBER> age interval note proportional increase mortality due covid<NUMBER> age class spike much <NUMBER> <NUMBER> fact <NUMBER> expected mortality already high regular times still first quarter <NUMBER> bergamo <NUMBER> mortality increased <NUMBER> males <NUMBER> females similar figures observed <NUMBER> <NUMBER> note age group <NUMBER> gender disparity covid<NUMBER> mortality reverses due naturally much higher number women living <NUMBER> years age niu et al <NUMBER> consistent outbreaks spreading care homes rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> usually undercounted official covid<NUMBER> mortality data countries comasherrera et al <NUMBER> brescia number relative increase mortality <NUMBER> lower bergamo female male mortality increasing <NUMBER> roughly <NUMBER> <NUMBER> respectively however much higher expected number <NUMBER> males <NUMBER> females infinite increase died brescia municipalities figure <NUMBER> shows trends daily mortality within two provinces raw data evident epidemic curve inflates age age effect particularly remarkable bergamo also clear last day observation already downward pattern daily mortality indeed <NUMBER>th april epidemic wave already towards end provinces allows us rely hard data part infection wave reducing reliance modelling estimation total number deaths related first wave infection graphs shown figure <NUMBER> also evident rumors unexpected peak flu mortality <NUMBER> rejected midmarch seasonal flu started december <NUMBER> final stages wave however first two months half <NUMBER> mortality across age classes show significant unexpected peak hence observed trends support hypothesis boost mortality could caused interaction covid<NUMBER> seasonal flu rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> may <NUMBER> httpsdoiorg<NUMBER> may <NUMBER> <NUMBER> doi medrxiv preprint graphs plot total daily death count january <NUMBER> april <NUMBER> <NUMBER> vs <NUMBER> average disaggregated four age classes males females combined red vertical lines show relevant dates evolution epidemic vertical lines show four relevant dates evolution epidemic misalignment drastic containment measures orange zone <NUMBER> march closure nonessential activities <NUMBER> march striking one considers time infection development severe critical conditions could long three weeks evident lockdowns imposed late order measure human life impact epidemic two provinces show two set results <NUMBER> changes age structure <NUMBER> changes life expectancy stated methods section predicting mortality rest year two scenarios defined conservative scenario harvesting complete overall mortality rates age end year maintained constant respect previous years unless number deaths <NUMBER> april already exceeds overall expected deaths <NUMBER> business usual scenario covid mortality drops regular values observed previous years harvesting thus set zero purpose estimation cumulative number people died covid compared expected annual death age important information figures a<NUMBER>a a<NUMBER>b appendix report evolution age classes provinces men women respectively impressive notice province bergamo number <NUMBER> men died <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> april already exceeded annual number age specific deaths municipalities <NUMBER> argued impact covid epidemic understood also looking age structure population dowd et al <NUMBER> evidence provided far clear age main risk factor covid related mortality figure <NUMBER> reports changes age pyramid <NUMBER> january <NUMBER> <NUMBER> april <NUMBER> b <NUMBER> december <NUMBER> two scenarios overall age pyramid going affected significantly top levels number missing people among elderlies end <NUMBER> going significant especially extreme scenario note also elderly women seem affected epidemic terms covid reflects fact among <NUMBER> <NUMBER> females life expectancy reduced accordingly shown figure <NUMBER> drop end observation period significant especially men bergamo seasonal life expectancy calculated reduction <NUMBER> males reaches <NUMBER> years women reduction less marked although seasonal life expectancy <NUMBER> april <NUMBER> around <NUMBER> years lower <NUMBER> refer discussion part interpretation figures life expectancy extrapolated whole year loss life expectancy course diluted longer period hence reduced conservative case full harvesting nothing rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> really changes respect previous years unlikely situation one represents potential upper bound mortality goes back regular times business usual life expectancy males females drop respectively <NUMBER> <NUMBER> years bergamo <NUMBER> <NUMBER> years brescia figure <NUMBER> shows decomposition associated loss life expectancy april <NUMBER> age sex clearly major role played older populations role mortality <NUMBER> years old men particularly evident time <NUMBER> women bergamo despite much older age still responsible half year loss life expectancy rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> able show excess mortality directly indirectly linked covid<NUMBER> without bias testing coverage classification cause deaths focusing two hardest hit areas lombardy italy bergamo brescia able capture full impact covid<NUMBER> population health human life first important piece evidence refers duration epidemic wave <NUMBER> april <NUMBER> daily mortality bergamo brescia approaching regular values observed <NUMBER> hence time first sign epidemic wave first three days march possible return normality likely <NUMBER> <NUMBER> weeks peak happening around two weeks start likely lockdown policy might contributed reduction mortality late stage epidemic wave however containment policies implemented initial spread infections virus circulated undetected lombardy hence played role reducing mortality first part epidemic wave regarding demographic characteristics two empirical regularities emerge clearly first age gradient mortality steep age represents evident risk factor covid<NUMBER> mortality sample men aged <NUMBER> <NUMBER> times <NUMBER> times likely die counterparts aged <NUMBER> <NUMBER> respectively second gender disparities percentages distribution deaths large <NUMBER> deaths involve male subjects reported whole nation italy <NUMBER> however figure misleading risk dying male <NUMBER> <NUMBER> higher female depending age class province considered men thus risk mortality since covid<NUMBER> affects elderly women overrepresented among aged <NUMBER> absolute figures show high number deaths also among females age gradient mortality affects age pyramid well elderly women associated sharpest reduction number end <NUMBER> terms life expectancy shown two main set results first focusing period <NUMBER> jan <NUMBER> april <NUMBER> life expectancy bergamo reduced around <NUMBER> <NUMBER> years compared <NUMBER> men women respectively <NUMBER> <NUMBER> years brescia one way understand figures imagine represent would happen <NUMBER> jan <NUMBER> april period stretched entire year epidemic would last around four months twelve fortunately case epidemic wave limited rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> duration nevertheless figures give us idea power epidemic wave crushed provinces return normality bergamo brescia going straightforward near future hard predict reason calculating life expectancy end year focus simple assumptions ie focusing impact first epidemic wave harvesting effect considered possible consequences covid<NUMBER> epidemic mortality two scenarios full harvesting conservative harvesting business usual introduced construction conservative scenario show significant changes end year although number deaths <NUMBER> april exceeded expected yearly number deaths age class small number hand harvesting scenario implies loss life expectancy around <NUMBER> <NUMBER> years males females respectively bergamo <NUMBER> <NUMBER> respectively brescia although conservative scenario represents logical extreme upper bound estimation life expectancy business usual realistic one interpret results one good feature life expectancy indicator provides historical perspective human consequence relevant shocks ghislandi et al <NUMBER> looking figure a<NUMBER> appendix appears evident sharp decrease life expectancy experienced modern history since second world war terms pandemic impact years life lost observing largescale loss life expectancy second spanish flu <NUMBER> according figure a<NUMBER> life expectancy italy dropped <NUMBER> years usa noymer garenne <NUMBER> estimate reduction life expectancy <NUMBER> years differences covid<NUMBER> pandemic <NUMBER> flu pandemic distinct first spanish flue typically killed young course else equal reduces life expectancy much second outbreak spanish flu occurred time first world war public health preventive measures implemented finally medical technology knowledge much less advanced penicillin crucial pharmaceutical products yet available thus said years life lost bergamo brescia although level achieved spanish flu substantial scale given much advanced medical technology absence war present day note analysis focuses local context given covid<NUMBER> outbreaks geographically concentrated looking country level life expectancy misleading underestimates actual impact pandemic indeed results fair conclude lifetime unprecedented shock residents bergamo brescia main limitation present study related limited coverage death registrations data used geographically temporally information provided retrieved number affected municipalities bergamo brescia estimation represents attempt describe measure human cost covid<NUMBER> among populations hit hardest country study represent experiences italy lombardy region also choice intend investigate impact covid<NUMBER> human life areas little containment interventions put place point view timing enough information actually picture entire evolution epidemic wave however comes life expectancy year <NUMBER> need rely harvesting assumptions exclude possible negative impact present future lockdown policies global economic recessions health human life sense paper focuses direct impact pandemic anything may underestimate years life lost due covid<NUMBER> nevertheless timing paper also strength indeed present analysis represents first attempt provide evidencebased assessment human life impact frontline covid<NUMBER> outbreak raise warning scientific public health community around world epidemic undetected contained easily get control cause relevant social human consequences defining lockdown strategies governments balance costs limiting social economic activities human costs possible epidemic waves vulnerable populations protected particular attention constant monitoring epidemic progression given priority order get caught surprise devastating epidemic waves like ones experienced bergamo brescia human life solid indicator human development represents health wellbeing population one key priority sustainable development goals many years life lost due covid<NUMBER> pandemic worrying since sets affected areas back level human development <NUMBER> years ago shown case bergamo brescia cost human life delay public interventions reduce virus transmission disturbingly high amidst countries preparation ease lockdown restrictions social distancing measures important keep mind conceivable risk viral reintroduction potential direct indirect cost pose human life wellplanned government measures prevent second wave infections along public collaboration keeping physical distancing practicing proper hygiene vaccine novel coronavirus available key achieve balance health economic protection maps plot change total number deaths recorded jan <NUMBER>apr <NUMBER> <NUMBER> respect <NUMBER> average rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure a<NUMBER>a cumulative deaths men rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure a<NUMBER>b cumulative deaths women rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> <NUMBER> origin virus sars viral respiratory disease zoonotic origin caused sars coronavirus sarscov origin sarscov still unsettled remains controversial subject date sarscov phylogenetically divergent coronaviruses associated human infections oc<NUMBER> nl<NUMBER> <NUMBER>e hku<NUMBER> closely related civet bat covs <NUMBER> however none currently known bat severe acute respiratory syndromerelated coronaviruses sarscov thought direct ancestor sarscov <NUMBER> sars first severe readily transmissible new communicable disease <NUMBER> st century <NUMBER> epidemic first started around midnovember <NUMBER> guangzhou least two patients atypical pneumonia unknown cause <NUMBER> initial cases meat handlers regular contact wild game <NUMBER> shortly similar cases reported five cities guangdong province however escalation public health measures announced february <NUMBER> outbreak unfolded <NUMBER> cases reported five mortalities <NUMBER> <NUMBER> hong kong <NUMBER> people infected <NUMBER> died <NUMBER> infected cases healthcare workers eight died <NUMBER> <NUMBER> case sars reported worldwide since <NUMBER> however suspicious cases reported time time <NUMBER> incubation period sarscov <NUMBER> <NUMBER> days mean <NUMBER> days <NUMBER> days symptoms usually develop <NUMBER> <NUMBER> days initial infection immune response includes immunoglobulin igm antibody sarscovthis peaks acute early convalescent phase week <NUMBER> declines week <NUMBER> igg antibody produced later peaks week <NUMBER> <NUMBER> first symptom sars fever <NUMBER>°c <NUMBER>°f higher followed nonspecific flulike symptoms chillsrigor muscle aches pain headaches diarrhea sore throat runny nose malaise symptoms usually last <NUMBER> <NUMBER> days affected patients may develop dry cough shortness breath pneumonia severe cases patient develop respiratory failure acute respiratory distress syndrome ards sars outbreak <NUMBER> <NUMBER> patients confirmed sars infection died <NUMBER> mortality rate much higher <NUMBER> years old mortality rates approaching <NUMBER> subset patients <NUMBER> sars epidemic around <NUMBER> pediatric sars cases reported worldwide majority hong kong <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pediatric cases presenting features nonspecific hence postive contact history environmental exposure became important diagnostic clues fever consistent symptom affected children lasted median duration <NUMBER> days common symptoms included cough <NUMBER> nausea vomiting <NUMBER> <NUMBER> <NUMBER> <NUMBER> teenage patients present symptoms malaise myalgia chill rigor addition cough respiratory symptoms similar adults younger children presented mainly cough runny nose <NUMBER> symptoms clinical course milder shorter young children lymphopenia important laboratory finding severe among teenagers <NUMBER> prominent radiological features included patchy infiltrates opacities areas consolidation predominantly lower lobes <NUMBER> pediatric mortalities reported literature <NUMBER> case series <NUMBER> children sars hong kong five required picu care one patient required invasive ventilatory support <NUMBER> <NUMBER> children <NUMBER> years age younger generally milder illness favorable outcome <NUMBER> pathophysiology milder disease course children clear proposed yet putative mechanisms include relatively low dosage ribavirin shorter course corticosteroids less mature immune system resulting less autoinflammatory injury young <NUMBER> followup sars patients <NUMBER> months illness showed mild residual changes exercise tolerance pulmonary function <NUMBER> osteonecrosis reported children whose sars treatment included steroids remained mostly asymptomatic managed conservatively <NUMBER> two reported cases transmission children adults reports transmission children children <NUMBER> vertical transmission reported cases maternal sars pregnancy infants survived perinatal transmission detected <NUMBER> summary respiratory symptoms milder nonrespiratory symptoms present pediatric patients mean incubation period merscov <NUMBER> days ranges <NUMBER> <NUMBER> days symptoms may range mild severe include fever cough diarrhea shortness breath spread humans typically involves close contact infected person humantohuman transmission limited mainly among family members healthcare workers clusters cases healthcare facilities infection prevention control practices suboptimal however spread uncommon outside hospitals <NUMBER> <NUMBER> overall <NUMBER> cases reported healthcare workers <NUMBER> reports sustained humantohuman transmission thus risk global population currently deemed fairly low <NUMBER> high morbidity associated mers may spurious due bias inadequate sampling missed much larger denominator elusive milder cases <NUMBER> <NUMBER> specific vaccine treatment disease number antiviral medications studied <NUMBER> recommends come contact camels wash hands frequently touch sick camels camelbased food products appropriately cooked essence symptomatic supportive treatments constitute therapies cases reported <NUMBER> mild symptoms <NUMBER> severe disease died <NUMBER> mers typically severe health problems half reported cases comorbidities eg diabetes mellitus hypertension heart disease chronic renal failure lung disease might explain high mortality rate <NUMBER> <NUMBER> overall risk death may lower reported mild symptoms may undiagnosed <NUMBER> rate pediatric merscov infection relatively low comparison adults <NUMBER> large saudi arabian study screened merscov polymerase chain reaction pcr testing selected atrisk population including <NUMBER> children <NUMBER> years old found <NUMBER> tested positive compared <NUMBER> adults <NUMBER> common source infection household contact acquired infection within healthcare facility <NUMBER> approximately <NUMBER> affected children asymptomatic <NUMBER> common presenting symptoms fever <NUMBER> vomiting <NUMBER> diarrhea <NUMBER> cough <NUMBER> <NUMBER> severity lower comparison adult population one series <NUMBER> pediatric cases one patient required intensive care support deaths <NUMBER> two fatal pediatric merscov cases found literature cases comorbidities infantile nephrotic syndrome cystic fibrosis <NUMBER> <NUMBER> covid<NUMBER> culprit recent pandemic <NUMBER> termed <NUMBER> according wuhan health officials pneumonia appeared viral nature patients placed isolation potential causes including influenza avian infleuenza adenovirus sarscov merscov ruled <NUMBER> since highly suggestive evidence outbreak associated exposure wuhans huanan seafood wholesale market market closed <NUMBER> january <NUMBER> <NUMBER> mean incubation period sarscov<NUMBER> estimated <NUMBER> <NUMBER> days average <NUMBER> days <NUMBER> evidence humantohuman transmission droplets direct contact precautions practiced healthcare settings prevent airborne transmission may underestimated among many uncertainties novel virus <NUMBER> confirmed cases healthcare workers reported cases <NUMBER> <NUMBER> total confirmed cases china italy respectively <NUMBER> <NUMBER> <NUMBER> ascertainment asymptomatic carriage risk transmission within community high <NUMBER> common symptoms include fever cough dyspnea myalgia fatigue <NUMBER> series <NUMBER> cases patient prominent upper respiratory tract signs even though abnormalities chest computed tomography ct images detected among patients <NUMBER> ct chest scans higher sensitivity diagnosis covid<NUMBER> compared pcr swab samples findings include bilateral subpleural groundglass opacities air bronchograms illdefined margins slight predominance right lower lobe <NUMBER> <NUMBER> indeed ct chest abnormalities diagnostic criteria latest novel coronavirus diagnosis treatment plan published national health commission peoples republic china <NUMBER> report <NUMBER> <NUMBER> cases prepared chinese center disease control prevention cdc majority <NUMBER> cases classified mild <NUMBER> critical cases <NUMBER> age group ≥<NUMBER> years old highest casefatality rate <NUMBER> <NUMBER> treatment mainly supportive antiviral treatment clinically proven effective sarscov<NUMBER> standard treatment guidelines recommended protease inhibitors lopinavirritonavir considered results recent clinical trial discouraging <NUMBER> remdesivir chloroquine shown good inhibitory effect sarscov<NUMBER> vitro <NUMBER> remdesivir undergoing phase ii clinical trials treating patients covid<NUMBER> <NUMBER> hydroxychloroquine sometimes combination azithromycin widely used europe us little evidence efficacy early analyses point increased risk higher mortality <NUMBER> <NUMBER> longterm outcome covid<NUMBER> patients yet de reported <NUMBER> recovered patients tested postive sarscov<NUMBER> followup checks several weeks discharge deemed likely due residual rna clinical samples rather reinfection <NUMBER> given robust test yet developed speculations results testing include false negativity time discharge inadequate specimen less desirable site specimen acquisition eg specimen taken throat vs nasopharynx testing discrepancies new tests finding virus lower respiratory tract reinfection infected children relatively milder symptoms recovered within <NUMBER> <NUMBER> weeks <NUMBER> several patients overt clinical symptoms found positive screening infected close contacts <NUMBER> study reviewing epidemiology <NUMBER> pediatric cases china revealed proportion severe critical illness higher younger age group particular infants <NUMBER> report us centres disease control prevention among aged less <NUMBER> year known hospitalized status <NUMBER> hospitalized compared <NUMBER> <NUMBER> among aged <NUMBER> <NUMBER> years <NUMBER> around <NUMBER> pediatric cases require admission intensive care low comparing adult population <NUMBER> less <NUMBER> pediatric deaths reported worldwide <NUMBER> <NUMBER> children may play major role communitybased viral transmission evidence covid<NUMBER> infections children occurring early epidemic <NUMBER> <NUMBER> convincing evidence hon et al <NUMBER> vertical transmission neonates far couple studies finding igm neonatal blood viral rna samples respiratory tract <NUMBER> <NUMBER> however early onset covid<NUMBER> disease neonates reported <NUMBER> reason decreased incidence childhood yet clarified postulated children less susceptible covid<NUMBER> lesser maturity function ace<NUMBER> receptor cell entry receptor sarscov<NUMBER> compared adults <NUMBER> <NUMBER> <NUMBER> officials experts compared similarities differences acronyms believed novel impactful syndromes may fever respiratory symptoms history contact travel animal vector novel coronavirus significant mortality morbidity relatively minimal differences acronyms except nomenclatures table <NUMBER> fact significant number patients covid<NUMBER> mildly symptomatic vs patients sars mers low mortality rates reflects sarscov<NUMBER> resembles common circulating respiratory viruses however lack population immunity sarscov<NUMBER> gives ability cause high attack rates overwhelm cripple healthcare systems managed carefully similarities differences sars mers covid<NUMBER> tabulated hereunder table <NUMBER> perhaps unnecessary coin confusing seemingly different acronyms recurring epidemics coronaviruses <NUMBER> syndrome approach sars opposed disease approach covid pros cons table <NUMBER> • clinical definition applied similar epidemics surveillance without knowing culprit pathogen • sensitive • sars concept surveillance easy apply epidemics • acronym used even afebrile asymptomatic carriers patients mild extrapulmonary symptoms laboratoryconfirmed sars patients • stigmatizing many patients definition nonspecific sensitive • may used noncoronavirus eg influenza measles another novel coronavirus eg mers even symptoms severe acute respiratory • may miss nonfebrile patients patients extrapulmonary symptoms • contact travel history good early phase epidemic • new acronym coined <NUMBER> characteristics whether beyond virus might environmental changes occurred twodecade history infections enhance spread rising temperatures yet determined atmospheric changes hoped devastation covid<NUMBER> carries wake large efforts invested search answers questions able wiser dealing threats future require combined efforts global community since current events clearly manifested interconnectedness interdependence hence shared vulnerability face calamity previously unexperienced magnitude kam lun hon httporcidorg<NUMBER> karen ka yan leung httporcidorg<NUMBER> following emerge novel coronavirus wuhan china december <NUMBER> respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> affected whole world declared pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> according worldometer metrics novel virus responsible approximately <NUMBER> infections <NUMBER> <NUMBER> <NUMBER> cases recovered <NUMBER> cases died worldwide june <NUMBER> <NUMBER> months efforts medical communities still specific approach prevention treatment coronavirus disease <NUMBER> also competition pandemic infodemic led many controversies challenges globally regard one hottest topics days role vitamin prevention treatment covid<NUMBER> several functions modulating adaptive immune system cellmediated immunity well increase antioxidativerelated genes expression proven vitamin adjuvant prevention treatment acute respiratory infections <NUMBER> <NUMBER> according available investigations seems functions lead cytokine storm suppression avoid acute respiratory distress syndrome ards studied pandemics infectious diseases recent years <NUMBER> <NUMBER> <NUMBER> best knowledge unfortunately several months adequate highquality data different treatments regimen raises questions gaps scientific works occasion essential need controlled randomized trials surprising see observational studies without control group nonrandomized controlled studies retrospective nature covering small number patients issue debatable <NUMBER>hydroxyvitamin <NUMBER>ohd hence concerning limitations analyze difficulties carried rapid systematic review metaanalysis great caution sensitivity order try maximizing use everything exists role vitamin covid<NUMBER> additionally along systematic review also performed ecological evaluation find relations global status vitamin covid<NUMBER> recoverymortality rates honest know working observational studies give overestimation required value therefore whatever result vitamin present result approaches also overestimation reality fascinating get current situation especially found ecological approach preferred reporting items systematic reviews metaanalyses prisma guideline considered study plan systematic search databases pubmed scopus embase cochrane library web science google scholar intitle well preprint database medrxiv biorxiv research square preprintsorg search engine sciencedirect rapid search famous journals done may <NUMBER> <NUMBER> moreover obtain data considered gray literatures references eligible papers search strategy included mesh terms free keywords found covid<NUMBER> sarscov<NUMBER> vitamin timelocation language limitation search four researchers screened selected papers independently supervisor solved disagreements studies met following criteria included metaanalysis <NUMBER> comparative noncomparative studies retrospective prospective nature <NUMBER> studies reported role vitamin confirmed covid<NUMBER> patients studies excluded <NUMBER> vitro studies experimental studies reviews <NUMBER> duplicate publications two researchers hj mm evaluated quality assessment papers extracted data selected papers supervisor dsh resolved disagreements step data extraction checklist included name first author publication year region study number patients comorbidity vitamin status serum <NUMBER>hydrovitamin levels ethnicity mean age medication dosage treatment duration adverse effects radiological results mortality modified newcastleottawa scale nos checklist crosssectional studies used value studies concerning various aspects methodology study process according risk factors older age male obesity underlying chronic disorders higher latitudes darker skin pigmentation etc common vitamin deficiency covid<NUMBER> toward severity condition despite various possible explanations hypothesize vitamin plays role severity responses covid<NUMBER> vitamin deficiency correlation covid<NUMBER> mortality rate recovery rate regard alongside main objective find second aim ecological investigation carried literature search pubmed database identifying national regional studies reported vitamin status throughout world data infection mortality recovery covid<NUMBER> cases gathered worldometer metrics metaanalysis done published studies region pooling vitamin mean levels case according international conference controversies vitamin <NUMBER> vitamin cutoff points considered follows isquare <NUMBER> statistic used heterogeneity evaluation following cochrane handbook systematic reviews interventions <NUMBER> <NUMBER> interpreted follows <NUMBER> <NUMBER> might important <NUMBER> <NUMBER> may represent moderate heterogeneity <NUMBER> <NUMBER> may represent substantial heterogeneity <NUMBER> <NUMBER> considerable heterogeneity importance observed value <NUMBER> depends magnitude direction effects ii strength evidence heterogeneity eg pvalue chisquared test confidence interval <NUMBER> thus randomeffects model used pooling outcomes case heterogeneity otherwise inverse variance fixedeffect model used forest plots presented visualize degree variation studies metaanalysis performed using comprehensive metaanalysis cma v <NUMBER> software pooling effect sizes done <NUMBER> confident interval ci fixedrandomeffects model used according heterogeneities case zero frequency correction value <NUMBER> used correlation mortality recovery rates covid<NUMBER> patients vitamin status evaluated using spearmans rank correlation coefficient r according cohens classification effect width <NUMBER> value r<NUMBER> considered small effect r<NUMBER> medium effect r<NUMBER> large effect pvalue less <NUMBER> considered statistically significant data analyzed using spss software version <NUMBER> spss inc chicago il usa beggs eggers tests well funnel plot used publication bias evaluation pvalue less <NUMBER> considered statistically significant ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint first search databases resulted <NUMBER> papers removing duplicated papers first step screening based title abstract <NUMBER> papers assessed eligibility finally nine papers entered qualitative synthesis six papers entered metaanalysis prisma flow diagram study selection process presented figure <NUMBER> among six studies included metaanalysis designed retrospective nature studies sample size ranged <NUMBER> <NUMBER> including <NUMBER> participants characteristics studies entered systematic review presented table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> results quality assessment studies entered metaanalysis based modified version nos tool crosssectional studies fair results beggs eggers tests effect size metaanalysis showed significant publication bias pb<NUMBER> pe<NUMBER> funnel plot publication bias studies presented fig <NUMBER> metaanalysis event rates showed <NUMBER> covid<NUMBER> patients suffering vitamin deficiency <NUMBER> ci <NUMBER> <NUMBER> patients levels vitamin lower normal range <NUMBER> ci <NUMBER> fig <NUMBER> table <NUMBER> world vitamin distribution map relations recovery rate well mortality presented fig <NUMBER> considering mean levels vitamin sarscov<NUMBER> infection well covid<NUMBER> mortality recovery data throughout world spearmans rank correlation coefficient analyses indicated correlation vitamin levels recovery rate r <NUMBER> well mortality rate r<NUMBER> globally detail asia overall mean levels <NUMBER> <NUMBER>ohd <NUMBER> ci <NUMBER> substantial direct correlation observed vitamin status recovery rate r <NUMBER> well significant reverse correlation mortality rate r <NUMBER> europe correlations recovery r <NUMBER> mortality rate r <NUMBER> middle east although direct correlation recovery rate vitamin status r <NUMBER> also mortality rate mediumly reverse correlation vitamin status r <NUMBER> north america surprisingly recovery r <NUMBER> mortality rates r <NUMBER> highly correlated vitamin levels sought america recovery rate r<NUMBER> mortality rate r<NUMBER> significant direct correlation <NUMBER>ohd levels oceania unexpectedly recovery r <NUMBER> mortality r <NUMBER> rates substantial reverse correlation <NUMBER>ohd levels considering latitude factor adjustment countries latitudes higher ±<NUMBER>° partial correlation analysis showed small reverse correlation mortality rate vitamin status throughout globe r <NUMBER> correlation observed recovery rate r <NUMBER> analysis showed direct correlation case mortality rate europe r <NUMBER> although comparing global statistics covid<NUMBER> outcomes difficult clear mortality rate higher several countries seems various factors age healthcare system quality general health status socioeconomic status etc nonetheless one underestimated factors might associated covid<NUMBER> outcome vitamin status every populations investigations respiratory infections indicated <NUMBER>hydroxyvitamin effectively induce host defense peptides bacterial viral agents vitamin insufficiencydeficiency lead noncommunicable well infectious diseases <NUMBER> <NUMBER> <NUMBER> potential role vitamin reduction inflammatory induced following sarscov<NUMBER> infection fact vitamin affects reninangiotensin system pathway promotes expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> downregulates sarscov<NUMBER> <NUMBER> concerning limitations adequate highquality data relation vitamin status covid<NUMBER> several months conducted systematic review metaanalysis order maximize use every available data would give us overview toward studies like done recently effectiveness hydroxychloroquine covid<NUMBER> patients <NUMBER> underestimated first value revealed also hypothesize vitamin deficiency correlation covid<NUMBER> mortality rates recovery rate studied ecological strategy unfortunately clinical trials highquality data regarding role vitamin covid<NUMBER> according available data entered metaanalysis could find approximately half patients infected sarscov<NUMBER> suffering vitamin deficiency vitamin insufficient <NUMBER> case relation vitamin levels mortalityrecovery rate covid<NUMBER> patients researchers reported dependence covid<NUMBER> morbidity mortality latitude <NUMBER> <NUMBER> similarly hypothetical strategy big data analysis resulted several direct reverse correlations regard quick look fig <NUMBER> shows regular relation mortality recovery rate increasing vitamin levels significant fluctuations observe regarding country despite fluctuation considering latitudes showed small reverse correlation vitamin status mortality rate worldwide indicates populations lower levels vitamin might higher risk sarscov<NUMBER> infection however focusing continents countries one one indicates interesting findings case example vitamin status asia middle east africa oceania correlated mortality reversely whereas direct correlation mortality north sought america might attract considerations racial ethnic aspects subject different regions populations <NUMBER> <NUMBER> case recovery rate continents indicated direct correlation vitamin status africa oceania significantly showed reverse correlation regard considering table <NUMBER> africa highest mean levels vitamin related guineabissau tanzania finding might due numerous challenges human resource health care systems budgetary poor management etc regions <NUMBER> <NUMBER> <NUMBER> unavoidably affects subject significantly oceania seems extremely high rate recovery australia new zealand led statistical outcome ultimately best knowledge comprehensive systematic review carried metaanalysis investigating role vitamin covid<NUMBER> patients along wide ecological consideration however releasing outcomes underway mentioned rcts updated systematic review metaanalysis subject could conclusive reliable worth noticing current metaanalysis includes following limitations<NUMBER> studies entered metaanalysis observational crosssectional thus comparative analyses applicable first part study <NUMBER> inevitable challenges reliability data due different strategies testing eg vitamin measurement covid<NUMBER> test etc various subpopulations etc first part ecological part study <NUMBER> immunomodulator factors eg vitamin c zinc selenium etc might effective outcome covid<NUMBER> patients considered included studies <NUMBER> type ii statistical errors following studies small sample size eventually overcome limitations bias results study confirmed robustly large multicentral randomized clinical trials conditional evidence recommends vitamin might important supportive agent immune system mainly cytokine response regulation pathogens systematic review metaanalysis along ecological approach found high percentage covid<NUMBER> patients suffer vitamin deficiency insufficiency importantly ecological investigation resulted substantial direct reverse correlations recovery mortality rate covid<NUMBER> patients vitamin status respectively different countries considering latitudes small reverse correlation vitamin status mortality rate found throughout world altogether seems populations lower levels vitamin might higher risk sarscov<NUMBER> infection however large clinical trials following comprehensive metaanalysis taken account order achieve reliable findings additionally due multiple limitations study allow quantify value c c e p e n u c r p <NUMBER> late <NUMBER> several pneumonia cases undetermined cause identified wuhan hubei province china similar cases rapidly observed chinese provinces countries <NUMBER> <NUMBER> january <NUMBER> <NUMBER> novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> isolated patients <NUMBER> corresponding disease subsequently named coronavirus <NUMBER> covid<NUMBER> world health organization severe cases including cases resulted death observed older patients patients comorbidities including hypertension coronary artery disease diabetes chronic kidney disease <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> sarscov<NUMBER> require human angiotensinconverting enzyme <NUMBER> ace<NUMBER> enter host cell <NUMBER> <NUMBER> interestingly ace<NUMBER> expression increased patients diabetes <NUMBER> treatment using reninangiotensinaldosterone system raas inhibitors ace inhibitors angiotensin receptor blockers arbs <NUMBER> given mechanism fact several chinese studies identified severe outcomes covid<NUMBER> patients comorbidities meet indications ace inhibitors arbs <NUMBER> <NUMBER> <NUMBER> concerns regarding use drugs covid<NUMBER> cases <NUMBER> addition sarscov<NUMBER> appears downregulate ace<NUMBER> expression key enzyme counteracts raas degrading angiotensin ii angiotensin<NUMBER> thereby attenuates organ injury <NUMBER> blockage raas increased ace<NUMBER> expression attenuated lung injury induced sarscov preclinical model <NUMBER> <NUMBER> nevertheless discontinuation raas inhibitor treatment could lead clinical deterioration patients cardiovascular diseases clinical data lacking regarding theoretical relationships raas inhibitor use covid<NUMBER> severity recent chinese studies demonstrated inpatient use raas inhibitors associated mortality c c e p e n u c r p <NUMBER> covid<NUMBER> patients hypertension <NUMBER> <NUMBER> however prehospital drug use evaluated studies thereby questioning adequate exposure raas inhibitors therefore nationwide populationbased cohort study evaluated records korean health insurance review assessment hira database determine whether prior use raas inhibitors associated clinical outcomes among patients covid<NUMBER> limited realworld clinical data available physicians policymakers covid<NUMBER> pandemic therefore republic koreas government decided share worlds first nationwide database deidentified covid<NUMBER> patient data domestic international researchers <NUMBER> database contains claim records including <NUMBER>year period hospitalization <NUMBER> individuals tested covid<NUMBER> hospitals issued claims hira april <NUMBER> <NUMBER> database includes detailed information regarding demographic characteristics diagnoses prescriptions procedures patient outcomes diagnostic codes assigned basis korean classification diseases seventh revision kcd<NUMBER> modified version tenth revision international classification diseases icd<NUMBER> use drugs identified using anatomical therapeutic chemical codes hira general name codes study protocol analysis deidentified patient data exempted review institutional review board chungang university <NUMBER>hr<NUMBER> included patients covid<NUMBER> ≥<NUMBER> years old confirmed covid<NUMBER> cases identified using following kcd<NUMBER>icd<NUMBER> codes b<NUMBER> coronavirus c c e p e n u c r p <NUMBER> infection unspecified site b<NUMBER> coronavirus cause diseases classified chapters u<NUMBER> provisional assignment new diseases uncertain etiology emergency use u<NUMBER> novel coronavirus infection u<NUMBER> coronavirus disease <NUMBER> diagnostic codes given definitive diagnosis covid<NUMBER> made based positive nasopharyngeal swab specimens tested realtime reverse transcriptionpolymerase chain reaction assays <NUMBER> index date defined date covid<NUMBER> diagnosis patients followed first instance death april <NUMBER> <NUMBER> study identified raas inhibitors including ace inhibitors arbs prescribed within <NUMBER> year index date present study raas inhibitor users defined patients raas inhibitor use <NUMBER> days index date whereas nonusers defined patients never received raas inhibitors received <NUMBER> days index date prescription duration ≥<NUMBER> days required define drug use detailed types codes raas inhibitors described supplementary table <NUMBER> comorbidities defined basis claim codes within <NUMBER> year index date evaluated basis charlson comorbidity index <NUMBER> presence hypertension included charlson comorbidity index separately identified using icd<NUMBER> codes see supplementary table <NUMBER> data also collected n u c r p <NUMBER> regarding previous use steroids oral intravenous ≥<NUMBER> days previous year immunosuppressants see supplementary table <NUMBER> immunosuppression identified basis underlying disease condition affected immune system eg human immunodeficiency virus infection malignancy patient receiving immunosuppressive therapy type hospital diagnosis covid<NUMBER> established defined according centers number beds medical specialties see supplementary material data extracted regarding antibiotics antivirals hydroxychloroquine steroids vasopressors used hospitalization see supplementary tables <NUMBER> <NUMBER> inhospital steroid treatment defined intravenous corticosteroid treatment methylprednisolone hydrocortisone vasopressor use defined administration norepinephrine epinephrine vasopressin dopamine dobutamine hospitalization procedure codes also used identify cases involved conventional oxygen therapy high flow nasal cannula mechanical ventilation extracorporeal membrane oxygenation ecmo renal replacement therapy see supplementary table <NUMBER> inhospital mortality defined primary study outcome secondary outcomes included vasopressor use modes ventilation ecmo renal replacement therapy acute cardiac events cardiac arrest myocardial infarction acute heart failure c c e p e n u c r p <NUMBER> logistic regression models used calculate odds ratios ors <NUMBER> confidence interval cis inhospital mortality according raas inhibitor use association raas inhibitor use inhospital mortality also assessed subgroup patients hypertension given fact previous studies identified severe outcomes patients multivariate logistic regression analysis performed adjust age sex charlson comorbidity index immunosuppression hospital type separate analysis also performed ascertain effects inhospital medication exposures vasopressor use mechanical ventilation rate excess ace<NUMBER> would disappear host cell membranes withdrawal raas inhibitors unclear thus sensitivity analysis patients received raas inhibitors time <NUMBER> days index date analyzed compare clinical outcomes raas inhibitor users nonusers associations raas inhibitor use mortality assessed basis stratification according age sex charlson comorbidity index diabetes hypertension myocardial infarction cerebrovascular disease chronic pulmonary disease chronic kidney disease immunosuppression evaluated whether prior raas inhibitor use significantly associated secondary outcomes tests twotailed differences considered statistically significant pvalues <NUMBER> statistical analyses performed using sas software version <NUMBER> sas institute cary c c e p e n u c r p among <NUMBER> individuals tested <NUMBER> patients confirmed covid<NUMBER> patients covid<NUMBER> classified raas inhibitor users <NUMBER> patients nonusers <NUMBER> patients <NUMBER> users <NUMBER> received arbs <NUMBER> patients received raas inhibitors <NUMBER> days index date classified nonusers see supplementary table <NUMBER> patients baseline characteristics described table <NUMBER> raas inhibitor users likely older male comorbidities listed table <NUMBER> moreover raas inhibitor users likely immunosuppressed among <NUMBER> patients covid<NUMBER> hospitalization observed <NUMBER> patients <NUMBER> based absence claims data assume remaining patients stayed home received outofhospital treatment community treatment centers hospitalized patients included <NUMBER> patients used raas inhibitors <NUMBER> patients nonusers <NUMBER> users <NUMBER> received arbs <NUMBER> patients received raas inhibitors <NUMBER> days index date classified nonusers see supplementary table <NUMBER> inhospital treatments included antibiotics <NUMBER> patients <NUMBER> antivirals <NUMBER> patients <NUMBER> hydroxychloroquine <NUMBER> patients <NUMBER> intravenous steroids <NUMBER> patients <NUMBER> see supplementary table <NUMBER> treatment type common among raas inhibitor users overall mortality rate entire cohort <NUMBER> <NUMBER> patients inhospital mortality observed <NUMBER> raas inhibitor users <NUMBER> <NUMBER> nonusers <NUMBER> p<NUMBER> table <NUMBER> survival curves entire cohort hospitalized patients shown supplementary figures <NUMBER> <NUMBER> table <NUMBER> relative nonusers raas inhibitor users likely develop cardiac arrest acute heart failure observations influenced evaluated subjects received raas inhibitors time <NUMBER> days index date see supplementary table <NUMBER> however multivariate analysis adjusted baseline imbalances revealed raas inhibitor use independently associated higher risk mortality among covid<NUMBER> patients adjusted <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> table <NUMBER> finding influenced evaluated subjects received raas inhibitors time <NUMBER> days index date see supplementary table <NUMBER> analysis additionally adjusted inhospital medications vasopressor use mechanical ventilation consistent overall results see supplementary table <NUMBER> multivariate results generally consistent across subgroups figure <NUMBER> generally significant differences secondary outcomes raas inhibitor users nonusers table <NUMBER> among <NUMBER> patients hypertension covid<NUMBER> <NUMBER> patients used raas inhibitors <NUMBER> patients nonusers raas inhibitor users likely diabetes nonusers likely malignancy immunosuppressed see supplementary table <NUMBER> inhospital mortality observed <NUMBER> raas inhibitor users <NUMBER> <NUMBER> nonusers <NUMBER> p<NUMBER> see supplementary table <NUMBER> multivariate analysis adjusted baseline imbalances revealed raas inhibitor use independently associated higher risk supplementary table <NUMBER> present study revealed significantly higher mortality rate among patients covid<NUMBER> using raas inhibitors relative patients receiving raas inhibitors however raas inhibitor users older comorbidities likely receive inhospital treatments elevated risk mortality among raas inhibitor users disappeared adjusting confounding factors use raas inhibitors thought upregulate ace<NUMBER> expression facilitate host cell entry sarscov <NUMBER> <NUMBER> furthermore ace<NUMBER> predominantly expressed lung alveolar epithelial cells many extrapulmonary tissues including heart kidneys <NUMBER> however preclinical models revealed inconsistent findings regarding effects raas inhibitors ace<NUMBER> expression <NUMBER> <NUMBER> moreover ace<NUMBER> may protect organ injury reducing angiotensin ii activity experimental models indicated decreased ace<NUMBER> activity may contribute respiratory virusinduced lung injury <NUMBER> recent study also suggested patients covid<NUMBER> appeared exhibit raas activation increased viral load levels subsequent lung injury <NUMBER> present study revealed relative nonusers raas inhibitor users higher mortality rate advanced ventilatory support nevertheless potential confounding precludes causal inference regarding relationship raas inhibitor use lung injury addition effects arbs ace<NUMBER> expression inconsistent animal models <NUMBER> <NUMBER> ace inhibitors affect directly activity ace<NUMBER> <NUMBER> thus would interesting perform subgroup analysis according specific raas inhibitors however study c c e p e n u c r p <NUMBER> relatively small sample ace inhibitor users relative arb users see supplementary three chinese studies patients severe covid<NUMBER> revealed hypertension diabetes coronary artery disease common comorbidities older age risk factor mortality <NUMBER> <NUMBER> <NUMBER> italian cohort critically ill patients predominantly older men hypertension common comorbidity followed cardiovascular disorders hypercholesterolemia diabetes <NUMBER> korea case fatality rate higher among older men comorbidities included cardiovascular disease diabetes neurologic disease <NUMBER> poor outcomes likely related agedependent defects immune function excessive host response viral infection <NUMBER> protective effects sex hormones second x chromosome carries several genes encoding innate immune molecules may explain low susceptibility female patients viral infections <NUMBER> moreover ace<NUMBER> located x chromosome possibility dosage effect sex chromosome may impact ace<NUMBER> activity due escape xinactivation <NUMBER> present study revealed <NUMBER> patients ≥<NUMBER> years old <NUMBER> patients men similar official statistics korea centers disease control prevention april <NUMBER> <NUMBER> ≥<NUMBER> years old <NUMBER> men <NUMBER> separately estimate individual risk factors mortality although would reasonable assume baseline factors eg age sex comorbidities affect study outcomes given associations raas inhibitor use disappeared adjustment factors c c e p e n u c r p <NUMBER> clinical practice raas inhibitors typically used treat cardiovascular diseases diabetes chronic kidney disease <NUMBER> <NUMBER> unfortunately withdrawal raas inhibitors may result severe clinical decompensation patients heart failure <NUMBER> addition myocardial dysfunction observed course covid<NUMBER> <NUMBER> dysregulation ace<NUMBER> may play role myocardial injury ace<NUMBER> knockout animal models led angiotensin iiinduced injury adverse left ventricular remodeling <NUMBER> furthermore ace<NUMBER> expression reduced viral rnapositive heart samples patients died sars <NUMBER> present study revealed raas inhibitor users higher proportions vasopressor use cardiac arrest acute heart failure although relationships significant adjustment confounding factors therefore findings suggest raas inhibitors continued covid<NUMBER> patients especially patients high risks heart failure myocardial infarction future studies needed evaluate association raas inhibitor discontinuation outcomes among covid<NUMBER> patients best knowledge first comprehensive study evaluate whether prior raas inhibitor use associated outcomes nationwide cohort asian covid<NUMBER> patients however findings suggest raas inhibitor use independently associated covid<NUMBER> outcomes adjusting baseline demographic characteristics comorbidities inhospital treatments data support recommendations major medical societies suggest continuation raas inhibitors patients covid<NUMBER> <NUMBER> <NUMBER> thus realworld evidence regarding relationship crucial given concerns regarding illadvised discontinuation among patients rely drugs <NUMBER> city cohorts <NUMBER> <NUMBER> <NUMBER> although studies provide information similar evaluation associations raas inhibitors covid<NUMBER>related outcomes asian population clinically relevant given east asian populations higher ace<NUMBER> expression tissues populations similar conditions <NUMBER> present study several limitations first accuracy diagnostic codes may limited always possibility overor undercoding however korean hira service vigorously audits insurance claims numerous peerreviewed publications based hira data also unlikely discrepancies database disease codes actual diseases epidemic investigations performed covid<NUMBER> cases moreover raas inhibitors available overthecounter drugs via selfpay prescriptions korea second retrospective observational design cannot exclude possibility residual confounding precludes causal inference regarding relationship raas inhibitors covid<NUMBER>related outcomes thus randomized controlled studies would needed establish causality although would likely feasible enroll sufficient number patients short period thus observational data currently best available evidence regarding raas inhibitor use among patients covid<NUMBER> third database limitations made impossible obtain information regarding potential control group eg patients sick enough tested covid <NUMBER> addition database include information regarding smoking status laboratory results nevertheless primary objective evaluate whether raas inhibitor use associated outcomes among patients covid<NUMBER> finally additional information regarding cause death available database study probability survival dropped abruptly first days entire cohort hospitalized patients possible early mortality may related acute cardiac event acute pulmonary embolism rather covid<NUMBER>related respiratory disease n u c r p <NUMBER> novel coronavirus covid<NUMBER> infection outbreak posed major threat international health system economy study aimed investigating biological epidemiological trends prevalence mortality due outbreaks novel coronavirus covid<NUMBER> infections data global outbreak covid<NUMBER> obtained world health organization worldometer centers disease control prevention cdc research institutes information also recorded research documents published global scientific journals indexed pub med institute scientific information isi web science trends prevalence mortality due covid<NUMBER> infection outbreaks results show rising trends transmission prevalence mortality rate due coronavirus covid<NUMBER> period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> infected <NUMBER> people worldwide resulting <NUMBER> deaths mortality rate <NUMBER> <NUMBER> infections frequent among male gender <NUMBER> years age mean growth rate index total number cases january <NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> growth rate index mortality rate <NUMBER> <NUMBER> positive association prevalence mortality rate r<NUMBER> <NUMBER> novel coronavirus covid<NUMBER> highly contagious affected large number people worldwide still spreading mutable prevalence mortality outbreak trends global health officials taken priority measures prevent outbreaks emerging pathogen across globe however rising number cases mortality risk estimates demonstrating enhanced public health mediations good hygienic conditions social distancing movement limitations may control covid<NUMBER> epidemics biological epidemiological trends prevalence mortality due outbreaks novel coronavirus covid<NUMBER> medical education pandemics uk perspective according world heath organization <NUMBER> confirmed cases <NUMBER> confirmed deaths novel coronavirus disease <NUMBER> <NUMBER>ncov reported throughout world april <NUMBER> <NUMBER> including <NUMBER> confirmed cases <NUMBER> deaths india <NUMBER> outbreak first announced health commission hubei province china cluster unexplained cases pneumonia unknown etiology unknown cases <NUMBER> lethal first identified wuhan capital city hubei seven largest city china december <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> later novel coronavirus disease called officially covid<NUMBER> <NUMBER> epidemic announced major public concern worldwide january <NUMBER> <NUMBER> world health organization <NUMBER> coronavirus enveloped virus described singlestranded positivesense rna belonging family coronaviridae nidovirales order extensively disseminated among humans well mammals <NUMBER> ongoing coronavirus epidemic announced pandemic world health organization january <NUMBER> <NUMBER> govt india announced <NUMBER> days nationwide lockdown march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> prevent stageiii spreading virus humantohuman transmission coronavirus causes typically mild infections sometimes lethal communicable disorders leading severe acute respiratory syndrome sars middle east respiratory syndrome mers present covid<NUMBER> pandemic general thought sarsrcov <NUMBER> mostly observed batscould create future disease outbreak <NUMBER> <NUMBER> important modes transmission coronavirus respiratory droplets contact transmission contaminated hands incubation period <NUMBER> days <NUMBER> <NUMBER> confirmed cases coronavirus symptoms range fever sneeze even runny nose dry cough fatigue breathing problem lung infiltration severely ill dying <NUMBER> shared surfaces also important risky since virus clings surfaces propagates soon another person touches shared surface virus also remain active <NUMBER> hours aerosolization droplets carrying virus mixed air plastic fifteen hours metallic surfaces fivesix hours continuing coronavirus outbreak announced widespread world health organization march <NUMBER> <NUMBER> united nations public health agency authenticated <NUMBER> confirmed cases including <NUMBER> deaths across <NUMBER> countries throughout world <NUMBER> <NUMBER> countries start shutting borders cutting international marketing quarantining cial places well contacts cases quarantine surveillance contact tracing <NUMBER> route outbreak described series important factors extremely difficult understand present coronavirus disease basic reproduction number r <NUMBER> one crucial quantities infectious diseases r <NUMBER> measures contagious disease r <NUMBER> designates number secondary infections infected one infected individual whole susceptible class specifically area epidemic curve r <NUMBER> <NUMBER> disease expected stop spreading r <NUMBER> <NUMBER> infected individual infect average <NUMBER> person spread disease stable disease spread become epidemic r <NUMBER> must greater <NUMBER> r <NUMBER> help us understand effectiveness disease condition disease stop spread values r <NUMBER> china around <NUMBER> primary stage outbreak coronavirus <NUMBER> spread coronavirus outbreak depends infectivity virus availability susceptible individuals mathematical modeling play vital role better understand disease dynamics designing policies manage quickly spreading infectious diseases lack effective vaccine specific antivirals <NUMBER> recently many mathematical model already studied understand complicated dynamics novel coronavirus cited references <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel coronavirus model established chen et al <NUMBER> find basic reproduction number imai et al <NUMBER> studied computational model novel coronavirus disease <NUMBER> wuhan city china model mainly focused humantohuman transmission tang et al <NUMBER> established compartmental model coronavirus incorporating symptomatic ill class obtain patients epidemiological status obtained basic reproduction number <NUMBER> high infectious diseases nadim et al <NUMBER> studied mathematical investigate coronavirus disease performed stability analysis validated model data hubei city china model originally established gumel et al <NUMBER> severe acute respiratory syndrome sars outbreak wu et al <NUMBER> established coronavirus model considering four classes namely susceptible exposed infected recovered study humanhuman transmission dynamics based data december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> computed reproduction number approximately <NUMBER> coronavirus disease conventional models governing outbreak infectious diseases mainly depend interplays among susceptible infected exposed classes moreover aspects vaccination huge news coverage educational campaigns rapid information flow create great psychological effects population thus remarkably change publics behavior affect implementation individuals intervention control strategies <NUMBER> mainly awareness program due media make individuals enlighten regarding disease take safeguards vaccination wearing protective masks social distancing etc minimize risks infected <NUMBER> <NUMBER> long effectual media related impact persists thus important issue future outbreak quantifying impact modeling process falls within scope investigation several mathematical models incorporated assumption media related awareness impact reducing contact rate susceptible infected population <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> influenced literatures develop analyze mathematical model coronavirus study impact media related awareness program obtain better insight important factors related control novel coronavirus community throughout world investigate dynamic model study epidemic coronavirus control four mostly affected states namely maharashtra delhi kerala west bengal overall india estimated important parameters namely β ξ q α h ξ h ξ γ using least square method calculate basic reproduction model four different states well india extend classical deterministic susceptibleexposedinfectiousremoved seir compartmental model refined introducing contact tracinghospitalization strategies study epidemiological properties coronavirus calibrate mathematical model using data gained form confirmed cases coronavirus india estimated basic reproduction number disease transmission order make mathematical model realistic consider following assumptions • model involves net inflow rate susceptible individuals λ per unit time • model zoonotic infections coronavirus considering epidemic spread human beings • effective control measures april <NUMBER> <NUMBER> • model involves demographic effects accepting proportional natural mortality subpopulations underlying dynamic model total population nt classified six subpopulations classes namely susceptible st exposed et asymptomatic clinically ill symptomatic hospitalized ht recovered rt respectively coronavirus outbreaks population throughout world news concerning coronavirus epidemics different media including television social networking sites newspaper well educational programs government nongovernment organization local bodies source information density media assumed proportional number symptomaticinfective individuals alter symptomatic population alters herein mt denotes cumulative density media individual mt <NUMBER> <NUMBER> mimic mathematical model developed donofrio et al <NUMBER> case nondelayed model mimics media variable incorporated media creates behavioral alteration susceptible populations save contracting infection example government senegal taken initiative sms campaign spread information regarding ebola awareness <NUMBER> albeit individuals informed media everyone responses due insufficiency resources irresponsive nature economic condition etc therefore part susceptible individuals news regarding coronavirus responding news corona symptoms altering behavior avoid infection move recovered individuals rate behavioral response media considered function densities susceptible populations media f st mt moreover assume source media function f source media depends density symptomatic populations schematic representation biological mechanism coronavirus human upon model based shown figure <NUMBER> dynamics novel coronavirus model governed following system nonlinear ordinary differential equations susceptible individual recruited population constant inflow rate λ decreased natural mortality mortality rate δ β α represents transmission coefficient asymptomatic individuals susceptible β α transmission coefficient symptomatic infected classes susceptible β α h denotes transmission coefficient hospitalized classes susceptible population consider β disease transmission coefficient infectiousness covid<NUMBER> contact rates adjustment factors α asymptomatic classes α symptomatic classes α h hospitalized individuals albeit coronavirus supposed spread completely symptomatic populations lower rate transmission asymptomatic populations cannot even ruled adjustment parameter α ≥ <NUMBER> take accounts varying levels hygiene preventions asymptomatic analogous explanation drawn adjustment parameters α α h symptomatic hospitalization respectively asymptomatic symptomatic hospitalization programmes hygiene preventions asymptomatic symptomatic hospitalization executed enriched progressively epidemic coronavirus spreading coefficients α β α β α h β asymptomatic symptomatic hospitalized rates could modeled timedependent parameters computations moreover interplay among susceptible infected population asymptomatic symptomatic hospitalized modeled utilizing standard homogeneous mixing incidence <NUMBER> <NUMBER> form total individuals rate change susceptible individuals represented following ordinary differential equation ode b dynamics exposed individuals et population exposed individuals yet developed clinical symptoms coronavirus exposed individual declined asymptomatic individuals rate γ e natural death rate δ e constant percapita rate γ e modeled progression exposed individuals e either asymptomatic individuals symptomatic individuals constant q <NUMBER> q <NUMBER> represents budget rate progress population move either asymptomatic partiallyinfectious class symptomatic class percapita rate γ e corresponding model dynamics exposed population presented following ode asymptomatic populations exposed coronavirus infectious community exposed classes move asymptomatic classes rate γ e constant portion <NUMBER> − q asymptotic individuals progress recovered class percapita rate ξ natural mortality rate δ rate change asymptomatic individuals govern following ode symptomatic individuals produced progression clinical symptoms coronavirus diagnosed clinicians asymptomatic individuals exposed individuals move symptomatic classes percapita rate γ e constant portion q symptomatic clinically ill individuals progress hospitalized isolated class h percapita rate γ natural mortality rate δ assumed γ percapita rate symptomatic clinically ill classes seek clinical attention therefore put hospitalized class bigger γ e percapita rate exposed individuals progress asymptomatic classes clinically ill classes class moved recover classes without diagnosed percapita rate ξ transmission dynamics symptomatic populations governed following ode f dynamics recovered individuals rt assumed recovered population enduring immunity coronavirus albeit date neither confirmed contradicted asymptomatic symptomatic hospitalized individuals recover coronavirus percapita rates ξ ξ ξ h respectively recovered individuals die percapita rate δ r rate change recovered individuals written ode assume source media related information index proportional number symptomatic individuals function f represents growth information index rate depend symptomatic individuals coronavirus outbreaks world health organization health agencies social media government nongovernment organization become dynamic spread information media awareness concerning prevalence coronavirus function f one consider function satisfying f <NUMBER> <NUMBER> f ′ <NUMBER> <NUMBER> easiest example f α α ∈ <NUMBER> <NUMBER> linear function present prevalence coronavirus could represent instance current standardized incidence serious cases coronavirus <NUMBER> one example could f αmi <NUMBER>βmi indicates nonlinear increasing function prevalence coronavirus could considered measure perceived risk infection rather original one <NUMBER> <NUMBER> α represents source rate information index β half saturation constant thus consider following ode model media awareness program based biological assumptions schematic representation coronavirus see figure <NUMBER> together specific forms formulate mathematical model novel coronavirus media awareness given following sevendimensional nonlinear system odes model satisfied following positive initial conditions since model system <NUMBER> monitors dynamics human population state variables assumed positive basic reproduction number symbolized r <NUMBER> expected number secondary cases produced completely susceptible population typical infective individual <NUMBER> <NUMBER> dimensionless basic reproduction number provides threshold play crucial role determining disease persists dies individual general way r <NUMBER> stated number new infections created typical infective population infection free equilibrium r <NUMBER> <NUMBER> determines average infected population creates less one new infected population course infective period infection die reverse way r <NUMBER> <NUMBER> determines infected population creates average one new infection disease spread population basic reproduction number r <NUMBER> computed using concept next generation matrix <NUMBER> <NUMBER> order consider nonnegative matrix f nonsingular m−matrix v expressing production newinfection transition part respectively system <NUMBER> described jacobian matrix system <NUMBER> computed infection free state e represents spectral radius next generation matrix f v −<NUMBER> thus system <NUMBER> get basic reproduction detailed elucidation computer simulations coronavirus model system <NUMBER> figure <NUMBER> designates prcc results implies highest positively correlated parameters disease transmission coefficient rate β proportion rate exposed individuals q rate ξ h hospitalized class converted recovered class rate α h susceptible individuals converted exposed class highly negatively correlated parameters rate ξ symptomatic individuals become recovered rate γ symptomatic individuals converted hospitalized class rate ξ asymptomatic individuals moved recovered individuals account uncertainty respect symptomatic population thus prcc analysis yields <NUMBER> parameters β q ξ γ ξ h α h ξ effective parameters <NUMBER> parameters therefore estimated <NUMBER> parameters using least square method calibrated coronavirus disease model <NUMBER> table iv output model daily new cases shown figure <NUMBER> also observed daily new coronavirus cases overlapped fig <NUMBER> also important observe total number coronavirus cases province observed daily cumulative confirmed coronavirus cases model simulation plotted fig <NUMBER> assure performance coronavirus system without media <NUMBER> table iii fitting data enables us quantify basic reproduction number r <NUMBER> expression <NUMBER> whereas slope simulated curve relatively high state kerala describe best diminish human impermanency morbidity due novel coronavirus essential see relative significance various factors responsible transmission initial disease transmission completely associated reproduction number r <NUMBER> calculate sensitivity indices regard r <NUMBER> parameters system <NUMBER> sensitivity indices describe us whether infectious diseases develop throughout individulas sensitivity analysis mainly utilized describe robustness reproduction number r <NUMBER> fluctuation system parameters also give us identify relative change state variable system parameter alters normalized forward sensitivity index r <NUMBER> respect parameter p defined follows explicit expression r <NUMBER> <NUMBER> obtain analytical formulae sensitivity indices r <NUMBER> γ r <NUMBER> p fourteen parameters stated table vi example sensitivity index r <NUMBER> regards β independent parameters represents r <NUMBER> increasing function respect β implies probability disease transmission high impact coronavirus control management parameters sensitivity indices specified table vi table vi noticed indices positive indices negative indicate indices signs increase value r <NUMBER> one increase signs decrease value r <NUMBER> increased sensitive parameter disease transmission coefficient β sensitivity index γ r <NUMBER> βs <NUMBER> indicates increasing β <NUMBER> increase r <NUMBER> <NUMBER> also sensitivity index ξ γ r <NUMBER> βs − <NUMBER> represents increasing ξ <NUMBER> decrease r <NUMBER> <NUMBER> similarly interpret parameters plot sensitivity indices r <NUMBER> model parameters using table vi shown figure <NUMBER> order control coronavirus outbreaks must target sensitive parameters great impact controlling system dynamics instance disease transmission coefficient β effective parameter controlling coronavirus diseases easily identified figure <NUMBER> well table vi control coronavirus outbreaks draw contour plots r <NUMBER> respect positively correlated parameters namely disease transmission coefficient β clinical outbreak rate q infected classes figure <NUMBER> contour plot represents dependence r <NUMBER> four states kerala delhi west bengal maharashtra republic india contour plot indicates higher values β q reproduction number r <NUMBER> become high means coronavirus may enter stage<NUMBER> spread community therefore control r <NUMBER> must restrict values transmission coefficient β portion q exposed class become symptomatically ill keep mortality rate low possible must take values β q small possible figure <NUMBER> table vi represents adjust factors α α α h positively correlated basic reproduction number r <NUMBER> thus must reduce adjust factors thus may conclude reduce coronavirus disease outbreak need maintain social distancing limit stop taking fairs theaters performances etc study impact media related awareness coronavirus disease simulate system <NUMBER> four provinces namely kerala maharashtra delhi west bengal republic india respect parameter values specified table also investigate media related awareness novel coronavirus diseases republic india four provinces namely kerala maharashtra west bengal delhi respect parameters listed table rest estimated parameters listed table ii initial individuals listed table iv impact media awareness effect daily cumulative confirmed cases coronavirus diseases symptomatic classes shown study future outbreaks coronavirus diseases simulate system <NUMBER> long days infected individuals namely asymptomatic individuals symptomatic clinically ill individuals parameters listed table considered estimated parameters table ii case indian data initial population sizes given table iv model simulation represented people overall india experience future epidemics control policies implemented effectively shown figure <NUMBER> number infected individuals asymptomatic symptomatic oscillate around <NUMBER> days around <NUMBER> days interpreted reproduction number r <NUMBER> always greater unity india see table v india otherwise say impact media related awareness dynamic process media great impact reducing transmission coronavirus outbreaks initial stage epidemic factors like low air temperature well low humidity great impact transmission novel coronavirus <NUMBER> moreover control future outbreaks novel coronavirus media related awareness programme control strategy must implemented properly manuscript propose compartmental epidemic model novel coronavirus diseases incorporating effect media awareness predict control outbreak model noted media awareness play key role generating public consciousness encouraging disease measures <NUMBER> proposed model consider two infectious individuals namely asymptomatic symptomatic individuals former fast spreader coronavirus diseases model formulation based work gumel et al <NUMBER> estimate system parameters based prcc sensitivity analysis early stage outbreak number cumulative classes grow exponentially calibrated proposed model fit data four different states namely maharashtra kerala delhi west bengal republic india important part perform sensitivity analysis <NUMBER> model parameters estimation identify key input parameters contributed symptomatic outcome strongly assisted implementation integrated policy various measures involving epidemic different phases diseases use sensitivity analysis using prcc techniques prcc analysis yields sensitive parameters β q γ α h ξ ξ h <NUMBER> input parameters without incorporating media impact estimated <NUMBER> parameters based data four different states entire india fitting data novel coronavirus cases january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> four different states india overall india proposed model able get estimates unknown parameters system fitting proposed model simply classical model without considering media impact system <NUMBER> real data obtained india covid<NUMBER> tracker httpswwwcovid<NUMBER>indiaorg able get acceptable estimations system parameters curve fitting shown figures <NUMBER> <NUMBER> ensure performance system without media compute numerical errors namely e ae e rm se within reasonable set parameters model simulations without incorporating media awareness obtained relatively good fits novel coronavirus data plotted figures <NUMBER> <NUMBER> basic reproduction number r <NUMBER> table v compared province kerala highly effective coronavirus diseases compare three provinces republic india nevertheless modelbased analysis also demonstrates basic reproduction number india four different provinces remains greater unity estimation basic reproduction number r <NUMBER> indicates strengthen control involvements mandatory reduce andor eradicate future coronavirus diseases thus scenario public must give utmost priority stay home quarantine successful lockdown combat coronavirus pandemic situation media related awareness mandatory aware every people maintain social distancing wear mask protect avoid cultural programme sensitivity indices see table vi figure <NUMBER> basic reproduction number r <NUMBER> observed disease transmission coefficient β portion q clinical outbreak rates infected classes positively correlated r <NUMBER> indicates reduce coronavirus diseases social distancing important factor reduce values β q control diseases know r <NUMBER> <NUMBER> diseases died thus keep control value r <NUMBER> must reduce β q investigating contour plot observe lower values β q reproduction number controlled reduced less unity shown figure <NUMBER> thus able control social distancing able control basic reproduction number r <NUMBER> hence able eradicate coronavirus diseases since r <NUMBER> quantifies initial epidemic transmission sensitivity indices enable us establish relative significance various parameters coronavirus transmission sensitivity basic reproduction number r <NUMBER> conclude effective control measures isolation close contacts strengthening selfprotection ability susceptible individuals table ii thus calibrated model predicted increasing pattern coronavirus diseases continued people aware diseases thus public must take precautions health care agencies concentrate successful implementation control mechanisms reduce andor eradicate disease order study longterm dynamics model observed interesting switching phenomena plotted figure <NUMBER> maybe happen due impact media awareness dynamic process disease epidemic also media awareness good impact mitigating disease transmission initial stage epidemic worthy mention media impact always remain efficacious mitigating disease transmission throughout epidemic <NUMBER> detailed understanding media awareness outbreak help progression implementable public health strategy particular interest designers strategies effects media awareness significant epidemic features size peak timing whole number diseases proposed model simulation like earlier investigations <NUMBER> <NUMBER> <NUMBER> <NUMBER> allow quantifying media effects gives additional insights model simulation prediction suggests novel coronavirus diseases potentiality exhibit oscillatory dynamics future controllable maintaining social distances effectiveness isolation hospitalization model forecasts isolation hospitalization populations coronavirus symptoms stringent hygiene safeguards social distancing able effectual control community may even eliminate diseases study also suggests size duration epidemic considerably affected timely implementation hospitalization isolation programme based model simulations prediction control coronavirus diseases provide particular inferences face emerging diseases avoidance mass gatherings rallies social distancing implement extensive lockdown ii provide essential personal safeguard staff involved emergency services iii timely give statistics coronavirus diseases community including number asymptomatic cases symptomatic cases hospitalized cases iv increase media awareness aware population organize targeted health care education selfprotection remove public mental disorder table rest parameters estimated taken table ii different states overall india initial values taken table iv <NUMBER> δ e mortality rate exposed individuals <NUMBER> ×<NUMBER> −<NUMBER> day −<NUMBER> <NUMBER> δ mortality rate asymptomatic individuals <NUMBER> ×<NUMBER> −<NUMBER> day −<NUMBER> <NUMBER> δ mortality rate symptomatic individuals <NUMBER> day −<NUMBER> <NUMBER> δ h mortality rate hospitalized individuals <NUMBER> ×<NUMBER> −<NUMBER> day −<NUMBER> <NUMBER> δ r mortality rate recovered individuals <NUMBER> ×<NUMBER> −<NUMBER> day −<NUMBER> <NUMBER> γ e conversion rate exposed asymptomatic individuals <NUMBER> day −<NUMBER> <NUMBER> γ rate symptomatic individuals become hospitalized estimated q proportion exposed individuals estimated ξ rate recovery asymptomatic individuals estimated ξ rate recovery symptomatic individuals estimated ξ h rate recovery hospitalized individuals estimated δ degradation media related information <NUMBER> <NUMBER> η rate media response <NUMBER> <NUMBER> <NUMBER> media related information index rate <NUMBER> day −<NUMBER> <NUMBER> α source rate information index <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> seventh type coronavirus isolated humans coronavirus belongs genus β envelope particles round oval often polymorphic <NUMBER> <NUMBER> nm diameter genetic characteristics sarscov<NUMBER> significantly different sarscov merscov current research shows sarscov<NUMBER> <NUMBER> homology bat sarslike coronavirus batslcov zc<NUMBER> <NUMBER> therefore believed original host sarscov<NUMBER> may rhinolophus sinicus <NUMBER> <NUMBER> post hoc investigations also revealed wildlife trade market sarscov<NUMBER> also isolated markets environment humantohuman transmission emerged shortly thereafter <NUMBER> patients covid<NUMBER> become main source infection covid<NUMBER> may capable transmission incubation period <NUMBER> <NUMBER> patients difficult diagnose isolate time causes great difficulties prevention control disease however date enough evidence support role asymptomatic patients transmission covid<NUMBER> addition presence virus detected patients recovery stage especially fecal specimens requiring longer detoxification times indicating possible risk fecaloral transmission <NUMBER> sarscov<NUMBER> positivestranded rna virus susceptible gene mutation recombination far significant mutations found humans environment <NUMBER> <NUMBER> <NUMBER> method spread present droplets inhaled respiratory tract contact transmission considered important routes transmission direct evidence showing covid<NUMBER> transmitted aerosols believes evidence needed assess possibility aerosol transmission however observations suggest aerosol propagation possible condition long exposure high concentrations aerosols relatively closed environment early stages outbreak sarscov<NUMBER> pneumonia uncertain whether stool samples patients infectious however lu et al <NUMBER> using computer structural simulation found sprotein sarscov<NUMBER> bind human angiotensinconverting enzyme <NUMBER> ace<NUMBER> spatial conformation letko et al <NUMBER> synthesized sprotein sars receptorbinding domain rbd sarscov<NUMBER> vitro reacted known human coronavirus receptors respectively result rbd sarscov<NUMBER> similar protein sars directly bind human ace<NUMBER> ace<NUMBER> metalloproteinase belonging type transmembrane glycoprotein expressed small intestine <NUMBER> <NUMBER> laboratory also found nucleic acid amplification testing stool samples still positive long time oral swab samples become negative addition large number clinical studies shown certain proportion sarscov<NUMBER> pneumonia patients develop symptoms diarrhea <NUMBER> <NUMBER> concluded development disease greater possibility virus stool recently sarscov<NUMBER> isolated stool confirmed patients wuhan shenzhen china united states <NUMBER> indicating virus replicate survive digestive tract however clear whether infection transmission caused eating food contaminated virus analysis current epidemic situation scholars believe viruses feces may retransmitted aerosol formation viruscontaining droplets sarscov<NUMBER> also adverse effects fetuses infants including restricted intrauterine growth premature birth spontaneous abortion perinatal death <NUMBER> however possibility intrauterine mothertochild transmission covid<NUMBER> low neither two existing retrospective clinical studies found direct evidence intrauterine vertical transmission <NUMBER> <NUMBER> close contact patients sarscov<NUMBER> pneumonia including family members patients high risk developing sarscov<NUMBER> infection medical staff treat patients also high risk infection nine percent patients admitted zhongnan hospital wuhan university <NUMBER> <NUMBER> january <NUMBER> medical staff <NUMBER> end <NUMBER> january <NUMBER> survey data <NUMBER> hospitals <NUMBER> provinces china showed infection rate medical staff high <NUMBER> <NUMBER> according report <NUMBER> march <NUMBER> world according available data mortality rate covid<NUMBER> china lower sars <NUMBER> <NUMBER> mers <NUMBER> <NUMBER> <NUMBER> march <NUMBER> <NUMBER> <NUMBER> deaths caused sarscov<NUMBER> pneumonia china hubei province earlier onset disease higher mortality rate suggesting pathogenicity may gradually decrease virus spreads may also occur improving ability medical staff diagnose treat disease national health commission china notified <NUMBER> february <NUMBER> population generally susceptible virus <NUMBER> deaths elderly people <NUMBER> years old time <NUMBER> deaths underlying diseases overall men linked higher risk death specific data section shown table <NUMBER> others mild condition among seven cases reported existing literature outside china except one case patient died remaining cases stable condition table <NUMBER> according latest data <NUMBER> march <NUMBER> found <NUMBER> patients tested positive nucleic acid discharge <NUMBER> many reasons positive nucleic acid test discharged patients <NUMBER> reagent detection method sampling method affect positive rate addition possibility disease recurrence cannot ruled genomic analysis virus different regions different periods different sources patients revealed sarscov<NUMBER> stable showed major variation patient cured immunity virus little chance reinfection detection sarscov<NUMBER> specific igm igg antibodies effective means determine whether patient immunity sarscov<NUMBER> patients still potential infect others therefore patient discharged hospital recommended continue isolation management health condition monitoring <NUMBER> days tips considerations selfisolation wear mask live single room good ventilation reduce close contact family members separate meals good hand hygiene avoid outdoor activities also recommended visit hospital reexamination <NUMBER>th <NUMBER>th days discharge early stages epidemic chinese government adopted principles four early four centralization address epidemic epidemic situation effectively controlled socalled four early principle early detection early reporting early isolation early treatment early detection isolation sarscov<NUMBER>infected people moving prevention control barrier forward accelerating gridbased management community improving detection capabilities optimizing diagnosis treatment process shortening diagnosis time effectively block spread epidemic reduce infection rate principle four centralization centralize patients centralize experts centralize resources centralize treatment patients severe illness centralized best hospital strongest comprehensive capacity treatment time centralize resources experts treat critically ill patients multidisciplinary comprehensive individualized diagnosis treatment applied accordance one person one strategy finally mortality rate effectively reduced addition <NUMBER> <NUMBER> medical staff parts china participated treatment patients sarscov<NUMBER> pneumonia wuhan hubei fully reflects noble qualities good professionalism chinese medical staff long since occurrence sarscov<NUMBER> pneumonia relatively reports literature opinions need verified multicenter big data addition infectious diseases different characteristics different stages whether findings opinions always applicable needs evaluation sarscov<NUMBER> originated huanan seafood market china controlled gradually improved study supported zhejiang university special scientific research fund covid<NUMBER> prevention control authors declare conflict interests dr ss qs full access data study takes december <NUMBER> clusters acute pneumonia cases unclear etiology identified wuhan city capital hubei province china <NUMBER>–<NUMBER> pathogen reported novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> world health organization made assessment coronavirus disease <NUMBER> covid<NUMBER> characterized pandemic disease still spreading rapidly around world especially united states spain russia <NUMBER> may <NUMBER> total <NUMBER> cases <NUMBER> deaths confirmed china including <NUMBER> cases <NUMBER> deaths wuhan city <NUMBER> national health commission china issued series diagnosis treatment recommendations suggested classifying disease four grades mild moderate severe critical <NUMBER> recent studies reported clinical characteristics prognosis varied severity grades covid<NUMBER> <NUMBER> <NUMBER> <NUMBER>–<NUMBER> underlying mechanisms novel coronavirus leading disease exacerbation organ dysfunction remain explored due high mortality lack effective treatments critically ill patients <NUMBER> <NUMBER> early identification prediction patients crucial risk factors severe illness death <NUMBER> identify groups likely poor outcomes focus prevention treatment efforts <NUMBER> studies needed huang et al <NUMBER> reported patients admitted intensive care unit icu severe clinical symptoms abnormal serum parameters however fewer studies published confirm early sensitive biomarker estimate disease severity prognosis covid<NUMBER> clinical work covid<NUMBER> epidemic wuhan observed high incidence hypocalcemia critically ill patients therefore hypothesized serum calcium levels associated disease severity prognosis patients covid<NUMBER> study performed test hypothesis explore causes hypocalcemia median serum calcium levels <NUMBER> iqr <NUMBER> mmoll admission divided patients three groups based serum calcium values ≤<NUMBER> mmoll defined group n <NUMBER> <NUMBER> mmoll defined group b n <NUMBER> <NUMBER> mmoll defined group c n <NUMBER> shown table <NUMBER> significant differences clinical variables except serum creatinine found among three groups differences found groups b p <NUMBER> also differences clinical variables except wbc count p <NUMBER> serum creatinine p <NUMBER> groups c whereas differences variables except wbc count p <NUMBER> alt p <NUMBER> lowest spo<NUMBER> p <NUMBER> serum creatinine p <NUMBER> found groups b c results indicated patients lower serum calcium levels worse clinical variables <NUMBER> patients <NUMBER> tested determine levels parathyroid hormone pth <NUMBER>hydroxyvitamin vd according clinical needs median serum calcium level <NUMBER> patients <NUMBER> iqr <NUMBER> mmoll median pth level <NUMBER> iqr <NUMBER> pgml median vd level <NUMBER> iqr <NUMBER> ngml patients low levels vd vd deficiency spss scatterplots correlation analyses serum calcium blood biomarkers shown figures <NUMBER> <NUMBER> serum calcium levels significantly positively correlated lymphocyte count figure <NUMBER>a p <NUMBER> albumin levels figure <NUMBER>b p <NUMBER> vd levels figure <NUMBER>c p <NUMBER> lowest spo<NUMBER> figure <NUMBER>d p <NUMBER> whereas significantly negatively correlated crp figure <NUMBER>a p <NUMBER> ddimer figure <NUMBER>b p <NUMBER> pth figure <NUMBER>c p <NUMBER> levels results indicated hypocalcemia may associated imbalanced vd pth acute phase covid<NUMBER> ards developed <NUMBER> <NUMBER> <NUMBER> patients liver injury developed <NUMBER> <NUMBER> aki developed <NUMBER> <NUMBER> cardiac injury developed <NUMBER> <NUMBER> patients research period twelve patients received mv <NUMBER> patients received crrt shown table <NUMBER> significant differences clinical severity outcome variables found among abovementioned three groups b c p <NUMBER> groups c p <NUMBER> also differences variables except liver injury incidence p <NUMBER> differences found groups b c p <NUMBER> results indicated patients serum calcium values ≤<NUMBER> mmoll higher <NUMBER>day mortality higher incidence organ injury moreover serum calcium values significantly lower patients died patients mods septic shock organ injury requiring mv crrt p <NUMBER> table <NUMBER> roc curves also performed assess associations serum calcium mods septic shock <NUMBER>day mortality shown figure <NUMBER> area curves aucs mods figure <NUMBER>a septic shock figure <NUMBER>b <NUMBER>day mortality figure <NUMBER>c <NUMBER> p <NUMBER> <NUMBER> p <NUMBER> <NUMBER> p <NUMBER> respectively optimal cutoff points serum calcium values derived roc curves optimal cutoff point mods <NUMBER> mmoll sensitivity <NUMBER> specificity <NUMBER> optimal cutoff point septic shock <NUMBER> mmoll sensitivity <NUMBER> specificity <NUMBER> optimal cutoff point <NUMBER>day mortality <NUMBER> mmoll sensitivity <NUMBER> specificity <NUMBER> figure <NUMBER> shows significant differences <NUMBER>day mortality among groups b c <NUMBER>day mortality group significantly higher groups b c p <NUMBER> difference found groups b c p <NUMBER> clinical retrospective study investigated correlations serum calcium clinical severity outcomes patients covid<NUMBER> incidence hypocalcemia <NUMBER> found patients lower serum calcium levels especially ≤<NUMBER> mmoll worse clinical variables higher incidences mods septic shock higher <NUMBER>day mortality hypocalcemia may associated imbalanced vd pth acute phase covid<NUMBER> overall mortality <NUMBER> <NUMBER> whereas mortality critically ill patients increased <NUMBER> <NUMBER> declared covid<NUMBER> pandemic disease still spreading rapidly around world <NUMBER> <NUMBER> patients diagnosed covid<NUMBER> worldwide nearly <NUMBER> died <NUMBER> although national health commission china issued series diagnosis treatment recommendations mortality critically ill patients still extremely high underlying mechanisms novel coronavirus causing organ dysfunction yet unknown crucial identify risk factors severe illness death <NUMBER> however reports published establish early sensitive biomarker predict disease severity prognosis covid<NUMBER> study found serum calcium levels associated disease severity prognosis patients covid<NUMBER> hypocalcemia common critically ill patients causes hypocalcemia include oversecretion pth vd deficiency decreased dietary intake hypoproteinemia hypomagnesemia drug interactions <NUMBER> hypocalcemia defined serum calcium level less <NUMBER> mmoll clinical laboratory present specific severity grading system hypocalcemia previous studies reported serum calcium levels less approximately <NUMBER> mmoll associated worse clinical outcomes critically ill patients <NUMBER>–<NUMBER> therefore divided patients three groups based serum calcium values ≤<NUMBER> mmoll <NUMBER> mmoll <NUMBER> mmoll found patients serum calcium values ≤<NUMBER> mmoll higher <NUMBER>day mortality higher incidence organ injury findings study consistent previous reports however first study investigate correlations serum calcium clinical outcomes patients covid<NUMBER> results suggested correcting hypocalcemia could important strategy improve prognosis patients covid<NUMBER> especially patients serum calcium values less <NUMBER> mmoll addition study also revealed hypocalcemia associated hypoproteinemia imbalanced vd pth acute phase covid<NUMBER> hypoproteinemia vd deficiency also common correlated increased mortality critically ill patients <NUMBER> <NUMBER> therefore improvement hypoproteinemia imbalanced hormone levels may also useful treatment covid<NUMBER> increased crp alt tni ddimer levels lymphocytopenia present critical covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> results also showed patients lower serum calcium values higher levels crp alt tni ddimer lower lymphocyte counts serum calcium values significantly correlated lymphocyte count crp ddimer levels moreover crp ddimer also indicators predict prognosis critically ill patients <NUMBER> findings study consistent previous reports confirmed serum calcium levels associated disease severity prognosis patients covid<NUMBER> lung main organ affected disease study median lowest spo<NUMBER> <NUMBER> iqr <NUMBER> range <NUMBER> spo<NUMBER> values significantly positively correlated serum calcium levels patients serum calcium values ≤<NUMBER> mmoll higher ards incidence patients ards also lower serum calcium values phenomena indicated hypocalcemia might crucial development ards early diagnosis treatment hypocalcemia may alleviate organ injury acute phase covid<NUMBER> limitations study discussed singlecenter retrospective design small sample size results might inconclusive accuracy confirmed largescale prospective clinical studies moreover study based pathophysiological models results hypothesis generating exact mechanisms hypocalcemia vd deficiency tested fundamental experiments addition values serum calcium total calcium rather ionized calcium study may precisely reflect extent decreased calcium conclusion retrospective clinical study found incidence hypocalcemia vd deficiency high patients covid<NUMBER> hypocalcemia may associated imbalanced vd pth levels patients lower serum calcium levels especially ≤<NUMBER> mmoll worse clinical variables higher incidences mods septic shock higher <NUMBER>day mortality overall mortality covid<NUMBER> <NUMBER> whereas mortality critically ill patients <NUMBER> february <NUMBER> february <NUMBER> <NUMBER> adult patients age ≥<NUMBER> years confirmed covid<NUMBER> admitted specialized isolation units tongji hospital huazhong university science technology wuhan enrolled clinical retrospective study patients chronic organ dysfunction eg hepatic renal dysfunction terminal cancer immunodeficiency history longterm use hormones excluded written informed consent waived institutional review board retrospective study assessed deidentified data included potential risk patients diagnosis covid<NUMBER> made according interim guidance recommendations national health commission china <NUMBER> <NUMBER> confirmed rna detection sarscov<NUMBER> clinical laboratory tongji hospital identified case covid<NUMBER> defined positive finding realtime reverse transcriptase–polymerase chain reaction rtpcr assay nasal pharyngeal swab specimens <NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed cases enrolled analysis clinical classifications covid<NUMBER> accordance chinese recommendations <NUMBER> mild minor clinical symptoms eg fever cough without imaging manifestations moderate fever respiratory tract infection symptoms imaging indicating pneumonia severe met following i—respiratory distress respiratory rate ≥<NUMBER> breathsmin ii—pulse oxygen saturation spo<NUMBER> ≤<NUMBER> rest iii—arterial partial pressure oxygen pao<NUMBER> fraction inspired oxygen fio<NUMBER> ≤<NUMBER> mmhg <NUMBER> mmhg <NUMBER> kpa critical met following i—respiratory failure mechanical ventilation mv ii—shock iii—multiple organ failure requiring icu treatment hypocalcemia defined serum calcium level less <NUMBER> mmoll clinical laboratory sepsis defined lifethreatening organ dysfunction caused dysregulated host response infection septic shock defined subset sepsis circulatory cellularmetabolic dysfunction associated higher risk mortality <NUMBER> diagnostic criteria acute respiratory distress syndrome ards accordance berlin definitions <NUMBER> definitions acute kidney injury aki based <NUMBER> kidney disease improving global outcomes kdigo guidelines <NUMBER> cardiac injury defined serum levels cardiac biomarkers eg troponin twice reference upper limit new abnormalities found electrocardiography echocardiography <NUMBER> liver injury defined serum levels hepatic biomarkers eg alanine aminotransferase twice reference upper limit disproportionate elevation alanine aminotransferase alt aspartate aminotransferase ast levels compared alkaline phosphatase levels <NUMBER> multiple organ dysfunction syndrome mods defined combined dysfunction two organs baseline clinical characteristics including age sex days onset admission initial symptoms signs clinical classifications collected electronic medical records laboratory tests performed according clinical needs patients levels serum calcium creactive protein crp alt albumin creatinine troponin tni plasma ddimer white blood cell wbc count lymphocyte count lowest spo<NUMBER> within <NUMBER> hours admission recorded hormone levels associated blood calcium eg parathyroid hormone <NUMBER>hydroxyvitamin also recorded blood parameters detected clinical laboratory tongji hospital moreover numbers patients ards aki cardiac injury liver injury septic shock mods patients receiving noninvasive ventilation niv highflow nasal cannula hfnc mv continuous renal replacement therapy crrt also recorded primary endpoints development septic shock mods <NUMBER>day mortality secondary endpoints disease severity parameters eg organ injury kolmogorovsmirnov test first performed test normal distribution data normally distributed data expressed means ± standard deviation compared tests abnormally distributed data expressed medians interquartile ranges iqr compared mannwhitney u test kruskalwallis test categorical variables presented absolute numbers percentages analyzed using χ<NUMBER> test fisher’s exact test take account repeated nature variables analysis variance anova repeated measurements general linear model implemented receiver operating characteristic roc curves used evaluate associations serum calcium septic shock mods <NUMBER>day mortality ibm statistical package social sciences spss version <NUMBER> ny usa software used statistical analysis p <NUMBER> considered statistically significant spss scatterplots correlation analysis performed evaluate relevance serum calcium blood biomarkers statistical methods study reviewed qiao liu biostatistician center disease control prevention jiangsu province china india fraction seen western countries indias recovery rate covid<NUMBER> higher many nations level infection due high suspicion diagnosis timely detection treatment possible reasons behind lower mortality figures india ambiguous many theories described try elucidate various reasons lower mortality rate indian subcontinent due covid investigated identified possible reasons hypotheses disparity mortality several parameters shall discuss details acknowledged elderly population makes high proportion covid<NUMBER> mortality across countries <NUMBER> <NUMBER> western natives significantly older asian african counterparts india young nation according report ministry statistics programme implementation share youth expected <NUMBER> total population india <NUMBER> <NUMBER> availability universal health care social culture family ties protection elderly india support high selfrated health amongst elders <NUMBER> certain immune variations genetic acquired differences might separate people fall severely ill develop pneumonia covid<NUMBER> contract infection hardly develop discernible symptom <NUMBER> differences fatality rates could linked genetic variations sarscov<NUMBER> current literature pertaining lacking individual genetic variation may help explain different immune responses virus across population particular understanding variation hla may affect course covid<NUMBER> could help identify individuals higher risk disease <NUMBER> studies found higher mortality rate western countries due genetics cell entry coronaviruses depends binding viral spike proteins cellular receptors sarscov<NUMBER> receptor ace<NUMBER>and protein priming host cell proteases serine protease tmprss<NUMBER> mechanisms sarscov<NUMBER> infection explained recent study angiotensinconverting enzyme <NUMBER> ace<NUMBER> responsible cleavage angiotensin angiotensin ii host cell surface receptor allowing viral infection covid<NUMBER> sarscov<NUMBER> infection causes decrease ace<NUMBER> expression leading severity lung damage <NUMBER> presence allele ace<NUMBER> genes associated reduced expression ace<NUMBER> genes results fewer ace<NUMBER> receptors thus lower chance infection increasing severity lung damage di polymorphism shows important geographical variation low allele frequencies reported asians compared european population could cause severe pulmonary infection due covid<NUMBER> deaths <NUMBER> hla gene variant tied high rates severe symptoms severe adult respiratory syndrome sars coronavirus related covid<NUMBER> occurrence development sarscov<NUMBER> depend interaction virus individuals immune system <NUMBER> genes responsible proteins prevent immune system attacking body come several variants shown people variants susceptible corona virus others variants may specific region <NUMBER> indous team researchers found indians compared world populations carry natural killer cells detect terminate infections early stage <NUMBER> mutations part natural life cycle virus indian council medical research icmr apex health research body india planning study genetic diversity virus study evolution sarscov<NUMBER> evaluate present strain evolved initial strain believed higher mortalities seen indian regions may due mutant virulent strain researchers cambridge university found virus may mutated spreads asia europe becoming resilient conditions europe thus deadlier however enough data available different strains <NUMBER> study identifies three strains virus b c type prevalent us australia type b wuhans major virus type b prevalent patients across east asia c variant major european type found early patients france italy sweden england <NUMBER> suggestions temperature variation humidity may also important factors affecting covid<NUMBER> mortality <NUMBER> <NUMBER> coronavirus spread slow hot humid weather spreads easily dry cold conditions <NUMBER> warmer asian countries saw infection spread slowly europe us start summer india temperatures <NUMBER> <NUMBER> degrees centigrade infection rate coming indicating may relevant factor high infection death rate due covid <NUMBER> also due stringency lockdown usa sweden iranand turkey implement strict curbs high rates mortality indias <NUMBER> days complete national wide lockdown one stringent world keeping number cases <NUMBER> current low levels mortality surely pointer happened lockdown began also possible covid<NUMBER> substantial mortality impact total deaths risen complete lockdown reduced noncovid deaths recent unlocking restrictions india seen rise numbers reported infections mortality <NUMBER> lack bcg vaccination claimed apossible explanation high heterogeneity infectionmortality rates across involved countriesthe widespread use bcg vaccination prevention tuberculosis tb india may reason lower rates covid<NUMBER> bcg vaccine approved vaccine product fda people previously infected mycobacteriumtuberculosis high risk infected bacillus appears countries routine bcg vaccination pandemic appears less severe vaccine general immunesystem enhancer bcg vaccination given indian children since <NUMBER> countries without universal policies bcg vaccination italy netherlandusa severely affected compared countries universal longstanding bcg policiescountries late start universal bcg policy iran <NUMBER> high mortality elderly population hence explanation demands indepth research explanation <NUMBER> bcg vaccine currently trialed reduce frequency severity covid<NUMBER> <NUMBER> hoped vaccine increase trained immunity immune system boosted coronavirus sarscov<NUMBER> indians suffer repeated attacks respiratory viruses keep immune system primed destroying pathogens attempting attackcould one important factor probably also provided prevention sars merscov nutritional factors tough life unhygienic conditions poor community hygiene etc may also responsiblefor repeated respiratory infections <NUMBER> obesity rates higher us western world india prevalence obesity usa around <NUMBER> versus prevalence <NUMBER>·<NUMBER> china <NUMBER> italy <NUMBER> spain <NUMBER> recent study demonstrated hospitalized patients younger <NUMBER> morbid obesity bmi ≥<NUMBER> kgm<NUMBER> likely die covid<NUMBER> <NUMBER> patients obesity associated impaired immune response endothelial dysfunction decreased functional residual capacity lungs hypoxemia expression ace<NUMBER> adipose tissue high affinity sarcov<NUMBER> virus <NUMBER> <NUMBER> effects covid<NUMBER> health racial ethnic minority groups still emerging however current data suggest disproportionate burden illness death cohort <NUMBER> factors influence racial ethnic minority group health include economic social conditions groups also find difficult access resources outbreaks covid<NUMBER> racial residential segregation living densely populated areas notallow principles social distancing underlying health conditions <NUMBER> scientific studies result improved understanding covid<NUMBER> may lead targeted effective community health care systembased interventions future hence analyzing disproportionate affliction black ethnic minority group essential <NUMBER> covid<NUMBER> pandemic struck india early march ie later countries hence substantial delay reported infections fatality india spread countries china almost simultaneous indias response initiated <NUMBER>th january much declared covid<NUMBER> public health emergency screening travelers abroad airports ports started exceedingly early jan <NUMBER> incoming travellers including indian nationals arriving visited china italy iran republic korea france spain germany <NUMBER>th february <NUMBER> quarantined minimum period <NUMBER> days <NUMBER> however many countries usa uk eu countries resort measures antimalarial drug hydroxychloroquine suggested reduce covid<NUMBER> risk health workers potential retinal cardiac toxicitythis drug diverse modes action including inhibition cytokine storms host cell work viral infections help prevent deaths <NUMBER> recent study found covid<NUMBER> infections higher countries malaria islessendemic lower countries malaria highly endemic large numbers mortality health care professionals acrossthe globe observed pandemic <NUMBER> india indian council medical research icmr recommended use hydroxychloroquine asymptomatic health professionals cared suspected confirmed covid<NUMBER> casesearly rise pandemic may prevented fatalities western countries <NUMBER> <NUMBER> however hard evidence hydroxychloroquine reduces risk covid<NUMBER> fara recent article lancet journal hydroxychloroquine role use retracted <NUMBER> covid<NUMBER> pandemic devastated global population hitting health individuals highly contagious disease caused high rate mortality particularly high risk individuals pattern infection mortality rates varied significantly amongst countries surprisingly affluent countries greater healthcare resources affected seen higher mortality rates compared less affluent countries like india southeast asian nations analyzed discussed several factors may responsible discrepancy pneumonia new novel coronavirus sarscov<NUMBER> virus detected wuhan china december <NUMBER> spread worldwide outbreak declared public health emergency international concern world health organization january <NUMBER> <NUMBER> announced name new coronavirus disease covid<NUMBER> since reporting first case covid<NUMBER> far affected <NUMBER> countries infected <NUMBER> million people globally <NUMBER> india covid<NUMBER> currently <NUMBER> total cases <NUMBER> active cases claimed <NUMBER> lives far figure keeps changing every day though number cases covid <NUMBER> increasing day day due relief lockdown measures migration people intriguing note far mortality remained lower level indian subcontinent countries similar numbers covid<NUMBER> infections table <NUMBER> figs <NUMBER>e<NUMBER> even poor infrastructure health facilities found india compared countries robust health facilities italy spain united kingdom united states america mortality data india fraction seen western countries indias recovery rate covid<NUMBER> higher many nations level infection due high suspicion diagnosis timely detection treatment possible reasons behind lower mortality figures india ambiguous many theories described try elucidate various reasons lower mortality rate indian subcontinent due covid<NUMBER> investigated identified possible reasons table <NUMBER> infection death rates worsthit ten countries covid<NUMBER> source worldometer httpswwwworldometersinfoaccessed june <NUMBER> <NUMBER> <NUMBER> hypotheses disparity mortality several parameters shall discuss details acknowledged elderly population makes high proportion covid<NUMBER> mortality across countries <NUMBER> <NUMBER> western natives significantly older asian african counterparts india young nation according report ministry statistics programme implementation share youth expected <NUMBER> total population india <NUMBER> <NUMBER> availability universal health care social culture family ties protection elderly india support high selfrated health amongst elders <NUMBER> certain immune variations genetic acquired differences might separate people fall severely ill develop pneumonia covid<NUMBER> contract infection hardly develop discernible symptom <NUMBER> differences fatality rates could linked genetic variations sarscov<NUMBER> current literature pertaining lacking individual genetic variation may help explain different immune responses virus across population particular understanding variation hla may affect course covid<NUMBER> could help identify individuals higher risk disease <NUMBER> studies found higher mortality rate western countries due genetics cell entry coronaviruses depends binding viral spike proteins cellular receptors sarscov<NUMBER> receptor ace<NUMBER>and protein priming host cell proteases serine protease tmprss<NUMBER> mechanisms sarscov<NUMBER> infection explained recent study angiotensinconverting enzyme <NUMBER> ace<NUMBER> responsible cleavage angiotensin angiotensin ii host cell surface receptor allowing viral infection covid<NUMBER> sarscov<NUMBER> infection causes decrease ace<NUMBER> expression leading severity lung damage <NUMBER> presence allele ace<NUMBER> genes associated reduced expression ace<NUMBER> genes results fewer ace<NUMBER> receptors thus lower chance infection increasing severity lung damage di polymorphism shows important geographical variation low allele frequencies reported asians compared european population could cause severe pulmonary infection due covid<NUMBER> deaths <NUMBER> hla gene variant tied high rates severe symptoms severe adult respiratory syndrome sars coronavirus related covid<NUMBER> occurrence development sarscov<NUMBER> depend interaction virus individuals immune system <NUMBER> genes responsible proteins prevent immune system attacking body come several variants shown people variants susceptible corona virus others variants may specific region <NUMBER> indous team researchers found indians compared world populations carry natural killer cells detect terminate infections early stage <NUMBER> mutations part natural life cycle virus indian council medical research icmr apex health research body india planning study genetic diversity virus study evolution sarscov<NUMBER> evaluate present strain evolved initial strain believed higher mortalities seen indian regions may due mutant virulent strain sarscov<NUMBER> virus <NUMBER> many mutations observed sarscov<NUMBER> sequences therefore expected current estimates mutation rate sarscov<NUMBER> one mutation two weeks currently least <NUMBER> different strains sarscov<NUMBER> causative agent covid<NUMBER> world researchers cambridge university found virus may mutated spreads asia europe becoming resilient conditions europe thus deadlier however enough data available different strains <NUMBER> study identifies three strains virus b c type prevalent us australia type b wuhans major virus type b prevalent patients across east asia c <NUMBER> variant major european type found early patients france italy sweden england <NUMBER> recently scientists identified several hundreds point mutations sarscov<NUMBER> across genome elucidate link constant change variable virulence increase mortality morbidity noted <NUMBER> key point mutations located along entire genome might impacted virulence response different antivirals sarscov<NUMBER> <NUMBER> furthermore eaaswarkhanth et al reported sd<NUMBER> g strains may virulent lead increasing severity infected individuals especially europe mutation prominent also plausible sarscov<NUMBER> mutations giving rise different phylogenetic clades responsible obvious death disparities around world <NUMBER> suggestions temperature variation humidity may also important factors affecting covid<NUMBER> mortality <NUMBER> <NUMBER> coronavirus spread slow hot humid weather spreads easily dry cold conditions <NUMBER> warmer asian countries saw infection spread slowly europe us start summer india temperatures <NUMBER>e<NUMBER> centigrade infection rate coming indicating may relevant factor high infection death rate due covid <NUMBER> also due stringency lockdown usa sweden iran turkey implement strict curbs high rates mortality indias <NUMBER> days complete national wide lockdown one stringent world keeping number cases <NUMBER> current low levels mortality surely pointer happened lockdown began also possible covid<NUMBER> substantial mortality impact total deaths risen complete lockdown reduced noncovid deaths recent unlocking restrictions india seen rise numbers reported infections mortality <NUMBER> lack bcg vaccination claimed possible explanation high heterogeneity infectionmortality rates across involved countries widespread use bcg vaccination prevention tuberculosis tb india may reason lower rates covid<NUMBER> bcg vaccine approved vaccine product fda people previously infected mycobacterium tuberculosis high risk infected bacillus appears countries routine bcg vaccination pandemic appears less severe vaccine general immunesystem enhancer bcg vaccination given indian children since <NUMBER> countries without universal policies bcg vaccination italy netherlandusa severely affected compared countries universal longstanding bcg policies countries late start universal bcg policy iran <NUMBER> high mortality elderly population hence explanation demands indepth research explanation <NUMBER> bcg vaccine currently trialed reduce frequency severity covid<NUMBER> <NUMBER> hoped vaccine increase trained immunity immune system boosted coronavirus sarscov<NUMBER> indians suffer repeated attacks respiratory viruses keep immune system primed destroying pathogens attempting attack could one important factor probably also provided prevention sars merscov nutritional factors tough life unhygienic conditions poor community hygiene etc may also responsible repeated respiratory infections <NUMBER> obesity rates higher us western world india prevalence obesity usa around <NUMBER> versus prevalence <NUMBER> china <NUMBER> italy <NUMBER> spain <NUMBER> recent study demonstrated hospitalized patients younger <NUMBER> morbid obesity bmi <NUMBER> kgm<NUMBER> likely die covid<NUMBER> <NUMBER> patients obesity associated impaired immune response endothelial dysfunction decreased functional residual capacity lungs hypoxemia expression ace<NUMBER> adipose tissue high affinity sarcov<NUMBER> virus <NUMBER> <NUMBER> effects covid<NUMBER> health racial ethnic minority groups still emerging however current data suggest disproportionate burden illness death cohort <NUMBER> factors influence racial ethnic minority group health include economic social conditions groups also find difficult access resources outbreaks covid<NUMBER> racial residential segregation living densely populated areas allow principles social distancing underlying health conditions <NUMBER> scientific studies result improved understanding covid<NUMBER> may lead targeted effective community health care systemebased interventions future hence analyzing disproportionate affliction black ethnic minority group essential <NUMBER> covid<NUMBER> pandemic struck india early march ie later countries hence substantial delay reported infections fatality india spread countries china almost simultaneous indias response initiated <NUMBER>th january much declared covid<NUMBER> public health emergency screening travelers abroad airports ports started exceedingly early jan <NUMBER> incoming travellers including indian nationals arriving visited china italy iran republic korea france spain germany february <NUMBER> <NUMBER> quarantined minimum period <NUMBER> days <NUMBER> however many countries usa uk eu countries resort measures antimalarial drug hydroxychloroquine suggested reduce covid<NUMBER> risk health workers potential retinal cardiac toxicity drug diverse modes action including inhibition cytokine storms host cell work viral infections help prevent deaths <NUMBER> recent study found covid<NUMBER> infections higher countries malaria islessendemic lower countries malaria highly endemic large numbers mortality health care professionals across globe observed pandemic <NUMBER> india indian council medical research icmr recommended use hydroxychloroquine asymptomatic health professionals cared suspected confirmed covid<NUMBER> cases early rise pandemic may prevented fatalities western countries <NUMBER> <NUMBER> however hard evidence hydroxychloroquine reduces risk covid<NUMBER> far recent article lancet journal hydroxychloroquine role use retracted <NUMBER> covid<NUMBER> pandemic devastated global population hitting health individuals highly contagious disease caused high rate mortality particularly high risk individuals pattern infection mortality rates varied significantly amongst countries surprisingly affluent countries greater healthcare resources affected seen higher mortality rates compared less affluent countries like india southeast asian nations analyzed discussed several factors may responsible discrepancy funding received none ongoing outbreak corona virus disease <NUMBER> covid <NUMBER> infection posed significant threats international health economy <NUMBER> <NUMBER> <NUMBER> <NUMBER> january <NUMBER> world health organization declared public health emergency international concern <NUMBER> march <NUMBER> <NUMBER> countries <NUMBER> cases covid<NUMBER> <NUMBER> deaths reported world number confirmed patients china gradually decreased increasing rapidly countries especially italy south korea iran lots doctors engaged combating <NUMBER> <NUMBER> sarscov<NUMBER> first reported samples bronchoalveolar lavage fluid three patients wuhan jinyintan hospital confirmed cause covid<NUMBER> january <NUMBER> <NUMBER> <NUMBER> deep examining fulllength genome found virus belongs betacoronavirus <NUMBER>b lineage phylogenetic tree <NUMBER> new humaninfecting betacoronavirus previously detected humans animals named covid<NUMBER> sarscov<NUMBER> international committee taxonomy viruses similar coronavirus responsible severe acute respiratory syndrome sarscov <NUMBER> shares <NUMBER> identity sequencing bat sarslike coronavirus shares <NUMBER> identity nucleotide original sars epidemic virus <NUMBER> <NUMBER> <NUMBER> coronavirus spike glycoproteins promote entry cells main target antibodies bind high affinity angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor humans manner similar sarscov <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> glycoprotein harbors furin cleavage site boundary s<NUMBER>s<NUMBER> subunits processed biogenesis sets virus apart sarscov sarsrelated covs <NUMBER> <NUMBER> present research reports incubation period people range <NUMBER> <NUMBER> days median <NUMBER> days incubation period may even long <NUMBER> days <NUMBER> reproductive number r<NUMBER> sarscov<NUMBER> although still preliminary estimated <NUMBER> <NUMBER> suggesting higher pandemic potential sars <NUMBER> fever cough may major symptom asymptomatic individuals also identified potential sources infection <NUMBER> present think new coronavirus mainly transmitted respiratory droplets close contact transmission asymptomatic carrier appears possible <NUMBER> report <NUMBER> pregnant patients suggests perinatal transmission unlikely larger studies needed confirm finding <NUMBER> although viral rna found stool whether transmitted fecaloral route still needs confirmed subsequent investigations <NUMBER> <NUMBER> recently patients found repositive treated negative nucleic acid tests twice symptoms disappeared difficult us decrease severity covid<NUMBER> owing complex structure unclear physiological mechanism increasing number confirmed cases clinical investigation patients antiviral treatment solution insufficient urgent need find alternative methods control spread disease order prove accurate conclusions prevalence comorbidity relation clinical characteristics mortality patients covid<NUMBER> searched relevant literatures carried single arm metaanalysis describe epidemiological clinical characteristics complications outcomes patients confirmed <NUMBER>ncov infection compare severity diabetes hypertension nondiabetes nonhypertension patients findings provide vital guidance current clinical work prevention treatment <NUMBER>ncov infection ethical approval patient consent required present study review previously published articles fulltext articles obtained detailed evaluation eligible studies included systematic review inclusion criteria following randomized controlled trial clinical trials series cases patients either sex diagnosed covid<NUMBER> patients laboratoryidentified sarscov<NUMBER> infection realtime reversetranscriptase polymerasechainreaction detection sarscov<NUMBER> nucleic acid positive throat swabs lower respiratory tract ct scanning lung inclusion epidemiological clinical characteristics laboratory radiological characteristics treatment outcome clear description clinical characteristics comorbidities including hypertension diabetes cardiovascular disease malignancy signs symptoms fever cough fatigue dyspnea clear description outcomes including major complications acute respiratory distress syndrome ards acute cardiac injuryaci acute kidney injuryaki shock incidence severity mortality exclusion criteria following absence clinical characteristics treatment outcome clinical experience case reports two authors independently extracted data reviewing titles abstracts searched papers disagreement choice literature exists third evaluator join make decision following information recorded included trials first author year publication number participants residence patients basic data gender age diagnosis extracted analyzed evaluate proportion comorbidity diabetes hypertension cardiovascular disease malignancy proportion symptoms fever cough fatigue dyspnea proportion clinical complications including ards aci aki shock severity mortality two readers independently extracted reviewed data enrolled studies ensure consistency quality included studies assessed newcastleottawa scale order objectively evaluate publication bias included studies egger test p <NUMBER> existence publication bias performed larger values considered publication bias single arm metaanalysis proportions <NUMBER> ci calculated clinical symptoms complication outcome selected comorbidities using stata <NUMBER> presence heterogeneity among identified studies cochrans q extent heterogeneity <NUMBER> index examined described previously original data included literature first transformed double arcsine method make conform normal distribution analyzed stata initial conclusion obtained metaanalysis restored using formula psintp<NUMBER> <NUMBER> reach final conclusion performed sensitivity analysis assess stability results investigate influence study omitting single study sequentially using egger test found evidence bias lag periods initial <NUMBER> citations identified based study subject summary literature <NUMBER> articles thereafter excluded duplication reviewing title abstract remaining <NUMBER> studies <NUMBER> fulltext studies evaluated assessment <NUMBER> obviously irrelevant records excluded eventually <NUMBER> clinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> consistent inclusion requirements detailed study flowdiagram shown fig <NUMBER> basic characteristics quality included studies illustrated table <NUMBER> twentyone studies selected total <NUMBER> patients <NUMBER> male <NUMBER> females representing approximately <NUMBER> confirmed one clinical trial investigated characteristics patients singapore others came china mainly wuhan systematic analysis studies describing epidemiological demographic clinical features covid<NUMBER> cases reporting prevalence number chronic diseases infectious disease undertaken number cases selected studies varied approximately <NUMBER>fold ranged <NUMBER> <NUMBER> cases sex ratio male female <NUMBER> overall average age subjects greater <NUMBER> years fortyone cases reported jinyintan hospital earliest confirmed cases patients treated wenzhou hospital almost mild xiaobo yang et al reported <NUMBER> cases covid<NUMBER> critical patients studies detailed pretreatment biochemical characteristics subsequent treatment eighteen studies reported comorbidity diabetes <NUMBER> introduced proportion severity <NUMBER> studies reported hypertension <NUMBER> introduced proportion severity <NUMBER> studies reported malignant <NUMBER> studies reported cad regard symptoms <NUMBER> studies recorded fever cough <NUMBER> studies reported fatigue <NUMBER> studies reported dyspnea seven studies recorded complication ards aci shock recorded <NUMBER> <NUMBER> studies respectively fifteen studies showed critical patients <NUMBER> research reported mortality studies provided incidence data least one kind comorbidity symptom complication sixteen forest plots used illustrate prevalence comorbidities covid<NUMBER> selected studies inspect heterogeneity individual findings metaanalysis identified studies showed prevalent clinical symptoms fever <NUMBER> <NUMBER>ci <NUMBER> cough <NUMBER> <NUMBER>ci <NUMBER> followed fatigue <NUMBER> <NUMBER>ci <NUMBER> shortness breath <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates clinical symptoms among examined studies p <NUMBER> <NUMBER> index varying <NUMBER> <NUMBER> prevalence diabetes hypertension comorbidities <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively incidence cardiovascular disease malignancy <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively fig <NUMBER> case complications including ards risk ranged <NUMBER> <NUMBER> pooled estimate <NUMBER> acute cardiac injury <NUMBER> <NUMBER>ci <NUMBER> acute kidney injury <NUMBER> <NUMBER>ci <NUMBER> shock <NUMBER> <NUMBER>ci <NUMBER> also present fig <NUMBER> risks severity mortality rate ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> pooled estimates <NUMBER> <NUMBER> respectively percentage severe cases diabetes hypertension cases <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> sensitivity analysis performed assess stability pooled results among <NUMBER> studies significant results obviously altered sequentially omitting study pooled results comparing incidence mortality excluding report chaolin huang et al heterogeneity decreased significantly <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> i² <NUMBER> showed significant difference preventing ards rate two groups hence regarded result heterogeneity likewise studies considered source heterogeneity heterogeneity significantly changed showed significant difference preventing ards two groups studies excluded pooled results comparing incidence ards sensitivity analysis conducted determine whether exclusion study would alter result exclusion study metaanalysis substantially influence results part study ards used assess publication bias egger test results showed pr jzj <NUMBER> therefore believe risk publication bias low metaanalysis outbreak covid<NUMBER> declared public health emergency international concern march <NUMBER> <NUMBER> epidemic spread <NUMBER> countries around world accordance experience china surgical masks widespread use beneficial prevent acquisition covid<NUMBER> addition italy started taking measures block traffic lockdown villages rising incidence covid<NUMBER> world feasible effective messaging clinical characteristics covid<NUMBER> greatly needed therefore focus analysis evaluate prevalence symptoms comorbidity complications different outcomes china singapore metaanalysis identified <NUMBER> published studies assessed proportion published rcts rapid development epidemic limited medical resources addition presence uncontrollable risk treatment much evidence effects cannot adequately studied randomized trials longterm rare outcomes therefore analyzed retrospective studies study main results found cases reported date suggest older adults difference susceptibility male female fever common symptom patients <NUMBER>ncov infection prevalent comorbidities hypertension diabetes associated rapid development severe illness ards aci may main obstacles patients treatment recovery severity mortality patients <NUMBER>ncov infection lower severe acute respiratory syndrome sars middle east respiratory syndrome mers prevalence covid<NUMBER> much higher sars mers two coronaviruses previously caused significant outbreaks associated critical disease sars coronavirus <NUMBER> middle east respiratory syndrome coronavirus emerged <NUMBER> <NUMBER> <NUMBER> <NUMBER> lot studies reported clinical characteristics patients covid<NUMBER> lack studies relation severity mortality comorbidity similarly metaanalysis published complications patients covid<NUMBER> infected therefore novel systematic review metaanalysis due inadequate evidence present metaanalysis consolidating multiple studies enable enhanced clinical decision making future report cohort patients laboratoryconfirmed <NUMBER>ncov infection patients serious sometimes fatal complications admitted designated hospital clinical presentations greatly resemble sarscov patients severe illness developed ards aki aci shock required icu admission oxygen therapy however despite comprehensive analysis also many limitations taken consideration metaanalysis first studies included metaanalysis rcts second literatureincluded studies treatment every hospital completely similar third owing treatment grading mild ordinary critical severity patients different hospitals varies greatly addition cause physio pathological mechanism unknown onset emerging infections treatment wuhan based clinical experience leading higher complication mortality fourth partial missing information articles may lead biased results attempted contact investigators study sponsors verify key study characteristics obtain missing numerical outcome data moreover clinical methodological heterogeneities observed several parameters metaanalysis given variation intervention techniques patient composition preferences among different cities true heterogeneity poor methodological quality could also lead asymmetric plot future larger higher quality clinical trials conducted conduct detailed subgroup analysis explore sources heterogeneity obtain reliable conclusion effort made answer questions future studies covid<NUMBER> emerging infectious disease global public health concern results note similarity clinical symptoms complications covid<NUMBER> previous betacoronavirus infections incidence severity mortality covid<NUMBER> much higher ordinary influenza prevalence chronic diseases including diabetes hypertension rising populations age lifestyle dietary habits change addition found diabetes hypertension closely related severity mortality improving protection covid<NUMBER> persons chronic disorders essential last least need limit humantohuman transmission including reducing secondary infections among close contacts healthcare workers thus preventing transmission amplification events preventing international spread authors declare known competing financial interests personal relationships could appeared influence work reported paper agencies public commercial notforprofit sectors previous human coronaviruses resulted highmorbidity mortality acute respiratory syndrome coronavirus sarscov sars<NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> driven development compounds could potentially active coronavirus disease <NUMBER> covid<NUMBER> caused novel coronavirus sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> approximately <NUMBER> patients confirmed covid<NUMBER> exhibit severe symptoms require hospitalization many requiring hospitalization may need intensive care resources <NUMBER> current number cases worldwide five million <NUMBER> deaths reported may <NUMBER> <NUMBER> case fatality mortality rates reported date based laboratory confirmed cases likely overestimate actual covid<NUMBER> mortality rate include mild asymptomatic cases recovered ideally infection fatality rate reported comprehensive data available would important inform planning response currently treatment prophylaxis proven effective covid<NUMBER> patients receive either symptomatic treatment milder presentations advanced lifesupport strategies moderate severe cases include oxygenation strategies hospitalized icu setting severe disease results rapid progression respiratory failure begins usually right dyspnea breathing difficulties hypoxemia cytokine release storm elevated blood inflammatory markers cardinal feature progression severe illness result severe organ failure forms kidney liver cardiac pathology injury indications coagulopathy potential shock global community eagerly awaits credible scientific solutions pandemic researchers scientists working hard identify effective therapeutic preventive strategies covid<NUMBER> recent research findings possible therapeutics antivirals antimalarials chloroquine hydroxychloroquine covid<NUMBER> patients mostly vague inconclusive negative typically underpinned lowquality research methodologies inadequate reporting<NUMBER> poor methodological quality thus far across covid<NUMBER> research landscape raises many concerns medical research community governments urgently seek effective prophylactic therapeutic methodologies reporting studies suboptimal randomized controlled trials rcts plagued suboptimal randomization lack allocation concealment questionable blinding small sample sizes small event numbers sparse reporting observational studies confounded small sample sizes small numbers events suboptimal absent statistical adjustments matching propensity score approach stratification methodological technique could mitigate risk biased estimates effect precious time vast amount resources potentially squandered trustworthy robust highquality research needed evidenceinformed decisionmaking policy decisions sidelined urgency clinical research included repurposing existing therapies diseases based indirect evidence example use corticosteroids covid<NUMBER> based therapeutic benefit seen randomized controlled trials rcts corticosteroid use patients acute respiratory distress syndrome ards<NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint initial evidence apparent efficacy remdesivir middle eastern respiratory syndrome mers sarscov<NUMBER> invitro models helped remdesivir gain attention possible therapeutic agent<NUMBER> prior pandemic remdesivir unapproved investigational product recent observational study examining compassionate use remdesivir patients severe covid<NUMBER> revealed <NUMBER> patients clinical improvement <NUMBER> april first rct remdesivir patients severe covid<NUMBER> published however able identify clinical benefit small sample size failed reach enrolment target early may <NUMBER> us federal drug administration fda authorized use remdesivir treatment individuals severe covid<NUMBER> based preliminary data actt<NUMBER> study due rapid spread covid<NUMBER> concerning morbidity mortality unlikely see randomized placebocontrolled doubleblind trials light existing data given urgency effective therapeutic conducted rapid review existing medical research literature assessing studies using remdesivir rcts patients covid<NUMBER> <NUMBER> alert considered studies published since global pandemic began january <NUMBER> recognizing two rcts would likely comprise final cohort included studies medline embase electronic databases searched january <NUMBER>st <NUMBER> may <NUMBER>nd <NUMBER> using mix keywords covid<NUMBER> remdesivir along relevant variants search use rct filter see appendix medline search example pubmed also searched daily period rapidly assess emerging publications evidence considered additional sources including google scholar online preprint servers prepublish studies yet completed peerreview process also searched largest clinical medicine preprint repository medrxivorg two reviewers independently duplicate extracted relevant data assessed risk bias using cochrane risk bias tool rcts <NUMBER> adopted response options risk bias yes probably yes probably thereby removing unclear response often reported reviewers use unclear response frequently hampers definitive interpretation risk bias <NUMBER> used fixedeffect inversevariance modeling analyses mantelhaenszel risk ratio rr dichotomous outcomes mean difference md continuous variables <NUMBER> intended modelling decision made priori based potential small number rcts would deem rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint eligible thus decision model whereby weight would given larger sample sized studies would however revert randomeffects approach number uncovered rcts high though anticipate data reported medians interquartile ranges would convert means standard deviations metaanalytical pooling <NUMBER> also planned conduct sensitivity analyses based random fixed effect modeling review manager <NUMBER> used conduct metaanalysis <NUMBER> assessed heterogeneity visual inspection forest plots cochrane chisquare statistical test heterogeneity i<NUMBER> statistic <NUMBER> considered significant heterogeneity warranting exploration explaining <NUMBER> report <NUMBER> confidence interval ci measures uncertainty presented estimates effect estimate baseline risk computing absolute effects used control event rate compute absolute effect multiplied baseline risk relative effect <NUMBER> cis utilized grading recommendations assessment development evaluation grade approach rate certainty evidence outcome entire body evidence <NUMBER> outcome centric approach rating effect estimate certainty considers body evidence via risk bias imprecision inconsistency heterogeneity indirectness publication bias domains assessing rcts rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint abbreviations used iqrinterquartile range sdstandard deviation serious adverse events detailed number patients serious adverse events footnote kaplanmeier estimator used calculate mortality rates due patients still followup publication preliminary results decision guided study authors reporting hazard ratio nonsignificant mortality correspond raw mortality data outcomes table search uncovered two rct citations rapid screening review two deemed eligible inform final review table <NUMBER> <NUMBER> one multicenter study conducted china second study international multicenter trial lead national institutes health niaidnih usa ages ranged <NUMBER> years old <NUMBER> years old percentage males ranged <NUMBER> <NUMBER> <NUMBER> deaths total <NUMBER> enrolled patients rcts judged lowmoderate risk biased estimates <NUMBER> <NUMBER> effect despite study reported biegel change primary outcome unblinding loss data reported due publication preliminary results full followup completed study participants otherwise methodologies robust reporting adequate also rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint developed funnel plots statistical tests publication bias due limited interpretability study number less optimal threshold <NUMBER> two studies reported mortality wang study<NUMBER> reported <NUMBER>day mortality biegel study<NUMBER> reported <NUMBER>day mortality due biegel study reporting preliminary results many subjects still within followup phase trial mortality estimates reported kaplanmeier estimator based reading reported mortality findings biegel<NUMBER> pooling <NUMBER>day mortality biegel<NUMBER> study kaplanmeier estimates wang<NUMBER> mortality data n<NUMBER> patients significant reduction mortality patients received remdesivir compared control group rr <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> p<NUMBER> i<NUMBER> <NUMBER> fixedeffect modeling low certainty figure <NUMBER> absolute effects <NUMBER> fewer deaths per <NUMBER> affected individuals <NUMBER> fewer <NUMBER> fewer grade evidence profile table <NUMBER> sensitivity analysis using randomeffects modeling use intention treat itt population biegel<NUMBER> use sample size reported available analysis reveals difference direction magnitude risk estimates fact raw mortality data utilized fixedeffect modelling reported full sample size found significant reduction mortality due remdesivir rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> however indicated modelled based kaplanmeier estimator two studies n<NUMBER> reported time clinical improvement revealed significant improvement time clinical improvement patients received remdesivir compared control group mean difference md <NUMBER>·<NUMBER> days <NUMBER> ci <NUMBER> days <NUMBER> days p<NUMBER> i<NUMBER> <NUMBER> fixedeffect modeling moderate certainty figure <NUMBER> absolute effects <NUMBER>·<NUMBER> fewer days <NUMBER> fewer days <NUMBER> fewer days grade evidence profile table <NUMBER> sensitivity analysis using randomeffect modeling reveals wider confidence interval difference direction risk estimates rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity two studies n<NUMBER> reported number patients adverse events revealed significant reduction serious adverse events patients received remdesivir compared control group rr <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> p<NUMBER> i<NUMBER> <NUMBER> fixedeffect modeling moderate certainty figure <NUMBER> absolute effects <NUMBER> fewer people adverse events per <NUMBER> affected individuals <NUMBER> fewer <NUMBER> fewer grade evidence profile table <NUMBER> sensitivity analysis using randomeffects modeling reveals difference direction risk estimates two studies n<NUMBER> reported number patients adverse events revealed significant reduction serious adverse events patients received remdesivir compared control group rr <NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER> <NUMBER>·<NUMBER> p<NUMBER> i<NUMBER> <NUMBER> fixedeffects modeling moderate certainty figure <NUMBER>a absolute effects <NUMBER> fewer people adverse events per <NUMBER> affected individuals <NUMBER> fewer <NUMBER> fewer grade evidence profile table <NUMBER> sensitivity analysis using randomeffects modeling reveals wider confidence interval crosses harms figure <NUMBER>b certified peer review authorfunder granted medrxiv license display preprint perpetuity certified peer review authorfunder granted medrxiv license display preprint perpetuity c downgraded due inconsistency elevated i<NUMBER> <NUMBER> cochrane q test p<NUMBER> ois met n<NUMBER> wide <NUMBER> ci could explained elevated heterogeneity one downgrade heterogeneity could explained part locations trials thus variation methods conduct differences standard care heterogeneity high must considered high i<NUMBER> <NUMBER> two randomizedcontrolled trial studies presented systematic review focused remdesivir use hospitalized covid<NUMBER> patients pooled analysis reveals remdesivir significantly reduces mortality time clinical improvement number people serious adverse events number people adverse events grade quality evidence also known certainty confidence estimates effect reflects extent certainty confidence estimates effect adequate support particular decision recommendation <NUMBER> found issues applying grade indirectness imprecision inconsistency across body evidence analyzed patientimportant outcomes low certainty confidence range mortality effects despite reportedly significant benefits decrease mortality <NUMBER> fewer deaths per <NUMBER> range <NUMBER> fewer <NUMBER> fewer death range mortality absolute risk effect ranges <NUMBER> reduction <NUMBER> reduction risk low certainty risk mortality estimates due serious concerns imprecision due small number events indirectness due pooling <NUMBER> day <NUMBER>day mortality results made judgement pool mortality data based hazard ratio kaplanmeier data simply raw data reported table <NUMBER> <NUMBER> remdesivir vs <NUMBER> placebo samples sizes <NUMBER> <NUMBER> respectively incidentally mortality reductions would even favourable employed fixeffect model given small number studies decision focus weight study larger sample size contributes information moderately confident remdesivir patients hospitalized covid<NUMBER> leads faster clinical improvement important significant decrease time clinical improvement using remdesivir <NUMBER> fewer days ranging <NUMBER> fewer <NUMBER> fewer days highly confident important significant decrease severe adverse events use remdesivir individuals hospitalized covid<NUMBER> <NUMBER> fewer severe events per <NUMBER> ranging <NUMBER> fewer <NUMBER> fewer serious adverse events using random effect modelling change pooled point estimates confidence intervals appreciably context harms benefits intervention reported outcomes except adverse events adverse events use randomeffects modeling led confidence interval spanned harms benefits fixedeffect modeling confidence interval wholly benefits portion leading us moderately certain modest reduction adverse events given reduction imprecision adverse events outcome grade assessment moderate fixed effect modeling low randomeffects modeling study several strengths firstly assessed eligibility studies risk bias independently duplicate intended summary pooling data judged data reliable enough allow meaningful pooled estimate effect additionally intended use grade approach assess certainty quality evidence analysis available literature significant limitations including paucity studies available analysis research evidence benefits remdesivir covid<NUMBER> however judgement based two rigorous multicenter trials additionally significant heterogeneity time clinical improvement could due location studies differences standard care studies conducted different periods context evolving evidence landscape pandemic timing initiation remdesivir may also impact clinical outcomes patients severe disease less likely survive seen actt<NUMBER> subgroups however unable pool data according subgroups due public health emergency covid<NUMBER> pandemic likely additional randomized placebocontrolled doubleblind trial determine remdesivirs efficacy patients covid<NUMBER> instead would incorporated standard care addition remdesivir appears reduce time clinical improvement number serious adverse events ameliorate conditions many overwhelmed hospitals facing pandemic patient surges rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity primary concern present context current crisis continued lack viable treatment option patients suffering sarscov<NUMBER> lifethreatening respiratory failure indeed persists still left questions clinicians must interpret pooled evidence caution though promising research use therapeutic agents covid<NUMBER> patients urgently needed likely remdesivir would utility used combination potential therapeutics based hopefully positive findings ongoing studies robust studies adequately powered rcts longer durations followup methodologically superior focuses harm outcomes primary concern present context current crisis continued lack viable treatment option patients suffering sarscov<NUMBER> lifethreatening respiratory failure indeed persists still left questions clinicians must interpret pooled evidence caution though data promising research use therapeutic agents covid<NUMBER> patients urgently needed likely remdesivir would utility used combination potential therapeutics based hopefully positive findings ongoing studies perhaps used earlier disease course robust studies adequately powered rcts longer durations followup sound methodology focuses harm outcomes closing remind safety patient suffering covid<NUMBER> key priority improve quality care provision health services currently therapeutic option shown effective though remdesivir presently revealing promise one option likely conjunction another treatment conclusively allows safe effective use mitigate eliminate causative agent covid<NUMBER> said prophylaxis whereby approximately <NUMBER> therapeutic options combinations investigated <NUMBER> clinical trials severely ill patients covid<NUMBER> frequently older adults established comorbidities given multiple concomitant medications without considering possible adverse events interactions area research overlooked potential toxicity due concomitant treatments must urgently addressed remind use medications chloroquine hydroxychloroquine alone combination azithromycin ivermectin antivirals immunomodulators among others considered within context patient consented randomized clinical trials evaluate safety efficacy ensuring safety patients covid<NUMBER> requires information surveillance systems include standardized procedures order report adverse events interactions according local settings public health reporting regulations exist must implemented immediately rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> china subsequently global pandemic involving <NUMBER> countries areas territories <NUMBER> approximately <NUMBER> million cases <NUMBER> deaths recorded worldwide may <NUMBER> <NUMBER> increasing experience disease led understanding illness <NUMBER> respiratory system significant cardiovascular effects recent works biomarkers troponin developed cardiac injury significantly <NUMBER> higher mortality without moreover multivariable analysis <NUMBER> patients found <NUMBER> cardiac injury independently associated increased risk mortality patients <NUMBER> covid<NUMBER> <NUMBER> therefore purpose study present systematic review <NUMBER> metaanalysis literature investigate incidence cardiac injury correlations co<NUMBER> morbidities outcomes possible mechanisms global covid<NUMBER> population <NUMBER> performed systematic literature search pubmed embase used following <NUMBER> search terms coronavirus cardiac injury myocardial injury myocarditis <NUMBER> troponin search limited chinese english articles jan <NUMBER> <NUMBER> <NUMBER> may <NUMBER> <NUMBER> reviewed original studies reported cardiac injury elevated troponin levels included review <NUMBER> articles metaanalysis case reports excluded aggregate data metaanalysis <NUMBER> performed extracted data included number patients enrolled study age primary outcome defined allcause mortality mortality patients without <NUMBER> cardiac injury directly reported mortality rate patients cardiac injury <NUMBER> calculated ratio deceased patients cardiac injury overall number patients <NUMBER> reported cardiac injury secondary outcome defined one death icu <NUMBER> admission respiratory failure need mechanical ventilation shock <NUMBER> odds ratio p value less <NUMBER> considered statistically significant statistical <NUMBER> heterogeneity evaluated using <NUMBER> statistic publication bias evaluated using funnel <NUMBER> plots sensitivity analyses performed identify potential heterogeneity leaving <NUMBER> study table <NUMBER> cardiac injury defined elevated serum troponin levels due differences types <NUMBER> troponin tested center sensitivity testing specific troponin cutoff criteria <NUMBER> included study also outlined table <NUMBER> table s<NUMBER> compiles incidence cardiac injury hospitalized covid<NUMBER> patients primary outcome allcause mortality hospitalized covid<NUMBER> patients cardiac <NUMBER> injury <NUMBER> <NUMBER> patients compared mortality rate <NUMBER> <NUMBER> patients <NUMBER> patients without cardiac injury or<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> z<NUMBER> p<NUMBER> <NUMBER> shown figure <NUMBER>a <NUMBER> since outbreak cardiac injury covid<NUMBER> patients needed inpatient care <NUMBER> described cardiac injury form myopericarditis reported china europe <NUMBER> <NUMBER> case reports ring bell potential involvement cardiovascular system <NUMBER> wider range covid<NUMBER> patients worldwide dozen studies reported <NUMBER> incidence cardiac injury hospitalized covid<NUMBER> patients ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however consensus reached overall incidence cardiac injury patients <NUMBER> li et al <NUMBER> performed metaanalysis attempted determine incidence cardiac injury <NUMBER> however two studies <NUMBER> patients analyzed overall incidence cardiac <NUMBER> injury <NUMBER> <NUMBER> although two studies patients included <NUMBER> elevated creatine kinase levels reported specific cardiac injury could <NUMBER> represent true incidence analysis <NUMBER> studies integrated look cardiac injury affected outcomes <NUMBER> hospitalized covid<NUMBER> patients discovered hospitalized covid<NUMBER> patients <NUMBER> cardiac injury significantly increased mortality rate compared without <NUMBER> <NUMBER> mortality rate hospitalized covid<NUMBER> patients cardiac injury found <NUMBER> <NUMBER> mortality rate significantly higher mortality rates reported far note high rates mortality associated covid<NUMBER> patients <NUMBER> hospitalized could applied require hospitalization range order analyze continuous variables conversion median <NUMBER> standard deviation necessary might introduce bias results metaanalysis revealed cardiac injury common hospitalized covid<NUMBER> patients <NUMBER> incidence similar chinese western population overall <NUMBER> mortality patients cardiac injury alarmingly high cardiac injury significantly <NUMBER> associated older age comorbidities including htn copd early screening triage <NUMBER> support warranted help reduce incidence cardiac injury hospitalized covid<NUMBER> <NUMBER> associated mortality coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global pandemic initially started wuhan china spread extremely quickly making way <NUMBER> countries novel coronavirus continues evolve still many limitations knowledge exactly virus would impact critically older adults people age underlying medical conditions hypertension diabetes shown worse prognosis <NUMBER> diabetic patients increased morbidity mortality rates linked hospitalization intensive care unit icu admissions <NUMBER> people chronic obstructive pulmonary disease copd respiratory illnesses also higher risk severe illness covid<NUMBER> <NUMBER> risk contracting covid<NUMBER> patients copd found <NUMBER>fold higher patients without copd <NUMBER> article part topical collection covid<NUMBER> adekunle sanyaolu sanyakunlehotmailcom <NUMBER> federal ministry health abuja nigeria retrospective study middleaged elderly patients covid<NUMBER> found elderly population susceptible illness likely admitted icu higher mortality rate <NUMBER> agerelated changes geriatric population may due changes lung anatomy muscle atrophy results changes physiologic function reduction lung reserve reduction airway clearance reduction defense barrier function <NUMBER> clinical outcomes length stay directly correlate underlying conditions age covid<NUMBER> patient researchers china studied <NUMBER> patients icu covid<NUMBER> <NUMBER> subjects <NUMBER> patients died <NUMBER>th day median survival <NUMBER> days <NUMBER> patients many different comorbidities <NUMBER> patients hypertension <NUMBER> survivors median duration hospitalization negative test result <NUMBER> days <NUMBER> furthermore another study conducted china studied <NUMBER> covid<NUMBER> patients <NUMBER> patients least one comorbidity concluded older individuals greater <NUMBER> years likely exhibit severe form covid<NUMBER> disease <NUMBER> study <NUMBER> patients median age <NUMBER> years died giving effective mortality rate <NUMBER> <NUMBER> concluded older patients likely succumb covid<NUMBER> disease usa centers disease control prevention cdc uses covidnet <NUMBER> states monitor demographics covid<NUMBER> patients hospitalized <NUMBER> march <NUMBER> <NUMBER> <NUMBER> total <NUMBER> patients covidnet <NUMBER> patients underlying comorbidity <NUMBER> <NUMBER> patients <NUMBER> aged <NUMBER> years older least comorbidity <NUMBER> common comorbidities found obesity hypertension diabetes mellitus <NUMBER> purpose paper review comorbidities given patients severe covid<NUMBER> cases comorbidity furthermore would like examine specific comorbidities relation covid<NUMBER> disease progression outcomes based literature report since outbreak electronic literature search performed using pubmed google scholar ebscohost mendeley medline plus search limited peerreviewed articles published january april <NUMBER> <NUMBER> article selected included keywords coronavirus covid<NUMBER> sarscov<NUMBER> clinical features comorbidity diabetes hypertension articles reviewed included based applicability topic confirmed reported cases covid<NUMBER> wide range symptoms mild complaints fever cough critical cases associated difficulty breathing <NUMBER> common symptoms include cough fever chills shortness breath sob muscle aches sore throat unexplained loss taste smell diarrhea headache <NUMBER> symptoms start mild become intense <NUMBER> <NUMBER> days worsening pneumonia develops patients <NUMBER> approximately <NUMBER> <NUMBER> infected individuals become seriously ill develop difficulty breathing especially elderly underlying health conditions <NUMBER> metaanalysis study covid<NUMBER> patients depicted fig <NUMBER> showed fever <NUMBER> common symptom followed dry cough <NUMBER> fatigue <NUMBER> <NUMBER> symptoms noted productive cough <NUMBER> sob <NUMBER> muscle pain <NUMBER> sore throat <NUMBER> headache <NUMBER> <NUMBER> least common symptoms diarrhea <NUMBER> nausea vomiting <NUMBER> rhinorrhea <NUMBER> abdominal pain <NUMBER> chest pain <NUMBER> <NUMBER> symptoms covid<NUMBER> may appear anytime <NUMBER> <NUMBER> days exposure therefore <NUMBER>day quarantine recommended <NUMBER> average incubation period covid<NUMBER> approximately <NUMBER> days <NUMBER> wuhan china common symptoms observed onset outbreak include fever cough fatigue features prevalent sputum production headache hemoptysis gastrointestinal gi symptom diarrhea <NUMBER> <NUMBER> another study conducted beijing china showed average age patients covid<NUMBER> <NUMBER> years mean <NUMBER> days onset symptoms admission hospital <NUMBER> study also showed fever present <NUMBER> patients persisted <NUMBER> days symptoms resolved <NUMBER> days negative test result <NUMBER> individuals infected develop symptoms <NUMBER> positive cases recover disease without treatment <NUMBER> however also instances transmissions covid<NUMBER> one person another person became aware sick symptoms mild person know heshe illness <NUMBER> becomes essential seek medical attention immediately person suspects heshe may infected confirmed case covid<NUMBER> experiencing respiratory distress blue lips constant pain pressure chest <NUMBER> also important note covid<NUMBER> infectious sarscov merscov due numerous epidemiological biological characteristics <NUMBER> due covid<NUMBER> relatively new understudied disease data available limited however cases emerged observed comorbidities increase chances infection <NUMBER> based current information clinical expertise elderly especially longterm care facilities people age serious underlying medical conditions greater risk getting covid<NUMBER> <NUMBER> elderly vulnerable population chronic health conditions diabetes cardiovascular lung disease higher risk developing severe illness also increased risk death become ill <NUMBER> people underlying uncontrolled medical conditions diabetes hypertension lung liver kidney disease cancer patients chemotherapy smokers transplant recipients patients taking steroids chronically increased risk covid<NUMBER> infection <NUMBER> metaanalysis study covid<NUMBER> comorbidities depicted fig <NUMBER> total <NUMBER> patients <NUMBER> male <NUMBER> female mean age <NUMBER> years old <NUMBER> common comorbidities identified patients hypertension <NUMBER> cardiovascular cerebrovascular conditions <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> less common comorbidities coexisting infection hiv hepatitis b <NUMBER> malignancy <NUMBER> respiratory illnesses <NUMBER> renal disorders <NUMBER> immunodeficiencies <NUMBER> <NUMBER> patients moderate severe asthma disadvantage virus affects respiratory tracts leading increased asthmatic attacks pneumonia acute respiratory distress <NUMBER> according cdcs morbidity mortality weekly report <NUMBER> patients aged <NUMBER> <NUMBER> years old underlying chronic lung disease asthma <NUMBER> iran case study reported genetic predisposition covid<NUMBER> increase probabilities getting infected sarscov<NUMBER> lead death virus <NUMBER> genetic predisposition seen <NUMBER> brothers iran <NUMBER> years apart age <NUMBER> <NUMBER> <NUMBER> years died due covid<NUMBER> despite identified comorbidities living separately one another <NUMBER> january <NUMBER> <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> <NUMBER> <NUMBER> men median age <NUMBER> years old <NUMBER> <NUMBER> patients exposed huanan market <NUMBER> <NUMBER> underlying diseases diabetes <NUMBER> <NUMBER> hypertension <NUMBER> <NUMBER> cardiovascular <NUMBER> <NUMBER> <NUMBER> patients hiv positive along low cd<NUMBER> count antiretroviral therapy higher risk incidence medical issues including covid<NUMBER> <NUMBER> according international aids society ias people <NUMBER> human immunodeficiency virus hiv positive taking antiretroviral treatment low cd<NUMBER> count risk covid<NUMBER> one without hiv <NUMBER> <NUMBER> depicted fig <NUMBER> populationbased surveillance report via covid<NUMBER>associated hospitalization surveillance network covidnet reported clinical data <NUMBER> covid<NUMBER>positive patient hospitalizations march <NUMBER> march <NUMBER> <NUMBER> <NUMBER> among <NUMBER> patients studied <NUMBER> adults showed clinical data underlying medical conditions prevalent hypertension <NUMBER> obesity close second <NUMBER> <NUMBER> medical conditions included chronic lung disease <NUMBER> diabetes mellitus <NUMBER> cardiovascular diseases <NUMBER> <NUMBER> outcome covid<NUMBER> cause severe disease leading hospitalization icu potentially death especially elderly comorbidities <NUMBER> according cdc <NUMBER> <NUMBER> deaths reported usa occurred adults <NUMBER> years old <NUMBER> roughly <NUMBER> covid<NUMBER>positive cases result full recovery illness without hospitalizations interventions <NUMBER> still many facts know covid<NUMBER> due gaps knowledge therefore many studies underway better understand virus <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> clinical outcomes shown <NUMBER> <NUMBER> fig <NUMBER> <NUMBER> <NUMBER> patients confirmed covid<NUMBER> hospital <NUMBER> pneumonia <NUMBER> developed acute respiratory distress syndrome ards <NUMBER> exhibited acute cardiac injury <NUMBER> acquired secondary infection <NUMBER> majority patients <NUMBER> discharged <NUMBER> remained hospitalized <NUMBER> ended icu <NUMBER> ended death <NUMBER> february <NUMBER> march <NUMBER> <NUMBER> study conducted evergreen washington characteristics outcomes <NUMBER> critically ill patients confirmed covid<NUMBER> diagnosis <NUMBER> study showed <NUMBER> patients required mechanical ventilation acute respiratory arrest seen <NUMBER> within <NUMBER> h developing ards <NUMBER> patients showed increasing severity respiratory problems leading poor shortterm outcomes higher risk death <NUMBER> march <NUMBER> <NUMBER> mortality rate <NUMBER> patients <NUMBER> critically ill <NUMBER> discharged hospital <NUMBER> shown cdcs mortality morbidity weekly report fig <NUMBER> case mortality increased patients age increased <NUMBER> <NUMBER> among age group ≤ <NUMBER> years icu admission mortality reported <NUMBER> covid<NUMBER> also noticed children disease took moderate course compared adults prognosis also seemingly better deaths infrequent <NUMBER> april <NUMBER> <NUMBER> reported <NUMBER> million confirmed covid<NUMBER> cases worldwide <NUMBER> cases resulting mortality <NUMBER> majority <NUMBER> deaths within usa <NUMBER> followed italy <NUMBER> spain <NUMBER> <NUMBER> new york hit hardest novel coronavirus spreading across usa cases deaths per capita state table <NUMBER> reports <NUMBER> covid<NUMBER> deaths involved least one comorbidity according new york state department health <NUMBER> multiple comorbidities associated severity covid<NUMBER> disease progression many poorer outcomes covid<NUMBER> related cardiovascular comorbid conditions <NUMBER> however may direct result cardiovascular condition attributed comorbidities along cardiovascular condition <NUMBER> patients type <NUMBER> diabetes also likely increased severity covid<NUMBER> <NUMBER> cohort study <NUMBER> patients covid<NUMBER> without type <NUMBER> diabetes shown type <NUMBER> diabetes required increased interventions hospital stay versus nondiabetic <NUMBER> shown poorer blood glucose control allaround increased mortality rate better glucose control <NUMBER> study concluded patients blood glucose specifically range <NUMBER> <NUMBER> mmoll overall decreased composite adverse events mortality <NUMBER> noted poor blood glucose control resulted substantially increased risk complications death <NUMBER> among comorbidities chronic obstructive pulmonary disease copd also associated poor disease progression metaanalysis multiple studies china found fourfold increase mortality patients preexisting copd diagnosed covid<NUMBER> <NUMBER> analysis smoking status patients severity covid<NUMBER> also studied one study found association smoking severe course covid<NUMBER> <NUMBER> study removed significant association smoking severe covid<NUMBER> disease <NUMBER> patients acute respiratory distress syndrome respiratory failure associated novel coronavirus may linked prothrombotic coagulopathy <NUMBER> autopsy covid<NUMBER>related deaths revealed dispersed microthrombi pulmonary vasculature demonstrating occlusive etiology respiratory failure <NUMBER> <NUMBER> <NUMBER> improvement noted three cases covid<NUMBER>related acute respiratory distress syndrome ards respiratory failure following treatment intravenous iv antithrombotic alteplase <NUMBER> results although reassuring transient two three cases recovery succumbing posttreatment <NUMBER> use antithrombolytic therapy needs studied ascertain results due treatment chance alone <NUMBER> retrospective metaanalysis including <NUMBER> covid<NUMBER> patients conducted march <NUMBER> <NUMBER> subjects underlying comorbidities risk acquiring covid<NUMBER> <NUMBER> common comorbidities hypertension copd diabetes cardiocerebrovascular disease observed significant risk factors subjects compared underlying disease states <NUMBER> intense supportive measures definitive treatment yet identified <NUMBER> authorities speculate subjects comorbidities linked severe disease outcome infected novel coronavirus compared patients underlying disease <NUMBER> study met barriers due diminutive sample size subjects one underlying comorbidity <NUMBER> literature earlier research underlying diseases increase mortality rate patients acquired covid<NUMBER> cardiac disease diabetes significant risk factors <NUMBER> insufficient sample size inadequate time led limitations data collected <NUMBER> <NUMBER> countries affected covid<NUMBER> resulting mass death worldwide cases evolve globally noted persons underlying chronic illnesses likely contract virus become severely ill due sars cov<NUMBER> relatively new virus data available limited however patients comorbidities deteriorating outcomes compared patients without covid<NUMBER> patients history hypertension obesity chronic lung disease diabetes cardiovascular <NUMBER> disease worst prognosis often end deteriorating outcomes ards pneumonia also elderly patients longterm care facilities chronic kidney disease patients cancer patients risk contracting virus significantly increased risk death among groups patients cases reported worldwide symptoms covid<NUMBER> ranged mild respiratory disease severe illness requires intubation mechanical ventilation since period patient asymptomatic incubation period <NUMBER> <NUMBER> days difficult establish early diagnosis much less curb transmission infection patient unknowingly exposed however within period respiratory symptoms develop important seek immediate care therefore patients comorbidities take necessary precautions avoid getting infected sars cov<NUMBER> usually worst prognosis precautions include regular handwashing soap water use alcoholbased hand sanitizer limiting persontoperson contact practicing social distancing wearing face mask public places overall limiting going public areas time unless necessary hence need global public health campaign raise awareness reducing burden comorbidity illnesses causing deaths covid<NUMBER>infected patients municipal population family planning commission foundation grantaward number wx<NUMBER>c<NUMBER> confidence interval <NUMBER> results suggest nlr hospital admission associated inhospital mortality among patients covid<NUMBER> therefore nlr appears significant prognostic biomarker outcomes critically ill patients covid<NUMBER> however investigation needed validate relationship data collected prospectively wuhan confirmed cause ncip <NUMBER> studies shown disease caused sarscov<NUMBER> recently named coronavirus disease <NUMBER> covid <NUMBER> world health organization could induce symptoms including fever dry cough dyspnea fatigue lymphopenia infected patients severe cases infections causing viral pneumonia may lead severe acute respiratory syndrome sars even death <NUMBER> <NUMBER> <NUMBER> initial cases covid<NUMBER> disease caused sarscov<NUMBER> related huanan seafood wholesale market sells aquatic products live poultries wild animals <NUMBER> first batch cases identified later showed exposure even relation huanan wholesale market humantohuman transmission confirmed moreover nosocomial infections reported health care workers <NUMBER> <NUMBER> number fatalities due covid<NUMBER> escalating however time specific vaccines treatments covid<NUMBER> therapy consists empirical antibiotics antiviral therapy oseltamivir systemic corticosteroids may limited effect fatal outcome evidence accumulating condition patients covid<NUMBER> deteriorates rapidly <NUMBER> may <NUMBER> whos online covid<NUMBER> situation dashboard reveals <NUMBER> <NUMBER> <NUMBER> confirmed cases covid<NUMBER> including <NUMBER> <NUMBER> deaths thus identifying prognostic predictors mortality patients covid<NUMBER> might useful assessing disease severity making optimal treatment decisions neutrophil lymphocyte ratio nlr suggested simple marker systemic inflammatory response critical care patients <NUMBER> <NUMBER> also reported independent prognostic factor noninfectious diseases acute myocardial infarction stroke several types cancers <NUMBER> <NUMBER> <NUMBER> addition nlr shown independent indicator shortterm longterm mortality critically ill patients <NUMBER> therefore nlr systemic inflammatory marker potential predictor clinical risk outcome many diseases knowledge utility nlr predict mortality patients covid<NUMBER> studied yet based previous studies hypothesized nlr might relate disease severity mortality patients covid<NUMBER> current study sought investigate whether nlr prognostic factor patients covid<NUMBER> adult age <NUMBER> years old patients diagnosed covid<NUMBER> according interim guidance screened died discharged <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> included study data collected patients cured discharged died without cure amplified tested primers used follows target <NUMBER> orf<NUMBER>ab forward primer ccctgtgggttttacacttaa reverse priand myocardial enzymes chest radiographs computed tomography scan also done inpatients <NUMBER> patients age <NUMBER> years neutrophil lymphocyte counts results within <NUMBER> hours admission included study patients missed neutrophil lymphocyte records chronic hematological disorder excluded electronic medical records patients reviewed trained research team physicians wuhan third hospital tongren hospital wuhan university epidemiological clinical laboratory treatment outcome data analyzed patient data included demographics medical history exposure history comorbidities symptoms signs laboratory findings treatment antiviral antibiotic corticosteroid therapies respiratory support data checked two physicians hc js third researcher sn adjudicated difference interpretation two primary reviewers baseline characteristics presented median interquartile range iqr continuous variables number percentage categorical variables comparisons continuous variables analyzed student mannwhitney u test based variable distribution categorical variables analyzed χ <NUMBER> test data tested kolmogorovsmirnov normality test homogeneity variance assess relationship nlr inhospital mortality receiver operating characteristics roc curve reported area roc curve next grouped patients based cutoff value nlr hospitalization addition adjust potential confounding variables multivariate regression analysis following variables considered multivariable adjustment age gender smoking status laboratory data comorbidities intensive care unit icu length stay results reported hazard ratio <NUMBER> confidence interval <NUMBER> ci statistical processes performed statistical package social sciences <NUMBER> spss inc chicago il twosided p value less <NUMBER> considered statistically significant nonparametric roc analysis showed cutoff value roc curve optimal threshold inhospital mortality <NUMBER> <NUMBER> nlr <NUMBER> model strongest predictive ability area curve <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> figure <NUMBER> sensitivity <NUMBER> specificity <NUMBER> yoden index <NUMBER> divided patients two groups using nlr greater less equal <NUMBER> criterion compare clinical characteristics patients high nlr low nlr table <NUMBER> multivariate logistic regression analysis highnlr remained independently associated inhospital death addition found higher levels hscrp ntprobnp blood urea nitrogen well history hypertension respiratory failure digestive system diseases cerebrovascular diseases also independently associated inhospital mortality table <NUMBER> study found association nlr clinical outcomes patients covid<NUMBER> <NUMBER> based roc curve analysis nlr showed significant performance predict inhospital mortality cutoff level nlr <NUMBER> figure <NUMBER> study supports high nlr strong predictor inhospital mortality pa worldwide outbreak new type coronavirus severe acute respiratory syndrome sars coronavirus <NUMBER> causing coronavirus disease covid<NUMBER> rapidly changed societies first <NUMBER> months <NUMBER> covid<NUMBER> first reported december <NUMBER> wuhan capital hubei province china <NUMBER> response broader disease threat china placed restrictions travel wuhan january <NUMBER> <NUMBER> virus detected europe already january countries france january <NUMBER> <NUMBER> finland january <NUMBER> <NUMBER> <NUMBER> currently known long active covid<NUMBER> cases circling europe different countries started react epidemic first death caused covid<NUMBER> outside asia occurred france february <NUMBER> <NUMBER> italy number infections started rise rapidly last week february <NUMBER> march <NUMBER> almost european countries placed least restrictions effort prevent uncontrolled spread virus much focus covid<NUMBER> discussion research centralized epidemiological factors reproductive number r<NUMBER> covid<NUMBER> considered higher sars recent review study average r<NUMBER> covid<NUMBER> found <NUMBER> median <NUMBER> <NUMBER> viral shedding novel coronavirus also long median <NUMBER> days survivors nonsurvivors died average <NUMBER> days illness onset <NUMBER> case fatality infection fatality ratios recently reported china <NUMBER> <NUMBER> respectively <NUMBER> europe similar estimations made yet covid<NUMBER> mortality particularly high regions lombardy italy data shows major country variations spread mortality rates covid<NUMBER> within europe reasons behind spread disease subsequent mortality remain partly unexplained different countries also responded epidemic different rates gives starting point investigations societal psychological factors related spread covid<NUMBER> social scientific perspective could help us understand covid<NUMBER> mortality social factors important epidemics always understood ecological context <NUMBER> means example social activity impact spread viruses european countries vary greatly terms population density also differences number social contacts people interact daily basis addition major cultural differences physical distance people keep interacting close friends people <NUMBER> instance southern european countries traditionally considered contact cultures comparison noncontact cultures north europe asia <NUMBER> epidemic physical social closeness people factors explain spread disease another important social factor explaining spread viruses trust trust institutions people considered important factor wellbeing overall functioning societies <NUMBER> institutional trust crucial part epidemic management prevention trust public systems authorities health care systems influences people use services follow instructions <NUMBER> trust institutions becomes important disruptive events terrorist attacks natural disasters epidemics <NUMBER> research evidence previous epidemics showed lower trust government less likely take precautions ebola virus disease liberia congo <NUMBER> outbreak <NUMBER> similar findings also noted <NUMBER> sars outbreak hong kong <NUMBER> great trust authorities also associated carrying avoidant behaviors swine flu epidemic united kingdom <NUMBER> dozens studies previously demonstrated significant country differences institutional trust making essential societal element consider <NUMBER> trust state institutions typically highest nordic countries finland denmark iceland norway sweden also rank high different welfare statistics worldwide <NUMBER> elsewhere europe institutional trust found low particularly eastern european countries also southern european countries italy <NUMBER> determinants institutional trust vary across different sides europe perceived lack responsiveness political governmental entities often results low received trust public east central europe older individuals women found show trust toward institutions trust political institutions lower among educated people <NUMBER> southern european countries italy spain socialization experiences largely associated low institutional trust attitudes toward political institutions deeply rooted cultural legacy <NUMBER> words institutional trust lowest countries characterized contact cultures combination social closeness lack trust authorities might turn lethal within europe least older adults aim study examine country variations covid<NUMBER> mortality europe analyzing social risk factors may explain spread disease restrictions control measures institutional trust expected find societal differences especially capability coping crisis situation study based analysis european social survey ess data <NUMBER> european countries n<NUMBER> data <NUMBER> ess<NUMBER> except bulgaria cyprus slovakia whose data <NUMBER> ess<NUMBER> denmark data <NUMBER> ess<NUMBER> ess data sets openly available research purposes ess web site <NUMBER> additional country information received eurostat world bank covid<NUMBER> mortality incidence figures drawn database built coronavirus resource centre johns hopkins university <NUMBER> data updated april <NUMBER> <NUMBER> article country restrictions drawn official websites states ministries related webpages created purpose providing covid<NUMBER> updates ess data publicly available downloadable ess website collection selfreported data based informed consent subscribes declaration professional ethics international statistical institute ess surveys gone ethical review ess european research infrastructure consortium research ethics board <NUMBER> analyses focused creating countrylevel information observations individual level used used data also publicly available data code available via open science framework <NUMBER> covid<NUMBER> mortality incidence time series data collected <NUMBER> european countries covered <NUMBER> days covid<NUMBER> epidemic january <NUMBER> april <NUMBER> <NUMBER> incidence rates also collected treated controls countries differ lot testing rates hence mortality figures provide accurate information spread epidemic february april <NUMBER> information country restrictions included national bans restrictions included bans public events curfews country border closures restrictions restaurant operations elementary school contact teaching public events curfews unauthorized outings reviewed applied date first nationwide restriction became effective country border closures determined starting date borders country closed restrictions restaurant operations elementary school contact teaching calculated date least national restrictions became effective restrictions varied exact content accuracy across countries general country information includes size population population density persons per square kilometer oldage dependency ratio ie ratio people aged <NUMBER> years older gender ratio life expectancy birth health care expenditure euros per inhabitant number tourist arrivals per year selfreported country information included perceived sociability household size proportion older people living children perceived institutional trust perceived sociability measured question “how often take part social activities compared others age” given responses <NUMBER> “much less most” <NUMBER> “less most” <NUMBER> “about same” <NUMBER> “more most” <NUMBER> “much most” household size based respondents’ information many people live regularly household proportion older adults living children calculated grouping respondents aged <NUMBER> years older according whether currently live household children institutional trust measured respondents’ trust five institutions namely parliament politicians political parties police legal system respondents asked much personally trust institutions scale <NUMBER> <NUMBER> <NUMBER> meant trust <NUMBER> meant complete trust reliability measure good cronbach alpha ranging <NUMBER> <NUMBER> analyses institutional trust categorized low <NUMBER> less low <NUMBER> high <NUMBER> high <NUMBER> illustrative map low less <NUMBER> high <NUMBER> based median random effects regression model statistical analyses conducted stata <NUMBER> software statacorp daily covid<NUMBER> mortality covid<NUMBER> epidemic europe analyzed multilevel mixed effects linear regression models multilevel models dependent variable square root transformed daily mortality count count based daily followups covid<NUMBER> mortality cases country starting first confirmed infection ending april <NUMBER> <NUMBER> resulted followup periods varied countries <NUMBER> days france <NUMBER> days cyprus assess relationship daily mortality count main theoretical variables conducted three separate models model <NUMBER> included perceived sociability model <NUMBER> included timing national restrictions model <NUMBER> included institutional trust independent variable models controlled following betweencountry factors average household size population population density oldage dependency ratio life expectancy birth health care expenditure per inhabitant high tourist arrival dummy variable based median length followup period country addition models included time withincountry predictor mortality end point followup period april <NUMBER> <NUMBER> coded zero point time variable preceding days negative values descending order first day country’s followup period thus time used estimate withincountry change mortality epidemic betweencountry variables estimated country differences mortality except time high touristarrival dummy variables independent variables mean centered adding regression models models conducted maximum likelihood estimation estimated huberwhite standard errors robust withincountry clustering modelled residuals account autocorrelated error structure longitudinal data models included random intercept random slope time unstructured covariances reported regression coefficients corresponding <NUMBER> confidence intervals p values fixed part models standard deviation <NUMBER> confidence interval random effects progression covid<NUMBER> mortality first covid<NUMBER> death analyzed random effects models account clustering country level modelled amount daily deaths low high institutional trust cutoff point median value <NUMBER> first covid<NUMBER> death time<NUMBER> used reference category analyzed countries reacting late restrictions placed first covid<NUMBER> death early restrictions placed first covid<NUMBER> death analyses time point day allowed separate coefficient covid<NUMBER> mortality value presented deathsmillion persons models presented figures adjusted population density gender oldage ratio proportion <NUMBER> years older living children life expectancy tourist arrivals models included country restrictions daily varying dummies <NUMBER>no control <NUMBER>control descriptive statistics <NUMBER> european countries shown table <NUMBER> spread covid<NUMBER> epidemic fast everywhere findings reveal significant differences countries impacted countries europe april <NUMBER> italy spain france see table <NUMBER> countries also significantly late implement national restrictions example italy placed national restrictions almost <NUMBER> weeks first covid<NUMBER> incident see figure <NUMBER> france already <NUMBER> death case february slowest react nationwide highly likely days virus able spread fast population explains later mortality figures multilevel linear regression models analyzed daily mortality <NUMBER> countries tables <NUMBER> <NUMBER> fixed effect time significant predictor mortality models indicating increasing trend deaths crisis period according random part models however betweencountry variation trend addition withincountry change found betweencountry factors significantly predicted mortality model <NUMBER> shows perceived sociability predicted higher daily mortality model <NUMBER> shows late restrictions associated higher numbers covid<NUMBER> deaths model <NUMBER> shows institutional trust negatively associated daily covid<NUMBER> mortality figures control variables population density life expectancy birth health care expenditure per inhabitant high tourist arrival length followup period positively associated daily mortality yet significance associations varied models final part analysis focused role institutional trust reaction time figure <NUMBER> shows map europe average number deaths per million inhabitants analyzed <NUMBER> countries categorized four country groups based level institutional trust map demonstrates countries low institutional trust deaths per million inhabitants average compared countries high trust analyzed difference countries low vs high perceived institutional trust using random effects regression model figure <NUMBER> shows development first covid<NUMBER> death case low hightrust countries statistically significant differences curves curves indicate increases mortality <NUMBER> weeks first covid<NUMBER> death case statistically significant differences figure <NUMBER> shows deaths per million inhabitants countries reacting late early see number deaths per day varied <NUMBER> days following first national restrictions statistically significant difference curves increases mortality rapid countries reacting late reacting early example <NUMBER> days first covid<NUMBER> death <NUMBER> times deaths latereacting countries <NUMBER> deathsmillion <NUMBER> ci <NUMBER> early reacting countries <NUMBER> deathsmillion <NUMBER> ci <NUMBER> starting points study major country differences observed covid<NUMBER> mortality related societal cultural differences well people act different societies current crisis situation analyzed social risk factors may explain spread covid<NUMBER> restrictions control measures institutional trust attempt understand prevailing country differences analysis showed major variations reactions worldwide epidemic able show mortality significantly associated studied social factors perceived sociability associated higher covid<NUMBER> mortality even adjusting number control factors might important understanding virus able spread fast countries italy also dense population results also reflect previous crosscultural findings showing italians spanish people smaller social personal intimate distances compared many european nations <NUMBER> countries also strong intergenerational ties may explain many older adults got sick <NUMBER> one key points analysis however covid<NUMBER> mortality tied societal processes found major differences fast countries reacting covid<NUMBER> outbreak compared china european countries time react yet national restrictions placed late countries hit hardest disease also ones slowest react nationwide notably italy spain france models showed late national restrictions predicted higher number deaths despite unity provided european union european countries working together emerging disease threat regulations progressed slowly taking one step time also delays putting restrictions action countries also taken different strategies covid<NUMBER> epidemic scandinavia example sweden adopted less restrictions denmark finland norway sweden also higher number deaths per inhabitants time writing example shows even within similar neighboring countries national precautions covid<NUMBER> different able demonstrate analysis institutional trust protective factor line previous studies indicating people higher institutional trust likely follow advice guidelines given health authorities <NUMBER> analysis covid<NUMBER> mortality figures progressed differently lowtrust countries hightrust countries remarkably lowtrust countries italy spain france late placing restrictions place harder measures later curfews people simply following recommendations socialize despite hard measures countries also sanction disobedient citizens example ministry interior italy reported intensive controls <NUMBER> people caught police breaking curfew <NUMBER> epidemiologists necessarily given enough attention societal social psychological factors explaining epidemics although virus epidemics crisis caused covid<NUMBER> created unique global situation demonstrating poorly previous epidemics eg sars middle east respiratory syndrome prepared countries deal disease <NUMBER> made covid<NUMBER> situation unique compared epidemics rapid spread virus unusually hard restrictions placed prevent physical contact closeness people european countries general rely individual freedom democracy difficult close shutdown societies completely becomes crucial understand different societies capable handling crisis situation typically reflected literature societal resilience institutional trust important part <NUMBER> crisis later developments reveal kind role institutional trust eventually wider picture also involves factors related social contacts people timely restrictions placed within societies analysis limited relatively short followup period inability control possible factors involved also wish note variations across countries exist involves example fact hightrust countries adopted different societal strategies tackle covid<NUMBER> crisis future studies continue using social scientific evidence investigations worldwide epidemics bariatric surgery used decades treat patients severe obesity <NUMBER> global guidelines established diabetes surgery summit dss international consensus conference series formally recognised gastrointestinal surgery standard therapy type <NUMBER> diabetes practice known metabolic surgery <NUMBER> coronavirus disease <NUMBER> covid <NUMBER> outbreak unprecedented pressure free inpatient capacity intraoperative risks viral contagion among patients staff hospitals worldwide obliged postpone elective operations including bariatric metabolic surgery increased hazards severe covid<NUMBER> complications patients obesity type <NUMBER> diabetes <NUMBER> support rationale pause elective surgery peak pandemic return normal services gradual surgeons competing reduced capacity address backlog elective procedures hence access bariatric metabolic surgery continue constrained given uncertainty regarding effects duration covid<NUMBER> outbreak combined progressive nature obesity diabetes related conditions delaying bariatric metabolic surgery could increase risks morbidity mortality surgical candidates risk harm however variable among individuals depending type severity disease indications bariatric metabolic surgery traditional weightcentric criteria patient selection bariatric surgery still commonly used today reflect severity disease <NUMBER> therefore cannot used prioritise treatment based actual clinical needs furthermore physical distancing policies continued lockdowns might limit adherence lifestyle interventions worsening metabolic deterioration among candidates bariatric metabolic surgery additionally reduced access nonurgent care covid<NUMBER> pandemic might impede postoperative monitoring potential surgical nutritional complications clear urgent need therefore exists strategies mitigate harm patients covid<NUMBER> pandemic approaches include nonsurgical interventions optimise metabolic weight control patients awaiting surgery telemedicine protocols postoperative surveillance use appropriate criteria triage surgical candidates foreseeable period reduced capacity elective surgery address issues dss <NUMBER> organisers directed group international experts assess effect covid<NUMBER> pandemic candidates surgical treatment obesity type <NUMBER> diabetes specific aim develop criteria help prioritise bariatric metabolic surgery elective surgery resumed beyond elective surgery refers operations planned scheduled advance procedures however optional important lifechanging implications access elective surgery reduced doctors prioritise patients greatest need greater risk harm delayed treatment healthcare systems elective surgery categorised urgent semiurgent nonurgent <NUMBER> <NUMBER> urgent elective surgery required within <NUMBER> days conditions might deteriorate quickly semiurgent conditions although likely deteriorate quickly could reasonably cause severe pain dysfunction harm delayed beyond <NUMBER> months nonurgent elective surgery planned conditions unlikely cause substantial discomfort dysfunction harm treated within <NUMBER> year although complications bariatric metabolic operations require emergency surgical treatment eg haemorrhage leak intestinal obstruction bariatric metabolic procedures represent genuine elective surgery date however consensus exists criteria identify urgent semiurgent nonurgent indications bariatric metabolic surgery basis type severity patients conditions many reasons bariatric metabolic operations suspended intense phase covid<NUMBER> pandemic including infection risks among patients staff factors inherent operations increased hazards severe covid<NUMBER> complications among patients obesity type <NUMBER> diabetes laparoscopic surgery involves aerosolgenerating techniques carbon dioxide pneumoperitoneum electro cautery ultrasonic shearing techniques could easily increase risk viral contagion staff <NUMBER> <NUMBER> including severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> upper gastrointestinal endoscopy another aerosolproducing procedure also commonly done bariatric metabolic surgery patients undergoing major surgery risk lifethreatening inflammatory complications infection including viruses systemic inflammatory response syndrome sepsis <NUMBER> although conclusive evidence laparoscopy upper endoscopy promote covid<NUMBER> transmission postponing elective metabolic bariatric interventions acute phase covid<NUMBER> outbreak seems sensible except urgent revisional surgery emergency endoscopic interventions complications eg haemorrhage stoma stenosis leaks despite potential higher risk contagion laparoscopic approach bariatric metabolic surgery associated substantial benefits compared traditional open surgery especially patients severe obesity benefits include lower rates mortality complications including pulmonary procedural shorter hospital stays <NUMBER> <NUMBER> reasons laparoscopic access remain preferred approach open techniques elective bariatric metabolic surgery resumes appropriate personal protective equipment used however given increased risk sarscov<NUMBER> infection staff obesity increases risk complications viral respiratory infections <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic california <NUMBER> people died obesity higher bmi associated mortality <NUMBER> patients admitted intensive care sarscov<NUMBER> class <NUMBER> obesity bmi <NUMBER> kgm² independent risk factor disease severity <NUMBER> similarly patients diabetes augmented risk severe covid<NUMBER> mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> several mechanisms suggested increase risk complications viral infections obesity type <NUMBER> diabetes including lowgrade chronic inflammation overproduction proinflammatory cytokines reduced natural killer cell number activity impaired antigenstimulation responses <NUMBER> <NUMBER> <NUMBER> another factor might role relationship obesity diabetes increased risk complications sarscov<NUMBER> enters host cells binding angiotensinconvertingenzyme <NUMBER> ace<NUMBER> receptor ace<NUMBER> transforms angiotensin <NUMBER> angiotensin <NUMBER> thereby reducing vaso constriction sodium retention inflammation metabolic degeneration <NUMBER> chronic hyperglycaemia regulates ace<NUMBER> expression <NUMBER> reduction ace<NUMBER> covid<NUMBER> infection could contribute hyperinflammation respiratory failure patients type <NUMBER> diabetes <NUMBER> people obesity also prone hypoventilation syndrome cardiovascular disease <NUMBER> heart failure <NUMBER> conditions could increase risk covid<NUMBER> mortality elective bariatric metabolic surgery resumes pandemic contained sarscov<NUMBER> probably still circulate population given risks severe complications covid<NUMBER> patients obesity type <NUMBER> diabetes recommend covid<NUMBER> screening mandatory preoperatively patients considering bariatric metabolic surgery class <NUMBER> obesity type <NUMBER> diabetes common indications bariatric metabolic surgery associated reduced quality life increased morbidity mortality ability cause lifethreatening complications however varies depending severity stage disease burden comorbidities degree harm delaying metabolic bariatric surgery depends patients condition surgical efficacy different stages disease availability effectiveness nonsurgical therapies control disease progression awaiting surgery understanding prognostic factors morbidity mortality obesity type <NUMBER> diabetes help define criteria surgical prioritisation diabetes major cause morbidity death including cardiovascular renal neurological retinal complications approximately twothirds people diabetes die cardiovascular disease relative risk <NUMBER>·<NUMBER>·<NUMBER> times greater people without diabetes <NUMBER> biological progression type <NUMBER> diabetes characterised declining βcell function continuing insulin resistance manifested clinically deteriorations multiple parameters including hba <NUMBER>c fasting postprandial glucose levels uk prospective diabetes study <NUMBER> reported significant associations hyperglycaemia development diabetes complications death <NUMBER> risk reduction diabetesrelated endpoint <NUMBER> absolute hba <NUMBER>c reduction factors beyond hyperglycaemia also influence type <NUMBER> diabetes prognosis triad study <NUMBER> <NUMBER> predictors allcause mortality <NUMBER> years <NUMBER> years study followup included older age male sex nonhispanic white race lower education income longer duration diabetes lower bmi hypertension macrovascular disease retinopathy nephropathy neuropathy among specific predictors cardiovascular mortality also treatment insulin without oral medication higher ldl cholesterol history nephropathy transient ischaemic attack stroke angina myocardial infarction coronary artery peripheral vascular disease use antihypertensive cholesterollowering medications obesity increases risks many illnesses including diabetes hypertension dyslipidaemia liver disease coronary artery cerebrovascular disease many cancers cholelithiasis infertility psychosocial dys function osteoarthritis chronic kidney disease also covid<NUMBER> together complications power fully reduce quality life exacerbate obesityassociated mortality even covid<NUMBER> obesity reduced life expectancy <NUMBER> years <NUMBER> notably higher allcause mortality associated obesity class <NUMBER> bmi <NUMBER>·<NUMBER> kgm² <NUMBER> bmi ≥<NUMBER> kgm² corresponding candidates bariatric surgery class <NUMBER> obesity bmi <NUMBER>·<NUMBER> kgm² <NUMBER> obesity hypoventilation syndrome obesityassociated heart failure substantially increase mortality obesity hypoventilation syndrome represents combination obesity chronic daytime hypercapnia <NUMBER> <NUMBER> prevalence obesity hypoventilation syndrome highest among patients bmi <NUMBER> kgm² <NUMBER> mortality untreated obesity hypoventilation syndrome high <NUMBER> <NUMBER>·<NUMBER> years diagnosis <NUMBER> obesity heart failure associated increased mortality <NUMBER>unit increase bmi heart failurerelated mortality increases <NUMBER>·<NUMBER> times <NUMBER> since bmi alone reflect obesityrelated mortality morbidity staging systems kings obesity criteria <NUMBER> edmonton obesity staging system eoss <NUMBER> developed assess individual patients risk basis evidence subclinical established endstage comorbidities <NUMBER> retrospective application eoss data national health nutrition examination survey showed patients stages <NUMBER> eoss increased allcause mortality compared stages <NUMBER> <NUMBER> finding supports idea presence type severity obesityrelated complications addition bmi <NUMBER> inform decision making prioritisation treatment especially surgery nonalcoholic fatty liver disease characterised excess hepatic fat aggressive form nonalcoholic steatohepatitis includes hepatocyte injury inflammation fibrosis <NUMBER> <NUMBER> <NUMBER> two conditions affect <NUMBER> western population rates rising worldwide <NUMBER> <NUMBER> patients obesity diabetes nonalcoholic fatty liver disease nonalcoholic steatohepatitis <NUMBER> <NUMBER> nonalcoholic steatohepatitis lead cirrhosis <NUMBER> cases liver failure hepatocellular carcinoma <NUMBER> beyond liverrelated mortality nonalcoholic steatohepatitis substantially increase microvascular macrovascular complications cardiovascular mortality patients obesity type <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonrandomised trials suggest rouxeny gastric bypass resolves histological features nonalcoholic steatohepatitis <NUMBER> patients <NUMBER> <NUMBER> randomised clinical trials observational studies show patients classes obesity bariatric metabolic surgery promotes greater longterm weight loss best available nonsurgical interventions regardless operation chosen <NUMBER> <NUMBER> <NUMBER> <NUMBER> multiple obser vational studies also indicate bariatric metabolic surgery lowers longterm risk allcause mortality compared matched nonsurgical patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data eight observational studies involving total <NUMBER> <NUMBER> patients suggest bariatric metabolic surgery associated reduced risk types cancer odds ratio or<NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> obesityassociated cancer or<NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> <NUMBER> <NUMBER> without exception <NUMBER> allcause mortality studies published date shows patients bariatric metabolic surgery live longer matched nonsurgical controls <NUMBER> concerning type <NUMBER> diabetes least <NUMBER> randomised controlled trials comparing bariatric metabolic surgery conventional diabetes therapies ie lifestyle plus medication patients type <NUMBER> diabetes show surgery superior control hyperglycaemia reduction cardiovascular overall mortality risk improvement quality life reduction risk renal complications <NUMBER> <NUMBER> <NUMBER> safety bariatric metabolic surgery compares favourably elective operations including hysterectomy chole cystectomy knee replacement surgical treatments diabetes highly costeffective cost per qualityadjusted lifeyear ranging us<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> based evidence dss guidelines formally endorsed <NUMBER> worldwide medical scientific organisations recognised payers worldwide recommend consideration bariatric metabolic surgery appropriate candidates including class <NUMBER> obesity achieve adequate glycaemic control medical therapy <NUMBER> delay bariatric metabolic surgery occurring due covid<NUMBER> augment burden disease among surgical candidates increase particularly affect patients type <NUMBER> diabetes given metabolic surgery causes remission hyperglycaemia cases <NUMBER> likelihood hyperglycaemia remission however depends upon soon operation done natural history diabetes algorithms designed predict surgical remission eg diarem<NUMBER> addiarem diabetter abcd <NUMBER> <NUMBER> <NUMBER> <NUMBER> consistently show longstanding disease one powerful indicators failure achieve benefit <NUMBER> remission rates drop notably <NUMBER> years diabetes moreover sos study <NUMBER> reported substantially lower type <NUMBER> diabetes remission among patients <NUMBER> years known disease <NUMBER> years known disease thus delaying metabolic surgery reduces chances diabetes remission delayed metabolic surgery might cause even greater harm patients type <NUMBER> diabetes higher risk microvascular macrovascular complications mortality especially medications lifestyle interventions achieving adequate metabolic control patients without diabetes severe respiratory obesity hypoventilation syndrome cardiac renal complications obesity individuals weight reduction crucial advancing timesensitive lifesaving treatments eg organ transplants also greater risks harm delaying bariatric metabolic surgery patients surgically remediable metabolic diseases especially diabetes incur healthcare costs per day without conditions studies compared costs <NUMBER> years surgical nonsurgical patients found pharmacy expenses decrease substantially bariatric metabolic surgery compared matched nonsurgical patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> primarily due lower diabetes medication costs <NUMBER> hence metabolic surgery decreases daily healthcare costs especially patients requiring multidrug therapy longer surgery delayed patients less costsaving becomes various nonsurgical options used mitigate harm delaying bariatric metabolic surgery manage patients surgery panel <NUMBER> regarding need optimise glycaemic control patients type <NUMBER> diabetes especially advanced microvascular macrovascular complications <NUMBER> considered available evidence pharmacological strategies promote weight loss glucagonlike peptide<NUMBER> receptor agonists glp<NUMBER>ra sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors <NUMBER> glp<NUMBER>ras reduce hba <NUMBER>c <NUMBER> <NUMBER> promoting clinically relevant weight loss <NUMBER> sglt<NUMBER> inhibitors however might contraindicated covid<NUMBER> concerns potential subclinical vascular congestion risk acute metabolic decompensation associated drugs <NUMBER> also considered available data regarding efficacy dietary pharmacological interventions weight loss <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> strategy achieve weight loss weight maintenance patients multiple weightresponsive comorbidities face prolonged waiting times bariatric metabolic surgery regarding strategies maximise surgical outcomes patients already surgery recommendations based results studies investigating efficacy pharmacological approaches people persistent recurrent type <NUMBER> diabetes surgery among individuals recent study <NUMBER> showed glp<NUMBER>ra liraglutide reduce hba <NUMBER>c <NUMBER>·<NUMBER> <NUMBER> additional weight loss reviewed existing evidencebased recommendations postoperative nutritional care <NUMBER> define safe pragmatic methods virtual consultation telemedicine panel <NUMBER> even covid<NUMBER> pandemic metabolic bariatric surgery underused many reasons including misconceptions stigma obesity bariatric surgery <NUMBER> barriers might penalise candidates surgery times limited resources given seriousness diseases require metabolic bariatric surgery clinicians hospital managers policy makers ensure operations delayed widespread misconception last resort <NUMBER> eventually covid<NUMBER> crisis abate elective operations resume leaving enormous backlog patients would benefit bariatric metabolic surgery prioritise serve first limited resources broad level answer simple patients well enough safe surgical candidates preference afforded greatest risk morbidity mortality disease probable risk reduced surgery logic would apply instance many surgical candidates poorly controlled type <NUMBER> diabetes substantial metabolic respiratory cardiovascular disease traditional bmicentric criteria patient selection however tend skew access bariatric metabolic surgery opposite direction despite strong evidence surgery achieves greatest health benefits among patients type <NUMBER> diabetes minority operations preoperative type <NUMBER> diabetes cardiometabolic disease <NUMBER> furthermore many publicly funded healthcare systems eg uk national health service candidates bariatric metabolic surgery currently placed single elective surgery waiting list regardless indication priority established largely firstcome firstserved basis rather nonsurgical options mitigate harm delaying surgery • glycaemic control optimised patients awaiting metabolic surgery type <NUMBER> diabetes especially advanced microvascular macrovascular complications desirable prepare surgery also case severe acute respiratory syndrome coronavirus <NUMBER> infection • patients achieve glycaemic targets lifestyle modifications metformin addition glucagonlike peptide<NUMBER> receptor agonist glp<NUMBER>ra sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitor advance combined goals improving metabolic control causing weight loss limiting weight gain use sglt<NUMBER> inhibitors however recommended case acute coronavirus disease <NUMBER> covid<NUMBER> infection concerns potential subclinical vascular congestion risk acute metabolic decompensation associated drugs • patients multiple weightresponsive comorbidities face prolonged waiting times surgery dietary pharmacological interventions weight control might become necessary • diets higher protein content lower glycaemic index effective considered • among patients already taking weightloss medications efforts made continue drugs surgery scheduled since rapid weight regain predictable discontinued • countries weightloss medications eg phentermine orlistat glp<NUMBER>ras naltrexonebupropion phenterminetopiramate accessible clinicians could consider use weight loss weight maintenance important patients multiple weightresponsive comorbidities • telemedicine strategies supervised specialist bariatric metabolic surgery providers used • people persistent recurrent type <NUMBER> diabetes surgery weightreducing diabetes medications eg glp<NUMBER>ras considered weight maintenance also encouraged patients type <NUMBER> diabetes remission mitigate risk disease recurrence • insufficient evidence justify deviations current evidencebased recommendations postoperative nutritional care patients bariatric metabolic surgery • minimise risk nutritionrelated complications providers engage patients intervals current guidelines • clinical signs eg weight visual changes rash weakness oedema anasarca neuropsychiatric signs symptoms eg nausea tingling bowelhabit changes fatigue nutritional deficiency must assessed virtual clinic sessions • routine laboratory tests eg albumin thiamine b<NUMBER> vitamin vitamin iron calcium deferred obtained standard intervals particularly patients operations greater risk nutrient malabsorption longlimb diversionary procedures • urgent facetoface meetings laboratory tests mandated symptoms suggest severe biochemical deficiencies surgical complications eg intestinal obstruction acute cholecystitis • misconceptions stigma obesity bariatric metabolic surgery might penalise candidates surgical treatment obesity diabetes times limited resources clinicians policy makers hospital managers recognise seriousness diseases require metabolic bariatric surgery ensure operations delayed • given risks severe complications covid<NUMBER> patients obesity type <NUMBER> diabetes covid<NUMBER> screening mandatory preoperatively patients considering bariatric metabolic surgery • despite potential higher risk contagion staff risk benefit laparoscopic approach remain favourable patients preferred use open techniques • appropriate personal protective equipment used recommended professional bodies public health agencies minimise risk staff operators clinical need approach comparable putting colorectal surgery candidates waiting list similar priority regardless whether diagnosis cancer benign neoplasia strong need therefore exists clinically sound criteria help prioritise access surgery times pandemics limited resources criteria also inform future waiting list management decision making structure surgical services prioritisation elective operation seek facilitate access according clinical need maximise equity access minimise harm delayed access adapted previous categorisations elective surgery <NUMBER> define objective prioritisation system reflecting principles bariatric meta bolic operations panel <NUMBER> figure given factors contributing morbidity mortality obesity type <NUMBER> diabetes surgical prioritisation based diseasespecific consider ations patients type <NUMBER> diabetes suggest surgery prioritised patients increased risk morbidity mortality risk would indicated poor glycaemic control despite maximal medical therapy use insulin previous cardiovascular disease albuminuria chronic kidney disease nonalcoholic steatohepatitis multiple cardio metabolic comorbidities <NUMBER> insulin use meaningful prioritisation criterion correlates increased cardiovascular mortality <NUMBER> reduced quality life <NUMBER> moreover metabolic surgery reduces abolishes figure examples conditions warrant expedited access bariatric metabolic surgery ahaamerican heart association severity obesityassociated symptoms eg mobility issues joint pain consequence extremely high bmi regardless comorbidities must also considered establishing priorities equally important effect obesityrelated conditions increase morbidity mortality eg obesity hypo ventilation syndrome chronic kidney disease severe obstructive sleep apnoea <NUMBER> availability nonsurgical options slow disease progression ie pharmacological diabetes treatments achieving adequate glycaemic control reduces need prior itisation expedited access surgery also considered bariatric metabolic operations used adjuvant therapy enable timesensitive treatments made unfeasible unsafe excess weight poor metabolic control figure many candidates bariatric metabolic surgery high risk morbidity mortality comorbid conditions patients access surgical treatment prioritised basis diseasefocused clinical needs rather primarily bmi mitigate harm delaying surgery approach especially needed periods access surgery reduced current covid<NUMBER> pandemic societal crises often spur developments provide benefits long storm passes diseaseoriented medically meaningful strategies triage patients seeking metabolic surgery covid<NUMBER> crisis help prioritise patients urgent need long future fr conceived idea initiative fr rvc gm cwr jim dea jv dec reviewed relevant medical literature prepared first draft report ga saa rlb sb gc sdp jbd rhe dh bmm apan apat fp prs pzz provided additional input appraisal evidence manuscript preparation coauthors participated development recommendations reviewed approved report rapid narrative literature review personal view references effect viral infections including coronavirus disease <NUMBER> covid<NUMBER> diabetes obesity laparoscopic surgery searched pubmed articles english published jan <NUMBER> <NUMBER> april <NUMBER> <NUMBER> used combinations terms sars h<NUMBER>n<NUMBER> coronavirus covid<NUMBER> sarscov<NUMBER> diabetes obesity bmi laparoscopy endoscopy severe acute respiratory syndrome acute respiratory distress syndrome comorbidities also reviewed recent guidelines professional organisations public health agencies elective surgery covid<NUMBER> pandemic evidence benefits bariatric metabolic surgery predicting factors morbidity mortality type <NUMBER> diabetes obesity nonalcoholic fatty liver disease nonalcoholic steatohepatitis classification elective surgery reviewed recently published systematic reviews consensus statements major scientific societies relevant individual articles cited documents members expert panel selected basis previous participation diabetes surgery summit series relevant expertise additional experts also invited join group provide complementary expertise ensure global representation subgroup expert panel first appraisal evidence draft recommendations generated first draft report synthetising literature review response specific query entire expert group engaged online discussion appraise evidence refine final consensus recommendations temporal dynamics viral pathogens depend several factors including transmission properties virus survival immune response spatial distribution hosts eg may <NUMBER> anderson may <NUMBER> general viruses show low pathogenicity prolonged infectiousness likely exhibit relatively high constant prevalence anderson may <NUMBER>a therefore termedendemic contrast viruses spread rapidly shorter duration infectiousness cause higher host mortality immunity likely generate discrete epidemics anderson may <NUMBER>b epidemic diseases characterized rapid changes prevalence infection may disappear host population extended periods pathogens likely require high host densities invasion persistence extent outbreaks increase size susceptible host population may <NUMBER> onstad carruthers <NUMBER> anderson may <NUMBER> jaee et al <NUMBER> populationlevel impact viral infections depend eects host survival reproduction may <NUMBER> dobson mccallum <NUMBER> recent empirical theoretical studies shown virulence advantageous parasite necessarily sideeect novel host±parasite combinations eg allison <NUMBER> ewald <NUMBER> anderson may <NUMBER> herre <NUMBER> lenski may <NUMBER> levin <NUMBER> although transient impacts novel parasites immense studies addressed longterm eects disease wildlife populations grenfell gulland <NUMBER> wildlife diseases studied via incidental post mortems manipulative experiments natural populations often impossible dobson mccallum <NUMBER> viruses implicated cause several major declines carnivore populations young <NUMBER> example canine distemper virus cdv killed <NUMBER> last remaining colony freeliving blackfooted ferrets thorne williams <NUMBER> phocine distemper killed <NUMBER> <NUMBER> harbour seals northern europe osterhaus vedder <NUMBER> rabies suggested cause population decline wolves ethiopian wolves african wild dogs eg macdonald <NUMBER> kat et al <NUMBER> weiler garner ritter <NUMBER> sillero king macdonald <NUMBER> ballard krausman <NUMBER> laurenson et al <NUMBER> perhaps beststudied example canine distemper virus cdv outbreak struck serengeti lions several species late <NUMBER>±early <NUMBER> roelkeparker et al <NUMBER> also see alexander appel <NUMBER> alexander et al <NUMBER> cdv originated large population domestic dogs surrounding serengeti ecosystem killed <NUMBER> serengeti lions within <NUMBER> months <NUMBER> lions infected many victims showed neurological disorders encephalitis pneumonia outbreak followed wellde®ned onset many viral epidemics inferred solely crosssectional serological surveys eg olmsted et al <NUMBER> spencer morkel <NUMBER> creel et al <NUMBER> detailedlongterm investigations virus±carnivore interactions rare grenfell gulland <NUMBER> dobson mccallum <NUMBER> present study evaluate temporal changes exposure african lions six different viruses viruses show variety transmission modes symptoms durations infectiousness domestic carnivores table <NUMBER> example feline immunode®ciency virus fiv lentivirus closely associated hiv feline herpesvirus permanently infect hosts elicit lasting immunity table <NUMBER> contrast canine distemper virus cdv feline calicivirus feline coronavirus feline parvovirus generally cause temporary infection although small proportion infected hosts may persist asymptomatic carriers using serological data two different lion populations ®rst classify viruses either endemic epidemic estimate timing epidemic combining temporal pattern seroprevalence information lions ages time sampling examine relationship extent epidemic proportion density susceptible hosts population finally measure impact viral infection lion mortality birth rates lions studied continuously serengeti since march <NUMBER> ngorongoro crater since <NUMBER> packer tatar collins <NUMBER> animals individually recognized natural markings packer pusey <NUMBER> regularly observed since birth pusey packer <NUMBER> thus precise age known individual blood samples collected serengeti year <NUMBER> crater lions sampled <NUMBER> <NUMBER> <NUMBER> table <NUMBER> annual sample sizes samples originally collected genetic assay obrien et al <NUMBER> packer et al <NUMBER>ab investigate cdv outbreak <NUMBER> roelkeparker et al <NUMBER> serological assays later performed assess lions exposure fiv olmsted et al <NUMBER> brown et al <NUMBER> cdv roelkeparker et al <NUMBER> feline leukaemia herpes parvo coronaand calicivirus <NUMBER> lions also tested felv none showed detectable levels antigens table <NUMBER> summarizes precise assays criteria used determine serostatus remaining six viruses many animals tested repeatedly repeat samples included descriptive analysis excluded statistical tests unless animal seroconverted lions considered beimmatures <NUMBER> years age females start breeding well third birthday males attain breeding status <NUMBER> years old packer et al <NUMBER> packer et al <NUMBER> serengeti study area covers southeastern quarter serengeti national park <NUMBER> km <NUMBER> area consists two contrasting habitats acacia woodland opengrass plains see packer et al <NUMBER> lions plains live lower densities endure lower levels food availability woodlands counter parts ngorongoro crater located <NUMBER> km southeast serengeti study area crater lions enjoy higher consistent levels food availability serengeti lions hanby bygott packer <NUMBER> however crater small isolated population <NUMBER>±<NUMBER> animals associated loss genetic diversity compared much larger serengeti population obrien et al <NUMBER> packer et al <NUMBER>b includes estimated <NUMBER>±<NUMBER> animals schaller <NUMBER> hanby bygott <NUMBER> adult serostatus usually indicates prior exposure virus rather current infection since older animal may still carrying antibodies childhood disease see therefore seroprevalence young animals provides stronger evidence recent exposure younger cohorts seronegative virus probably absent several years assumptions ®rst use seroprevalence data determine whether virus wasendemic orepidemic <NUMBER>year period provide estimates timing speci®c outbreaks epidemic viruses based sudden changes frequency seropositive hosts consistent pattern chronic infection lion populations showed constant high levels seroprevalence fiv feline herpes virus rates fiv infection vary signi®cantly across years either adults immatures fig <NUMBER>a sex cf courchamp et al <NUMBER> combining data years small cubs quickly seroconverted fiv trend similar serengeti ngorongoro crater fig <NUMBER> two <NUMBER> animals serengeti ngorongoro positive herpes virus fig <NUMBER>b including eight cubs sampled ®rst birthday remaining four viruses appeared absent serengeti <NUMBER>±<NUMBER> years followed sudden resurgence frequency seropositive hosts fig <NUMBER> sporadic nature widespread infections conspicuous youngest age classes precise timing outbreak diered serengeti ngorongoro crater cdv seroprevalence varied years serengeti adults immatures fig <NUMBER>a sharp rise <NUMBER>±<NUMBER> cdv seroprevalence adults immatures due outbreak documented roelkeparker et al <NUMBER> whereas declining adult seroprevalence mid<NUMBER>s re¯ected earlier outbreak ngorongoro crater lions also appear infected <NUMBER> epidemics end sampling period <NUMBER> see fig <NUMBER> parvovirus annual seroprevalence adult lions varied somewhat serengeti seroprevalence immatures varied signi®cantly among years fig <NUMBER>b immatures showed highest frequency exposure <NUMBER> see hofmannlehmann et al <NUMBER> <NUMBER> none immatures ngorongoro crater tested positive parvovirus see coronavirus annual seroprevalence serengeti varied signi®cantly immatures fig <NUMBER>c ngorongoro crater evidence new infections <NUMBER> <NUMBER> sample size inadequate con®rm signi®cant variation years calicivirus seroprevalence varied across years serengeti varied dramatically immatures fig <NUMBER>d immatures showed highest seroprevalence <NUMBER> <NUMBER> calicivirus absent ngorongoro crater fourepidemic viruses showed¯uctuating prevalence study population often increasing discrete outbreaks timing outbreaks estimated seroprevalence data conjunction age study animal example serengeti lions sampled <NUMBER> october <NUMBER> animals born july <NUMBER> seropositive cdv fig <NUMBER>a every lion born <NUMBER> seronegative cdv <NUMBER> new epidemic swept population infecting lions ages fig <NUMBER>b pattern strongly suggests virus absent serengeti <NUMBER> end <NUMBER> data ngorongoro suggest cdv infected crater lions sometime <NUMBER> disappeared population following <NUMBER> years youngest seropositive animal born june <NUMBER> animal born later date infected end last sampling eort <NUMBER> fig <NUMBER>c similar heterogeneities ageprevalence data could discerned three viruses one example virus plotted fig <NUMBER> interpret marked discontinuities seroprevalence viruses indicate high rate infection similar cdv outbreak <NUMBER> fig <NUMBER>b support assumption almost putative outbreaks simultaneously infected multiple prides included cubs well adults exception outbreak calicivirus crater virtually every animal infected fiv <NUMBER>th birthday although lions serengeti plains show lower rate infection two habitats ± <NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> even controlling age multivariate analysis eect age <NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> eect serengeti plains ±<NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> <NUMBER> infected members single pride located along northern boundary serengeti study area approximate enddates outbreaks virus summarized table <NUMBER> except <NUMBER> cdv epidemic comparable data yet available dates presumed beginning prolonged intervals new seroconversions occurred besides extreme discontinuities exposure seroprevalence data also suggest several earlier outbreaks astairstep pattern example fig <NUMBER>a shows virtually animals born <NUMBER> <NUMBER> seropositive cdv <NUMBER>±<NUMBER> sampling period whereas animals born <NUMBER>±<NUMBER> showed consistently lower prevalence pattern may easily explained two epidemics ended <NUMBER> <NUMBER> similar pattern evident calicivirus separate epidemics resulted higher seroprevalence animals born <NUMBER>±<NUMBER> born <NUMBER>±<NUMBER> fig <NUMBER>c viruses occur discrete epidemics antibody titres seroprevalence decline years following outbreak strength individuals immune response weakens time however resampled enough individuals test prediction directly two viruses fifteen parvo animals resampled <NUMBER> <NUMBER> parvovirus outbreaks titre levels declined signi®cantly n <NUMBER> animals whose titre levels changed <NUMBER> p <NUMBER>´<NUMBER> signedranks test two seropositive animals became seronegative <NUMBER>´<NUMBER> <NUMBER>´<NUMBER> years respectively two cdv animals resampled <NUMBER>s showed decline antibody titres <NUMBER> <NUMBER> including animals old enough exposed virus seroprevalence consistently declined presumed end fig <NUMBER> annual seroprevalence serengeti cdv parvovirus coronavirus calicivirus note statistical analyses include years sucient sample size n r <NUMBER> perform chisquare tests cdv seroprevalence adults varied signi®cantly across years w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> varied even younger lions w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> b parvovirus seroprevalence adults varied nonsigni®cantly across years w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> varied signi®cantly younger animals w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> c coronavirus seroprevalence adults vary across years w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> varied signi®cantly younger lions w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> calicivirus seroprevalence adults varied across years w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> varied younger animals w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> epidemic fig <NUMBER> responses three viruses cdv caliciand parvovirus declined remarkably similar rate coronavirus response declined rapidly predicted individual titre levels also declined time cdv ±<NUMBER>´<NUMBER> n <NUMBER> seropositive animals p <NUMBER>´<NUMBER> r <NUMBER> <NUMBER>´<NUMBER> parvovirus ±<NUMBER>´<NUMBER> n <NUMBER> seropositives p <NUMBER>´<NUMBER> r <NUMBER> <NUMBER>´<NUMBER> although coronavirus ±<NUMBER>´<NUMBER> n <NUMBER> p <NUMBER>´<NUMBER> batch eects calicivirus assays elisa values could tested note titre levels also declined animals age end epidemic cdv p <NUMBER>´<NUMBER> parvovirus p <NUMBER>´<NUMBER> drop time epidemic remained highly signi®cant multiple regression model controlled age p <NUMBER>´<NUMBER> eect age also signi®cant p <NUMBER>´<NUMBER> epidemics frequent extensive large host populations indication viral outbreaks varied according overall host population size figure <NUMBER> shows size study populations serengeti ngorongoro crater past <NUMBER> years well approximate timing outbreaks listed table <NUMBER> serengeti coronaand parvovirus typically occurred years high population density study areas include three contrasting habitats associated dierences lion density calicivirus absent small isolated crater population prevalence coronavirus outbreak lower w <NUMBER> <NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> n <NUMBER> lowdensity serengeti plains prides small pride ranges <NUMBER>±<NUMBER> km <NUMBER> adjacent woodlands prides large pride ranges <NUMBER>±<NUMBER> km <NUMBER> ageprevalence fiv also lowest plains fig <NUMBER> pattern similar domestic cats fiv prevalence lower lowdensity areas malik et al <NUMBER> although total host density associated changes disease prevalence cases epidemiological theory speci®es susceptible subset hosts regulate invasion rate spread viral infection following sections therefore estimated size susceptible population virus time use estimates evaluate association susceptible host density viral outbreaks serological survey included small subset study populations sample size varied year year table <NUMBER> provide rough estimates overall number susceptibles base estimates following simplifying assumptions every animal population exposed virus outbreak ii survivors outbreak gained immunity persisted remaining lifespans thus iii animals born recent outbreak weresusceptible viral infection assumptions clearly underestimate size susceptible population ®rst unlikely <NUMBER> population exposed virus outbreak secondly proportion seropositive animals may lose immunity time implied fig <NUMBER> however absence complete information procedure least provides standardized estimate minimum number susceptibles population total number ofnew susceptibles ie individuals born epidemic yet exposed virus presented fig <NUMBER> note analysis restricted serengeti since estimates require least two outbreaks virus parvovirus calicivirus successive outbreaks occurred shortly population crossed apparent threshold number new susceptibles parvovirus outbreaks occurred number new susceptibles reached <NUMBER> animals whereas calicivirus outbreaks required least <NUMBER> new susceptibles contrast consistent patterns cdv <NUMBER> outbreak coinciding <NUMBER> new susceptibles vs <NUMBER> susceptibles late <NUMBER> coronavirus approximately <NUMBER> susceptibles <NUMBER> vs approximately <NUMBER> <NUMBER> case cdv important note lions measured isolation cdv infected large numbers serengeti canids late <NUMBER>s early <NUMBER>s true number susceptibles ecosystem also include host species table <NUMBER> dates viral epidemics presumed endedpattern distinguishes two situationspresence absence indicates consecutive cohorts seronegative whereas older cohorts largely seropositive andstairstep designates consecutive cohorts moderately seropositive older cohorts showed even higher seroprevalencesigni®cance refers dierence seroprevalence cohorts born within <NUMBER> years prior endpoint vs born ®rst <NUMBER> years thereafter tested w <NUMBER> <NUMBER> df <NUMBER> parvovirus <NUMBER> <NUMBER> coronavirus epidemics showed qualitative pattern statistically robust outbreaks therefore included subsequent analyses however <NUMBER> calicivirus outbreak omitted consideration small proportion atrisk individuals became seropositive three animals lived pride edge study area presenceabsence p <NUMBER>´<NUMBER> n <NUMBER> fig <NUMBER> seroprevalence plotted function number years elapsed presumed end epidemic data restricted animals alive putative outbreak thus could exposed virus decline seroprevalence time statistically signi®cant four viruses cdv ±<NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> n <NUMBER> logistic regression parvovirus ±<NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> n <NUMBER> coronavirus ±<NUMBER>´<NUMBER> <NUMBER> <NUMBER>´<NUMBER> n <NUMBER> calicivirus ±<NUMBER>´<NUMBER> p <NUMBER>´<NUMBER> n <NUMBER> remain signi®cant age eects included multivariate logisticregression analysis estimate proportion susceptibles became infected outbreak recalculated annual seroprevalence serengti lions analysis assumed seronegative animals never infected birth time sampled assumed seropositive animals seropositive year following recent outbreak particular virus made assumptions serostatus prior recent outbreak way age serostatus sampled lions used estimate seroprevalence year sampled also previous years thus reducing random variance produced small sample sizes estimates presented fig <NUMBER> broadly similar raw data presented fig <NUMBER> however estimates interpolate data years <NUMBER>±<NUMBER> samples collected extrapolate backwards years serological samples collected important fig <NUMBER> provides approximation magnitude outbreak example <NUMBER>±<NUMBER> cdv outbreak struck population entirely seronegative <NUMBER> population seroconverted course epidemic contrast <NUMBER> calicivirus epidemic struck nearly <NUMBER> population seropositive calicivirus seroprevalence increased <NUMBER> used data estimate extent outbreak de®neincidence proportion susceptibles became seropositive time course single outbreak thus increase seroprevalence <NUMBER> <NUMBER> indicates reduction susceptibles <NUMBER> <NUMBER> anincidence <NUMBER>´<NUMBER>´<NUMBER> <NUMBER>´<NUMBER> increase seroprevalence <NUMBER> <NUMBER> would give anincidence <NUMBER>´<NUMBER>´<NUMBER> <NUMBER>´<NUMBER> using data four viruses fig <NUMBER> shows epidemics highestincidence associated highest initial proportion susceptibles trend verges statistical signi®cance restricted wellde®ned epidemics listed table <NUMBER> arcsinetransformed linear regression ±<NUMBER>´<NUMBER> r <NUMBER> <NUMBER>´<NUMBER> n <NUMBER> p <NUMBER>´<NUMBER> relationship becomes highly signi®cant include <NUMBER> calicivirus table <NUMBER> horizontal lines show span samples collected outbreak spread beyond single pride ±<NUMBER>´<NUMBER> r <NUMBER> <NUMBER>´<NUMBER> n <NUMBER> p <NUMBER>´<NUMBER> although overall trend fig <NUMBER> quite striking data based rough approximations <NUMBER>±<NUMBER> outbreaks per virus within virus calicivirus shows trend direction overall pattern paired outbreaks parvovirus coronavirus show slight trends opposite direction overall pattern perhaps noteworthy two points pair similar suggests epidemics parvovirus coronavirus spread typical magnitude strike typical level seroprevalence noteworthy possibility parvovirus may consistently infect higher proportion susceptibles coronavirus perhaps due longer persistence outside host weeks parvovirus vs hours coronavirus provide limited data precise cause mortality animals lions simply disappear study area observed fatalities result direct combat lions injuries sustained prey capture packer et al <NUMBER> clearcut examples death due disease occurred cdv outbreak <NUMBER> roelkeparker et al <NUMBER> following section rely demographic analysis determine whether viruses associated widespread mortality infertility assessments depend whether virus endemic epidemic two lions tested negative herpesvirus lack control group compare infected animals therefore unable measure eects herpes infection host ®tness although virtually every lion fiv age <NUMBER> years fig <NUMBER> <NUMBER> <NUMBER>±<NUMBER>yearolds fiv± thus restrict analysis longterm survival young animals domestic cats fiv infection permanent in¯icts mortality <NUMBER>±<NUMBER> years initial infection see fig <NUMBER> estimated number ofnew susceptibles virus year serengetinew susceptibles include animals born subsequent outbreak remain susceptible next successive outbreak whereupon cubs contribute next set new susceptibles table <NUMBER> fiv similarly harmful lions would expect fiv lions suer shorter life expectancy fiv± lions comparable age note though fiv± animals presumably contracted virus fourth birthday analysis therefore contrasts survival animals infected early life vs would infected later age figure <NUMBER> shows annual agespeci®c mortality lions according fiv status yearlings top <NUMBER>yearolds bottom data plotted separately males females contrasting life histories subadults packer et al <NUMBER> fiv measurably increase mortality either short term fiv± animals presumably still uninfected long term overall seven fiv animals survived <NUMBER> years although data limited detect subtle eects mortality seen clinical signs immune de®ciency except cdv outbreak <NUMBER> cdv immunosuppressive association clinical pathology fiv status cdv victims roelkeparker et al <NUMBER> found evidence coinfection viruses in¯uenced longevity fiv individuals statistical tests nonsigni®cant entire adult population fiv cannot assess eects viral infection fecundity fig <NUMBER> estimated annual seroprevalence virus serengeti seronegatives assumed seronegative entire lives seropositives assumed exposed virus recent outbreak assumptions made earlier serostatus fig <NUMBER> theincidence serengeti outbreak plotted function estimated seroprevalence onset epidemic incidence de®ned text <NUMBER> calicivirusoutbreak plotted parentheses since spread beyond single pride sporadic appearance epidemic virus enabled us test whether epidemics coincided overall reductions lion mortality fecundity analysis examine survival reproduction individuals could susceptible virus onset epidemic outbreaks virus occurred <NUMBER>±<NUMBER>year intervals table <NUMBER> therefore restricted analysis annual mortality lions <NUMBER> years old since cohorts consisted entirely ofsusceptibles onset outbreak cub mortality particular interest since diseaseinduced mortality restricted kittens domestic cats table <NUMBER> survival rates young lions depended age and¯uctuated year year fig <NUMBER> consistent pattern associated particular virus example cub survival signi®cantly reduced calicivirus outbreak <NUMBER> w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> although cub survival also belowaverage calicivirus outbreak <NUMBER> cubs enjoyed higher survival average <NUMBER> calicivirus epidemic <NUMBER> cdv outbreak in¯icted lower survival every agegroup signi®cant declines yearlings w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> <NUMBER>yearolds w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> however neither <NUMBER> cdv outbreak serengeti <NUMBER> outbreak ngorongoro appreciable impact lion survival although two serengeti lions developed myoclonus <NUMBER> without clear signs illness cannot rule possibility spurious association single disease outbreak year low survival however cdv outbreak <NUMBER> welldocumented included clearly observed cases seizures myoclonus roelkeparker et al <NUMBER> suggests high survival rates earlier outbreaks cdv may due nonpathogenic strains virus possible estimate extent earlier cdv epidemics least noteworthy cdv <NUMBER> extensive documented outbreak struck largest population susceptibles fig <NUMBER> agespeci®c mortality rates females b males according fiv status sampled ages <NUMBER>±<NUMBER> years top <NUMBER>±<NUMBER> years bottom sample sizes fiv animals given normal type fiv± animals italics signi®cant eect fiv status mortality rates either sex either ageclass combined data set unfortunately unable collect blood samples ngorongoro crater since <NUMBER> cannot test whether recent decline population see fig <NUMBER> associated viral outbreak domestic dog cdv found crater rim october <NUMBER> cleaveland <NUMBER> several ngorongoro crater lions conspicuously ill time none showed neurological symptoms cdv measuredfecundity proportion females gave birth particular year high adult seroprevalence viruses adult females could beensusceptible virus interval outbreaks suciently long analysis therefore restricted seven widelyspaced outbreaks serengeti includes young hence susceptible females agerelated changes fecundity packer et al <NUMBER> well mediumterm ecological variations compare reproductive performance <NUMBER>±<NUMBER>yearold females ®rst <NUMBER> years andor outbreak mortality analysis none four viruses consistently in¯icted signi®cant loss fecundity although seems recurring eect cdv fig <NUMBER> possible strain dierences fecundity slightly lowered <NUMBER> parvovirus calicivirus outbreaks high annual variation around <NUMBER> calicivirus <NUMBER> coronavirus epidemics dicult interpret presumably re¯ects ecological factors annual variations prey availability population density social disruption see packer et al <NUMBER> temporal variation seroprevalence indicates fiv herpesvirus endemic lion populations show consistently high prevalence figs <NUMBER> <NUMBER> appear relatively harmless although dicult compare ®tness infected uninfected hosts domestic cats fiv follows similar aetiology hiv humans pedersen et al <NUMBER> yamamoto et al <NUMBER> torten et al <NUMBER> like hiv humans fiv appears infected domestic cats recently rigby et al <NUMBER> carpenter obrien <NUMBER> could ®nd evidence fiv status in¯uenced lion mortality fig <NUMBER> observe obvious signs immunode®ciency clinical pathology fiv individuals see poli et al <NUMBER> phylogenetic analysis fiv sequences study animals suggests lions hosts virus long periods time brown et al <NUMBER> attenuated eect fiv infection may arisen variety coevolutionary mechanisms reviewed carpenter obrien <NUMBER> alternatively studies domestic cats suggest fiv may pathogenic individuals coinfected felv courchamp et al <NUMBER> thus low impact fiv lions may coinfected felv remaining four viruses showed high temporal variation seroprevalence indicative epidemic outbreaks disease figs <NUMBER> <NUMBER> outbreaks typically occurred large number susceptibles recruited population fig <NUMBER> extent outbreak apparently depended size susceptible host population figs <NUMBER> <NUMBER> previous studies documented existence threshold host densities establishment pathogens natural populations jaee et al <NUMBER> dobson hudson <NUMBER> dobson meagher <NUMBER> lions calicivirus parvovirus extent coronavirus showed evidence viral invasion required threshold density susceptible hosts fig <NUMBER> minimum estimates susceptible host density varied among viruses ranged <NUMBER> <NUMBER> animals serengeti study area includes <NUMBER> overall serengeti lion population viruses associated higher initial rates spread estimated measure incidence also required highest threshold densities seronegative hosts example calicivirus coronavirus outbreaks occurred susceptible host densities relatively low associated smaller increases seroprevalence contrast parvovirus required larger number susceptibles infected larger proportion susceptibles outbreaks cdv exception rule pattern cdv infected numerous carnivore species late <NUMBER>s well <NUMBER> reviewed roelkeparker et al <NUMBER> cleaveland <NUMBER> thesusceptible population <NUMBER> lions <NUMBER> <NUMBER> lions <NUMBER> actually included uncounted numbers susceptible canids hyenas large felids however lion population large also <NUMBER> susceptible <NUMBER> cdv epidemic <NUMBER> lions infected within months none epidemic viruses consistently lowered host ®tness <NUMBER> cdv outbreak conspicuously harmful emphasized sharp decline fig <NUMBER> annual female fecundity associated epidemics numbers indicate sample sizes arrows indicate years epidemics occurred years prior outbreak data include adult females yet exposed virus year outbreak data include adult females exposed virus ®rst time year following years data include adult females exposed ®rst time outbreak including females exposed subadults analysis includes datapoints based least ®ve females annual fecundity varied signi®cantly years around <NUMBER> coronavirus outbreak w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> <NUMBER> calicivirus outbreak w <NUMBER> <NUMBER>´<NUMBER> df <NUMBER> p <NUMBER>´<NUMBER> serengeti population see fig <NUMBER> <NUMBER> calicivirus epidemic may in¯icted considerable cub mortality outbreaks viruses appeared essentially harmless indeed none viruses regularly in¯icted degree mortality observed domestic cats table <NUMBER> sequence data available <NUMBER> cdv strain roelkeparker et al <NUMBER> cannot make similar assessments coevolutionary history fiv comment genetic dierences strains virus however strain dierences pathogenicity well documented morbiliviruses besides cdv eg rinderpest plowright <NUMBER> also possible viruses harmful extent demographic analysis coarsegrained detect eects timing outbreak estimated retrospectively could control confounding interactions ecological variables lions doubt coinfected additional pathogens parasites ®eld analysis could ever provide sort comparisons would available controlled experiments dobson mccallum <NUMBER> dobson mccallum <NUMBER> jaenike <NUMBER> shown host populations limited pathogens in¯ict moderate eects host mortality moderate large eects fertility viruses included study cdv appears suciently virulent cause measurable declines serengetingorongoro lion populations cdv caused considerable mortality <NUMBER> may lowered host fertility <NUMBER> <NUMBER> outbreaks however cdv entered lion population discrete widelyspaced epidemics epidemics suciently infrequent in¯ict lasting consequences serengeti population recovered rapidly <NUMBER> epidemic regaining former size middle <NUMBER> fig <NUMBER> domestic dogs primary reservoir cdv serengetingorongoro region cleaveland <NUMBER> dog population grown dramatically growing human population past <NUMBER> years raising prospects frequent extensive virulent cdv epidemics lions wild carnivores attempts inoculate reservoir cdv currently underway kaare cleaveland <NUMBER> recent pandemic coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused unprecedented morbidity mortality almost continents <NUMBER> despite implementations extensive control measures spread disease eventual fatality could effectively halted till date major cause death covid<NUMBER> due virusinduced pneumonia leading respiratory failure <NUMBER> epidemiological evidence suggests older age associated comorbidities cardiovascular disease diabetes put patients higher risk mortality <NUMBER> thus identification novel risk factors predictive patients outcome including mortality needed using publicly available clinical data kaggle employed machine learning tool identify risk factors could potentially contribute mortality covid<NUMBER> patients <NUMBER> countries <NUMBER> continents show older age delayed hospitalisation symptomatic patients two major risk factors mortality covid<NUMBER> patients dataset downloaded kaggle httpswwwkagglecomsudalairajkumarnovelcoronavirus<NUMBER>datasetcovid<NUMBER>linelistdatacsv <NUMBER> rd march <NUMBER> contained total <NUMBER> reported cases covid<NUMBER> <NUMBER> th january <NUMBER> th february <NUMBER> missing values removed variables obtain dataset <NUMBER> individuals <NUMBER> cases filtered dataset date hospital visit preceded date symptom onset among <NUMBER> cases selected finally <NUMBER> countries asia australia europe rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity north america cases <NUMBER> deaths <NUMBER> recoveries descriptive statistics deaths confirmed recovered cases depicted table <NUMBER> random forest classification algorithm <NUMBER> implemented dataset <NUMBER> deaths <NUMBER> recoveries using randomforest package r dataset randomly split training test dataset containing <NUMBER> <NUMBER> total samples respectively evaluate model performance area roc curve calculated test dataset variable importance plot generated using importance predictors outcome importance variables reported according mean decrease gini mean decrease accuracy partial dependency plots finally generated using pdp package r determine marginal effect age time hospitalization fate covid<NUMBER> infection descriptive summary data represented mean standard deviation sd numerical variables compared groups independentsamples twosided students ttest categorical variables tested using chisquare test statistical analyses performed rstudio version <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint auroc curve validation test dataset auroc test dataset found <NUMBER> age important variable model predicting fate interestingly followed time gap onset symptoms hospitalization importance variables terms mean decrease accuracy mean decrease gini graphically shown figure <NUMBER> b order inspect marginal effect predictors mortality patients covid<NUMBER> generated partial dependency plots odds death among covid<NUMBER> patients age days onset symptoms hospitalisation shown figure <NUMBER> c accentuation odds death found age beyond <NUMBER> years well beyond time gap <NUMBER> days onset symptoms hospitalisation taken together analysis identifies older age <NUMBER> years delayed hospitalisation two important predictors mortality among patients covid<NUMBER> mortality critically ill patients covid<NUMBER> high comorbidities including hypertension diabetes coronary artery disease often present hospitalised patients though <NUMBER> nonsurvivors comorbid disease multivariate analyses independent associations inhospital death found present older age high sequential organ failure assessment sofa score elevated ddimer levels <NUMBER> another study also identified older patients high risk group mortality <NUMBER> agreement previously published studies analysis also identified age important risk factor mortality among covid<NUMBER> patients however role delayed hospitalisation following development symptoms another significant risk factor mortality among covid<NUMBER> patients age reported first time inadequacy healthcare resources already reported associate increased mortality among covid<NUMBER> patients <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted march <NUMBER> <NUMBER> data represented means ± sd pvalue <NUMBER> considered statistically significant outbreak novel coronavirus severe acute respiratory syndrome coronavirus sarscov<NUMBER> first reported wuhan china contributed increased morbidity mortality declared major worldwide pandemic world health organization <NUMBER> since recent advances understanding pathological progression transmission coronavirus disease contributed efforts toward development pharmacological nonpharmacological strategies although coronaviruses covs initially contemplated cause multifaceted diseases mammals birds origin bats <NUMBER> evolution virus resulted increased pathogenicity humans covs general deemed important veterinary responses however since outbreak human coronavirus hcov causing severe acute respiratory syndrome sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> recent outbreak sarscov<NUMBER> labeled emerging pathogen humans given high pathogenicity humans extent global impact caused hcov outbreaks past two decades topic great interest hence mechanistic action virus thoroughly investigated researchers causative agent current pandemic presenting viral pneumonia sarscov<NUMBER> group large enveloped rna viruses coronaviridae family classified specifically nidovirales order <NUMBER> cumulative line evidence demonstrates sarscov<NUMBER> shares <NUMBER> sequence identity sarscov outbreak <NUMBER> genomic level genomic sequence almost <NUMBER> identical bat coronavirus <NUMBER> provides significant insight understanding covid<NUMBER> origin understanding origin evolution sarscov<NUMBER> imminent clinical manifestation virus humans increasing number symptomatic asymptomatic carriers every day presents growing concern public health aggressive growth numbers emerging cases suggests rapid spread virus naïve population improvement diagnostic capability covid<NUMBER> outbreak however increasing evidence epidemiological disparity disease burden urban rural areas <NUMBER> <NUMBER> <NUMBER> differences urban rural areas highly determine influence viral pandemic terms viral transmission diagnostics morbidity mortality <NUMBER> differences mainly arise socioeconomic factors access healthcare pandemic preparedness given higher percentage us rural population old age ≥ <NUMBER> individuals obesity body mass index bmi ≥ <NUMBER> associated comorbidities along smoking status factors puts higher risk infection severe complications arising covid<NUMBER> hence review aims provide insight modality transmission dynamics sarscov<NUMBER> clinical characteristics persistent virus discuss efforts toward development pharmacological nonpharmacological strategies combat progression humans review also aims assess challenges covid<NUMBER> pandemic rural settings based past pandemic experiences overall effect rural population methodology study followed principles literature review study conducted based literature identification collection literature analysis literature categorization databases research included academic search premier pubmed proquest science direct google scholar extensive search performed various governmental websites including world health organization centers disease control prevention cdc keywords used search included following coronavirus pandemic pathogenesis sarscov<NUMBER> covid<NUMBER> human transmission pharmacological nonpharmacological clinical characteristics us rural healthcare articles retrieved search distinguished relevancy research articles chosen reviewed government guidelines mitigation strategies persisting symptoms covid<NUMBER> morbidity mortality us rural healthcare inclusion exclusion criteria set evaluate articles data published <NUMBER> <NUMBER> order limit search furthermore search restricted articles available full text published english language relevancy information deemed important also included articles published outside us total <NUMBER> articles assessed three reviewers relevancy <NUMBER> references citations utilized articles reviewed based abstracts find relevancy study conclusively findings presented subheadings pathogenesis covid<NUMBER> transmission dynamics covid<NUMBER> clinical characteristics persistent covid<NUMBER> pharmacological nonpharmacological intervention finally challenges rural population covs normally cause enteric diseases several animal species affect respiratory tract mammals including humans lead mildtosevere respiratory tract infections <NUMBER> studies report five major protein regions hcovs replicase complex spike envelope membrane nucleocapsid proteins function viral structure assembly replications <NUMBER> overlapping open reading frames orfs replicase complex orf<NUMBER>a orf<NUMBER>b encode <NUMBER> nonstructural proteins nsp viral rna synthesis complex proteolytic processing <NUMBER> nsp<NUMBER> viral rnadependent rna polymerase together cofactors nsp<NUMBER> nsp<NUMBER> possessing high polymerase activity recent study showed <NUMBER> similarity amino acid sequences seven conserved replicase domains orf<NUMBER>ab sarscov sarscov<NUMBER> <NUMBER> spike transmembrane glycoprotein comprises two domains s<NUMBER> s<NUMBER> play pivotal role mediating viral infection binding host receptor <NUMBER> <NUMBER> interaction s<NUMBER> domain cognate receptor triggers conformational change protein promotes membrane fusion viral cell membrane s<NUMBER> domain <NUMBER> three short insertions nterminal domain well changes four five key residues receptorbinding motif compared sequence sarscov key differences recently found scientists gene sarscov<NUMBER> <NUMBER> major host cell receptors utilized hcovs aminopeptidase n hcov<NUMBER>e <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> sarscov <NUMBER> hcovnl<NUMBER> <NUMBER> <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> merscov <NUMBER> <NUMBER>oacetylated sialic acid hcovoc<NUMBER> hcovhku<NUMBER> <NUMBER> <NUMBER> recent study showed covid<NUMBER> able utilize membranebound ace<NUMBER> entry receptor ace<NUMBER>expressing cells higher affinity sarscov use coronavirus receptors <NUMBER> <NUMBER> ace<NUMBER> highly expressed mouth tongue facilitating viral entry host lungs expressed lower lungs type ii alveolar epithelial cells infection sarscov<NUMBER> entry starts binding spike glycoprotein expressed viral envelope ace<NUMBER> alveolar surface binding sarscov<NUMBER> ace<NUMBER> stimulates clathrindependent endocytosis whole sarscov<NUMBER> ace<NUMBER> complex inducing fusion cell membrane <NUMBER> membrane fusion endosomal cell entry facilitated low ph cellular environment phdependent endosomal cysteine protease cathepsins <NUMBER> inside cells sarscov<NUMBER> exploits endogenous transcriptional machinery alveolar cells replicate spreads entire lung <NUMBER> nucleocapsid helps packaging viral genome protein oligomerization infection progresses deleteriously affects normal activity ciliated cells alveoli clear airways consequent progressive accumulation debris fluids lungs eventually leads acute respiratory distress syndrome ards addition alveolar cells lungs ace<NUMBER> expression reported organs including kidney heart gut <NUMBER> supports commonly reported comorbidities covid<NUMBER> acute kidney injury aki cardiac damage abdominal pain first cases covid<NUMBER> linked direct exposure huanan seafood wholesale market wuhan china animaltohuman transmission initially presumed <NUMBER> <NUMBER> however subsequent cases revealed scope humantohuman transmission individuals incubation stage showing symptoms widespread information available recent increase understanding sarscov<NUMBER> virus appears incubation time ranging <NUMBER> <NUMBER> days <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent report suggested symptomatic patients higher viral loads detected nose throat following onset symptoms <NUMBER> viral loads peaked around <NUMBER> days following symptoms onset <NUMBER> consequently asymptomatic patients viral load similar symptomatic patients <NUMBER> hence humantohuman transmission symptomatic asymptomatic carriers caused epidemic gradually grow weeks eventually becoming global pandemic humantohuman transmission mainly inhalation respiratory droplets coughing sneezing contact infected surfaces mediating infection mouth nose eyes <NUMBER> transmission via inhalation exhaled respiratory droplets may occur aerosol droplets survive prolonged periods mediating longrange humantohuman transmission via air movement inhalation virusladen fine particles could transport virus deeper alveolar tracheobronchial regions could increase chance infective transmission oxidant pollutants air impair immune function attenuate efficiency lung clear virus lungs proinflammation injury fibrosis inhaled airborne particulate matters combined immune response cytokine storm induced sarscov<NUMBER> infection could enhance infection severity <NUMBER> since humantohuman transmission primary mode transmission virus international public health response toward mitigating covid<NUMBER> largely based socialphysical distancing isolation cases quarantine measures <NUMBER> studies also shown infectious viruses including covs survive long periods outside host organism increasing opportunity transmission via touch <NUMBER> reported sarscov<NUMBER> last three days plastic stainless steel surfaces one day cardboard surfaces four hours copper surfaces <NUMBER> <NUMBER> despite evidences thought main way virus spreads cdc apart covs previously reported remain infectious water sewage days weeks <NUMBER> adds another potential transmission route quality personal hygiene poor however mode transmission covid<NUMBER> contaminated water enough scientific evidence hence requires studies validate among earlier studies covid<NUMBER> reported mean serial interval <NUMBER> days defined delay disease onset dates successive cases chains transmission <NUMBER> using data serial interval distribution basic reproductive number estimated <NUMBER> <NUMBER> identification characteristics important study extensively inferred doubling covid<NUMBER> every seven days since patient transmitted infection additional <NUMBER> individuals similarly modeling studies estimated basic case reproduction rate ranging <NUMBER> <NUMBER> published early estimation ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> may present range symptoms humans varying mild coldlike symptoms severe lifethreatening respiratory tract infections infection begins gradual onset symptoms following incubation period <NUMBER> days exposure <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> basis disease severity clinical manifestations categorized mild <NUMBER> severe <NUMBER> critical <NUMBER> noted covid<NUMBER> positive patients <NUMBER> initial infectious stage characterized mild constitutional symptoms upper respiratory tract infection <NUMBER> frequently experienced symptoms include fever dry cough sore throat sputum production fatigue shortness breath headache <NUMBER> followed vague symptoms nasal congestion rhinorrhea sneezing malaise muscle pain drowsiness myalgia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> number cases increasing worldwide symptoms also reported ever evolving differ depending population studies however question whether symptoms directly correlated covid<NUMBER> manifestation remains elusive requires scientific clinical evidence following antecedent <NUMBER> days primary viral manifestations initially mild symptoms manifest progressively advanced disease accompanied pneumonia ards ominous feature infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> secondary manifestations could present rnaemia continuum ards chronic dyspnea tachypnea hypoxia diarrhea abdominal pain metabolic acidosis coagulation dysfunction <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover critical cases virus also trigger severe complications sepsis septic shock multiple organ dysfunction acute cardiac renal injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> complications also linked high levels proinflammatory cytokines <NUMBER> <NUMBER> hematological changes including leukopenia <NUMBER> lymphopenia <NUMBER> thrombocytopenia <NUMBER> <NUMBER> critical cases secondary infections may also present coinfections bacteria fungi <NUMBER> addition overt symptoms growing concern asymptomatic cases <NUMBER> immunocompetent viral carriers present asymptomatic infections manifesting symptoms unanimously pose imminent danger may grave outcomes recent studies signified emergence asymptomatic mildly symptomatic infections potential portal viral transmission needs vigilant control detect mitigate communityacquired infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> individuals viral tolerance present potential challenge annihilation infection especially rural america inadequate health care infrastructure high rates chronic clinical issues <NUMBER> consistent recent studies majority critically ill covid<NUMBER> patients known underlying chronic medical conditions cardiovascular disease diabetes chronic respiratory disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical conditions also significant health issue rural population therefore patients vulnerable developing severe covid<NUMBER> symptoms <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> specific antiviral drugs vaccine recommended specifically sarscov<NUMBER> infection potential therapy humans till date scientists endeavoring find drugs treat disease currently treatment symptomatic oxygen therapy considered major treatment intervention patients severe infection <NUMBER> pharmacological interventions prevent mild state progressing severe critical state significantly improve overall prognosis disease order reduce disease worsening mortality rate developing effective approach modulate immune system suppress reactive cytokine production crucial importance studies currently testing efficacy existing broadspectrum antiviral drugs inhibiting sarscov<NUMBER> replication major drugs exhibited promising inhibitory effects remdesivir chloroquine remdesivir adenosine analogue cause premature termination viral replication recently recognized promising antiviral drug wide array rna virus including sarsmerscov<NUMBER> infections various experimental models <NUMBER> <NUMBER> reports show remdesivir inhibit covid<NUMBER> infection efficiently human cell line human liver cancer huh<NUMBER> cells sensitive covid<NUMBER> <NUMBER> recent studies also reported remdesivir yielded promising results treatment patient covid<NUMBER> us <NUMBER> studies currently progress evaluate efficacy safety drug chloroquine antimalarial drug known exert potent antiviral effect virtue ability increase endosomal ph required viruscell fusion interfere glycosylation cellular receptors sarscov <NUMBER> study demonstrated chloroquine could function entry postentry stages covid<NUMBER> infection vero e<NUMBER> cells immunemodulating activity may synergistically enhance antiviral effect vivo <NUMBER> hydroxychloroquine antirheumatic drug similar chemical structure chloroquine exhibits strong immunomodulatory capacity prevents inflammation flareups organ damage <NUMBER> also increase intracellular ph interrupt tolllike receptor tlr signaling subsequent attenuation proinflammatory signaling activation production cytokines type interferons interleukin<NUMBER> il<NUMBER> tumor necrosis factorα tnfα <NUMBER> severe covid<NUMBER> due overactivation immune system triggered covid<NUMBER> infection hydroxychloroquine suggested attenuate progression disease mild severe ifnα broadspectrum antiviral used treat hepatitis reported inhibit sarscov reproduction vitro <NUMBER> lopinavirritonavir medication used treat human immunodeficiency virus hiv also found exhibit antisarscov activity vitro clinical studies <NUMBER> ribavirin nucleoside analogue broadspectrum antiviral effects exhibited lower risk ards death used combination lopinavirritonavir <NUMBER> favipiravir new type rnadependent rna polymerase inhibitor reported possess antiinfluenza virus activity capable blocking replication flavi alpha filo bunya arena noro rna viruses <NUMBER> clinical trials favipiravir covid<NUMBER> infection initiated clinical medical research center national infectious diseases third peoples hospital shenzhen potential drugs include type ii transmembrane serine protease tmspss<NUMBER> inhibitors bcrabl kinase inhibitor imatinib ability drugs block entry inhibit fusion virions endosomal membrane may provide anticoronal activity <NUMBER> <NUMBER> discussed earlier light recently published reports <NUMBER>ncov utilize ace<NUMBER> entry receptor ace<NUMBER>expressing cells higher affinity sarscov suggesting potential drug targets therapeutic development <NUMBER> ace<NUMBER> also plays important role reninangiotensin system ras imbalance aceang iiat<NUMBER>r pathway ace<NUMBER>ang <NUMBER>mas receptor pathway ras lead multisystem inflammation studies shown ras inhibitors could effectively relieve symptoms acute severe pneumonia respiratory failure <NUMBER> one previously published articles highlights possible interactions cytochrome p<NUMBER> cypderived arachidonic acid metabolite <NUMBER>hydroxyeicosatetraenoic acid <NUMBER>hete ras <NUMBER> findings showed <NUMBER>heteinduced hypertension cyp<NUMBER>a<NUMBER>transduced rats associated ras upregulation abrogated ace inhibition angiotensin type <NUMBER> receptor at<NUMBER>r blockade study evaluates effect lisinopril losartan <NUMBER>hede <NUMBER>hete antagonist <NUMBER>hydroxyeicosa<NUMBER>z <NUMBER>zdienoic acid het<NUMBER> inhibitor <NUMBER>hete modulating ras ace various downstream signaling molecules involved pathway hence findings also provide valuable lead ongoing future investigations therapeutic interventions covid<NUMBER> pandemic continues affect increasing number people scientists around world actively exploring efficacy safety drugs treatment covid<NUMBER> findings need validated preclinical clinical trials nonpharmaceutical public health measures vital curtailing disease spread <NUMBER> <NUMBER> <NUMBER> constrain local transmission reduce impact covid<NUMBER> pandemic recommended nonpharmacological interventions specifically geared limit spread infection person person reduce number mortalities <NUMBER> strategies mitigate transmission entail personal communitybased actions <NUMBER> nonpharmacological interventions perhaps effective ways prevent widespread mortality disease slowing rate infection manageable level healthcare systems withhold personal interventions include frequent hand washing every <NUMBER> min <NUMBER> use hand sanitizers ≥<NUMBER> alcohol content wearing face masks encouraging people cover mouth nose coughing sneezing keeping distance sick people avoiding contact face mouth unwashed hands <NUMBER> <NUMBER> selfquarantine person feels unwell <NUMBER> whereas communitybased mitigation strategies include social distancing avoiding crowded areas restriction public gathering nonessential traveling <NUMBER> <NUMBER> addition measures studies shown supportive effects herbal nutritional interventions including immuneboosting nutrients herbs help overcome upper respiratory tract viral infections <NUMBER> complementary therapies boost immune response initial stage covid<NUMBER> infection might prudent approach overcome symptoms associated infection <NUMBER> also evidence traditional herbal medicine helped improve condition patients covid<NUMBER> presented symptoms study chinese population following traditional chinese medicine found patients treated qingfei paidu decoction qpd herbal chinese traditional medicine combination <NUMBER> different herbal formulas consisting <NUMBER> herbs total found effective cure rate <NUMBER> <NUMBER> confirmed cases covid<NUMBER> <NUMBER> <NUMBER> light evidence chinese government promoted herbal treatment used diagnosis treatment patients suspected covid<NUMBER> qpd also recommended korean governments guidelines severe cases covid<NUMBER> <NUMBER> combined remedies herbal medicine western medicine also found effective using western medicine alone treating patients covid<NUMBER> <NUMBER> furthermore response current pandemic recently supported use scientifically proven traditional medicines recognition toward traditional herbal complementary medicine included use medicinal plant artemisia annua coronavirus used african countries use artemisia annua also boosted madagascar form herbal drink widely known covidorganics although ample evidence present positive effects medicinal plant <NUMBER> <NUMBER> <NUMBER> <NUMBER> advised testing efficacy adverse side effects plant rigorous clinical trials prescribing covid<NUMBER> affected patients therefore nonpharmacological interventions suggested used countries possess potential defense spread infection even drugs vaccines available measures provide protection individuals exposed virus limiting symptomatic complications arising covid<NUMBER> eventually reducing overall mortality rate future studies recommended provide valid reliable containment measures control local transmission infection worldwide escalation clinical manifestation covid<NUMBER> despite constant efforts healthcare workers respective governments minimize impact may still underdiagnosed studies demonstrated risk mortality covid<NUMBER> significantly higher aging population including patients preexisting comorbidities reflecting earlier data <NUMBER> mortality related covid<NUMBER> noted among adults aged ≥<NUMBER> years <NUMBER> observations raise serious public health concerns considering <NUMBER> us population resides rural areas average age rural americans <NUMBER> years <NUMBER> us consensus also high rate obesity rural populations <NUMBER> important indications possible reason higher mortality rate covid<NUMBER> italy compared china could fact higher percentage obesity older adults italy noting similar pattern occurred h<NUMBER>n<NUMBER> pandemic <NUMBER> besides rural areas tend higher percentage smoking within population <NUMBER> covid<NUMBER> respiratory illness individuals smoking history higher chances affected virus severe case requires ventilation compounded several strategies adopted prevent spread urban populations preventing transmission dynamics spread covid<NUMBER> rural regions received limited attention although rural regions limited human mobility relatively lower population densities urban settings <NUMBER> extent morbidity mortality might significantly higher viralinflicted rural population making containment mitigation viral transmission unmanageable apart potential significant impact covid<NUMBER> aging population rural america rural healthcare delivery system remains relatively underresourced rural areas across world greatly impacted pandemics past clear covid<NUMBER> ongoing issues related infrastructure communities addressed previous pandemics h<NUMBER>n<NUMBER> influenza caused high mortality rates rural turkey deaths directly linked lack advanced intensive care unit icu facilities preliminary ventilator support <NUMBER> could easily contribute existing problem among issues late diagnosis late antiviral therapy limited availability icu facilities still issue rural areas particularly united states although trend increasing number icu beds added hospitals icu beds found concentrated large urban hospitals smalltomedium hospitals decreased icu capacity <NUMBER> noted previously severe cases covid<NUMBER> require ventilation primarily available icus rural populations less access resources mortality rate rise besides lack icu availability healthcare rural america noted significant disparity terms distribution professional resources lack healthcare workers major healthcare institutions overwhelming financial burden compared urban settings <NUMBER> limited physicians healthcare training opportunities delayed care disparities patient demographics older population substandard quality healthcare already reflected overall health outcomes mortality higher rural populations <NUMBER> observations suggest lack pandemic preparedness rural america hence global spread covid<NUMBER> may significantly impact rural communities greater extent effectiveness covid<NUMBER> pandemic mitigation primarily requires high level participation individual adequate knowledge viral transmission engaging appropriate selfcare following selfhygiene guidelines social distancing fundamental avoiding preventable hospitalizations <NUMBER> however due lower socioeconomic resources rural setting limited literacy specially health literacy among rural population may exacerbate impact covid<NUMBER> rural areas <NUMBER> cumulative line evidence demonstrated poor adult literacy strongly correlated reduced health knowledge selfmanagement skills reduced physical mental health higher rates hospitalizations increased morbidity mortality <NUMBER> <NUMBER> <NUMBER> hence consequences covid<NUMBER> pandemic rural population depend partly health risk communication viral awareness pandemic communication gaps may increase vulnerability among rural populations may trigger disease misconceptions uninformed policies insufficient planning fostering nonresilience predisposing population communicable viral risks <NUMBER> one way potentially fix gap could using ensuring local news media ie local news channels local newspapers accurate current practical advice viewers rural areas rely heavily media specifically local media information yet study rural area california found general many local news sources include important information health issues affecting area <NUMBER> dealing covid<NUMBER> imperative use key news sources reach areas traditional media accurate data advice presented sources indispensable asset preventing reach inaccurate misconceptions increase participation communitybased mitigation strategies viral outbreak covid<NUMBER> declared global pandemic continues overwhelm healthcare system increasing number patients presenting clinical symptoms coronavirus increasing rate incidence contagion presents challenges burdening healthcare institutions global economy impacting physical mental health people worldwide although several strategies adopted mitigate effects viral outbreak rural population largely ignored despite high risks morbidity mortality among population review aims provide clinical insight outbreak covid<NUMBER> outlining pathogenesis transmission dynamics clinical characteristics patients tested positive virus figure <NUMBER> although development sarscov<NUMBER>specific vaccines still clinical trials review discusses pharmacological nonpharmacological interventions widely used healthcare professionals manage symptoms combat impact virus patients finally review provides outline challenges implications covid<NUMBER> rural population given large percentage population rural setting frail subjects preexisting comorbidities individuals obesity individuals smoking history higher risk mortality considering age stratification preexisting comorbidities obesity smoking status along limited healthcare access resources health literacy rural population might significant risk dynamic nature pandemic conceptual framework required current postpandemic stages covid<NUMBER> inclusive strategies mitigate risks contagion rural population coronavirus increasing rate incidence contagion presents challenges burdening healthcare institutions global economy impacting physical mental health people worldwide although several strategies adopted mitigate effects viral outbreak rural population largely ignored despite high risks morbidity mortality among population review aims provide clinical insight outbreak covid<NUMBER> outlining pathogenesis transmission dynamics clinical characteristics patients tested positive virus figure <NUMBER> although development sarscov<NUMBER>specific vaccines still clinical trials review discusses pharmacological nonpharmacological interventions widely used healthcare professionals manage symptoms combat impact virus patients finally review provides outline challenges implications covid<NUMBER> rural population given large percentage population rural setting frail subjects preexisting comorbidities individuals obesity individuals smoking history higher risk mortality considering age stratification preexisting comorbidities obesity smoking status along limited healthcare access resources health literacy rural population might significant risk dynamic nature pandemic conceptual framework required current postpandemic stages covid<NUMBER> inclusive strategies mitigate risks contagion rural population funding research received external funding authors declare conflict interest funding research received external funding authors declare conflict interest since first reported case coronavirus disease china december <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infected <NUMBER> people killed <NUMBER> people worldwide may <NUMBER> <NUMBER> according world health organization <NUMBER> last <NUMBER> <NUMBER> months overflow scientific nonscientific information sarscov<NUMBER> covid<NUMBER> relationship age covid<NUMBER>associated morbidity mortality also addressed among health professionals general population surge infected patients beyond limits medical systems raised social concerns whether age considered determining treatment intensity <NUMBER> perception young peoples morbid condition relatively less severe also lowered awareness preventing infection regions one critical issues dealt clinical public health professionals pandemic spectrum illness severity affects triage diagnostic therapeutic decision making prognostic expectations therefore understanding covid<NUMBER>associated morbidity mortality according age important however data published country inconsistent multiple reasons different populations extent available laboratory tests medical systems hence reviewed covid<NUMBER> epidemiology data published several countries identify consistent trends relationship age covid<NUMBER>associated morbidity mortality also reviewed literature studies explaining difference host response sarscov<NUMBER> infection according age covid<NUMBER> fatality rates vary significantly depending country <NUMBER> qatar <NUMBER> belgium may <NUMBER> <NUMBER> <NUMBER> variation fatality rates may due differences healthcare adequacy andor epidemiological characteristics patients frequency diagnostic screening asymptomatic mildly symptomatic patients may also influence rate <NUMBER> however consistent clear pattern agebased exponential increase fatality rate regardless geographic region according korea centers disease control prevention overall case fatality rate cfr <NUMBER> <NUMBER> patients confirmed cases may <NUMBER> <NUMBER> much higher elderly <NUMBER> patients aged <NUMBER> <NUMBER> years <NUMBER> patients ≥<NUMBER> years <NUMBER> another analysis <NUMBER> cases china diagnosed february <NUMBER> <NUMBER> overall cfr <NUMBER> however cfr <NUMBER> patients aged <NUMBER> <NUMBER> years <NUMBER> patients aged ≥<NUMBER> years <NUMBER> report released higher institute health italy overall cfr march <NUMBER> <NUMBER> <NUMBER> four times higher korea china however pattern increasing fatality age similar korea china cfr <NUMBER> age group <NUMBER> years rapidly increased age group ≥<NUMBER> years reaching <NUMBER> <NUMBER> age group <NUMBER> <NUMBER> years ≥<NUMBER> years respectively fig <NUMBER>a <NUMBER> terms death per <NUMBER> individuals population may <NUMBER> <NUMBER> data new york city department health mental hygiene may <NUMBER> <NUMBER> data office national statistics united kingdom clear patterns agebased exponential increase fatality observed fig <NUMBER>b <NUMBER> <NUMBER> influenza commonly reported pandemic disease human history wshaped mortality distribution pandemic fig <NUMBER>c <NUMBER> <NUMBER> atypical pattern mortality elevated relative absolute risk death middleage groups usually explained differences agerelated susceptibility infection affected preexisting agerelated immunity <NUMBER> sarscov<NUMBER> novel virus introduced human type mortality distribution unlikely expected however agerelated pattern covid<NUMBER> fatality differs respiratory viral infections wherein severity pattern often described ushaped curve morbidity mortality concentrated extreme age groups younger children elderly populationbased studies seasonal influenza typically shown type mortality distribution according age fig <NUMBER>c <NUMBER> several cohort studies shown hospitalization rate influenza highest age group <NUMBER> <NUMBER> years compared age groups indicates children age <NUMBER> years could vulnerable influenza andor severely affected <NUMBER> <NUMBER> hospitalization fatality rate relatively low age group <NUMBER> <NUMBER> years <NUMBER> <NUMBER> mortality curve based <NUMBER> individuals showed much smaller peak age group elderly age group however type mortality peak observed thus far children affected covid<NUMBER> suggests children could less susceptible infection experience less severe symptoms low cfr dynamics agespecific mortality covid<NUMBER> relatively familiar mirror major causes mortality especially chronic diseases cardiovascular disease fig <NUMBER>d <NUMBER> promislow et al shown mortality rate doubling time mrdt allcause mortality <NUMBER> years united states approximately covid<NUMBER> reported new york city <NUMBER> words increasing case fatality mortality rate age specific finding covid<NUMBER> however many scientists media paid considerable attention age risk factor mortality covid<NUMBER> might due surge infected patients within short period hence death pattern high mortality older people became apparent investigating susceptibility infection unlike mortality case fatality general population complicated mildly symptomatic asymptomatic patients may tested uneven chance exposed source infection depending groups closure child care facilities preschools schools vs nonclosure longterm care facilities case rate covid<NUMBER> age reported wide regional variability according new york city data may <NUMBER> <NUMBER> cfr covid<NUMBER> general population cases per <NUMBER> seemed increase age fig <NUMBER>a <NUMBER> contrarily korea may <NUMBER> <NUMBER> diagnostic tests performed intensely groups associated certain religious gatherings regardless symptoms cfr seemed highest <NUMBER> <NUMBER>years age group fig <NUMBER>b et al compared relative illness ratio rir age different countries fig <NUMBER> <NUMBER> study mar <NUMBER> <NUMBER> rir spain italy increased age china korea <NUMBER> middle younger age groups seemed higher rir could explained extensive testing performed china korea countries would help better measure morbidity among young age groups italy new york city surge number covid<NUMBER> patients short period likely viral test performed first individuals apparent severe symptoms asymptomatic mildly symptomatic patients tested overall findings suggest susceptibility symptomatic infection seems increase age susceptibility infection probably similar among different age groups relative illness ratio <NUMBER>year age groups relative illness ratio rir measure morbidity calculated according following formula share covid<NUMBER> cases age group regard total number morbidity cases divided share population age group riri ccovidi∑iccovidipi∑ipi covid estimated number cases covid<NUMBER> age group ἰ p population age group value <NUMBER> indicates higher proportion cases age group relative age groups considering differences size population adapted natale et al <NUMBER> among covid<NUMBER> patients elderly patients higher mortality rate due high cfr symptomatic infection rate approximately <NUMBER> <NUMBER> deaths occurred patients aged <NUMBER> years ≥<NUMBER> years korea italy respectively <NUMBER> <NUMBER> similar pattern observed countries affected covid<NUMBER> several studies reported old age significant risk factor covid<NUMBER> mortality <NUMBER> <NUMBER> age also affects time hospitalization death viral clearance <NUMBER> <NUMBER> animal study sarscov<NUMBER> caused severe interstitial pneumonia viral replication lung tissues old monkeys young monkeys <NUMBER> immunopathology vulnerability infection elderly usually explained immunosenescence <NUMBER> immunosenescence quite complicated briefly old age production naïve b cells decreases function innate immune cells impaired hence cells involved innate immunity get activated efficiently infection progression adaptive immune response occur coordinated manner <NUMBER> changes reduce effectiveness viral clearance increase likelihood triggering dysregulated immune response cytokines released extensively activated immune cells resulting cytokine storm <NUMBER> another wellrecognized feature aging immunity chronic subclinical systemic inflammation also known inflammaging inflammation key pathogenic mechanism covid<NUMBER> hence inflammaging estimated contribute poorer outcome elderly patients covid <NUMBER> <NUMBER> scientists claimed biologically plausible pathomechanism explaining difference vulnerability sarscov<NUMBER> infection involves socalled antibodydependent enhancement ade <NUMBER> <NUMBER> <NUMBER> <NUMBER> ade wellknown cascade events viruses may infect susceptible cells interactions virions complexed antibodies fc receptors extensively endocytosed eventually replicated efficiently <NUMBER> antibodies bind virions could neutralizing nonneutralizing antibodies previously formed response sarscov<NUMBER> coronaviruses similar antigenicity sarscov<NUMBER> fact seroprevalence communityacquired coronaviruses among adults high <NUMBER> <NUMBER> <NUMBER> pediatrics presented evidence <NUMBER> addition aging immunity ade several factors related aging could reasons higher mortality morbidity elderly average number comorbid conditions steadily increased age according liu et al elderly covid<NUMBER> patients significantly higher performance score young middleaged patients <NUMBER> addition older adults living longterm care facilities highest risk chronic illness impact congregate housing <NUMBER> based published data sarscov<NUMBER> infection seems affect children less frequently less severely adults according data published different regions proportion children among covid<NUMBER> patients quite low <NUMBER> <NUMBER> china <NUMBER> italy <NUMBER> australia <NUMBER> korea <NUMBER> <NUMBER> <NUMBER> largest pediatric study date analyzed <NUMBER> children infected sarscov<NUMBER> <NUMBER> children showed severe critical illness <NUMBER> contrary pediatric study <NUMBER> patients severe critical among age groups analysis <NUMBER> chinese cases covid<NUMBER> <NUMBER> among children dong et al found infants relatively vulnerable sarscov<NUMBER> infection proportion severe critical cases <NUMBER> <NUMBER> however study also included suspected cases laboratory confirmed cases <NUMBER> study population possibility pathogens sarscov<NUMBER> responsible clinical observations remains controversial studies even though small number cases reported severe outcome infants observed <NUMBER> <NUMBER> <NUMBER> although findings similar generally accepted fact children aged <NUMBER> years vulnerable respiratory viral infections common aspect previous finding observed sarscov middle east respiratory syndrome coronavirus merscov epidemics also childrensparing pattern <NUMBER> <NUMBER> <NUMBER> stockman et al reported clinical outcome sars favorable children aged <NUMBER> years age age groups <NUMBER> deaths reported children sarscov infection <NUMBER> merscov epidemic two pediatric deaths reported serious comorbidities infantile nephrotic syndrome cystic fibrosis <NUMBER> <NUMBER> <NUMBER> thus far clear explanation childrensparing pattern sarscov<NUMBER> infection following hypotheses reported literature <NUMBER> possibility children less frequently exposed infection sources due closure child care facilities preschools schools <NUMBER> children less susceptible infection <NUMBER> children less likely symptomatic develop severe symptoms hence number cases underestimated <NUMBER> <NUMBER> <NUMBER> evidence studies needed prove hypotheses however recently bi et al reported result tracing <NUMBER> close contacts china children likely infected adults infection rate children aged <NUMBER> years <NUMBER> vs population average <NUMBER> less likely symptomatic develop severe symptoms <NUMBER> milder symptom low cfr children sarscov<NUMBER> infection could explained interaction host immunological response viral pathogen mechanism <NUMBER> <NUMBER> differences distribution maturation function viral receptors host frequently reported possible reason agerelated difference infection angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov hcovnl<NUMBER> sarscov<NUMBER> attracted increasing attention ace<NUMBER> plays key role catalyzing hydrolysis angiotensin ii angiotensin <NUMBER> antihypertensive profibrotic effect <NUMBER> <NUMBER> following viral entry ace<NUMBER> expression downregulated <NUMBER> downregulation ace<NUMBER> expression leads compensatory overproduction angiotensin ii ace angiotensin ii turn stimulates type <NUMBER>a receptor increases lung vascular permeability potentiates lung pathology <NUMBER> <NUMBER> <NUMBER> study conducted xie et al ace<NUMBER> expression observed dramatically decrease aging rat model <NUMBER> low levels ace<NUMBER> detected patients underlying chronic conditions generally affect pediatric population <NUMBER> <NUMBER> findings suggest increased levels ace<NUMBER> receptors lung pneumocytes children may protective effect severe clinical manifestations sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> active rapid innate immune response antigen elevated number b lymphocytes lymphocytes natural killer cells also suggested immunological mechanism children resist infection <NUMBER> <NUMBER> <NUMBER> however general immunological characteristics children insufficient explain childrensparing pattern sarscov<NUMBER> distinctive feature respiratory viral infections known many children asymptomatic mild symptoms increasing concerns childrens role transmitting disease however importance children transmitting virus remains uncertain majority children infected sarscov<NUMBER> reported thus far documented household contact often showing symptoms infected children suggesting possibility children important reservoir sarscov<NUMBER> another emerging childrenrelated issue multisystem inflammatory syndrome mentioned scientific brief report published may <NUMBER> <NUMBER> <NUMBER> report describes clusters children adolescents requiring admission intensive care units children multisystem inflammatory condition features similar kawasaki disease toxic shock syndrome europe north america <NUMBER> <NUMBER> <NUMBER> syndrome reported regions thus far full spectrum disease still unclear hence special attention warranted children covid<NUMBER> <NUMBER> cfr susceptibility symptomatic covid<NUMBER> higher elderly definitive therapeutic drug vaccine prevention important strategy older adults added strain social distancing vulnerable population acknowledged managed furthermore studies immunopathology determining severity sarscov<NUMBER> infection warranted develop effective therapeutic preventive strategies • first study covering countries affected covid<NUMBER> verifying association climate variables • negative association country average temperature covid<NUMBER> infections • positive associations country precipitation covid<NUMBER> infections • association deaths country temperature precipitation b r c r c l e n f third time less two decades world authorities facing epidemic high transmissibility caused subtypes coronavirus munster et al <NUMBER> gorbalenya <NUMBER> first epidemic occurred <NUMBER> <NUMBER> guangdong province china disease termed severe acute respiratory syndrome sars caused newly identified coronavirus named sars coronavirus sarscov lin et al <NUMBER> sarscov infected <NUMBER> individuals several countries resulted <NUMBER> deaths second epidemic occurred <NUMBER> middle east disease termed middle east respiratory syndrome caused new virus called mers coronavirus merscov merscov infected <NUMBER> individuals resulted around <NUMBER> deaths munster et al <NUMBER> end <NUMBER> third epidemic occurred caused another new type coronavirus designated world health organization sarscov<NUMBER> resultant disease named coronavirus disease disease worldwide pandemic gorbalenya <NUMBER> recently emerged sarscov<NUMBER> first identified city wuhan hubei province china virus infects humans variety animals mainly pigs bats velavan meyer <NUMBER> infection results spectrum clinical manifestations mainly respiratory ranging severity benign lethal sometimes asymptomatic velavan meyer <NUMBER> fehr perlman <NUMBER> attempt understand epidemics studies examined factors could influence spread coronaviruses chan et al <NUMBER> general three factors affect epidemiology communicable diseases agent transmission host environment lin et al <NUMBER> historically occurrences sars partly associated environmental factors lin et al <NUMBER> ecological study conducted china found air pollution associated lethality individuals affected sars attributed fact shortor longterm exposure certain pollutants compromise lung function cui et al <NUMBER> another environmental factor air temperature lin et al <NUMBER> identified first time incidence sars <NUMBER> times higher lower air temperatures higher temperatures authors reported respiratory system diseases common colder environments virulence agents deteriorates higher climatic temperatures may able withstand environmental changes addition pointed transmissibility sarscov terms climatic fluctuations similar influenza virus furthermore incidence influenza increases significantly low temperatures high relative humidity park <NUMBER> indicating climatic factors significantly affect viral transmission case sarscov<NUMBER> meteorological factors seem influence spread virus oliveiros et al <NUMBER> bao et al <NUMBER> oliveiros et al <NUMBER> identified speed transmission positively correlated temperature correlated humidity thus expected temperature rises <NUMBER>°c transmission rates increase average <NUMBER> days regarding temperature mortality rate study conducted four chinese cities found colder temperatures greater effect mortality bao et al <NUMBER> contrast results study li et al <NUMBER> showed cold heat adversely impact mortality resulting respiratory syndromes basis assumption different climatic conditions play significant role course covid<NUMBER> essential identify associations environmental factors average maximum minimum temperatures precipitation demographic density sarscov<NUMBER> transmission covid<NUMBER> mortality humans data period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> collected meteorological variables weather station data extracted national oceanic atmospheric administration noaa database daily data meteorological stations segregated country following variables recorded precipitation average temperature maximum temperature minimum temperature noaa <NUMBER> daily averages meteorological variable different countries calculated finally data daily infection death rates extracted world health organization reports <NUMBER> demographic density country used control variable data obtained food agriculture organization world bank population estimates year <NUMBER> world bank <NUMBER> countrys time exposure epidemic calculated temporal distance days first case registered territory time study summary variables provided table <NUMBER> analyze association number cases deaths covid<NUMBER> climatic aspects used eq <NUMBER> estimated panel data strategy wooldridge <NUMBER> dependent variable total number cases sarscov<NUMBER> infections total number deaths covid<NUMBER> <NUMBER> countries period december <NUMBER> <NUMBER> march <NUMBER> <NUMBER> σ constant u control specific characteristics countries fixed analyzed period x vector includes explanatory variables model including variable interest mean temperature addition included controls may related disease average rainfall countrys time exposure epidemic included binary variables captures specific effects associated months january february ε error term equation includes factors associated included equation advantage strategy relation traditional ordinary least squares estimate control countryspecific factors fixed time associated number deaths associated sarscov<NUMBER> infection two specific outcomes measures considered first analyzed influence climatic variables sarscov<NUMBER> infections second analyzed influence climatic variables covid<NUMBER> mortality three estimates tested outcome shown fig <NUMBER> first included average temperature second included average temperature minimum temperature maximum temperature precipitation countrys time exposure epidemic third included average temperature minimum temperature maximum temperature precipitation countrys time exposure epidemic population density variable capture specific month effects complete specification table <NUMBER> shows results correlation analysis number confirmed covid<NUMBER> cases average temperature country first estimated model negative correlation two variables significance relationship remains even inclusion additional variables maximum minimum temperatures averages time exposure disease even complete specification includes two binary variables capturing specific effects months year controlling population density results suggest increase temperature associated decrease number infections coefficients shown table <NUMBER> cannot measure causality several factors affect variable interest information number beds patients respective levels social isolation however association observed climate number covid<NUMBER> cases models appear quite robust particularly incorporation controls additional climate variables also month fixed effects table <NUMBER> shows results correlation analysis covid<NUMBER> mortality climatic variables outcome measure significant associations coefficients mortality average temperature possible factors climate related mortality first estimate evaluated relationship covid<NUMBER> mortality rates average temperature country significant second estimate included average minimum maximum temperatures well countrys time exposure disease identify significant association last estimate addition controls already included previous specification also incorporated binary variables capture effects specific period however significant correlation identified covid<NUMBER> mortality rates temperature several factors influence sarcov<NUMBER> transmission including environmental variables population density medical care study aimed identify associations environmental variables sarscov<NUMBER> transmissioncovid<NUMBER> mortality negative correlation identified temperature number infections although known influence temperature human health vary countries even regions hajat kosatky <NUMBER> findings study agreement current literature temperature influences transmission viruses cause respiratory syndromes influenza virus park <NUMBER> sarscov<NUMBER> et al <NUMBER> investigating relationship temperature respiratory diseases studies indicated sarscov influenza virus survive certain climatic conditions transmissibility sensitive rising temperatures jaakkola et al <NUMBER> chan et al <NUMBER> similar transmissibility sarscov<NUMBER> influenza virus transmissible lower temperatures lowen steel <NUMBER> cold weather results weakening host immunity increasing susceptibility infection kudo et al <NUMBER> considering transmissibility coronaviruses similar influenza virus lin et al <NUMBER> assumed mechanisms also apply transmission sarscov<NUMBER> model considered average temperature observed correlation indicated every one degree fahrenheit increase temperature reduction number infections <NUMBER> casesday composite model estimate <NUMBER> outcome measure <NUMBER> association stronger decrease number infections <NUMBER> casesday degree increase temperature second finding study significant association mortality average temperature maintained variables added indicating nonclimatic variables may related covid<NUMBER> mortality finding differs findings et al <NUMBER> stated temperature covid<NUMBER> mortality negatively associated one possible reason conflicting results limited geographical scope study et al focused china climate study included data range countries climatic regions environmental factors influence relationship temperature mortality latitude bao et al <NUMBER> humidity jaakkola et al <NUMBER> kudo et al <NUMBER> air pollution cai et al <NUMBER> sociodemographic factors age sex income bao et al <NUMBER> reported chan et al <NUMBER> reported people live low latitudes relatively weak adaptive capacity cold strong adaptive capacity heat reverse also shown high humidity associated low temperatures important factor transmissibility influenza virus either conserving virulence weakening host cooling body drying respiratory tract jaakkola et al <NUMBER> study reported temperature humidity associated higher risk covid<NUMBER> therefore although humidity considered research lack information variable meteorological stations precipitation seems important factor must considered found positive correlation precipitation sarscov<NUMBER> transmission showing <NUMBER>in increase precipitationday increase <NUMBER> casesday another result concerns countrys time exposure sarscov<NUMBER> expected variable also showed positive correlation showing additional day exposure average increase <NUMBER> casesday finding consistent behavioral evidence sarscov<NUMBER> transmission community infection transmission follows geometric progression correia et al <NUMBER> important mention study interpreted significance coefficients magnitude probable existence endogeneity estimated relationships considering series regressors associated temperature disease mortality time first global study covering countries affected covid<NUMBER> examined associations climatic variables sarscov<NUMBER> transmission covid<NUMBER> mortality findings showed negative correlation countrys average temperature number covid<NUMBER> cases absence correlation mortality average temperature positive correlation countrys time exposure virus number cases addition study reported precipitation important factor transmissibility virus research provides important information inform decisions local global health authorities climatic variations associated transmissibility sarscov<NUMBER> new policies reinforce health systems social isolation methods adopted depending temperature precipitation patterns limitation highlight absence humidity data view important role virulence respiratory syndromes however current data restrictions factor could considered included future studies also suggest future studies focus microregions capture temperature patterns include variables related solar radiation authors declare conflict interest uk currently middle coronavirus disease <NUMBER> covid <NUMBER> pandemic causative virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel strain coronavirus previously unidentified humans thought zoonotic origin <NUMBER> sarscov<NUMBER> exposure may result wide variety outcomes ranging asymptomatic infection development respiratory failure requiring ventilatory support <NUMBER> covid<NUMBER> extremely contagious <NUMBER> may <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> <NUMBER> deaths reported uk alone <NUMBER> <NUMBER> globally huge disruption everyday life without vaccine effective treatment governments reliant upon strategies social distancing quarantine measures limit sarscov<NUMBER> infection level managed healthcare systems <NUMBER> furthermore additional burden placed healthcare services probably affect quality care patients suffering unrelated health problems particular relevance oncologists prompt diagnosis treatment make significant difference patient outcomes addition individuals significant comorbidity cancer may particularly vulnerable coronavirus infection potential consequence immunosuppressed state <NUMBER> <NUMBER> <NUMBER> leaves us oncologists faced challenging decisions proceed treatment patients cancer risks covid<NUMBER> infection incorporated decision making impact practice months potentially years come led need difficult conversations patients covid<NUMBER> pandemic affects treatment realistic weighing potential benefits harms occur experience patients remarkably pragmatic current situation measures putting place emotive area conversations stopping delaying treatment difficult effectively compassionately conversations need informed best evidence available present limited much current published literature around covid<NUMBER> cancer guidelines published studies largely based around smaller numbers patients chinese population liang et al <NUMBER> study included <NUMBER> patients confirmed diagnosis covid<NUMBER> cancer total <NUMBER> cases study noted worse outcomes cancer cohort seven <NUMBER> suffering severe adverse outcome compared <NUMBER> <NUMBER> overall <NUMBER> report zhang et al <NUMBER> showed similar outcomes <NUMBER> <NUMBER> <NUMBER> included patients suffering severe events <NUMBER> mortality rate eight deaths yu et al <NUMBER> identified <NUMBER> cancer patients population <NUMBER> three died largest currently reported cohort patients compared <NUMBER> patients covid<NUMBER> cancer <NUMBER> matched noncancer patients <NUMBER> reporting higher rate mortality aq<NUMBER>or <NUMBER> intensive care unit admission aq<NUMBER>or <NUMBER> patients cancer compared control group particular higher rates mortality aq<NUMBER>or <NUMBER> intensive care unit admission aq<NUMBER>or <NUMBER> observed stage iv cancer patients nonmetastatic cancer patients similar outcomes matched control group cancer patients also longer mean length stay <NUMBER> days compared <NUMBER> days control group patients lung cancer largest cohort represented studies dai et al <NUMBER> reported lung cancer represented <NUMBER> followed gastrointestinal <NUMBER> breast <NUMBER> haematological cancer representing <NUMBER> cases <NUMBER> although smaller proportion total cases highest mortality rate noted patients haematological cancers <NUMBER> nine patients lung cancer patients mortality rate <NUMBER> four <NUMBER> cases limitations hospital resources meaning usual support manage anticancer treatment toxicities potentially reduced unavailable additional risk patients cancer contract concurrent covid<NUMBER> infection <NUMBER> <NUMBER> oncological treatments may confer unacceptable risk perceived patients clinicians altered cancelled deferred guidance produced best balance risks treating risks changing away standard treatment royal college radiologists guidelines radiotherapy covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pragmatically absence definite understanding covid<NUMBER> affect patients cancer key approach minimise chance patient contracting covid<NUMBER> infection number strategies already adopted majority uk cancer centres mitigate risk including delivery outpatient reviews telephone rather clinic deferral nonurgent anticancer treatments shortening radiotherapy fractionation schedules available evidence efficacy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> balanced know risks covid<NUMBER> form consensus guidance available studies note recent treatment affected outcomes impact differed modalities small patient numbers limit ability draw conclusions liang et al <NUMBER> reported severe adverse events three four patients treated aq<NUMBER>within month zhang et al <NUMBER> noted frequent adverse events treated within <NUMBER> days hazard ratio <NUMBER> n <NUMBER> dai et al <NUMBER> reported patients receiving radiotherapy <NUMBER> within <NUMBER> days prior infection show worse outcomes compared agematched controls six patients <NUMBER> receiving immunotherapy <NUMBER> mortality rate poor outcome hypothesised relate acute respiratory distress syndrome induced cytokine storm contrasts bersanellis <NUMBER> hypothesis immunotherapy could protective covid<NUMBER> although noting possibility immune toxicity pneumonitis covid<NUMBER> infection coinciding could cause worse outcomes covid<NUMBER> antipdl<NUMBER> agents cause cytokine release syndrome leading acute respiratory distress syndrome despite uncertainty treatments safe continue full extent risks covid<NUMBER> pandemic risk patients underlying malignancy ignored although considering nine paediatric patients hrusak et al <NUMBER> noted risks harm untreated malignancy appeared outweigh risks covid<NUMBER> paediatric population although potentially children less impacted covid<NUMBER> compared adults would emphasise importance continuing treat patients safe evidence true impact covid<NUMBER> uk population becomes available need continue review guidelines make best use evidence available support safe practice enable informed discussion patients risks treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite increased difficulty treating cancer patients present medical professionals around uk shown adaptable resilient collaborative crossdisciplinary approach hugely important optimising delivery patient care enabled ability share information experiences core part going forward uk coronavirus cancer monitoring project aims monitor impact covid<NUMBER> cancer patients enable oncologists gain crucial insights inform clinicaland infrastructurebased decision making uk coronavirus cancer monitoring project launched <NUMBER> march <NUMBER> following discussions clinical oncologists cancer centres project consists local emergency response reporting group cancer centres enables data collection sarscov<NUMBER>positive cancer patients primary end point measure study allcause mortality following hospitalisation laboratory confirmed sarscov<NUMBER> infection project attempt define factors associated increased mortalitymorbidity covid<NUMBER> including patient factors age gender comorbidities smoking status ethnicity cancer factors subtype stage cancer treatment intent modality line treatment covid<NUMBER> symptoms treatments date <NUMBER> patients registry potentially interest readership <NUMBER> patients radiotherapy within <NUMBER> weeks admission subgroup increasing size hopefully enable clinical oncology community answer aforementioned clinical questions given enough time collaboration therefore believe panuk information key understanding interactions covid<NUMBER> treatment regimens project continue analyse disseminate data real time enable cancer centres assess impact coronavirus cancer patients assess impact treatment interventions potentially allow maintenance best possible standard cancer patient care within challenging circumstances information uk coronavirus cancer monitoring project see httpsukcoronaviruscancermonitoringcom aq<NUMBER>some authors comprise part uk coronavirus monitoring project team donating time resources support project conflicts interest declared towns four northern italian provinces milano bergamo brescia lodi heavily infected coronavirus first months <NUMBER> towns substantial excess mortality • nembro <NUMBER> extra deaths population <NUMBER> excess mortality <NUMBER> percent • alzano lombardo <NUMBER> extra deaths population <NUMBER> excess mortality <NUMBER> percent towns fully infected period excess mortality would provide estimate mortality due covid<NUMBER> since towns may less fully infected provide lower bounds excess mortality provides valuable bound covid<NUMBER> mortality would generalizing idea multiple towns provides better precision estimates opens way estimating mortality age sex poisson count model provides statistical framework pool data across towns estimating ageand sexspecific mortality rates controlling differences across towns degree excess mortality <NUMBER> towns deaths age sex available istat january <NUMBER> april <NUMBER> years <NUMBER> northern provinces milano bergamo brescia lodi population <NUMBER> <NUMBER> percent regional population townspecific random effects control differences across towns level excess mortality presumably results differences infection rates also provide method estimating mortality mostinfected towns upper tail <NUMBER>th percentile town distribution corresponds highestmortality towns presumably infected coronavirus <NUMBER>th percentile <NUMBER> towns roughly <NUMBER>th town upper tail simply mostinfected town table <NUMBER> shows overall excess mortality <NUMBER> percent <NUMBER> ci <NUMBER> <NUMBER> ifr higher many published estimates eg ioannidis <NUMBER> surveying published studies reports <NUMBER> percent <NUMBER> percent cdc <NUMBER> uses upper bound disease severity case fatality rate <NUMBER> percent asymptomatic case percentage <NUMBER> percent implying ifr <NUMBER> percent grewelle leo <NUMBER> estimate higher global ifr <NUMBER> percent equal lower bound ifr shows dramatic age sex profile men age <NUMBER> excess mortality <NUMBER>times higher younger men <NUMBER>times higher women age applying ageand sexspecific excess mortality us age profile produces bound us overall ifr <NUMBER> percent table <NUMBER> estimates allcause excess mortality provide particularly firm useful bounds covid<NUMBER> mortality depend assumptions often necessary measures depend ascribing cause death determining exposure proportion asymptomatic infections excess mortality estimates provide lower bounds covid<NUMBER> ifr realistic circumstances need discuss interpretation infection fatality rate ifr key variable epidemiological modeling usually considered constant reality ifr vary circumstances three channels covid<NUMBER> epidemic affect mortality first death caused directly covid<NUMBER> good medical treatment might call clinical bestcase ifr usually meant discussing ifr second higher mortality still caused directly covid<NUMBER> due ineffective lesser medical care may exist initial outbreak disorganized medical conditions third excess mortality causes due disorganized medical treatment example cardiac cases seeking receiving adequate care technically part ifr still mortality resulting disease <NUMBER> three channels combined might label initial response realworld worstcase ifr due clinical conditions infection also realworld treatment challenges fog war fighting new disease reports response hospitals icu beds lombardy eg manca <NUMBER> grasselli et al <NUMBER> indicate medical system stressed overwhelmed hospitals responded large increases icu capacity anecdotal reports appears increased mortality due third channel nontreatment noncovid conditions small due second channel ineffective covid care probably substantial nonetheless time knowledge medical practice progresses initial response ifr likely decrease estimates table <NUMBER> provide benchmarks compare parameters used epidemiological modeling respect instructive examine recent cdc simulations cdc <NUMBER> reweighting agespecific estimates us population shown table <NUMBER> find <NUMBER> percent overall <NUMBER> percent age <NUMBER> cdc scenario <NUMBER> current best estimates assumes <NUMBER> percent asymptomatic cases case fatality rates <NUMBER> percent overall <NUMBER> percent <NUMBER> <NUMBER> percent age <NUMBER> implying ifr <NUMBER> percent overall <NUMBER> percent <NUMBER> <NUMBER> percent age <NUMBER> substantially lower observations northern italy raise question whether us mortality fact improved relative italy factor three <NUMBER> estimating excess mortality using fixed effects demographic town effects examine townbytown mortality still pooling data across demographics towns table <NUMBER> shows six towns <NUMBER>th <NUMBER>th percentile highest predicted overall mortality <NUMBER> number towns tail overall mortality distribution examplegazzaniga castiglione dadda nembro moderate populations statistically significant estimated fixed effects indicates estimates tail random effects estimator shown table <NUMBER> simply statistical artifact <NUMBER> fourth possible source observed increase mortality unobserved confounding factor increased mortality northern italian towns spring <NUMBER> although logically possible unlikely major factor case particularly given two observations clear identification mechanism virus disease causing increased mortality globally significant increases mortality northern italian towns occurred time identified covid<NUMBER> infection tandem groups except youngest <NUMBER> cdc scenario <NUMBER> highest implied ifr <NUMBER> percent overall <NUMBER> percent <NUMBER> still lower lower bounds <NUMBER> agespecific mortality predicted town weighted using towns population weights <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> estimates upper tail random effects estimator individual towns tell story high excess mortality highlyinfected towns <NUMBER> towns roughly <NUMBER>th <NUMBER>th percentiles distribution overall predicted excess mortality towns <NUMBER> <NUMBER> <NUMBER> towns actual excess mortality males aged <NUMBER> <NUMBER> also show pooling across towns valuable towns low population substantial random variation particularly groups low mortality even overall town mortality enough provide reliable overall mortality estimates agespecific mortality measures may reliable town valbondione provides example town population <NUMBER> <NUMBER> men aged <NUMBER> one death <NUMBER> versus none <NUMBER> town large negative excess mortality fact variation number deaths likely due random chance given small size relevant population <NUMBER> towns comunes data provided istat four provinces milano bergamo brescia lodi table <NUMBER> shows summary statistics median town population <NUMBER> median observed mortality <NUMBER> <NUMBER> percent median excess mortality <NUMBER> percent <NUMBER> substantial variation <NUMBER> mortality across towns substantially <NUMBER> interquartile range <NUMBER> percentage points versus <NUMBER> percentage points <NUMBER> variation observed mortality carries excess mortality presumably due variation across towns overall <NUMBER> predicted overall morality random effects estimation shown table <NUMBER> lower towns <NUMBER>th percentile effect shrinkage random effects distribution characteristic mixed models see clark <NUMBER> <NUMBER> observed excess mortality calculated difference <NUMBER> mortality <NUMBER> mortality townbytown basis median excess mortality may equal difference medians <NUMBER> <NUMBER> predicted excess mortality calculated fixed effects estimator <NUMBER> predicted mortality versus pre<NUMBER> mortality estimated using <NUMBER> <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint infection rates variation particularly upper tail distribution excess mortality across towns exploit calculate lower bounds ifr using raw mortality estimating ifr bounds specific age sex groupingsx presents problems however towns low population groups low underlying mortality rates purely random variation sometimes produce small number excess deaths towns small populations excess deaths translate unusually high mortality rates high rates bias upwards upper tail acrosstown distribution table <NUMBER> shows problem median town males <NUMBER> low overall mortality zero excess mortality contrast upper tail <NUMBER>th percentile shows high observed excess mortality <NUMBER> percent reliable estimate poisson mixed effects model provides reliable estimates figures <NUMBER> <NUMBER> shows location towns figure <NUMBER> simple quantile map showing towns predicted <NUMBER> excess mortality figure <NUMBER> clusters towns excess mortality contiguity euclidean distance maps indicate mortality high around bergamo particularly valleys northeast bergamo milan surroundings appear lightly infected authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> predicted excess mortality rate fixed effect estimation clustered geoda using kmeans clustering <NUMBER> clusters geometric centroids weighted <NUMBER> cluster center excess mortality standardizing <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> istat istituto nazionale de statistica italian statistical agency publish data deaths regions due coronavirus httpswwwistatititarchivio<NUMBER> cover page titled decessi e cause di morte cosa produce listat deaths causes death istat produces dataset analitico con decessi giornalieri ogni singolo comune di residenza analytical dataset daily deaths single municipality residence httpswwwistatititfiles<NUMBER>datasetdecessicomunaligiornalierietracciatorecordzip report mortality gender fiveyear age classes first <NUMBER> months years <NUMBER> <NUMBER> <NUMBER> municipalities italy first three months <NUMBER> <NUMBER> municipalities period <NUMBER> january <NUMBER> april <NUMBER> <NUMBER> municipalities verified anpr aggregate istat data extract includes deaths <NUMBER> april years <NUMBER> observations days <NUMBER> april excluded ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint httpdemoistatitpopyyyyindexcoeffhtml istat reports population town region lombardy four provinces milano bergamo brescia lodi particularly badly hit coronavirus <NUMBER> towns mortality data reported observations • ijt deaths town demographic group year january <NUMBER> april <NUMBER>th years <NUMBER> • p op ijt population town demographic group years <NUMBER> <NUMBER> population used <NUMBER> • c ijt covid treatment indicator variable pre<NUMBER> vs <NUMBER> mixed effects model grouping town demographic group j data treatment covid versus pre<NUMBER> intercepts slopes specified β <NUMBER>i α <NUMBER> α <NUMBER>i town pre<NUMBER> effect intercept β <NUMBER>i α <NUMBER> α <NUMBER>i town <NUMBER> effect slope β <NUMBER>j γ <NUMBER> γ <NUMBER>j demographic pre<NUMBER> effect intercept β <NUMBER>j γ <NUMBER> γ <NUMBER>j demographic <NUMBER> effect slope going treat demographic factors fixed potentially allow town effects random seems reasonable large number towns relatively small number observations eight demographic groups preand post<NUMBER> small number demographic groups large number observations <NUMBER> towns preand post<NUMBER> course also examine treating factors fixed case combined model logey ijt c α <NUMBER> γ <NUMBER> γ <NUMBER>j α <NUMBER> c ijt γ <NUMBER> c ijt γ <NUMBER>j c ijt fixedeffects <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> error structure definition number deaths going think mortality rather ifr infection separately equation <NUMBER> terms α <NUMBER> γ <NUMBER> γ <NUMBER>j represent pre<NUMBER> agespecific mortality median town terms α <NUMBER> γ <NUMBER> γ <NUMBER>j represent agespecific excess mortality median town terms α <NUMBER>i represent random variation pre<NUMBER> townspecific mortality α <NUMBER>i <NUMBER> townspecific excess mortality demographic effects treated fixed effects estimated • α <NUMBER> γ <NUMBER> γ <NUMBER>j <NUMBER> parameters demographic groups precovid pre<NUMBER> • α <NUMBER> γ <NUMBER> γ <NUMBER>j <NUMBER> parameters demographic groups covid mortality <NUMBER> town effects α <NUMBER>i α <NUMBER>i treated either fixed random effects <NUMBER> towns mostaffected regions milano bergamo brescia lodi gives either <NUMBER>x fixed effects <NUMBER> pre<NUMBER> <NUMBER> <NUMBER> two random effects one pre<NUMBER> one <NUMBER> pre<NUMBER> effects measures inherent basecase mortality differences across towns due different age sex distributions since population mortality measured eight demographic categories listed pre<NUMBER> effects estimated using mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> effects provide differences across towns excess pre<NUMBER> mortality mortality differences presumably result different infection rates across towns possibly factors care treatment provided locally fixed effects estimators appropriate estimating specific town mortality controlling precovid mortality levels noise <NUMBER> mortality towns low population low mortality counts substantial variability counts across large sample towns towns produce large rates simply due random variation randomly high counts small towns translate high rates potentially biasing observations using raw rates <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> predicted mortality townspecific rates using fixed effects estimates reliable raw observations particularly demographic group pooling agespecific counts across towns estimate agespecific rates pooling townspecific counts across age groups estimate town fixed effect standard errors estimated fixed effects provide information confidence assign townspecific estimates random effects appropriate estimating overall effect covid<NUMBER> estimated pre<NUMBER> agespecific mortality effects α <NUMBER>i provide estimates average town precovid <NUMBER> effects α <NUMBER>i estimate excess mortality average <NUMBER> town average pre<NUMBER> mortality <NUMBER> infection rate table <NUMBER> shows coefficients estimating equation <NUMBER> mixed effect poisson count model town effects treated random demographic effects fixed using estimates calculate predicted counts thus predicted rates eight demographic groups precovid <NUMBER> set random effects zero estimate excess mortality middle random effects distribution ie median town terms precovid <NUMBER> mortality results shown table <NUMBER> <NUMBER> r using glmer lme<NUMBER> package optimizer bobyqa note fixed effects parametrized overall <NUMBER> effect difference pre<NUMBER> <NUMBER> intercept excluded agespecific <NUMBER> effects measured relative pre<NUMBER> reported standard errors appropriate testing individual agespecific effects different zero standard r parametrization used overall <NUMBER> effect would included f<NUMBER> excluded testing one agespecific <NUMBER> effects would require testing sum overall<NUMBER>ef f ect agespef icif ef f ect standard error would involve correlation coefficients want predicted excess mortality upper tail distribution towns high excess mortality thus presumably heavily infected estimated distribution <NUMBER> random effect α <NUMBER>i measures right tail infected towns provide lower bound agespecific ifr use <NUMBER>th percentile α <NUMBER>i distribution estimated <NUMBER> demographic fixed effect group j iŝ α <NUMBER> γ <NUMBER> γ <NUMBER>j variance α <NUMBER>i distribution isσ town<NUMBER> <NUMBER>th percentile <NUMBER>σ <NUMBER> mortality larger pre<NUMBER> mortality factor exp α <NUMBER> γ <NUMBER> γ <NUMBER>j <NUMBER> ·σ town<NUMBER> excess mortality group j exp α <NUMBER> γ <NUMBER> γ <NUMBER>j · exp α <NUMBER> γ <NUMBER> γ <NUMBER>j <NUMBER> ·σ town<NUMBER> − <NUMBER> coefficients table <NUMBER> show age sex profile mortality ratio terms excess mortality table <NUMBER> show differences rates equation <NUMBER> mortality demographic group j <NUMBER>thpercentile town increased factor exp α <NUMBER> γ <NUMBER> γ <NUMBER>j <NUMBER> ·σ town<NUMBER> increases ratio pre<NUMBER> mortality shown table <NUMBER> large larger older men male mortality higher female precovid every age ratio given exp γ <NUMBER>f j − γ <NUMBER>m j ratio exp γ <NUMBER>f j − γ <NUMBER>m j measures much ratio increases <NUMBER> table <NUMBER> shows summary statistics test random fixed effects models estimate three nested models random fixed effect specification first includes estimates <NUMBER> effectssetting α <NUMBER> γ <NUMBER> γ <NUMBER>j α <NUMBER>i zero second includes townspecific effects estimating α <NUMBER>i random fixed effects models likelihood ratio test shows townspecific <NUMBER> effects important third model includes <NUMBER> agespecific excess mortality effectsα <NUMBER> γ <NUMBER> γ <NUMBER>j likelihood ratio test shows effects highly significant residual deviance table <NUMBER> provides test whether poisson regression adequately accounts observed variation whether overdispersion relative poisson assumption residual deviance asymptotically χ <NUMBER> distributed large value implies model account data well random fixed effects model residual deviance small relative χ <NUMBER> random variable probability observing value large larger reported <NUMBER> reference table <NUMBER> shows estimated excess mortality median town towns presumably modest overall infection rate calculating standard errors excess mortality difficult specific age group would <NUMBER>th percentile <NUMBER> rate less basecase pre<NUMBER> rate shown equation <NUMBER> standard errors expression easy nonlinear expression coefficients one might try deltamethod complicated two factors first standard error forσ town<NUMBER> easy obtain second want aggregate ageand sexspecific rates overall rates using regional <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint excess mortality rates calculated eight agesex categories weighted totals using agespecific population regions milano bergamo brescia lodi nonparametric bootstrap confidence intervals population weights leading weighted averages terms like equation <NUMBER> feasible alternative bootstrapping nonparametric bootstrapping towns sampled original distribution equation <NUMBER> reestimated sample tables <NUMBER> <NUMBER> show results bootstrapping <NUMBER> samples sampling replacement town distribution <NUMBER> figure <NUMBER> shows histogram estimated <NUMBER> excess mortality across <NUMBER> towns shows towns varied <NUMBER> excess mortality presumably resulting different coronavirus infection rates ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> <NUMBER> comparative insight prospects coronavirusbased epidemic <NUMBER> affected animals died feline infectious peritonitis fip caused feline coronavirus fcov also called fipv presence cheetah coronavirus ajucov acinonyx jubatus coronavirus inferred based upon presence fipv antibodies observation coronaviruslike particles <NUMBER> <NUMBER> domestic cats fcov occurs two varieties virulent fipv causes severe fipv antibody mediated fatal disease <NUMBER> infected cats subclinical enteric feline coronavirus fecv infection within months arrival two infected cheetahs winston safari cheetahs park fell ill retrospective serum samples tested antibodies demonstrated prior <NUMBER> cheetah serum negative within six months sacramento cheetahs arrival <NUMBER> cheetahs seroconverted titers <NUMBER> supplemental figure s<NUMBER> ninety percent <NUMBER> cheetahs park developed disease symptoms including jaundice diarrhea weight loss gingivitis hepatic renal pathology mortality <NUMBER> within <NUMBER> years extreme outbreak coronavirus species recorded characterize genomic disposition cheetahs ajucov strain pcr primers based alignment seven coronavirus gene segments pol<NUMBER>a pol<NUMBER>b n <NUMBER>a<NUMBER>b <NUMBER>′ ′utr used amplify cdna archived cheetah liver kidney tissues collected winston outbreak tissues five different cheetahs successfully used amplification <NUMBER> bp pol <NUMBER>b gene <NUMBER> bp pol <NUMBER>a <NUMBER> bp n<NUMBER>a <NUMBER> bp <NUMBER>′ ′utr region phylogenetic analyses aligned virus genome sequences confirm monophyly three previously discovered antigenic groups coronavirus plus divergent sarscov genome figure <NUMBER> supplemental data cheetah isolates nested within group domestic cat viruses using pol <NUMBER>a n<NUMBER>a also polyphyletic intermix <NUMBER>′ ′utr gene segment phylogenetic analyses indicate close similarity ajucov fcov strains suggesting cheetah virus closely related indistinguishable domestic cat isolates likely scenario explain results fcov jumped domestic cat cheetah interestingly two cheetahs exported sacramento winston visited uc davis veterinary hospital many domestic cat fcov isolates originally isolated suggesting opportunity cross species transmission second cats cheetahs humans viruses highly contagious spreading rapidly close quarters weeks days third despite similarities clear difference age sensitivity sars virtually childhood cases mortality reaches <NUMBER> people <NUMBER> preexisting medical complications <NUMBER> cheetahs domestic cats mortality highest neonates infants subadults <NUMBER> cheetah cubs succumbed winston outbreak <NUMBER> fourth mortality among humans sars symptoms house cats fcov low around <NUMBER> cheetahs ajucov exhibited opposite extreme showing <NUMBER> morbidity <NUMBER> mortality two plausible explanations cheetahs extreme sensitivity ajucov one slight mutational differences transform relatively benign coronavirus strain virulent hot strain among coronaviruses scenario proposed proven transition fecv fipv cats <NUMBER> hypothesis less likely cheetahs outbreak mentioned lions became infected concurrently cheetahs developed overt symptoms <NUMBER> also experimental transmission ajucov three domestic kittens failed cause disease <NUMBER> perhaps also relevant human sarscov induced domestic cats developed symptoms <NUMBER> cheetahs known worlds fastest land animal also extreme genetic uniformity consequence escape extinction <NUMBER> years ago remarkably unrelated cheetahs accept skin grafts nonrelatives characteristic highly inbred laboratory strains mice rats <NUMBER> likely explanation high mortality cheetahs genetic uniformity particularly immune genes like mhc may rendered species susceptible emerging virulent strain evolved circumvent defenses first victim hypothesis correct greater genetic diversity domestic cats humans may reduce severity epidemic also contribute occurrence rare genetically determined sarscov superspreaders infect high virulence explanation emphasizes critical role intrinsic genomic diversity among immune defense genes fatal epidemic search explicating genetic susceptibility polymorphisms may inform prognosis spread therapy prevention emerging pathogens seems warranted particularly anticipate future episodes deadly sars coronavirus coronaviruses enveloped positivesense rna viruses vary <NUMBER> nm <NUMBER> nm diameter projections form spikes give appearance crown hence name november <NUMBER> four known coronaviruses presented humans causing mild respiratory infections hku<NUMBER> nl<NUMBER> <NUMBER>e oc<NUMBER> <NUMBER> <NUMBER> appearance new human coronavirus recently described first reported city wuhan china novel coronavirus sarscov<NUMBER> beta coronavirus subgenus sarbecovirus subfamily orthocoronavirinae organization viral genome wuhan human<NUMBER> coronavirus determined sequencing alignment two beta coronaviruses one associated humans sarscov tor<NUMBER> one associated bats bat slcovzc<NUMBER> <NUMBER> <NUMBER> infectious disease due coronavirus sonamed world health organization february <NUMBER> <NUMBER> caused sarscov<NUMBER> virus causal agent potentially fatal disease become huge public health problem across globe <NUMBER> february <NUMBER> <NUMBER> <NUMBER> confirmed cases registered worldwide least <NUMBER> countries <NUMBER> deaths resulting worldwide health emergency declared <NUMBER> mexico first case reported february <NUMBER> two days later four cases confirmed mexican health department cases traced back individual bergamo italy <NUMBER> progression pandemic rising worldwide <NUMBER> confirmed cases reported may <NUMBER> <NUMBER> mortality rate <NUMBER> mexico date <NUMBER> confirmed j u r n l p r e p r f cases <NUMBER> deaths due covid<NUMBER> <NUMBER> even though disease whose severe manifestations atypical pneumonia sepsis digestive tract particularly liver recently reported affected sarscov<NUMBER> <NUMBER> <NUMBER> therefore aim present work review available literature topic provide recommendations related role covid<NUMBER> healthy diseased livers platform ictrp search carried within time frame january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> utilizing search term coronavirus combined following terms sarscov<NUMBER> liver hepatic enzymes acute chronic cirrhosis liver failure hepatitis covid<NUMBER> spanish equivalents found <NUMBER> works included <NUMBER> present review excluded articles case reports duplicate publications language spanish english j u r n l p r e p r f clinical manifestations covid<NUMBER> varied range asymptomatic state severe acute respiratory distress syndrome ards multiorgan dysfunction common signs symptoms fever cough sore throat headache fatigue myalgia dyspnea conjunctivitis progress pneumonia respiratory failure death <NUMBER> addition patients covid<NUMBER> infection also presented gastrointestinal symptoms diarrhea low percentage patients merscov sarscov present similar gastrointestinal complaints symptoms appear incubation period approximately <NUMBER> days <NUMBER> metalloproteinase called angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified functional receptor coronavirus cell entry ace<NUMBER> microrna expression found multiple organs human tissue including oral nasal mucosa nasopharynx lung stomach small bowel colon skin lymph nodes thymus bone marrow spleen kidney brain biliary epithelium liver making expression potential target infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus liver organ affected covid<NUMBER> information liver either healthy presenting preexisting hepatic disease pathophysiologic target family coronaviruses liver injury hepatitis patients sars manifested mildtomoderate elevation alanine aminotransferase alt aspartate aminotransferase ast early disease stage well decrease serum albumin increase serum bilirubin levels autopsy findings patients sars show large number j u r n l p r e p r f viral particles lungs also parenchymal cells vascular endothelium organs including liver <NUMBER> incidence liver injury specifically associated covid<NUMBER> varies <NUMBER> majority case series reported alterations alt ast elevated total bilirubin low serum albumin <NUMBER> chen et al reported case series <NUMBER> cases pneumonia due covid<NUMBER> one patient lesion severe hepatocellular pattern elevated alt ast whereas rest patients moderately elevated aminotransferase levels decrease albumin present majority cases respect coagulation profile prothrombin time increased <NUMBER> cases highlighting increase dimer levels onethird patients fig <NUMBER> <NUMBER> likewise huang et al found similar liver biochemistry alterations describing elevated ast levels <NUMBER> patients higher number cases patients admitted intensive care unit icu <NUMBER> vs <NUMBER> <NUMBER> case series <NUMBER> covid<NUMBER> cases wang et al also found statistically higher ast levels patients required icu admission p <NUMBER> <NUMBER> addition studies presence liver alterations related death case series mortality sarscov<NUMBER> <NUMBER> cases zhang et al reported median time symptom onset death <NUMBER> days respect transaminase elevation significant association ast p <NUMBER> alt p <NUMBER> time symptom onset death <NUMBER> another report huang et al described clinical characteristics <NUMBER> patients survive covid<NUMBER> liver chemistry alterations behaved similarly previous reports elevated alt <NUMBER> elevated ast <NUMBER> decrease albumin <NUMBER> increase total bilirubin <NUMBER> increase dimer <NUMBER> cases <NUMBER> finally zhou et al reported <NUMBER> patients covid<NUMBER> <NUMBER> presented elevation alt <NUMBER> ul subgroup patients died alt elevated <NUMBER> cases vs <NUMBER> patients group survived p <NUMBER> <NUMBER> context report <NUMBER> patients covid<NUMBER> conducted guang et al stated ast elevation <NUMBER> ul <NUMBER> patients alt elevation <NUMBER> ul <NUMBER> patients severe disease patients required icu admission mechanical ventilation died <NUMBER> elevated ast <NUMBER> elevated alt <NUMBER> table <NUMBER> summarizes characteristics liver chemistry alterations outcomes due problem access biopsy autopsy reports histopathologic findings new disease yet completely defined case report xu et al <NUMBER> presented postmortem biopsy results <NUMBER>yearold man died severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> respect liver biopsies microvesicular steatosis mild lobular portal inflammatory activity nevertheless completely certain liver injury due sarscov<NUMBER> druginduced liver injury dili latter diagnostic probability sustained fact numerous drugs great hepatotoxic potential remdesivir tocilizumab chloroquine statins empirically used cases treat severe sarscov<NUMBER> make j u r n l p r e p r f coronavirus patient prone developing dili <NUMBER> also information case report comorbidities know patient could risk due preexisting liver disease leads hypothesis elevated aminotransferases may result direct effect hepatocyte mediated virus liver injury mediated immune inflammatory activation associated infection patients cirrhosis liver cl immunocompromised susceptible developing spontaneous bacterial infections due uncommon pathogens reflected higher mortality rate close <NUMBER> <NUMBER> patients cl especially decompensated stage susceptible development infections whose prevalence increase <NUMBER> <NUMBER> thus cl state immune dysfunction encompasses immunodeficiency systemic inflammation exhibiting least two known phenotypes immune dysfunction cirrhosis proinflammatory immunodeficient characterized differences cytokine activity phagocyte activity hla expression among others present throughout pathophysiologic stages compensated stages decompensated stages acuteonchronic liver failure aclf <NUMBER> said immunodeficiency also results reduced synthesis pattern recognition receptors prrs <NUMBER> different classes germlineencoded prrs recognize invasive pathogens monitor extracellular intracellular compartments host cells detect signs invasion microorganisms <NUMBER> liver primary source prrs eg creactive protein lipopolysaccharide throughout history outbreaks epidemics viral diseases especially respiratory diseases recent covid<NUMBER> pandemic patients chronic liver disease cld present multifactorial immune dysfunction <NUMBER> <NUMBER> due fact infection site affects outcome patients cld acute respiratory diseases acquire great importance produce almost <NUMBER>fold increase hospitalization rate compared general population <NUMBER> also generate <NUMBER>fold increase <NUMBER>day mortality community setting <NUMBER>fold increase hospital setting highest among isolated infectious complications <NUMBER> prevalence pneumonia influenza reported <NUMBER> united states <NUMBER> <NUMBER> respectively <NUMBER> expected patients higher grade decompensation higher mortality rate types events associated factors inadequate antibiotic use bacteremia leukocyte count total bilirubin j u r n l p r e p r f advanced age alcoholic disease etiology well development organ failure aclf <NUMBER> models developed community outbreaks influenzalike disease indicate increase morbidity mortality patients cld mainly related organ failure complications associated liver disease gastrointestinal bleeding <NUMBER> patients cld prone developing respiratory failure due numerous causes also present disease modifiers worsen natural history smoking chronic obstructive pulmonary disease malnutrition muscle deconditioning wasting hypoalbuminemia coagulopathy multiple transfusions etc addition ascites directly affects pulmonary respiratory mechanics increasing intraabdominal pressure hepatic encephalopathy increases risk microaspirations ineffective cough <NUMBER> thus <NUMBER> patients cld present arterial hypoxemia assisted ventilation event patients cirrhosis especially context ards mortality rate <NUMBER> <NUMBER> nontransplant hospitals <NUMBER> mortality rate patients cld icus <NUMBER> context ards outcome appears associated development extrapulmonary accumulated mortality rate infection patients cirrhosis <NUMBER> whereas mortality rate infection <NUMBER> <NUMBER> furthermore shortterm longterm outcomes occur acute respiratory failure event must added especially mechanical ventilation required generally worse outcomes cirrhotic patients without conditions <NUMBER> first epidemiologic reports characterizing patients covid<NUMBER> came china one reports provided data <NUMBER> patients <NUMBER> chronic hepatitis b virus hbv infection <NUMBER> probability presented hbv greater patients severe covid<NUMBER> disease nonsevere cases <NUMBER> another report wuhan china total <NUMBER> patients four presented cld require icu admission current experience renmin hospital university wuhan patients decompensated liver cirrhosis provided data <NUMBER> patients mean age <NUMBER> years <NUMBER> outpatients <NUMBER> inpatients <NUMBER> recent report lombardy italy <NUMBER> critically ill patients <NUMBER> cld <NUMBER> psychologic support vast importance prevent treatment interruption relapse alcohol consumption patients alcoholrelated cld patients must made aware keep abreast changes recommendations social policies instructed take substances medications prescribed physician including supplements alternative products measures prevention strengthen immune system etc long pandemic last known therefore essential recommendation influenza vaccination regimen patients cld date standard medical care patients hospitalized due causes covid<NUMBER> remains certain recommendations selection emergency elective procedures outlined table <NUMBER> likewise despite fact standardized treatment covid<NUMBER> management patients severe disease indications liver health summarized table <NUMBER> taken account according information reported international medical literature hepatic manifestations sarscov<NUMBER> common severe alterations j u r n l p r e p r f associated poor outcome severe cases beginning present mexico underlining importance aware hepatic manifestations general population cases potentially requiring opportune hospitalization recognized hand covid<NUMBER> infection patients preexisting cld implies greater risk probability liver dysfunction healthcare professionals charge patients recommended alert regarding development potential complications may questions usefulness strategies proposed herein dealing emerging pathology current magnitude impossible provide recommendations proven <NUMBER> disease behavior data reported past months dynamic thus considered definitive unalterable benefit patients cirrhosis liver must continuously updating information also important recognize studies different populations needed complete understanding morbidity mortality associated sarscov<NUMBER> cirrhotic patient based upon positive severe acute respiratory syndrome coronavirus <NUMBER> polymerase chain reaction assay performed either georgia department public health referral laboratory hospitalbased clinical laboratory study period icu capacity enabled timely admission patients requiring critical care covidicu patients admitted covidicu cared traditional icu care team led critical caretrained attending physician standard ie precovid icu staffing ratios critical shortages medications ventilators dialysis machines critical care equipment patient data including sociodemographic information clinical data laboratory data obtained electronic medical record data abstracted may <NUMBER> <NUMBER> data analyzed using chisquare wilcoxon ranksum test categorical continuous variables respectively twosided p value less <NUMBER> considered statistically significant stata version <NUMBER> statacorp llc college station tx study approved emory university institutional review board march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> <NUMBER> critically ill adults covid<NUMBER> infection admitted icu fig <NUMBER>a initial icu clinical findings critical care interventions outcomes summarized table <NUMBER> admission icu median sequential organ failure assessment sofa score <NUMBER> iqr <NUMBER> median ddimer <NUMBER> ngml iqr <NUMBER> ngml upper limit normal <NUMBER> ngml median creactive protein <NUMBER> mgl iqr <NUMBER> mgl upper limit normal <NUMBER> mgl median initial pao <NUMBER> fio <NUMBER> ratio <NUMBER> iqr <NUMBER> <NUMBER> patients <NUMBER> received invasive mechanical ventilation median static lung compliance first day intubation <NUMBER> mlcm h <NUMBER> iqr <NUMBER> ml cm h <NUMBER> total <NUMBER> patients <NUMBER> required vasopressor support shock <NUMBER> <NUMBER> required renal replacement therapy either form continuous renal replacement therapy intermittent hemodialysis use inhaled pulmonary vasodilators relatively uncommon <NUMBER> <NUMBER> four patients <NUMBER> received extracorporeal membrane oxygenation overall <NUMBER> patients <NUMBER> received least one dose hydroxychloroquine <NUMBER> patients <NUMBER> enrolled national institutes healthfunded adaptive clinical treatment trial actt remdesivir clinicaltrials gov nct<NUMBER> among <NUMBER> patients cohort <NUMBER> <NUMBER> transferred alive icu <NUMBER> died <NUMBER> icu five additional deaths occurred among patients transferred floor <NUMBER> <NUMBER> remain icu still mechanically ventilated fig <NUMBER>a three patients transferred icu went directly longterm acute care facility still receiving mechanical ventilation tracheostomy median icu length stay patients still icu <NUMBER> days iqr <NUMBER> among patients received invasive mechanical ventilation icu mortality <NUMBER> <NUMBER> hospital mortality <NUMBER> <NUMBER> fig <NUMBER>b median age patients died significantly older survived <NUMBER> yr iqr <NUMBER> yr vs <NUMBER> yr iqr <NUMBER> yr p <NUMBER> table <NUMBER> difference survival sexes patients died less likely morbidly obese although patients asian race higher mortality seven asian patients cohort patients either chronic kidney disease stage <NUMBER> higher endstage renal disease requiring hemodialysis also higher mortality patients died higher sofa score icu admission median <NUMBER> iqr <NUMBER> survived median <NUMBER> iqr <NUMBER> p <NUMBER> table <NUMBER> median ddimer values two times higher died survived <NUMBER> iqr <NUMBER> vs <NUMBER> iqr <NUMBER> p <NUMBER> similarly initial creactive protein pao <NUMBER> fio <NUMBER> ratios significantly worse patients died icu p <NUMBER> <NUMBER> respectively compared survived patients died icu likely respiratory failure requiring invasive mechanical ventilation <NUMBER> vs <NUMBER> p <NUMBER> shock requiring vasopressors <NUMBER> vs <NUMBER> p <NUMBER> renal failure requiring renal replacement therapy <NUMBER> vs <NUMBER> p <NUMBER> receive inhaled vasodilators <NUMBER> vs <NUMBER> p <NUMBER> overall mortality among patients received vasopressors <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> renal failure requiring renal replacement therapy died twelve <NUMBER> patients <NUMBER> received inhaled vasodilator refractory hypoxemia died among <NUMBER> patients died icu including three patients advance directive intubated median time icu admission death <NUMBER> days iqr <NUMBER> early experience large cohort critically ill patients covid<NUMBER> demonstrates mortality rate <NUMBER> overall substantially lower <NUMBER> reported published literature date <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally <NUMBER> mortality approximately threequarters patients cohort required mechanical ventilation also markedly lower previous reports data indicate majority critically ill patients covid<NUMBER> good clinical outcomes support ongoing use mechanical ventilation patients acute respiratory failure earliest reports covid<NUMBER> wuhan mortality rates among admitted icus ranged <NUMBER> <NUMBER> increased <NUMBER> among requiring invasive mechanical ventilation <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent data united kingdom <NUMBER> received mechanical ventilation died compared <NUMBER> patients intubated viral pneumonia preceding <NUMBER> years <NUMBER> early reports smaller cohorts seattle first covid<NUMBER> outbreaks occurred united states indicated <NUMBER> patients admitted icu <NUMBER> receiving invasive mechanical ventilation died <NUMBER> <NUMBER> recently published report new york found <NUMBER> mortality among required mechanical ventilation <NUMBER> patients still admitted hospital <NUMBER> taken together reports raised concerns survival among receiving mechanical ventilation exceedingly poor <NUMBER> <NUMBER> <NUMBER> <NUMBER> contrast majority prior reports data provide evidence mortality rates covid<NUMBER> comparable seen ards infectious pneumonias <NUMBER> <NUMBER> <NUMBER> <NUMBER> cohort mortality associated older age <NUMBER> mortality age <NUMBER> compared <NUMBER> age <NUMBER> mortality also associated severity illness arrival icu need icu interventions including mechanical ventilation vasopressor support renal replacement therapy inhaled vasodilators approximately half cohort received least one dose hydroxychloroquine nearly onequarter received least one dose study drug part actt trial remdesivir vs placebo difference survival either groups finally although eight patients <NUMBER> still admitted icu time report <NUMBER> <NUMBER> discharged hospital several local regional considerations may influenced observed outcomes first arrival peak covid<NUMBER> pandemic georgia later many regions earlier reports delay provided time establish organizational structures acquire equipment prepare personnel create consensusdriven clinical protocols align resources across large healthcare system addition patient volumes merit redesignation several specialty icus covidicus critically ill patients covid<NUMBER> admitted preexisting icus cared critical care teams experience managing acute respiratory failure standard patienttoprovider ratios analysis impact clinical interventions survival beyond scope brief report internal cohort critically ill adults covid<NUMBER> report early mortality rate <NUMBER> overall <NUMBER> patients received mechanical ventilation although may several factors underlying findings results suggest patients acute respiratory failure covid<NUMBER> may recover even severe disease requiring intubation mechanical ventilation coronavirus infection outbreaks occurred frequently last two decades led significant mortality despite focus reducing mortality preventing spread virus patients died due several complications illness understanding pathological mechanisms implications continuously evolving number symptoms occur patients due involvement various endocrine glands clinical presentations went largely unnoticed first outbreak severe acute respiratory syndrome sars <NUMBER> <NUMBER> derangements continued convalescence phase sometimes occurred recovery similar pathological biochemical changes reported novel coronavirus disease outbreak <NUMBER> review focus endocrine changes reported sars coronavirus sars coronavirus<NUMBER> battle pandemic becomes imperative address underlying endocrine disturbances contributing towards predicting mortality patients <NUMBER> december <NUMBER> office china informed cases pneumonia unknown cause originating city wuhan hubei china <NUMBER> next <NUMBER> months severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> illness commonly called covid<NUMBER> affected four million people globally <NUMBER> million cases usa making new epicentre illness followed much western europe mortality rates different parts world show vast differences studies consistently shown presence comorbidities specially type <NUMBER> diabetes mellitus significantly increases mortality patients sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> study china also showed patients intensive care unit sarscov<NUMBER> infection likely underlying diabetes <NUMBER> vs <NUMBER> others <NUMBER> certain forms hypophysitis thyroiditis adrenalitis viral aetiologies changes endocrine functions observed previous coronavirus outbreak sarscov led considerable morbidity important predictors mortality therefore imperative know endocrinopathic impact sarscov<NUMBER> illness purpose review highlight available data endocrine changes patients recapitulate existing knowledge previous coronavirus outbreaks better risk stratification management patients sarscov<NUMBER> infection articles reporting endocrine changes sarscov<NUMBER> sarscov patients considered electronic database pubmed searched using medical subject headings mesh terms related sarscov<NUMBER> sarscov different hormones since sarscov outbreak occurred <NUMBER> search results limited january <NUMBER> onwards consider articles pertaining outbreaks viruses considerable number articles chinese language included translated english supplemented handsearching reference lists additional studies case reports similarly google scholar database handsearched studies listing type <NUMBER> diabetes mellitus risk factor sarscov<NUMBER> sarscov excluded since mention biochemical changes articles corticosteroid induced hyperglycaemia audio interviews articles detailing reninangiotensin aldosterone system raas inhibitors excluded initial search showed <NUMBER> articles finally <NUMBER> included figure <NUMBER> coronavirus infections cause systemic disease injures many organs patients manifest many hormonal metabolic disturbances changes thyroid pancreas adrenal glands reported detail sarscov current sarscov<NUMBER> infections pathology data clinical features management outcome endocrinopathies highlighted figure <NUMBER> detailed histopathological study effects sars infection thyroid gland done sarscov outbreak <NUMBER> extensive injury parafollicular cells follicular epithelium destruction exfoliation epithelial cells follicle leading disruption changes responsible lower levels thyroid hormones noted clinical studies parafollicular cells responsible calcitonin production could identified sections tissue sample patients sars damage interfollicular tissue including parafollicular cells may adversely affect calcitonin production interesting finding absence inflammatory infiltrate features cellular necrosis supporting hypothesis extensive apoptosis responsible thyroid injury pathology data thyroid gland patients sarscov<NUMBER> infection published yao et al conducted minimally invasive autopsies different organs patients died sarscov<NUMBER> investigated pathological changes <NUMBER> reported abnormalities thyroid follicular morphology note lymphocytic infiltration interstitium none tissue immunohistochemistry pcr analyses detected sarscov<NUMBER> thyroid gland findings variance reported sarscov though patient characteristics two studies nearly however irrespective pathological findings studies found similar pattern biochemical changes limited data suggest thyroid gland hypothalamopituitarythyroid hpt axis directly affected sarscov<NUMBER> illness study <NUMBER> patients sarscov<NUMBER> showed thyroid stimulating hormone tsh free triiodothyronine t<NUMBER> concentrations significantly lower deceased patients <NUMBER> miuml <NUMBER> pmoll recovered patients <NUMBER> miuml <NUMBER> pmoll difference thyroxine t<NUMBER> levels statistically significant <NUMBER> study wang et al reported serum levels t<NUMBER> t<NUMBER> patients sarscov significantly lower control group low t<NUMBER> levels correlated disease severity serum t<NUMBER> t<NUMBER> levels decreased respectively <NUMBER> <NUMBER> <NUMBER> patients sarscov acute phase <NUMBER> <NUMBER> convalescent phase disease <NUMBER> authors also noted lower levels tsh patients dysfunction hpt axis caused diminished level serum tsh patients sarscov despite low serum t<NUMBER> t<NUMBER> significant difference serum parathyroid hormone level observed patients sarscov control group acute convalescent phases illness changes thyroid hormone levels may persist clinical recovery leow et al studied sarscov survivors hormonal derangements <NUMBER> months recovery noted <NUMBER> patients developed biochemical hypothyroidism <NUMBER> majority patients <NUMBER> central aetiology <NUMBER> developed primary hypothyroidism positive antibodies continued receive thyroid hormone replacement end study followup changes thyroid profile patients central hypothyroidism normalised central hypocortisolism also present <NUMBER> patients central hypothyroidism authors suggested dysfunctional hpt axis evidenced results thyroid hormones coexistence central hypocortisolism studies suggest monitoring thyroid function tests acute illness well convalescence sarscov<NUMBER> possibility replacement therapy indicated reports recovery thyroid function <NUMBER> months sarscov patients implying reassessment survivors current pandemic <NUMBER> many viruses enteroviruses coxsackie b virus <NUMBER> retroviruses rubella mumps cytomegalovirus epsteinbarr varicella zoster virus implicated development diabetes mellitus humans <NUMBER> review coronavirus also reported cause diabetes animal human studies case report foal suggested pancreas could direct viral damage due coronavirus leading diarrhoea transient diabetes mellitus simultaneously <NUMBER> demonstrated coronaviruses enter human lungs pancreas tissues interacting ace<NUMBER> receptor expression ace<NUMBER> much stronger pancreatic endocrine tissue compared exocrine tissue <NUMBER> extent tissue damage sarscov direct function level expression tissue ace<NUMBER> thus sarscov viruses may damage pancreatic islets cause acute insulin dependent diabetes mellitus acute pancreatitis pancreatic biopsy findings sarscov<NUMBER> patients identical previous studies sarscov patients yao et al reported obvious abnormalities epithelial cells exocrine pancreas however degeneration islet cells noted <NUMBER> observed patients mild sarscov receive glucocorticoid medications disease course higher level fasting plasma glucose fpg first day hospitalisation nonsars pneumonia newonset diabetes developed <NUMBER> sarscov patients previous diabetes received steroid treatment illness <NUMBER> hyperglycaemia independent predictor mortality morbidity sarscov patients without history diabetes mellitus <NUMBER> yang et al demonstrated steroid treatment mean fpg level significantly higher sarscov patients deceased vs survivors vs nonsars pneumonia group <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll p<NUMBER> hyperglycaemia fpg≥<NUMBER> mmoll steroid treatment significantly associated death <NUMBER> adjustment age gender incremental rise mortality increasing fpg another interesting association noted hypoxaemia higher fpg levels <NUMBER> among patients known history diabetes commencement steroid therapy hypoxaemia arterial oxygen saturation <NUMBER> higher fpg levels hypoxia survivor <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll deceased <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll groups estimated every <NUMBER> mmoll increase fpg hr increased <NUMBER>fold death <NUMBER>fold hypoxia morbidity survivors deceased patients irrespective steroid dosage elevated fpg values started falling third week indicating gradual recovery islet cell function half billion people currently living diabetes worldwide patients diabetes poorer outcome previous epidemics sarscov h<NUMBER>n<NUMBER> epidemics <NUMBER> <NUMBER> clinical course sarscov<NUMBER> infection patients diabetes without comorbidities recently reported guo et al wuhan china <NUMBER> patients diabetes may present milder symptoms initially higher risk rapid progression severe pneumonia uncontrolled cytokine storm hypercoagulable state contributing poorer prognosis interleukin<NUMBER> il<NUMBER> level found higher sarscov<NUMBER> cases diabetes without diabetes wang et al hypothesised sarscov<NUMBER> infection patients diabetes might trigger stress condition increase secretion hyperglycaemic hormones glucocorticoid catecholamines resulting elevated blood glucose abnormal glucose variability diabetic complications turn leading higher mortality morbidity rates patients <NUMBER> study <NUMBER> sarscov<NUMBER> patients demonstrated <NUMBER> patients elevated blood glucose mean glucose value <NUMBER> mmoll <NUMBER> wu et al <NUMBER> showed sarscov<NUMBER> patients developing acute respiratory distress syndrome ards higher glucose levels <NUMBER> vs <NUMBER> mmoll compared patients develop ards hr <NUMBER> similarly sarscov<NUMBER> patients presenting gastrointestinal symptoms increased glucose level independent risk factor severecritical illness multivariate analysis <NUMBER> <NUMBER> sarscov<NUMBER> patients diabetes high risk progressing rapidly ards septic shock et al recommended fpg <NUMBER> mmoll <NUMBER>hour postprandial plasma glucose <NUMBER> h pg <NUMBER> mmoll mild cases fpg <NUMBER> mmoll <NUMBER> h pg <NUMBER> mmoll critically ill patients sarscov<NUMBER> <NUMBER> sum sarscov infections damage islet cells causing acute temporary diabetes high fpg associated metabolic changes lead increased morbidity mortality patients addition preexisting diabetes may considered risk factor poorer outcomes sarscov<NUMBER> pneumonia intensive blood glucose monitoring insulin therapy obtain optimal metabolic control may improve outcome patients tocilizumab monoclonal antibody il<NUMBER> may role patients diabetes control overexpressed il<NUMBER> used offlabel currently randomised controlled trial testing utility <NUMBER> european society endocrinology statement advises patients diabetes avoid physician office visits seek telephonicelectronic consultations optimal control blood sugar need get early referral emergency services case possible symptoms sarscov<NUMBER> <NUMBER> histological changes adrenal glands patients dying sarscov described ding et al postmortem biopsy samples <NUMBER> noted adrenal medulla infiltrated mainly monocytes lymphocytes another interesting finding focal necrosis gland addition vasculitis small veins adrenal medulla present similar studies conducted sarscov<NUMBER> patients date however reasons believe similar adrenal gland changes could occur given similarity viral structure mechanism entry human host cells sarscov genome sequences detected cytoplasm numerous neurons hypothalamus cortex <NUMBER> might induce either hypophysitis directly affect hypothalamus leading hypothalamicpituitary dysfunction leow et al <NUMBER> studied hypocortisolism patients recovered sarscov patients intact hypothalamicpituitaryadrenal hpa axis time acquiring sarscov included study patients also symptoms like lethargy malaise lassitude fatigue weakness orthostatic dizziness anorexia apathy anxiety depression recovery three months recovery <NUMBER>·<NUMBER> patients hypocortisolism <NUMBER>·<NUMBER> central hypocortisolism depicted low adrenocorticotropic hormone acth levels interesting note majority patients received systemic glucocorticoids part treatment sars ruling possibility hpa axis suppression exogenous corticosteroid use hypocortisolism however transient resolved <NUMBER>·<NUMBER> patients within year average duration <NUMBER>·<NUMBER>±<NUMBER>·<NUMBER> months patients also reported resolution symptoms including orthostatic hypotension comparison start study six patients <NUMBER> continued residual hypocortisolism <NUMBER>year followup one still required hydrocortisone replacement findings sarscov sarscov<NUMBER> patients suggest actively monitoring biochemical changes like serum cortisol acth shall biochemical changes go unnoticed may complicate postsars recovery symptomatic patients orthostatic hypotension may require physiological doses hydrocortisone replacement hpa axis recovery addition patients adrenal insufficiency cushings syndrome increased risk sarscov<NUMBER> infection adhere enhanced preventive steps changes cells anterior pituitary noted biopsy samples sarscov patients <NUMBER> immunohistochemical staining number somatotrophs thyrotrophs corticotrophs reduced number lactotrophs gonadotrophs significantly increased findings correlated biochemical abnormalities increased prolactin luteinising hormone follicle stimulating hormone sarscov reported earlier chinese literature seasonal h<NUMBER>n<NUMBER> influenza virus h<NUMBER>n<NUMBER> pandemic associated increased severity greater risk morbidity mortality obese persons compared normal weight persons overweight obesity negatively impact cellular immune response h<NUMBER>n<NUMBER> influenza <NUMBER> obesity associated several chronic diseases like diabetes mellitus obstructive sleep apnoea surfactant dysfunction lungs may increase risk complications sarscov<NUMBER> intensive care management patients severe obesity always challenging difficult <NUMBER> likely obesity independent risk factor severe sarscov<NUMBER> illness investigated early studies linked increased mortality rates sarscov<NUMBER> patients presence diabetes mellitus increased glucose levels associated development ards worsening sarscov<NUMBER> illness requiring intubation mechanical ventilation hyperglycaemia useful predictor assess patients triage effectively provide early management strategies strict glucose management required patients reduce mortality central hypothyroidism central hypocortisolism seem occur commonly patients infected coronavirus changes usually transient occur illness recovery crucial information calls reassessment survivors current pandemic identifying changes early prompt management prevent complications prospective randomised clinical trials cohort studies age gender deceased patient stated official documents press conferences considered following data abstracted gender age time symptom onset hospital admission time hospital admission death medical history first symptoms measure studied confidence interval central tendency calculated eg proportion male mean age computation done spreadsheet microsoft office excel version <NUMBER> regression model estimated regressing time hospital admission death variables computation done software r adjusted r <NUMBER> used model selection criterion moreover different functional forms attempted ensure normally distributed residuals free autocorrelation heteroskedasticity fortysix fatal cases identified included study including <NUMBER> cases hubei <NUMBER> one chongqing <NUMBER> two henan <NUMBER> two heilongjiang <NUMBER> one hebei <NUMBER> one sichuan <NUMBER> seven cases outside hubei three travel history wuhan demographic common clinical characteristics illustrated table <NUMBER> average age <NUMBER> years n <NUMBER> <NUMBER> ci <NUMBER> significant difference men women test p <NUMBER> eightyfour percent deceased patients age <NUMBER> men accounted <NUMBER> <NUMBER> ci <NUMBER> deceased patients time first symptom onset hospital admission normally distributed mean <NUMBER> days time hospital admission death lognormally distributed mean <NUMBER> days median <NUMBER> days suggested jarquebera normality test p <NUMBER> logtransformed data therefore logtransformed time hospital admission death regressed model based adjusted r <NUMBER> time symptom onset hospital admission cardiovascular cerebrovascular comorbidities age selected independent variables table <NUMBER> exception cardiovascular cerebrovascular comorbidities variables significant <NUMBER> level signs coefficients reasonable time hospitalisation death inversely related age time symptom onset hospitalisation statistical significance time symptom onset hospital suggests need timely hospitalisation fact coefficient time symptom onset hospital admission means two identical patients eventually expire hospital admission <NUMBER> day apart expected time hospital admission death patient later hospital admission <NUMBER> shorter patient else equal although patient admitted hospital palpitation <NUMBER> november <NUMBER> important note palpitation common symptom covid<NUMBER> infection  myocardial injury associated higher mortality patients coronavirus disease <NUMBER> metaanalysis december <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused novel coronavirus sarscov<NUMBER> broke wuhan china spread widely world reaching pandemic level <NUMBER> according latest report <NUMBER> cases covid<NUMBER> confirmed globally march <NUMBER> <NUMBER> <NUMBER> deaths <NUMBER> covid<NUMBER> highly contagious harmful crucial determine predictors severe infection death risk stratification guiding clinical treatment intervention  respiratory symptoms prevalent manifestations covid<NUMBER> however studies shown acute cardiac injury common complication covid<NUMBER> patients <NUMBER> <NUMBER> indeed study early stage disease outbreak showed <NUMBER> <NUMBER> patients diagnosed covid<NUMBER> acute myocardial injury characterized significant increase level hypersensitive troponin hsctni <NUMBER> heart autopsy results three covid<NUMBER> cases revealed pathological changes cardiomyocyte hypertrophy partial cardiomyocyte degeneration necrosis mild interstitial congestion edema accompanied small number lymphocytes monocytes neutrophil infiltration <NUMBER> additionally metaanalysis showed hsctni significantly increased patients severe covid<NUMBER> compared mild forms <NUMBER> therefore myocardial injury likely important prognostic factor covid<NUMBER> summarize current literature explore correlation myocardial injury mortality patients covid<NUMBER> pubmed web science medrxiv covid<NUMBER> academic research communication platforms articles chinese httpmedjournalscn<NUMBER>ncpindexdo authors contributed equally manuscript correspondence yangyn<NUMBER>com used search articles published march <NUMBER> <NUMBER> without language restriction application following keywords used coronavirus disease <NUMBER> covid<NUMBER> novel coronavirus pneumonia <NUMBER>ncov sarscov<NUMBER> heart injury cardiac injury myocardial injury death mortality nonsurvivor deceased alone combination title abstract full text documents identified using search criteria assessed reporting mortality rate covid<NUMBER> patients without myocardial injury included metaanalysis reference lists studies also analyzed identify additional eligible studies metaanalysis performed retrievable data including estimation odds ratio <NUMBER> confidence interval ci mortality patients without myocardial injury statistical analyses conducted revman <NUMBER> software chichester uk centre cochrane collaboration mantelhaenszel statistical method fixed effect analysis model models employed assess outcomes forest plots utilized visually illustrate effect estimates included studies funnel plots used examine publication bias used newcastleottawa scale nos evaluate quality observational studies nos score <NUMBER> considered good quality <NUMBER> overall <NUMBER> studies originally detected based electronic reference search screening title abstract full text <NUMBER> studies excluded specifically related covid<NUMBER> n <NUMBER> review articles n <NUMBER> provide relevant data n <NUMBER> editorials n <NUMBER> compared patients severity mortality n <NUMBER> ultimately <NUMBER> studies involving total <NUMBER> patients enrolled <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> characteristics included studies described table <NUMBER> treatment clinical outcome patients described table <NUMBER> articles included metaanalysis high quality according nos mortality rate without myocardial injury patients covid<NUMBER> depicted figure <NUMBER>a study overall mortality rate <NUMBER> mortality rate patients without myocardial injury considerably lower patients myocardial injury <NUMBER> vs <NUMBER> p <NUMBER> myocardial injury significantly associated increased mortality patients covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> heterogeneity among studies borderline significant <NUMBER> <NUMBER> p <NUMBER> funnel plot showed symmetry indicating low risk publication bias figure <NUMBER>b sarscov<NUMBER> causes myocardial injury direct indirect pathogenic pathways singlecell data analysis identified human myocardial cells express angiotensinconverting enzyme <NUMBER> ace<NUMBER> higher expression present patients heart failure <NUMBER> sarscov<NUMBER> may invade cells binding ace<NUMBER> causing direct damage cardiomyocytes however autopsy results covid<NUMBER> cases failed detect sarscov<NUMBER> virus components myocardial tissue electron microscope observation immunohistochemical staining pcr <NUMBER> sarscov<NUMBER> infection may also cause myocardial injury overactivetion immune system release large number cytokines cytokine storms <NUMBER> <NUMBER> addition pulmonary infectioninduced hypoxemia respiratory failure shock might lead insufficient myocardial oxygen supply infection burden heart increases imbalance oxygen supply demand leads myocardial injury <NUMBER> overall studies necessary clarify mechanism sarscov<NUMBER>induced myocardial injury overall mortality rate <NUMBER> metaanalysis much higher value <NUMBER> <NUMBER> confirmed cases reported study chinese centers disease control prevention <NUMBER> possible reason involved studies included high proportion critically ill patients large sample size report also showed case fatality rate associated disease severity death cases among critical patients metaanalysis showed covid<NUMBER> patients myocardial injury higher mortality rate previous metaanalysis also reported significant increase ctni patients severe sarscov<NUMBER> infection indicating myocardial injury might related covid<NUMBER> severity <NUMBER> therefore existence myocardial injury regarded important index risk stratification disease severity death covid<NUMBER> continuous monitoring myocardial injury markers cardiac function hospitalization strengthened patients myocardial injury believe doctors conduct comprehensive treatment including correcting hypoxemia improving myocardial oxygen supplementation applying immunoglobulins inhibit excessive immune response improving myocardial energy metabolism maintaining waterelectrolyte balance improve prognosis covid<NUMBER> patients httpwwwjgc<NUMBER>com jgcjgc<NUMBER>com journal geriatric cardiology december <NUMBER> group patients pneumonia unknown cause later confirmed infected novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> wuhan hubei province china <NUMBER> <NUMBER> clinical spectrum sarscov<NUMBER> infection appeared wide ranging asymptomatic infection mild upper respiratory tract illness severe even fatal cases accommodate wide spectrum clinical presentations outcomes infections caused sarscov<NUMBER> <NUMBER>à<NUMBER> later introduced rather unspecific name covid<NUMBER> coronavirus disease <NUMBER> denote disease rapid emergence covid<NUMBER> wuhan city hubei province china resulted thousands deaths <NUMBER> recently covid<NUMBER> spread rapidly around world caused death hundreds thousands patients <NUMBER> present effective therapies vaccines covid<NUMBER> reported death mainly severe patients many infected patients presented mild flulike symptoms quickly recover <NUMBER> however differences clinical characteristics severe nonsevere cases little reported <NUMBER> <NUMBER> particular comparison clinical characteristics survivors nonsurvivors severe patients risk factors survival reported study aimed identify risk factors mortality severe patients establish risk model predict mortality clinicians effectively consider medical resources patients different risks retrospective cohort study included three institutions zhongnan hospital wuhan university <NUMBER> hospital wuhan leishenshan hospital wuhan china zhongnan hospital responsible treatments covid<NUMBER> assigned government <NUMBER> hospital wuhan one designated hospitals hospitalization patients covid<NUMBER> entrusted zhongnan hospital wuhan university since january <NUMBER> leishenshan hospital hospital specially built treat patients covid<NUMBER> taken zhongnna hospital wuhan university consecutive patients confirmed covid<NUMBER> according interim guidance january <NUMBER> march <NUMBER> <NUMBER> enrolled present study <NUMBER> patients absent negative sarscov<NUMBER> test results excluded study patients involved study living wuhan outbreak period covid<NUMBER> clinical outcomes discharges mortality monitored march <NUMBER> <NUMBER> final date followup patients covid<NUMBER> experienced definite outcome study conducted according principles helsinki approved ethics committee zhongnan hospital wuhan university <NUMBER> epidemiological clinical laboratory radiological characteristics treatment outcomes data obtained electronic medical records standardized data collection forms data reviewed trained team physicians covid<NUMBER> defined positive result high throughput sequencing realtime reversetranscriptaseàpolymerasechainreaction rtpcr assay nasal pharyngeal swab specimens <NUMBER> targeted region rtpcr viral rna detection included open reading frame <NUMBER>ab orf<NUMBER>ab nucleocapsid protein n target <NUMBER> orf<NUMBER>ab forward primer ccctgtgggttttacacttaa reverse primer acgattgtgcatcagctga probe <NUMBER>vicccgtctgcggtatgtggaaaggttatggbhq<NUMBER> target <NUMBER> n forward primer ggggaacttctcctgctagaat reverse primer cagacattttgctctcaagctg probe <NUMBER>famttgctgctgcttgacagatttamra<NUMBER> radiologic assessments included chest radiography computed tomography ct laboratory examinations consisted complete blood count serum biochemical tests including liver renal function creatine kinase mb isoenzyme electrolytes coagulation profile creactive protein crp procalcitonin pct antisarscov<NUMBER> antibodies igg igm also tracked igm igg antibodies measured covid<NUMBER> igmigg chemiluminescence test kit shenzhen yahuilong biotechnology co ltd china tests performed iflash <NUMBER> automated analyzer durations illness onset complications hospital admission discharged death recorded criteria discharge absence fever least <NUMBER> days substantial improvement lungs chest ct clinical remission respiratory symptoms two throatswab samples negative sarscov<NUMBER> rna obtained least <NUMBER> h apart fever defined axillary temperature <NUMBER>¢<NUMBER>°c higher septic shock defined according <NUMBER> third international consensus definition <NUMBER> acute kidney injury aki identified according kidney disease improving global outcomes definition <NUMBER> <NUMBER> acute liver injury ali defined liver enzymes bilirubin twice upper limit normal <NUMBER> <NUMBER> acute myocardial injury ami defined serum levels evidence study searched pubmed march <NUMBER> <NUMBER> articles documented risk factors mortality scoring system predict inhospital death patients coronavirus disease <NUMBER> covid <NUMBER> resulting infection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> using search terms novel coronavirus sarscov<NUMBER> covid<NUMBER> death mortality model scoring system language time restrictions older age higher sequential organ failure assessment sofa score ddimer levels comorbidities lymphocytopenia elevated alanine aminotransferase highsensitive cardiac troponin reported associated mortality however published works found establish scoring system predict inhospital deaths patients severe covid<NUMBER> retrospective cohort study three hospitals wuhan china found old age coronary heart disease condition percentage lymphocytes <NUMBER> procalcitonin<NUMBER>¢<NUMBER> ngml ddimer <NUMBER>¢<NUMBER> ugml independent risk factors mortality based variables scoring system covid<NUMBER> css established divide patients lowrisk highrisk groups model displayed good discrimination auc<NUMBER>¢<NUMBER> calibration p<NUMBER>¢<NUMBER> complications lowrisk highrisk groups significantly different p<NUMBER>¢<NUMBER> use corticosteroids lowrisk groups increased hospital stays <NUMBER>¢<NUMBER> days p<NUMBER>¢<NUMBER> durations disease <NUMBER>¢<NUMBER> days p<NUMBER>¢<NUMBER> compared corticosteroids old age coronary heart disease condition lymphopenia elevated procalcitonin ddimer independently related mortality css useful predicting inhospital mortality complications could help clinicians identify highrisk patients poor outcomes cardiac biomarkers <NUMBER>th percentile upper reference limit new abnormalities shown electrocardiography echocardiography <NUMBER> coagulopathy defined <NUMBER>s extension prothrombin time <NUMBER>s extension activated partial thromboplastin time <NUMBER> illness severity covid<NUMBER> defined according chinese management guideline covid<NUMBER> version <NUMBER>¢<NUMBER> <NUMBER> covid<NUMBER> patients stratified follows mild ie mild clinical symptoms without imaging feature pneumonia ordinary ie clinical symptoms fever cough imaging feature pneumonia severe ie dyspnea respiratory frequency <NUMBER>min blood oxygen saturation <NUMBER> partial pressure arterial oxygen fraction inspired oxygen ratio <NUMBER> andor lung infiltrates <NUMBER> within <NUMBER> <NUMBER> h critical ill cases ie respiratory failure septic shock andor multiple organ dysfunction failure analysis severe cases included severe critical ill classification <NUMBER>th edition survival time defined illness onset death normality distribution continuous variables tested kolmogorovàsmirnov test used chisquare test fishers exact test categorical variables mannàwhitney u test continuous variables compare differences survivors nonsurvivors ibm spss statistics software version <NUMBER>¢<NUMBER> cutoff value continuous variables defined based receiver operating characteristic roc curve optimal sensitivity specificity training cohort missing values variable proportion missing values exceed <NUMBER> multiple imputation methods applied supplement missing values obtain complete data using mice package r version <NUMBER>¢<NUMBER>¢<NUMBER> software least absolute shrinkage selection operator lasso regression performed identify variables nonzero coefficients using package glmnet coefficients multivariable analyses used generate prediction model quantify discrimination performance model roc curve measured rms package r software comparing observed actual data predicted probability model calibration curves plotted accompanied hosmeràlemeshow test cumulative risk events estimated training independent validation cohort using kaplanàmeier method highand lowrisk groups logrank test assess statistical significance difference reported p values twosided significancelevel <NUMBER>¢<NUMBER> work supported key project anti<NUMBER> novel coronavirus pneumonia ministry science technology china grant number <NUMBER>yfc<NUMBER> total <NUMBER> patients hospitalized zhongnan hospital <NUMBER> hospital wuhan leishenshan hospital covid<NUMBER> total <NUMBER> cases complete data defined outcomes included among <NUMBER> cases <NUMBER> severe severe patients relatively high mortality rates zhongnan hospital wuhan university <NUMBER> <NUMBER> hospital wuhan <NUMBER> mortality rate leishenshan hospital <NUMBER> lower therefore <NUMBER> severe patients zhongnan hospital <NUMBER> hospital wuhan included training cohort compare characteristics survivors nonsurvivors <NUMBER> leishenshan hospital assigned independent validation cohort demographic clinical characteristics shown tables <NUMBER> <NUMBER> s<NUMBER> training cohort <NUMBER> nonsurvivors hospitalization median age severe patients <NUMBER> years range <NUMBER>à<NUMBER> years interquartile ranges <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> years <NUMBER>¢<NUMBER> years nonsurvivors number men women table <NUMBER> patients aged <NUMBER>à<NUMBER> years accounted largest proportion proportion <NUMBER>¢<NUMBER> among population training cohort <NUMBER> <NUMBER>¢<NUMBER> patients least one underlying comorbidity common hypertension <NUMBER>¢<NUMBER> followed coronary heart disease <NUMBER>¢<NUMBER> diabetes <NUMBER>¢<NUMBER> table <NUMBER> coronary heart disease chd diabetes statistical differences survivors nonsurvivors severe covid<NUMBER> abnormal radiologic findings chest present study nineteen patients <NUMBER>¢<NUMBER> coinfection virus admission influenza b coinfection <NUMBER> common table <NUMBER> treatment <NUMBER> <NUMBER>¢<NUMBER> patients received antibiotics <NUMBER> <NUMBER>¢<NUMBER> received antiviral drugs table <NUMBER> intravenous immunoglobulin use <NUMBER>¢<NUMBER> systematic corticosteroid application accounted <NUMBER> survivors <NUMBER> nonsurvivors p<NUMBER>¢<NUMBER> comparison treatment outcomes training cohort shown tables <NUMBER> <NUMBER> respiratory failure <NUMBER>¢<NUMBER> frequently observed complication followed ami <NUMBER>¢<NUMBER> ali <NUMBER>¢<NUMBER> aki <NUMBER>¢<NUMBER> table <NUMBER> secondary infection occurred <NUMBER>¢<NUMBER> patients sepsis acidosis occurred nonsurvivors frequency complications higher nonsurvivors survivors p<NUMBER>¢<NUMBER> table <NUMBER> median time illness onset admission similar survivors nonsurvivors p<NUMBER>¢<NUMBER> median duration <NUMBER>¢<NUMBER> days <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> survivors <NUMBER>¢<NUMBER> days <NUMBER>à<NUMBER>¢<NUMBER> nonsurvivors table <NUMBER> median time illness onset discharge <NUMBER>¢<NUMBER> days range <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> interquartile ranges <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> survivors whereas median time death <NUMBER>¢<NUMBER> days range <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> interquartile ranges <NUMBER>¢<NUMBER>à<NUMBER>¢<NUMBER> nonsurvivors p<NUMBER>¢<NUMBER> median time illness onset complication statistical differences survivors nonsurvivors p<NUMBER>¢<NUMBER> table <NUMBER> median time illness onset progression respiratory failure <NUMBER>¢<NUMBER> days followed secondary infection <NUMBER>¢<NUMBER> days ami <NUMBER> days ali <NUMBER>¢<NUMBER> days aki <NUMBER>¢<NUMBER> days acidosis <NUMBER>¢<NUMBER> days coagulopathy <NUMBER>¢<NUMBER> days sepsis <NUMBER>¢<NUMBER> days table <NUMBER> fig <NUMBER>a among nonsurvivors median time illness onset admission admission progression complication complication occurred death shown fig <NUMBER> b median time coagulopathy acidosis death shortest <NUMBER> days followed aki ali ami sepsis respiratory failure secondary infection cases zhongnan hospital <NUMBER> nonsevere serums <NUMBER> severe serums tested antisarscov<NUMBER> antibodies patients covid<NUMBER> igg igm levels severe nonsevere patients shown fig <NUMBER>c maximum time antibody monitoring <NUMBER> days illness onset antibody levels severe nonsevere patients statistical differences p<NUMBER> igg p<NUMBER> igm igg levels reached highest <NUMBER>à<NUMBER> days severe nonsevere covid<NUMBER> patients severe patients level igg gradually declined <NUMBER> days nonsevere patients remained stable igm levels stabilized low levels nonsevere patients whereas gradually increased <NUMBER> days onset symptoms severe patients declined <NUMBER> days total <NUMBER> characteristics analyzed lasso binary logistic regression training cohort <NUMBER> candidate variables reliably associated survival selected fig <NUMBER> weight factor associated infection obtained calculating coefficients logλà<NUMBER>¢<NUMBER> λ<NUMBER>¢<NUMBER> lasso binary logistic regression model fig <NUMBER>a b coefficients parameter follows <NUMBER>¢<NUMBER> age <NUMBER>¢<NUMBER> diabetes <NUMBER>¢<NUMBER> chd <NUMBER>¢<NUMBER> percentage lymphocytes lym<NUMBER> <NUMBER>¢<NUMBER> pct<NUMBER>¢<NUMBER> ngml <NUMBER>¢<NUMBER> blood urea nitrogen bun <NUMBER>¢<NUMBER> mmoll <NUMBER>¢<NUMBER> c reactive protein crp <NUMBER> mgl <NUMBER>¢<NUMBER> <NUMBER>¢<NUMBER> <NUMBER>¢<NUMBER> <NUMBER>¢<NUMBER> <NUMBER>¢<NUMBER> inflammatory indicators coagulation function pct ngml ddimer dd <NUMBER>¢<NUMBER> ugml multivariable analysis age chd lym pct dd remained independent risk factors mortality hazard ratios hrs five variables shown fig <NUMBER>c according multivariable analysis coefficients lasso binary logistic regression scoring system covid<NUMBER> css generated shown fig <NUMBER>d score distributions follows age <NUMBER> <NUMBER> points <NUMBER> point older <NUMBER> <NUMBER> points chd condition <NUMBER> point lym <NUMBER> <NUMBER> point pct<NUMBER>¢<NUMBER> ngml <NUMBER> points dd<NUMBER>¢<NUMBER> ugml <NUMBER> point defined total <NUMBER> <NUMBER> points low risk total points <NUMBER> high risk cutoff value groups selected based best sensitivityspecificity ratio model showed great prognostic accuracy training cohort independent validation cohort using roc analysis fig <NUMBER>a performance model validated calibration plots probability death demonstrated good agreement prediction actual observation training cohort fig <NUMBER>b hosmeràlemeshow test yielded nonsignificant statistic p<NUMBER>¢<NUMBER> indicating departure perfect fit illustration cumulative risk events performed training independent validation cohorts showed significantly increased deaths highrisk group compared lowrisk group fig <NUMBER>c f lowrisk group number patients <NUMBER> <NUMBER> nonsurvivors highrisk group number patients <NUMBER> <NUMBER> nonsurvivors mortality rates <NUMBER>¢<NUMBER> lowrisk group <NUMBER>¢<NUMBER> highrisk group p<NUMBER>¢<NUMBER> also statistical differences complications lowrisk highrisk groups except sepsis lowrisk group median time illness death <NUMBER>¢<NUMBER> days whereas <NUMBER>¢<NUMBER> days highrisk group p<NUMBER>¢<NUMBER> fig <NUMBER> b indicating lowrisk patients longer survival time survivors median time illness discharge <NUMBER>¢<NUMBER> days lowrisk group <NUMBER>¢<NUMBER> highrisk group p<NUMBER>¢<NUMBER> fig <NUMBER>b lowrisk group <NUMBER> survivors received systemic corticosteroids treatment <NUMBER> survivors whose mean hospital durations <NUMBER>¢<NUMBER> days <NUMBER>¢<NUMBER> days respectively p<NUMBER>¢<NUMBER> fig <NUMBER>a median time illness onset discharge <NUMBER>¢<NUMBER> days <NUMBER>¢<NUMBER> days p<NUMBER>¢<NUMBER> fig <NUMBER>b highrisk group <NUMBER> nonsurvivors received systemic corticosteroids treatment <NUMBER> nonsurvivors median survival time <NUMBER>¢<NUMBER> days <NUMBER>¢<NUMBER> days respectively p<NUMBER>¢<NUMBER> fig <NUMBER>b conclusion lowrisk group absence systemic corticosteroids could shorten duration disease <NUMBER>¢<NUMBER> days hospital duration <NUMBER>¢<NUMBER> days meanwhile whether use systemic corticosteroids highrisk group effect survival data <NUMBER> patients complete clinical course including <NUMBER> severe survivors <NUMBER> severe nonsurvivors analyzed track scores admission discharge death fig <NUMBER>a among survivors scores gradually decreased hospitalization discharge whereas scores gradually increased death nonsurvivors meanwhile last laboratory findings lym dd pct recorded obtain discharge death scores finally <NUMBER> nonsurvivors <NUMBER> survivors included compare scores admission discharge death fig <NUMBER>b nonsurvivors scores death higher admission p<NUMBER> survivors scores discharge seemed lower admission difference statistically significant p<NUMBER> retrospective cohort study median time illness onset death <NUMBER>¢<NUMBER> days severe covid<NUMBER> nonsurvivors total <NUMBER>¢<NUMBER> patients complications proportion nonsurvivors higher survivors p<NUMBER>¢<NUMBER> reported organ damage hospitalization patients covid<NUMBER> associated inhospital mortality <NUMBER>à<NUMBER> respiratory failure <NUMBER>¢<NUMBER> common complication followed ami <NUMBER>¢<NUMBER> ali <NUMBER>¢<NUMBER> aki <NUMBER>¢<NUMBER> nonsurvivors respiratory failure secondary infection occurred firstly followed ami aki ali ami occurred earlier aki ali heart becomes first organ involved might explained fact cardiac highly expressed angiotensinconverting enzyme <NUMBER> ace<NUMBER> human cell receptor strong binding affinity spike protein sarscov<NUMBER> leading directly attacked virus <NUMBER> <NUMBER> <NUMBER> covid<NUMBER>induced kidney liver injury might related drug hepatotoxicity subsequent immunemediated inflammation cytokine storm pneumoniaassociated hypoxia shock <NUMBER> <NUMBER> <NUMBER> worth noting time aki death shorter ami ali cui coworkers indicated cytopathic effects sarscov<NUMBER> podocytes proximal straight tubule cells may cause aki patients covid<NUMBER> <NUMBER> early monitoring renal function paid attention study identified several factors associated mortality severe patients covid<NUMBER> aged chd condition decreased lym elevated levels pct dd admission associated high odds inhospital death nonsurvivors scored less <NUMBER> points death dynamic profile points showed high score indicated progression disease higher risk death fig <NUMBER> css established divide mortality risk severe cases highrisk lowrisk groups risk death highrisk group increased significantly p<NUMBER>¢<NUMBER> also statistical differences complications lowrisk highrisk group css demonstrated good predictive performance roc curve auc<NUMBER>¢<NUMBER> training cohort <NUMBER>¢<NUMBER> independent validation cohort calibration curve p<NUMBER>¢<NUMBER> training cohort analysis validation cohort css seemed underestimate mortality lowrisk patients overestimate mortality highrisk patients calibration curve fig <NUMBER>d could explained low mortality rate wuhan leishenshan hospital since critically ill patients transferred hospitals reduce mortality lead predicted death inconsistent actual observed death data wuhan leishenshan hospital might reflect actual mortality rate severe covid<NUMBER> wuhan china elderly considered important independent predictor mortality sars mers also confirmed associated mortality patients covid<NUMBER> <NUMBER>à<NUMBER> also confirmed current study mortality rate highest patients severe covid<NUMBER> older <NUMBER> years <NUMBER>¢<NUMBER> followed patients aged <NUMBER>à<NUMBER> years old <NUMBER>¢<NUMBER> younger <NUMBER> years <NUMBER>¢<NUMBER> worth noting number patients aged <NUMBER>à<NUMBER> years largest table <NUMBER> elderly patients covid<NUMBER> deserved special attention myocardial injury reported common complication significantly associated fatal outcome covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> lu et al demonstrated patients underlying cardiovascular disease including chd prone experience myocardial injury course covid<NUMBER> higher risk death <NUMBER> chd also found associated acute cardiac events poor outcomes influenza respiratory viral infections <NUMBER> <NUMBER> present study chd one independent risk factors patients covid<NUMBER> mechanism might release inflammatory cytokines infection probably caused reduction coronary blood flow decreased oxygen supply destabilization coronary plaque microthrombogenesis leading myocardial injury heart failure <NUMBER> <NUMBER> <NUMBER> majority patients died multiple organ failure overexpression proinflammatory cytokines chemokines released activated immune cells infected cells involved development organ dysfunction sars patients covid<NUMBER> mortality <NUMBER> analysis pct one inflammatory indicators strong correlation mortality severe covid<NUMBER> patients ddimer greater <NUMBER>¢<NUMBER> mgml also associated fatal outcome elevated ddimer levels indicating coagulation activation considered related sustained inflammatory response consequently covid<NUMBER> mortality might due virusactivated cytokine storm valuable incorporate inflammation indicators scoring system predict risk mortality lymphopenia believed related increased disease severity decease covid<NUMBER> patients <NUMBER> lymphocytopenia also common critically ill patients mers infection considered result lymphocytes apoptosis <NUMBER> <NUMBER> therefore could postulated necrosis apoptosis lymphocytes also induced lymphocytopenia severe patients sarscov<NUMBER> infection <NUMBER> severity lymphocytopenia reflected severity covid<NUMBER> possessed ability predict mortality powerful predictor <NUMBER> besides decreased lym partly reflected increase proportion neutrophils may related cytokine storm induced virus invasion analysis also tracked antibodies response serum patients covid<NUMBER> considered longest tracking best knowledge seen fig <NUMBER> igg reached peak <NUMBER>à<NUMBER> days severe nonsevere covid<NUMBER> patients severe patients level igg declined <NUMBER> days might due lymphocyte depletion <NUMBER> igm levels still high <NUMBER> days illness onset severe patients might explained viruses existed severe patients relatively long time <NUMBER> reported serum antibody covid<NUMBER> potential diagnostic value higher titer antibody independently associated worse clinical classification <NUMBER> <NUMBER> statistically significant difference antibody levels severe nonsevere patients analysis number severe cases small present study might result less accurate results cases time period tests needed verify antiviral treatment coronavirus infection proven effective given high levels cytokines induced sarscov merscov sarscov<NUMBER> infections systemic corticosteroids often used treat severe patients possible benefit reducing inflammatoryinduced lung injury <NUMBER>à<NUMBER> however controversial use corticosteroids treating influenzaassociated pneumonia ards <NUMBER> several studies demonstrated association corticosteroid use mortality bacterial fungal infection emergence antiviral resistance <NUMBER> <NUMBER> evidence show receiving corticosteroids patients sars mers effect mortality rather delayed viral clearance <NUMBER>à<NUMBER> evidence urgently needed assess whether systematic corticosteroid treatment beneficial harmful patients covid<NUMBER> <NUMBER> present cohort <NUMBER>¢<NUMBER> severe covid<NUMBER> patients complications secondary infection associated use corticosteroids difference statistically significant p<NUMBER>¢<NUMBER> secondary infection may due immune deficiency caused virus <NUMBER> addition whether use corticosteroids effect mortality use corticosteroids lowrisk group prolonged hospital stay <NUMBER>¢<NUMBER> days durations <NUMBER>¢<NUMBER> days css provided guidance rational application corticosteroids applicable populations study several limitations firstly <NUMBER> severe patients covid<NUMBER> included training cohort independent validation group number deaths small larger cohort studies needed validate scoring system established secondly retrospective study possible risk factors reported studies lactate dehydrogenase interleukin <NUMBER> presented study laboratory tests done patients resulting incomplete data <NUMBER> role might underestimated predicting inhospital death reasonable assume possible risk factors included analyses might independently associated inhospital death current model based five variables shown good performance predict clinical outcomes thirdly since vast majority chest imaging findings bilateral lung lesions <NUMBER> used presence lung lesions admission positive indicator chest imaging without considering severity lungs may underestimate role lung lesions predictive model combined lung lesions also needs evaluated finally data score development validation entirely wuhan china due differences medical resources data study may fully representative population china even world could potentially limit generalizability risk score areas world additional validation studies areas outside china completed however absence severe covid<NUMBER> death risk scoring system scoring system help clinicians worldwide judge inhospital deaths conclusion complications associated mortality covid<NUMBER> time aki death shorter ali ami early monitoring renal function paid attention dynamic changes antibodies worth tracking since higher titer antibody considered independently associated worse clinical classification found aged chd condition decreased percentage lymphocyte elevated ddimer pct admission related mortality severe patients covid<NUMBER> css well classified severe patients lowrisk highrisk groups helpful predicting inhospital mortality complications css could help clinicians identify highrisk patients alert occurrence complications authors declare competing interests first case pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sars‐cov‐<NUMBER> reported wuhan hubei province china december <NUMBER> <NUMBER> march coronavirus disease <NUMBER> covid‐<NUMBER> caused virus spread around world sars‐cov‐<NUMBER> human coronavirus belong group benign coronaviruses cause common cold smaller group coronaviruses cause acute respiratory distress syndrome severe acute respiratory syndrome coronavirus—sars middle east respiratory syndrome coronavirus—mers <NUMBER> <NUMBER> recently published studies showed arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease prevalent among patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigations outcome patients scarce data limited nevertheless hypertension considered one important risk factors covid‐<NUMBER> relationship hypertension adverse outcome still questionable aim review paper summarize current knowledge relationship hypertension covid‐<NUMBER> role hypertension outcome patients comprehensive search performed pubmed scopus web science google scholar find review papers topic published may <NUMBER> <NUMBER> sars‐cov‐<NUMBER> infection triggered s‐protein virus binds angiotensin‐converting enzyme <NUMBER> ace<NUMBER> highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways <NUMBER> sars‐cov‐<NUMBER> binds ace<NUMBER> much higher affinity compared sars‐cov <NUMBER> additionally sars‐cov‐<NUMBER> shows pathogenic activity attacking type ii alveolar epithelial cells expressing ace<NUMBER> previous studies coronavirus causes sars demonstrated virus binds ace<NUMBER> pulmonary alveoli superficial spike proteins causes lung damage even lung function failure <NUMBER> loss ace<NUMBER> caused binding sars‐cov‐<NUMBER> may shift system overall higher angiotensin ii lower angiotensin‐<NUMBER>‐<NUMBER> tone role angiotensin ii covid‐<NUMBER> hypertensive patients seems crucial due role functioning renin‐angiotensin‐aldosterone system raas promotes vasoconstriction sodium retention oxidative stress inflammation fibrosis increases bioactive peptide angiotensin‐<NUMBER>‐<NUMBER> <NUMBER> epidemiological data coming china indicate arterial hypertension cardiovascular diseases diabetes chronic obstructive pulmonary disease prevalent concomitant diseases patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> number investigations provided least short follow‐up intrahospital outcome limited even though data demonstrated prevalence hypertension covid‐<NUMBER> patients lethal outcome high <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> still debated whether hypertension predictor mortality independently cardiovascular risk factors age obesity diabetes comorbidities coronary artery disease heart failure atrial fibrillation cerebrovascular disease renal impairment prevalence hypertension among patients covid‐<NUMBER> different studies ranged <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several reasons variations average age significantly higher patients elevated prevalence hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> might important reason different prevalence hypertensive patients among studies advanced age associated higher prevalence comorbidities diabetes renal impairment arterial hypertension obesity altogether increased proportion hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence overweight obesity reported available studies covid‐<NUMBER> “circulus vitiosus” hypertension obesity diabetes difficult break therefore conclusion cannot made without detailed data links chain impact smoking forgotten relation copd hypertension higher propensity covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however results conflicting majority authors find higher prevalence smoking patients adverse outcome <NUMBER> <NUMBER> <NUMBER> level renal damage cannot excluded one contribute factor higher percentage hypertension advance stage covid‐<NUMBER> hypertensive patients studies reported large prevalence cardiovascular diseases covid‐<NUMBER> patients also classified therefore difficult estimate individual effect coronary artery disease heart failure atrial fibrillation occurrence severity covid‐<NUMBER> li et al summarized findings <NUMBER> studies showed prevalence hypertension cardio‐ cerebrovascular disease diabetes patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> incidences hypertension cardio‐cerebrovascular diseases diabetes two‐ threefolds higher patients severe type covid‐<NUMBER> non‐severe counterparts yang et al included <NUMBER> covid‐<NUMBER> patients <NUMBER> studies reported prevalent comorbidities hypertension diabetes cardiovascular diseases respiratory system disease <NUMBER> frequent comorbidities severe patients hypertension respiratory system disease cardiovascular disease large meta‐analysis included <NUMBER> patients covid‐<NUMBER> found pooled prevalence hypertension cardiovascular disease smoking history diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> table <NUMBER> authors meta‐analyses agreed large heterogeneity studies obviously limited quality study partly explained different designs large variation sample size among studies <NUMBER> <NUMBER> essential data still missing would dangerous ascribe large portion risk sars‐cov‐<NUMBER> infection severity covid‐<NUMBER> risk factor including hypertension would reasonable hypothesize uncontrolled comorbidities well combination concomitant diseases may increase risk infection severity covid‐<NUMBER> examined many controversies effect angiotensin‐converting enzyme inhibitors acei angiotensin ii receptor blockers arb covid‐<NUMBER> patients <NUMBER> authors expressed concern use renin‐angiotensin‐aldosterone system raas inhibitors variation ace<NUMBER> expression may partly responsible sars‐cov‐<NUMBER> virulence <NUMBER> <NUMBER> population‐based studies estimated small proportion hypertensive patients china <NUMBER> <NUMBER> treated antihypertensive therapy raas inhibitors used <NUMBER> <NUMBER> treated patients <NUMBER> <NUMBER> therefore anticipated small percentage covid‐<NUMBER> patients china actually treated acei arb hand prevalence cardiac damage covid‐<NUMBER> patients negligible associated adverse outcome subjects <NUMBER> <NUMBER> data regarding frequency heart failure covid‐<NUMBER> patients scarce valid chronic kidney disease therapeutic point view acei arb important roles treatment conditions—cardiac injury heart failure renal impairment particularly albuminuria therefore withdrawing raas inhibitors switching medications would uncertain benefits certain disadvantages would expected problem raas inhibitors would escalate western countries europe usa patients taking antihypertensive medications particularly raas inhibitors significantly higher percentage china however studies italy usa show association raas inhibitors susceptibility coronavirus complications mortality covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> even new investigation china confirmed findings <NUMBER> switching raas inhibitors another antihypertensive therapy would lead insufficient blood pressure control could induce complications covid‐<NUMBER> patients infection sars‐cov‐<NUMBER> novel data showed raas inhibitors could even improve outcome hypertensive patients covid‐<NUMBER> <NUMBER> authors hypothesized raas inhibitors indirect antiviral role regulating immune function inhibiting inflammatory responses <NUMBER> based available data despite theoretical possibilities multiple specialty societies recommended covid‐<NUMBER> patients continue therapy raas inhibitors <NUMBER> <NUMBER> <NUMBER> limited number studies provided outcome data short follow‐up therefore one careful interpretation findings guan et al demonstrated patients severe covid‐<NUMBER> primary end point admission intensive care unit use mechanical ventilation death significantly higher percentage hypertension diabetes coronary artery disease cerebrovascular disease copd chronic renal disease cancer <NUMBER> authors investigate relationship different demographic clinical parameters severity disease outcome shi et al reported hypertension diabetes coronary artery disease cerebrovascular disease copd cancer prevalent patients myocardial injury diagnosed elevation high‐sensitivity troponin creatinine kinase‐myocardial band ck‐mb <NUMBER> cardiac injury associated significantly higher mortality <NUMBER> vs <NUMBER> authors investigate comorbidities associated cardiac injury mortality must noted patients cardiac injury significantly older guo et al demonstrated similar results compared covid‐<NUMBER> patients without elevation troponin found <NUMBER> patients covid‐<NUMBER> cardiac injury <NUMBER> study chronic renal dysfunction usage raas also prevalent patients cardiac injury however patients cardiac injury almost <NUMBER> years older frequently men without injury also taken account also reported underlying cardiovascular disease worsening outcome patients myocardial injury <NUMBER> defining myocardial injury elevation troponin circumstances could questionable biomarker may increased many conditions inflammation andor sepsissystemic inflammatory response syndrome kidney injury authors clearly stated disorders included term “cardiovascular disease” clear whether hypertension included term furthermore difficult understand cardiomyopathies included whether patients heart failure included chen et al reported hypertension cardiovascular disease diabetes prevalent among covid‐<NUMBER> patients died comparison survivors <NUMBER> however large difference age sex distribution groups authors investigate effect comorbidities outcome population <NUMBER> table <NUMBER> zhou et al reported hypertension diabetes coronary heart disease chronic renal disease copd frequent among non‐survivors survivors <NUMBER> authors found hypertension diabetes coronary heart disease predictors mortality covid‐<NUMBER> patients nevertheless none comorbidities remained significant predictor mortality adjustment age sex smoking status findings confirmed importance comprehensive risk assessment including relevant risk factors comorbidities large original study included <NUMBER> patients guan et al showed adjusting age smoking status patients copd diabetes hypertension malignancy likely reach composite end points admission intensive care unit invasive ventilation death without <NUMBER> malignancy copd hypertension diabetes increased risk adverse outcome <NUMBER>‐ <NUMBER>‐ <NUMBER>‐ <NUMBER>‐fold respectively <NUMBER> patients two comorbidities significantly higher risk composite end point patients single comorbidity stratification patients according age <NUMBER> years vs ≥<NUMBER> years show significant difference strength associations number comorbidities mortality covid‐<NUMBER> <NUMBER> however cannot excluded confounding factors besides aging smoking might also responsible association comorbidities outcome would also helpful divide primary outcome two separate outcomes admission intensive care unit andor invasive ventilation b death would provide separated information independent predictors severity mortality covid‐<NUMBER> performed small study authors found hypertension diabetes predictors acute respiratory distress syndrome mortality covid‐<NUMBER> patients <NUMBER> unfortunately multivariable analysis adjustment relevant confounding factors performed investigation number limitations mentioned investigations self‐reporting comorbidities hospital admission represents one under‐reporting comorbidities due lack awareness andor lack diagnostic testing could interfere associations comorbidities clinical outcome importantly duration follow‐up short patients remained hospital time publishing studies means real outcome unknown obesity reported available studies influence could investigated furthermore one study reported basal values systolic diastolic blood pressure would help estimate percentage uncontrolled hypertension refers prevalence patients uncontrolled diabetes studies included small number patients additional obstacle one forget fact majority studies come china cautious extrapolating findings countries outbreak covid‐<NUMBER> studies consider potential sources bias confounding additional investigations improved design warranted recent findings reported arterial hypertension represented one common comorbidities patients covid‐<NUMBER> prevalence ranged <NUMBER> <NUMBER> impact hypertension outcome particularly mortality covid‐<NUMBER> patients clear due lack data studies provide evidence raas inhibitors avoided switched patients large studies consider potential sources bias confounding factors well longer follow‐up necessary public pressure find answers high physicians duty stay rational scientific approach available upcoming data coronaviruses cause spectrum illness asymptomatic disease respiratory failure early reports coronavirus infections suggested infections mild <NUMBER> sars epidemic associated significant morbidity mortality <NUMBER> september <NUMBER> novel coronavirus identified <NUMBER>year old man saudi arabia <NUMBER> second case identified qatari patient hospitalized united kingdom <NUMBER> two coronaviruses genetically identical similar isolates obtained bats <NUMBER> july <NUMBER> coronavirus study group named new virus middle east respiratory syndrome coronavirus merscov <NUMBER> december <NUMBER> <NUMBER> <NUMBER> cases worldwide <NUMBER> deaths <NUMBER> epidemiology clinical manifestations disease described spectrum illness asymptomatic infection severe respiratory failure death overall mortality rate remains <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> importantly known effective treatments <NUMBER> increase merscov cases reported jeddah region saudi arabia describe changing epidemiology outcomes report clinical features treatment outcomes patients admitted regional referral hospital jeddah saudi arabia king fahd general hospital <NUMBER>bed hospital jeddah kingdom saudi arabia regional coronavirus referral center <NUMBER> icu beds one infectious disease physician serves hospital january december <NUMBER> patients admitted transferred king fahd hospital positive mers coronavirus pcr clinical nasal swabs nasopharyngeal aspirates included pcr testing performed ministry health regional lab jeddah magna pure compact magna pure <NUMBER> roche automated system used extract rna samples primers probes upe orf <NUMBER>a targets merscov used tib molbiol germany along master mix roche light cycler <NUMBER> ii roche used amplify upe orf <NUMBER>a gene targets samples tested positive upe orf <NUMBER>a gene targets cycle threshold time less <NUMBER> considered confirmed cases positive negative controls used monitor amplification process check inhibition amplification medical charts patients reviewed data abstracted standardized data collection forms infectious disease trained physician demographic clinical laboratory data entered database understand epidemiology age categorized <NUMBER> <NUMBER> <NUMBER> hypotension defined blood pressure <NUMBER> mm hg tachypnea respiratory rate greater <NUMBER> hypoxia oxygen saturation <NUMBER> thrombocytopenia platelets <NUMBER> cubic millimeter leukopenia defined white blood cell count <NUMBER> cellscubic millimeter leukocytosis white blood cell count <NUMBER> cells cubic millimeter renal insufficiency defined creatinine <NUMBER> mgdl liver function abnormalities defined lactate dehydrogenase ldh <NUMBER> uliter alanine transaminase alt <NUMBER> uliter aspartate aminotransferase ast <NUMBER> uliter immunosuppression defined aids history organ transplant neutropenia known malignancy taking immunosuppressive medication congenital immunodeficiency pregnancy considered immunosuppressed state modified acute physiologic chronic health evaluation apache <NUMBER> score calculated using age temperature mean arterial blood pressure respiratory rate potassium creatinine acute renal failure comorbid conditions estimate severity illness <NUMBER> pao<NUMBER> estimated using pulse oximetry oxygen saturation results hematocrit calculated multiplying hemoglobin times three statistical analyses performed using stata software version <NUMBER> college station tx percent distribution clinical variables among patients survived died compared using fisher exact test multivariate logistic regression done treatments administered severity illness determine treatments associated survival mycophenolate mofetil included logistic regression analysis <NUMBER> patients receiving mycophenolate mofetil survived association severity illness treatments administered assessed performing linear regression treatments administered onto modified apache <NUMBER> score total <NUMBER> cases thirty patients <NUMBER> saudi nationals <NUMBER> <NUMBER> foreign nationals median age <NUMBER> years old iqr <NUMBER> male n <NUMBER> <NUMBER> twentyone patients <NUMBER> exposure known patient mers coronavirus <NUMBER> <NUMBER> healthcare workers none patients animal exposure two patients <NUMBER> pilgrimage mecca overall <NUMBER> patient least one comorbid condition seventeen patients diabetes <NUMBER> <NUMBER> hypertension <NUMBER> <NUMBER> <NUMBER> end stage renal disease eight <NUMBER> coronary artery disease six <NUMBER> patients immunosuppressed two pregnant patients received variety novel treatments including immunosuppressants antivirals fortytwo <NUMBER> patients received broadspectrum antibiotics five <NUMBER> received hydrocortisone thirty one patients received antiviral treatment twentythree patients <NUMBER> treated interferon beta eight <NUMBER> treated interferon alpha variety antiviral combinations used eight patients <NUMBER> received mycophenolate mofetil seven patients received combination interferon beta nineteen <NUMBER> patients required intensive care unit icu care <NUMBER> patients received extracorporeal membrane oxygenation ecmo patients treated icu patients receiving ecmo died recent cohort comparing survivors nonsurvivors survival associated male gender vomiting admission elevated respiratory rate abnormal lung exam physical exam working healthcare worker history hypertension elevated alt clearance mers cov repeat pcr testing receiving mycophenolate mofetil beta interferon table <NUMBER> contrast markers severe disease like hypotension hypoxemia chest radiographic abnormalities leukocytosis elevated creatinine thrombocytopenia anemia renal failure associated death treatments given based indicated based clinical assessment infectious disease consult team thirtyone patients received antivirals ribavirin alpha beta interferon <NUMBER> patients received immunosuppressive medication patients received combination alpha interferon ribavirin <NUMBER> <NUMBER> beta interferon ribavirin <NUMBER> <NUMBER> beta interferon alone <NUMBER> <NUMBER> two patients received alpha interferon alone <NUMBER> eight patients received mycophenolate mofetil <NUMBER> seven received combination betainterferon five patients received hydrocortisone two combination beta interferon ribavirin <NUMBER> combination alpha interferon ribavirin eight patients given mycophenolate mofetil survived therefore mycophenolate mofetil could evaluated model results univariable analysis demonstrated improved survival patients treated betainterferon mycophenolate mofetil multivariable analysis included marker severity illness demonstrated strong association severity illness reduced survival association treatment beta interferon survival mycophenolate mofetil evaluable model table <NUMBER> analyzing relationship severity illness treatments administered beta interferon mycophenolate mofetil given less severely ill patients table <NUMBER> discussion merscov emerging disease initial epidemiology described indepth clinical studies role therapy incompletely understood clinical features merscov described several large case series <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> paucity literature therapy results relatively large number patients demonstrate similar clinical features mortality previous studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cohort treatment beta interferon mycophenolate mofetil may predictive survival greatest predictor survival severity illness presentation improved diagnostics demonstrated expanded spectrum disease includes less severe cases previously reported understand merscov causes acute respiratory disease syndrome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> may partially related epidemiology increased disease transmission healthcare settings rather true host risk factor laboratory findings nonspecific consistent viral infections thrombocytopenia <NUMBER> lymphopenia <NUMBER> commonly described patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> forty three percent acute kidney injury <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cxr abnormalities bibasilar infiltrates common finding <NUMBER> <NUMBER> <NUMBER> outcomes severely ill patients remain poor <NUMBER> required icu care <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> icu setting required invasive ventilation median <NUMBER> days <NUMBER> <NUMBER> <NUMBER> addition mechanical ventilation several patients received extracorpeal membrane oxygenation ecmo support ventilation nonrandomized data world health organization five six patients receiving ecmo died <NUMBER> fiftyeight <NUMBER> required renal replacement therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> hospitalized patients died <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> severity illness partially explained widespread lung disease caused merscov appears mortality patients requiring intensive care extremely high although autopsy data available explanted lung infection merscov causes widespread infection alveolar disease <NUMBER> <NUMBER> clinical features cohort similarly also show high proportion patients fever <NUMBER> cough <NUMBER> shortness breath <NUMBER> almost one third patients <NUMBER> gastrointestinal symptoms cohort consisted ill patients hypotension <NUMBER> tachypnea <NUMBER> hypoxia <NUMBER> thirty seven percent required icu care <NUMBER> patients received ecmo similar previous results patients received ecmo died <NUMBER> known effective treatment mers cov many compounds screened vitro possible activity coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> however vivo efficacy subjected clinical investigation vitro data suggests merscov inhibits host interferon production various molecular pathways <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mycophenic acid active agent prodrug mycophenolate mofetil cyclosporine strongly inhibit mers coronavirus human monkey cell lines even inhibit sars coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> interferon alpha interferon beta reduce mers coronavirus replication explanted lung tissue <NUMBER> vivo comparing host response two patients mers coronavirus differing outcomes patient able clear mers cov infection able mount interferon response patient died low levels interferon alpha suggesting therapeutic role interferon <NUMBER> combination interferon alpha ribavirin used successfully rhesus monkeys infected mers coronavirus <NUMBER> small case series <NUMBER> <NUMBER> <NUMBER> betainterferon seems even potent inhibitor mers coronavirus vitro <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one small study exceptionally high mortality rates using interferon beta treatment found difference mortality interferon beta use interferon alpha use <NUMBER> data albeit retrospective cohort support findings interferon beta associated decrease mortality limited data efficacy treatment regiments virulent disease present data retrospective cohort ill patients merscov results evaluation clinical efficacy beta interferon beta alpha interferon ribavirin mycophenolate mofetil addition routine supportive care forty five percent patents <NUMBER> patients received interferon beta cohort sixteen percent patients received interferon alpha <NUMBER> patients <NUMBER> patients <NUMBER> patients received ribavirin either conjunction interferon alpha interferon beta <NUMBER> patient received mycophenolate mofetil patients receiving beta interferon mofetil improved survival however confounded severity illness presentation beta interferon patients received mycophenolate mofetil survived however small number could analyze independent efficacy mycophenolate mofetil relatively large series merscov cases primary limitation study retrospective review cases randomized trial thus subject confounding seen cohort used modified apache <NUMBER> score without clinical variables may underestimated association severity illness reduced survival importantly mortality patients receiving additional therapies modulate immune response low eight patients received mycophenolate mofetil study survived hence may reasonable study agent controlled trials observational study investigates novel treatment options like beta interferon mycophenolate mofetil merscov humans vitro activity cohort demonstrated severity illness important effect modifier needs considered evaluating novel agents better assess efficacy therapies international prospective randomized trials adequate numbers patients needed evaluate impact treatments addition routine supportive care compared treatment options study reviewed approved johns hopkins university institutional review board directorate health affairs data supporting findings manuscript additional data available upon request abbreviations aids acquired immune deficiency syndrome alt alanine transaminase apache <NUMBER> acute physiologic chronic health evaluation ast aspartate aminotransferase cxr chest x ray ecmo extracorporeal membrane oxygenation icu intensive care unit ldh lactate dehydrogenase mers cov middle eastern respiratory syndrome coronavirus pcr polymerase chain reaction authors declare competing interests authors contributions conceived study participated design helped draft manuscript ka participated data collection analysis reviewed manuscript yg participated data collection analysis reviewed manuscript aa participated data collection analysis reviewed manuscript fs participated data collection analysis reviewed manuscript aa participated data collection analysis reviewed manuscript mb participated data collection analysis reviewed manuscript tmp participated design analysis well writing manuscript dv participated statistical analysis study gs helped analyze data write manuscript authors read approved final manuscript infections <NUMBER> main complications hematopoietic cell transplantation hsct respiratory viral infections rvi increasingly recognized important complications hsct variable degrees morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent years growing number hsct utilizing alternative donors cord progenitor stem cells along common use serotherapy contributed significant increase viral infections hsct <NUMBER> <NUMBER> wellknown viruses herpes simplex virus hsv cytomegalovirus cmv major causes morbidity mortality hsct <NUMBER> <NUMBER> however since prophylactic preemptive antihsvcmv therapy became standard practice morbidity mortality hsv cmv disease rare <NUMBER> <NUMBER> nonetheless respiratory viruses influenza parainfluenza respiratory syncytial virus rsv continue major cause morbidity mortality patients hsct increased awareness diagnosis infections however prophylactic approach viruses exists hsct recipients hence studys aim investigate incidence risk factors rvi children hsct describe shortand longterm outcomes patients study approved institutional research ethics board medical records children received hsct january <NUMBER> biology blood marrow transplantation j u r n l h e p g e w w w b b r g december <NUMBER> hospital sick children toronto reviewed identify patients positive test respiratory virus obtained nasopharyngeal aspirate npa bronchoalveolar lavage bal pleural tap lung biopsy specimen microbiological testing included following methodologies <NUMBER> following definitions used study upper respiratory tract infection urti defined detection rvi upper respiratory secretions together symptoms upper respiratory tract nose throat lower respiratory tract infection lrti defined either hypoxia pulmonary infiltrates together identification rvi upper respiratory secretion bal pleural tap lung biopsy day engraftment defined first <NUMBER> consecutive days peripheral absolute neutrophil count <NUMBER> â <NUMBER> <NUMBER> l trm defined either due rvi transplantation toxicities death due rvi defined death respiratory failure cause pneumonia longterm pulmonary complication defined limitation pulmonary status including pulmonary function tests relapse defined finding hematologic cytogenetic recurrence initiation therapy recurrence progressive disease defined tumor growth <NUMBER> spreading since undergoing transplantation <NUMBER> patients nursed protective isolation single rooms highefficiency particulate air filters patients indwelling central venous catheters majority received nutritional support nasogastric feeding total parenteral nutrition infection prophylaxis included fluconazole fungal prophylaxis ganciclovir cmv prophylaxis <NUMBER> <NUMBER> preemptive strategy <NUMBER> onwards growth factors given indicated laminar air flow rooms used day <NUMBER> engraftment intravenous immunoglobulin dose <NUMBER> gkg supplemented igg level less <NUMBER> mgdl igg level routinely monitored every week patients pneumocystis jiroveci prophylaxis given hsct hsct least <NUMBER> months pneumococcal prophylaxis penicillin continued least <NUMBER> year administration pneumococcal vaccine blood products transfused maintain hemoglobin concentration <NUMBER> mgl platelet counts <NUMBER>mm <NUMBER> fever neutropenic phase treated broadspectrum antibiotics amphotericin caspofungin necessary modified subsequently according results blood tissue cultures patients received preparatory regimen underwent transplantation recovered hospital examined medical team twice day achieved engraftment patients respiratory symptoms investigated presence respiratory viruses chest radiographs computed tomography scans obtained clinically indicated npas throat swaps nasal swabs used obtaining upper respiratory specimens bal pleural tap andor lung biopsy used obtaining lower respiratory specimens primary endpoint study review rvipositive patients hsct describe outcome terms trm longterm pulmonary complications univariate logistic regression models constructed analyze impact risk factors trm within first <NUMBER> days including transplantation type allogeneic versus autologous graft type bone marrow versus peripheral blood stem cells versus cord blood utilization serotherapy antithymocyte globulin alemtuzumab mabcampath genzyme canada inc mississauga ontario serotherapy underlying disorder malignant versus benign reported p values <NUMBER>sided significance level <NUMBER> used statistical analyses carried using spss version <NUMBER> eight hundred fortyfour patients underwent hsct hospital sick children toronto canada study period comprise study population transplant recipients consisted <NUMBER> female <NUMBER> male patients median age <NUMBER> years range <NUMBER> month <NUMBER> years hsct allogeneic <NUMBER> patients autologous <NUMBER> patients diseases hsct performed acute lymphoblastic leukemia n ¼ <NUMBER> acute myeloid leukemia n ¼ <NUMBER> myelodysplastic syndrome n ¼ <NUMBER> severe aplastic anemia n ¼ <NUMBER> inherited marrow failure n ¼ <NUMBER> primary immune deficiency n ¼ <NUMBER> nonhodgkin lymphoma n ¼ <NUMBER> hodgkin disease n ¼ <NUMBER> chronic myelogenous leukemia n ¼ <NUMBER> metabolic diseases n ¼ <NUMBER> hemophagocytic lymphohistiocytosis n ¼ <NUMBER> brain tumors n ¼ <NUMBER> solid tumors n ¼ <NUMBER> thalassemia n ¼ <NUMBER> others n ¼ <NUMBER> study period among <NUMBER> hsct recipients <NUMBER> patients rvi documented screening causes death <NUMBER> patients found rvi never cause death day <NUMBER> hsct first <NUMBER> days hsct <NUMBER> patients rvi <NUMBER> patients focus study diagnosis conditioning regimen including use serotherapy described table <NUMBER> <NUMBER> patient diagnosis severe combined immune deficiency scidomenns syndrome received conditioning busulfan cyclophosphamide remaining <NUMBER> scid patients receive conditioning regimen analyzing utilization serotherapy found <NUMBER> patients received antithymocyte globulin <NUMBER> received alemtuzumab overall frequency documented rvi first <NUMBER> days hsct <NUMBER> frequency slightly higher allogeneic <NUMBER> autologous <NUMBER> transplantations p ¼ <NUMBER> twentythree patients lrti <NUMBER> occurring allogeneic patients <NUMBER> autologous hsct patients frequency lrti <NUMBER> allogeneic <NUMBER> autologous hsct patients nineteen patients parainfluenza infections <NUMBER> allogeneic <NUMBER> autologous figure <NUMBER> number patients contracted rvi month displayed thirtyfive <NUMBER> total rvi contracted october march high flu season canada march worst month comparing positive rvi patients versus negative patients statistically significant difference contracting rvi high season versus low season <NUMBER> <NUMBER> versus <NUMBER> <NUMBER> p ¼ <NUMBER> eleven patients required mechanical ventilation parainfluenza <NUMBER> influenza <NUMBER> rsv <NUMBER> adenovirus <NUMBER> four allogeneic <NUMBER> autologous hsct recipients died within <NUMBER> days transplantation rvi mechanically ventilated thus overall mortality <NUMBER> <NUMBER> allogeneic <NUMBER> autologous p ¼ <NUMBER> none <NUMBER> allogeneic transplant recipients died acute gvhd two <NUMBER> patients parainfluenza infections died <NUMBER> patient treated ribavirin two additional patients parainfluenza infection died <NUMBER> liver venoocclusive disease another pulmonary hypertension thus mortality caused parainfluenza <NUMBER> total mortality diagnosis parainfluenza <NUMBER> adenovirus respiratory infection n ¼ <NUMBER> <NUMBER> patients died adenovirus infections mortality caused adenovirus infection <NUMBER> one <NUMBER> patients died rsv infection mortality caused rsv infection <NUMBER> patient treated ribavirin none <NUMBER> patients influenza hmpv coronavirus rhinovirus infections died respiratory complications day <NUMBER> hsct <NUMBER> patients died trm death related respiratory problems remaining <NUMBER> patients followed median <NUMBER> years range <NUMBER> <NUMBER> chronic pulmonary complication alloimmune lung syndrome observed two patients died parainfluenza lrti <NUMBER>yearold patient wiskottaldrich syndrome underwent unrelated cord blood transplantation developed respiratory distress day <NUMBER> transplantation npa positive parainfluenza type <NUMBER> antigen ribavirin nitric oxide highfrequency oscillator support given second patient <NUMBER>yearold boy diagnosis relapse acute myeloid leukemia underwent matched sibling bone marrow transplantation parainfluenza type <NUMBER> antigen positive npa day <NUMBER> hsct patient developed acute respiratory distress syndrome ards radiographic findings consistent pneumonitis <NUMBER>monthold patient diagnosis scid omenns syndrome underwent matched sibling bone marrow transplantation patient developed ards rsv pneumonitis day <NUMBER> hsct two patients died adenovirus pneumonitis ards <NUMBER>monthold patient diagnosis neuroblastoma stage <NUMBER> underwent autologous hsct highdose chemotherapy patient delayed engraftment developed ards positive adenovirus bal pleural fluid another patient <NUMBER>yearold boy underwent unrelated cord blood transplantation severe aplastic anemia patient primary graft failure subsequently developed respiratory distress required highfrequency oscillation adenovirus positive bal lung biopsy type transplantation graft type utilization serotherapy underlying malignant disorder analyzed using univariate analysis none factors significantly correlated trm type transplantation p ¼ large pediatric study found <NUMBER> patients receiving allogeneic autologous hsct positive rvi led <NUMBER> overall mortality first <NUMBER> days hsct mortality higher allogeneic recipients <NUMBER> compared <NUMBER> autologous recipients furthermore median followup <NUMBER> years range <NUMBER> <NUMBER> patients tested positive respiratory virus die longterm pulmonary complications patients contracted virus <NUMBER> days hsct adverse event total incidence rvi study consistent within range <NUMBER> <NUMBER> previous published data pediatric hsct recipients <NUMBER> <NUMBER> however study particularly reported incidence rvi within first <NUMBER> days transplantation distinct pattern population different aforementioned studies data showed rvi episodes clustering within first <NUMBER> days transplantation <NUMBER> patient developed influenza urti <NUMBER> months hsct serious respiratory complication observed similar patients diagnosed urti lrti <NUMBER> months hsct none prolonged admission died respiratory illnesses supplemented routine viral respiratory diagnostics pcr testing adenovirus pcr pandemic influenza pcr multiplex respiratory pcr requested treating physician pcr proven specific sensitive rapid method detecting respiratory viruses compared antigen testing viral culture likely responsible increasing rates detection though changes methodology study time frame mean testing algorithms applied differently testing methodologies changed <NUMBER> <NUMBER> <NUMBER> even lower incidence adenovirus compared parainfluenza rsv infections study respiratoryrelated mortality higher adenovirus ie <NUMBER> <NUMBER> patients confirmed positive adenovirus pcr either bal pleural fluid lung biopsy diagnosis lrti moreover <NUMBER> patients died severe pneumonitis ards positive adenovirus pcr test another apparent cause respiratory illness described disseminated adenovirus infection cause pulmonary consolidation bacterial pneumonia <NUMBER> <NUMBER> similar clinical radiographic findings adenovirus infection may underrecognized cause fatal pneumonia immunocompromised patients severe lymphopenia lymphocyte dysfunction likewise <NUMBER> patients adenovirus infection delayed engraftment adenovirus infection associated high mortality <NUMBER> pediatric hsct <NUMBER> <NUMBER> <NUMBER> routine monitoring adenoviremia recommended hsct asymptomatic reactivation cases <NUMBER> cidofovir widely used preemptive therapeutic treatment adenovirus infection despite wellrecognized toxicities <NUMBER> <NUMBER> identification patients risk adenovirus infection crucial immune reconstitution key factor reactivation rapid withdrawal immunosuppressive medications also considered whenever possible <NUMBER> respiratoryrelated mortality parainfluenza virus study lower <NUMBER> studies showed approximately <NUMBER> <NUMBER> could explained early years transplantations completed mainly adult study population previous reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> large retrospective cohort study fred hutchinson cancer research center described unrelated transplantation major risk factor parainfluenza virus acquisition well use highdose corticosteroids <NUMBER> <NUMBER> patients died parainfluenza virus pneumonia <NUMBER> diagnosis wiskottaldrich syndrome received methylprednisolone gvhd prophylaxis unrelated cord blood transplantation however another patient relapsed acute myeloid leukemia develop gvhd receive corticosteroids treatment aerosolized ribavirin given first patient given later course pneumonia benefit using aerosolized ribavirin treatment parainfluenza pneumonia among hsct recipients controversial <NUMBER> <NUMBER> early diagnosis parainfluenza infection could expedite ribavirin treatment initiation improve outcome <NUMBER> incidence rsv infection study <NUMBER> lrti composed one half rsv infections interestingly mortality <NUMBER> lower <NUMBER> <NUMBER> studies hsct recipients <NUMBER> treatment aerosolized ribavirin <NUMBER> <NUMBER> patients rsv lrti may potentially reason lowered mortality although <NUMBER> fatal case observed patient received ribavirin hsct recipients high potential progression urti severe lrti without welldefined specific risk factors death <NUMBER> <NUMBER> <NUMBER> pooled analysis shah chemaly suggested ribavirin treatment withwithout rsvspecific immunoglobulin palivizumab lower rates mortality almost onethird review <NUMBER> separate studies <NUMBER> another small retrospective analysis palivizumab given rsv urti show protective effect progression lrti <NUMBER> <NUMBER> <NUMBER> death associated influenza hmpv rhinovirus coronavirus infections observed study high mortality <NUMBER> <NUMBER> reported hsct recipients influenza infection recent data showed improvement availability neuraminidase inhibitors <NUMBER> <NUMBER> inactivated vaccine prophylactic approach influenza infection appears less effective hsct recipients particularly first months transplantation well patients required immunosuppressive agents gvhd treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> however influenza vaccine considered safe major local general adverse effects reported use transplant recipients <NUMBER> hmpv infection reported incidence <NUMBER> <NUMBER> adult hsct recipients patients hematologic malignancies hmpv may associated severe pneumonia fatal lower respiratory tract disease hsct recipients <NUMBER> even though hmpv infections documented asymptomatic cases <NUMBER> analysis larger number patients necessary identify real impact transplantation population human rhinovirus coronavirus despite high incidence infections among hsct recipients morbidity mortality relatively low asymptomatic detections common accounting <NUMBER> <NUMBER> patients rhinovirus coronavirus respectively <NUMBER> mortality higher allogeneic hsct recipients cord blood transplants however significant difference observed univariate analysis previous studies revealed gvhd use immunosuppressive agents major risk factors associated lrti mortality <NUMBER> <NUMBER> <NUMBER> small number patients developed gvhd study logistic regression analysis could performed likewise various conditioning regimens used <NUMBER> patients died rvi unable establish correlation transplantation type respiratory viruseassociated death strength study large number patients examined single center uniform isolation practice contact precautions supportive care limitation retrospective nature study design nonetheless incidence <NUMBER> among hsct recipients prospective studies could challenge using multiple centers another challenge arises terms isolation practices infection precautions supportive care heterogeneity among hsct centers finally given high mortality associated viral infections first <NUMBER> days hsct study may intuitive avoid admission patients high season respiratory viruses especially country canada significant difference summer winter temperatures canada high season respiratory viral infections span october march study <NUMBER> patients <NUMBER> contracted rvi high season compared <NUMBER> patients <NUMBER> remaining months may feasible children need hsct urgently example aggressive leukemia may appropriate elective nonmalignant hsct minimize risk acquiring infections early hsct outbreak novel coronavirus disease began simple case pneumonia wuhan china late december <NUMBER> <NUMBER> th january <NUMBER> world health organization declared disease public health emergency international concern renamed covid <NUMBER> <NUMBER> less month later february <NUMBER> th state kuwait confirmed <NUMBER> patients flight coming islamic republic iran contracted virus marking start outbreak country <NUMBER> <NUMBER> rd march <NUMBER> first covid<NUMBER> patient admitted icu next couple months <NUMBER> covid<NUMBER> confirmed cases got admitted icu covid<NUMBER> pandemic considered one greatest global public health crisis since <NUMBER> influenza pandemic <NUMBER> although clinical spectrum infection appears broad patients infected covid<NUMBER> found high risk developing pneumonia ards multiorgan failure requires hospitalization admission critical care unit <NUMBER> major etiology agent covid<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> coronaviruses minute singlestranded rna viruses belong broad family named coronaviridae earlier viruses believed infect animals <NUMBER> world saw first instance human coronavirus infection spread severe acute respiratory syndrome sars china main etiological agent responsible sars identified sarscov <NUMBER> next major coronavirusrelated disease middle east respiratory syndrome mers arose saudi arabia <NUMBER> caused merscov <NUMBER> sarscov<NUMBER> closely related sarscov difference two viruses lies mortality transmission rates transmission rate sarscov<NUMBER> much higher sarscov well merscov however sarscov<NUMBER> much lower mortality rate <NUMBER> compared sarscov <NUMBER> however even encountering two coronavirusrelated diseases lack adequate preparedness late implementation countermeasures led drastic global spread covid<NUMBER> within short period time furthermore lack appropriate vaccine also contributed spread disease high mortality despite low mortality rate virus several epidemiological studies shown advanced age presence history severe comorbidities cardiovascular diseases significantly associated covid<NUMBER>related mortality moreover covid<NUMBER>related mortality attributed virusactivated cytokine storm syndrome <NUMBER> till date several studies still conducted elucidate epidemiology prevalence covid<NUMBER> across different countries high rate spread disease put lot burden already overwhelmed healthcare system led development new covid<NUMBER>specific treatment centers prioritizing use medical resources based patient characteristics understanding risk factors ofintensive care unit icu admission important factor triage decision making identification patients might benefit critical care services <NUMBER> assessed clinical characteristics identified mortalityassociated predictive factors covid<NUMBER> patients kuwait admitted icu best knowledge literature describes clinical characteristics icuadmitted covid<NUMBER> patients demographic region conducted retrospective study consisting patientsadmitted icu jaber alahmad hospital <NUMBER> st march <NUMBER> <NUMBER> th april <NUMBER>the patient outcome followed till <NUMBER> th may <NUMBER> jaber alahmad al sabah hospital designated national hospital management covid<NUMBER> infected patients kuwait hospital initially hadthree icus <NUMBER> beds pandemic progressed icu bed capacity increased <NUMBER> beds enrolled patients aged ≥ <NUMBER> years admitted icu due covid<NUMBER> infection confirmed realtime reverse transcriptase polymerase chainreaction rtpcr assay nasopharyngeal swab specimens management treatment covid<NUMBER> icu patients according published international local guidelines <NUMBER> patient data wereextracted electronic medical records using standardized data collection sheet recorded information preexisting medical condition including hypertension diabetes ischemic heart disease hyperlipidemia bronchial asthma chronic renal failuremalignancy autoimmune diseases home medications exposure history ie travel sick contact presenting symptoms prior admission fever sore throat nasal sinus congestion coughchest pain vomitingdiarrhea fatiguemyalgia collected laboratory radiological test results upon admission icu chest xray ctscan findings categorized normal unilateral infiltration bilateral infiltration ground glass appearancectscan chest echocardiographs requested clinically indicated discretion treating physicians also recorded data maximum respiratory support ie low flow nasal cannula noninvasive mechanical ventilation intubation additional adjunctive support including inhaled nitric oxide inotropes renal replacement therapy rrt extracorporeal membrane oxygenation ecmo information patientspecific therapies administration hydroxychloroquine antivirals convalescent plasmawas also collected rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> acute respiratory distress syndrome ards defined according berlin guidelines <NUMBER> quick sequential failure assessment qsofa score calculated upon admission according third international consensus definitions task force sepsis septic shock <NUMBER> secondary infection defined clinical signs pneumonia bacteremia positive culture blood body fluid endotracheal bronchoalveolar lavage specimens study protocol approved ethics committee ministry health kuwait irb <NUMBER> reported continuous variables median interquartile range iqr categorical variables number percentage mortality outcome interest differences deceased patients discharged patients analyzed using fishers exact test categorical variables mannwhitney u test continuous variables dichotomized laboratory findings based clinical assessment normal references used multivariate logistic regression model identify predictors mortality variables found significant univariate analysis included multivariate regression model age included final model described risk factor mortality previous studies <NUMBER> variables <NUMBER> missing values included model high sensitivity cardiac troponin final model fitting evaluated using hosmerlemeshow goodnessoffit testp value<NUMBER> statistical analysis performed using stataic <NUMBER> stata corp college station texas <NUMBER>tailed p <NUMBER> considered statistically significant without adjustment multiple testing may <NUMBER> th <NUMBER> among <NUMBER> patients <NUMBER> <NUMBER>patients discharged <NUMBER> <NUMBER> patients died <NUMBER> <NUMBER> patients remained icu median age <NUMBER> years iqr <NUMBER> majority patients <NUMBER> <NUMBER> male two comorbidities present <NUMBER> <NUMBER> patients diabetes mellitus common <NUMBER> <NUMBER> patients followed hypertension <NUMBER> patientsabout <NUMBER> <NUMBER> <NUMBER> patients insulin beta blockers angiotensin converting enzyme inhibitors acei respectively common presenting symptoms fever <NUMBER> followed coughchest pain <NUMBER> travel history contact exposure covid<NUMBER> infected person documented <NUMBER> patients median duration symptoms <NUMBER> days iqr<NUMBER> <NUMBER> days iqr<NUMBER> prior hospital icu admission respectively table <NUMBER> significant difference age gender nationality discharged deceased patients deceased patients likely two comorbidities compared discharged patients <NUMBER> versus <NUMBER> p <NUMBER> higher proportion deceased patients hypertensive compared discharged group <NUMBER> versus <NUMBER> p <NUMBER> travel history less likely reported among deceased patients compared discharged patients <NUMBER> versus <NUMBER> p <NUMBER> moreover deceased patients tended exhibit higher qsofa score discharged patients p <NUMBER> table <NUMBER> table <NUMBER> shows laboratory radiological findings patients admission icu total lymphocyte countsand serum albumin levels significantly lower among deceased patients levels creatinine procalcitonin pct creactive protein crp rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> difference groups basis radiological findings treatment clinical course shown table <NUMBER> patients <NUMBER> treated antibioticsantiviral therapy ritonavirlopinavir used <NUMBER> patients oseltamivir used <NUMBER> patients hydroxychloroquine administered <NUMBER> patients among <NUMBER> patients <NUMBER> received systemic steroids majority patients <NUMBER> intubated mechanically ventilated <NUMBER> patients wereprone positioneda total nine patients <NUMBER> required ecmo nine patients <NUMBER> received inhaled nitric oxide ino three patients <NUMBER> received convalescent plasma moderate severe ards present <NUMBER> patients <NUMBER> patients developed secondary bacterial infection inotropic support used <NUMBER> patients proportion deceased patients required inotropic support significantly higher discharged patients <NUMBER> versus <NUMBER> p <NUMBER> renal replacement therapy rrt used <NUMBER> patients two patients preexisting chronic kidney disease needed rrt moreover among deceased patientsintubation rrt moderatesevere ardsand secondary bacterial infection observed frequently discharged patients median time discharge icu <NUMBER> days iqr<NUMBER> median time death <NUMBER> days iqr <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> table <NUMBER> retrospective case series described clinical characteristics mortalityrelated predictors adult patients confirmed covid<NUMBER> admitted critical care unit <NUMBER> rd march <NUMBER> <NUMBER> th april <NUMBER> patient outcome followed <NUMBER> th may <NUMBER> major outcome assessed patient mortality median age patients <NUMBER> years evaluated association patients demographic laboratory clinical data mortality found similar studies correlation mortality gender however unlike studies find significant correlation advancing age patient mortality finding could attributed fact patients recruited aged <NUMBER> <NUMBER> years studies include higher proportion individuals <NUMBER> years age results significant association age mortality <NUMBER> <NUMBER> several studies shown presence comorbidities cardiovascular disease secondary infections contributes significantly disease severity mortality among covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> study found <NUMBER> patients admitted icu exhibited presence previous comorbidities common diabetes <NUMBER> hypertension <NUMBER> similarly death group patients suffered hypertension <NUMBER> diabetes <NUMBER> finding consistent rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint previous studies <NUMBER> furthermore results also indicated hypertension independent risk factor mortality adjusted <NUMBER> <NUMBER>ci <NUMBER> moreover compared discharge group double number patients death group suffered two comorbidities several studies icu mortality associated organ dysfunction qsofa recently developed scoring system used assess organ dysfunction although qsofa score directly evaluate patient mortality previous studies demonstrated relationship mortality dysfunction <NUMBER> study higher proportion patients death group showed higher qsofa scores compared patients discharged group <NUMBER> vs <NUMBER> respectively however difference statistically significant p <NUMBER> results also indicated patient mortality significantly associated higher levels hs troponin pct crp elevated hs troponin levels previously associated acute coronary syndrome reduced left ventricular function higher levels il<NUMBER> tnfalpha ultimately leads mortality among icu patients <NUMBER> pct precursor calcitonin mainly released bacterial sepsis tissue injury previously recognized indicator severity organ failure mortality among icu patients <NUMBER> <NUMBER> noteworthy high pct levels associated bacterial infection indicates death among covid<NUMBER> patients elevated pct might due secondary bacterial infections assumption supported results showed compared discharge group higher proportion patients death group suffered bacterial infections crp wellknown plasma protein involved inflammatory reactions elevated crp levels significantly associated several cardiovascular disorders organ failure mortality among icu patients <NUMBER> <NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint furthermore lower levels lymphocytes lymphopenia albumin also associated patient mortality within death group <NUMBER> <NUMBER> patients exhibited albumin <NUMBER> gl lymphocytes <NUMBER> x <NUMBER> <NUMBER> l significantly higher compared discharge group <NUMBER> <NUMBER> respectively p <NUMBER> results corroborated previous studies <NUMBER> <NUMBER> furthermore ddimer previously shown sensitive independent predictor mortality among icu patients <NUMBER> corroborated results observed compared discharge group significantly higher proportion patients death group exhibited ddimer <NUMBER> ngml p <NUMBER> however studies discouraged use ddimer quantification mortality prediction icu patients <NUMBER> respect treatment approach adopted found requirement inotropic support intubation significantly higher among patients death group addition rrt requirement also found significantly associated patient mortality even adjusting confounding factors adjusted <NUMBER> <NUMBER>ci <NUMBER> worth mentioning although high flow nasal cannula noninvasive mechanical ventilation used <NUMBER> <NUMBER> patients respectively none died could indicate survival benefit patients receive noninvasive ventilation however difficult draw conclusion point due nature study result could confounded several limitations study firstly sample size study relatively small recruitment higher number patients could provided clearer picture secondly patient data collected retrospectively electronic records often incomplete information could lead information bias thirdly standard protocol laboratory workup patients icu admission led absence results laboratory tests patients due rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint laboratorybased data patients could included regression model might lead discrepancy respect mortality predictors finally end followup period <NUMBER> patients still icu among six intubated one ecmo could lead bias final analysis mortality among patients remained undefined propose future studies recruit higher number patients follow longer duration elucidate factors contribute mortality among covid<NUMBER> patients observational study involving critically ill patients confirmed covid<NUMBER> showed significant differences mortality based age gender nationality several risk factors identified predict mortality based results established set predictive factors hard pal used tool predict mortality critically ill covid<NUMBER> patients multicentric large studies needed validate significance predictors respect patient mortality severe ards po<NUMBER>fio<NUMBER> less <NUMBER> r renal replacement therapy rrt ddimer <NUMBER> ngml p procalcitonin level <NUMBER> ngml serum albumin less <NUMBER> gl l lymphocytic count less <NUMBER> <NUMBER> <NUMBER> l rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint december <NUMBER> outbreak coronavirus disease <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection causing pneumonia began wuhan china rapidly spreading worldwide <NUMBER> april <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases covid<NUMBER> diagnosed <NUMBER> cases covid<NUMBER> patients died chinese center disease control prevention reported <NUMBER> mild <NUMBER> severe <NUMBER> critical cases <NUMBER> case fatality rate estimated <NUMBER> <NUMBER> lower severe acute respiratory syndrome sars middle east respiratory syndrome higher influenza <NUMBER> several established clinical scoring systems detecting patients high risk suspected infection systemic inflammatory response syndrome sirs score developed <NUMBER> consensus conference improve early detection sepsis patients <NUMBER> sirs consists four variables body temperature heart rate respiration rate whitebloodcell count differentials however limited value predicting mortality among infected adults <NUMBER> outside <NUMBER> intensive care unit icu setting quick sequential organ failure assessment qsofa criteria consisting respiratory rate glasgow coma scale systolic blood pressure proposed <NUMBER> qsofa better predicting inhospital mortality sirs outside icu setting <NUMBER> lower prognostic accuracy inhospital mortality increase qsofa score <NUMBER> icu setting <NUMBER> national early warning score news consists seven parameters improve early detection response clinical deterioration <NUMBER> news equivalent superior accuracy sirs qsofa predicting clinical deterioration infected patients outside icu <NUMBER> <NUMBER> date effective antiviral treatment covid<NUMBER> thus early recognition patients high risk important close monitoring provide necessary interventions right time study compared predictive values preexisting clinical scoring systems patients covid<NUMBER> performed retrospective observational study <NUMBER> patients sarscov<NUMBER> infection hospitalised yeungnam university medical center <NUMBER>bed universityaffiliated tertiary referral hospital daegu south korea february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> final date followup april <NUMBER> <NUMBER> study period consecutive adult patients age ≥ <NUMBER> years sarscov<NUMBER> infection admitted hospital via emergency outpatient department eligible inclusion seven patients transferred hospitals whose final clinical results unknown excluded analyses patients electronic medical records reviewed data patients age sex comorbidities vital signs complications collected sirs <NUMBER> assesses systemic inflammatory response variety severe clinical situations sirs manifested two following conditions temperature <NUMBER>°c <NUMBER>°c heart rate <NUMBER> beats per minute respiratory rate <NUMBER> breaths per minute paco <NUMBER> <NUMBER> mm hg whitebloodcell count <NUMBER>cu mm <NUMBER>cu mm <NUMBER> immature band forms qsofa <NUMBER> rapid bedside clinical scoring system detecting patients suspected infection higher risk poor clinical outcome qsofa scale assigns score <NUMBER> point three parameters related organ function respiratory rate glasgow coma scale systolic blood pressure qsofa scores <NUMBER> higher indicate higher inhospital mortality news <NUMBER> early warning score improve early detection response clinical deterioration composed seven parameters pulse oximetry oxygen pulse rate systolic blood pressure respiration rate temperature central nervous system status parameter assigned score <NUMBER> points score reflects extent parameters differ news stratified three categories low risk <NUMBER> medium risk <NUMBER> <NUMBER> high risk ≥ <NUMBER> <NUMBER> critical outcomes defined icu care death critical patients defined patients representing critical outcomes acute respiratory distress syndrome ards defined according berlin definition <NUMBER> septic shock defined according third international consensus definitions sepsis septic shock sepsis<NUMBER> <NUMBER> primary endpoints <NUMBER>day mortality critical outcomes secondary endpoints complications ards septic shock icu care continuous variables expressed means ± standard deviations sds compared using students ttest mannwhitney u test categorical variables compared using χ <NUMBER> test fishers exact test area receiver operating characteristic auroc curve analyses performed assess effectiveness sirs qsofa news predicting covid<NUMBER> prognosis compare effectiveness three scoring systems pairwise comparisons auroc curves conducted survival probability calculated according news stratification using kaplanmeier analyses compared using logrank test analyses p <NUMBER> twotailed tests considered indicate statistical significance statistical procedures performed using spss software ver <NUMBER> spss inc chicago il usa study conducted accordance tenets declaration helsinki reviewed approved institutional review board yeungnam university hospital yuh irb <NUMBER> requirement informed consent waived retrospective study design demographic baseline characteristics patients presented table <NUMBER> study included <NUMBER> patients sarscov<NUMBER> <NUMBER> <NUMBER> critical cases sixty two patients women <NUMBER> mean age <NUMBER> ± <NUMBER> years critical group significantly older noncritical group years p <NUMBER> critical group significantly likely diabetes mellitus <NUMBER> vs <NUMBER> p <NUMBER> respiration rates significantly higher critical group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> critical group many complications ards <NUMBER> patients <NUMBER> <NUMBER> septic shock <NUMBER> <NUMBER> icu care <NUMBER> <NUMBER> <NUMBER> <NUMBER>day mortality high <NUMBER> <NUMBER> sirs qsofa news differed significantly critical noncritical groups comparisons components scoring systems patients covid<NUMBER> shown table <NUMBER> based sirs respirationrate scores significantly higher critical group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> based qsofa respirationrate scores significantly higher critical group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> systolic bp scores significantly lower critical group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> based news respiration rates oxygen saturation supplemental oxygen heartrate scores differed significantly two groups receiver operating characteristic roc curves prediction complications mortality using three scoring systems table <NUMBER> shows prevalence complications <NUMBER>day mortality critical outcomes different stratifications sirs qsofa news sensitivity specificity positive predictive value ppv negative predictive value npv news prediction critical outcomes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively news ≥ <NUMBER> medium risk threshold value <NUMBER> points high risk values <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively table <NUMBER> kaplanmeier survival curves cumulative risk <NUMBER>day mortality according news stratification shown fig <NUMBER> survival time significantly shorter patients news ≥ <NUMBER> news <NUMBER> logrank test p <NUMBER> study <NUMBER> hospitalised patients sarscov<NUMBER> infection analysed <NUMBER> <NUMBER> critical cases <NUMBER>day mortality rate <NUMBER> auroc values prediction <NUMBER>day mortality sirs <NUMBER> <NUMBER> septic shock sepsis<NUMBER> issued <NUMBER> <NUMBER> previous definition sepsis infection two four sirs criteria focused inflammatory excess sirs criteria reflect dysregulated host responses presence organ dysfunction infection two four sirs criteria used define sepsis one eight people infection organ failure significant mortality rates excluded <NUMBER> addition almost <NUMBER> patients hospitalised general wards developed sirs least hospitalisation suggesting sirs criteria poor discriminant validity ineffective detecting sepsis <NUMBER> definitions sepsis septic shock revised <NUMBER> increase sofa score two better prognostic accuracy predicting mortality compared sirs patients infection <NUMBER> <NUMBER> <NUMBER> however sofa score includes six parameters requires laboratory tests pao <NUMBER> platelets bilirubin creatinine using simpler useful criteria qsofa introduced showed great prediction validity inhospital mortality auroc <NUMBER> <NUMBER> ci <NUMBER> statistically better sofa change sofa score nonicu patients <NUMBER> news showed great ability discriminate infected patients high risk clinical deterioration time admission <NUMBER> emergency department <NUMBER> outside icu <NUMBER> data focussed covid<NUMBER> patients time admission study sirs qsofa news significantly high scores critical patient group cases significant differences scores related breathing oxygenation sun et al <NUMBER> reported oxygen supplementation independent risk factor novel coronavirus pneumonia progressing critical condition blood oxygen saturation spo <NUMBER> <NUMBER> breathing room air needs criticalcare management chinese center disease control prevention divided clinical manifestations disease three degrees severity dyspnea respiratory frequency ≥ <NUMBER>min spo<NUMBER> ≤ <NUMBER> classified severe disease <NUMBER> based results findings difficulty breathing hypoxia oxygen requirements early stage hospitalisation considered important indicators predicting progress serious condition study news admission showed equivalent superior accuracy sirs qsofa predicting clinical deterioration ards septic shock icu care <NUMBER>day mortality critical outcomes covid<NUMBER> patients shown table <NUMBER> sirs qsofa indicated higher frequency poor clinical outcomes groups lower risk low accuracy sirs qsofa prediction covid<NUMBER> clinical outcomes many silent hypoxemia patients severe covid<NUMBER> patients silent hypoxemia seem breathe comfortably fact oxygen saturation often low measured pulse oximetry reason sirs qsofa limitations predicting outcomes covid<NUMBER> high accuracy news predictions covid<NUMBER> clinical outcomes interpreted related aforementioned factors breathing hypoxia oxygen requirements three variables news early detection important covid<NUMBER> pneumonia caused novel coronavirus often fatal due rapid progression addition drug proven effective covid<NUMBER> early interventions implemented patients five news points expected develop disease progression first since covid<NUMBER> highly contagious infectious disease requiring medical staff wear personal protective equipment resulting less contact patients compared patients due limitations discovery worsening patients may delayed news allows intensive monitoring selecting patients likely progress critical illness second use highflow nasal cannula hfnc noninvasive ventilation niv considered patients ards alveolar collapse hypercapnia early identification highrisk patients noninvasive measures give patients chance recover third due nature pandemic medical personnel facilities equipment often depleted news help detect highrisk patients quickly early thus save patients emergency evacuation locations medical personnel facilities equipment available study several limitations first retrospective study conducted single centre relatively small number covid<NUMBER> patients results cannot generalised external validation needed studies future large cohorts covid<NUMBER> patients confirm efficacy news predicting poor clinical outcomes second efficacy former sofa assessed contact covid<NUMBER> patients challenging obtaining arterial blood gas analyses measuring pao <NUMBER> fio <NUMBER> ratios feasible patients third selection bias cannot avoided use data large population severity covid<NUMBER> may differ among hospitals countries however strength study first evaluate efficacy preexisting scoring systems prediction clinical deterioration covid<NUMBER> patients conclusion calculation news time hospital admission predict critical clinical outcomes patients covid<NUMBER> predictive value superior sirs qsofa early detection highrisk group using news early interventions highrisk patients improve clinical outcomes covid<NUMBER> patients last two decades coronaviruses recognized one critical human pathogenic viruses affect global health cause concern world health system <NUMBER> coronavirus classified four genera alpha beta delta gamma major <NUMBER> mortality <NUMBER> vaccine targeted treatment currently available covid<NUMBER> infection treatment mostly supportive although multiple experimental antiviral medications evaluated <NUMBER> <NUMBER> thus prevention rapid diagnosis infected patients crucial trigger rapid screening treatment covid<NUMBER> patients based clinical symptoms laboratory radiographic findings similar sars mers infections study attempted distinguish clinical symptoms laboratory findings radiographic signs outcomes confirmed covid<NUMBER> sars mers patients findings compared determine unique features among data could helpful early diagnosis prevention infection well providing reliable epidemiological data largescale health care policies future studies study conducted according preferred reporting items systematic reviews metaanalyses statement prisma guidelines registered prospero database id <NUMBER> <NUMBER> searched studies published <NUMBER> february <NUMBER> following databases embase scopus pubmed web science cochrane library search medical subject headings mesh terms used covid<NUMBER> coronavirus severe acute respiratory syndrome sars virus severe acute respiratory syndrome coronavirus <NUMBER> coronavirus infections middle east respiratory syndrome coronavirus synonyms like wuhan coronavirus sarscov<NUMBER> covid<NUMBER> <NUMBER>ncov mers moreover searched unpublished grey literature google scholar centre disease controls cdc databases also examined references included articles find additional relevant studies language restriction included studies written english chinese languages latter translated httpstranslategooglecom additional search strategy details provided table s<NUMBER> duplicate studies removed using endnote x<NUMBER> thomson reuters new york ny usa records initially screened title abstract independently four authors ap sg ak rf fulltext potentially eligible records retrieved examined discrepancies resolved consensus studies fulfill following predetermined criteria eligible inclusion metaanalysis casecontrol crosssectional cohort studies case reports case series peerreviewed studies included reported number confirmed cases patients demographic data clinical data laboratory data risk factor data studies excluded report number confirmed cases letters editor individual case reports review articles news reports also excluded duplicate information patient combined counted single case data reported twice covid<NUMBER> included publications published <NUMBER> patients china following items extracted article first author center study location china countries sample collection time patient followup time reference standard infection confirmation number confirmed cases study type demographic clinical laboratory data risk factor data three authors sg ak rf independently extracted data extracted data checked randomly another author ap differences resolved consensus quality assessments studies performed two reviewers independently according critical appraisal checklist recommended joanna briggs institute <NUMBER> disagreements resolved consensus checklist composed nine questions reviewers addressed study yes answer question received one point thus final scores study could range zero nine table s<NUMBER> data cleaning preparation done microsoft excel <NUMBER> microsoft© redmond wa usa analyses carried via comprehensive metaanalysis software version <NUMBER> biostat englewood nj determination heterogeneity among studies undertaken using chisquared test cochrans q assess appropriateness pooling data depending heterogeneity test used either random fixedeffect models pooled results case high heterogeneity i<NUMBER> <NUMBER> random effect model mh heterogeneity applied low heterogeneity cases i<NUMBER> <NUMBER> fixedeffect model used <NUMBER> percentages means ± sds calculated describe distributions categorical continuous variables respectively p values reflect study heterogeneity <NUMBER> significant also used funnel plot beggs eggers tests based symmetry assumption detect publication bias figure s<NUMBER> process study selection displayed figure <NUMBER> quality assessment included studies performed based critical appraisal checklist final quality scores included studies represented table s<NUMBER> brief studies chen et al <NUMBER> wang et al <NUMBER> huang et al <NUMBER> guan et al <NUMBER> zhang et al <NUMBER> cheng et al <NUMBER> li et al <NUMBER> xu et al <NUMBER> figure s<NUMBER> cough second common symptom presenting covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> sars <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> mers <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> patients figure s<NUMBER> age exception presented mean age years <NUMBER> ci <NUMBER> p <NUMBER> runny nose <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> detail information demographics clinical characterization covid<NUMBER> table s<NUMBER> sars table s<NUMBER> mers patients table s<NUMBER> demonstrated supplementary material greatest risk covid<NUMBER> patients <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> february <NUMBER> history recent travel wuhan contact people wuhan wuhan residents <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> exposure seafood markets table s<NUMBER> sars table s<NUMBER> mers patients table s<NUMBER> demonstrated supplementary material covid<NUMBER> confirmed patients required hospitalization <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> deemed critical condition mortality rate covid<NUMBER> confirmed cases <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> sars <NUMBER> <NUMBER> <NUMBER> p <NUMBER> mers <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure <NUMBER> laboratory findings showed among subset patients <NUMBER> increased percentage value actual mortality rate covid<NUMBER> almost certainly much lower found study data emerges screening asymptomatic mildly symptomatic individuals china around world exact mortality rate better understood among covid<NUMBER> sars mers patients leukocytosis found <NUMBER> <NUMBER> <NUMBER> respectively leukopenia <NUMBER> <NUMBER> <NUMBER> respectively patients coronavirus abnormal chest radiological findings hand runny nose rhinorrhea less common symptoms coronavirusinfected patients <NUMBER> typically expressed pulmonary alveolar epithelial cells <NUMBER> another study reported following covid<NUMBER> infection deregulated cytokinechemokine response higher virus titer causes inflammatory cytokine storm lung immunopathological injury <NUMBER> inflammation related cytokine storm lungs may spread throughout body via circulation system covid<NUMBER> patients reported increased plasma concentration inflammationrelated cytokines including interleukin il<NUMBER> tumor necrosis factorα tnfα monocyte chemoattractant protein mcpi especially moribund patients <NUMBER> several limitations study exist publication bias study heterogeneity unavoidable type study therefore considered interpreting outcomes reports final data set furthermore study likely overestimates disease severity due lack screening asymptomatic mildly symptomatic individuals subsequent publication bias related factors likely many infected persons detected thus falsely elevating rates hospitalization critical condition mortality lower quality analysis reporting included publications another limitation study prevent language bias included reports languages english additionally searched variety sites databases prevent internet platform bias using eggers regression test find significant publication bias journal bias issue facing carry metaanalysis yet usually affect general conclusions <NUMBER> however cannot reject occurrence biases study choice bias since several journals indexed embase scopus pubmed web science cochrane library unpublished data regions world fever cough common symptoms covid<NUMBER> sars mersinfected patients mortality rate covid<NUMBER> confirmed cases lower sarsand mersinfected patients clinical outcomes findings may biased reporting confirmed cases considered interpreting data coronavirus disease <NUMBER> covid<NUMBER> caused <NUMBER> novel coronavirus <NUMBER>ncov caused significant mortality declared global pandemic world health organization infection mainly presents fever cough breathing difficulty patients develop severe symptoms purpose review analyze impact virus kidney covid<NUMBER> infection causes acute kidney injury aki independent risk factor mortality angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors direct viral damage immunemediated damage play important roles pathogenesis aki covid<NUMBER> infection could synergistic effect virusinduced direct cytotropic effect cytokineinduced systemic inflammatory response aki caused viral infection analyzed available epidemiological studies proportion patients developing aki significantly higher develop severe disease continuous renal replacement therapy crrt used blood purification technique needed impact covid<NUMBER> infection chronic kidney disease ckd renal transplant patients also discussed manuscript vaccine developed <NUMBER>ncov virus date critical aspect management supportive care several investigative drugs studied drugs approved indications used several clinical trials underway across globe recently remdesivir received emergency use authorization food drug administration fda usa use patients hospitalized covid<NUMBER> prevention infection holds key management patients underlying kidney problems renal transplant patients vulnerable developing covid<NUMBER> infection covid<NUMBER> pandemic causing acute kidney injury impact patients chronic kidney disease renal transplantation series pneumonia cases unexplained etiology wuhan china since december <NUMBER> created public health concern resulted identification viral cause initial reports viral infection traced huanan seafood market wuhan china etiological agent identified coronavirus <NUMBER> world health organization named virus <NUMBER> novel coronavirus <NUMBER>ncov january <NUMBER> <NUMBER> declared public health emergency globally january <NUMBER> <NUMBER> <NUMBER> disease caused virus named coronavirus disease <NUMBER> covid<NUMBER> february <NUMBER> <NUMBER> <NUMBER> international committee taxonomy viruses designated etiological coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> number cases multiplying alarming rate globally resulting mortality declared covid<NUMBER> pandemic march <NUMBER> <NUMBER> <NUMBER> may <NUMBER> <NUMBER> <NUMBER> million confirmed cases covid<NUMBER> infection cases globally number reported deaths <NUMBER> <NUMBER> sars middle eastern respiratory syndrome mers covid<NUMBER> third known zoonotic cov infection belong betacov cluster <NUMBER> determination animal species carrying ncov preliminary studies showed ncov closely related adapa et al j clin med res <NUMBER> coronavirus isolated bats postulating theory possible transmission bats humans <NUMBER> genome homology sequence sarsncov sarscov <NUMBER> sarsncov high homology bat cov <NUMBER> studies suggest evidence strongly sarsncov might originated bats intermediate host transmission humans yet ascertained ji et al found snakes wildlife repositories sarsncov <NUMBER> various studies reported epidemiological data sarsncov studies shown elderly patients affected higher male preponderance mortality higher elderly severe comorbid conditions <NUMBER> case fatality rate estimated <NUMBER> depending case series described <NUMBER> <NUMBER> median incubation period <NUMBER> days median time first symptom death less elderly <NUMBER> mode transmission close contact people infection respiratory droplets infected person coughs sneezes another possible mechanism infected surfaces objects epidemiological data revealed severe illness rate covid<NUMBER> infection high <NUMBER> even though lungs main organs affected kidney also one main organs affected severe illness <NUMBER> acute kidney injury aki seen <NUMBER> cases infected sarscov merscov higher mortality rate <NUMBER> per literature <NUMBER> covid<NUMBER> infection causes aki independent risk factor mortality <NUMBER> <NUMBER> also impacts patients chronic kidney disease ckd patients chronic replacement therapies patients kidney transplant mohamed et al <NUMBER> evaluated contributing factors developing aki <NUMBER> intensive care unit icu patients study incidence aki <NUMBER> approximately <NUMBER> patients developed aki history ckd stages <NUMBER> <NUMBER> twentyeight percent patients ckd stages <NUMBER> <NUMBER> aki <NUMBER> sarscov<NUMBER> spike protein attaches angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors protein cleaved activated transmembrane serine proteases family tmprss allows virus release fusion peptide aids membrane fusion <NUMBER> aki covid<NUMBER> infection could synergistic effect virusinduced direct cytotropic effect cytokineinduced systemic inflammatory response aki pronounced patients severe disease acute respiratory distress syndrome ards needing icu admission possible mechanisms aki could acute tubular necrosis atn due multiorgan failure shock possible prerenal etiology volume depletion secondary decreased oral intake high fever drug toxicity hemodynamic insult contrast exposure also play role workup aki covid<NUMBER> infection similar causes aki mohamed et al <NUMBER> discussed different etiologies aki study include ischemic acute tubular injury toxic acute tubular injury combination acute interstitial nephritis de novo glomerular disease prerenal azotemia unspecified reasons contributing factors different etiologies include hypotension shock rapid atrial fibrillation prolonged volume depletion rhabdomyolysis toxic agents vancomycin iodinated contrast overt proteinuria <NUMBER> prior studies shown positive sarscov ribonucleic acid rna polymerase gene fragments detected immunohistochemistry situ hybridization kidney specimens autopsy patients died sars <NUMBER> merscov infections also shown cause kidney epithelial cell damage apoptosis mediated receptors <NUMBER> studies suggest injury coronavirus direct cytotoxic effect kidney epithelial cells diao et al analyzed kidney tissue six patients autopsy immunohistochemistry demonstrated presence sarscov<NUMBER> nucleocapsid np protein kidney tubule possibly related potential direct tubular injury virus <NUMBER> sarscov<NUMBER> rna detected urine patients quantitative realtime polymerase chain reaction qrtpcr <NUMBER> normal human lung type <NUMBER> type <NUMBER> alveolar epithelial cells express ace<NUMBER> expressed <NUMBER> type <NUMBER> cells men higher expression rate ace<NUMBER> levels compared women similarly asians express higher ace<NUMBER> levels compared white african american populations <NUMBER> analysis xu et al found ace<NUMBER> receptor expression kidney less lung comparative analysis <NUMBER> podocytes proximal convoluted tubule cells significantly coexpress ace<NUMBER> tmprss genes potential targets sarscov<NUMBER> kidney tissue expresses ace<NUMBER> gene higher lung tissue binding affinity sarscov<NUMBER> ace<NUMBER> receptors <NUMBER> <NUMBER> times higher sarscov described wrapp colleagues <NUMBER> proinflammatory cytokine levels elevated covid<NUMBER> infection probable activation tcell response <NUMBER> possible occurrence cytokine storm severe cases evidenced significantly higher cytokine levels cytokine storm immune system damages healthy tissues rather sarscov<NUMBER> <NUMBER> autopsies six kidney tissues light microscopy revealed cluster differentiation <NUMBER> cd<NUMBER> macrophage infiltration tubulointerstitium severe atn tubules showed complement <NUMBER>b<NUMBER> deposition six cases deposition glomeruli capillaries seldom seen cd<NUMBER> lymphocyte cells cd<NUMBER> natural killer cells seen kidney tissue <NUMBER> recently published studies china showed incidence aki patients infected covid<NUMBER> around <NUMBER> <NUMBER> <NUMBER> patients severe covid<NUMBER> infection icu rates aki increased significantly <NUMBER> <NUMBER> <NUMBER> variation reporting incidence aki depends number patients severity infection reporting aki across studies diagnosis aki based kidney disease improving global outcomes kdigo classification summarized table <NUMBER> <NUMBER> cheng colleagues analyzed large cohort <NUMBER> patients kidney disease confirmed covid<NUMBER> admitted tongji hospital january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> years age patients history renal transplant maintenance dialysis excluded study baseline serum creatinine elevated <NUMBER> patients admission patients elevated serum creatinine group elderly higher percentage males days onset illness hospital admission shorter patients also severe disease comorbidities compared normal baseline serum creatinine patients pronounced aki higher rates mechanical ventilation hospital mortality rate higher patients elevated serum creatinine also leukocytosis lymphopenia thrombocytopenia prolonged activated partial thromboplastin time higher ddimer levels patients elevated baseline serum creatinine higher percentage increased procalcitonin aspartate aminotransferase lactic dehydrogenase levels aki occurred within <NUMBER> days much quicker severe elevated baseline serum creatinine group patients normal baseline creatinine later onset aki recovered quickly elevated blood urea nitrogen bun creatinine highgrade proteinuria hematuria elevated baseline serum creatinine patients along significantly lower estimated glomerular filtration rate egfr significant gap peak baseline creatinine elevated serum creatinine group patients elevated serum creatinine baseline worse outcomes compared patients normal baseline serum creatinine study li et al <NUMBER> analyzed <NUMBER> cases inpatients multiple hospitals around wuhan january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> covid<NUMBER> disease <NUMBER> patients diagnosed severe cases according chinese nation health guidance three patients died severe cases <NUMBER> proteinuria present <NUMBER> patients many detected protein first day admission suggesting presence prior renal impairment bun elevated <NUMBER> patients also higher level bun present two patients died serum creatinine elevated <NUMBER> patients patients died extremely high levels density reduced computed tomography ct images kidney suggestive edema inflammation study wang et al <NUMBER> patients needing icu admission higher bun creatinine levels hospital admission compared nonicu admission patients overall patients general bun creatinine levels continued get worse nonsurvivors death <NUMBER> summarized finding multiple studies including patient characteristics comorbidities incidence aki general well icuseverely ill patients number patients requiring continuous renal replacement therapy crrt extracorporeal membrane oxygenation ecmo mortality table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients developed aki covid<NUMBER> infection around <NUMBER> required rrt form crrt <NUMBER> <NUMBER> proportion patients needing rrt increased <NUMBER> severe infection <NUMBER> <NUMBER> per international experts severe covid<NUMBER> cases hypoxemic respira tory failure along renal liver dysfunction ecmo without crrt used crrt used blood purification modality clinical practice severe covid<NUMBER> patients sepsis ards hemoperfusionplasma adsorption treatment also selected clear inflammatory mediators <NUMBER> recommendations care hospitalized patients covid<NUMBER> kidney failure needing rrt american society nephrology asn summarized <NUMBER> health care personnel follow centers disease control prevention cdcrecommended personal protective equipment ppe safety guidelines interactions patients health care personnel work team limit exposure infection indications rrt similar patients aki providers significant expertise place dialysis catheters patients cohorted dedicated icus possible preferred dialysis modality crrt slow lowefficiency dialysis sled available intermittent hemodialysis ihd also performed crrt sled available crrt preferred ihd setting isolation ihd needs oneonone nursing support patients needing crrt exceeds machines available prolonged intermittent treatments eg <NUMBER> h instead continuous higher flow rates eg <NUMBER> <NUMBER> mlkgh terminal cleaning used another patient patients cohorted dedicated floor possible patients active suspected covid<NUMBER> needing dialysis treatment transported central acute dialysis unit ihd provided oneonone nursing care patient negative pressure room covid<NUMBER> patients isolated one floor one dialysis nurse may able monitor two three patients ihd video electronic monitoring available nurse enters room patient needs anything troubleshoot machine peritoneal dialysis continued automated peritoneal dialysis apd limit exposure medical staff dialysis equipment cleaned disinfectant removing room hospital infection control policy directs proper disposable rrt machine equipment per hospital protocol crrt filters need changed every <NUMBER> h longer continuous venovenous hemofiltration also known cvvh continuous venovenous hemodiafiltration cvvhdf preferred techniques usa continuous venovenous hemodialysis cvvhd common modality used volume overloaded patients treated using slow continuous ultrafiltration scuf keep fluid balance net negative <NUMBER> temporary dialysis catheters recommended vascular access providers significant expertise place dialysis catheters recommended use doublelayered protection personnel performing procedure filters high ultrafiltration coefficient high molecular weight cutoff membrane <NUMBER> <NUMBER> nm membrane pore size suggested <NUMBER> would help clearing high molecular weight inflammatory mediators however albumin would need replaced removed concurrently essential assess patients bleeding risk choosing anticoagulation patients severe covid<NUMBER> infection high bleeding risk recommended avoid anticoagulation normal hypercoagulable states one use heparin citratebased anticoagulation depending hospital protocols using crrt combination ecmo anticoagulation needed ecmo utilizes systemic heparinization <NUMBER> essential pay close attention hemodynamics volume status patients covid<NUMBER> infection using arterial central venous pressure cvp monitors patients frequent renal panels checks every <NUMBER> <NUMBER> h monitor strict input output maintain net negative fluid balance ards patients patients without ards volume status assessed maintain euvolemic state patients monitored recovery kidney function daily basis rrt discontinued patient nonoliguric euvolemic improved ventilation requirements also supported improved laboratory findings without alarming electrolyte acidbase imbalance aki associated increased inhospital mortality patient meticulously managed providing hemodynamic support avoiding nonsteroidal antiinflammatory drugs nsaids nephrotoxins contrast early institution crrt improve outcomes proteinuria hematuria also associated inhospital mortality close attention paid urine analysis inpatient outpatient settings experience various published studies patients infected covid<NUMBER> infection showed aki associcovid<NUMBER> pandemic kidney injury j clin med res <NUMBER> ated mortality shi et al analyzed <NUMBER> patients died covid<NUMBER> infection showed <NUMBER> aki <NUMBER> patient underlying ckd bun myoglogin levels higher patients died within <NUMBER> days median time hospitalization death <NUMBER> days <NUMBER> cheng analysis showed elevated baseline serum creatinine elevated bun peak serum creatinine <NUMBER> proteinuria hematuria aki stages <NUMBER> <NUMBER> associated mortality adjusting confounding factors <NUMBER> impact covid<NUMBER> infection ckd reported incidence known ckd patients varied <NUMBER> depending upon series described <NUMBER> <NUMBER> increased mortality patients described one study <NUMBER> incidence aki higher patients established ckd <NUMBER> studies analyzed kidney function patients admitted confirmed covid<NUMBER> infection revealed incidence proteinuria hematuria <NUMBER> <NUMBER> significant number patients proteinuria day admission could related cytotropic effects virus podocytes proteinuria may result direct podocyte injury expression ace<NUMBER> <NUMBER> patients recovered covid<NUMBER> infection proteinuria hematuria need followed closely resolution patients sustained aki infection need monitored ckd ongoing outbreak covid<NUMBER> amassed great concern worldwide influence transplant recipients unknown previously experienced coronavirus outbreaks taught us transplant recipients easily affected infections <NUMBER> <NUMBER> said little known risk donor receive transmission disease several factors concerning donor exposure like infectivity incubation period etc play important role although strict guidelines donor restrictions would advisable potential donors hold organ donation suffering respiratory illness american red cross european centre disease prevention control ecdc recommend <NUMBER>day <NUMBER>day period delay respectively potential organ donors history recent travel highrisk areas contact person suspected proven coivd<NUMBER> <NUMBER> <NUMBER> ecdc recommends <NUMBER>day delay recovery confirmed infection michaels colleagues recently well described possible risks associated transplants covid<NUMBER>positive recipients <NUMBER> andrea et al italy described experience institution limiting liver transplantation urgent cases residents epidemic area <NUMBER> liberal allocation policy used patients outside epidemic areas however recipients screened avoid transplantation sarscov<NUMBER>positive subjects internal board consistently reviews updates transplant list every <NUMBER> weeks according new insights covid<NUMBER> continuously train healthcare providers screen nasopharyngeal swabs frequent intervals providing timely information patients caregivers raise awareness time avoid panic confusion important <NUMBER> per review literature best knowledge one case covid<NUMBER> infection described kidney transplant recipients <NUMBER> years <NUMBER> patient successfully managed initially cessation immunosuppression given intravenous stress dose steroids prevent adrenal insufficiency patient improved clinically immunosuppression resumed gradually overall clinical characteristics including symptoms radiological findings lung imaging laboratory findings similar nontransplanted adult patients covid<NUMBER> pneumonia case reported far difficult say possible see atypical findings severe presentations covid<NUMBER> disease transplant recipients healthcare providers aware experimental drugs like remdesivir lopinavirritonavir could cause drugdrug interactions calcineurin inhibitors <NUMBER> therefore recommended use drugs extreme caution regarding treatment kidney transplant recipients covid<NUMBER> infection much information available help guide therapy immunosuppression regimens would recommended use due diligence tailor management treatment options based patients clinical status duration transplant severity illness pandemic progresses expect information available guidance vaccine developed sarscov<NUMBER> virus date critical aspect management supportive care multiple treatments empiric antibiotics antiviral therapy systemic corticosteroids used worldwide several investigative drugs studied drugs approved indications used several clinical trials underway across globe one promising therapies remdesivir inhibits viral replication premature termination rna transcription shown activity beta coronaviruses vitro activity sarscov<NUMBER> <NUMBER> received emergency use authorization food drug administration fda usa use patients hospitalized covid<NUMBER> recommended <NUMBER> days patients mechanical ventilation ecmo recommended <NUMBER> days patients mechanical ventilation ecmo <NUMBER> recommended patients lower gfr gfr <NUMBER> mlmin <NUMBER> others drug gained attention chloro quine hydroxychloroquine either alone combination azithromycin chloroquine hydroxychloroquine vitro activity sarscov<NUMBER> <NUMBER> used several countries treating covid<NUMBER> infection based anecdotal data invitro studies news report china chloroquine increased viral clearance decreased disease progression improved radiological findings <NUMBER> <NUMBER> another clinical trial reported france nonrandomized openlabel trial <NUMBER> patients compared hydroxychloroquine combination hydroxychloroquine azithromycin versus standard care control group combination hydroxychloroquine azithromycin six patients resulted superior viral clearance compared hydroxychloroquine monotherapy <NUMBER> recent study among <NUMBER> veterans found benefit hydroxychloroquine associated risks due side effect profile <NUMBER> medications used caution patients renal hepatic impairment cause qt prolongation electrocardiogram hydroxychloroquine use pre postexposure prophylaxis treatment sarscov<NUMBER> infection currently investigation several clinical trials planned usa test usage hydroxychloroquine treatment prophylaxis covid<NUMBER> clinicians using different doses hydroxychloroquine prophylaxis treatment recent clinical trial china show efficacy lopinavirritonavir treatment pneumonia covid<NUMBER> patients trial underpowered <NUMBER> launched global mega trial called solidarity four promising coronavirus treatments remdesivir chloroquine hydroxychloroquine ritonavirlopinavir ritonavir lopinavir interferon beta <NUMBER> antiretroviral medications coronavirus treatment used like lopinavir ritonavir dose adjustments medications crrt needed <NUMBER> protein bound particular attention paid dosing drugs drugs interferon beta interferon alpha mefloquine favipiravir darunavir ribavirin umifenovir tocilizumab type ii transmembrane serine protease tmspss<NUMBER> inhibitors support therapies using vitamin b c e thymosin alpha <NUMBER> thymopentin selenium zinc pyrithione combination used treatment sarscov<NUMBER> infection <NUMBER> <NUMBER> covid<NUMBER> infection spreading rapidly causing mortality daily worldwide unfortunately knowledge novel virus limited causes significant clinical threat general population healthcare workers several countries imposed strict regulations public limit spread virus many government agencies like cdc fda hospitals public health systems working every day usa contain spread infection studies shown involvement kidneys covid<NUMBER> infection associated high mortality health care providers recognize aspect early appropriate management instituted soon possible patients underlying kidney problems renal transplant patients vulnerable developing covid<NUMBER> infection limited understanding pathogenesis disease virulence virus moment prevention critical aspect management several vaccines promising treatments undergoing clinical trials hope finding cure global crisis soon coronaviruses rna viruses usually cause mild upper respiratory illnesses emergence sars severe acute respiratory syndrome mers middle east respiratory syndrome focussed global attention clinical significance cornaviruses current middle east respiratory syndrome novel coronavirus merscov first isolated june <NUMBER> respiratory tract businessman bisha area saudi arabia subsequently died pneumonia renal failure <NUMBER> <NUMBER> july <NUMBER> merscov caused <NUMBER> laboratory confirmed cases <NUMBER> deaths representing high case fatality rate <NUMBER> <NUMBER> high case fatality rate likely related pattern disease probably seeing tip iceberg critically ill admitted patients high fatality rate likely decline milder clinical cases emerge similar sars common symptoms patients merscov include fever cough shortness breath gastrointestinal symptoms patients pneumonia majority reported multiple comorbid conditions <NUMBER> <NUMBER> rapid deployment effective therapeutics high priority currently specific therapy vaccine merscov clinical experience sars suggests number interventions including ribavirin without corticosteroids interferon alfa corticosteroids ribavirin lopinavir ritonavir convalescent plasma may improve outcome patients data conclusive <NUMBER> purpose review first summarize effectiveness treatments attempt identify therapeutic approach could help select appropriate therapeutic options patients merscov infections middle east respiratory syndrome coronavirus merscov detected number countries middle east europe apparently high mortality rate phylogenetically related sars coronavirus also associated severe respiratory illness well nosocomial transmission healthcare settings current international recommendations support specific therapies however number agents used sars epidemic <NUMBER> possible might active related mers coronavirus reviewed literature safety efficacy therapies used patients sars view potential use patients merscov infections ß <NUMBER> international society infectious diseases published elsevier ltd rights reserved inconclusive mention total number respondents rather surprising patients long treatment delay good response partly related allocation different regimens randomized criteria described paper parameters influenced treatment response time symptom onset treatment day p<NUMBER> time admission treatment day p<NUMBER> time maximal radiographic score treatment day p<NUMBER> <NUMBER> maximal radiographic score p<NUMBER> sao<NUMBER> maximal radiographic score p <NUMBER> case series agents included ribavirin interferon lopinavir ritonavir lpvr convalescent plasma exclude corticosteroid studies beyond scope review management severe pneumonia well covered guideline <NUMBER> data extracted publications include authors name publication year type study level evidence sample size interventions dose duration indication route time administration number patients efficacy safety outcome interventions outcomes interest included mortality rate measures morbidity adverse effects outcomes reported selected studies included death mechanical ventilation improvement symptoms admission intensive care unit infectious complications successful discharge adverse effects clinical studies critically appraised aspects assessed included study design possibility bias selection control group treatment allocation whether treatment regimen reporting outcomes consistent studies tabulated summarized narrative way grouped treatment strategy categorized article depending drug used tabulated results type study dose duration time administration indication medication number patients included study plus final outcomes studies scored using us preventive services task force scoring system <NUMBER> level evidence loe evidence obtained least one properly designed randomized controlled trial level ii<NUMBER> evidence obtained welldesigned controlled trials without randomization level ii<NUMBER> evidence obtained welldesigned cohort casecontrol analytic studies preferably one center research group level ii<NUMBER> evidence obtained multiple time series without intervention dramatic results uncontrolled trials might also regarded type evidence level iii opinions respected authorities based clinical experience descriptive studies reports expert committees identified <NUMBER> studies sars coronavirus included <NUMBER> studies excluded <NUMBER> studies since <NUMBER> vitro studies <NUMBER> corticosteroid studies <NUMBER> nontherapeutic studies overall analyzed <NUMBER> studies nine used ribavirin alone interferon table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> two used lopinavir ritonavir table <NUMBER> <NUMBER> <NUMBER> six used convalescent plasma table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> one study interferon alpha table <NUMBER> <NUMBER> one study comparing interferon alpha versus ribavirin <NUMBER> summaries different studies presented tables <NUMBER> lot concern worldwide emergence merscov although infection control molecular diagnostics international public health improved considerably since <NUMBER> sars epidemic still proven licensed therapies coronavirus infection high mortality associated merscov led us conduct systematic review summarize available options treatment novel coronavirus infection based previous reports therapy sars related coronavirus commonly used agent broad spectrum antiviral ribavirin seven reports use ribavirin sars patients although four reported control groups mortality benefit inconsistent mortality rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> two studies showed improvements symptoms <NUMBER> patients icu admission rates <NUMBER> <NUMBER> <NUMBER> major problem ribavirin significant incidence adverse events especially hemolysis reported <NUMBER> <NUMBER> timing start antiviral agents important virus infections one study compared oseltamivir versus ribavirin showed obvious response ribavirin however treatment started <NUMBER> days symptoms might led poorer outcomes <NUMBER> one randomized controlled trial compared ribavirin versus interferon<NUMBER>a showed advantage ribavirin interferon patients sars <NUMBER> addition observational studies comparing interferon<NUMBER>a untreated controls <NUMBER> interferon led improvements clinical laboratory parameters compared control patients <NUMBER> however standard regime used adverse events well documented addition lopinavirritonavir ribavirin regimen associated improved clinical outcome reduces death rate comparing ribavirin regimen alone observational studies <NUMBER> <NUMBER> studies detailed table <NUMBER> studies addressed effect convalescent plasma <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies mainly case reports limit generalizability findings three studies sars patients patients interferon alfacon<NUMBER> treatment group shorter time <NUMBER> resolution lung radiographic abnormalities p <NUMBER> better oxygen saturation p <NUMBER> resolved need supplemental oxygen rapidly p <NUMBER> less increase creatine kinase levels p <NUMBER> showed trend toward rapid resolution lactate dehydrogenase levels compared group receiving corticosteroids alone inconclusive mechanical ventilation <NUMBER> <NUMBER> lower mortality comparator group <NUMBER> versus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> intriguingly vitro study showed convalescent plasma sars patients might contain crossreactive antibodies betacoronavirus including merscov <NUMBER> <NUMBER> sera <NUMBER> <NUMBER> antibodies antimerscov neutralizing antibodies low titers <NUMBER> convalescent sera recommended recent study international severe acute respiratory emerging infection consortium isaric <NUMBER> crossreactive antibodies may present convalescent plasma sars patients betacoronavirus may associated better outcome reduced mortality shorter hospital stay <NUMBER> <NUMBER> <NUMBER> <NUMBER> considerable technical hurdles overcome convalescent sera widely recommended therapeutic agent modern era currently need establish serology test diagnose patients mild disease thus identify patients possible donors convalescent sera conclude use ribavirin may improve outcome reduce mortality shown number studies one reasons failure ribavirin reports may timing use ribavirin <NUMBER> days symptom <NUMBER> <NUMBER> <NUMBER> compared studies showed benefits ribavirin started within <NUMBER> hours hospitalization diagnosis sars established <NUMBER> <NUMBER> <NUMBER> <NUMBER> major limitation ribavarin significant toxicity doses used treat patients sars although addition lopinavirritonavir ribavirin appeared better outcome patients sars <NUMBER> <NUMBER> reports lopinavirritonavir active vitro merscov <NUMBER> vitro studies failed yield potent therapeutic agents despite search including dpp<NUMBER> inhibitors <NUMBER> among limitations review heterogeneity reviewed studies terms wide range treatment dosages frequency route administration duration timing administration reported treatment effects interpreted caution due lack randomized controlled trials also drawn sars literature sars closely related virus clearly differences sars merscov data might able directly extrapolated merscov infected patients use discussed agents would require monitoring hematological biochemical parameters treatment detect prevent adverse effects associated therapy possible dosages discussed agents especially unavailability intravenous ribavarin listed table <NUMBER> table also includes possible dosage pegelated interferona pegifna commonly used treatment hepatitis c virus infection pegifna <NUMBER> times effective vitro merscov sarscov <NUMBER> long halflife pegifna associated adverse effects calls extra attention use shorteracting interferon <NUMBER> use interferon therapy ribavirin recommended patients hepatitis c virus infection renal dysfunction clcr <NUMBER> mlminute emergence merscov lack high quality clinical evidence support recommendations use available therapeutic options clear need developing protocols used randomizedcontrolled trials order determine effective therapies novel emerging pathogen wuhan city capital hubei december <NUMBER> china outbreak representing pneumonia unidentified origin occurred <NUMBER> january <NUMBER> scientists china could isolate new strain coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> affected patients <NUMBER> causes disease coronavirus disease <NUMBER> covid<NUMBER> stated february <NUMBER> <NUMBER> although outbreak mostly started zoonotic transmission large seafood market also traded live wild animals soon became obvious efficient persontoperson transmission also possible <NUMBER> clinical spectrum covid<NUMBER> disease appears wide ranging asymptomatic infection mild upper respiratory tract illness severe viral pneumonia respiratory failure death evaluation risk factors severity disease possibility death important issue prediction possible outcome study conducted zhou et al <NUMBER> confirmed increased age patients covid<NUMBER> associated death decrease tcell bcell functions depending age additional production type <NUMBER> cytokines could lead lack control viral replication load exacerbation proinflammatory responses may lead increase severity disease poor outcome <NUMBER> petrilli et al <NUMBER> described characteristics <NUMBER> patients new york city laboratoryconfirmed covid<NUMBER> disease <NUMBER> needed hospital admission <NUMBER> needed icu respiratory support discharged hospital andor died found older age one important predictors hospitalization vital predictor severe outcomes nasiri et al <NUMBER> showed sex affected mortality rate mortality females covid<NUMBER> significantly lower males odds ratio <NUMBER> <NUMBER> ci <NUMBER> p value <NUMBER> hand significant difference male female regarding icu admissions earlier coronavirus epidemics sars mers resulted similar form higher mortality males females karlberg et al <NUMBER> also showed difference mortality rates according sex distribution affected cases higher younger males <NUMBER> years old rr<NUMBER> compared age group <NUMBER>years old rr<NUMBER> also another study conducted alghamdi et al <NUMBER> showed regarding mers number diseases males double females <NUMBER> vs <NUMBER> patients coronary heart disease also found severe acute cardiac events poor outcomes respiratory viral infections including influenza <NUMBER> study conducted zhou et al showed increasing level highsensitivity cardiac troponin ictni hospitalization presented half cases died covid<NUMBER> <NUMBER> li et al <NUMBER> reported clinical characteristics <NUMBER> cases died covid<NUMBER> clinical profile patients showed important risk factors death patients represented age underlying diseases regarding underlying diseases associated death recorded one chronic hypertension diabetes mellitus chronic cardiac diseases cerebral infarction kidney disease chronic obstructive pulmonary disease malignant tumors acute pancreatitis li et al <NUMBER> demonstrated respiratory failure leading cause death patients confirmed lungs patients important target organ sarscov<NUMBER> multiple organ failure could observed patients heart came lung common damaged organ kidney liver results study verified death patients covid<NUMBER> may large extent related impaired cardiopulmonary function patients albumin levels <NUMBER> <NUMBER> patients rbc hb levels decreased indicates malnutrition one causes severe covid<NUMBER> measures inflammation process found much important comorbidities demographic characteristics hospitalized patients covid<NUMBER> <NUMBER> exaggerated inflammatory response well defined severe sepsis <NUMBER> even though extent inflammation caused covid<NUMBER> similar different caused sepsis unknown case reports recommend patients critical covid<NUMBER> disease showing complications hypercoagulability <NUMBER> pulmonary emboli <NUMBER> microscopic thrombi <NUMBER> notable obesity chronic condition strongest association critical illness odds ratio higher cardiovascular pulmonary disease obesity recognized proinflammatory condition <NUMBER> <NUMBER> guan et al <NUMBER> observed among patients covid<NUMBER> circulatory endocrine comorbidities common patients one comorbidities associated worse clinical outcomes <NUMBER> cases <NUMBER> <NUMBER> least one comorbidity prevalence specific comorbidities hypertension <NUMBER> <NUMBER> cardiovascular diseases <NUMBER> diabetes <NUMBER> <NUMBER> cerebrovascular diseases <NUMBER> <NUMBER> hepatitis b infections <NUMBER> <NUMBER> chronic obstructive pulmonary disease <NUMBER> <NUMBER> chronic kidney diseases <NUMBER> <NUMBER> malignancy <NUMBER> <NUMBER> immunodeficiency <NUMBER> <NUMBER> least single comorbidity commonly seen severe cases nonsevere cases <NUMBER> vs <NUMBER> hospitalized covid<NUMBER> patients prevalence kidney impairment abnormal urine analysis kidney dysfunction high adjustment confounders kidney impairment related higher risk inhospital mortality clinicians increase attention kidney impairment hospitalized covid<NUMBER> patients early discovery effective intervention kidney impairment help reduce mortality covid<NUMBER> patients clinical practice <NUMBER> petrilliet al <NUMBER> reported particularly strong association chronic kidney disease risk hospitalization also declared importance hypoxia even supplemental oxygen distinguishing among patients develop critical illness blood picture patients covid<NUMBER> characterized normal low count wbcs decreased level lymphocytes <NUMBER> increased levels wbcs neutrophils found <NUMBER> <NUMBER> patients similarly elevation procalcitonin pct levels observed <NUMBER> patients <NUMBER> ddimers fragments produced plasmin cleaves fibrin break clots routinely used exclude diagnosis thrombosis however plasma ddimer increases pathologic nonpathologic process increases fibrin production breakdown <NUMBER> study conducted zhou et al <NUMBER> found ddimer <NUMBER> μgml associated mortality covid<NUMBER> high levels ddimer associated <NUMBER>day mortality patients sepsis infection identified emergency department <NUMBER> petrilli et al <NUMBER> reported striking findings regarding predictive value inflammatory markers distinguish future critical noncritical illness early elevation ddimer level strongest association prolonged hospitalization need mechanical ventilation death <NUMBER> many studies reported ddimer levels associated severity clinical outcome communityacquired pneumonia <NUMBER> mechanisms include proinflammatory cytokine responses considered one mediators atherosclerosis disease contribute plaque rupture local inflammation induce procoagulant factors haemodynamic changes trigger thrombosis formation ischemic diseases <NUMBER> also angiotensin converting enzyme <NUMBER> ace <NUMBER> considered receptor sarscov<NUMBER> expressed vascular endothelial cells myocytes <NUMBER> therefore least theoretical possibility direct affection heart virus creactive protein useful marker gauge inflammation plays important role host defense invading pathogens well inflammation <NUMBER> early rise creactive protein also strongest association mechanical ventilation mortality <NUMBER> serum amyloid saa plasma protein transports lipids inflammation <NUMBER> li et al <NUMBER> showed increased levels saa crp death <NUMBER> <NUMBER> patients suggestive serious inflammatory cascade patients covid<NUMBER> intend monitor biochemical indicators important monitoring severity disease progress li et al <NUMBER> consulted results laboratory test dead patients among <NUMBER>patients repeated measurements saa maintained high level patients result indicated raised saa levels closely related poor prognosis patients first test level neutrophils <NUMBER> crp <NUMBER> pct <NUMBER> ctni <NUMBER> ddimer <NUMBER> lactate dehydrogenase ldh <NUMBER> increased last test levels lymphocytes decreased <NUMBER> suggesting increasing neutrophils crp ddimer pct ctni ldh levels used markers disease severity progress similarly decline lymphocytes counts nasiri et al <NUMBER> identified common laboratory findings associated poor outcome including lymphopenia <NUMBER> raised creactive protein <NUMBER> increased levels ldh <NUMBER> also thrombocytopenia found <NUMBER> cases studies performed huang et al <NUMBER> lippi et al <NUMBER> suggested thrombocytopenia lymphopenia patients covid<NUMBER> associated prolonged hospitalization worse outcomes patients sars indicated higher percentage lymphopenia <NUMBER> thrombocytopenia <NUMBER> covid<NUMBER> <NUMBER> thrombocytopenia lymphopenia previously associated greater risk mortality sars influenza <NUMBER> <NUMBER> liver changes one common finding covid<NUMBER> infected subjects <NUMBER> however significant ast rising found number subjects <NUMBER> also level alt <NUMBER> previous viral infections including sars changes impaired liver function noticed collateral damage perhaps caused direct damaging hepatic tissue pathogen <NUMBER> although could situation covid<NUMBER> iatrogenic trauma medications used lopinavir covid<NUMBER> therapy play role method level virus replication duration life important factors evaluating root transmission guiding protocols patients protection isolation coronavirus rna detection sensitive isolation virus studies gave care use qualitative quantitative viral rna tests possible marker infectious coronavirus sarscov viral rna obtained respiratory specimens third patients affected virus least <NUMBER> weeks onset disease <NUMBER> regarding merscov rna duration viral detection lower respiratory specimens continued long <NUMBER> weeks <NUMBER> study conducted zhou et al <NUMBER> found duration sarscov<NUMBER> rna survivors could reach median <NUMBER> days even though could still till death nonsurvivors result important role decision patients isolation guidelines regarding length treatment protocols usually serious influenza virus infection continued viral replication associated worse outcome may fatal also delay starting suitable antiviral treatment important effect viral replication detection <NUMBER> patients covid<NUMBER> serum level ferritin significantly elevated nonsurvivors compared survivors clinical stages disease raised case deterioration <NUMBER> shoenfeldreported hchain ferritin role activating macrophages raise secretion inflammatory cytokines understanding pathogenesis hyperferritinemic syndrome including infection covid<NUMBER> became obvious <NUMBER> many studies noted chest xray ct abnormalities study populations including unilateral pneumonia <NUMBER> bilateral pneumonia <NUMBER> bilateral infiltrates <NUMBER> ground glass opacities <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cao et al found mortality rate <NUMBER> patients found groundglass opacity associated mortality present <NUMBER> cases died versus <NUMBER> lived <NUMBER> summary risk factors critical illness mortality predictors covid<NUMBER> presented figure <NUMBER> covid<NUMBER> emerging disease world spreading unpredicted rate resulting significant influences global economies public health present review assessed risk factors related outcomes sarscov<NUMBER> infections included old age male gender obesity associated comorbidities form cardiovascular diseases diabetes mellitus chronic kidney disease liver disease cerebrovascular diseases copd laboratory parameters associated critical covid<NUMBER> disease lymphopenia thrombocytopenia leucocytosis increased neutrophils increased c reactive protein ferritin increased dimer raised alt andor ast decreased albumin increased cardiac troponin elevated ldh finally groundglass opacities present ct chest considered important imaging indicator covid<NUMBER> severity funding na authors report conflicts interest work severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus responsible novel coronavirus disease covid<NUMBER> led global pandemic <NUMBER> million confirmed cases including <NUMBER> confirmed cases <NUMBER> deaths united states <NUMBER> state georgia first case novel coronavirus covid<NUMBER> detected march <NUMBER> <NUMBER> first death attributed covid<NUMBER> <NUMBER> days later march <NUMBER> april <NUMBER> <NUMBER> confirmed cases <NUMBER> patients hospitalized <NUMBER> deaths attributed covid<NUMBER> <NUMBER> furthermore forecasted georgia <NUMBER> deaths attributed covid<NUMBER> march <NUMBER> june <NUMBER> <NUMBER> <NUMBER> hospital critical care capacity represents important medical care factor preventing deaths covid<NUMBER> understanding geographic areas highest disease burden morbidity allow policy makers public health professionals critical care providers appropriately allocate resources adequately prepare disease pandemic specific populations present overall prevalence confirmed covid<NUMBER> cases overall mortality rates attributed covid<NUMBER> biweekly incidence rates confirmed covid<NUMBER> cases georgia stratified counties using counties units analysis examined geographic calculated <NUMBER> measures disease morbidity county level <NUMBER> biweekly confirmed case incidence rate per <NUMBER> population performed statistical analysis using sas version <NUMBER> executed mapping using arcgis version <NUMBER> figure s<NUMBER>a counties ≥<NUMBER> male residents <NUMBER> higher incidence rates incidence rate ratio <NUMBER> <NUMBER> ci <NUMBER> compared counties <NUMBER> male residents figure s<NUMBER>a among <NUMBER> confirmed cases <NUMBER> <NUMBER> hospitalized <NUMBER> died <NUMBER> confirmed casefatality rate <NUMBER> ci <NUMBER> due complications covid<NUMBER> present mortality rates confirmed covid<NUMBER> per county figure <NUMBER>b among counties table <NUMBER> including counties deaths order understand similarities dissimilarities counties yet experience mortality disease observed counties highest mortality rates nhblack residents <NUMBER>fold higher mortality rates mortality rate ratio <NUMBER> <NUMBER> ci <NUMBER> compared counties <NUMBER> nhblack residents figure s<NUMBER>b counties ≥<NUMBER> male residents <NUMBER> higher mortality rates mortality rate ratio <NUMBER> <NUMBER> ci <NUMBER> compared counties <NUMBER> male residents figure s<NUMBER>b increases countylevel incidence rates function true incidence widespread testing reported hospital critical care infrastructure county using number icu beds primary care physicians proxies unable account number available ventilator supplies additionally hospital critical care infrastructure static hospitals may capacity increase staffing icu bed space covid<NUMBER> pandemic however urban centers may equipped increase critical care capacity rural centers limitation lacked data transfers critically ill patients rural areas facilities large urban areas date knowledge one first studies describe epidemiology covid<NUMBER> state georgia geographic trends elucidating possible countylevel differences correlated higher mortality rates <NUMBER> order mitigate burden excess deaths due covid<NUMBER> varying stakeholders including policymakers politicians medical professionals community leaders need strategize appropriately allocate resources underresourced areas georgia peak covid<NUMBER> pandemic estimated arrive late april <NUMBER> state local governments strongly support rural counties southwestern georgia area supplying increased icu beds ventilators emergency medical staff urban centers georgia account bulk covid<NUMBER> cases high mortality rates low critical care capacity rural georgia becoming highly detrimental factor fighting pandemic especially concerning given hospital critical care capacity may important medical system stopgap terms preventinglimiting deaths associated covid<NUMBER> conflicts declare justin xavier moore responsible conception design data acquisition analysis drafting manuscript marvin e langston responsible conception design drafting manuscript varghese george responsible conception critical revision important intellectual content steven coughlin responsible conception critical revision important intellectual content novel coronavirus sarscov<NUMBER> first emerged december <NUMBER> wuhan china rapidly grew largescale global pandemic <NUMBER> tracking severity impact time writing critical need hampered testing issues reporting lags key epidemiological indicators many countries including us caught offguard speed covid<NUMBER> spread china without adequate capacity test sarscov<NUMBER> virus causing covid<NUMBER> much february march <NUMBER> available laboratoryconfirmed cases captured estimated <NUMBER> infections <NUMBER> although countries adopted strategy preferentially test severe cases estimating number severe infections deaths caused covid<NUMBER> challenge typically large proportion deaths caused infectious diseases attributed specific pathogen limited availability testing novel coronavirus imperfect sensitivity tests <NUMBER> <NUMBER> undoubtedly number deaths caused virus counted official tallies even situations ample testing deaths viral pathogens including sarscov<NUMBER> occur indirectly via secondary bacterial infections exacerbation chronic conditions midst large outbreak unavoidable delay compilation death certificates ascertainment cause deaths contributes uncertainty severity burden finally us high degree variability public health resources laboratory testing recognition outbreak state level could lead significant underestimation true impact outbreak certain geographies estimate burden death due novel respiratory pathogens previous studies compared observed incidence influenzarelated deaths ascribed pneumonia influenza pi baseline incidence pi would expected time year <NUMBER> <NUMBER> excess deaths provide estimate pathogenspecific burden approach used early months <NUMBER> influenza ah<NUMBER>n<NUMBER>pdm pandemic estimated <NUMBER> <NUMBER> pandemicrelated deaths captured laboratory testing <NUMBER> us <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> study estimated increase pi deaths across united states week excess seasonal baseline capture direct indirect mortality burden covid<NUMBER> compare estimates excess deaths reported numbers deaths due covid<NUMBER> different states evaluate trajectories increases relation volume testing indicators covid<NUMBER> morbidity analyses provide insights burden covid<NUMBER> early months outbreak united states serve surveillance platform updated new data accrue data deaths due pneumonia influenza pi icd<NUMBER> codes j<NUMBER>j<NUMBER> allcauses state week obtained national center health statistics nchs mortality surveillance system <NUMBER> analyze spikes pi mortality rather straight pneumonia comprehensive influenzacoded deaths necessarily require laboratory confirmation influenza infection overlap symptoms influenza covid<NUMBER> pi mortality used us monitor severity influenza respiratory pathogens since <NUMBER> pandemic addition analysis spikes allcause mortality provides full picture direct indirect burden covid<NUMBER> nchs mortality data available <NUMBER>week lag partially complete recent weeks pi mortality data provide provisional number deaths due pneumonia influenza ie deaths code pneumonia influenza anywhere death certificate adjusted total number deaths reported real time week connecticut north carolina west virginia missing mortality data recent months therefore excluded analyses pi grouping include individuals listed cause death covid<NUMBER> along pi code well people covid<NUMBER> listed cause death capture people covid<NUMBER> listed cause death pi recorded among causes ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> also compiled data covid<NUMBER>related morbidity gauge timing intensity pandemic different locations influenzalike illness ili longstanding indicator morbidity acute respiratory pathogens including sarscov<NUMBER> weekly statelevel ili data obtained cdcs ilinet system <NUMBER> aggregates data network outpatient providers adjust activity non sarscov<NUMBER> respiratory pathogens used statelevel data laboratoryconfirmed influenza activity cdcs national respiratory enteric virus surveillance system nrevss <NUMBER> dataset captures number tests performed influenza number positive week state ili data provide percent visits participating outpatient providers ili ilinet nrevss data available <NUMBER>week lag ili nrevss mortality datasets accessed cdcs fluview portal using cdcfluview package r data nchs ilinet nrevss obtained weeks ending january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> compare burden estimates official covid<NUMBER> tallies compiled weekly reports laboratoryconfirmed deaths due covid<NUMBER> state several sources including covid tracking project <NUMBER> nchs <NUMBER> statespecific testing information obtained covid tracking project <NUMBER> <NUMBER> largest states population washington state analyzed individually remaining states data grouped corresponding health regions defined us department health human services hhs regions fit poisson regression models weekly statelevel counts reported deaths due pi january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> see supplement details baseline projected forward march <NUMBER> <NUMBER> adjusted seasonality using harmonic variables included yeartoyear baseline variation influenza activity controlled adjusting percent tests positive influenza previous week <NUMBER>week lag testing data mortality data accounts delay influenza testing death number allcause deaths used denominator poisson <NUMBER> prediction intervals estimated sampling uncertainty distributions estimated model parameters <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint calculate number covid<NUMBER> related excess deaths subtracted expected number deaths week observed number deaths period february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> reporting deaths recent weeks incomplete nchs calculates completeness score <NUMBER> <NUMBER> based number death reports received state number expected state based previous years excess deaths divided completeness score week get estimate excess cases adjusted reporting delays evaluate sensitivity estimates excess mortality adjustment influenza activity refit regression excluding influenza covariate also fit model structure allcause mortality without denominator get measurement outpatient visits related covid<NUMBER> model fit data influenzalike illness analyses run using r v <NUMBER> analysis scripts archives data available httpsgithubcomweinbergerlabexcesspicovid results many states experienced notable increase proportion total deaths due pi starting midmarch march <NUMBER> compared would expected based time year influenza activity figure <NUMBER> figure <NUMBER> expressed relative increase baseline increases particularly notable new jersey washington new york illinois georgia increase new york largely driven spikes new york city figure s<NUMBER> states florida georgia increase deaths due pi preceded widespread adoption testing novel coronavirus several weeks figure <NUMBER> result increase pi preceded first reported covid<NUMBER> deaths excess pi greater number reported covid<NUMBER> deaths week contrast washington ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> state concordance reported covid<NUMBER> deaths excess pi deaths increase testing timing epidemic varied across states states regions yet seen large increases deaths earlier epidemic though indication sharp increases outpatient visits ili eg ohio texas figure <NUMBER> increase pi mortality typically lags behind increase ili visits increases excess pi deaths might expected coming weeks degree underreporting states seen comparing estimated excess deaths due pi number reported covid<NUMBER> cases march <NUMBER> agreement reported covid<NUMBER> deaths excess pi deaths figure <NUMBER> figure s<NUMBER> michigan number excess pi deaths notably lower number reported covid<NUMBER> deaths potentially reflecting reporting delays pi data overall states evaluated period february <NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> excess pi deaths compared <NUMBER> reported deaths due covid<NUMBER> covid tracking project <NUMBER> deaths due covid<NUMBER> provisionally reported nchs entire us period deaths due pi represent fraction deaths caused covid<NUMBER> highlight compared increases deaths due cause new york new jersey increases deaths due pi reported deaths due covid<NUMBER> figure s<NUMBER> <NUMBER> times many excess allcause deaths reported covid<NUMBER> deaths excess pi deaths new york city discrepancy even stark <NUMBER> times many excess allcause deaths pi deaths figure s<NUMBER> observation excess pi deaths underestimate burden covid<NUMBER> born nchs data fewer half deaths recorded due covid<NUMBER> pneumonia listed cause death <NUMBER> proportion covid<NUMBER>coded deaths pneumonia diagnosis varies considerably state table s<NUMBER> sensitivity analyses refit seasonal baseline adjust influenza activity table s<NUMBER> calculated excess pi mortality without using correction factor ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint incomplete reporting table s<NUMBER> changes influence specific estimates states smaller increases affect overall pattern mortality data released weekly regularlyupdated analyses available httpsweinbergerlabgithubioexcesspicovid excess pi mortality used method tracking influenza mortality century used similar strategy capture covid<NUMBER> deaths attributed specifically pandemic coronavirus monitoring trends broad mortality outcomes like pi allcauses provides window magnitude mortality burden missed official tallies covid<NUMBER> deaths given lack adequate testing geographical variability testing intensity type monitoring provides key information severity epidemic different geographic regions also provides indication degree viral testing missing deaths associated covid<NUMBER> directly indirectly findings suggest degree deaths due covid<NUMBER> correctly attributed sarscov<NUMBER> varies state states florida pennsylvania might missed deaths early might undercounting deaths substantial degree currently states like washington accurate estimate mortality burden pandemic virus due intense testing states hit hard pandemic virus new jersey new york total excess mortality burden <NUMBER> times ascribed covid<NUMBER> official statistics together findings demonstrate estimates death toll covid<NUMBER> based excess pi allcause mortality reliable relying reported deaths particularly places lack widespread testing local epidemics covid<NUMBER> started different times across us states early epidemics like new york new jersey reporting large increases pi allcause mortality states later epidemic onsets entering period rapid growth deaths states instituted social distancing measures earlier phase epidemic might benefit reducing intensity peak deaths syndromic endpoints deaths due pi outpatient visits ili emergency department visits fever provide crude informative measure progression ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint outbreak <NUMBER> measures biased changes health seeking behavior conditions recorded however absence widespread systematic testing covid<NUMBER> provide useful measure epidemic progression effect interventions get complete picture burden burden deaths due covid<NUMBER> necessary evaluate spikes allcause mortality done new york new jersey however difficult analyses reliably real time provisional death statistics data incomplete recent weeks delays reporting determined retrospectively analyses suggest excess pi deaths represent fraction deaths related covid<NUMBER> <NUMBER> based preliminary data pi excess mortality estimates present represent lower bound burden often lag reporting death statistics nchs reports data <NUMBER> weeks prior provisional data typically still incomplete main analysis addressed adjusting deaths due pi allcause deaths assumption reporting delays pi similar reporting delays causes death calculating excess deaths attempted adjust reporting delays using nchs estimate data completeness multiplier however estimate data completeness based numbers deaths previous years might reliable pandemic period anything would expect longer reporting lags would tend underestimate excess mortality burden covid<NUMBER> realtime analyses estimated covid<NUMBER> epidemic europe predates us weeks several european countries experienced high death toll particularly italy conclusion monitoring syndromic causes death provide crucial additional information severity progression covid<NUMBER> pandemic estimates excess deaths due pi allcauses less biased variations viral testing reporting lags properly accounted together information official tallies covid ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint <NUMBER> deaths monitoring excess mortality provides key tool evaluating effects ongoing pandemic ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table <NUMBER> excess deaths due pneumonia influenza deaths due covid<NUMBER> reported covid tracking project february <NUMBER> <NUMBER> mar <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint supplemental figures figure s<NUMBER> excess allcause deaths black line shows observed number deaths per week regardless cause red line shaded area represent <NUMBER> prediction interval latest data week ending <NUMBER> note adjusted percent completeness data using nchs estimate data completeness clear jumps allcause mortality ny nj states stable decreasing likely due reporting delays ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure s<NUMBER> excess allcause deaths black vs excess deaths due pneumonia influenza red reported covid<NUMBER> deaths covid tracking project blue dashed line new york including new york city new jersey figure s<NUMBER> excess pi deaths per week red vs allcause excess deaths black new york city ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure s<NUMBER> map excess deaths state covid<NUMBER> deaths reported covid tracking project ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table s<NUMBER> proportion covid<NUMBER> deaths pneumonia code state recent date note values greater tables <NUMBER> weeks behind ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table s<NUMBER> comparison estimates estimates excess cases adjusted based estimated completeness database excess deaths due pneumonia influenza february <NUMBER> <NUMBER> mar <NUMBER> <NUMBER> without adjustment delayed reporting developed regression model pi deaths epidemiological year julyjune week function seasonal parameters percent positive influenza tests prior week models fit separately location data january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> fitted values projected period march <NUMBER> <NUMBER> let pideathsit number pi deaths let flupctposit<NUMBER> percent positive influenza tests modeled pideathsit poisson log ittotaldeathit <NUMBER> <NUMBER>sinθt <NUMBER>cosθt <NUMBER>sinθt<NUMBER> <NUMBER>cosθt<NUMBER> <NUMBER>logflupctposit<NUMBER> ilogflupctposit<NUMBER> θt<NUMBER> t<NUMBER> compute prediction intervals used following procedure regression coefficients estimated extracted estimated asymptotic covariance matrix parameters constructed multivariate normal distribution approximating sampling distribution centered estimated parameter values drew <NUMBER> samples parameter distribution computed resulting mean value drew <NUMBER> samples ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint poisson distribution mean resulted <NUMBER> samples empirical predictive distribution pideathsit empirical <NUMBER> prediction intervals computed taking <NUMBER>th <NUMBER>th percentiles resulting distribution sensitivity analyses evaluated model flupctpos excluded altogether ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint deaths due novel coronavirus covid<NUMBER> increasing sharply united states since midmarch however efforts track severity public health impact coivd<NUMBER> us hampered testing issues reporting lags inconsistency states result reported number deaths likely represents underestimate true burden evaluate increases deaths due pneumonia across united states relate increases number reported deaths due covid<NUMBER> different states evaluate trajectories increases relation volume testing indicators morbidity provides complete picture mortality due covid<NUMBER> us demonstrates delays testing led many coronavirus deaths counted certain states number deaths reported due covid<NUMBER> represents fraction deaths linked pandemic monitoring trends deaths due pneumonia allcauses provides complete picture tool disease ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint abstract background efforts track severity public health impact novel coronavirus covid<NUMBER> us hampered testing issues reporting lags inconsistency states evaluating unexplained increases deaths attributed broad outcomes pneumonia influenza pi causes provide complete consistent picture burden caused covid<NUMBER> evaluated increases occurrence deaths due pi seasonal baseline adjusted influenza activity due cause across united states february march <NUMBER> estimates compared reported deaths due covid<NUMBER> testing data notable increases rate death due pi february march <NUMBER> number states deaths predated increases covid<NUMBER> testing rates counted official records related covid<NUMBER> substantial variability states discrepancy reported rates death due covid<NUMBER> estimated burden excess deaths due pi increase allcause deaths new york new jersey <NUMBER> times higher official tally covid<NUMBER> confirmed deaths estimated excess death due pi excess pi deaths provide conservative estimate covid<NUMBER> burden indicate covid<NUMBER>related deaths missed locations inadequate testing intense pandemic activity ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint novel coronavirus sarscov<NUMBER> first emerged december <NUMBER> wuhan china rapidly grew largescale global pandemic <NUMBER> tracking severity impact covid<NUMBER> time writing critical need hampered testing issues reporting lags key epidemiological indicators many countries including us caught offguard speed covid<NUMBER> spread china without adequate capacity test sarscov<NUMBER> virus causing covid<NUMBER> much february march <NUMBER> available laboratoryconfirmed cases captured estimated <NUMBER> infections <NUMBER> although countries adopted strategy preferentially test severe cases estimating number severe infections deaths caused covid<NUMBER> challenge typically large proportion deaths caused infectious diseases attributed specific pathogen limited availability testing novel coronavirus imperfect sensitivity tests <NUMBER> <NUMBER> undoubtedly number deaths caused virus counted official tallies even situations ample testing deaths viral pathogens including sarscov<NUMBER> occur indirectly via secondary bacterial infections exacerbation chronic conditions midst large outbreak unavoidable delay compilation death certificates ascertainment cause deaths contributes uncertainty severity burden finally us high degree variability public health resources laboratory testing recognition outbreak state level could lead significant underestimation true impact outbreak certain geographies estimate burden death due novel respiratory pathogens previous studies compared observed incidence influenzarelated deaths ascribed pneumonia influenza pi baseline incidence pi would expected time year <NUMBER> <NUMBER> excess deaths provide estimate pathogenspecific burden approach used early months <NUMBER> influenza ah<NUMBER>n<NUMBER>pdm pandemic estimated <NUMBER> <NUMBER> pandemicrelated deaths captured laboratory testing <NUMBER> us <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> study estimated increase pi deaths across united states week excess seasonal baseline capture direct indirect mortality burden covid<NUMBER> compare estimates excess deaths reported numbers deaths due covid<NUMBER> different states evaluate trajectories increases relation volume testing indicators covid<NUMBER> morbidity analyses provide insights burden covid<NUMBER> early months outbreak united states serve surveillance platform updated new data accrue data deaths due pneumonia influenza pi icd<NUMBER> codes j<NUMBER>j<NUMBER> allcauses state week obtained national center health statistics nchs mortality surveillance system <NUMBER> analyze spikes pi mortality rather straight pneumonia comprehensive influenzacoded deaths necessarily require laboratory confirmation influenza infection overlap symptoms influenza covid<NUMBER> pi mortality used us monitor severity influenza respiratory pathogens since <NUMBER> pandemic addition analysis spikes allcause mortality provides full picture direct indirect burden covid<NUMBER> nchs mortality data available <NUMBER>week lag partially complete recent weeks pi mortality data provide provisional number deaths due pneumonia influenza ie deaths code pneumonia influenza anywhere death certificate adjusted total number deaths reported real time week connecticut north carolina west virginia missing mortality data recent months therefore excluded analyses pi grouping include individuals listed cause death covid<NUMBER> along pi code well people covid<NUMBER> listed cause death capture people covid<NUMBER> listed cause death pi recorded among causes ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> also compiled data covid<NUMBER>related morbidity gauge timing intensity pandemic different locations influenzalike illness ili longstanding indicator morbidity acute respiratory pathogens including sarscov<NUMBER> weekly statelevel ili data obtained cdcs ilinet system <NUMBER> aggregates data network outpatient providers adjust activity non sarscov<NUMBER> respiratory pathogens used statelevel data laboratoryconfirmed influenza activity cdcs national respiratory enteric virus surveillance system nrevss <NUMBER> dataset captures number tests performed influenza number positive week state ili data provide percent visits participating outpatient providers ili ilinet nrevss data available <NUMBER>week lag ili nrevss mortality datasets accessed cdcs fluview portal using cdcfluview package r data nchs ilinet nrevss obtained weeks ending january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> compare burden estimates official covid<NUMBER> tallies compiled weekly reports laboratoryconfirmed deaths due covid<NUMBER> state several sources including covid tracking project <NUMBER> nchs <NUMBER> statespecific testing information obtained covid tracking project <NUMBER> <NUMBER> largest states population washington state analyzed individually remaining states data grouped corresponding health regions defined us department health human services hhs regions fit poisson regression models weekly statelevel counts reported deaths due pi january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> see supplement details baseline projected forward march <NUMBER> <NUMBER> adjusted seasonality using harmonic variables included yeartoyear baseline variation influenza activity controlled adjusting percent tests positive influenza previous week <NUMBER>week lag testing data mortality data accounts delay influenza testing death number allcause deaths used denominator poisson <NUMBER> prediction intervals estimated sampling uncertainty distributions estimated model parameters <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint calculate number covid<NUMBER> related excess deaths subtracted expected number deaths week observed number deaths period february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> reporting deaths recent weeks incomplete nchs calculates completeness score <NUMBER> <NUMBER> based number death reports received state number expected state based previous years excess deaths divided completeness score week get estimate excess cases adjusted reporting delays evaluate sensitivity estimates excess mortality adjustment influenza activity refit regression excluding influenza covariate also fit model structure allcause mortality without denominator get measurement outpatient visits related covid<NUMBER> model fit data influenzalike illness analyses run using r v <NUMBER> analysis scripts archives data available httpsgithubcomweinbergerlabexcesspicovid results many states experienced notable increase proportion total deaths due pi starting midmarch march <NUMBER> compared would expected based time year influenza activity figure <NUMBER> figure <NUMBER> expressed relative increase baseline increases particularly notable new jersey washington new york illinois georgia increase new york largely driven spikes new york city figure s<NUMBER> states florida georgia increase deaths due pi preceded widespread adoption testing novel coronavirus several weeks figure <NUMBER> result increase pi preceded first reported covid<NUMBER> deaths excess pi greater number reported covid<NUMBER> deaths week contrast washington ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> agreement reported covid<NUMBER> deaths excess pi deaths figure <NUMBER> figure s<NUMBER> michigan number excess pi deaths notably lower number reported covid<NUMBER> deaths potentially reflecting reporting delays pi data overall states evaluated period february <NUMBER> march <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> excess pi deaths compared <NUMBER> reported deaths due covid<NUMBER> covid tracking project <NUMBER> deaths due covid<NUMBER> provisionally reported nchs entire us period deaths due pi represent fraction deaths caused covid<NUMBER> highlight compared increases deaths due cause new york new jersey increases deaths due pi reported deaths due covid<NUMBER> figure s<NUMBER> <NUMBER> times many excess allcause deaths reported covid<NUMBER> deaths excess pi deaths new york city discrepancy even stark <NUMBER> times many excess allcause deaths pi deaths figure s<NUMBER> observation excess pi deaths underestimate burden covid<NUMBER> born nchs data fewer half deaths recorded due covid<NUMBER> pneumonia listed cause death <NUMBER> proportion covid<NUMBER>coded deaths pneumonia diagnosis varies considerably state table s<NUMBER> sensitivity analyses refit seasonal baseline adjust influenza activity table s<NUMBER> calculated excess pi mortality without using correction factor ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint incomplete reporting table s<NUMBER> changes influence specific estimates states smaller increases affect overall pattern mortality data released weekly regularlyupdated analyses available httpsweinbergerlabgithubioexcesspicovid excess pi mortality used method tracking influenza mortality century used similar strategy capture covid<NUMBER> deaths attributed specifically pandemic coronavirus monitoring trends broad mortality outcomes like pi allcauses provides window magnitude mortality burden missed official tallies covid<NUMBER> deaths given lack adequate testing geographical variability testing intensity type monitoring provides key information severity epidemic different geographic regions also provides indication degree viral testing missing deaths associated covid<NUMBER> directly indirectly findings suggest degree deaths due covid<NUMBER> correctly attributed sarscov<NUMBER> varies state states florida pennsylvania might missed deaths early might undercounting deaths substantial degree currently states like washington accurate estimate mortality burden pandemic virus due intense testing states hit hard pandemic virus new jersey new york total excess mortality burden <NUMBER> times ascribed covid<NUMBER> official statistics together findings demonstrate estimates death toll covid<NUMBER> based excess pi allcause mortality reliable relying reported deaths particularly places lack widespread testing local epidemics covid<NUMBER> started different times across us states early epidemics like new york new jersey reporting large increases pi allcause mortality states later epidemic onsets entering period rapid growth deaths states instituted social distancing measures earlier phase epidemic might benefit reducing intensity peak deaths syndromic endpoints deaths due pi outpatient visits ili emergency department visits fever provide crude informative measure progression ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint outbreak <NUMBER> measures biased changes health seeking behavior conditions recorded however absence widespread systematic testing covid<NUMBER> provide useful measure epidemic progression effect interventions get complete picture burden burden deaths due covid<NUMBER> necessary evaluate spikes allcause mortality done new york new jersey however difficult analyses reliably real time provisional death statistics data incomplete recent weeks delays reporting determined retrospectively analyses suggest excess pi deaths represent fraction deaths related covid<NUMBER> <NUMBER> based preliminary data pi excess mortality estimates present represent lower bound burden often lag reporting death statistics nchs reports data <NUMBER> weeks prior provisional data typically still incomplete main analysis addressed adjusting deaths due pi allcause deaths assumption reporting delays pi similar reporting delays causes death calculating excess deaths attempted adjust reporting delays using nchs estimate data completeness multiplier however estimate data completeness based numbers deaths previous years might reliable pandemic period anything would expect longer reporting lags would tend underestimate excess mortality burden covid<NUMBER> realtime analyses estimated covid<NUMBER> epidemic europe predates us weeks several european countries experienced high death toll particularly italy conclusion monitoring syndromic causes death provide crucial additional information severity progression covid<NUMBER> pandemic estimates excess deaths due pi allcauses less biased variations viral testing reporting lags properly accounted together information official tallies covid ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> deaths monitoring excess mortality provides key tool evaluating effects ongoing pandemic ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table <NUMBER> excess deaths due pneumonia influenza deaths due covid<NUMBER> reported covid tracking project february <NUMBER> <NUMBER> mar <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint supplemental figures figure s<NUMBER> excess allcause deaths black line shows observed number deaths per week regardless cause red line shaded area represent <NUMBER> prediction interval latest data week ending <NUMBER> note adjusted percent completeness data using nchs estimate data completeness clear jumps allcause mortality ny nj states stable decreasing likely due reporting delays ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure s<NUMBER> excess allcause deaths black vs excess deaths due pneumonia influenza red reported covid<NUMBER> deaths covid tracking project blue dashed line new york including new york city new jersey figure s<NUMBER> excess pi deaths per week red vs allcause excess deaths black new york city ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint figure s<NUMBER> map excess deaths state covid<NUMBER> deaths reported covid tracking project ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint table s<NUMBER> proportion covid<NUMBER> deaths pneumonia code state recent date note values greater tables <NUMBER> weeks behind ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint table s<NUMBER> comparison estimates estimates excess cases adjusted based estimated completeness database excess deaths due pneumonia influenza february <NUMBER> <NUMBER> mar <NUMBER> <NUMBER> without adjustment delayed reporting developed regression model pi deaths epidemiological year julyjune week function seasonal parameters percent positive influenza tests prior week models fit separately location data january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> fitted values projected period march <NUMBER> <NUMBER> let pideathsit number pi deaths let flupctposit<NUMBER> percent positive influenza tests modeled pideathsit poisson log ittotaldeathit <NUMBER> <NUMBER>sinθt <NUMBER>cosθt <NUMBER>sinθt<NUMBER> <NUMBER>cosθt<NUMBER> <NUMBER>logflupctposit<NUMBER> ilogflupctposit<NUMBER> θt<NUMBER> t<NUMBER> compute prediction intervals used following procedure regression coefficients estimated extracted estimated asymptotic covariance matrix parameters constructed multivariate normal distribution approximating sampling distribution centered estimated parameter values drew <NUMBER> samples parameter distribution computed resulting mean value drew <NUMBER> samples ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint poisson distribution mean resulted <NUMBER> samples empirical predictive distribution pideathsit empirical <NUMBER> prediction intervals computed taking <NUMBER>th <NUMBER>th percentiles resulting distribution sensitivity analyses evaluated model flupctpos excluded altogether ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint viewpoints research theme <NUMBER> china recently passed virus transmission becoming severe around world showing characteristics pandemic europe become new center epidemic march <NUMBER> <NUMBER> covid<NUMBER> spread <NUMBER> countries around world cumulative <NUMBER> <NUMBER> confirmed diagnoses worldwide among number confirmed infections america italy spain germany france iran already exceeded <NUMBER> <NUMBER> <NUMBER> china strict prevention control earned time mitigation covid<NUMBER> experience lessons accumulated china exploration novel coronavirus deserve summed may useful countries address challenge therefore purpose study sort china countermeasures experience collect chinese experts advice fighting covid<NUMBER> expected serve warning global covid<NUMBER> prevention control provide reference formulation prevention control strategies countries regions questionnaire prevent control covid<NUMBER> distributed relevant experts advice collected high frequency word analysis content analysis railway stations coach stations passenger terminals <NUMBER> january <NUMBER> hubei province launched secondary public health emergency alert wuhan closed city january <NUMBER> <NUMBER> january <NUMBER> january <NUMBER> <NUMBER> provinces china successively initiated firstlevel responses major public health emergencies <NUMBER> many regions practiced closedoff management march <NUMBER> <NUMBER> provinces autonomous regions municipalities nationwide lowered emergency response levels <NUMBER> closed zone management closed management implemented urban communities rural villages noncommunity nonvillage residents vehicles allowed enter communities villages even local residents needed temperature measured allowed area community village areas epidemic prevention control groups established could divided many subgroups different functions propaganda group environment group key personnel prevention control group personal control group material support group others order complete epidemic prevention control work allencompassing manner <NUMBER> personal management february <NUMBER> citizens wuhan required scan enter identifying information assessed open public places <NUMBER> march <NUMBER> <NUMBER> reference architecture technical guide epidemic prevention access code issued according regulation chinese citizens report health status online general health status captured twodimensional codes code could also work electronic voucher citizens go local places health assessment based twodimensional codes universal whole city even whole country <NUMBER> staff support january <NUMBER> shanghai guangdong sent first medical teams wuhan <NUMBER> january <NUMBER> <NUMBER> people across <NUMBER> medical teams nationwide went support hubei <NUMBER> march <NUMBER> total <NUMBER> medical teams <NUMBER> <NUMBER> medical staff arrived hubei fighting virus alongside local medical staff <NUMBER> funding support january <NUMBER> national development reform commission urgently issued <NUMBER> million yuan rmb support hubei central budget <NUMBER> billion yuan issued national finances levels subsidies disease prevention control <NUMBER> march <NUMBER> <NUMBER> billion yuan arranged government finances levels prevention control <NUMBER> facility construction wuhan city worst epidemic situation become key area epidemic prevention control order fight covid<NUMBER> wuhan set vulcan mountain thor mountain hospitals took <NUMBER> days finish treat severe patients <NUMBER> addition <NUMBER> cabin hospitals built mild patients dozen hotels schools recruited isolate mild patients close contacts <NUMBER> policy patients well close contacts changed selfisolation home beginning allisolation hospital hotel end recognition novel coronavirus understanding novel coronavirus gradually developing process december <NUMBER> <NUMBER> wuhan municipal health commission notified first confirmed case showed symptoms day january <NUMBER> <NUMBER> whole genome sequence novel coronavirus obtained wuhan institute virology chinese academy sciences <NUMBER> press conference national health commission people republic china january <NUMBER> professor zhong nanshan confirmed novel coronavirus transmitted person person <NUMBER> detection reagents treatment plan terms detection reagents january <NUMBER> china centre disease control developed specific pcr detection reagent january <NUMBER> china centre disease control provided pcr detection reagents wuhan hospitals january <NUMBER> national medical products administration approved <NUMBER> novel coronavirus detection products <NUMBER> chinese companies <NUMBER> regarding diagnosis treatment plan january <NUMBER> national health commission china issued first trail edition diagnosis treatment plan covid<NUMBER> february <NUMBER> versions constantly updated seventh versions diagnosis treatment plan issued <NUMBER> diagnostic criteria changed diagnosis based results novel coronavirus pcr test diagnosis based clinical ct results viewpoints research theme <NUMBER> drug research development january <NUMBER> research development novel coronavirus mrna vaccine officially initiated <NUMBER> february <NUMBER> clinical trials remdesivir began <NUMBER> february <NUMBER> ministry science technology stated vaccine submitted clinical trials soon late april <NUMBER> march <NUMBER> chloroquine phosphate became clinical treatment medication <NUMBER> addition chinese traditional medicines demonstrated effective <NUMBER> facing severe situation brought covid<NUMBER> china government adopted series strict prevention control countermeasures effectively controlled spread epidemic china gained time prevention control covid<NUMBER> countries according daily outbreak data released national health commission china national point view mortality rate patients declining proportion patients severe illness decreasing trend cumulative cases china shown figure <NUMBER> trend new cases china shown figure <NUMBER> figure <NUMBER> shows changes relevant national data since outbreak covid<NUMBER> numbers newly diagnosed patients suspected patients well newly added deaths risen period time currently declining phase current data demonstrates china countermeasures effectively slowing spread covid<NUMBER> may give piece evidence experience global covid<NUMBER> prevention control near future march <NUMBER> china accumulated <NUMBER> <NUMBER> confirmed diagnoses <NUMBER> existing confirmed diagnoses <NUMBER> deaths <NUMBER> <NUMBER> cured patients <NUMBER> based current data china cure rate <NUMBER> mortality rate <NUMBER> worth noting <NUMBER> cases imported overseas table <NUMBER> shows wuhan hubei national global cumulative number mortality rate data demonstrates mortality rate could obviously drop sufficient medical resource example mortality rate rest china excluding hubei much lower places quite clear overall casefatality rate based denominator includes positively tested infected symptoms considering casefatality rate covid<NUMBER> china <NUMBER> globe <NUMBER> people may consider disease affecting underlying diseases mainly old persons however based china experience treating pneumonia would entirely true ten facts china novel coronavirus pneumonia listed ten facts well worth global vigilance according investigations <NUMBER> medical staffs wuhan infected since outbreak <NUMBER> warning world infection rate novel coronavirus high attention must paid infection medical staff nosocomial infection china adopted home quarantine policy beginning large number household cluster infections even tragedies would deaths entire families <NUMBER> proved high infection rate novel coronavirus home quarantine policy may good choice infected covid<NUMBER> patients better isolated separated families although generally believed elderly patients underlying diseases higher mortality rates <NUMBER> proven healthy young people also develop severe illness severity disease may related cytokine storm <NUMBER> addition still cases infant children infection results molecular diagnosis may false negative false positive beginning clinical diagnosis based detecting method molecular biology pcr polymerase chain reaction throat swabs nose swabs taken samplingthere patients whose test results showed negative one patients false negative <NUMBER> times <NUMBER> meanwhile also asymptomatic carriers positive molecular diagnosis results symptoms <NUMBER> false positive falsenegative results molecular diagnosis unique diagnostic criteria challenged later combining pcr clinical ct results recommended basis diagnosis covid<NUMBER> patients condition might suddenly rapid worsen even recovery period treatment clinical cases convalescent patients significantly improved symptoms however patiens condition would suddenly deteriorate would pass away within hours mechanism death cause remains unknown one hand covid<NUMBER> outbreaks cause serious medical supplies shortage hand public panic make much worse shortage medical materials staff supplies expected phenomenon deserves attention regions world storage medical materials particularly important especially early stage outbreak due large amount medical resources invested treatment novel coronavirus disease clinic treatments surgery emergency medical treatment tumor radiotherapy chemotherapy available <NUMBER> lead increased mortality patients diseases hospital specific effective treatment covid<NUMBER> clinical treatment covid<NUMBER> mainly oxygen inhalation symptomatic treatment specific effective drugs saving life severe patients present <NUMBER> viewpoints research theme <NUMBER> multi participation unified action guarantee epidemic control since covid<NUMBER> first occurred wuhan central government local government china paid great attention besides <NUMBER> <NUMBER> medical staff provinces sent wuhan participants transportation traffic military industries actively took part preparing medical material food supplies took nationallevel unified action effectively control covid<NUMBER> isolation effective way reduce risk covid<NUMBER> strict closure cities quarantine measures demonstrated chinese isolation countermeasures achieved good results achievement wuhan released closure april <NUMBER> isolation measures effectively reduce covid<NUMBER> incidence rate save many people lives therefore isolation countermeasure worth recommended countries policy makers twelve chinese public health professionals disease control center experts investigated prevent control covid<NUMBER> recently advice analyzed high frequency word analysis content analysis keywords used generalize literature content keyword frequency may reflect main content group documents table <NUMBER> shows top <NUMBER> keywords frequency weight value integrating high frequency terms found experts advice preventing controlling covid<NUMBER> included specific keywords material prevention control pathogeny propaganda education hygiene technology medical care overall planning policy panic keywords reflect main concerns chinese experts covid<NUMBER> content analysis used summarize experts advice preventing controlling covid<NUMBER> main advices sorted analyzed four aspects publicity education various subjects medical materials law construction chinese experts advice listed table <NUMBER> epidemic prevention covid<NUMBER> battle fought wuhan also battle china eventually world based analyzing experience lessons china epidemic prevention control work consulting opinions suggestions chinese experts propose following advice global covid<NUMBER> prevention control viewpoints research theme <NUMBER> covid<NUMBER> pandemic first addition making full use two important communication tools television internet various forms publicity used make public fully aware severity covid<NUMBER> public well informed novel coronavirus special times emphasized attend large gatherings wash hands frequently cover mouth nose sneezing coughing wear mask necessary strengthen awareness prevention second important report epidemic information timely accurate manner effectively avoid panic mistakes due misinformation cut route transmission using isolation covid<NUMBER> highly infectious except patients obvious symptoms mild atypical patients even asymptomatic infections possible sources transmission therefore controlling source infection cutting transmission routes fundamental measures prevention control epidemic wuhan closure work stoppage school suspension community closed management well firstlevel response major public health events launched nationwide measures effectively controlled movement people spread epidemic isolation effective approach worth promoting around world hand home isolation may lead household cluster infection noteworthy therefore possible covid<NUMBER> patients treated covid<NUMBER> designated hospitals centralized treatment plan reduce nosocomial infection susceptible persons close contacts asked stay hotels idle factories large sports grounds standby isolation places centralized isolation infected patients close contacts found selfconscious online reporting currently isolation may unique effective way cut route transmission decrease incidence covid<NUMBER> addition order prevent spread infection caused secondary pollution attention paid reasonable disposal covid<NUMBER> medical waste carry various forms publicity including internet publicity tv programs newspapers books comics lectures etc people fully understand new crown pneumonia effectively protect reducing social panic unified voice authoritative media ordinary people strictly control flow personnel covid<NUMBER> patients admitted hospitals asymptomatic close contacts isolated home isolation mode centralized isolation mode noncovid<NUMBER> patients guarantee normal basic treatment decreasing secondary disasters frontline medical staffs trained duty provided sufficient protection materials salary remuneration grassroots staffs open community prevention control mechanism strengthen basic protective measures scientific research strengthen international cooperation scientific research strive new progress drug research vaccine development epidemiological investigation meet medical material needs hospitals prevention treatment covid<NUMBER> meet ordinary people needs prevention control materials basic daily necessities guarantee production circulation reserve medical materials covid<NUMBER> severely punish persons disturb stability market driving prices hoarding severely punish persons make rumor fraud cause public panic severely punish behavior disobeying management escaping isolation area without permission respect protect personal information rights interests covid<NUMBER> affected population avoid privacy disclosure avoid covid<NUMBER> inducing district stigmatization discrimination fully take advantage information communications technology ict disease control diagnosis treatment establish longterm mechanism infectious disease monitoring public opinion surveillance establishing longterm mechanism training public health global health emergency professionals viewpoints research theme <NUMBER> protect susceptible groups especially highrisk groups according survey hubei <NUMBER> covid<NUMBER> infections hospitals <NUMBER> communities warning global epidemic prevention susceptible groups covid<NUMBER> include frontline medical staff elderly population gregarious groups including nursing homes residential schools barracks prisons etc therefore protection provided must given priority global work prevention control take advantage internet technology reasonably allocate medical resources response outbreak combination online offline medical consulting china effective solve problem shortage clinical doctors global work prevention control relevant countries regions allocate medical staff reasonably triage patients properly admission improve efficiency treatment prevent crossinfection adequate medical supplies orderly distribution important effective epidemic prevention control sufficient human material support helpful ensure success treatment noncovid<NUMBER> patients country around world deal global epidemic health global issue global health local thus fight covid<NUMBER> relies local efforts every country around world important countries timely share indicators information global cooperation include three aspects first world join hands together share information epidemic situation openly transparently second scientists world cooperate study origin virus formulate diagnostic criteria search specific clinical drugs develop vaccines jointly fight covid<NUMBER> third countries unified action leading global unified action plan duration fighting covid<NUMBER> shorter era globalization nations share weal woe face covid<NUMBER> epidemic country stand alone maintain safety people world put aside differences ideology religious belief politics economy culture countries work together fight virus instead shifting blame suspecting must condemned government individual take advantage new pneumonia stigmatize countries mankind community destiny closer cooperation mutual help countries successfully overcome pandemic global war covid<NUMBER> injury may secondary ischemic nonischemic processes <NUMBER> <NUMBER> traditionally elevated troponin concentrations considered equivalent myocardial infarction however improvements troponin assays elevated levels without overt symptoms signs myocardial ischemia common hence fourth universal definition myocardial infarction considers myocardial injury separate unique entity <NUMBER> based current evidence myocardial injury without overt ischemia represents approximately <NUMBER> cases abnormal troponin elevation <NUMBER> differential diagnosis broad cases recognized variety cardiac acute heart failure pulmonary embolism myocarditis cardiac surgery procedures cardiac arrhythmias hypertension stressinduced cardiomyopathy several noncardiac conditions acute renal failure sepsis anemia hypoxia critical illness druginduced rhabdomyolysis among others <NUMBER> <NUMBER> association viral infections myocardial injury well recognized common associations involve adenoviruses enteroviruses coxsackie viruses <NUMBER> according data previous influenza virus coronavirus epidemics viral infections also shown cause myocardial injury cases myocarditis described caused influenza coronaviruses <NUMBER> <NUMBER> although sarscov<NUMBER> infection predominantly causes pulmonary complications pneumonia ards disease also associated variety cardiovascular complications including acute myocardial injury myocarditis arrhythmia heart failure venous thromboembolism <NUMBER> moreover studies shown patients covid<NUMBER> preexisting cardiovascular disease cvd increased risk acquiring illness subsequently severe disease death <NUMBER> <NUMBER> clinical bulletin issued american college cardiology acc overall casefatality rate <NUMBER> mortality reached <NUMBER> patients underlying cvd <NUMBER> among various cardiac complications acute cardiac injury elevated cardiac biomarkers described early studies china hospitalized patients covid<NUMBER> discuss prevalence mechanism clinical characteristics management prognostic implications sarscov<NUMBER>induced myocardial injury according current published research sarscov mers may also result cardiovascular complications although data anecdotal absence systematic studies although sarscov infection associated cardiovascular manifestations clear reported cases myocarditis <NUMBER> <NUMBER> <NUMBER> <NUMBER> however <NUMBER> saudi arabia outbreak merscov reported cause acute myocarditis heart failure table <NUMBER> <NUMBER> first author cohort size cardiovascular manifestation outcomes sars yu et al <NUMBER> n<NUMBER> tachycardia <NUMBER> hypotension <NUMBER> bradycardia <NUMBER> cardiomegaly <NUMBER> paroxysmal atrial fibrillation one patient transient pan et al <NUMBER> n<NUMBER> cardiac arrest death li et al <NUMBER> n<NUMBER> subclinical diastolic dysfunction without systolic impairment reversible recovery peiris et al <NUMBER> n<NUMBER> acute myocardial infarction cause death two five fatal cases mers alhogbani <NUMBER> n<NUMBER> acute myocarditis acute onset heart failure recovered acute cardiac injury reported highly prevalent hospitalized patients covid<NUMBER> earliest singlecenter retrospective study conducted china involving <NUMBER> hospitalized patients covid<NUMBER> detected acute cardiac injury five <NUMBER> patients study diagnosis acute cardiac injury made serum levels cardiac biomarkers troponin <NUMBER>th percentile upper reference limit new abnormalities detected electrocardiography ecg echocardiography <NUMBER> since numerous retrospective studies reported increased prevalence myocardial injury hospitalized patients covid<NUMBER> frequency <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence cardiac injury increased severity disease however data regarding troponin elevation asymptomatic mildly symptomatic nonhospitalized patients available mechanism cardiac injury among patients covid<NUMBER> remains uncertain following potential mechanisms suggested one potential mechanism direct myocardial involvement mediated via angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> betacoronaviruses infect human hosts ace<NUMBER> membranebound protein expressed many human cells including vascular endothelia renal tissue cardiovascular tissue small intestinal epithelia ace<NUMBER> negatively regulates reninangiotensin system inactivating angiotensin ii likely protect acute lung failure murine model demonstrated pulmonary infection sarscov also precipitates ace<NUMBER>dependent myocardial infarction among humans toronto sars outbreak sarscov viral rna detected <NUMBER> autopsied hearts thus raising possibility direct damage cardiomyocytes virus <NUMBER> phylogenetic analysis demonstrated sarscov<NUMBER> similar receptor binding domainmotif sars coronavirus thus suggesting sarscov<NUMBER> may use ace<NUMBER> receptor enter human cells causes direct damage lung epithelia thereby leading pneumonia ards ace<NUMBER> also highly expressed heart covid<NUMBER> induced cardiac injury might potentially mediated ace<NUMBER> although whether sarscov<NUMBER> binding alters ace<NUMBER> expression causes dysregulation reninangiotensinaldosterone system raas pathway remains unclear <NUMBER> <NUMBER> <NUMBER> <NUMBER> hence one potential explanation higher likelihood acquiring infection increased risk severe disease adverse outcomes patients covid<NUMBER> preexisting cvd maybe elevated secretion ace<NUMBER> patients thus making susceptible direct viral damage cardiac myocytes <NUMBER> yet demonstrated pathology studies case report describing autopsy results <NUMBER>yearold man died covid<NUMBER> associated ards histologic examination biopsied cardiac tissue showed rare interstitial mononuclear inflammatory infiltrates without substantial myocardial damage however troponin level reported study <NUMBER> another suggested mechanism covid<NUMBER> related cardiac involvement overwhelming immuneinflammatory response cytokine storm <NUMBER> <NUMBER> <NUMBER> hallmark cytokine storm syndrome uncontrolled dysfunctional immune response involving continuous activation proliferation lymphocytes macrophages <NUMBER> huang et al found patients covid<NUMBER> admitted intensive care unit higher plasma levels cytokines including interleukins il<NUMBER> il<NUMBER> il<NUMBER> granulocytecolony stimulating factor igginduced protein <NUMBER> monocyte chemoattractant protein<NUMBER> macrophage inflammatory protein <NUMBER>alpha tumor necrosis factor α <NUMBER> previous study sarscov infection cardiovascular complications subclinical diastolic left ventricular impairment appears common acute sars infection reversible recovery thus suggesting left ventricular dysfunction acute phase might associated cytokine storm syndrome <NUMBER> several studies shown patients covid<NUMBER> myocardial injury show evidence severe systemic inflammation including elevated leukocyte neutrophil counts interleukin levels creactive protein procalcitonin globulin biomarkers myocardial injury stress creatine kinase myoglobin nterminal probtype natriuretic peptide ntprobnp thus linking myocardial injury severity inflammation subsequent ventricular dysfunction <NUMBER> <NUMBER> <NUMBER> similarly case report sarscov <NUMBER> induced fulminant myocarditis described patient markedly elevated interleukin <NUMBER> thus suggesting presence cytokine storms might caused increased vascular wall permeability myocardial edema thus resulting observed thickening interventricular septum myocarditis transient recovery enhanced use continuous renal replacement therapy crrt myocardial injury considered associated excessive immune response mediated viral infection <NUMBER> severe hypoxia due acute lung injury several systemic complications caused virus result oxidative stress hence secondary myocardial injury due increased myocardial oxygen demand <NUMBER> <NUMBER> example one study characteristic pattern rise cardiac troponin time troponin level normal admission subsequently increased <NUMBER> patients especially died patients troponin level significantly increased week preceding death coinciding severe systemic disorders including multiple organ failure severe electrolyte disturbances management ventilation extracorporeal membrane oxygenation ecmo severe metabolic acidosis coagulation dysfunction potentially lead secondary myocardial injury due increased oxidative stress heart <NUMBER> studies demonstrated patients underlying cvd comorbid conditions predisposed myocardial injury covid<NUMBER> prevalence hypertension among patients cardiac injury reported high <NUMBER> coronary artery disease cad reported approximately <NUMBER> thus making plaques prone rupture inflammation also causes endothelial dysfunction increases procoagulant activity blood thereby contributing formation occlusive thrombi ruptured coronary plaques predisposing patients ischemic myocardial injury <NUMBER> several clinically diagnosed myocarditis cases patients covid<NUMBER> supporting imaging study among <NUMBER> patients covid <NUMBER> four <NUMBER> clinically diagnosed sarscov<NUMBER> myocarditis based updated diagnostic criteria viral myocarditis <NUMBER> however singlecenter retrospective study <NUMBER> admitted patients confirmed covid<NUMBER> authors explored whether sarscov<NUMBER> caused myocarditis performing least one echocardiographic evaluation patients hospitalization total <NUMBER> patients <NUMBER> presented abnormalities suggestive possible myocarditis elevation troponin myocarditis diagnosis based findings triple elevation cardiac troponin <NUMBER> ngml plus abnormalities echocardiography andor ecg abnormalities echocardiography defined reduced left ventricular ejection fraction lvef <NUMBER> segmental wall motion abnormality left ventricular wall thickening <NUMBER> mm andor presence pericardial effusion ≥<NUMBER> mm abnormalities ecg defined stsegment elevationstt changes echocardiography show typical signs myocarditis stated except presence small pericardial effusion patients nonspecific ecg manifestations commonly tachycardia typical myocardial injury suggestive systemic causes hence authors suggested myocardial injury may likely result systemic consequences rather direct damage sarscov<NUMBER> <NUMBER> uncertainties exist whether sarscov<NUMBER> directly cause cardiomyocyte infection biopsyor autopsydemonstrated sarscov<NUMBER> localization within cardiomyocytes reported date study covid<NUMBER> postmortem needle core biopsy lung liver heart four patients died covid<NUMBER> pneumonia cardiac biopsy performed two patients cardiac troponin elevated hospital course showed mild focal fibrosis mild myocardial hypertrophy probably associated underlying conditions hypertensionassociated myocardial hypertrophy past ischemic injury however evidence inflammatory cellular infiltration indicate myocarditis <NUMBER> tavazzi et al described first case biopsy demonstrated myocardial localization viral particles suggestive sarscov<NUMBER> patient presenting cardiogenic shock <NUMBER> clinical presentation suggestive fulminant myocarditis however pathologic study demonstrated lowgrade myocardial inflammation without evidence myocardial necrosis given viral particles observed interstitial cytopathic macrophages surroundings cardiac myocytes authors could infer viral cardiotropism suggested either viremic phase migration infected macrophages lung likely occur patients covid<NUMBER> nonischemic acute myocardial injury <NUMBER> investigations along histological demonstration myocarditis inflammatory lymphomonocytic infiltrates plus myocyte necrosis typical ischemia <NUMBER> identification viral genome cardiac tissue required future clarify direct association covid<NUMBER> myocarditis myocardial injury shown present three different patterns <NUMBER> common pattern mild troponin elevation typically <NUMBER>th percentile upper reference limit modest rise fall subsequent days frequently observed patients without cardiac symptoms survive hospitalization <NUMBER> <NUMBER> <NUMBER> second pattern progressive patients normal troponin levels moderate troponin elevation admission however level progressively increases patients experience clinical deterioration respiratory failure along increase biomarkers eg interleukin<NUMBER> ferritin lactate dehydrogenase usually occurs second week hospitalization pattern observed among nonsurvivors death occurs around median <NUMBER> days symptom onset one study demonstrated four days symptom onset median high sensitivity cardiac tni hsctni levels <NUMBER> pgml nonsurvivors vs <NUMBER> pgml survivors followup median hsctni among survivors change significantly <NUMBER> pgml whereas rose <NUMBER> pgml day <NUMBER> <NUMBER> pgml day <NUMBER> <NUMBER> pgml day <NUMBER> <NUMBER> pgml day <NUMBER> nonsurvivors <NUMBER> <NUMBER> <NUMBER> <NUMBER> third pattern early moderate troponin elevation may approach exceed <NUMBER>th percentile upper reference limit subsequently fall course illness pattern usually seen patients clinically suspected myocarditis presenting predominantly cardiac symptoms <NUMBER> <NUMBER> <NUMBER> studies shown patients cardiac injury likely older median age <NUMBER> years without cardiac injury <NUMBER> <NUMBER> <NUMBER> patients present typical symptoms covid<NUMBER> like fever cough fatigue dyspnea study <NUMBER> covid<NUMBER> patients <NUMBER> evidence cardiac injury patients complained chest pain palpitations common symptoms illness onset groups patients without cardiac injury similar included fever cough headache fatigue dyspnea <NUMBER> however minority patients cardiac injury might present cardiac symptoms without respiratory symptoms another study <NUMBER> <NUMBER> <NUMBER> patients myocardial injury presented chest pain compared <NUMBER> <NUMBER> <NUMBER> patients without cardiac injury p<NUMBER> <NUMBER> case report myocarditis initial presenting symptom chest pain respiratory involvement atypical presentation without respiratory symptoms also described <NUMBER> <NUMBER> terms radiologic findings bilateral multiple mottling groundglass opacity prevalent patients without cardiac injury <NUMBER> limited studies patients cardiac injury underwent ecg revealed ecg abnormalities twave depression inversion stsegment depression q waves <NUMBER> patients clinically suspected myocarditis found stsegment elevations <NUMBER> <NUMBER> patients cardiac injury elevated troponin likely admitted intensive care unit develop complications including ards malignant arrhythmias including ventricular tachycardiaventricular fibrillation acute coagulopathy electrolyte disturbances acute kidney injury receive mechanical ventilation crrt extracorporeal membrane oxygenation vasopressor therapy thus suggesting cardiac injury might associated clinical outcomes covid<NUMBER> use antibiotic treatment glucocorticoids intravenous immunoglobulin treatment also significantly higher patients cardiac injury without cardiac injury <NUMBER> <NUMBER> studies shown cardiac injury associated higher mortality patients covid <NUMBER> tables <NUMBER> <NUMBER> similarly another case series even though patients covid<NUMBER> cardiac injury underlying cvd highest mortality <NUMBER> patients underlying cvd normal tnt levels disease course favorable prognoses patients elevated tnt levels underlying cvd mortality <NUMBER> vs <NUMBER> thus indicating relatively favorable prognosis patients underlying cvd without myocardial injury <NUMBER> studies demonstrate cardiac injury might independently associated increased risk mortality patients covid<NUMBER> moreover mortality rate directly increases magnitude reference value cardiac troponin singlecenter retrospective cohort study including <NUMBER> patients covid<NUMBER> wuhan china conducted explore whether heart injury occurred covid<NUMBER> admission later increased mortality approximately <NUMBER> patients highsensitivity cardiac troponin hstni exceeding clinical upper normal limit admission patients high levels hstni admission significantly higher mortality <NUMBER> patients moderate low levels hstni <NUMBER> <NUMBER> besides hstni level admission significantly negatively correlated number survival days r<NUMBER> p<NUMBER> <NUMBER> study guo et al showed tnt ntprobnp levels increased significantly hospitalization patients ultimately died whereas dynamic changes tnt ntprobnp levels evident survivors <NUMBER> based studies initial measurement cardiac biomarkers immediately hospitalization sarscov<NUMBER> infection longitudinal monitoring hospital stay may aid identifying subset patients might progress poorer clinical condition however evidence studies required myocardial injury suspected patients covid<NUMBER> troponin elevation new abnormalities ecg could related type <NUMBER> type <NUMBER> myocardial infarction myocarditis stressinduced cardiomyopathy cytokine inducedmyocardial injury <NUMBER> <NUMBER> approach evaluating myocardial injury patients known suspected covid<NUMBER> based balancing benefits evaluation changing management strategy versus potential risk nosocomial spread covid<NUMBER> infection <NUMBER> <NUMBER> elevated troponin levels considered evidence acute myocardial infarction diagnosed based symptoms signs ischemia ecg changes <NUMBER> multicenter case series study form six hospitals new york inpatients confirmed covid<NUMBER> stsegment elevation ecg elevation cardiac enzymes <NUMBER> <NUMBER> patients classified noncoronary myocardial injury evidence obstructive disease coronary angiography normal wall motion echocardiography eight patients received clinical diagnosis myocardial infarction median peak troponin level higher patients myocardial infarction clinical diagnosis noncoronary myocardial injury <NUMBER> clinical presentation suggestive acute coronary syndrome acs timely evaluation required determine need urgent intervention patients covid<NUMBER> mild moderate troponin elevation without symptoms signs acute heart failure clinical monitoring may performed without routine cardiac imaging recovery acute viral syndrome <NUMBER> patients clinical signs symptoms heart failure echocardiography may performed management strategy prognosis would likely change diagnosis possible diagnosis patients ventricular wall motion abnormalities elevated troponin acs include clinically suspected myocarditis stress cardiomyopathy <NUMBER> established therapy clinically suspected myocarditis routine evaluation cardiovascular magnetic resonance endomyocardial biopsy cases recommended <NUMBER> regardless fulminant nonfulminant presentation american college cardiology recommends routine endomyocardial biopsy patients active covid<NUMBER> abnormal cardiac enzymes biopsy unlikely change immediate clinical management whether etiology due myocarditis cytokineinduced myocardial injury type<NUMBER> myocardial infarction <NUMBER> <NUMBER> unfortunately beyond guidelines treating patients ischemic myocardial injury consensus exists regarding routine management patients covid<NUMBER> myocardial injury management myocardial injury focuses identifying treating underlying cause supportive care including management heart failure therapy arrhythmias avoidance cardiotoxins <NUMBER> <NUMBER> patient clinically deteriorates develop hemodynamic instability severely elevated rapidly rising troponin detailed evaluation cardiology consultation enrollment clinical trials experimental therapies like antiviral agents anticytokines il<NUMBER> inhibitors tocilizumab convalescent plasma may considered casebycase basis <NUMBER> although use steroids recommended general treatment covid<NUMBER> reports described patients recovering fulminant myocarditis intravenous immunoglobulin steroids however studies needed determine patient would benefit therapies <NUMBER> patients refractory shock ventricular arrhythmias secondary fulminant myocarditis early institution mechanical support ecmo considered case reports successful rescue patients described <NUMBER> general presence cvd myocardial injury covid<NUMBER> patients associated severe outcomes increased mortality triaging patients covid<NUMBER> according presence underlying cvd evidence myocardial injury prioritized treatment strategies may reasonable <NUMBER> finally several therapies potential cardiovascular side effects currently studied caution must used administering therapies patients underlying cardiovascular disease example preliminary clinical research suggested potential efficacy hydroxychloroquine alone combination azithromycin treatment covid<NUMBER> associated qtc prolongation risk fatal arrhythmias thus warranting regular monitoring qtc <NUMBER> controversy remains concerning use aceiarb covid<NUMBER> preclinical studies suggested raas inhibitors may increase ace<NUMBER> functional receptor sarscov<NUMBER> expression raising concerns regarding safety patients covid<NUMBER> however data remain anecdotal clinical studies evaluated effects raas inhibitors covid<NUMBER> several leading professional societies recommend continuation raas inhibitors patients risk evaluated currently covid<NUMBER> taking medications treat conditions agents known beneficial heart failure ischemic heart disease <NUMBER> studies conducted chinese cohorts thus generalizability results countries including united states remains determined studies singlecentered retrospective studies enrollment small numbers patients larger cohorts multicenter prospective studies planned include assessment detailed heart function related data particularly ecg echocardiography possibly cardiovascular magnetic resonance imaging determine myocardial function etiology mechanism cardiac injury studies discussed troponin measured first place data available support different management strategy patients elevated troponin studies must planned define whether adjunctive cardioprotective therapies corticosteroids immunosuppressants antivirals agents interferons andor immunomodulatory therapy immunoglobulins may advisable patients significant elevation cardiac injury biomarkers pathological examination myocardial tissue patients covid<NUMBER> definite myocardial injury needed provide pathological evidence etiology myocardial injury establish covid<NUMBER> new etiological agent myocarditis conclusion covid<NUMBER> associated increased prevalence acute cardiac injury even patients severe disease presence preexisting cardiovascular disease increases risk cardiac injury patients covid<NUMBER> although exact mechanism underlying association cardiac injury patients covid<NUMBER> remains unclear direct virusinduced cardiomyocyte injury leading viral myocarditis systemic cytokinemediated myocardial injury hypoxiainduced myocardial oxidative stress suggested presence myocardial injury independently associated mortality may predictor progression severe disease adverse clinical outcomes patients covid<NUMBER> studies needed elucidate predominant etiology myocardial injury patients covid<NUMBER> promote targeted treatment programs improve patient prognosis compliance icmje uniform disclosure form authors declare following paymentservices info authors declared financial support received organization submitted work financial relationships authors declared financial relationships present within previous three years organizations might interest submitted work relationships authors declared relationships activities could appear influenced submitted work porcine epidemic diarrhoea ped highly contagious infectious disease caused coronavirus porcine epidemic diarrhoea virus pedv causes acute watery diarrhoea pigs ages although severe signs reported piglets less two weeks old diarrhoea leads severe dehydration associated mortalities reach <NUMBER> affected litters first clinical description ped occurred uk belgium early seventies however <NUMBER> etiological agent diarrhoeal outbreaks new coronavirus identified <NUMBER> <NUMBER> soon afterwards studies research group led professor pensaert ghent belgium demonstrated specific antibodies pedv sera collected sows prior <NUMBER> confirming pedv new virus european swine population information available potential origin virus distribution first description uk belgium pedv spread throughout european countries causing diarrhoeal outbreaks relevant number pig herds <NUMBER> <NUMBER> <NUMBER> pedv specific antibodies pedv reported several european countries belgium uk netherlands germany hungary bulgaria france switzerland spain seventies eighties <NUMBER> <NUMBER> <NUMBER> mortality piglets less two weeks old varied <NUMBER> <NUMBER> usually lower described outbreaks diarrhoea caused transmissible gastroenteritis virus tgev another porcine coronavirus classically recognized cause diarrhoea disease swine however unknown reasons ped outbreaks markedly decreased nineties subsequent years europe isolated outbreaks associated low mortality piglets reported countries ie spain <NUMBER> hungary <NUMBER> uk <NUMBER> czech republic <NUMBER> <NUMBER> welldocumented ped epidemic last <NUMBER> years europe occurred winter <NUMBER> northern italy average preweaning mortality raised <NUMBER> <NUMBER> peaking <NUMBER> one particular farm <NUMBER> recent ped outbreaks reported germany <NUMBER> <NUMBER> <NUMBER> italy <NUMBER> <NUMBER> netherlands <NUMBER> belgium <NUMBER> france <NUMBER> ukraine <NUMBER> european countries unpublished data contrast situation europe pedv remained major cause diarrhoea outbreaks swine farms asia <NUMBER> years virallike diarrhoea outbreaks reported pig farms shanghai china <NUMBER> despite fact tgev known enteropathogenic agents ruled aetiology could determined pedv firstly demonstrated area <NUMBER> china <NUMBER> japan <NUMBER> nineties virus spread neighbouring countries korea <NUMBER> philippines thailand <NUMBER> later reported taiwan <NUMBER> <NUMBER> vietnam <NUMBER> <NUMBER> due relevance area attenuated killed vaccines confer partial protection pedv used several asian countries vaccines used china since <NUMBER> also introduced japan <NUMBER> south korea <NUMBER> philippines <NUMBER> <NUMBER> relevant point october <NUMBER> largescale severe ped outbreak reported several provinces southern china spread provinces within country well neighbouring countries <NUMBER> <NUMBER> outbreak caused high mortality among suckling piglets <NUMBER> <NUMBER> given fact china clearly naïve country regarding pedv infection proposed probably new variant pedv higher virulence circulating recently april <NUMBER> pedv identified first time usa pig farms located ohio <NUMBER> virus spread quickly within country <NUMBER> year first description number ped affected farms exceeded <NUMBER> spreading <NUMBER> states addition virus spread countries north central south america ped outbreaks reported first time pig farms mexico july <NUMBER> peru october <NUMBER> dominican republic november <NUMBER> canada january <NUMBER> colombia march <NUMBER> ecuador july <NUMBER> <NUMBER> based genomic analysis coronaviridae family recently divided four genera alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus <NUMBER> pedv member genus alphacoronavirus together coronaviruses infect pigs tgev respiratory variant porcine respiratory coronavirus prcv dogs canine coronavirus cats feline infectious peritonitis virus humans human coronavirus <NUMBER>e human coronavirus nl<NUMBER> bats also swine coronaviruses table <NUMBER> porcine hemagglutinating encephalomyelitis virus phev betacoronavirus causes infection associated chronic emaciation death young pigs vomiting wasting disease porcine deltacoronavirus pdcov member genus deltacoronavirus recently identified etiological agent enteric disease similar ped tge <NUMBER> coronaviruses enveloped viruses possess positivesense singlestranded rna genome morphologically characterized presence projections peplomers surface like members alphacoronavirus genus pedv possesses four structural proteins three membrane proteins identified protein spike protein protein membrane protein e protein previously sm small membrane protein nucleocapsid protein n protein encapsidates viral rna protein particularly relevant among structural proteins glycoprotein induces neutralizing antibodies interacts cell receptor host also three nonstructural proteins two encoded open reading frames orf <NUMBER>a <NUMBER>b involved genome replication transcription third encoded orf<NUMBER> reported ionchannel protein <NUMBER> <NUMBER> <NUMBER> antigenic relationships pedv coronavirus researched <NUMBER> although crossreactivity pedv tgev associated one epitope nterminal region n protein recently reported pig tgev antisera neutralized pedv vice versa crossreactivity reported pedv coronavirus beta gamma delta genera direct indirect pedv transmission occurs mainly faecaloral route viral shedding faeces starts postinfection day one two continues period <NUMBER> <NUMBER> days <NUMBER> <NUMBER> although extend <NUMBER> weeks animals <NUMBER> <NUMBER> transmission infection facilitated high viral load faeces infected animals <NUMBER> <NUMBER> well minimum infectious dose required infect naïve pigs <NUMBER> moreover resistance virus environment facilitates faecaloral transmission pedv stable low temperatures adversely affected high temperatures survives ph <NUMBER> <NUMBER>°c ph <NUMBER> <NUMBER>°c survive least <NUMBER> days slurry <NUMBER>°c <NUMBER> days contaminated dry feed <NUMBER>°c <NUMBER> days contaminated wet feed <NUMBER>°c <NUMBER> fact favours indirect transmission different faecescontaminated fomites transport vehicles <NUMBER> feed <NUMBER> clothing footwear genetic phylogenetic analyses american pedv isolates revealed close relationship chinese isolates likely chinese origin <NUMBER> however virus might travelled china usa matter speculation rapid spread pedv swine farms usa raised questions regarding possibility airborne transmission infection although undoubtedly faecaloral route main source pedv transmission suggested <NUMBER> pedv may travel air short distances faecal dust particles least certain conditions however airborne transmission pedv shown experimental conditions infectious pedv demonstrated field air samples containing pedv genetic material <NUMBER> <NUMBER> role vectors play transmission pedv also investigated far evidence pedv replication nonporcine hosts including rodents starlings <NUMBER> <NUMBER> <NUMBER> however potential role vectors mechanic transmission virus one farm another cannot ruled described tgev <NUMBER> using highly sensitive molecular assays presence viral rna reported milk samples infected lactating sows <NUMBER> <NUMBER> well semen samples <NUMBER> <NUMBER> however infectious pedv samples demonstrated contamination faecal material sampling cannot excluded moreover viral rna detected serum fraction whole blood samples infected pigs <NUMBER> <NUMBER> role spraydried porcine plasma sdpp normally used feed additive potential vehicle transmission pedv researched number experimental studies demonstrated spraydrying process well storage conditions sufficient inactivate infectious pedv sdpp <NUMBER> <NUMBER> infectivity commercial sdpp positive pedvrna also investigated research group canada managed reproduce pedv infection sdppinoculated piglets although failed reproduce infection animals receiving feed supplemented pedvpositive sdpp <NUMBER> similarly neither clinical signs pedv rna faeces pedv specific antibodies detected pigs fed diet containing <NUMBER> sdpp confirmed positive pedv bioassay experiment conducted opriessnig et al <NUMBER> according experimental evidence pedv transmission pcr positive sdpp supplemented feed experimental data corroborated fact despite use large amounts pedv positive sdpp usa feed pigs brazil western canada areas remained free pedv infection <NUMBER> pedv replicates cytoplasm villous enterocytes small intestine causes villous shortening reduced enzymatic absorptive capacity small intestine causing profuse watery diarrhoea lasts week <NUMBER> <NUMBER> <NUMBER> clinical signs frequently associated pedv infection include vomiting anorexia fever although pigs ages affected severity ped higher suckling piglets less one week old may die due severe dehydration slower turnover enterocytes neonatal piglets <NUMBER> days compared three weeksold piglets <NUMBER> days could explain least partially higher susceptibility young piglets pedv <NUMBER> pedv also detected epithelial cells colon experimentally naturally infected pigs although villous atrophy demonstrated large intestine <NUMBER> replication pedv classically circumscribed intestinal tract <NUMBER> recent research showed pedv replication alveolar macrophages <NUMBER> dayoldcolostrumfree piglets experimentally inoculated korean wildtype pedv isolate <NUMBER> studies needed confirm whether extraintestinal replication also occurs pedv isolates well determine clinical epidemiological relevance two epidemiologic presentations ped described farms epidemic ped outbreaks occur pedv introduced naïve farm animals pedv seronegative disease spreads rapidly affecting pigs ages morbidity approaching <NUMBER> moreover pedv persist become b endemic farm affecting postweaning piglets lost lactogenic immunity well newly introduced seronegative gilts mortality associated ped outbreaks highly dependent age infected animals mortality reach <NUMBER> suckling piglets less one week old weaned pigs mortality rates typically <NUMBER> <NUMBER> <NUMBER> <NUMBER> mortality associated ped usually observed among adult pigs already mentioned differences severity ped outbreaks reported particularly severe ped outbreaks described asia since <NUMBER> also usa differences virulence pedv isolates proposed explain variability <NUMBER> <NUMBER> <NUMBER> point view one relevant questions face regarding ped nowadays reason reasons could explain variations clinical outcome outbreak although reports suggested could associated differences virulence pedv isolates exhaustive challenge studies using pig adapted virus cell culture adapted isolates suckling piglets needed elucidate role strain insights obtained related virulence different strains usa least two main variants pedv recently identified using molecular methods first one seems highly virulent virus similar viruses described several asian countries <NUMBER> second indel variant associated mild clinical outbreaks <NUMBER> indel variant includes particular insertions deletions gene also similar asian isolates part recovered <NUMBER> classical european reference strain pedv cv<NUMBER> also indel isolate although located different cluster well differentiated american indel isolates fig <NUMBER>a b pedv isolates recovered european countries germany italy belgium netherlands france <NUMBER> <NUMBER> characterized found indel isolates similar variant described usa <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent ped outbreaks europe occurred fattening farms expected mortality observed however pedv isolates recently recovered severe outbreaks pedv ukraine shown genome nucleotide similarity reaching <NUMBER> nonindel isolates united states mexico <NUMBER> far report pedv nonindel isolates europe apart differences virulence pedv strains many parameters including management immune status population herd sanitary status could also explain variations clinical outcome ped outbreaks <NUMBER> thus contribution coinfections viruses particularly enteric viruses porcine delta coronavirus pdcov recently described mammalian orthoreovirus <NUMBER> mrv<NUMBER> also pointed viruses detected faecal samples collected pedv positive farms usa pdcov associated mild moderate diarrhoea experimentally inoculated naïve suckling piglets <NUMBER> mrv<NUMBER> caused severe diarrhoea <NUMBER> mortality <NUMBER>dayold piglets <NUMBER> although rapid spread disease characterized profuse watery diarrhoea affecting pigs ages allows clinician suspect viral agent involved infection differential diagnosis identify pedv laboratory would needed direct detection pedv faecal samples conventional realtime pcr frequent assays used present <NUMBER> pcrassays generally based amplification fragments within n protein genes associated high sensitivity specificity also elisas usually based use monoclonal antibodies pedv although analytical sensitivity generally lower pcr assays <NUMBER> useful field conditions amount virus faecal samples diseased animals epidemic outbreaks ped high immunohistochemistry ihc also useful tool based detection pedv antigens within infected cells formalinfixed sections small intestine less sensitive molecular diagnostic methods contrast allows evaluation tissue lesions <NUMBER> order increase sensitivity ihc assays several sections small intestine affected pigs sacrificed acute phase infection investigated indirect methods focused detection antibodies detection pedv specific antibodies useful investigation diarrhoea outbreaks determine whether animal herd previously infected virus taking approach account serology good tool surveillance provides useful information regarding viral spread region country however number tests detection pedv specific antibodies limited elisas indirect immunofluorescence assays ifa immunoperoxidase monolayer assays ipma seroneutralization tests inhouse assays information regarding sensitivity specificity usually scarce general elisa tests proven capable detecting pedv specific antibodies little earlier longer periods time ifa tests <NUMBER> specific treatment pedv supportive care symptomatic treatment mortality occurs suckling piglets result dehydration corrected using oral electrolyte solutions adult pigs dry feed withdrawn period <NUMBER> h carefully reintroduced water kept freely available <NUMBER> <NUMBER> order increase passive immunity piglets minimize losses sows due farrow least <NUMBER> weeks deliberately exposed virulent virus oral route recent study revealed morbidity reduced <NUMBER> <NUMBER> litters exposed virulent pedv sows previously exposed mild virulent strain indel variant pedv <NUMBER> oral administration chicken eggyolk cow colostrum containing pedv immunoglobulins could offer immunoprophilactic defence <NUMBER> <NUMBER> increase lactogenic immunity also aim pedv vaccines used pregnant sows attenuated killed vaccines pedv used several asian countries years <NUMBER> however suggested live vaccines revert virulence use usefulness field conditions questioned <NUMBER> <NUMBER> <NUMBER> recently pedv subunit vaccine based protein gene pedv well vaccine killed virus licensed usa <NUMBER> although still studies prove efficacy however pedv vaccines never used europe disease sufficient economic importance area general pedv vaccines reported useful booster antibody response animals already infected pedv specific treatments control potential eradication disease herd preventive measures preclude introduction virus new pedv strains area country farm paramount importance supported detection methods mentioned diagnosis surveillance used certify trading swine related derivatives cause spread new strains virus lorries used transport highlighted relevant source transmission <NUMBER> special attention paid effectiveness cleaning disinfecting protocols inactivate remove virus herd level basic external biosecurity rules quarantine reposition ban entrance unwashed vehicles strict visitor policies time interval visiting two farms provide footwear appropriate clothing showers carried without exception internal biosecurity controlling slurry level carcasses disposal carcass bin cleaning movement caretakers farm could prevent establishment endemic form disease finally many virucidal disinfectants shown effective inactivating pedv phenol quaternary ammonium compounds glutaraldehyde bleach examples disinfectants water temperature crucial factor temperatures <NUMBER>°c help inactivate virus proper cleaning disinfecting facilities equipment crucial control pedv emergence spread pedv us pig farms aroused growing interest coronavirus main areas recent research disease focused molecular characterization isolates well sources infection means transmission despite fact relevant knowledge increased still number questions answered one hand difference virulence among pedv variants described needs clarified hand rapid spread virus usa raised concerns transmission mechanisms pedv mainly spreads faecaloral route either direct indirect contact feed fomites vehicles routes sources transmission airtransmission vectors sdpp investigated although implication clearly demonstrated recent ped outbreak american continent also shows research needed control disease based development useful vaccines surveillance virus standardising detection laboratories final goal limiting spread authors declare competing interests authors helped draft manuscript read approved final manuscript submit next manuscript biomed central take full advantage n december <NUMBER> novel pneumonia syndrome identified patients clustered around huanan seafood market wuhan china <NUMBER> next generation sequencing used identify novel coronavirus known severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> bronchoalveolar lavage fluid three patients infection sarscov<NUMBER> leads syndrome coronavirus disease <NUMBER> rapid international spread potentially lethal virus caused global concern <NUMBER> cases <NUMBER> deaths reported date <NUMBER> <NUMBER> summarize latest insights biology sarscov<NUMBER> implications anesthesiologists perioperative intensive care settings relative assortment viruses cause human upper respiratory tract infection group viruses cause lower respiratory tract infection smaller includes influenza parainfluenza respiratory syncytial virus cytomegalovirus hantavirus infections mostly limited tracheobronchitis healthy individuals cause severe viral pneumonias immunocompromised patients influenza one bestknown causes pneumonia intensive care unit icu presentation frequently related bacterial superinfection staphylococcus aureus <NUMBER> rarity viral pneumonia attributed types cells viruses infect termed tropism thus common influenza strains like h<NUMBER>n<NUMBER> target cells trachea bronchi influenza pneumonia particularly linked avian strains like h<NUMBER>n<NUMBER> skip upper respiratory epithelium infect alveolar epithelial cells lower respiratory tract <NUMBER> sarscov<NUMBER> betacoronavirus family includes original severe acute respiratory syndrome sars virus well middle east respiratory syndromerelated coronavirus mers endemic human pathogens common causes cold including oc<NUMBER> hku<NUMBER> betacoronaviruses around <NUMBER> yr outbreaks lethal strains sarscov <NUMBER> middle east respiratory syndromerelated coronavirus <NUMBER> added notoriety <NUMBER> sarscov middle east respiratory syndromerelated coronavirus sarscov<NUMBER> likely originated bats sarscov using civets intermediary hosts middle east respiratory syndromerelated coronavirus passing though camels pangolins also known scaly anteaters implicated passage sarscov<NUMBER> humans basis sequence similarity pangolin coronaviruses <NUMBER> variable clinical manifestations caused distinct coronavirus strains attributed structural differences virus proteins affecting tropism replication corona description references crownlike halo viral spike proteins observed electron microscopy fig <NUMBER> variations sprotein determine proteins coronavirions use enter cells early investigations sarscov<NUMBER> suggest uses tissue angiotensin converting enzyme<NUMBER> receptor trait shared sars middle east respiratory syndromerelated coronavirus common endemic human coronaviruses oc<NUMBER> hku<NUMBER> <NUMBER> <NUMBER> angiotensin converting enzyme<NUMBER> special section expressed lower respiratory tract bronchi well enterocytes small intestine <NUMBER> thus angiotensin converting enzyme<NUMBER> dependence may explain clinical presentations lower respiratory tract infection enteritis covid<NUMBER> angiotensin converting enzyme<NUMBER> expression vascular endothelium cardiac myocytes also implicated acute cardiac injury resulting covid<NUMBER> <NUMBER> animal models angiotensin converting enzyme inhibitors angiotensinreceptor blockers increase angiotensin converting enzyme<NUMBER> expression activity respectively leading speculation medications could possibly potentiate sarscov<NUMBER> infection <NUMBER> major cardiology societies recommend changing renin angiotensin aldosterone system antagonist treatments based covid<NUMBER> risk time <NUMBER> sites express angiotensin converting enzyme<NUMBER> tongue parts genitourinary tract clinical significance finding covid<NUMBER> unclear <NUMBER> binding sprotein angiotensin converting enzyme<NUMBER> likely contributes directly pathogenesis resulting downregulation angiotensin converting enzyme<NUMBER> increased production angiotensin ii resulting increased pulmonary vascular permeability <NUMBER> sarscov<NUMBER>susceptible angiotensin converting enzyme<NUMBER> appears universally expressed humans may genetic variations regulating angiotensin converting enzyme<NUMBER> expression could lead differential susceptibilities across populations genotypes <NUMBER> viral binding angiotensin converting enzyme<NUMBER> virus may endocytosed directly fuse cell membrane fig <NUMBER> positivesense viral rna transcript translated host cell yielding two polypeptides polypeptides subsequently divided viral proteases yielding viral replication machinery coronaviruses employ multiple mechanisms shield viral rna host detection subsequent induction antiviral interferon responses including direct antagonism interferon signaling proteins replication viral rna double membrane vesicles <NUMBER> nonetheless covid<NUMBER> strongly induces cytokines chemokines including interleukin<NUMBER> interleukin<NUMBER> interleukin<NUMBER> interleukin<NUMBER> interleukin<NUMBER> interferonɣ tumor necrosis factorɑ macrophage inflammatory protein<NUMBER>ɑ suggesting broad type <NUMBER> type <NUMBER> helper tcell response <NUMBER> remains uncertain extent direct viral cytotoxicity versus host cytokine storm immune responses contributes morbidity covid<NUMBER> initial coronavirus infection immune responses appear effective controlling viral infection suggesting vaccines feasible important caveats animal vaccine models antibody responses waned quickly indicating immune responses might longlasting <NUMBER> also one mouse coronavirus model sars natural killer cell antibody interferon responses beneficial tcell responses paradoxically worsened outcomes <NUMBER> accordingly vaccines need demonstrate safety effectiveness widespread adoption incubation period sarscov<NUMBER> appears <NUMBER> <NUMBER> days initial reports demonstrated rapid persontoperson viral transmission number infected individuals doubling every <NUMBER> days <NUMBER> viral evolution patterns inferred viral gene sequence variations suggest much viral transmission occurred united states undiagnosed two cases reported <NUMBER> weeks apart could potentially represent cluster hundreds infections <NUMBER> two distinct groups sarscov<NUMBER> sequences identified ltype represented <NUMBER> cases wuhan ancestral stype found <NUMBER> cases outside wuhan postulated stype could less severe thus capable rapid spread less negative selective pressure <NUMBER> majority patients covid<NUMBER> infection present fever first symptom common symptoms onset illness include cough fatigue less commonly reported symptoms include palpitations headache diarrhea subset patients develop dyspnea days <NUMBER> <NUMBER> hospitalization commonly reported hematologic laboratory abnormalities covid<NUMBER> leukopenia lymphopenia <NUMBER> <NUMBER> <NUMBER> <NUMBER> cause leukopenia well understood could relate bone marrow suppression lymphocyte sequestration apoptosis <NUMBER> clinical spectrum covid<NUMBER> cases ranged asymptomatic critically ill <NUMBER> majority patients mild symptoms good prognosis <NUMBER> patients develop pneumonia acute respiratory distress syndrome ards cardiac injury renal injury multiorgan failure days <NUMBER> <NUMBER> hospitalization subset patients covid<NUMBER> require admission icu respiratory support noninvasive invasive ventilation potentially extracorporeal membrane oxygenation <NUMBER> <NUMBER> <NUMBER> <NUMBER> summary covid<NUMBER> symptoms complications treatment initial wave case series publications presented table <NUMBER> concern anesthesiologists perioperative setting patients present minimal respiratory symptoms one initial case series patient abdominal symptoms admitted surgical service infected least <NUMBER> healthcare providers <NUMBER> abdominal symptoms covid<NUMBER> may reflect angiotensin converting enzyme<NUMBER> expression small intestine potentially underappreciated since patients gastrointestinal symptoms may tested sarscov<NUMBER> indeed sarscov<NUMBER> may transmitted via fecaloral route via contaminated surfaces <NUMBER> pneumonia abnormalities chest computed tomography images detected almost hospitalized patients covid<NUMBER> characteristic radiographic findings ground glass opacities typically bilateral peripheral coexisting consolidations cordlike opacities <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> progresses reverse halo crazypaving radiologic patterns may become apparent notably radiologic features rare covid<NUMBER> lymphadenopathy nodules pleural effusions cavitation would potentially suggest pathologies <NUMBER> diagnosis sarscov<NUMBER> reverse transcriptasepolymerase chain reaction testing standard assay throat swab nasal swab samples commonly used reverse transcriptasepolymerase chain reaction reverse transcriptasepolymerase chain reaction useful test confirm diagnosis covid<NUMBER> limitations sample collection kit performance total positive rate reverse transcriptasepolymerase chain reaction throat swab samples reported <NUMBER> <NUMBER> initial presentation <NUMBER> serial reverse transcriptasepolymerase chain reaction testing inclusion lower airway sampling improve sensitivity testing commercially <NUMBER> endocytosis potential target chloroquine prevents endosomal acidification triggers viral membrane fusion chloroquine may also modify ace<NUMBER> terminal glycosylation inhibit coronavirus binding viral rna transcribed generate polyproteins pp<NUMBER>a pp<NUMBER>ab cleaved protease generate viral replication machinery polyproteins cleaved form replicationtranscription protein complexes rtcs viral protease <NUMBER>chymotrypsinlike protease <NUMBER>clpro <NUMBER>clpro postulated target human immunodeficiency virus protease inhibitors lopinavir ritonavir although silico studies questioned theory <NUMBER> viral rna replicated transcribed double membraned vesicles dmv replicationtranscription protein complexes include rnadependent rna polymerase putative target remdesivir viral mrna translated virions assembled endoplasmic reticulum golgi available molecular tests endemic coronaviruses filmarray respiratory panel biofire diagnostics usa detect sarscov<NUMBER> currently expected sarscov<NUMBER> added soon <NUMBER> chest computed tomography may higher sensitivity covid<NUMBER> infection sensitivity high <NUMBER> one study <NUMBER> based challenges reverse transcriptasepolymerase chain reaction testing computed tomography imaging proposed primary tool covid<NUMBER> detection hospitalized patients epidemic areas however within first <NUMBER> days symptom onset majority patients may normal computed tomography imaging <NUMBER> thus early disease course may diagnostic sufficiently sensitive exclude covid<NUMBER> pathology findings covid<NUMBER> reported cases <NUMBER> <NUMBER> many pathologic findings similar seen coronavirusassociated severe acute respiratory syndrome caused sarscov middle east respiratory syndromerelated coronavirus inflammatory infiltrates hyaline membrane formation findings inspissated spherical secretions fibromyxoid exudates prominent covid<NUMBER> infection accumulation thick secretions likely causes decreased alveolar gas exchange predisposing respiratory failure suggesting potential role airway clearance bronchial hygiene treatment covid<NUMBER> full ramifications sarscov<NUMBER> infection yet understood early work points wide variety psychiatric complications affecting patients families providers larger communities relating anxiety isolation frustration stigma guilt <NUMBER> disease also poses increased risk specific subpopulations transplant candidates recipients <NUMBER> patients cancer <NUMBER> highlighted published case series wide variation clinical presentations covid<NUMBER> ranging symptoms intractable ards shock determinants varied outcomes remain unknown experience viruses suggests variation dose viral inoculum route inoculation underlying immune status patient lead widely variable host responses <NUMBER> higher viral loads random sampling identified individuals greater symptom burden influenza <NUMBER> greater mortality adenoviral pneumonia <NUMBER> time moderate sarscov<NUMBER> viral loads detected nasal swabs <NUMBER> weeks onset symptoms asymptomatic individuals <NUMBER> attributable risk higher viral inocula difficult quantify realworld settings higher viral loads critically ill patients pose least theoretical risk healthcare providers <NUMBER> major risk factors mortality among early reported cases covid<NUMBER> old age underlying na na na na na na na <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> retrospective <NUMBER> hospitalized zhejiang province china <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> na na na na na <NUMBER> na na <NUMBER> <NUMBER> <NUMBER> retrospective <NUMBER> hospitalized singapore <NUMBER> <NUMBER> na <NUMBER> na na na na na na <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ards acute respiratory distress syndrome ecmo extracorporeal membrane oxygenation icu intensive care unit na applicable reported respiratory disease <NUMBER> reasons age associations unknown multiple theories extrapolated hostpathogen biology example immunosenescence could contribute increased risk among aged individuals age frequency naive b cells diminishes implying less capacity recognize adapt novel antigens time aged immune cells less proliferative functional capacity even responding known antigens agerelated changes cellular immunity manifest decreased vaccine effectiveness worse outcomes setting influenza respiratory syncytial virus herpes zoster infections <NUMBER> demonstrated mouse models coronavirus infection <NUMBER> lung ages airway epithelium restorative capacity also diminished telomere dysfunction one biologic mechanism aging primarily manifests pulmonary fibrosis also restrict leukocyte proliferation conceivable poor outcomes covid<NUMBER> could linked short telomeres reported pulmonary fibrosis ards sepsis <NUMBER> <NUMBER> also possible younger individuals may differential susceptibility sarscov<NUMBER> interestingly rat lung angiotensin converting enzyme<NUMBER> expression decreases age <NUMBER> children also could benefit immunity developed coronavirus infections indeed modest crossreactivity observed endemic coronaviruses oc<NUMBER> sarscov <NUMBER> potentially protective crossreactive immunity would limited age immunosenescence fecaloral transmission resulted milder gastroenteritis presentation sarscov<NUMBER> also conceivable children could subsequently protected covid<NUMBER> respiratory syndrome currently speculate causes variation covid<NUMBER> presentations mechanisms likely hold important clues inform management therapeutics patients covid<NUMBER> appear relatively mild disease course subset develop hypoxemic respiratory failure imaging patterns consistent diffuse viral pneumonitis organizing pneumonia diffuse alveolar damage <NUMBER> <NUMBER> true incidence severe pulmonary disease associated sarscov<NUMBER> yet clear several studies hubei province reported <NUMBER> <NUMBER> icu admission rate among hospitalized patients confirmed sarscov<NUMBER> ards diagnosis <NUMBER> <NUMBER> patients admitted icu table <NUMBER> <NUMBER> <NUMBER> among patients develop dyspnea hypoxemia median time onset symptoms development dyspnea appears <NUMBER> <NUMBER> days ards developing smaller subset patients <NUMBER> <NUMBER> days <NUMBER> <NUMBER> <NUMBER> management severe hypoxemia covid<NUMBER> drawn management ards also informed experience <NUMBER> sarscov <NUMBER> middle east respiratory syndromerelated coronavirus outbreaks world health organization published practice guideline clinical management covid<NUMBER> severe respiratory infection <NUMBER> several groups also published practice recommendations care patients covid<NUMBER>associated ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> treatment patients covid<NUMBER>associated ards made complex due necessary infection control interventions use isolation rooms need care providers wear appropriate personal protective equipment transmission sarscov<NUMBER> patients healthcare workers reported infection control primary importance protect healthcare workers prevent spread sarscov<NUMBER> <NUMBER> <NUMBER> world health organization guideline recommends addition routine standard precautions providers use droplet contact precautions caring patients confirmed suspected sarscov<NUMBER> infection addition airborne precautions aerosolgenerating procedure intubation bronchoscopy suctioning cardiopulmonary resuscitation performed <NUMBER> additional guidelines frontline reports groups hubei province suggest many providers utilizing airborne precautions times caring covid<NUMBER> patients additional safety measure <NUMBER> <NUMBER> select patients covid<NUMBER>associated respiratory failure presenting hypoxemia adequately treated low flow nasal cannula oxygen conventional facemask trial either noninvasive positive pressure ventilation heated humidified high flow nasal cannula oxygen may reasonable endotracheal intubation mechanical ventilation <NUMBER> world health organization covid<NUMBER> management guidelines among others suggest trial limited duration <NUMBER> h avoid unrecognized severe respiratory decompensation requires emergent intervention use high flow nasal cannula noninvasive positive pressure ventilation contraindicated patients hemodynamic instability multiorgan failure altered mental status <NUMBER> <NUMBER> high flow nasal cannula provide <NUMBER> oxygen patients high flow rate adds low <NUMBER> <NUMBER> cm h <NUMBER> <NUMBER> positive endexpiratory pressure peep effect reduces work breathing patients acute respiratory failure <NUMBER> <NUMBER> high flow nasal cannula used treat ards good safety profile given recent clinical introduction little data outbreaks guide use covid<NUMBER> associated respiratory failure <NUMBER> <NUMBER> one study <NUMBER> patients ards randomized receive initial high flow nasal cannula noninvasive positive pressure ventilation conventional oxygen therapy use high flow nasal cannula significantly reduce intubation rates overall patients special section covid<NUMBER> randomized high flow nasal cannula arm lower <NUMBER>day mortality rate <NUMBER> patients moderate severe ards less likely require conversion mechanical ventilation randomized high flow nasal cannula arm trial <NUMBER> systematic review use high flow nasal cannula ards find difference mortality intubation rates compared usual care found high flow nasal cannula well tolerated patients <NUMBER> use novel indices ratio oxygen saturationfraction inspired oxygen respiratory rate may helpful predict clinical deterioration need intubation high flow nasal cannula used <NUMBER> given existing literature base use high flow nasal cannula initial strategy treatment covid<NUMBER>associated respiratory failure appears reasonable patients closely monitored worsening respiratory distress world health organization covid<NUMBER> guidelines others recommend avoiding high flow nasal cannula use patients severe worsening hypercapnia hemodynamic instability multiorgan failure altered mental status <NUMBER> <NUMBER> although guidelines recommend use noninvasive positive pressure ventilation management acute respiratory failure due cardiogenic pulmonary edema patients chronic obstructive pulmonary disease copd exacerbation leading respiratory acidosis recommendations made regarding use noninvasive positive pressure ventilation ards <NUMBER> use noninvasive positive pressure ventilation patients ards evaluated several large trials recent study reported high greater <NUMBER> rate noninvasive positive pressure ventilation failure leading invasive mechanical ventilation patients moderate severe ards <NUMBER> study noninvasive positive pressure ventilation failure associated increased mortality use noninvasive positive pressure ventilation patients severe ards pao <NUMBER> fio <NUMBER> less <NUMBER> mmhg <NUMBER> several authors suggested increased mortality observed noninvasive positive pressure ventilation used patients severe ards ultimately require invasive mechanical ventilation may explained noninvasive positive pressure ventilation delaying time needed intubation lung injury caused uncontrolled high tidal volumes noninvasive positive pressure ventilation <NUMBER> <NUMBER> <NUMBER> limited data suggest noninvasive positive pressure ventilation delivered via helmet patients ards failure rates mortality may lower conventional noninvasive positive pressure ventilation facemask used helmet mask may additionally beneficial infection control perspective intervention widely available <NUMBER> experience <NUMBER> h<NUMBER>n<NUMBER> influenza epidemic middle east respiratory syndromerelated coronavirus epidemic also informs recommendations use noninvasive positive pressure ventilation covid<NUMBER> large observational study h<NUMBER>n<NUMBER> patients reported greater <NUMBER> noninvasive positive pressure ventilation failure rate increased mortality patients failed initial noninvasive positive pressure ventilation required invasive mechanical ventilation <NUMBER> observational study treatment patients middle east respiratory syndromerelated coronavirus reported greater <NUMBER> failure rate use noninvasive positive pressure ventilation <NUMBER> based best available data use noninvasive positive pressure ventilation initial strategy treatment covid<NUMBER>associated ards likely reasonable subset patients mild ards copd exacerbation heart failure may also contributing respiratory distress patient closely monitored improvement worsening respiratory distress <NUMBER> <NUMBER> substantial concern using noninvasive positive pressure ventilation high flow nasal cannula patients viral respiratory illness results increased production aerosolized virus particles creating risk healthcare workers contaminating clinical environment multiple studies <NUMBER> sars epidemic identified participation tracheal intubation risk factor viral spread healthcare workers noninvasive ventilation identified risk factor two small studies considered robust enough establish risk transmission <NUMBER> metaanalysis <NUMBER> <NUMBER> <NUMBER> experimental studies exhaled air dispersion mannequins isolation rooms using conventional low flow nasal cannula high flow nasal cannula continuous positive airway pressure nasal pillows full facemask demonstrated greater exhaled air dispersion conventional low flow nasal cannula <NUMBER> lmin <NUMBER> patients face compared either high flow nasal cannula continuous positive airway pressure <NUMBER> <NUMBER> authors postulated lower exhaled air dispersion high flow nasal cannula continuous positive airway pressure masks could related tighter fit face modalities also humidified air generated modalities could result exhalation larger droplets shorter trajectory due gravity <NUMBER> use full noninvasive positive pressure ventilation facemask might also prevent spread aerosolized droplets patient sneezing coughing <NUMBER> thus risk method oxygen delivery patient covid<NUMBER>associated respiratory distress result spread viruscontaining exhaled air especially mask poorly fitted leaking concern use noninvasive positive pressure ventilation high flow nasal cannula specifically leads worse environmental contamination substantiated current available evidence patients receiving supplemental oxygen therapy cared airborne isolation rooms whenever possible staff using full contact droplet airborne isolation precautions <NUMBER> <NUMBER> providers aware coronaviruses remain infectious inanimate surfaces <NUMBER> days surfaces equipment used sars<NUMBER>covinfected patients carefully disinfected <NUMBER> greater ethanol small surfaces <NUMBER> greater sodium hypochlorite larger surfaces <NUMBER> regardless choice initial oxygen therapy patients covid<NUMBER>associated respiratory failure patients closely monitored deterioration intubated promptly avoid need emergent intervention <NUMBER> <NUMBER> experience <NUMBER> sars epidemic suggests intubation time healthcare workers high risk viral transmission infected patients odds ratio <NUMBER> <NUMBER> noted however several healthcare providers contracted sars intubating patients wearing standard surgical facemasks time intubation strong evidence link intubation risk transmission virus healthcare workers proper airborne precautions taken <NUMBER> note several post hoc reports <NUMBER> sars epidemic emerging reports current epidemic recommend use higher level personal protective equipment powered airpurifying respirators double gloves coveralls foot covers hoods performing aerosol generating procedures intubation appear evidence support superiority measures standard droplet contact aerosol precautions <NUMBER> <NUMBER> <NUMBER> even suggested use increasing layers barrier precautions without strong evidence support application makes patient care challenging could increase risk contamination lengthy complex personal protective equipment removal procedures <NUMBER> <NUMBER> application full barrier precautions reported take least <NUMBER> min ideally performed emergently <NUMBER> endotracheal intubation indicated world health organization covid<NUMBER> clinical guidelines suggest performed experienced provider using airborne precautions <NUMBER> guidelines also recommend use modality nonrebreather mask bag valve mask high flow nasal cannula noninvasive positive pressure ventilation preoxygenation <NUMBER> oxygen <NUMBER> min use rapid sequence induction possible avoid coughing need positive pressure breaths <NUMBER> additional guidelines experiential reports hubei province largely echo recommendations <NUMBER> <NUMBER> note data recent metaanalysis note benefit use high flow nasal cannula periintubation preoxygenation compared usual oxygen therapy patients hypoxemic respiratory failure <NUMBER> however high flow nasal cannula may benefit prevent severe hypoxemia intubations prolonged apneic times patients severe hypoxemia <NUMBER> see table <NUMBER> additional clinical recommendations regarding airway management intubation management covid<NUMBER>associated respiratory failure ards causes us european union recently released united kingdom ards guidelines strongly recommend use low tidal volume ventilation <NUMBER> <NUMBER> mlkg predicted body weight useuropean union guidelines less <NUMBER> mlkg united kingdom guidelines maintain plateau pressures less <NUMBER> cm h <NUMBER> <NUMBER> permissive hypercapnia <NUMBER> <NUMBER> us european union united kingdom guidelines also strongly recommend use prone positioning greater <NUMBER> h per day patients severe moderatesevere united kingdom guidelines ards recommendation echoed world health organization sarscov<NUMBER> guideline <NUMBER> <NUMBER> however prone ventilation resourceintensive intervention endotracheal tube lines may become displaced recommended sufficient human resources expertise within medical center intervention performed safely <NUMBER> world health organization guidelines management covid<NUMBER> echo united kingdom ards guidelines recommending conservative fluid management strategy patients without evidence tissue hypoperfusion <NUMBER> <NUMBER> useuropean union united kingdom ards guidelines weakly recommend use higher peep moderate severe ards united kingdom guidelines weakly recommend use neuromuscular blockade continuous infusion early moderate severe ards recent clinical trials challenge recommendations thus various components best clinical practice ards remain unclear time <NUMBER> <NUMBER> large multicenter trial patients randomized receive either conventional low peep ventilation strategy titrated peep strategy resulting high peep combined lung recruitment maneuvers found increased mortality higher peep lung recruitment maneuver arm <NUMBER> regarding use neuromuscular blockade recent multicenter randomized trial found mortality benefit use early moderate severe ards adverse cardiovascular events paralysis arm study <NUMBER> trials mind world health organization guidelines suggest cautious use higher peep moderate severe ards routine use neuromuscular blockade <NUMBER> patients refractory hypoxemia despite lung protective ventilation best practices limited data guide effectiveness use extracorporeal membrane oxygenation united kingdom ards guidelines weakly recommend consideration extracorporeal membrane oxygenation patients severe ards refractory hypoxemia although recommendation published results randomized controlled trial extracorporeal membrane oxygenation ards stopped early due lack statistically significant mortality benefit extracorporeal membrane oxygenation special section covid<NUMBER> • strict adherence universal precautions times <NUMBER> • perform practice drills familiarize providers appropriate procedures donningdoffing personal protective equipment nonemergent emergent situations • perform crisis management simulation help providers prepare intubation code blue events isolation rooms intubation • delay intubation patients worsening respiratory failure avoid emergent situations personal protective equipment must applied haste <NUMBER> • intubations either operating room icu wear least gown n<NUMBER> higher mask cap face shield gloves sources suggest powered airpurifying respirators double gloves boots coveralls <NUMBER> • using powered airpurifying respirator consider n<NUMBER> minimize risk contamination removing powered airpurifying respirator <NUMBER> • colleague personal protective equipment champion check proper personal protective equipment application entering patients room operating room • consider writing provider names gowns hoods worn make identification easier <NUMBER> • consider assembly intubation kits needed supplies advance avoid multiple entriesexits isolation room delays obtaining necessary supplies <NUMBER> • consider reviewing intubation plan providers entering patient room • minimal number experienced personnel room whenever possible <NUMBER> <NUMBER> <NUMBER> <NUMBER> • use disposable equipment whenever possible <NUMBER> • preoxygenate <NUMBER> min <NUMBER> oxygen avoid manual ventilation possible <NUMBER> • possible use rapid sequence modified rapid sequence induction avoid bag mask ventilation patient <NUMBER> • consider inserting laryngeal mask airway prolonged need mask patient anticipated <NUMBER> • rocuronium may preferred succinylcholine paralytic rapid sequence induction avoid potential paralysis wear patient cough intubation procedure prolonged <NUMBER> • attach high efficiency hydrophobic filter mask endotracheal tube bag <NUMBER> <NUMBER> • avoid awake fiberoptic intubation possible decrease patient coughing intubation <NUMBER> • use video laryngoscopy available increase distance patient intubating provider <NUMBER> • put cuff immediately intubation trachea <NUMBER> • monitor intubation success capnographyuse personal protective equipment may make auscultation stethoscope difficult impossible <NUMBER> <NUMBER> <NUMBER> • consider use ultrasound chest radiograph confirm tracheal rather bronchial intubation auscultation may difficult impossible <NUMBER> • note standard <NUMBER> sodium hypochlorite effective inactivating coronavirus <NUMBER> double concentration sodium hypochlorite <NUMBER> • clearly label rooms hot zones patients covid<NUMBER> providers know put appropriate personal protective equipment <NUMBER> • colleague personal protective equipment champion check proper personal protective equipment removal exiting patients room oxygen ventilator management • use noninvasive positive pressure ventilation high flow nasal cannula mechanical ventilation single airborne isolation rooms <NUMBER> • consider patients supplementary oxygen via nasal cannula wear surgical mask tubing <NUMBER> • consider use inline suction systems minimize suctioning possible <NUMBER> • frequently empty condensation tubing lines <NUMBER> • consider using medications dexmedetomidine lidocaine remifentanil extubation minimize coughing prepostoperative care units • designate isolated covid<NUMBER> holdingrecovery area ideally dedicated room negative pressure ventilation <NUMBER> <NUMBER> • consider requiring patients providers wear masks perioperative setting <NUMBER> • consider patients transported operating rooms wear surgical mask n<NUMBER> <NUMBER> • consider dedicated hallways patient transport routes covid<NUMBER> patients possible <NUMBER> operating room • consider dedicated operating room patients covid<NUMBER> ideally anteroom negative pressure negative pressure operating rooms work engineering turn positivepressure system <NUMBER> • consider using negative pressure isolation icu room operating room surgery necessary patient covid<NUMBER> <NUMBER> • use dedicated anesthesia machine high efficiency hydrophobic filters inspiratory expiratory limbs circuit change filters every <NUMBER> <NUMBER> h operative cases <NUMBER> • consider general anesthesia patients reduce risk coughing intubated patients wear surgical mask n<NUMBER> • minimize staff handoffs • operating room ventilator must completely cleaned use pay special attention patient chart pens phones disinfecting code blue • create modular code packs bring rooms prevent contamination code blue carts make needed equipment easily accessible isolation room emergency <NUMBER> • consider implementing special designation protected code blue distinguish code blue patient covid<NUMBER> code events <NUMBER> • designated protected code blue coach makes sure care providers entering exiting room follow safe dondoff procedures personal protective equipment <NUMBER> perioperative clinic • case epidemic consider screening preoperative patients fever sending ill febrile emergency room home appropriate • consider providers use contact droplet potentially aerosol transmission precautions seeing patients preoperative clinic group medical management group <NUMBER> <NUMBER> <NUMBER> however reanalysis data trial well metaanalysis incorporating new trial data suggest extracorporeal membrane oxygenation may provide mortality benefit patients severe ards <NUMBER> small casecontrol series middle east respiratory syndromerelated coronavirus outbreak use extracorporeal membrane oxygenation refractory hypoxemia associated lower inhospital mortality <NUMBER> considering data may reasonable refer covid<NUMBER> patients refractory hypoxemia despite lung protective ventilation extracorporeal membrane oxygenation centers expertise resources properly manage complex patients <NUMBER> <NUMBER> patients covid<NUMBER>associated respiratory failure develop superimposed septic shock adherence standard sepsis treatment protocols advised <NUMBER> additional nonevidencebased recommendations management covid<NUMBER>associated respiratory failure promulgated variety guidelines published sources largely focusing minimizing viral spread healthcare workers environment recommendations include minimizing ventilator disconnections use inline catheters airway suction <NUMBER> using high efficiency hydrophobic filter patient breathing circuit <NUMBER> <NUMBER> avoiding use nebulized medications favor metered dose inhalers bronchodilators indicated <NUMBER> collected list practical recommendations guide anesthetic critical care management covid<NUMBER> patients found table <NUMBER> table <NUMBER> provides list organizations offering updated guidelines resources providers caring patients covid<NUMBER> drugs specifically approved treatment covid<NUMBER> multiple ongoing clinical trials number drugs show promise sarscov<NUMBER> rna virus like human immunodeficiency virus hiv ebola molecules developed rna viruses may useful targets fig <NUMBER> particular remdesivir nucleotide analog developed use ebola infection drug inhibits rnadependent rna polymerase used coronavirions replicate genome <NUMBER> based vitro evidence effectiveness manufacturer initiated two phase <NUMBER> clinical trials use remdesivir covid<NUMBER> trial nos nct<NUMBER> nct<NUMBER> similar trials severe moderate cases covid<NUMBER> underway china trial nos nct<NUMBER> nct<NUMBER> remdesivir also initial treatment arm adaptive clinical trial sponsored national institute allergy infectious diseases trial nct<NUMBER> adaptive trial actively modified add novel drugs interest replace control arm current best supported regimen interestingly antimalaria drug chloroquine also shown inhibit sarscov<NUMBER> micromolar concentrations agent blocks virus infection entry postentry stages used therapeutic prophylactic regimens <NUMBER> yr safety profile including prominent neurologic gastrointestinal side effects well known <NUMBER> among possible mechanisms action altering ph endosomes directly modifying angiotensin converting enzyme<NUMBER> <NUMBER> compared historical control cohort sarscov<NUMBER> patients treated combination lopinavirritonavir significantly lower risk ards death <NUMBER> combination lopinavirritonavir used covid<NUMBER> cases well based sars data vitro effectiveness <NUMBER> <NUMBER> however clinical effectiveness remains unproven providers cognizant known side effect profile medication monitor hepatotoxicity hyperglycemia arrythmias <NUMBER> ongoing clinical trial comparing patients randomized lopinavirritonavir viral fusion inhibitor arbidol trial nct<NUMBER> optimal regimen remains determined affected patients consider enrolling clinical trials whenever available world health organization centers disease control prevention recommendations <NUMBER> discourage use corticosteroids given risk precipitating infectious noninfectious complications secondary bacterial infections hyperglycemia middle east respiratory syndromerelated coronavirus patients steroid therapy associated delayed viral clearance improvement survival <NUMBER> however difficult account bias sicker patients likely receive steroids ards despite multiple randomized controlled studies corticosteroids benefits corticosteroids remain equivocal <NUMBER> likely benefits greater select ards patients early disease course superimposed septic shock <NUMBER> covid<NUMBER> patients multiple distinct radiologic patterns diffuse ground glass reticulation consolidation suggestive pneumonitis diffuse alveolar damage organizing pneumonia <NUMBER> cryptogenic organizing pneumonia steroid administration suggested prevent progression hypoxemic respiratory failure case series <NUMBER> time requirement steroids shown less relevant organizing pneumonia identified cause covid<NUMBER> <NUMBER> compared steroids patients treated macrolides mild cryptogenic organizing pneumonia also demonstrated symptom resolution albeit higher relapse rates <NUMBER> case series covid<NUMBER> patients steroids macrolides commonly used lack data effectiveness <NUMBER> <NUMBER> retrospective analysis could confounded indication steroid therapy associated decreased risk death patients ards covid<NUMBER> <NUMBER> specific studies covid<NUMBER> patients needed determine whether corticosteroids macrolides could beneficial subset patients organizing pneumonia patterns face rapidly emerging global threat several reasons optimism future control described number antiviral drugs shown promise vitro even partially effective antiviral could allow sufficient reduction viral load immune system recover respond prevent lethal disease even potential antivirals could used chemoprophylaxis prevent transmission recently exposed individuals resistance antivirals developed quickly patients hiv studies coronaviruses suggest might less problem <NUMBER> similarly hiv readily evades cellular humoral immunity sharply limiting vaccination approaches <NUMBER> sarscov infection appeared induce broad longlasting immunity less evidence immune escape <NUMBER> thus likely covid<NUMBER> evolves physicians variety therapeutic vaccination options minimize morbidity mortality arrive anesthesiologists called upon provide supportive care minimizing risk viral transmission others severity symptoms variable categorized mild severe critical mild cases included nonpneumonia mild pneumonia cases severe characterized dyspnea respiratory frequency ≥ <NUMBER>minute blood oxygen saturation ≤ <NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> within <NUMBER> hours critical cases exhibited respiratory failure septic shock andor multiple organ dysfunctionfailure <NUMBER> medians interquartile ranges calculated summaries continuous variables categorical variables percentages patients category determined poor outcome defined earliest death time death investigated using survival analysis follow starting hospital admission ending <NUMBER> february <NUMBER> primary end point death patients censored end end follow still alive mortality kaplanmeier method used timetodeath plot comparisons groups timetodeath data made using cox proportional hazards model multivariate cox proportional hazards model used analyze independent risk factors mortality three variables age onset dyspnea presence comorbidities method used identify risk factors adverse outcomes spss version <NUMBER> used statistical analyses p value less <NUMBER> considered statistically significant initial study cohort comprised <NUMBER> elder patients five patients contracted j u r n l p r e p r f <NUMBER> covid<NUMBER> hospital prolonged stay began well median time onset symptoms admission <NUMBER> days <NUMBER> days iqr time selfreported earliest known exposure onset symptoms <NUMBER>days <NUMBER>days prodrome fatigue myalgia <NUMBER> days <NUMBER> days selfreported fever <NUMBER> days <NUMBER> days diarrhea <NUMBER> days <NUMBER> days cough dyspnea laboratory data admission shown table <NUMBER> univariate cox proportional hazards model showed mortality risk <NUMBER> times aged <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> p<NUMBER> every <NUMBER> years increase age risk death increased <NUMBER> however difference proportion men women mortality initial state covid<NUMBER> admission closely associated mortality elderly severe critical cases associated increased mortality risk <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER>the presence comorbidities increased mortality risk hazards ratio hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> copd hr <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> p <NUMBER> chronic renal failure hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> important comorbidities table <NUMBER> presence cardiovascular disease increased mortality <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> similar hypertension increased mortality <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER>figure <NUMBER>other j u r n l p r e p r f <NUMBER> comorbidities factors cancer diabetes mellitus significant effects mortality addition onset dyspnea admission increased mortality risk hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> leucocytosis neutrophilia ph values ckmb levels ultratni ddimer albumin procalcitonin partial pressure carbon dioxide partial pressure oxygen oxygen saturation also associated death conducted cohort <NUMBER> elder patients <NUMBER> years hospitalized covid<NUMBER> wuhan china observed similar clinical features recently reported covid<NUMBER> common symptoms fever cough dyspnea fever first symptom reported many patients <NUMBER> onset dyspnea might help physicians identify patients poor prognosis<NUMBER> patients classified severe even critical cases admission overall rate serious illness higher reported previous studies addition significant portion patients showed bilateral infiltrate chest radiograph results admission univariate analysis showed age <NUMBER> years older comorbidity hypertension j u r n l p r e p r f cardiovascular disease copd chronic renal failure onset dyspnea several laboratory indices abnormalities associated poor outcome multivariable cox proportional hazards model dyspnea older age neutrophilia elevated ultratni independently associated poor outcomes study reported <NUMBER> death covid<NUMBER> patients pulmonary consolidation hypoxemia difficult recover clinical characteristics patients indicated age underlying diseases important risk factors death every <NUMBER> years increase age risk death increased <NUMBER> common underlying disease hypertension followed cardiovascular disease diabetes copd malignant tumors kidney disease effects age comorbidities also addressed cohorts patients covid<NUMBER> <NUMBER> presence cancer diabetes mellitus related higher mortality rate adverse outcome studies <NUMBER> could predispose superimposed nosocomial pneumonia due staphylococcus aureus agents already critically ill patients although observed patients however presence copd chronic renal failure cardiovascular disease hypertension related higher mortality rate data patients underlying disease lung heart kidney vulnerable severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> likely angiotensin converting enzyme ii ace<NUMBER> protein abundant expression many kinds cells renal tubular epithelial cells alveolar epithelial cells heart artery smooth muscle cells <NUMBER> coronavirus threedimensional structure spike j u r n l p r e p r f protein closely bound human cell receptor ace<NUMBER> therefore cells ace<NUMBER> expression may act target cells susceptible covid<NUMBER> infection type ii alveolar cells at<NUMBER> lung <NUMBER> terms laboratory tests count lymphocytes patients reduced result suggests covid<NUMBER> viral disease characterized decreased lymphocyte count like recently reported <NUMBER> <NUMBER> <NUMBER> although lymphopenia commonly observed absolute lymphocyte count associated poor outcome study patients albumin levels <NUMBER> hemoglobin levels decreased indicates malnutrition common elderly patients elevated alanine aminotransferase aspartate aminotransferase levels prevalent admission cohort high levels ddimer found half patients infection findings quite different associated pneumonia caused common bacterial pathogens similar previously observed patients sarscov infection <NUMBER> <NUMBER> routine blood test pct used reflect changes inflammatory response covid<NUMBER> increased white blood cell neutrophils count observed <NUMBER> <NUMBER> patients particular high neutrophil count independent predictor poor outcome neutrophilia observed cytokine storm induced virus infection <NUMBER> <NUMBER> <NUMBER> study betsy et al autopsy showed neutrophils infiltrating lung context cytokine storm triggered ards caused organ damage mortality covidwhich seriously damage lung function resulted dyspnea acute respiratory failure fluid builds air sacs lungs elevated levels ultratni commonly seen covid<NUMBER> cardiac complications common patients pneumonia cohort high level ultratni another independent predictor poor outcome present understanding human cardiovascular response infections including pneumonia derived mainly studies critically ill patients septic shock <NUMBER> research needed investigate pathogenesis sepsis covid<NUMBER> illness largest case series date covid<NUMBER> total <NUMBER> deaths occurred among <NUMBER> confirmed cases overall case fatality rate <NUMBER> <NUMBER> ≥<NUMBER> age group highest case fatality rate age groups <NUMBER> however case series≥ <NUMBER> years old age group case fatality rate <NUMBER> much higher possible explanation cases cohort stage epidemic outbreak patients isolated home without medical support due lack inpatient beds hospital twothird patients studies received empirical therapy hospital ten days admission covid<NUMBER> illness mild severe moreover case fatality rate unsurprisingly highest among critical cases <NUMBER> however difficult calculate true mortality rate disease epidemic continuing impossible ascertain remaining patients eventually die discharged specific antiviral treatment recommended coronavirus j u r n l p r e p r f infection infected older patients harder treat without supportive care currently approaches control disease prevent sources use personal protective equipment reduce transmission early diagnosis isolation supportive treatments study suggests elderly patients covid<NUMBER> rapid course disease higher case fatality ratio severe cases admission often subjected higher death rates according current diagnostic criteria viral nucleic acid test results confirmed rtpcr assay play vital role determining whether hospitalize patient overall sensitivity rtpcr test coronavirus patients <NUMBER> <NUMBER> needs improved might affected sample quality methods obtaining samples well viral load early diagnosis supportive care hospital great importance elderly covid<NUMBER> patients elderly patient acute dyspnea seek medical attention immediately results study must interpreted caution research subject several limitations retrospective case series study based data medical records clinical notes patient charts accordingly certain information missing various patients certain data may based patient memory details concerning exposure history timing onset symptoms maybe affected recall bias laboratory tests done patients laboratory parameter documented studies finally effort quickly disseminate information clinicians worldwide assessed shortterm outcomes followup evaluation determine longterm repercussions late december <NUMBER> china reported outbreak viral pneumonia wuhan hubei province china spread rapidly areas <NUMBER> <NUMBER> revealed causative agent cluster acute respiratory illness rna enveloped beta coronavirus sarbecovirus subgenus coronaviridaes family termed novel coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> counts third outbreak betacoronaviruses twentyfirst century causing public health crisis global concern <NUMBER> <NUMBER> previous outbreaks viral family described <NUMBER> <NUMBER> former respiratory disease identified severe acute respiratory syndrome coronavirus sarscov involving <NUMBER> countries latter known middle east respiratory syndrome coronavirus merscov affected <NUMBER> countries overall mortality rate two epidemics sarscov merscov <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> global concern become significant health problem since number infected cases affected countries escalated rapidly <NUMBER> march <NUMBER> <NUMBER> world health organization confirmed covid<NUMBER> pandemic march <NUMBER> <NUMBER> <NUMBER> cases covid reported death toll <NUMBER> patients around <NUMBER> recovered cases <NUMBER> countries territories worldwide among topranking countries iran placed seventh position <NUMBER> confirmed cases <NUMBER> deaths around <NUMBER> recovered cases <NUMBER> <NUMBER> however actual number cases may much higher challenges confirming cases due limited pcr diagnostic test kits available staff hospitals based literature incubation period disease could <NUMBER> days <NUMBER> cases mild symptoms fever cough sore throat myalgia however cases present severe conditions multiple organ failure acute respiratory distress syndrome pulmonary edema pneumonia <NUMBER> <NUMBER> <NUMBER> based radiological findings previous studies frequent ct findings included bilateral pulmonary parenchymal groundglass consolidative pulmonary opacities occasionally rounded morphology peripheral lung distribution <NUMBER> <NUMBER> respect laboratory data decrease absolute value lymphocytes patients found <NUMBER> indicating virus may mainly act lymphocytes especially tcells damage lymphocytes primary factor resulting exacerbations patients <NUMBER> clinical practice low absolute value lymphocytes could assist reference index diagnosing new cases coronavirus infections due severity disease <NUMBER> critical patients mortality rate <NUMBER> covid<NUMBER> global health emergency <NUMBER> therefore early detection appropriate treatment critical cases essential importance present lack information regarding epidemiology clinical features covid<NUMBER> patients middle east especially iran country considered one important focal points disease throughout world therefore study conducted evaluate clinical features covid<NUMBER> patients fars province southern iran center control prevention <NUMBER> novel coronavirus disease covid<NUMBER> established february <NUMBER> <NUMBER> monitor spread covid<NUMBER> fars province irans fourth populated province center assigned provide services five hospitals affiliated shiraz university medical sciences approach disease based iran national health guidelines adapted guidelines latest studies covid<NUMBER> <NUMBER> incubation period covid<NUMBER> defined time exposure onset illness based reports china world assumed <NUMBER> <NUMBER> days patient symptoms fever rhinorrhea cough sore throat possibly respiratory distress defined suspected covid<NUMBER> especially positive history close contact highly suspected confirmed covid<NUMBER> patient travel history covid<NUMBER> affected country city <NUMBER> confirmed covid<NUMBER> cases admitted quarantined centers allocated covid<NUMBER> diagnosis management shiraz university medical sciences severity disease based american thoracic society guidelines communityacquired pneumonia severe nonsevere similar studies <NUMBER> <NUMBER> research reference intensive care unit icu nonicu admission epidemiological clinical including clinical records laboratory data well data regarding chest high resolution ct hrct scans data confirmed covid<NUMBER> patients february <NUMBER> <NUMBER> march <NUMBER> <NUMBER> allocated centers covid<NUMBER> diagnosis management shiraz university medical sciences collected data recruited consecutively available patients also extracted hospital records cases discharged patients physical examinations performed solo physician furthermore primary chest ct scan reviewed independently unaccompanied trained specialized radiologist blind primary impression clinical symptoms patients outcome ethics committee shiraz university medical sciences approved current study ethical code number irsumsrec<NUMBER> confidentiality patient information guaranteed protected recording birth date gender marital status occupation comorbid disease goal study explained patients written informed consents obtained realtime reverse transcriptasepolymerase chain reaction rtpcr used confirm suspected cases rtpcr assays performed following protocol established <NUMBER> nasopharyngeal oropharyngeal swab samples collected tested sarscov<NUMBER> patient biosafety cabinet according laboratory biosafety guidelines rnas extracted using qiaamp™ viral rna mini kit qiagen™ according manufacturers instructions egene rdrpgene probeprimer superscript™ iii platinum onestep qrtpcr kit invitrogen company mixtures prepared mixtures transferred roche light cycler™ <NUMBER> applied biosystem abi step one plus™ real time thermal cyclers positive control template control ntc well internal control <NUMBER> cycles produced graphs observed rise noise cycle <NUMBER> considered positive sarscov <NUMBER> <NUMBER> <NUMBER> collected data summarized means ±sd standard deviation medians interquartile ranges particular variables percentage patients group calculated unpaired students ttest chisquare test fishers exact test used compare clinical characteristics covid<NUMBER> patients appropriate p value less <NUMBER> considered indicating statistical significance statistical analyses performed statistical package social sciences spss inc chicago illinois usa version <NUMBER> study population consisted <NUMBER> confirmed covid<NUMBER> cases mean age <NUMBER> years sd <NUMBER> range <NUMBER> patients consisted <NUMBER> <NUMBER> males <NUMBER> <NUMBER> females among patients study <NUMBER> <NUMBER> admitted intensive care units due severity disease average time initiation symptoms hospital admission <NUMBER> days average duration hospitalization <NUMBER> days average number days start symptoms development dyspnea progression acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> days respectively among patients study <NUMBER> <NUMBER> one coexisting medical conditions alongside covid<NUMBER> frequent hypertension <NUMBER> <NUMBER> diabetes <NUMBER> <NUMBER> cardiovascular diseases <NUMBER> <NUMBER> table <NUMBER> among hospitalized patients common symptoms onset disease fatigue <NUMBER> cough <NUMBER> fever <NUMBER> less common hemoptysis <NUMBER> conjunctival congestion <NUMBER> table <NUMBER> based patients vital signs admission <NUMBER> <NUMBER> patients fever also <NUMBER> <NUMBER> elevated heart rates <NUMBER>min <NUMBER> <NUMBER> elevated respiratory rate <NUMBER>min <NUMBER> <NUMBER> elevated blood pressure admission values differ severe nonsevere patients lower among deceased patients although significant oxygen saturation patients also measured admission showed <NUMBER> <NUMBER> patients <NUMBER> saturation less <NUMBER> also mean saturation <NUMBER> significantly lower among icu admitted patients p <NUMBER> also significantly lower among deceased patients p <NUMBER> table <NUMBER> terms lung examinations seven patients <NUMBER> significant rales significantly correlated severity disease among signs infection common throat congestion <NUMBER> <NUMBER> swelling tonsils <NUMBER> table <NUMBER> numerous variations laboratory findings seen among severe nonsevere well deceased living patients table <NUMBER> icu admitted patients significantly higher lymphocyte count nonicu patients although correlation significant mortality rate patients study severe group deceased group higher levels white blood cells neutrophil count although lower levels hemoglobin hematocrit platelet count detected compared nonsevere living groups differences statistically significant based coagulation tests significantly higher international normalized ratio inr levels prolonged partial thromboplastin time ptt among severe nonsevere group p <NUMBER> however significance finding among deceased group valid inr p <NUMBER> among biochemical tests severe group showed higher blood urea nitrogen bun creatinine aspartate aminotransferase ast c reactive protein erythrocyte sedimentation rate esr compared nonsevere group although significant table <NUMBER> neutrophil lymphocyte ratio nlr calculated compared based severity mortality patients study results showed significantly higher nlr among icu admitted group severe group expired group p <NUMBER> <NUMBER> respectively difference also significant among patients <NUMBER> years age p <NUMBER> <NUMBER> however average nlr among patients <NUMBER> years icu admission <NUMBER> radiological evaluation revealed <NUMBER> <NUMBER> patients normal ct scans none among severe mortality group patients dominantly male <NUMBER> <NUMBER> years age although significant correlation achieved gender age normal ct finding common abnormality groundglass opacity <NUMBER> <NUMBER> followed consolidation <NUMBER> <NUMBER> also radiological findings crazy paving significantly frequent nonsevere living patients p <NUMBER> table <NUMBER> fig <NUMBER> main treatments initiated patients consisted antiviral therapy <NUMBER> <NUMBER> antibiotic therapy <NUMBER> <NUMBER> corticosteroid <NUMBER> <NUMBER> also based oxygen support administered patients majority nonsevere patients used nasal cannula <NUMBER> addition severe cases modalities invasive mechanical ventilation noninvasive ventilation high flow masks used according condition patients study patients using invasive mechanical ventilation significantly higher mortality study p <NUMBER> table <NUMBER> based prognosis disease overall <NUMBER> mortality rate documented among patients study majority among icu admitted patients <NUMBER> <NUMBER> also <NUMBER> <NUMBER> patients achieved total recovery <NUMBER> <NUMBER> discharged followup home isolation based results study march <NUMBER> <NUMBER> total number <NUMBER> patients admitted shiraz hospitals capital fars province iran diagnosis covid<NUMBER> mean age hospitalized patients <NUMBER> years old male female ratio <NUMBER> patients <NUMBER> <NUMBER> still hospitalized <NUMBER> <NUMBER> discharged <NUMBER> <NUMBER> discharged outpatient treatment <NUMBER> <NUMBER> died <NUMBER> <NUMBER> cases admitted icu due severity disease virological findings indicated asian populations may potentially susceptible covid<NUMBER> races <NUMBER> <NUMBER> <NUMBER> chan et al confirmed persontoperson transmission virus <NUMBER> results showed covid<NUMBER> infects men women findings consistent findings previous studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> early reports china susceptibility men contracting disease believed relationship link seafood market workers men <NUMBER> nevertheless disease spread countries throughout world theory weakened men also susceptible disease countries several theories proposed respect li et al reported male female ratio attributed role sex hormones protection x chromosome plays essential role adaptive innate immunity <NUMBER> however may assumed due iranian culture men tend person person contact work outside house women usually stay home household chores taking patients age consideration patients severe conditions aged <NUMBER> years comorbid diseases hypertension diabetes aligned data previously reported <NUMBER> <NUMBER> fang et al described theory stating since coronavirus binds target angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed epithelial cells kidney lung blood vessels infection facilitate increased risk developing severe covid<NUMBER> individuals take ace inhibitors angiotensin ii typei receptor blockers arbs also among diabetic patients tend increase ace<NUMBER> expression <NUMBER> <NUMBER> <NUMBER> putting aside typical symptoms fever cough myalgia <NUMBER> <NUMBER> <NUMBER> data revealed many patients presented atypical symptoms abdominal pain diarrhea nausea vomiting vertigo study carried lechien et al <NUMBER> europe headache loss smell rhinorrhea nasal obstruction among common symptoms patients following typical symptoms moreover spinato et al <NUMBER> however due design study incomplete hospital records data collected study data suggest aside focus typical symptoms atypical presentations disease must kept mind patients developed gastrointestinal symptoms observed earlier diagnosis facilitated prevention spread disease moreover differences presentation virus might due alterations virus genotype level expression virus receptors including ace<NUMBER> necessitates studies evaluation based data lower <NUMBER> saturation admission presented rales physical examination significantly associated severely ill achieving poorer prognosis furthermore severely ill lower heart rates blood pressure findings explained theory coronavirus affects respiratory system also cardiovascular system based published studies covid<NUMBER> patients high levels myocardial injury biomarkers blood samples <NUMBER> <NUMBER> furthermore zheng et al stated myocardial injury might related ace<NUMBER> widely expressed cardiovascular system well respiratory system <NUMBER> terms laboratory data abnormalities included leukocytosis <NUMBER> lymphopenia <NUMBER> thrombocytopenia <NUMBER> pt ptt <NUMBER> <NUMBER> seen patients patients severe conditions higher increases c reactive protein esr levels died higher levels lactate dehydrogenase furthermore severe cases covid<NUMBER> laboratory abnormalities admitted general wards results reported previous studies except fact number cases lymphopenia study lower studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> worth mentioning study nlr ratio significantly higher admitted icu died average level nlr patients higher <NUMBER> therefore assume higher cut approach covid<NUMBER> patients based nlr ratio might beneficial lie et al reported appropriate cutoff <NUMBER> <NUMBER> overall results laboratory data suggest novel coronavirus infection associated activation immune system responses impact lymphocytes activation coagulation cascade thus studies area beneficial treatment covid<NUMBER> based data <NUMBER> <NUMBER> patients <NUMBER> years old severely ill normal chest ct scans hu et al also reported <NUMBER> younger asymptomatic patients study normal radiologic findings <NUMBER> abnormal radiologic findings consisted groundglass opacities consolidation crazy paving presented mostly lungs peripheral areas data consistent publications suggest ct scan play crucial role diagnosis evaluation severity disease <NUMBER> <NUMBER> <NUMBER> fatality rate patients included current study <NUMBER> quite near national mortality rate iran reported <NUMBER> based documented covid<NUMBER> patients significantly higher fig <NUMBER> axial ct scans <NUMBER> yearold male selected cut noncontrast chest ct lung window sub pleural crescentshaped groundglass opacities well smooth interlobular septal thickening seen lungs involving mostly peripheral zone b axial ct scans <NUMBER> yearold male selected image noncontrast chest ct scans lung window extensive consolidation seen lower lobes air bronchograms c axial ct scans <NUMBER> yearold male level carina c day <NUMBER> symptom onset patchy consolidation affecting bilateral peripheral lung parenchyma day <NUMBER> expansion consolidation lungs well ground glass opacities right side e axial ct scans <NUMBER> yearold male selected image noncontrast chest ct scans lung window mixed consolidation ground glass opacities seen lower lobes right middle lobe lingula left upper lobe f g axial ct scans <NUMBER> yearold male selected image noncontrast chest ct scans lung window f day <NUMBER> symptom onset ground glass opacities lower lobe associated mal focus consolidation g day <NUMBER> expansion consolidation lungs well ggo right middle lobe black arrow mild pleural effusion seen bilaterally yellow arrows h axial ct scans <NUMBER>year old female selected image noncontrast chest ct scans lung window multiple patchy consolidation lower lobe axial ct scans <NUMBER> yearold male selected image noncontrast chest ct scans lung window crazypaving pattern ggo superimposed interand intralobular septal thickening seen bilaterally j axial ct scans <NUMBER> yearold male selected image noncontrast chest ct scans lung window groundglass opacities affecting bilateral lung field reverse halo sign groundglass opacity surrounded denser consolidation crescentic shape left lower lobe arrow pleural effusion seen bilaterally compared studies china <NUMBER> <NUMBER> <NUMBER> although reported higher equal mortality rate hospitalized patients <NUMBER> <NUMBER> given china history sars outbreak <NUMBER> able successfully control disease help previous experience appropriate leadership inadequate awareness towards disease early stages lack medical protection high infectivity virus lack treatment measures iran led rapid increase number patients mortality rate <NUMBER> moreover since developed mild symptoms seek medical treatment actual mortality rate society might even lower controlling source infection taking preventive measures early diagnosis isolation suspicious cases supportive care taken consideration cease spread virus although many randomized controlled trials initiated around world specific treatment vaccine yet proposed covid<NUMBER> antiviral antibiotic therapies used treat covid<NUMBER> however none found properly beneficial <NUMBER> <NUMBER> present study patients received antiviral therapy except one received antibiotic treatment <NUMBER> cases <NUMBER> received corticosteroids hospitalbased study study limitations firstly encountered missing data variations patients documents two hospitals due limited time shortage trained medical staff secondly patients still admitted hospital time writing manuscript could affected outcome results thirdly due limited number patients given fact patients mild symptoms hospitalized included study communitybased studies justified explore clarify different aspects disease iran one important focal points disease multicenter case series <NUMBER> hospitalized patients <NUMBER> mortality rate covid<NUMBER> patients south iran reported patients developed atypical symptoms time admission makes diagnosis difficult finding source infection studying behavior covid<NUMBER> crucial understanding pandemic furthermore early diagnosis improving detection methods timely isolation proper treatment key factors fighting infection coronaviruses rna viruses may infect respiratory gastrointestinal hepatic central nervous systems humans livestock species avian species many mammals wild animals <NUMBER> humans infection four coronaviruses namely hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> usually lead mild selflimiting upper respiratory tract infections <NUMBER> however coronaviruses associated severe acute respiratory syndrome sars middle east respiratory syndrome mers may cause severe respiratory disease caused total <NUMBER> laboratoryconfirmed cases globally past two decades <NUMBER> <NUMBER> casefatality rate respectively <NUMBER> <NUMBER> december <NUMBER> novel coronavirus <NUMBER> novel coronavirus <NUMBER>ncov emerged wuhan hubei china clinical manifestations humans resembling viral pneumonia <NUMBER> february <NUMBER> <NUMBER> <NUMBER> confirmed cases identified china <NUMBER> deaths worryingly <NUMBER> confirmed cases coronavirus disease <NUMBER> covid <NUMBER> identified outside china <NUMBER> symptoms infection nonspecific include fever cough myalgia <NUMBER> diarrhea without subsequent development dyspnea <NUMBER> severe cases respiratory distress sepsis septic shock reported <NUMBER> sars epidemic <NUMBER> therapeutic systemic glucocorticoids widely administered patients infected severe acute respiratory syndrome coronavirus sarscov subsequently developed severe respiratory disease one cohort study patients sars outbreak showed use pulsed highdose methylprednisolone associated clinical improvement patients sars <NUMBER> another study <NUMBER> patients sars certain cytokine levels interleukin<NUMBER> monocyte chemoattractant protein<NUMBER> th<NUMBER> chemokine interferonginducible protein<NUMBER> found reduced <NUMBER> <NUMBER> days glucocorticoid therapy <NUMBER> however previous retrospective study indicated pulsed doses methylprednisolone risk factor associated increased <NUMBER>day mortality adjusted odds ratio <NUMBER> <NUMBER> confidence interval <NUMBER> p <NUMBER> <NUMBER> addition retrospective observational study found glucocorticoid therapy patients mers associated delayed middle east respiratory syndrome coronavirus merscov rna clearance <NUMBER> clinical therapeutic effects systemic glucocorticoid therapy patients covid<NUMBER> currently clear case use systemic glucocorticoids severe cases covid<NUMBER> warrants investigation study proposes investigate effectiveness glucocorticoid therapy patients severe covid<NUMBER> major objective observe whether clinical necessity therapeutic justification use systemic glucocorticoids patients severe covid<NUMBER> study approved ethics committee chongqing public health medical center <NUMBER>ky publish results study medical journals conclusion study patient names appear published articles access data may obtained exception researchers members hospital ethics committee study conducted openlabeled randomized controlled trial enroll <NUMBER> subjects chongqing public health medical center study protocol written devised accordance standard protocol items recommendations interventional trials statement <NUMBER> enrolment intervention assessment processes described figure <NUMBER> obtaining informed consent subjects group invited <NUMBER> days followup scheduled four consecutive visit points table <NUMBER> blood urine samples collected laboratory testing including hematologic analysis urinalysis clinical chemistry studies electrolytes coagulation testing myocardial enzymes creactive protein erythrocyte sedimentation rate procalcitonin cluster differentiation <NUMBER> cd<NUMBER> cell counts cd<NUMBER> cell counts blood gas analysis <NUMBER>ncov realtime reverse transcriptionpolymerase chain reaction rtpcr items considered tested followup period listed table <NUMBER> adverse events aes defined undesirable outcomes experienced patients study whether related treatment glucocorticoids aes described patients observed medical team duly documented serious aes documented detail investigators notified soon possible aes recorded clinical history patient case report form appropriate medical terminology aes expeditiously resolved shortterm glucocorticoid therapy usually causes mild side effects including hypokalemia glucose intolerance hypertension pancreatitis cutaneous hematologic immunologic neuropsychologic effects <NUMBER> mild side effects reversible upon discontinuation glucocorticoids side effects associated longterm glucocorticoid use considered relevant study short duration glucocorticoids prescribed study <NUMBER> days diagnosis severe covid<NUMBER> subjects meet following criteria <NUMBER> <NUMBER> identification <NUMBER>ncov via rtpcr blood samples sputum samples bronchoalveolar lavage fluid nasopharyngeal swab samples <NUMBER> least one following conditions respiratory distress ≥<NUMBER> timesmin b oxygen saturation <NUMBER> rest c arterial partial pressure oxygen pao <NUMBER> fraction inspiration <NUMBER> fio <NUMBER> <NUMBER> mmhg <NUMBER> mmhg <NUMBER> kpa respiratory failure requiring mechanical ventilation e septic shock development f critical organ failure requiring intensive care unit care subjects included study satisfy following criteria <NUMBER> aged <NUMBER> years <NUMBER> severe covid<NUMBER> <NUMBER> willing give informed consent subjects excluded study satisfy following criteria <NUMBER> allergic intolerant therapeutic drugs used study <NUMBER> pregnant lactating women <NUMBER> presence severe systemic illness may affect effectiveness safety evaluation study microsoft excel <NUMBER> microsoft corporation redmond wa usa used generate random numbers subject consent eligibility confirmed investigators designers randomize subjects control group intervention group <NUMBER> ratio results recorded entered twice independently data documented case report forms immediately recorded excel database missing values verified ensure completeness accuracy data much possible data obviously abnormal beyond upper limit normal laboratory items exceeding <NUMBER> normal value must explained necessary explanation must given physician dropouts aes recorded timely manner drugs used trial supplied stored distributed recycled according relevant regulations data lock record signed principal researcher sponsor statistical analyst data manager data administrator perform database lock subjects receive conventional treatment covid<NUMBER> according guidelines diagnosis treatment covid<NUMBER> version <NUMBER> patients randomized intervention group receive methylprednisolone intravenous injection <NUMBER> mgkgday <NUMBER> days whereas control group receive glucocorticoid therapy discontinuation regimen may occur participants substantial improvement full course treatment subjects whose clinical condition deteriorate course treatment primary endpoint change sequential organ failure assessment sofa <NUMBER> days randomization <NUMBER> secondary endpoints proportion mechanical ventilation use <NUMBER> <NUMBER> weeks mortality <NUMBER> <NUMBER> weeks duration hospitalization trial randomized controlled trial two parallel groups without masking <NUMBER> allocation ratio randomized controlled trials evaluated changes sofa scores patients <NUMBER>ncov infection without glucocorticoid therapy samplesize calculation based primary hypothesis detecting reduction <NUMBER> sofa scores treatment nontreatment groups <NUMBER> days glucocorticoid therapy pass software version <NUMBER> ncss llc kaysville ut usa used power <NUMBER> level <NUMBER> confidence considering dropout rate <NUMBER> sample size estimated <NUMBER> cases group randomized controlled trial <NUMBER> aimed compare plasma sarscov rna concentrations patients early hydrocortisonetreated group patients placebo group <NUMBER> study enrolled total <NUMBER> subjects conducted end sars outbreak fewer appropriate patients available recruited taking account uncertainty duration outbreak final sample size may adjusted unlike wuhan chongqing currently relatively small number confirmed cases covid<NUMBER> even smaller number severe cases covid<NUMBER> hoped eventually recruit cohort <NUMBER> patients study may settle even smaller cohort suitable subjects available primary outcome analysis presented intervention group control group using descriptive statistics normality data distribution evaluated kolmogorovsmirnov test continuous variables described mean values standard deviation mean ± standard deviation analyzed using test independent samples categorical variables analyzed using chisquared test fishers exact test verify magnitude difference relative risk success estimated intervention group control group confidence interval set <NUMBER> values p <NUMBER> considered statistically significance analyses performed using spss software version <NUMBER> spss inc chicago il usa since <NUMBER>ncov first reported december <NUMBER> <NUMBER> attracted global attention owing similarity sarscov merscov causing fatal respiratory disease potential propagating largescale human infection economic disruption systemic glucocorticoid therapy could considered critically ill patients covid<NUMBER> impact clinical outcomes uncertain <NUMBER> available data systemic glucocorticoid therapy among coronavirusinfected patients mainly comes studies patients sars mers whether glucocorticoid therapy definitively beneficial clinical management two coronavirus infections still debated <NUMBER> <NUMBER> <NUMBER> glucocorticoid therapy used treatment severe sars early anecdotal experience supported radiologic findings histologic features critically ill patients sars similar patients acute respiratory distress syndrome ards <NUMBER> <NUMBER> <NUMBER> <NUMBER> early march <NUMBER> china first summarized experience management sars suggested highdose glucocorticoids used patients fever persisting <NUMBER> days radiologic findings suggestive persistent lung involvement progressive deterioration <NUMBER> three different regimens used physicians hong kong china including methylprednisolone <NUMBER> mgkg qid <NUMBER> mgkg tid iv followed oral prednisolone varying periods disparate dosages per clinical evaluation hydrocortisone <NUMBER> mgkg qid <NUMBER> mgkg tid iv followed oral prednisolone varying periods doses per clinical evaluation pulsed methylprednisolone <NUMBER> mg iv daily <NUMBER> days followed maintenance oral prednisolone <NUMBER> mg bid reduced <NUMBER> mg daily day <NUMBER> per clinical evaluation <NUMBER> suggested glucocorticoid therapeutic doses sars outbreak high approximating treatment doses acute severe asthma prescribed doses similar prescribed organ rejection transplant patients ards <NUMBER> one study compared pulsed glucocorticoid therapy methylprednisolone ≥<NUMBER> mgday nonpulsed glucocorticoid methylprednisolone <NUMBER> mgday therapy finding pulsed glucocorticoid therapy appeared efficacious patients using pulsed glucocorticoid therapy lower oxygen requirements better radiographic outcomes decreased likelihood requiring rescue unfortunately stated study randomized controlled trial thus open possibility bias impact outcomes <NUMBER> however also staunch advocates using systemic glucocorticoids patients one systematic review studies patients sarscov including <NUMBER> studies documenting glucocorticoid use found <NUMBER> studies inconclusive regarding role adjunctive use glucocorticoids four studies demonstrated use systemic glucocorticoids patients sars may cause possible harm <NUMBER> prospective randomized doubleblinded placebocontrolled trial compared early hydrocortisone treatment day <NUMBER> illness placebo finding early hydrocortisone therapy associated higher subsequent plasma viral load <NUMBER> meanwhile many possible complications glucocorticoid use profound immunosuppression possible emergence severe commensal viral bacterial infections invasive fungal infections osteonecrosis psychosis may occur prolonged highdose glucocorticoid therapy <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> glucocorticoid therapy also commonly used critically ill patients mers one study hypoxemic patients merscov pneumonia moderate levels positive endexpiratory pressure initiated glucocorticoid therapy <NUMBER> patients difference <NUMBER>day mortality patients associated delayed merscov rna clearance many patients severe mers treated systemic highdose glucocorticoids intending reverse progression respiratory distress prevent lung chinese medical journal <NUMBER>volno wwwcmjorg fibrosis however approach proven successful <NUMBER> one study including total <NUMBER> patients symptomatic merscov found glucocorticoid use associated increased mortality patients <NUMBER> retrospective cohort study compared <NUMBER> patients glucocorticoid group <NUMBER> patients nonglucocorticoid group finding mortality glucocorticoid group similar nonglucocorticoid group glucocorticoid therapy associated delayed merscov rna clearance adjustment baseline timevarying confounding factors <NUMBER> infection <NUMBER>ncov occurs patients develop mild symptoms significant fraction patients progress severe ards require intensive care <NUMBER> <NUMBER> use glucocorticoids patients ards still controversial divergent results existing literature <NUMBER> highdose glucocorticoid one frequently used adjuncts ards <NUMBER> <NUMBER> countries even though effectiveness management acute lung injury yet clear <NUMBER> one systematic review conducted analysis individual patient data randomized trials demonstrated compared placebo group prolonged glucocorticoid treatment improve clinical outcomes <NUMBER> another randomized controlled trial showed glucocorticoid therapy could downregulate ardsrelated inflammation associated significant improvements lung extrapulmonary organ dysfunction well reduce mechanical ventilation duration intensive care unit hospital admission duration <NUMBER> studies meduri et al <NUMBER> <NUMBER> found prolonged methylprednisolone treatment may complement positive modulation systemic inflammation inducing recovery induced glucocorticoid resistance coexisting decreased production endogenous glucocorticoids <NUMBER> <NUMBER> animal experiments recent years provided evidence use glucocorticoids reduce inflammation attenuation acute lung injury reduction mortality acute phase severe disease <NUMBER> <NUMBER> however studies suggested glucocorticoid therapy ards necessary may even aggravate clinical picture use hydrocortisone improves lung function sepsisassociated ards significant survival benefit observed patients <NUMBER> higher mortality rate observed patients ards took highdose glucocorticoids within <NUMBER> days hospital admission compared treated without highdose glucocorticoid <NUMBER> existing studies ards assessed effects glucocorticoids identical types patients identical processes disease <NUMBER> therefore results studies cannot considered congruent adjunctive glucocorticoid therapy specific diseases causing ards pneumocystis jirovecii pneumonia shown reduce mortality adult patients <NUMBER> additionally dosage glucocorticoid used needs factored highdose glucocorticoid therapy may increase ventilator dependence may possibly induce worse outcome <NUMBER> development osteonecrosis discovered patients receiving highdose glucocorticoids sars epidemic <NUMBER> number osteonecrotic lesions directly related dosage glucocorticoid prescribed <NUMBER> <NUMBER> additionally highdose glucocorticoid use one causes neuropsychiatric outcomes patients sars <NUMBER> noted lung injury effectively controlled appropriate doses glucocorticoids based disease severity may beneficial better outcomes sars <NUMBER> <NUMBER> study investigate whether use middose shortcourse adjunctive glucocorticoid therapy treat severe covid<NUMBER> advantageous safe effective work supported chongqing special research project prevention control novel coronavirus pneumonia cstc<NUMBER>jscxfyzx<NUMBER> none severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> novel coronavirus first detected wuhan china causes coronavirus disease <NUMBER> covid <NUMBER> <NUMBER> since initial virus detection <NUMBER> cases covid<NUMBER> confirmed worldwide first reported cases lombardy region northern italy occurring end february <NUMBER> <NUMBER> number cases region continues rise april <NUMBER> <NUMBER> <NUMBER> confirmed sarscov<NUMBER> infections <NUMBER> deaths <NUMBER> least seven relatively largescale case studies china reported clinical features patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data indicate <NUMBER> patients covid<NUMBER> preexisting liver diseases recently grasselli et al reported among first <NUMBER> patients admitted intensive care units icu lombardy due sarscov<NUMBER> infection <NUMBER> history chronic liver disease <NUMBER> patients preexisting cirrhosis might susceptible sarscov<NUMBER> infection systemic immunocompromised status moreover patients severity covid<NUMBER> rate complications potentially leading increased <NUMBER> liverrelated mortality might pronounced general population hypothesis derives studies bacterial infections common cause decompensation patients cirrhosis conversely data impact viral infections less studied population <NUMBER> reported viral influenza may increase risk decompensation cirrhotic patients recently high risk hepatic function deterioration pandemic <NUMBER> h<NUMBER>n<NUMBER> influenza virus even patients stable liver disease reported <NUMBER> study premkumar et al <NUMBER> patients cirrhosis ah<NUMBER>n<NUMBER> died pneumonia acute respiratory distress syndrome despite timely antiviral treatment severity respiratory distress kidney impairment independent predictors mortality <NUMBER> since data covid<NUMBER> patients cirrhosis lacking performed multicenter retrospective study describe demographic clinical biochemical characteristics cirrhotic patients sarscov<NUMBER> infection lombardy region outcomes included cirrhotic patients laboratoryconfirmed sarscov<NUMBER> infection managed nine hospitals lombardy northern italy march <NUMBER> st march <NUMBER> th <NUMBER> therefore information registered <NUMBER> april <NUMBER> datalock entered database confirmed case sarscov<NUMBER> defined positive result reversetranscriptasepolymerasechainreaction rtpcr assay specimen collected nasopharyngeal swab previously described <NUMBER> demographic clinical data including clinical symptoms signs presentation laboratory radiologic results covid<NUMBER> management well administered antiviral therapies antithrombotic prophylaxis collected laboratory tests radiologic assessments performed treating physician discretion data last outpatient clinic visit covid<NUMBER> also collected comparison sarscov<NUMBER> infection occurred hospitalization data covid<NUMBER> diagnosis compared collected hospital admission liver disease meld clifof clifc scores assessed liver injury defined alanine aminotransferase alt level <NUMBER> ul males <NUMBER> ul females patients normal alt levels last outpatient visit <NUMBER> hepatic flare defined alt level ≥<NUMBER> x upper limit normality acute chronic liver failure aclf diagnosis covid<NUMBER> retrospectively defined graded according easlclif definition <NUMBER> coexisting conditions obtained medical records scrutiny causes liver function deterioration included history counter medication use overdiuresis alcohol intake use hepatotoxic medications assess impact sarscov<NUMBER> infection survival hospitalized cirrhotic patients compared survival cohort control group included cirrhotic patients hospitalized last year liver decompensation due bacterial infection two units <NUMBER> involved multicenter study control patients identified discharge database consecutively selected among diagnosed cirrhosis infection ie pneumonia urinary tract infection spontaneous bacterial peritonitis spontaneous bacteraemia data retrieved hospital records compare mortality covid<NUMBER> patients without cirrhosis retrospectively extracted mortality rates due covid<NUMBER> patients without cirrhosis hospitalized foundation irccs ca granda ospedale maggiore policlinico within period finally sarscov<NUMBER>related mortality data general population retrieved regional report italian istituto superiore di sanità iss used benchmark descriptive statistics used summarize data results reported median interquartile range iqr mean standard deviation appropriate categorical variables compared using χ <NUMBER> fishers exact tests continuous variables compared using studentttest mannwhitney utest kruskallwallis test appropriate tests twosided used significance level <NUMBER> survival curves estimated kaplanmeier method cox regression analysis used identify factors associated <NUMBER>day mortality data handling analysis performed using stata software release <NUMBER> stata corporation college station tx sarscov<NUMBER> diagnosis <NUMBER> <NUMBER> patients presented least one symptom <NUMBER> <NUMBER> presented cough <NUMBER> <NUMBER> polypnea shortness breath <NUMBER> <NUMBER> fever <NUMBER> <NUMBER> acute hepatic encephalopathy table <NUMBER> six <NUMBER> patients asymptomatic presentation cases nasopharyngeal swab performed according surveillance protocols ie contact positive subjects finally <NUMBER> <NUMBER> patients hospitalized included <NUMBER> patients already hospitalized reasons <NUMBER> required admission sarscov<NUMBER> infection thirtytwo <NUMBER> patients needed noninvasive respiratory support hospitalization two patients admitted icu received invasive mechanical ventilation table <NUMBER> detail acute respiratory distress syndrome present <NUMBER> <NUMBER> patients mild <NUMBER> mmhg pao<NUMBER>fio<NUMBER> ≤ <NUMBER> mmhg <NUMBER> moderate <NUMBER> mmhg pao<NUMBER>fio<NUMBER> ≤ <NUMBER> mmhg <NUMBER> severe pao<NUMBER>fio<NUMBER> <NUMBER> mmhg <NUMBER> patients moreover <NUMBER> <NUMBER> patients experienced hypotension needed vasopressors overall <NUMBER> <NUMBER> patients received specific antisarscov<NUMBER> treatment <NUMBER> <NUMBER> received hydroxychloroquine alone <NUMBER> <NUMBER> received antiviral therapy lopinavirritonavir <NUMBER> <NUMBER> received antiviral treatment hydroxychloroquine none patients treated tocilizumab remdesivir mild gastrointestinal adverse events reported patients treated hydroxychloroquine whilst one patient showed mild increase alt values one case treated hydroxychloroquine plus lopinavirritonavir prolongation electrocardiographic qt interval occurred leading treatment discontinuation however without sequelae thromboprophylaxis heparin mainly low molecular weight heparin lmwh started covid<NUMBER> diagnosis <NUMBER> patients two minor haemorrhagic events epistaxis haematuria still hospitalized median stay length datalock <NUMBER> <NUMBER> days compared last outpatient visit median timelapse <NUMBER> <NUMBER> months blood tests performed admission sarscov<NUMBER> infection parameters changed time covid<NUMBER> diagnosis bilirubin inr alt creatinine p<NUMBER> significantly increased p<NUMBER> p<NUMBER> p<NUMBER> respectively whilst albumin levels significantly decreased p<NUMBER> thus influencing cpt meld scores table <NUMBER> distribution cpt scores significantly changed p<NUMBER> table <NUMBER> <NUMBER>day cumulative probability overall mortality <NUMBER> <NUMBER> confidence interval ci <NUMBER> figure <NUMBER>a corresponding features covid<NUMBER>and liverrelated mortality <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively figure <NUMBER>b predictors mortality reported table <NUMBER> multivariate analysis clifof hr <NUMBER> <NUMBER>ci <NUMBER> p≤<NUMBER> moderatesevere lung failure hr <NUMBER> <NUMBER>ci <NUMBER> p<NUMBER> independently predicted mortality clifc introduced meld clifc moderatesevere respiratory failure remained independent predictors meld clif independently predicted mortality also analysed dichotomous variables figure <NUMBER>a <NUMBER>b show cumulative probability mortality according meld≥<NUMBER> clifof<NUMBER> diagnosis meld≥<NUMBER> development sarscov<NUMBER> infection occurred <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients meld scores <NUMBER> <NUMBER> <NUMBER> last record sarscov<NUMBER> infection respectively p<NUMBER> table <NUMBER> shows comparison main cohort ie <NUMBER> cirrhotics hospitalized covid<NUMBER> <NUMBER> cirrhotics hospitalized acute liver decompensation due bacterial infection served controls control group bacterial pneumonia diagnosed <NUMBER> <NUMBER> patients spontaneous bacteraemia <NUMBER> <NUMBER> cholangitis <NUMBER> <NUMBER> urinary tract infection <NUMBER> <NUMBER> spontaneous bacterial peritonitis <NUMBER> <NUMBER> patients arthritis one <NUMBER> gastroenteritis due clostridioides difficile one <NUMBER> patients covid<NUMBER> significantly older lower white blood cells counts despite concomitant infection lower meld cpt bc scores however aclf prevalence similar case series clearly demonstrates poor outcome cirrhotic patients either compensated decompensated liver disease develop covid<NUMBER> main causes death respiratory complications also sudden worsening liver function leading endstage liver disease best knowledge first report clinical impact sarscov<NUMBER> infection patients cirrhosis retrospectively collected data <NUMBER> patients known cirrhosis covid<NUMBER> managed nine hospitals lombardy interestingly healthcare related sarscov<NUMBER> infection registered <NUMBER> patients fact could consequence general increased need hospitalization assistance due cirrhosis complications well increased susceptibility infections according italian iss report nosocomial sarscov<NUMBER> infection rate <NUMBER> italy lower observed cohort moreover clinical presentation sarscov<NUMBER> infection cohort cirrhotics slightly differed reported general population indeed fever less frequent <NUMBER> whilst expected increase cirrhosis complications rate observed particularly hepatic encephalopathy study <NUMBER>days mortality rate higher patients moderatesevere respiratory failure deteriorated liver function indicated increased meld clifof scores covid<NUMBER> diagnosis association severity lung failure early mortality expected study first define predictive role clif meld scores setting acute failure chronic liver disease due covid<NUMBER> corresponding <NUMBER>day mortality rate noncirrhotic patients hospitalized following covid<NUMBER> diagnosis significantly lower higher median age deceased patients unfortunately data available role factors ie comorbidities lung failure severity etc potentially influencing mortality rates control group icd<NUMBER> system used data collection period <NUMBER> <NUMBER> <NUMBER> patients sarscov<NUMBER> infection died lombardy median age <NUMBER> years <NUMBER> data significantly differ reported cirrhotic cohort characterized higher mortality rate lower age death otherwise stable cirrhotic patients <NUMBER> cpt patients low meld score experienced rapid deterioration liver function cpt score increased bc covid<NUMBER> diagnosis third even worst patients decompensated disease sarscov<NUMBER> infection since reported high meld scores last visit independently predicted risk meld≥<NUMBER> covid<NUMBER> diagnosis short interval last outpatient visit hospital admission sarscov<NUMBER> diagnosis supports role acute infection worsening liver function common cirrhotic patients aetiology comparative analysis cirrhotic patients hospitalized decompensation due bacterial infections confirmed mortality rate due infections high independently etiological agent however <NUMBER>day mortality covid<NUMBER> cirrhotics higher reported among cirrhotics hospitalized following bacterial infections although meld score lower former group multivariate analysis confirmed covid<NUMBER> together high clifof independently associated <NUMBER>day mortality probably due several factors include unavailability effective treatments sarscov<NUMBER> well impact lung failure early mortality even patients died esld fact also cirrhotic patients died esld respiratory function severely compromised sarscov<NUMBER> since needed respiratory support several papers reported impact sarscov<NUMBER> infection transaminases levels general population although specifically focused clinical significance alterations terms morbidity mortality especially cirrhotic patients <NUMBER> setting chronic liver diseases persistent andor severe alteration transaminases may negatively impact cirrhosis course also patients remained stable free livercomplications long time recently dong et al reported <NUMBER> alt increase <NUMBER> consecutive patients confirmed covid<NUMBER> included <NUMBER> nonalcoholic fatty liver disease nafld interestingly authors reported nafld patients higher likelihood abnormal liver function tests admission discharge <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> p<NUMBER> <NUMBER> study first reporting impact sarscov<NUMBER> infection alt levels patients cirrhosis showing acute liver injury observed nearly half patients previously normal transaminases values moreover hepatitis flare uncommon sarscov<NUMBER> diagnosis however data needed clarify impact alt increase natural history cirrhotic patients sarscov<NUMBER> better explain pathogenic mechanism coronavirus causing liver damage level liver cells potential direct cytopathic effect suggested since abundant ace<NUMBER> receptors liver might favour sarscov<NUMBER> entry hepatocytes <NUMBER> otherwise liver might indirectly involved severe inflammatory response following sarscov<NUMBER> infection contains large number macrophages kupffer cells potent cytokine producer <NUMBER> specific treatment sarscov<NUMBER> standardized cohort rather based upon regional guidelines issued scientific societies expert opinions single physicians decision every patient balance rapidly available repurposed drugs acceptable tolerability safety patients received hydroxychloroquine one third received lopinavirritonavir caveats small sample size one major adverse event reported qt prolongation leading drug discontinuation generally lopinavirritonavir used cautiously patients advanced cirrhosis due known hepatic metabolism possible detrimental effect residual hepatic function time data collection phase ii trial tocilizumab available referral centers thus excluding chance enrol patients cirrhosis period datalock access remdesivir reserved mechanically ventilated patients basis treating physicianinitiated request compassionate use program two intubated patients cohort receive remdesivir reason applying compassionate use two cases unknown could due difficult access programs experimental drugs dramatic hospital emergency faced march <NUMBER> lombardy interestingly patients <NUMBER> cohort received thromboprophylaxis mainly lmwh without evidence major haemorrhagic complications high prevalence thromboprophylaxis cohort might explained established awareness increased thrombotic risk population well ascertained skill antithrombotic management centers dealing cirrhotic patients aware study suffers limitations mainly due retrospective design study include limited number patients short followup following diagnosis sarscov<NUMBER> infection low number patients admitted icus however believe last point might consequence retrospective collection data also effective limited access icus patients severe comorbidities cirrhotics fact study period faced dramatic scarcity bed icus trying cope awesome outbreak sarscov<NUMBER> infection covid<NUMBER> italy another limitation imbalance baseline characteristics age meld patients viral bacterial infection although multivariate analysis confirmed sarscov<NUMBER> infection independent predictor <NUMBER>day mortality hand strengths study involvement tertiary referral centers infectious liver diseases lombardy thus limiting risk underestimating number hospitalized cirrhotics within regionas well availability historical information almost patients inclusion control groups well characterized hospitalized patients cirrhosis acute decompensation following bacterial infection without cirrhosis covid<NUMBER> strengthens present study conclusion current pandemic sarscov<NUMBER> spreading physicians hepatologists aware potential detrimental effects infection shortterm outcome fragile patient population cirrhotics clifof score <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> world currently witnessing dramatic disruption everyday life owing rapid progression coronavirus disease <NUMBER> covid<NUMBER> pandemic pandemic evolves urgent need better understand epidemiology characterize potential impact identify mitigatory strategies avert pandemicrelated mortality need tool algorithm evaluate extent public health policy andor economic preparedness measures effectively averting covid<NUMBER> related mortality present simple yet practical epidemiological tool pandemic efficiency index pei utilized globally test relative efficiency measures put place avert death resulting covid<NUMBER> infection using pei current covid<NUMBER>related mortality determined far germany demonstrates highest pei <NUMBER> <NUMBER> among countries <NUMBER> recorded cases infection indicating high quality measures instituted country avert death pandemic italy france currently lowest covid<NUMBER>related peis epidemics pandemics come go local national global abilities determine efficiency efforts averting deaths critical global ranking covid<NUMBER>related mortality country using novel pandemic efficiency index pei towards end <NUMBER> novel respiratory infection caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported wuhan capital hubei province peoples republic china illness already assigned name coronavirus disease<NUMBER> covid<NUMBER> world health organization <NUMBER> sarscov<NUMBER> belongs family viruses cause variety symptoms range severity mild cold symptoms severe infections disproportionately account high mortality rate among elderly individuals immunocompromised pandemic reached almost every country globe least <NUMBER> countries time writing epidemiological variability lethality covid<NUMBER> general specific populations reported <NUMBER> <NUMBER> world currently witnessing substantial disruption daily lives socially psychologically economically result progression covid<NUMBER> pandemic pandemic rumbles nations leaving behind considerable death damaged economies effective treatment seems sight <NUMBER> preventive measures enveloped public health advocacy individual societal levels reinforced national regulations seem best bet shortening life span pandemic various countries instituted diverse policies laws protect citizens natural history disease progresses however witness differences degree public health preparedness across nations also subdued lack simple epidemiological tools could capture broad terms comparative effectiveness measures put place different countries mitigate impact pandemic human lives paper present simple epidemiological tool could utilized globally test relative efficiency measures put place avert death resulting covid<NUMBER> infection simplicity refer assessment tool pandemic efficiency index pei pei could used potentially rank countries assist distilling best practices countries optimal outcomes pandemic higher pei greater efficiency country protecting citizens death resulting covid<NUMBER> pandemic using pei nations learn adapt best practices pandemic control nations systematically reverseengineer practices countries higher pei used achieve lower covid<NUMBER>related mortality collected information current details covid<NUMBER> cases across globe worldometer <NUMBER> worldometer independent company operates reference website acknowledged american library association one best free online reference sources world website providing live updates covid<NUMBER> related total cases new cases deaths recoveries critical cases country territory conveyance worldometer gathers compiles information various sources including newspapers government websites social media twitter etc countries <NUMBER> cases coronavirus march <NUMBER> <NUMBER> included study classified high impact countries calculated mortality rate dividing total deaths total number cases associated disease high impact territory disease originated china used chinas mortality rate reference formula covid<NUMBER> pandemic efficiency index pei country x global ranking highimpact countries based covid <NUMBER> pei illustrated figure <NUMBER> germany country fifth largest number cases <NUMBER> far experienced <NUMBER> deaths resulting covid<NUMBER> infection highest pei <NUMBER> among high impact countries austria <NUMBER> cases second highest pei <NUMBER> followed canada <NUMBER> turkey <NUMBER> usa <NUMBER> th list pei <NUMBER> italy france countries lowest pei <NUMBER> <NUMBER> respectively covid<NUMBER> latest global health threat confronting nations research medical communities national global efforts applauded criticized <NUMBER> almost <NUMBER> months first confirmed case virus identified china declared disease pandemic making first declaration since <NUMBER> h<NUMBER>n<NUMBER> swine flu outbreak estimated covid<NUMBER> mortality rate <NUMBER> three weeks ago <NUMBER> however due rapid progression disease differential efficiency disease mortality prevention across affected countries mortality rate risen <NUMBER> march <NUMBER> <NUMBER> covid<NUMBER> deadly <NUMBER> h<NUMBER>n<NUMBER> swine flu pandemic registered case fatality rate <NUMBER> first time since outbreak wuhan china reported new cases march <NUMBER> th <NUMBER> usa acquired status country reporting largest number new covid<NUMBER> infections worldwide according various analyses us centers disease control prevention cdc older adults underlying comorbidities like heart disease lung disease diabetes vulnerable severe forms covid<NUMBER> die disease <NUMBER> results observed citizens countries performed worse pei scale ie low pei italy spain uk etc higher median age counterparts parts world surprising low mortality rate <NUMBER> highest pei <NUMBER> germany spite fact ranks <NUMBER> th world highest median age <NUMBER> austria portugal two countries high pei median age <NUMBER> years pei innovative tool compare countries terms impact disaster preparedness management protocols although covid<NUMBER> global affliction different countries adopted different approaches confronting pandemic pei represents simple intuitive epidemiologic tool compare efficiency policies strategies various countries adopting curtail impact covid<NUMBER> pandemic lessons learned natural experiments would allow us identify effective measures mortality countries high pei due pandemic dynamics numbers constantly changing possible final pei available end current pandemic authors report conflict interest fundingsupport none ethical approval study used publicly available data subject irb approval acknowledgements none ribavirin molecule synthesised first time <NUMBER> also known name virazole <NUMBER>f<NUMBER>dribofuranosyl<NUMBER>triazole<NUMBER>carboxamide pyrimidine nucleoside designed vitro broadspectrum agent first description published journal science <NUMBER> action dna herpes virus <NUMBER> <NUMBER> murine cytomegalovirus vaccine virus adenovirus type <NUMBER> rna viruses rabiesrelated viruses virus responsible myxoma parainfluenza virus types <NUMBER> <NUMBER> influenza b rhinovirus <NUMBER>a <NUMBER> <NUMBER> coxsackie b poliovirus type <NUMBER> vesicular stomatitis virus semliki forest virus detailed work subsequently activity viral diseases determined found place clinical practice almost exclusively treatment hepatitis c virus hcv paper review references pubmed database <NUMBER> december <NUMBER> carried crossing english keyword ribavirin corresponding following viruses diseases adenovirus hantavirus syncytial respiratory virus lassa fever crimeancongo haemorrhagic fever argentinian haemorrhagic fever coronavirus articles written english spanish reviewed preferentially selecting metaanalyses disease event exist phase ii iii iv clinical trials reviewed finally found previous searches review cases case series <NUMBER>x© <NUMBER> elsevier españa slu sociedad española de enfermedades infecciosas microbiología clínica rights reserved published performed cases references works obtained articles reviewed different mechanisms action proposed molecule likely scenario works different ways different viruses <NUMBER> first mechanism suggested interference de novo synthesis guanosine derivatives particular guanosine triphosphate gtp inosine monophosphate dehydrogenase catalyses formation xanthine monophosphate inosine monophosphate subsequently continue synthesis pathway guanosine derivatives ribavirin monophosphate capable competitively potently inhibiting enzyme reducing reserves nucleotides nucleosides half treated cells antiviral activity parallel depletion gtp reserves demonstrated studies yellow fever virus paramyxovirus respiratory syncytial virus rsv secondly immunomodulatory activity suggested indicating ribavirin may increase activity lymphocytes particular th lymphocytes hypothesis based observation treatment ribavirin patients infected hcv could reduce cytolysis without modifying circulating viral load therefore would exclusively antiviral effect observation lenantiomer ribavirin levovirin present direct antiviral activity capable also producing induction th<NUMBER> response murine model supported hypothesis however possible recognise immunomodulatory effect vivo even mathematical models designed concluded effect based direct antiviral activity another mechanism proposed direct inhibition polymerase main intracellular metabolite ribavirin ribavirin triphosphate rtp way could competitive inhibitor similar nitrogenous bases adenosine triphosphate atp gtp effect observed studies conducted influenza virus reovirus vesicular stomatitis virus rna viruses contain structure <NUMBER>methylguanosine essential stability rna synthesised three different catalytic processes viruses translation process measured molecule known eukaryotic translation initiation factor <NUMBER>e eif<NUMBER>e ribavirin molecule could interact enzymes responsible capping rna cap synthesis bind eif<NUMBER>e preventing start translation mechanism could responsible antiviral activity observed viruses lassa fever sars lastly mechanism mutagenesis proposed given structural similarity incorporation ribavirin rna chain would possible would produce mutant viruses replication however would alter original chain replacing gtp rtp also binding complementary bases cytidine thymidine uracil efficacy due spatial arrangement flexibility rotation carboxamide group mutagenic effect ribavirin demonstrated studies poliovirus handfootandmouth disease west nile virus hantavirus mentioned previously clinical use ribavirin almost exclusively limited treatment hcv infection however review performed indications main medicines agencies spanish agency medicines medical devices european medicines agency us food drug administration fda less wellknown approved indications found • drug virazole form vials respiratory inhalation found website spanish agency medicines medical devices <NUMBER> mention specific indication stating drug currently marketed spain supply problems used aerosols children severe lower respiratory tract infection caused rsv treatment consisted nebulisation <NUMBER> h period three seven days • european medicines agencys website <NUMBER> two applications ribavirin investigated apart indication hcv also found adenovirus infections hantavirus infections cases decided withdraw consideration indications • finally approval virazole nebulisation indicated fdas website <NUMBER> although conditions specified review clinical evidence effectiveness ribavirin treating infections caused rsv adenovirus hantavirus metaanalysis carried cochrane database systematic reviews <NUMBER> relation use ribavirin lower respiratory tract infections children adolescents two subsequent updates one withdrawn <NUMBER> latest review therefore one published <NUMBER> review analysing <NUMBER> clinical trials conclusion reached ribavirin effective reducing mortality development respiratory deterioration however reduction hospital stay number days mechanical ventilation approximately two days cases observed another different aspect use ribavirin transplant recipients treatment respiratory infections caused rsv shah chemaly <NUMBER> carried review literature regarding works performed adult transplant recipients rsv infection published <NUMBER> <NUMBER> evaluated <NUMBER> studies prospective retrospective randomised observational clinical trials main variable mortality attributed rsv disease progression use ribavirin form aerosolised oral intravenous appeared works overall conclusion use ribavirin whether associated immunoglobulins reduced progression disease lower respiratory tracts reduced mortality inhaled ribavirin useful especially effective associated immunoglobulin although diffusion consolidated parenchyma could reduced cost main drawback therapy approximately <NUMBER> per patient firstly must pointed published literature reviewed <NUMBER> articles pubmed metaanalyses clinical trials scientific evidence available case series isolated cases seven published case series <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> isolated cases accounts total published experience less <NUMBER> cases tables <NUMBER> <NUMBER> observed heterogeneity regarding virus treated serotypes characteristics patients age gender risk factors syndromes produced pneumonia cystitis digestive disease focaldisseminated disease disease progression time combination drugs etc therefore conclusion cannot obtained reason use approved date regarding use ribavirin diseases caused hantavirus metaanalysis published <NUMBER> moreli et al <NUMBER> worthy indepth review systematic review <NUMBER> studies identified applying exclusion criteria seven studies analysed accounts total <NUMBER> patients two groups haemorrhagic fever renal syndrome hantavirus pulmonary syndrome addition two subgroups studies conducted animals <NUMBER> humans <NUMBER> distinguished overall mortality <NUMBER> hantavirus pulmonary syndrome group randomised study three prospective cohorts identified animal studies reduction mortality observed treatment group versus placebo studies humans mortality rate groups <NUMBER> haemorrhagic fever renal syndrome group three studies included reduction mortality observed ribavirin used compared placebo <NUMBER> versus <NUMBER> mortality relative risk rr <NUMBER> <NUMBER> animal human subgroups existing data metaanalysis could suggested old world hantavirus infections haemorrhagic fever renal syndrome could benefit use ribavirin whereas would useful hantavirus pulmonary syndrome authors state able consider time diagnosis administration ribavirin hantavirus pulmonary syndrome mortality rate <NUMBER> may indicate rapid progression disease haemorrhagic fever renal syndrome mortality rate <NUMBER> would key factor indicating greater need start therapy early stage another bias may restriction works selected according language works published english spanish portuguese selected given china cases hantavirus haemorrhagic fever period <NUMBER> <NUMBER> total <NUMBER> cases haemorrhagic fever renal syndrome reported clear tendency reduce incidence possible priori information published chinese eliminated would modify results obtained lastly must taken account list hantaviruses extensive <NUMBER> including hantaan seoul puumala dobrava viruses haemorrhagic fever renal syndrome sin nombre andes viruses hantavirus pulmonary syndrome heterogeneity viruses syndromes may determine results may indicated recent study conducted evaluate efficacy safety ribavirin treatment haemorrhagic fever renal syndrome caused puumala virus benefit use ribavirin <NUMBER> open randomised study <NUMBER> patients <NUMBER> received standard support therapy <NUMBER> therapy addition intravenous ribavirin study able demonstrate efficacy clinical aspects viral kinetics treatment important side effects mainly anaemia hyperbilirubinaemia sinus bradycardia skin rash review performed treatment lassa fever ribavirin <NUMBER> publications obtained however clinical trials metaanalyses evaluated one reference relation effectiveness treatment found <NUMBER> study conducted sierra leone <NUMBER> ministry health collaboration centers disease control prevention also comorbidities splenectomy pancreatectomy mycobacterium aviumintracellulare infection c death due colon adenocarcinoma cases disease due merscov treated interferon ribavirin regimen <NUMBER> mg loading dose <NUMBER> mg<NUMBER> h <NUMBER> days <NUMBER> mg<NUMBER> h <NUMBER> days regimen b loading dose <NUMBER> mg <NUMBER> mg subsequently <NUMBER> mg<NUMBER> h doses lopinavirritonavir <NUMBER> mg<NUMBER> h administered orally regimen c loading dose <NUMBER> mg <NUMBER> mg<NUMBER> h orally cdc started <NUMBER> administration convalescent plasma oral ribavirin intravenous ribavirin evaluated study rather complex however despite fact concluded treatment intravenous oral ribavirin recommended time disease effective first six days disease initially phase casecontrol study clinical diagnostic aspects lassa fever untreated patients designed <NUMBER> clinical laboratory variables collected analysed subsequently variables collected randomised trial conducted <NUMBER> patients <NUMBER> oral ribavirin <NUMBER> plasma pregnant women included without randomised latter group without knowing time results analysis variables collected cases treatment started first <NUMBER> h subsequently elevation transaminases viraemia greater <NUMBER> copiesml identified poor prognosis variables later stage variables indicating poor prognosis determined phase ii study developed selecting patients one poor prognosis variables elevation transaminases upon diagnosis viraemia available two groups patients <NUMBER> patients intravenous ribavirin group <NUMBER> intravenous ribavirin plus plasma group randomised pregnant women received two plasma units overall treatment ribavirin reduced mortality included analysis patients included phase study phase ii study patients viraemia <NUMBER> copiesml treated ribavirin mortality lower receiving treatment mortality intravenous ribavirin <NUMBER> versus <NUMBER> without therapy p <NUMBER> mortality oral ribavirin <NUMBER> versus <NUMBER> without therapy p <NUMBER> occurred viraemia <NUMBER> copiesml mortality intravenous ribavirin <NUMBER> versus <NUMBER> without therapy p <NUMBER> mortality oral ribavirin <NUMBER> versus <NUMBER> without therapy p <NUMBER> second study conducted fisherhoch et al <NUMBER> appears pubmed clinical trial regarding use ribavirin lassa fever although true refers use clinical trial describes onset adverse effect associated recovery shiveringchills seems related speed administration drug <NUMBER> min side effects disappeared correcting speed infusion studies conducted evaluate ribavirin postexposure prophylaxis provided conclusive results <NUMBER> <NUMBER> crimeancongo haemorrhagic fever one randomised clinical trial evaluates use ribavirin crimeancongo haemorrhagic fever conducted <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> baseline form differences gender age incubation period around five days clinical analytical characteristics administration ribavirin done confirming diagnosis meaning time administration around four days differences found terms mortality analytical recovery length hospital stay subsequently two metaanalyses evaluated usefulness ribavirin crimeancongo haemorrhagic fever first <NUMBER> <NUMBER> reviews <NUMBER> works conclusion authors draw ribavirin clinical trial superior using ribavirin joint evaluation results mortality reduced rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> participants found difference duration hospital admission second metaanalysis <NUMBER> <NUMBER> also includes randomised clinical trial seven works observational control group introduced benefit ribavirin aggregated data found either metaanalyses underline risk bias works whether selection external validity attrition bias ribavirin managed demonstrate usefulness reduction mortality due junin virus argentine haemorrhagic fever two small clinical trials <NUMBER> <NUMBER> nevertheless first study blocked viral replication delay time death observed compared historical controls clearance viraemia even obtained patients died phase disease virus detected <NUMBER> cases given treatment proven effective administered first seven days disease convalescent serum studies used ribavirin conducted advanced stages disease would justify poor outcomes probably possible conduct new studies regard since also vaccine proven effective reducing incidence disease <NUMBER> practically reported cases machupo virus treated ribavirin bolivian haemorrhagic fever two isolated cases intravenous ribavirin administered recovered <NUMBER> applies cases sabia virus <NUMBER> one case sabia virus treated intravenous ribavirin managing cure patient <NUMBER> one retrospective study conducted <NUMBER> patients coronavirus <NUMBER> compare combination interferon ribavirin versus placebo observing improvement survival <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> days <NUMBER> vs <NUMBER> favour combination table <NUMBER> case series disease due merscov treated ribavirin ifn drugs although difference <NUMBER> days statistically significant probably due small sample size mean treatment initiation time ribavirin three days addition isolated cases <NUMBER> case series <NUMBER> reflect variable degrees therapeutic success tables <NUMBER> <NUMBER> reported new applications ribavirin currently investigated four studies investigate usefulness influenza three arbovirus three hepatitis b three hantavirus two paramyxovirus two coxsackie virus one coronavirus registered ribavirin broadspectrum antiviral currently looking new role treatment various infections availability administration via oral intravenous inhaled route beneficial characteristic evidence benefit rsv infection lassa fever use proposed certain situations disease due hantavirus crimeancongo haemorrhagic fever coronavirus middle east respiratory syndrome coronavirus merscov availability ribavirin oral formulation currently exists spain inhaled intravenous forms must requested spanish agency medicines medical devices early december <NUMBER> outbreak novel coronavirus disease wuhan city rapidly spread throughout china put world alert highthroughput sequencing revealed novel β coronavirus currently named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> resembled severe acute respiratory syndrome coronavirus sarscov <NUMBER> patients covid<NUMBER> mild moderate patients often experienced dyspnea one week severe patients progressed rapidly critical conditions including acute respiratory distress syndrome ards acute respiratory failure coagulopathy septic shock metabolic acidosis early identification risk factors critical conditions urgently warranted identify defining clinical epidemiological characteristics greater precision also facilitated appropriate supportive care promptly access intensive care unit icu necessary chinese health authority announced total number confirmed cases chinese mainland reached <NUMBER> <NUMBER> people died disease feb <NUMBER> among <NUMBER> deceased patients old twothirds males though detailed data reported <NUMBER> raises question men susceptible getting dying covid<NUMBER> reported clinical characteristics recent case series <NUMBER> patients <NUMBER> sarscov<NUMBER> infection treated public data set first <NUMBER> cases died sarscov<NUMBER> wuhan city <NUMBER> survived patients sarscov<NUMBER> six cities high prevalence disease aimed compare severity mortality male female patients covid<NUMBER> explore useful prognostic factor individualized assessment sarscov<NUMBER> infection ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint case series analysis recent case series <NUMBER> patients covid<NUMBER> treated wuhan union hospital medical team beijing tongren hospital january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> respiratory specimens collected local center disease control prevention cdc shipped designated authoritative laboratories detect sarscov<NUMBER> presence sarscov<NUMBER> respiratory specimens detected realtime rtpcr methods rtpcr assay conducted accordance protocol established world health organization public data set first <NUMBER> cases died covid<NUMBER> wuhan city <NUMBER> survived patients covid<NUMBER> six cities high prevalence disease obtained chinese public health science data center case data included basic demographic information classification date symptom onset date diagnosis date hospitalization date discharge date death etc study protocol approved ethics committee beijing tongren hospital capital medical university data expressed mean ± sd median interquartile range iqr percentage appropriate compared differences two groups mean values percentages compared two groups student ttest mannwhitney u test chisquare χ <NUMBER> test kaplanmeier survival curves logrank test used testing survival males females statistical analyses performed using sas software version <NUMBER> p <NUMBER> twotailed considered statistically significant demographic clinical characteristics shown table <NUMBER> median age <NUMBER> years iqr <NUMBER> <NUMBER> fever <NUMBER> cough <NUMBER> common symptoms diarrhea <NUMBER> common <NUMBER> patients least one underlying disorder ie hypertension diabetes cardiovascular diseases chronic lung diseases ages symptoms comorbidities comparable men women expected men higher level hemoglobin however male ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint patients also elevated serum creatinine white blood cells neutrophils among <NUMBER>case series <NUMBER> <NUMBER> diagnosed mild common pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> diagnosed severe critical pneumonia respectively chisquare χ <NUMBER> test trend indicated men tend serious women p<NUMBER> according clinical classification severity figure <NUMBER> deceased patients fever <NUMBER> cough <NUMBER> common diarrhea uncommon <NUMBER> median period symptom onset death <NUMBER> days ranging <NUMBER> <NUMBER> days deceased patients <NUMBER> least one underlying disorder ie hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease table <NUMBER> <NUMBER> hefei city n<NUMBER> respectively cities total <NUMBER> men survived cases however <NUMBER> deceased patients <NUMBER> <NUMBER> men men women susceptibility men prone dying χ <NUMBER> test p<NUMBER> figure <NUMBER>c ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint march <NUMBER> may <NUMBER> <NUMBER> total <NUMBER> patients died sars beijing area reported <NUMBER> hospitals enrolled analysis fever <NUMBER> cough <NUMBER> common symptoms diarrhea <NUMBER> common <NUMBER> patients least one concomitant diseases including hypertension diabetes cardiovascular diseases chronic lung diseases mean duration selfreported symptom death <NUMBER> iqr <NUMBER> days table <NUMBER> summarizes clinical biochemical characteristics sars patients median age deceased patients much higher survived patients <NUMBER> vs <NUMBER> p<NUMBER> rate concomitant diseases deceased patients also higher survived patients <NUMBER> vs <NUMBER> p<NUMBER> deceased patients significantly older survived patients figure <NUMBER>a ages comparable men women deceased survived patients sars figure <NUMBER>b proportion males higher deceased group survived group χ <NUMBER> test p<NUMBER> figure <NUMBER>c survival analysis showed men hazard ratio <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> significantly higher mortality rate women figure <NUMBER>d coronavirus large family viruses cause illness ranging common cold severe pneumonia sars <NUMBER> older age high number comorbidities associated severity ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> wang et al reported compared patients treated icu n<NUMBER> patients treated icu n<NUMBER> older median age <NUMBER> years vs <NUMBER> years <NUMBER> consistent previous reports older patients ≥<NUMBER> years old likely severe type covid<NUMBER> case series patients present study public data set also found percentage older age ≥<NUMBER> years much higher deceased patient survived patients <NUMBER> <NUMBER> deceased patients vs <NUMBER> <NUMBER> survived patients results indicated older age associated high mortality patients first preliminary study investigating gender role morbidity mortality sarscov<NUMBER> infection suggested covid<NUMBER> likely affect older males comorbidities result severe even fatal respiratory diseases ards <NUMBER> among <NUMBER> patients covid<NUMBER> <NUMBER> male indicating males may susceptible sarscov<NUMBER> infection females <NUMBER> <NUMBER> hospitalized patients covid<NUMBER> approximately <NUMBER> ratio male <NUMBER> female patients found <NUMBER> four case series reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> men present study however similar susceptible sarscov<NUMBER> males females observed <NUMBER> survived patients <NUMBER> males collected six cities case series <NUMBER> hospitalized patient <NUMBER> males although deceased patients significantly older survived patients covid<NUMBER> study ages comparable males females deceased survived patients consistent predominance also found proportion male higher deceased group survived group sars patients survival analysis showed men ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint significantly higher mortality rate women sars patients therefore gender risk factor higher severity mortality patients covid<NUMBER> sars independent age susceptibility early <NUMBER> participated beijing municipal medical taskforce sars <NUMBER> reanalyzed data large population <NUMBER> sars patients including <NUMBER> deaths beijing summarized experience lessons present use sarscov<NUMBER> sarscov attack cells via receptor ace<NUMBER> <NUMBER> previously reported high protein expression ace<NUMBER> receptor specific organs correlated specific organ failures indicated corresponding clinical parameters sars patients <NUMBER> interestingly ace<NUMBER> gene located xchromosome shown circulating ace<NUMBER> levels higher men women patients diabetes cardiovascular diseases <NUMBER> therefore male patients may prone die sarscov<NUMBER> high expression ace<NUMBER> though research mechanism needed study limitations first severity analysis case series <NUMBER> patients sarscov<NUMBER> included detailed patient information particularly regarding clinical outcomes unavailable public data set second mortality analysis first <NUMBER>cases died sarscov<NUMBER> wuhan city included however first preliminary data investigating gender role morbidity mortality patients sarscov<NUMBER> clinical basic research regarding gender prognostic factors individualized assessment treatment needed future conclusion older age predominant risk factor severity morbidity ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity chisquare χ <NUMBER> test trend indicated males tend serious females according clinical classification severity including mildcommon severe critical ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity peerreviewed copyright holder preprint httpsdoiorg<NUMBER> doi medrxiv preprint since first reported coronavirus disease <NUMBER> covid <NUMBER> case identified wuhan china <NUMBER> quickly spreads declared public health emergency international concern january <NUMBER> <NUMBER> pandemic march <NUMBER> <NUMBER> world health organization april <NUMBER> <NUMBER> nearly three millions confirmed covid<NUMBER> cases <NUMBER> confirmed deaths globally <NUMBER> much effort put understanding covid<NUMBER> virus infection mechanism developing effective vaccines covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> becomes epidemic us geographic variations number covid<NUMBER> confirmed cases related deaths might due differences epidemiologic populationlevel factors <NUMBER> study population level ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint investigated potential correlations health demographic factors infection mortality rates covid<NUMBER> us counties number confirmed covid<NUMBER> cases related deaths us counties january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> obtained website <NUMBER>point<NUMBER>acrescom outcome variables include infection rate covid<NUMBER> number confirmed cases divided population mortality rate covid<NUMBER> number deaths divided number confirmed cases us county logtransformation infection mortality rates covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint multivariable linear mixed effects models used investigate correlations outcome variables prediction variables correlations counties within state considered compound symmetry variancecovariance structure assumes correlations counties within state covariates controlled final statistical models selected purposeful selection covariates method <NUMBER> coefficient estimates <NUMBER> confidence intervals cis used quantify correlation positive estimate indicates positive correlation negative estimate indicates negative correlation covariates outcome variables pvalue <NUMBER> indicates significance contribution variable statistical models analyses conducted using proc mixed procedure sas v<NUMBER> sas institute inc cary nc among <NUMBER> counties county equivalents united states april <NUMBER> <NUMBER> based website <NUMBER>point<NUMBER>acrescom <NUMBER> us counties reported covid<NUMBER> cases ranging <NUMBER> <NUMBER> cases total confirmed cases <NUMBER> considering difference total population among different counties calculated covid<NUMBER> infection rate number covid<NUMBER> cases divided total population county investigate potential correlation health demographic factors covid<NUMBER> infection rate county level performed multivariable linear mixed effects model table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> covid<NUMBER> infection rates different among us counties covid<NUMBER> mortality rate number covid<NUMBER> related deaths divided number confirmed cases also varied among us counties ranging <NUMBER> <NUMBER> mean <NUMBER> standard deviation ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> examine impact health demographic factors mortality rate covid<NUMBER> us counties multivariable linear mixed effects model performed shown table <NUMBER> results showed number days since first reported case county positively correlated infection rate covid<NUMBER> negatively correlated mortality rate covid<NUMBER> addition infection rate significantly negatively correlated mortality rate covid<NUMBER> one possible explanation could health professionals medical system developed efficient medical practices increase icu beds enhance social distancing treat covid<NUMBER> patients mortality rate decreasing even though infection rate increasing spreading covid<NUMBER> time study showed population density positively correlated infection mortality rates covid<NUMBER> even though estimated coefficients small higher population density social distancing might challenging could contribute higher infection mortality rates covid<NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> <NUMBER> showed population level percentage smokers us counties negative correlated infection rate covid<NUMBER> however several studies showed smoking could worsen health outcomes covid<NUMBER> patients <NUMBER> <NUMBER> requires investigation smoking affects infection mortality covid<NUMBER> careful caution taken interpret results smoking discouraged study showed percentage population <NUMBER> positively correlated mortality rate covid<NUMBER> population level one study covid<NUMBER> patients china countries showed older age group <NUMBER> years significantly higher death rate younger age group <NUMBER> years <NUMBER> centers disease control prevention reported <NUMBER> <NUMBER> deaths us related adults age <NUMBER> one possible reason high death rate elder patients majority elder patients covid<NUMBER> comorbidities respiratory diseases kidney failure heart conditions might contribute fatal ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint outcome even contribution sarscov<NUMBER> therefore seniors need careful avoid covid<NUMBER> infection due high fatality rate shown association influenza vaccination coronavirus <NUMBER> however one study showed influenza vaccine derived virus interference significantly associated coronavirus <NUMBER> showed percentage people vaccination negatively correlated mortality rate covid<NUMBER> considering difference influenza viruses coronaviruses influenza vaccines less likely prevent infections coronavirus study observe significant correlation influenza vaccination infection rate covid<NUMBER> however without influenza vaccination covid<NUMBER> patients might severe symptoms influenza infection might lead higher fatality rate whether influenza vaccines could lead low mortality rate covid<NUMBER> requires investigation statistical model showed percentage rural positively correlated mortality rate covid<NUMBER> moreover counties farmdependent miningdependent high mortality rate covid<NUMBER> one possible explanation could medical systems rural areas well equipped prepared covid<NUMBER> infection finding alarming since rural areas limited medical resources respond pandemic treat covid<NUMBER> patients <NUMBER> additional measures professional health experts wellequipped hospitals taken covid<NUMBER> becomes epidemic rural areas study number confirmed covid<NUMBER> cases deaths <NUMBER>point<NUMBER>acrescom subject errors unreported cases addition examined correlation health demographic factors infection mortality rates covid<NUMBER> population level therefore causal relationship could ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint infection rapidly spread worldwide becoming pandemic weeks probably large amount international air travel many mass public gatherings lack appropriate precautions doubt one greatest worst pandemics human history alert promotion changes lifestyles information initial hospitalized patients china suggested older age comorbidities associated severe disease mortality addition men covid<NUMBER> severe disease higher mortality rate women <NUMBER> <NUMBER> <NUMBER> xie et al <NUMBER> reported <NUMBER> chinese patients died acute phase disease <NUMBER> men median age <NUMBER> interquartile range <NUMBER> <NUMBER> <NUMBER> older <NUMBER> years <NUMBER> one comorbidities guan et al <NUMBER> also reported data <NUMBER> laboratoryconfirmed covid<NUMBER> patients <NUMBER> hospitals <NUMBER> chinese provinces january <NUMBER> total <NUMBER> women severe disease older median <NUMBER> years without severe disease presence coexisting illness also common among severe disease opposed nonsevere disease <NUMBER> vs <NUMBER> systematic review rozenberg et al <NUMBER> suggested higher mortality risk men women authors also reviewed different factors associated covid<NUMBER>related fatalities zhu et al <NUMBER> metaanalysis summarizes relevant aspects new disease among chinese people reported males accounted <NUMBER> deaths past months several reports highlighting fact mortality higher men women england wales germany <NUMBER> hence objective present study examine mortality risk gender europe different similar china pubmed search strategy performed using following terms covid<NUMBER> sars europe mortality gender yielded <NUMBER> publications however information regarding specific topic terms comparing fatalities gender different european countries addition preprint medrxiv <NUMBER> biorxiv <NUMBER> repository servers scientific research searched may <NUMBER> <NUMBER> search also performed j u r n l p r e p r f google may <NUMBER> <NUMBER> using strategy rendering list <NUMBER> items sites relevant information first <NUMBER> items reported consulted information matter targeted issue mortality gender differences patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> procedure previously validated obtain relevant medical information google <NUMBER> remaining web links initial <NUMBER> top google references report different specific information regarding covid<NUMBER> mortality gender european countries source information mortality related covid<NUMBER> gender european countries global health <NUMBER> repository <NUMBER> extracted public information accumulated may <NUMBER> <NUMBER> data repository related mortality country gender global health <NUMBER> nonprofit organization highlights gender health inequalities currently studying along cable news network <NUMBER> influence gender evolution covid<NUMBER> present analysis extracted information reported online country <NUMBER> may <NUMBER> <NUMBER> corresponding national authorities results eligible information mortality number cases separately reported gender european countries two researchers independently evaluated study eligibility discrepancies study selection process discussed resolved author consensus primary outcome mortality due covid<NUMBER> affecting men women separately reported gender outcomes available definitions case inclusion based national standards time country report extracted data included country total number covid<NUMBER> cases total number related deaths indicators gender reported corresponding national authorities variables available extraction country excluded metaanalyzed countries presented figure <NUMBER> randomeffect models inverse variance method used metaanalyses effects reported risk ratios rrs cases mortality country gender divided covid<NUMBER> infected cases gender corresponding <NUMBER> confidence intervals cis p value <NUMBER> chi <NUMBER> test used define heterogeneity tau <NUMBER> value <NUMBER> defined presence substantial statistical heterogeneity <NUMBER> value <NUMBER> defined low heterogeneity <NUMBER> moderate heterogeneity <NUMBER> substantial heterogeneity <NUMBER> explore reasons heterogeneity predefined subgroup analyses excluding countries reporting fewer <NUMBER> fewer <NUMBER> cases publication bias assessed since one single source information although included <NUMBER> countries statistical analyses conducted using review manager revman <NUMBER> cochrane collaboration oxford uk twentythree countries reported extractable data required predefined information giving total <NUMBER> men <NUMBER> women positive covid<NUMBER> metaanalysis gender indicates men significantly higher risk covid<NUMBER>related death women rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> tau <NUMBER> <NUMBER> df <NUMBER> p <NUMBER> figure <NUMBER> gender mortality trend similar countries fewer <NUMBER> cases rr <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> women <NUMBER> men <NUMBER> <NUMBER> fewer <NUMBER> cases excluded rr <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> women <NUMBER> men since one source information high risk bias sensitivity analyses performed omitting country one one order evaluate stability results <NUMBER> still <NUMBER> present analysis information global health <NUMBER> demonstrates men vulnerable covid<NUMBER> women terms mortality effect persists even countries reporting fewer cases excluded analysis results suggest mortality risk significantly higher men women suggested results china <NUMBER> finding seems apply regardless individual baseline health characteristics social economic healthcare systems indeed although studied endpoint covid<NUMBER> deaths analyzed countries sample heterogeneous terms local clinical facilities political orientations structure healthcare organizations instance european countries recommend j u r n l p r e p r f confinement measures eg sweden others applied confinement lockdown late eg spain <NUMBER> although exact information seems impact covid<NUMBER> crisis focused countries general vulnerable segments population elders comorbid conditions living residentials elderly perhaps younger individuals prioritized access intensive care units information currently available require appropriate detailed analysis order identify health disparities especially relation populations paid healthcare cover despite limitations metaanalysis suggests causes inherent gender determine higher mortality rate males females differences observed among several asiatic countries terms covid<NUMBER> prevalence related mortality <NUMBER> situation suggests social healthcare differences ii heterogeneity outcomes including prevalence mortality iii factors related social organizations political interventions <NUMBER> europe healthcare policies social recommendations applied corresponding national authorities also diverse heterogeneous sense one mention application confinement measures eg applied early others applied later late never applied <NUMBER> current research shows poor prognosis covid<NUMBER> related factors gender male age <NUMBER> years underlying diseases hypertension diabetes cardiovascular disease secondary acute respiratory distress syndrome ards among others <NUMBER> <NUMBER> one narrative review underlined differences related gender diagnosis prognosis mortality rates among covid<NUMBER> patients <NUMBER> results mathematically analyzed sense metaanalyzed found significant gender difference covid<NUMBER> related deaths among europeans several limitations related available data mortality associated covid<NUMBER> pandemic present time scientific reports compare mortality rate gender european countries results reported heterogeneous manner different european countries analyzed data global health <NUMBER> include limitation current total number covid<NUMBER>related deaths likely higher number confirmed deaths suggest different reasons underrecording likely result limited testing capacity problems attribution cause death j u r n l p r e p r f ii recorded covid<NUMBER>related death registries may differ countries eg may count hospital deaths whilst started include deaths home deaths residential settings elderly iii countries delay reporting covid<NUMBER>related deaths hence data always date iv available information gender include age may confounding factor current metaanalysis despite aforementioned limitations best knowledge global health <NUMBER> current source european information reporting gender despite mentioned limitations analysis strengths indeed based potential covid<NUMBER>related outcome requires reporting death relation number cases stratified gender european countries supposedly obligation report health outcomes supranational organisations current analysis allows conclusion drawn men living europe significantly higher risk covid<NUMBER>related death however detailed information urgently needed examine factors involved covid<NUMBER> mortality including age basal health status comorbidity lifestyle sense unfortunately european centre disease prevention control <NUMBER> agency charge information supranational level report aforementioned covid<NUMBER>related information urgent need situation improved conclusion last months mortality rate related covid<NUMBER> pandemic significantly higher european males european females causes mechanisms circumstances difference identifiable available evidence supranational health authorities design appropriate strategies overcome lack accurate information faustino r pérezlópez conceived designed supervised drafted article extracted data global health <NUMBER> repository calculated outcomes interest mauricio tajada contributed searches pubmed google preprint repositories ricardo saviróncornudella contributed searches pubmed google preprint repositories 